country,term,count
DZ,CHOLANGITIS SCLEROSING,4
DZ,VERTIGO,3
DZ,DYSPNOEA,2
DZ,HEADACHE,2
DZ,LOSS OF CONSCIOUSNESS,2
DZ,LYMPHADENOPATHY,2
DZ,PULMONARY EMBOLISM,2
DZ,THROMBOPHLEBITIS,2
DZ,ACUTE GRAFT VERSUS HOST DISEASE,1
DZ,ALOPECIA,1
DZ,ANAEMIA,1
DZ,ASTHENIA,1
DZ,BALANCE DISORDER,1
DZ,BIOPSY LYMPH GLAND ABNORMAL,1
DZ,BLOOD TRIGLYCERIDES INCREASED,1
DZ,BREAST NEOPLASM,1
DZ,C-REACTIVE PROTEIN INCREASED,1
DZ,CELLULITIS,1
DZ,CHEST DISCOMFORT,1
DZ,CHEST PAIN,1
DZ,CHILLS,1
DZ,COUGH,1
DZ,DEATH,1
DZ,DIARRHOEA,1
DZ,DISEASE RECURRENCE,1
DZ,ENCEPHALITIS,1
DZ,ENDOMETRIAL ADENOCARCINOMA,1
DZ,FATIGUE,1
DZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
DZ,GRAFT VERSUS HOST DISEASE,1
DZ,HAEMATOTOXICITY,1
DZ,HEPATOTOXICITY,1
DZ,HIGH DENSITY LIPOPROTEIN DECREASED,1
DZ,HUNGER,1
DZ,HYPERGLYCAEMIA,1
DZ,HYPERSENSITIVITY,1
DZ,HYPERTENSION,1
DZ,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
DZ,INCREASED APPETITE,1
DZ,INFUSION RELATED REACTION,1
DZ,JOINT SWELLING,1
DZ,LICHENIFICATION,1
DZ,LYMPH NODE TUBERCULOSIS,1
DZ,METRORRHAGIA,1
DZ,MYALGIA,1
DZ,MYOCLONIC EPILEPSY,1
DZ,NAUSEA,1
DZ,NEUTROPENIA,1
DZ,NYSTAGMUS,1
DZ,OEDEMA,1
DZ,OPTIC NEUROPATHY,1
DZ,ORTHOSTATIC HYPOTENSION,1
DZ,PAPILLOEDEMA,1
DZ,PARANEOPLASTIC SYNDROME,1
DZ,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
DZ,PULMONARY FIBROSIS,1
DZ,PULMONARY TUBERCULOSIS,1
DZ,PUPILLARY DEFORMITY,1
DZ,PURPURA,1
DZ,PYREXIA,1
DZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
DZ,RENAL FAILURE,1
DZ,RENAL FUNCTION TEST ABNORMAL,1
DZ,RETINAL HAEMORRHAGE,1
DZ,RHINORRHOEA,1
DZ,SKIN LESION,1
DZ,TACHYCARDIA,1
DZ,TACHYPNOEA,1
DZ,THROMBOCYTOPENIA,1
DZ,TREMOR,1
DZ,TUBERCULOSIS,1
DZ,VASCULITIS,1
DZ,VISUAL ACUITY REDUCED,1
DZ,VISUAL IMPAIRMENT,1
DZ,VOMITING,1
DZ,WEIGHT INCREASED,1
DZ,WHITE BLOOD CELL COUNT INCREASED,1
AR,PAIN,85
AR,RHEUMATOID ARTHRITIS,45
AR,PAIN IN EXTREMITY,35
AR,PYREXIA,34
AR,DRUG INEFFECTIVE,33
AR,ARTHRALGIA,31
AR,PNEUMONIA,30
AR,ARTHROPATHY,27
AR,GAIT DISTURBANCE,27
AR,FALL,26
AR,DECREASED IMMUNE RESPONSIVENESS,24
AR,MALAISE,23
AR,ABASIA,22
AR,ARTHRITIS,21
AR,URINARY TRACT INFECTION,20
AR,ANAEMIA,17
AR,CONDITION AGGRAVATED,17
AR,COUGH,17
AR,INFLUENZA,16
AR,HEADACHE,15
AR,FATIGUE,14
AR,INFECTION,13
AR,JOINT SWELLING,13
AR,LUNG DISORDER,13
AR,CELLULITIS,12
AR,DYSPNOEA,12
AR,PHARYNGITIS,12
AR,PULMONARY FIBROSIS,12
AR,BACK PAIN,11
AR,CARDIAC FAILURE,11
AR,CHOLELITHIASIS,11
AR,ASTHENIA,10
AR,DIABETES MELLITUS,10
AR,HYPERSENSITIVITY,10
AR,INFLAMMATION,10
AR,LIVER DISORDER,10
AR,OSTEOARTHRITIS,10
AR,PNEUMONITIS,10
AR,PSORIASIS,10
AR,PSORIATIC ARTHROPATHY,10
AR,DIARRHOEA,9
AR,DIZZINESS,9
AR,FOOT DEFORMITY,9
AR,PULMONARY MASS,9
AR,LOCAL SWELLING,8
AR,MOBILITY DECREASED,8
AR,NASOPHARYNGITIS,8
AR,RASH,8
AR,SWELLING,8
AR,CARDIAC DISORDER,7
AR,DEATH,7
AR,DEPRESSION,7
AR,IMMUNOSUPPRESSION,7
AR,INJECTION SITE PAIN,7
AR,JOINT DISLOCATION,7
AR,MYOCARDIAL INFARCTION,7
AR,NERVOUSNESS,7
AR,NODULE,7
AR,OSTEOPOROSIS,7
AR,PERIPHERAL SWELLING,7
AR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,7
AR,RENAL FAILURE,7
AR,SOMNOLENCE,7
AR,SYSTEMIC LUPUS ERYTHEMATOSUS,7
AR,VIRAL INFECTION,7
AR,WEIGHT DECREASED,7
AR,ARRHYTHMIA,6
AR,BRONCHITIS,6
AR,CEREBROVASCULAR ACCIDENT,6
AR,DRUG INTOLERANCE,6
AR,FUNGAL INFECTION,6
AR,GASTRITIS,6
AR,HYPERTENSION,6
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
AR,LIMB INJURY,6
AR,LOSS OF CONSCIOUSNESS,6
AR,SPINAL DISORDER,6
AR,VISUAL ACUITY REDUCED,6
AR,VOMITING,6
AR,WHITE BLOOD CELL COUNT INCREASED,6
AR,ABORTION SPONTANEOUS,5
AR,AGITATION,5
AR,BLINDNESS,5
AR,BONE PAIN,5
AR,BREAST CANCER,5
AR,BRONCHIECTASIS,5
AR,CARDIO-RESPIRATORY ARREST,5
AR,CATARACT,5
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
AR,DEVICE DISLOCATION,5
AR,DEVICE RELATED INFECTION,5
AR,DISEASE PROGRESSION,5
AR,EMPHYSEMA,5
AR,EXPOSURE DURING PREGNANCY,5
AR,FEELING ABNORMAL,5
AR,GASTROINTESTINAL DISORDER,5
AR,GLAUCOMA,5
AR,HAND DEFORMITY,5
AR,HEPATITIS,5
AR,HERPES ZOSTER,5
AR,HIP FRACTURE,5
AR,JOINT EFFUSION,5
AR,LUNG INFILTRATION,5
AR,MUCOSAL INFLAMMATION,5
AR,MUSCULAR WEAKNESS,5
AR,MUSCULOSKELETAL PAIN,5
AR,NEUROPATHY PERIPHERAL,5
AR,OEDEMA PERIPHERAL,5
AR,OSTEOMYELITIS,5
AR,PARAESTHESIA,5
AR,STOMATITIS,5
AR,THYROID DISORDER,5
AR,TUBERCULOSIS,5
AR,URTICARIA,5
AR,UVEITIS,5
AR,VISUAL IMPAIRMENT,5
AR,WRIST FRACTURE,5
AR,ABDOMINAL DISCOMFORT,4
AR,ABDOMINAL PAIN UPPER,4
AR,ACNE,4
AR,ACUTE MYOCARDIAL INFARCTION,4
AR,ASTHMA,4
AR,BACTERIAL INFECTION,4
AR,BONE DISORDER,4
AR,BONE MARROW FAILURE,4
AR,BRONCHOSPASM,4
AR,CYST,4
AR,DRUG-INDUCED LIVER INJURY,4
AR,DRY EYE,4
AR,DYSPHONIA,4
AR,EAR PAIN,4
AR,ERYTHEMA,4
AR,FEBRILE NEUTROPENIA,4
AR,FINGER DEFORMITY,4
AR,GENERAL PHYSICAL HEALTH DETERIORATION,4
AR,HAEMORRHAGE,4
AR,HEPATOTOXICITY,4
AR,HYPOTENSION,4
AR,INTERVERTEBRAL DISCITIS,4
AR,LUNG INFECTION,4
AR,LYMPHADENOPATHY,4
AR,MENTAL DISORDER,4
AR,MIGRAINE,4
AR,NEUTROPENIA,4
AR,OROPHARYNGEAL PAIN,4
AR,PANCREATITIS,4
AR,PERICARDIAL EFFUSION,4
AR,RED BLOOD CELL COUNT INCREASED,4
AR,RESPIRATORY DISORDER,4
AR,SCIATICA,4
AR,SEPTIC SHOCK,4
AR,STRESS,4
AR,SYNOVIAL CYST,4
AR,THROMBOSIS,4
AR,TONSILLITIS,4
AR,TOXICITY TO VARIOUS AGENTS,4
AR,WEIGHT INCREASED,4
AR,WHITE BLOOD CELL COUNT DECREASED,4
AR,ABDOMINAL PAIN,3
AR,ALOPECIA,3
AR,ANXIETY,3
AR,APPLICATION SITE PAIN,3
AR,ASCITES,3
AR,BALANCE DISORDER,3
AR,BLINDNESS UNILATERAL,3
AR,BLOOD CREATININE INCREASED,3
AR,BLOOD DISORDER,3
AR,BLOOD PRESSURE ABNORMAL,3
AR,BONE DEFORMITY,3
AR,CENTRAL NERVOUS SYSTEM LESION,3
AR,CHEST PAIN,3
AR,COLITIS,3
AR,DEEP VEIN THROMBOSIS,3
AR,DEFORMITY,3
AR,DISCOMFORT,3
AR,DISEASE RECURRENCE,3
AR,DRUG EFFECT DECREASED,3
AR,DRUG HYPERSENSITIVITY,3
AR,FEMUR FRACTURE,3
AR,FOETAL GROWTH RESTRICTION,3
AR,GALLBLADDER DISORDER,3
AR,GASTRIC DISORDER,3
AR,GASTROENTERITIS,3
AR,GRANULOMA,3
AR,HAEMATOMA,3
AR,HAEMATOTOXICITY,3
AR,HAEMOPTYSIS,3
AR,HEPATIC CIRRHOSIS,3
AR,HEPATIC ENZYME INCREASED,3
AR,HEPATIC PAIN,3
AR,HIATUS HERNIA,3
AR,IMPAIRED HEALING,3
AR,INFARCTION,3
AR,INFLAMMATORY BOWEL DISEASE,3
AR,INTERVERTEBRAL DISC PROTRUSION,3
AR,JOINT INJURY,3
AR,KIDNEY INFECTION,3
AR,LABORATORY TEST ABNORMAL,3
AR,LEUKOPENIA,3
AR,LOW BIRTH WEIGHT BABY,3
AR,MENISCUS INJURY,3
AR,MULTI-ORGAN FAILURE,3
AR,MUSCLE CONTRACTURE,3
AR,MUSCLE RIGIDITY,3
AR,MUSCULOSKELETAL DISORDER,3
AR,MUSCULOSKELETAL STIFFNESS,3
AR,NECK PAIN,3
AR,NEOPLASM,3
AR,NEPHROLITHIASIS,3
AR,NEPHROPATHY TOXIC,3
AR,NUCHAL RIGIDITY,3
AR,OCULAR HYPERAEMIA,3
AR,OSTEONECROSIS,3
AR,OVERDOSE,3
AR,OVERWEIGHT,3
AR,PANCYTOPENIA,3
AR,PHOTOSENSITIVITY REACTION,3
AR,PREMATURE BABY,3
AR,PRODUCT USE ISSUE,3
AR,RED BLOOD CELL COUNT DECREASED,3
AR,RENAL DISORDER,3
AR,RENAL PAIN,3
AR,SEPSIS,3
AR,SKIN DISORDER,3
AR,SKIN ULCER,3
AR,SPEECH DISORDER,3
AR,SYNCOPE,3
AR,TOOTH DISORDER,3
AR,TREMOR,3
AR,UPPER LIMB FRACTURE,3
AR,ABDOMINAL DISTENSION,2
AR,ABSCESS LIMB,2
AR,ACCIDENTAL OVERDOSE,2
AR,ADENOMA BENIGN,2
AR,ALANINE AMINOTRANSFERASE INCREASED,2
AR,AMNESIA,2
AR,ANAPHYLACTIC REACTION,2
AR,ANGER,2
AR,ANGINA PECTORIS,2
AR,ANGIOEDEMA,2
AR,ANKYLOSING SPONDYLITIS,2
AR,ANTINUCLEAR ANTIBODY POSITIVE,2
AR,APHASIA,2
AR,ARTHROPOD BITE,2
AR,ASPARTATE AMINOTRANSFERASE INCREASED,2
AR,ASPERGILLUS INFECTION,2
AR,ATRIOVENTRICULAR BLOCK,2
AR,BARTHOLINITIS,2
AR,BASAL CELL CARCINOMA,2
AR,BEDRIDDEN,2
AR,BILIARY TRACT DISORDER,2
AR,BLISTER,2
AR,BLOOD CHOLESTEROL DECREASED,2
AR,BLOOD ERYTHROPOIETIN INCREASED,2
AR,BLOOD TRIGLYCERIDES DECREASED,2
AR,BLOOD UREA INCREASED,2
AR,BONE MARROW TOXICITY,2
AR,BRAIN OEDEMA,2
AR,BUNION,2
AR,BURSITIS,2
AR,C-REACTIVE PROTEIN DECREASED,2
AR,CARCINOGENICITY,2
AR,CARDIOMEGALY,2
AR,CARDIOMYOPATHY,2
AR,CAROTID ARTERY OCCLUSION,2
AR,CATARRH,2
AR,CEREBRAL ASPERGILLOSIS,2
AR,CERVIX DISORDER,2
AR,CHEST DISCOMFORT,2
AR,CHOLECYSTITIS ACUTE,2
AR,CHRONIC GASTRITIS,2
AR,COAGULOPATHY,2
AR,CONGENITAL SKIN DIMPLES,2
AR,CRYING,2
AR,DACRYOSTENOSIS ACQUIRED,2
AR,DEAFNESS UNILATERAL,2
AR,DECREASED APPETITE,2
AR,DEHYDRATION,2
AR,DELAYED FONTANELLE CLOSURE,2
AR,DEMENTIA,2
AR,DEPRESSED MOOD,2
AR,DIVERTICULUM,2
AR,DIVERTICULUM INTESTINAL,2
AR,DRUG ADMINISTRATION ERROR,2
AR,DRUG EFFECT INCOMPLETE,2
AR,DYSSTASIA,2
AR,EMOTIONAL DISORDER,2
AR,EPILEPSY,2
AR,ERYSIPELAS,2
AR,EYE ALLERGY,2
AR,EYE DISORDER,2
AR,EYE PAIN,2
AR,FEELING COLD,2
AR,FIBROMYALGIA,2
AR,FIBULA FRACTURE,2
AR,FLUID RETENTION,2
AR,FOETAL DEATH,2
AR,FURUNCLE,2
AR,GASTRIC HAEMORRHAGE,2
AR,GASTRIC ULCER,2
AR,GASTROINTESTINAL HAEMORRHAGE,2
AR,GASTROINTESTINAL INFECTION,2
AR,HEAT STROKE,2
AR,HEPATOMEGALY,2
AR,HERNIA,2
AR,HIGH ARCHED PALATE,2
AR,HISTIOCYTOSIS HAEMATOPHAGIC,2
AR,HISTOPLASMOSIS,2
AR,HUMERUS FRACTURE,2
AR,HYPERGLYCAEMIA,2
AR,HYPERKERATOSIS,2
AR,HYPOAESTHESIA,2
AR,HYPOTHERMIA,2
AR,INFUSION RELATED REACTION,2
AR,INJECTION SITE HAEMATOMA,2
AR,INJECTION SITE MASS,2
AR,INJECTION SITE URTICARIA,2
AR,INSOMNIA,2
AR,ISCHAEMIC STROKE,2
AR,JOINT RANGE OF MOTION DECREASED,2
AR,LARYNGEAL OEDEMA,2
AR,LIVER INJURY,2
AR,LOCALISED INFECTION,2
AR,LOW SET EARS,2
AR,LUPUS-LIKE SYNDROME,2
AR,MATERNAL EXPOSURE DURING PREGNANCY,2
AR,MEDICATION ERROR,2
AR,MICROCEPHALY,2
AR,MOTOR DYSFUNCTION,2
AR,MOVEMENT DISORDER,2
AR,MULTI-ORGAN DISORDER,2
AR,MULTIPLE CONGENITAL ABNORMALITIES,2
AR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AR,NERVOUS SYSTEM DISORDER,2
AR,OEDEMA,2
AR,ORAL DISORDER,2
AR,PALPITATIONS,2
AR,PERITONITIS,2
AR,PHARYNGEAL ERYTHEMA,2
AR,PLATELET COUNT DECREASED,2
AR,PLEURAL EFFUSION,2
AR,PLEURISY,2
AR,POLYNEUROPATHY,2
AR,POST PROCEDURAL INFECTION,2
AR,POSTOPERATIVE WOUND COMPLICATION,2
AR,PRODUCTIVE COUGH,2
AR,PRURITUS,2
AR,PULMONARY EMBOLISM,2
AR,PULMONARY OEDEMA,2
AR,PULMONARY THROMBOSIS,2
AR,RENAL CANCER,2
AR,RENAL IMPAIRMENT,2
AR,RENAL NEOPLASM,2
AR,RESPIRATORY FAILURE,2
AR,RETINAL INFARCTION,2
AR,ROAD TRAFFIC ACCIDENT,2
AR,ROTATOR CUFF SYNDROME,2
AR,SCAB,2
AR,SCOLIOSIS,2
AR,SEIZURE,2
AR,SENSITIVITY TO WEATHER CHANGE,2
AR,SPINAL FRACTURE,2
AR,SPINAL OPERATION,2
AR,SPINAL PAIN,2
AR,TACHYCARDIA,2
AR,TALIPES,2
AR,TENDON DISORDER,2
AR,TENDON RUPTURE,2
AR,THERAPEUTIC RESPONSE DECREASED,2
AR,THYROID NEOPLASM,2
AR,TIBIA FRACTURE,2
AR,TOOTH FRACTURE,2
AR,TRANSAMINASES INCREASED,2
AR,TRIGEMINAL PALSY,2
AR,ULCER,2
AR,UNDERWEIGHT,2
AR,UTERINE CANCER,2
AR,UTERINE DISORDER,2
AR,VAGINAL HAEMORRHAGE,2
AR,VARICOSE VEIN,2
AR,VASCULITIS,2
AR,VERTIGO,2
AR,VIITH NERVE PARALYSIS,2
AR,WRIST DEFORMITY,2
AR,XEROPHTHALMIA,2
AR,ABDOMINAL ABSCESS,1
AR,ABORTION INDUCED,1
AR,ABSCESS NECK,1
AR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
AR,ACUTE KIDNEY INJURY,1
AR,ACUTE RESPIRATORY FAILURE,1
AR,ACUTE SINUSITIS,1
AR,ADACTYLY,1
AR,ADENOCARCINOMA PANCREAS,1
AR,ADENOVIRUS INFECTION,1
AR,ADRENAL INSUFFICIENCY,1
AR,ADVERSE EVENT,1
AR,AMERICAN TRYPANOSOMIASIS,1
AR,AMYOTROPHIC LATERAL SCLEROSIS,1
AR,ANAL ABSCESS,1
AR,ANAL FISSURE,1
AR,ANAL FISTULA,1
AR,ANAL SPHINCTER ATONY,1
AR,ANASTOMOTIC ULCER HAEMORRHAGE,1
AR,ANEURYSM,1
AR,ANGIOPATHY,1
AR,AORTIC ARTERIOSCLEROSIS,1
AR,APHONIA,1
AR,APNOEA,1
AR,APPENDICITIS,1
AR,APPLICATION SITE CELLULITIS,1
AR,APPLICATION SITE DISCOLOURATION,1
AR,APPLICATION SITE ECZEMA,1
AR,APPLICATION SITE PRURITUS,1
AR,APPLICATION SITE RASH,1
AR,APPLICATION SITE SWELLING,1
AR,ARM AMPUTATION,1
AR,ARTERIAL RUPTURE,1
AR,ARTHRITIS BACTERIAL,1
AR,ARTHRITIS INFECTIVE,1
AR,ARTHRODESIS,1
AR,ASPIRATION,1
AR,ASTIGMATISM,1
AR,ASTROCYTOMA_ LOW GRADE,1
AR,ATRIOVENTRICULAR SEPTAL DEFECT,1
AR,AUTOIMMUNE DISORDER,1
AR,AUTOIMMUNE HEPATITIS,1
AR,B-CELL LYMPHOMA,1
AR,BACTERAEMIA,1
AR,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AR,BILE DUCT STONE,1
AR,BLADDER CANCER,1
AR,BLADDER PROLAPSE,1
AR,BLOOD CHOLESTEROL ABNORMAL,1
AR,BLOOD CHOLESTEROL INCREASED,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BLOOD INSULIN DECREASED,1
AR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
AR,BLOOD PRESSURE INCREASED,1
AR,BONE EROSION,1
AR,BONE FISSURE,1
AR,BRADYCARDIA,1
AR,BRAIN NEOPLASM,1
AR,BREAST ABSCESS,1
AR,BREAST CALCIFICATIONS,1
AR,BREAST CYST,1
AR,BRONCHIAL DISORDER,1
AR,BRONCHOPNEUMONIA,1
AR,BRONCHOPULMONARY ASPERGILLOSIS,1
AR,BUNDLE BRANCH BLOCK LEFT,1
AR,CALCINOSIS,1
AR,CARDIAC ARREST,1
AR,CARDIAC MURMUR,1
AR,CARDIAC VALVE DISEASE,1
AR,CARDIOVASCULAR DISORDER,1
AR,CARTILAGE ATROPHY,1
AR,CARTILAGE INJURY,1
AR,CAUDA EQUINA SYNDROME,1
AR,CELLULITIS STAPHYLOCOCCAL,1
AR,CEREBELLAR INFARCTION,1
AR,CEREBRAL CYST,1
AR,CEREBRAL HAEMATOMA,1
AR,CERVICAL VERTEBRAL FRACTURE,1
AR,CERVIX CARCINOMA,1
AR,CHLOASMA,1
AR,CHOKING,1
AR,CHOKING SENSATION,1
AR,CHOLECYSTITIS,1
AR,CLAVICLE FRACTURE,1
AR,CLEAR CELL RENAL CELL CARCINOMA,1
AR,COAGULATION TIME PROLONGED,1
AR,COLON ADENOMA,1
AR,COLON DYSPLASIA,1
AR,COLON NEOPLASM,1
AR,CONCOMITANT DISEASE AGGRAVATED,1
AR,CONGENITAL MUSCULOSKELETAL ANOMALY,1
AR,CONGENITAL NOSE MALFORMATION,1
AR,CONJUNCTIVITIS VIRAL,1
AR,CORNEAL ABSCESS,1
AR,CORONARY ARTERY DISEASE,1
AR,CORONARY ARTERY STENOSIS,1
AR,CORONARY ARTERY THROMBOSIS,1
AR,CRANIOSYNOSTOSIS,1
AR,CRITICAL ILLNESS MYOPATHY,1
AR,CRITICAL ILLNESS POLYNEUROPATHY,1
AR,CSF GLUCOSE DECREASED,1
AR,CYANOSIS,1
AR,CYSTITIS,1
AR,CYTOPENIA,1
AR,DACRYOCANALICULITIS,1
AR,DEMENTIA ALZHEIMER^S TYPE,1
AR,DEMYELINATING POLYNEUROPATHY,1
AR,DENGUE FEVER,1
AR,DEPENDENCE,1
AR,DERMAL CYST,1
AR,DERMATITIS ALLERGIC,1
AR,DEVICE FAILURE,1
AR,DEVICE OCCLUSION,1
AR,DIFFUSE LARGE B-CELL LYMPHOMA,1
AR,DISLOCATION OF VERTEBRA,1
AR,DISORIENTATION,1
AR,DISSEMINATED TUBERCULOSIS,1
AR,DIVERTICULAR PERFORATION,1
AR,DRUG DOSE OMISSION,1
AR,DRUG RESISTANCE,1
AR,DRUG TOLERANCE,1
AR,DRY SKIN,1
AR,DYSPEPSIA,1
AR,DYSPLASIA,1
AR,EATING DISORDER,1
AR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
AR,ELECTROCARDIOGRAM T WAVE INVERSION,1
AR,EMBOLISM,1
AR,ENCHONDROMATOSIS,1
AR,ENDOCARDITIS,1
AR,ENDOCRINE DISORDER,1
AR,ENDOMETRIAL ADENOCARCINOMA,1
AR,ENDOPHTHALMITIS,1
AR,EOSINOPHILIA,1
AR,EPISTAXIS,1
AR,ERYTHEMA NODOSUM,1
AR,ESCHERICHIA TEST POSITIVE,1
AR,EXOPHTHALMOS,1
AR,EXOPHTHALMOS CONGENITAL,1
AR,EXTENSOR PLANTAR RESPONSE,1
AR,EXTRA DOSE ADMINISTERED,1
AR,EYE ABSCESS,1
AR,EYE COMPLICATION ASSOCIATED WITH DEVICE,1
AR,EYE HAEMORRHAGE,1
AR,EYE INFECTION,1
AR,EYE INFECTION BACTERIAL,1
AR,EYE ULCER,1
AR,FACIAL BONES FRACTURE,1
AR,FACIAL PARALYSIS,1
AR,FACIAL PARESIS,1
AR,FAECAL INCONTINENCE,1
AR,FAECES DISCOLOURED,1
AR,FALLOPIAN TUBE DISORDER,1
AR,FEAR,1
AR,FEELING HOT,1
AR,FOETAL EXPOSURE DURING PREGNANCY,1
AR,FOREIGN BODY,1
AR,FRACTURE,1
AR,FRACTURE MALUNION,1
AR,GAIT INABILITY,1
AR,GASTRIC CANCER,1
AR,GASTRIC MUCOSAL HYPERTROPHY,1
AR,GASTRIC NEOPLASM,1
AR,GASTRITIS BACTERIAL,1
AR,GASTROINTESTINAL INFLAMMATION,1
AR,GASTROINTESTINAL NECROSIS,1
AR,GESTATIONAL TROPHOBLASTIC DETACHMENT,1
AR,GOITRE,1
AR,GRAFT VERSUS HOST DISEASE,1
AR,GROIN PAIN,1
AR,HAEMANGIOMA,1
AR,HAEMARTHROSIS,1
AR,HAEMATEMESIS,1
AR,HAEMATOCRIT DECREASED,1
AR,HAEMATURIA,1
AR,HAEMOGLOBIN DECREASED,1
AR,HAEMORRHAGE IN PREGNANCY,1
AR,HAEMORRHAGIC STROKE,1
AR,HAEMORRHOIDS,1
AR,HAEMORRHOIDS THROMBOSED,1
AR,HALLUCINATION,1
AR,HAND FRACTURE,1
AR,HEART RATE INCREASED,1
AR,HEPATIC CYST,1
AR,HEPATIC FUNCTION ABNORMAL,1
AR,HEPATIC HAEMORRHAGE,1
AR,HEPATIC INFECTION,1
AR,HEPATIC STEATOSIS,1
AR,HEPATITIS C,1
AR,HEPATITIS TOXIC,1
AR,HERPES OPHTHALMIC,1
AR,HERPES VIRUS INFECTION,1
AR,HYPERCOAGULATION,1
AR,HYPERHIDROSIS,1
AR,HYPERSENSITIVITY VASCULITIS,1
AR,HYPERTHYROIDISM,1
AR,HYPOACUSIS,1
AR,HYPOKINESIA,1
AR,HYPOTHYROIDISM,1
AR,IMMOBILE,1
AR,IMMUNODEFICIENCY,1
AR,INCOHERENT,1
AR,INCONTINENCE,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INFECTED BUNION,1
AR,INFECTED SKIN ULCER,1
AR,INJECTION SITE INDURATION,1
AR,INJECTION SITE INFECTION,1
AR,INJECTION SITE PRURITUS,1
AR,INJECTION SITE SWELLING,1
AR,INJECTION SITE VESICLES,1
AR,INJECTION SITE WARMTH,1
AR,INTERSTITIAL LUNG DISEASE,1
AR,INTESTINAL OBSTRUCTION,1
AR,INVASIVE DUCTAL BREAST CARCINOMA,1
AR,IRIDOCYCLITIS,1
AR,IRRITABLE BOWEL SYNDROME,1
AR,JAUNDICE,1
AR,JAW DISORDER,1
AR,JC VIRUS TEST POSITIVE,1
AR,JOINT INSTABILITY,1
AR,JOINT STIFFNESS,1
AR,JUVENILE IDIOPATHIC ARTHRITIS,1
AR,KERATITIS,1
AR,KERATOPATHY,1
AR,KNEE OPERATION,1
AR,LACERATION,1
AR,LARGE INTESTINAL ULCER,1
AR,LARGE INTESTINE POLYP,1
AR,LARYNGEAL DISORDER,1
AR,LARYNGEAL OBSTRUCTION,1
AR,LARYNGITIS,1
AR,LETHARGY,1
AR,LEUKOCYTOCLASTIC VASCULITIS,1
AR,LEUKOCYTOSIS,1
AR,LIGAMENT RUPTURE,1
AR,LIGAMENT SPRAIN,1
AR,LIMB DEFORMITY,1
AR,LIMB DISCOMFORT,1
AR,LIP DRY,1
AR,LIPOEDEMA,1
AR,LIVE BIRTH,1
AR,LIVER FUNCTION TEST ABNORMAL,1
AR,LOCALISED OEDEMA,1
AR,LOWER LIMB FRACTURE,1
AR,LUNG ABSCESS,1
AR,LUNG ADENOCARCINOMA,1
AR,LUNG CYST,1
AR,LUNG NEOPLASM,1
AR,LYMPHADENITIS,1
AR,LYMPHADENOPATHY MEDIASTINAL,1
AR,LYMPHOEDEMA,1
AR,LYMPHOPENIA,1
AR,MACULOPATHY,1
AR,MALPOSITIONED TEETH,1
AR,MEDICAL DEVICE COMPLICATION,1
AR,MEDICAL DEVICE PAIN,1
AR,MEGACOLON,1
AR,MEMORY IMPAIRMENT,1
AR,MENINGITIS,1
AR,MENINGITIS TUBERCULOUS,1
AR,MENSTRUATION DELAYED,1
AR,METASTASES TO BONE,1
AR,METASTASES TO LIVER,1
AR,METASTASES TO OVARY,1
AR,METASTASES TO PERITONEUM,1
AR,METASTATIC LYMPHOMA,1
AR,METATARSALGIA,1
AR,METRORRHAGIA,1
AR,MITRAL VALVE CALCIFICATION,1
AR,MITRAL VALVE INCOMPETENCE,1
AR,MOLLUSCUM CONTAGIOSUM,1
AR,MONARTHRITIS,1
AR,MONONUCLEOSIS SYNDROME,1
AR,MOUTH ULCERATION,1
AR,MULTIPLE FRACTURES,1
AR,MUSCLE ATROPHY,1
AR,MUSCLE SPASMS,1
AR,MUSCLE STRAIN,1
AR,MUSCULOSKELETAL DISCOMFORT,1
AR,MYALGIA,1
AR,MYELITIS TRANSVERSE,1
AR,NAIL INJURY,1
AR,NASAL CONGESTION,1
AR,NASAL DRYNESS,1
AR,NASAL OBSTRUCTION,1
AR,NAUSEA,1
AR,NECK DEFORMITY,1
AR,NEOPLASM PROGRESSION,1
AR,NEPHRITIC SYNDROME,1
AR,NERVE COMPRESSION,1
AR,NERVE INJURY,1
AR,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
AR,NEUROGENIC BLADDER,1
AR,NEUROLOGICAL SYMPTOM,1
AR,NIGHT SWEATS,1
AR,NOSE DEFORMITY,1
AR,OESOPHAGEAL CARCINOMA,1
AR,OESOPHAGEAL VARICES HAEMORRHAGE,1
AR,OPEN GLOBE INJURY,1
AR,OPHTHALMIC HERPES ZOSTER,1
AR,ORAL INFECTION,1
AR,ORAL MUCOSAL BLISTERING,1
AR,ORAL PAIN,1
AR,OROPHARYNGEAL PLAQUE,1
AR,OSTEOPENIA,1
AR,OSTEOPOROTIC FRACTURE,1
AR,OVARIAN CANCER,1
AR,OVARIAN CYST,1
AR,OVARIAN ENLARGEMENT,1
AR,OXYGEN SATURATION DECREASED,1
AR,PAIN IN JAW,1
AR,PALLOR,1
AR,PAPILLARY THYROID CANCER,1
AR,PARAPARESIS,1
AR,PATELLA FRACTURE,1
AR,PATIENT-DEVICE INCOMPATIBILITY,1
AR,PELVIC FRACTURE,1
AR,PERIPHERAL PARALYSIS,1
AR,PERIPHERAL VASCULAR DISORDER,1
AR,PHARYNGEAL ULCERATION,1
AR,PHARYNGOTONSILLITIS,1
AR,PLASMA CELL MYELOMA,1
AR,PLATELET ADHESIVENESS ABNORMAL,1
AR,PLEOCYTOSIS,1
AR,PNEUMOCOCCAL INFECTION,1
AR,PNEUMONITIS CHEMICAL,1
AR,PNEUMOTHORAX,1
AR,POLYMYOSITIS,1
AR,POST HERPETIC NEURALGIA,1
AR,POST PROCEDURAL COMPLICATION,1
AR,PREGNANCY ON CONTRACEPTIVE,1
AR,PROCEDURAL HAEMORRHAGE,1
AR,PRODUCT QUALITY ISSUE,1
AR,PRODUCT STORAGE ERROR,1
AR,PROTEINURIA,1
AR,PRURITUS GENERALISED,1
AR,PULMONARY ALVEOLAR HAEMORRHAGE,1
AR,PULMONARY CAVITATION,1
AR,PULMONARY HYPERTENSION,1
AR,PULSE ABSENT,1
AR,PYELONEPHRITIS ACUTE,1
AR,PYURIA,1
AR,RALES,1
AR,RASH ERYTHEMATOUS,1
AR,RASH GENERALISED,1
AR,RASH MACULAR,1
AR,RAYNAUD^S PHENOMENON,1
AR,RECTAL CANCER,1
AR,RED BLOOD CELL ABNORMALITY,1
AR,REFLEXES ABNORMAL,1
AR,RENAL CANCER STAGE I,1
AR,RENAL FAILURE ACUTE,1
AR,RESPIRATORY DISTRESS,1
AR,RESPIRATORY RATE INCREASED,1
AR,RESPIRATORY TRACT CONGESTION,1
AR,RETINAL INJURY,1
AR,RHEUMATOID NODULE,1
AR,RHINITIS,1
AR,SARCOIDOSIS,1
AR,SCAPHOCEPHALY,1
AR,SCAPULA FRACTURE,1
AR,SCIATIC NERVE INJURY,1
AR,SCIATIC NERVE NEUROPATHY,1
AR,SENSE OF OPPRESSION,1
AR,SENSITIVITY OF TEETH,1
AR,SENSORIMOTOR DISORDER,1
AR,SENSORY DISTURBANCE,1
AR,SHOCK,1
AR,SINUSITIS,1
AR,SJOGREN^S SYNDROME,1
AR,SKIN CANCER,1
AR,SKIN DISCOLOURATION,1
AR,SKIN FISSURES,1
AR,SKIN HAEMORRHAGE,1
AR,SKIN INDURATION,1
AR,SKIN INFECTION,1
AR,SLEEP DISORDER,1
AR,SNEEZING,1
AR,SNORING,1
AR,SOFT TISSUE INFECTION,1
AR,SPINAL COMPRESSION FRACTURE,1
AR,SPINAL CORD OEDEMA,1
AR,SPINAL OSTEOARTHRITIS,1
AR,SPLENOMEGALY,1
AR,STAPHYLOCOCCAL ABSCESS,1
AR,STICKLER^S SYNDROME,1
AR,STRABISMUS,1
AR,STREPTOCOCCAL INFECTION,1
AR,SUBCUTANEOUS ABSCESS,1
AR,SUDDEN DEATH,1
AR,SUPERINFECTION,1
AR,SUPRAVENTRICULAR TACHYCARDIA,1
AR,SURGICAL FAILURE,1
AR,SUTURE RELATED COMPLICATION,1
AR,SWOLLEN TONGUE,1
AR,SYNOVITIS,1
AR,TEETH BRITTLE,1
AR,TENDON INJURY,1
AR,TENOSYNOVITIS,1
AR,TESTICULAR NEOPLASM,1
AR,THERMAL BURN,1
AR,THIRST,1
AR,THROAT IRRITATION,1
AR,THYROID CANCER,1
AR,TINEA PEDIS,1
AR,TINNITUS,1
AR,TOE AMPUTATION,1
AR,TONGUE DISCOMFORT,1
AR,TONGUE OEDEMA,1
AR,TONGUE SPASM,1
AR,TOOTH INFECTION,1
AR,TOXIC SKIN ERUPTION,1
AR,TRANSIENT ISCHAEMIC ATTACK,1
AR,TREATMENT FAILURE,1
AR,TRIGGER FINGER,1
AR,TRIPLE A SYNDROME,1
AR,TRISMUS,1
AR,TRISOMY 21,1
AR,TROPONIN INCREASED,1
AR,TUBULOINTERSTITIAL NEPHRITIS,1
AR,TUMOUR INVASION,1
AR,TUMOUR ULCERATION,1
AR,TYMPANIC MEMBRANE PERFORATION,1
AR,UMBILICAL CORD AROUND NECK,1
AR,UNEVALUABLE EVENT,1
AR,UNRESPONSIVE TO STIMULI,1
AR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AR,UPPER RESPIRATORY TRACT INFECTION,1
AR,UROSEPSIS,1
AR,UTERINE HAEMORRHAGE,1
AR,UTERINE POLYP,1
AR,UTERINE PROLAPSE,1
AR,VASCULAR OCCLUSION,1
AR,VENOUS OCCLUSION,1
AR,VIRAL SEPSIS,1
AR,VISION BLURRED,1
AR,VISUAL FIELD DEFECT,1
AR,WALKING DISABILITY,1
AR,WARM TYPE HAEMOLYTIC ANAEMIA,1
AR,WHEEZING,1
AR,WHITE MATTER LESION,1
AR,WOUND,1
AR,WOUND ABSCESS,1
AR,WOUND INFECTION BACTERIAL,1
AR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AM,COMPLEMENT FACTOR C3 DECREASED,1
AM,COMPLEMENT FACTOR C4 DECREASED,1
AM,JOINT SWELLING,1
AM,LYMPHADENOPATHY,1
AM,SPLENOMEGALY,1
AM,VENOUS THROMBOSIS,1
AU,DRUG INEFFECTIVE,82
AU,ARTHRALGIA,71
AU,NAUSEA,64
AU,MALAISE,60
AU,LOWER RESPIRATORY TRACT INFECTION,55
AU,PAIN,53
AU,VOMITING,52
AU,DIARRHOEA,51
AU,FATIGUE,51
AU,RHEUMATOID ARTHRITIS,50
AU,FALL,48
AU,DYSPNOEA,45
AU,PYREXIA,39
AU,OSTEONECROSIS,37
AU,HEADACHE,33
AU,HYPERTENSION,33
AU,MOUTH ULCERATION,33
AU,PNEUMONIA,31
AU,SEPSIS,31
AU,URINARY TRACT INFECTION,29
AU,CROHN^S DISEASE,27
AU,INFECTION,27
AU,PAIN IN EXTREMITY,27
AU,WEIGHT DECREASED,27
AU,NEUTROPENIA,26
AU,RASH,25
AU,COUGH,24
AU,DEATH,24
AU,RENAL IMPAIRMENT,24
AU,ABDOMINAL PAIN,23
AU,PANCYTOPENIA,23
AU,ARTHROPATHY,22
AU,CONDITION AGGRAVATED,22
AU,INFLUENZA LIKE ILLNESS,22
AU,PSORIASIS,22
AU,BACK PAIN,20
AU,DIZZINESS,20
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,20
AU,WEIGHT INCREASED,20
AU,FEBRILE NEUTROPENIA,19
AU,LETHARGY,19
AU,SINUSITIS,19
AU,DEPRESSION,18
AU,HYPOTENSION,18
AU,ASTHENIA,17
AU,DEEP VEIN THROMBOSIS,17
AU,DRUG EFFECT INCOMPLETE,17
AU,CEREBROVASCULAR ACCIDENT,16
AU,CHEST PAIN,16
AU,DECREASED APPETITE,16
AU,LIVER FUNCTION TEST ABNORMAL,16
AU,ACUTE KIDNEY INJURY,15
AU,ANAEMIA,15
AU,ARTHRITIS,15
AU,BREAST CANCER,15
AU,SKIN CANCER,15
AU,SKIN ULCER,15
AU,SQUAMOUS CELL CARCINOMA,15
AU,SYNCOPE,15
AU,CONFUSIONAL STATE,14
AU,MUSCULOSKELETAL PAIN,14
AU,ACUTE MYOCARDIAL INFARCTION,13
AU,ALOPECIA,13
AU,DISEASE PROGRESSION,13
AU,NASOPHARYNGITIS,13
AU,OSTEOARTHRITIS,13
AU,PULMONARY EMBOLISM,13
AU,TREATMENT FAILURE,13
AU,BASAL CELL CARCINOMA,12
AU,BRONCHITIS,12
AU,CATARACT,12
AU,CONTUSION,12
AU,HAEMORRHAGE,12
AU,HYPERSENSITIVITY,12
AU,ASTHMA,11
AU,ATRIAL FIBRILLATION,11
AU,CHILLS,11
AU,DEHYDRATION,11
AU,DIABETES MELLITUS,11
AU,GAIT DISTURBANCE,11
AU,INTERSTITIAL LUNG DISEASE,11
AU,MULTI-ORGAN FAILURE,11
AU,MUSCULAR WEAKNESS,11
AU,ERYTHEMA,10
AU,GRAFT VERSUS HOST DISEASE,10
AU,INFLUENZA,10
AU,INSOMNIA,10
AU,JOINT SWELLING,10
AU,LOSS OF CONSCIOUSNESS,10
AU,LUNG DISORDER,10
AU,MUSCULOSKELETAL STIFFNESS,10
AU,OEDEMA PERIPHERAL,10
AU,OROPHARYNGEAL PAIN,10
AU,PALPITATIONS,10
AU,PRODUCT USE ISSUE,10
AU,PRODUCTIVE COUGH,10
AU,STOMATITIS,10
AU,VASCULITIS,10
AU,ABDOMINAL DISCOMFORT,9
AU,DRUG DEPENDENCE,9
AU,DRUG DOSE OMISSION,9
AU,HYPERHIDROSIS,9
AU,LUNG INFECTION,9
AU,MOBILITY DECREASED,9
AU,RECTAL HAEMORRHAGE,9
AU,SKIN LESION,9
AU,SURGERY,9
AU,SYSTEMIC MYCOSIS,9
AU,THROMBOCYTOPENIA,9
AU,URTICARIA,9
AU,VIRAL INFECTION,9
AU,ABDOMINAL DISTENSION,8
AU,ABDOMINAL PAIN UPPER,8
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,8
AU,ANXIETY,8
AU,ASPERGILLUS INFECTION,8
AU,CUSHING^S SYNDROME,8
AU,DEPRESSED MOOD,8
AU,DIVERTICULITIS,8
AU,DRUG INTOLERANCE,8
AU,DRUG LEVEL DECREASED,8
AU,EPSTEIN-BARR VIRUS INFECTION,8
AU,FEELING ABNORMAL,8
AU,GASTROINTESTINAL CARCINOMA,8
AU,HODGKIN^S DISEASE,8
AU,HYPOKALAEMIA,8
AU,LUNG NEOPLASM MALIGNANT,8
AU,LYMPHADENOPATHY,8
AU,MUCOSAL INFLAMMATION,8
AU,MYALGIA,8
AU,PSORIATIC ARTHROPATHY,8
AU,SKIN NEOPLASM EXCISION,8
AU,SWELLING,8
AU,TRANSAMINASES INCREASED,8
AU,VERTIGO,8
AU,BONE MARROW FAILURE,7
AU,BRONCHIECTASIS,7
AU,C-REACTIVE PROTEIN INCREASED,7
AU,CONSTIPATION,7
AU,DRUG EFFECT DECREASED,7
AU,HEPATOTOXICITY,7
AU,HERPES ZOSTER,7
AU,HYPOAESTHESIA,7
AU,HYPONATRAEMIA,7
AU,ILL-DEFINED DISORDER,7
AU,INFECTED SKIN ULCER,7
AU,INFLAMMATION,7
AU,INFUSION RELATED REACTION,7
AU,INTESTINAL OBSTRUCTION,7
AU,KNEE ARTHROPLASTY,7
AU,LOCALISED INFECTION,7
AU,MATERNAL EXPOSURE DURING PREGNANCY,7
AU,MEMORY IMPAIRMENT,7
AU,NECK PAIN,7
AU,NEUROPATHY PERIPHERAL,7
AU,OSTEOPOROSIS,7
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
AU,PRURITUS,7
AU,RESPIRATORY TRACT INFECTION,7
AU,SQUAMOUS CELL CARCINOMA OF SKIN,7
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,7
AU,WHITE BLOOD CELL COUNT DECREASED,7
AU,ACUTE MYELOID LEUKAEMIA,6
AU,ANAL FISTULA,6
AU,APHASIA,6
AU,BALANCE DISORDER,6
AU,BLISTER,6
AU,CARDIAC ARREST,6
AU,CELLULITIS,6
AU,CYTOMEGALOVIRUS INFECTION,6
AU,DRUG PRESCRIBING ERROR,6
AU,DRUG-INDUCED LIVER INJURY,6
AU,DYSPHAGIA,6
AU,FUNGAL INFECTION,6
AU,GASTROINTESTINAL DISORDER,6
AU,GASTROINTESTINAL HAEMORRHAGE,6
AU,GENERAL PHYSICAL HEALTH DETERIORATION,6
AU,HAEMOGLOBIN DECREASED,6
AU,HIP FRACTURE,6
AU,HYPOCALCAEMIA,6
AU,IMMUNE SYSTEM DISORDER,6
AU,IMMUNOSUPPRESSION,6
AU,INJECTION SITE REACTION,6
AU,INTESTINAL PERFORATION,6
AU,JOINT DISLOCATION,6
AU,JOINT STIFFNESS,6
AU,MYOPATHY,6
AU,NERVOUS SYSTEM DISORDER,6
AU,NIGHT SWEATS,6
AU,ORAL HERPES,6
AU,PANCREATITIS,6
AU,PERIPHERAL SWELLING,6
AU,PNEUMOTHORAX,6
AU,POST PROCEDURAL COMPLICATION,6
AU,POST PROCEDURAL INFECTION,6
AU,PRODUCT USE IN UNAPPROVED INDICATION,6
AU,RENAL FAILURE,6
AU,STAPHYLOCOCCAL INFECTION,6
AU,SUICIDAL IDEATION,6
AU,TACHYCARDIA,6
AU,THERAPEUTIC RESPONSE DECREASED,6
AU,TOXICITY TO VARIOUS AGENTS,6
AU,TREMOR,6
AU,UNEVALUABLE EVENT,6
AU,ABASIA,5
AU,ADRENAL INSUFFICIENCY,5
AU,ADVERSE DRUG REACTION,5
AU,ANKYLOSING SPONDYLITIS,5
AU,ARTHRITIS BACTERIAL,5
AU,CANDIDA OSTEOMYELITIS,5
AU,CARDIAC DISORDER,5
AU,CARDIOTOXICITY,5
AU,CHRONIC GRAFT VERSUS HOST DISEASE,5
AU,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,5
AU,CLOSTRIDIUM DIFFICILE INFECTION,5
AU,COLITIS ULCERATIVE,5
AU,CYTOPENIA,5
AU,DEVICE RELATED INFECTION,5
AU,DRUG HYPERSENSITIVITY,5
AU,DRY MOUTH,5
AU,EPISTAXIS,5
AU,FEMUR FRACTURE,5
AU,GASTROINTESTINAL INFLAMMATION,5
AU,HAEMATOTOXICITY,5
AU,HEPATIC CIRRHOSIS,5
AU,HEPATIC FAILURE,5
AU,HEPATIC FUNCTION ABNORMAL,5
AU,INJECTION SITE PAIN,5
AU,JOINT DESTRUCTION,5
AU,KIDNEY INFECTION,5
AU,LIMB DISCOMFORT,5
AU,LOCAL SWELLING,5
AU,METASTATIC MALIGNANT MELANOMA,5
AU,MUCOCUTANEOUS ULCERATION,5
AU,MUSCLE SPASMS,5
AU,MYOCARDIAL INFARCTION,5
AU,NEPHROLITHIASIS,5
AU,NEUTROPENIC SEPSIS,5
AU,OSTEOMYELITIS,5
AU,PARAESTHESIA,5
AU,POLYARTHRITIS,5
AU,PULMONARY FIBROSIS,5
AU,PULMONARY MASS,5
AU,PULMONARY TOXICITY,5
AU,PYODERMA GANGRENOSUM,5
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
AU,RESPIRATORY FAILURE,5
AU,SOMNOLENCE,5
AU,TOOTH INFECTION,5
AU,TOOTHACHE,5
AU,VISION BLURRED,5
AU,WOUND INFECTION,5
AU,WRIST FRACTURE,5
AU,ALANINE AMINOTRANSFERASE INCREASED,4
AU,ANGINA PECTORIS,4
AU,ANGINA UNSTABLE,4
AU,ANKLE FRACTURE,4
AU,BLOOD CHOLESTEROL INCREASED,4
AU,BLOOD CREATININE INCREASED,4
AU,BLOOD POTASSIUM DECREASED,4
AU,BLOOD PRESSURE INCREASED,4
AU,BLOOD SODIUM DECREASED,4
AU,BLOOD TEST ABNORMAL,4
AU,BONE DISORDER,4
AU,BONE MARROW TOXICITY,4
AU,BRADYCARDIA,4
AU,BRAIN ABSCESS,4
AU,CIRCULATORY COLLAPSE,4
AU,COLITIS,4
AU,DRUG LEVEL BELOW THERAPEUTIC,4
AU,DRUG RESISTANCE,4
AU,DYSARTHRIA,4
AU,DYSPEPSIA,4
AU,DYSPNOEA EXERTIONAL,4
AU,ELECTROLYTE IMBALANCE,4
AU,ENCEPHALITIS TOXIC,4
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
AU,GASTROENTERITIS,4
AU,GASTROINTESTINAL INFECTION,4
AU,GOUT,4
AU,HEART RATE IRREGULAR,4
AU,HEMIPARESIS,4
AU,HEPATIC ENZYME INCREASED,4
AU,HEPATIC STEATOSIS,4
AU,HYPOALBUMINAEMIA,4
AU,IMPAIRED HEALING,4
AU,INFECTIVE ANEURYSM,4
AU,INFLAMMATORY MARKER INCREASED,4
AU,INJECTION SITE MASS,4
AU,INTERVERTEBRAL DISC PROTRUSION,4
AU,LIVER DISORDER,4
AU,LUNG NEOPLASM,4
AU,LYMPHOPENIA,4
AU,MALIGNANT NEOPLASM PROGRESSION,4
AU,MEDICATION ERROR,4
AU,NEUROTOXICITY,4
AU,NEUTROPHIL COUNT DECREASED,4
AU,NODULE,4
AU,PELVIC FRACTURE,4
AU,PLEURAL EFFUSION,4
AU,PNEUMONITIS,4
AU,POLYP,4
AU,PRESYNCOPE,4
AU,RASH ERYTHEMATOUS,4
AU,RIB FRACTURE,4
AU,SEIZURE,4
AU,SKIN DISORDER,4
AU,SKIN GRAFT,4
AU,SMALL INTESTINAL OBSTRUCTION,4
AU,STAPHYLOCOCCAL SKIN INFECTION,4
AU,STENOTROPHOMONAS INFECTION,4
AU,SWELLING FACE,4
AU,THROMBOSIS,4
AU,UPPER RESPIRATORY TRACT INFECTION,4
AU,VAGINAL HAEMORRHAGE,4
AU,VASCULITIS NECROTISING,4
AU,VENTRICULAR TACHYCARDIA,4
AU,ABORTION SPONTANEOUS,3
AU,ACTINIC KERATOSIS,3
AU,ANAL ABSCESS,3
AU,ARRHYTHMIA,3
AU,BACTERIAL INFECTION,3
AU,BACTERIAL SEPSIS,3
AU,BLOOD GLUCOSE INCREASED,3
AU,BLOOD IRON DECREASED,3
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,3
AU,BONE LOSS,3
AU,CANCER SURGERY,3
AU,CARDIAC FAILURE,3
AU,CARDIAC FAILURE CONGESTIVE,3
AU,CARTILAGE INJURY,3
AU,CATARACT OPERATION,3
AU,CEREBRAL HAEMORRHAGE,3
AU,CHEST DISCOMFORT,3
AU,CHOLANGITIS,3
AU,CHOLECYSTECTOMY,3
AU,CHOLELITHIASIS,3
AU,CHRONIC SINUSITIS,3
AU,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,3
AU,COGNITIVE DISORDER,3
AU,COLECTOMY,3
AU,CONJUNCTIVITIS,3
AU,CYST,3
AU,DELUSION,3
AU,DEMENTIA,3
AU,DEMYELINATION,3
AU,DEVICE DISLOCATION,3
AU,DIPLOPIA,3
AU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
AU,DRUG SPECIFIC ANTIBODY PRESENT,3
AU,DRY SKIN,3
AU,ECZEMA,3
AU,ELECTROCARDIOGRAM QT PROLONGED,3
AU,EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER,3
AU,EXOSTOSIS,3
AU,EXPOSURE DURING PREGNANCY,3
AU,EYE DISORDER,3
AU,EYE HAEMORRHAGE,3
AU,FAECAL CALPROTECTIN INCREASED,3
AU,FLUSHING,3
AU,FOETAL DEATH,3
AU,FOOT FRACTURE,3
AU,FULL BLOOD COUNT DECREASED,3
AU,FURUNCLE,3
AU,GASTRIC ULCER,3
AU,GASTRITIS,3
AU,GLUCOSE TOLERANCE IMPAIRED,3
AU,GRAFT VERSUS HOST DISEASE IN SKIN,3
AU,HAEMATOCHEZIA,3
AU,HAEMATOMA,3
AU,HAEMOPTYSIS,3
AU,HEMIPLEGIA,3
AU,HEPATOSPLENIC T-CELL LYMPHOMA,3
AU,HERPES SIMPLEX,3
AU,HISTOPLASMOSIS,3
AU,HOT FLUSH,3
AU,HUMERUS FRACTURE,3
AU,HYPOXIA,3
AU,ILEAL STENOSIS,3
AU,ILEOSTOMY,3
AU,IMPAIRED QUALITY OF LIFE,3
AU,INCONTINENCE,3
AU,INJECTION SITE BRUISING,3
AU,INJECTION SITE ERYTHEMA,3
AU,INJECTION SITE HYPERSENSITIVITY,3
AU,INTESTINAL HAEMORRHAGE,3
AU,INTESTINAL RESECTION,3
AU,JAUNDICE,3
AU,JOINT EFFUSION,3
AU,JUVENILE IDIOPATHIC ARTHRITIS,3
AU,LACERATION,3
AU,LEUKOENCEPHALOPATHY,3
AU,LIMB INJURY,3
AU,LIVER INJURY,3
AU,LUNG INFILTRATION,3
AU,LUPUS-LIKE SYNDROME,3
AU,MALIGNANT MELANOMA,3
AU,MALNUTRITION,3
AU,MELANOCYTIC NAEVUS,3
AU,MENINGITIS ASEPTIC,3
AU,MICROSPORIDIA INFECTION,3
AU,MOOD ALTERED,3
AU,MUSCLE RUPTURE,3
AU,MYOCARDIAL ISCHAEMIA,3
AU,MYOSITIS,3
AU,NECROSIS,3
AU,NEPHROPATHY TOXIC,3
AU,NEPHROTIC SYNDROME,3
AU,OESOPHAGEAL PERFORATION,3
AU,OVARIAN CYST,3
AU,OVERDOSE,3
AU,PELVIC VENOUS THROMBOSIS,3
AU,PERICARDIAL EFFUSION,3
AU,PHARYNGITIS,3
AU,PHOTOSENSITIVITY REACTION,3
AU,PLATELET COUNT DECREASED,3
AU,POLLAKIURIA,3
AU,POLYURIA,3
AU,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,3
AU,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
AU,POSTOPERATIVE WOUND COMPLICATION,3
AU,POSTOPERATIVE WOUND INFECTION,3
AU,PRESCRIBED UNDERDOSE,3
AU,PROCTALGIA,3
AU,PRODUCT QUALITY ISSUE,3
AU,PROSTATE CANCER,3
AU,PULMONARY ARTERY OCCLUSION,3
AU,PULMONARY HYPOPERFUSION,3
AU,PULMONARY OEDEMA,3
AU,QUALITY OF LIFE DECREASED,3
AU,RASH GENERALISED,3
AU,RASH MACULO-PAPULAR,3
AU,RENAL CELL CARCINOMA,3
AU,RHEUMATOID NODULE,3
AU,RHINORRHOEA,3
AU,SEPTIC SHOCK,3
AU,SKIN INFECTION,3
AU,SKIN REACTION,3
AU,SLEEP APNOEA SYNDROME,3
AU,SPINAL DISORDER,3
AU,SPINAL FRACTURE,3
AU,SPLENOMEGALY,3
AU,STAPHYLOCOCCAL SEPSIS,3
AU,STRESS,3
AU,SUBCUTANEOUS ABSCESS,3
AU,TENDON DISORDER,3
AU,THERAPY NON-RESPONDER,3
AU,TRANSIENT ACANTHOLYTIC DERMATOSIS,3
AU,TYPE 2 DIABETES MELLITUS,3
AU,ULCER,3
AU,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,3
AU,UVEITIS,3
AU,VENTRICULAR EXTRASYSTOLES,3
AU,VISUAL IMPAIRMENT,3
AU,ABDOMINAL ABSCESS,2
AU,ACCIDENT,2
AU,ACCIDENTAL OVERDOSE,2
AU,ACNE,2
AU,ACROMEGALY,2
AU,ACUTE GRAFT VERSUS HOST DISEASE,2
AU,ACUTE MYELOID LEUKAEMIA RECURRENT,2
AU,ACUTE PHOSPHATE NEPHROPATHY,2
AU,ADENOVIRUS INFECTION,2
AU,AGGRESSION,2
AU,ALLERGIC OEDEMA,2
AU,ANAPHYLACTIC REACTION,2
AU,ANASTOMOTIC LEAK,2
AU,ANGIOCENTRIC LYMPHOMA,2
AU,ANGIOEDEMA,2
AU,ANTINUCLEAR ANTIBODY POSITIVE,2
AU,ANURIA,2
AU,APPENDICEAL ABSCESS,2
AU,ASPARTATE AMINOTRANSFERASE INCREASED,2
AU,AUTOIMMUNE THYROIDITIS,2
AU,B-CELL LYMPHOMA,2
AU,BACILLUS INFECTION,2
AU,BACK INJURY,2
AU,BENIGN PROSTATIC HYPERPLASIA,2
AU,BIPOLAR DISORDER,2
AU,BLINDNESS,2
AU,BLINDNESS TRANSIENT,2
AU,BLISTER INFECTED,2
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,2
AU,BLOOD GLUCOSE FLUCTUATION,2
AU,BONE DENSITY DECREASED,2
AU,BONE LESION,2
AU,BRAIN DEATH,2
AU,BRAIN NEOPLASM,2
AU,BRONCHOPULMONARY ASPERGILLOSIS,2
AU,C-REACTIVE PROTEIN ABNORMAL,2
AU,CALCINOSIS,2
AU,CANDIDA INFECTION,2
AU,CARDIAC PACEMAKER INSERTION,2
AU,CARDIO-RESPIRATORY ARREST,2
AU,CARDIOVASCULAR DISORDER,2
AU,CEREBRAL CALCIFICATION,2
AU,CEREBRAL CYST,2
AU,CEREBRAL INFARCTION,2
AU,CHLOROMA,2
AU,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,2
AU,CHRONIC KIDNEY DISEASE,2
AU,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
AU,CLOSTRIDIUM DIFFICILE COLITIS,2
AU,COLD SWEAT,2
AU,COMBINED IMMUNODEFICIENCY,2
AU,COMPLETED SUICIDE,2
AU,COMPRESSION FRACTURE,2
AU,CONVULSION,2
AU,CORONARY ARTERY DISEASE,2
AU,CORONARY ARTERY OCCLUSION,2
AU,CORONARY ARTERY STENOSIS,2
AU,COSTOCHONDRITIS,2
AU,CROUP INFECTIOUS,2
AU,CUSHINGOID,2
AU,DEAFNESS NEUROSENSORY,2
AU,DENTAL CARIES,2
AU,DEVICE BREAKAGE,2
AU,DEVICE FAILURE,2
AU,DEVICE MALFUNCTION,2
AU,DIARRHOEA HAEMORRHAGIC,2
AU,DISEASE RECURRENCE,2
AU,DISTURBANCE IN ATTENTION,2
AU,DRUG DISPENSING ERROR,2
AU,DRUG LEVEL ABOVE THERAPEUTIC,2
AU,DRY EYE,2
AU,DYSGEUSIA,2
AU,DYSLIPIDAEMIA,2
AU,DYSPRAXIA,2
AU,DYSSTASIA,2
AU,DYSURIA,2
AU,EMOTIONAL DISTRESS,2
AU,EOSINOPHILIC FASCIITIS,2
AU,EPISCLERITIS,2
AU,ERYTHEMA NODOSUM,2
AU,EYE INFECTION,2
AU,EYE PRURITUS,2
AU,EYE SWELLING,2
AU,FEELING COLD,2
AU,FEELING HOT,2
AU,FEMALE GENITAL TRACT FISTULA,2
AU,FEMORAL NECK FRACTURE,2
AU,FIBROSIS,2
AU,FISTULA DISCHARGE,2
AU,FLUID RETENTION,2
AU,FOLATE DEFICIENCY,2
AU,FOOD ALLERGY,2
AU,FOOT OPERATION,2
AU,FRACTURE,2
AU,GALLBLADDER DISORDER,2
AU,GASTRIC DISORDER,2
AU,GASTRIC ULCER HAEMORRHAGE,2
AU,GASTROINTESTINAL PAIN,2
AU,GASTROOESOPHAGEAL REFLUX DISEASE,2
AU,GENERALISED TONIC-CLONIC SEIZURE,2
AU,GENITAL HERPES SIMPLEX,2
AU,GENITAL TRACT INFLAMMATION,2
AU,GINGIVAL DISORDER,2
AU,GLOMERULAR FILTRATION RATE DECREASED,2
AU,GRAFT VERSUS HOST DISEASE IN LUNG,2
AU,GRANULOMA,2
AU,GUILLAIN-BARRE SYNDROME,2
AU,HAEMORRHOIDS,2
AU,HALLUCINATION,2
AU,HEMIANOPIA HOMONYMOUS,2
AU,HEPATIC ENZYME ABNORMAL,2
AU,HEPATIC LESION,2
AU,HEPATIC NECROSIS,2
AU,HEPATITIS B,2
AU,HERPES ZOSTER MENINGOENCEPHALITIS,2
AU,HIP ARTHROPLASTY,2
AU,HOSPITALISATION,2
AU,HYPERBILIRUBINAEMIA,2
AU,HYPERGLYCAEMIA,2
AU,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,2
AU,HYPERLIPIDAEMIA,2
AU,HYPOMAGNESAEMIA,2
AU,HYPOTHYROIDISM,2
AU,ILEAL FISTULA,2
AU,ILEAL ULCER,2
AU,IMMUNODEFICIENCY,2
AU,IMPAIRED WORK ABILITY,2
AU,INJECTION SITE PRURITUS,2
AU,INTENTIONAL SELF-INJURY,2
AU,INTERNATIONAL NORMALISED RATIO INCREASED,2
AU,INTERVERTEBRAL DISC DISORDER,2
AU,INTESTINAL OPERATION,2
AU,INTESTINAL STENOSIS,2
AU,INTESTINAL ULCER,2
AU,INTRACRANIAL ANEURYSM,2
AU,INTRACRANIAL PRESSURE INCREASED,2
AU,INTRAOCULAR PRESSURE INCREASED,2
AU,JOINT INJURY,2
AU,JOINT LOCK,2
AU,KERATITIS,2
AU,KLEBSIELLA SEPSIS,2
AU,LESION EXCISION,2
AU,LEUKAEMIA,2
AU,LEUKAEMIA RECURRENT,2
AU,LIGAMENT RUPTURE,2
AU,LIGAMENT SPRAIN,2
AU,LIMB OPERATION,2
AU,LUMBAR VERTEBRAL FRACTURE,2
AU,LUNG ABSCESS,2
AU,LYMPHOCYTE COUNT DECREASED,2
AU,LYMPHOCYTOSIS,2
AU,LYMPHOMA,2
AU,LYMPHOPROLIFERATIVE DISORDER,2
AU,MASS,2
AU,MESENTERIC VEIN THROMBOSIS,2
AU,METASTASES TO LIVER,2
AU,METASTASES TO LUNG,2
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AU,MULTIPLE SCLEROSIS RELAPSE,2
AU,MYELITIS TRANSVERSE,2
AU,MYELOFIBROSIS,2
AU,NASAL ULCER,2
AU,NEOPLASM MALIGNANT,2
AU,NERVE COMPRESSION,2
AU,NEURALGIA,2
AU,NON-HODGKIN^S LYMPHOMA,2
AU,OBESITY,2
AU,OCCULT BLOOD POSITIVE,2
AU,OEDEMA,2
AU,ORAL CANDIDIASIS,2
AU,ORAL PAIN,2
AU,OSTEITIS,2
AU,OTOTOXICITY,2
AU,OVERWEIGHT,2
AU,PALLOR,2
AU,PAPILLOEDEMA,2
AU,PERICARDITIS TUBERCULOUS,2
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
AU,PERONEAL NERVE PALSY,2
AU,PHARYNGEAL ULCERATION,2
AU,PIGMENTATION DISORDER,2
AU,PITUITARY TUMOUR,2
AU,PLACENTAL INSUFFICIENCY,2
AU,PLASMA CELL MYELOMA,2
AU,PLEURITIC PAIN,2
AU,PNEUMOCOCCAL SEPSIS,2
AU,PNEUMONIA ASPIRATION,2
AU,PNEUMONIA PSEUDOMONAL,2
AU,POOR QUALITY SLEEP,2
AU,PORENCEPHALY,2
AU,POST LUMBAR PUNCTURE SYNDROME,2
AU,PROCTITIS,2
AU,PROCTOCOLECTOMY,2
AU,PSEUDOMONAS INFECTION,2
AU,PSYCHOTIC DISORDER,2
AU,RASH MACULAR,2
AU,RASH PRURITIC,2
AU,RECTAL ULCER,2
AU,RENAL DISORDER,2
AU,RENAL FAILURE ACUTE,2
AU,RENAL FUNCTION TEST ABNORMAL,2
AU,RESPIRATORY TRACT ULCERATION,2
AU,RESTRICTIVE PULMONARY DISEASE,2
AU,REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT,2
AU,RHEUMATOID LUNG,2
AU,RHINITIS,2
AU,SALMONELLOSIS,2
AU,SARCOIDOSIS,2
AU,SCAR,2
AU,SCIATICA,2
AU,SENSORY DISTURBANCE,2
AU,SERUM SICKNESS,2
AU,SHOULDER DEFORMITY,2
AU,SHOULDER OPERATION,2
AU,SINUS TACHYCARDIA,2
AU,SKIN DISCOLOURATION,2
AU,SKIN LESION REMOVAL,2
AU,SLEEP DISORDER,2
AU,SMALL INTESTINAL STENOSIS,2
AU,SOFT TISSUE INJURY,2
AU,SOLAR LENTIGO,2
AU,SPLENIC LESION,2
AU,SPUTUM DISCOLOURED,2
AU,SYNOVIAL CYST,2
AU,SYNOVITIS,2
AU,SYSTEMIC CANDIDA,2
AU,TEMPORAL ARTERITIS,2
AU,TEMPOROMANDIBULAR JOINT SYNDROME,2
AU,TENDON INJURY,2
AU,TENDON OPERATION,2
AU,TENDON RUPTURE,2
AU,TENDONITIS,2
AU,THERMAL BURN,2
AU,THORACIC VERTEBRAL FRACTURE,2
AU,THROAT TIGHTNESS,2
AU,THROMBOCYTOPENIC PURPURA,2
AU,TONGUE ULCERATION,2
AU,TONSILLITIS,2
AU,TOOTH EXTRACTION,2
AU,TRANSIENT ISCHAEMIC ATTACK,2
AU,TREATMENT NONCOMPLIANCE,2
AU,TUBERCULOSIS,2
AU,UNDERDOSE,2
AU,UPPER LIMB FRACTURE,2
AU,URINARY RETENTION,2
AU,UROSEPSIS,2
AU,VENOOCCLUSIVE LIVER DISEASE,2
AU,VENOUS THROMBOSIS,2
AU,VENTRICULAR FIBRILLATION,2
AU,VERTIGO POSITIONAL,2
AU,VESTIBULAR NEURONITIS,2
AU,VIITH NERVE PARALYSIS,2
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
AU,VITAMIN D DEFICIENCY,2
AU,WOUND,2
AU,WOUND COMPLICATION,2
AU,WOUND DEHISCENCE,2
AU,WOUND SECRETION,2
AU,ABDOMINAL ADHESIONS,1
AU,ABDOMINAL HERNIA,1
AU,ABDOMINAL HERNIA REPAIR,1
AU,ABDOMINAL PAIN LOWER,1
AU,ABDOMINAL SEPSIS,1
AU,ABDOMINAL TENDERNESS,1
AU,ABORTION INDUCED,1
AU,ABSCESS DRAINAGE,1
AU,ABSCESS INTESTINAL,1
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
AU,ACUTE CORONARY SYNDROME,1
AU,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
AU,ACUTE HEPATIC FAILURE,1
AU,ACUTE HIV INFECTION,1
AU,ACUTE INTERSTITIAL PNEUMONITIS,1
AU,ACUTE LEUKAEMIA,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
AU,ACUTE PROMYELOCYTIC LEUKAEMIA,1
AU,ACUTE PULMONARY OEDEMA,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,ACUTE RESPIRATORY FAILURE,1
AU,ADDISON^S DISEASE,1
AU,ADENOCARCINOMA,1
AU,ADNEXAL TORSION,1
AU,ADRENAL GLAND CANCER,1
AU,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
AU,ADVERSE EVENT,1
AU,ALOPECIA TOTALIS,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,ALVEOLITIS,1
AU,AMNESIA,1
AU,ANAL INFLAMMATION,1
AU,ANASTOMOTIC FISTULA,1
AU,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
AU,ANGIOPLASTY,1
AU,ANHEDONIA,1
AU,ANKLE ARTHROPLASTY,1
AU,ANKLE OPERATION,1
AU,ANORECTAL DISCOMFORT,1
AU,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
AU,ANTIBODY TEST POSITIVE,1
AU,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
AU,ANTINUCLEAR ANTIBODY INCREASED,1
AU,AORTIC ANEURYSM,1
AU,AORTIC ANEURYSM RUPTURE,1
AU,AORTIC DISSECTION,1
AU,AORTIC VALVE INCOMPETENCE,1
AU,APATHY,1
AU,APHONIA,1
AU,APNOEA,1
AU,APPENDICECTOMY,1
AU,APPENDICITIS PERFORATED,1
AU,ARTERIAL DISORDER,1
AU,ARTERIAL OCCLUSIVE DISEASE,1
AU,ARTERIAL STENOSIS,1
AU,ARTERIAL THROMBOSIS,1
AU,ARTERIOVENOUS FISTULA SITE INFECTION,1
AU,ARTHRITIS ENTEROPATHIC,1
AU,ARTHRITIS FUNGAL,1
AU,ARTHRITIS INFECTIVE,1
AU,ARTHRODESIS,1
AU,ARTHROPOD BITE,1
AU,ARTHROSCOPY,1
AU,ASBESTOSIS,1
AU,ASPERGILLUS TEST,1
AU,ASPIRATION,1
AU,ASTHENOPIA,1
AU,ATAXIA,1
AU,ATRIAL FLUTTER,1
AU,ATYPICAL FEMUR FRACTURE,1
AU,ATYPICAL PNEUMONIA,1
AU,AURA,1
AU,AUTOIMMUNE DISORDER,1
AU,AUTOIMMUNE HEPATITIS,1
AU,AUTOPHOBIA,1
AU,B PRECURSOR TYPE ACUTE LEUKAEMIA,1
AU,BACTERAEMIA,1
AU,BILE DUCT STONE,1
AU,BIOPSY LUNG ABNORMAL,1
AU,BLADDER CANCER,1
AU,BLADDER DISORDER,1
AU,BLADDER DYSFUNCTION,1
AU,BLADDER INJURY,1
AU,BLEPHARITIS,1
AU,BLOOD BILIRUBIN INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
AU,BLOOD GLUCOSE ABNORMAL,1
AU,BLOOD IMMUNOGLOBULIN E INCREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD POTASSIUM INCREASED,1
AU,BLOOD PRESSURE ABNORMAL,1
AU,BLOOD PRESSURE FLUCTUATION,1
AU,BLOOD PRESSURE SYSTOLIC DECREASED,1
AU,BLOOD URINE PRESENT,1
AU,BODY TEMPERATURE INCREASED,1
AU,BONE CANCER METASTATIC,1
AU,BONE CYST,1
AU,BONE MARROW OEDEMA,1
AU,BRADYARRHYTHMIA,1
AU,BREAST CANCER FEMALE,1
AU,BREAST CANCER METASTATIC,1
AU,BREAST DISORDER FEMALE,1
AU,BREAST ENLARGEMENT,1
AU,BREAST HAEMORRHAGE,1
AU,BREAST HYPERPLASIA,1
AU,BREAST PAIN,1
AU,BREAST SWELLING,1
AU,BREAST TENDERNESS,1
AU,BRONCHIOLITIS,1
AU,BRONCHITIS CHRONIC,1
AU,BUNDLE BRANCH BLOCK RIGHT,1
AU,BURNING SENSATION,1
AU,BURSITIS,1
AU,BUTTERFLY RASH,1
AU,CARDIAC INFECTION,1
AU,CARDIAC MURMUR,1
AU,CARDIAC TAMPONADE,1
AU,CAROTID ARTERY ANEURYSM,1
AU,CARPAL TUNNEL SYNDROME,1
AU,CATHETER SITE INFECTION,1
AU,CATHETER SITE PAIN,1
AU,CD4 LYMPHOCYTES DECREASED,1
AU,CELLULITIS ORBITAL,1
AU,CENTRAL NERVOUS SYSTEM INFECTION,1
AU,CEREBRAL AMYLOID ANGIOPATHY,1
AU,CEREBRAL DISORDER,1
AU,CEREBRAL HYPOPERFUSION,1
AU,CHANGE OF BOWEL HABIT,1
AU,CHEST EXPANSION DECREASED,1
AU,CHOLANGIOCARCINOMA,1
AU,CHOLANGITIS ACUTE,1
AU,CHOLANGITIS INFECTIVE,1
AU,CHOLECYSTITIS,1
AU,CHROMATURIA,1
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AU,CHRONIC SPONTANEOUS URTICARIA,1
AU,CLONIC CONVULSION,1
AU,CLOSTRIDIAL INFECTION,1
AU,CLOSTRIDIUM TEST POSITIVE,1
AU,COELIAC DISEASE,1
AU,COLITIS MICROSCOPIC,1
AU,COLON ADENOMA,1
AU,COLON CANCER METASTATIC,1
AU,COLON DYSPLASIA,1
AU,COLOSTOMY,1
AU,COMA,1
AU,COMA SCALE ABNORMAL,1
AU,COMPLICATION OF PREGNANCY,1
AU,COMPUTERISED TOMOGRAM ABNORMAL,1
AU,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
AU,CONGENITAL ARTERIAL MALFORMATION,1
AU,CORNEAL DISORDER,1
AU,CORONARY ARTERY BYPASS,1
AU,CRANIAL NERVE PALSIES MULTIPLE,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CUBITAL TUNNEL SYNDROME,1
AU,CUTANEOUS LUPUS ERYTHEMATOSUS,1
AU,CUTANEOUS SARCOIDOSIS,1
AU,CYSTITIS,1
AU,CYSTITIS KLEBSIELLA,1
AU,CYTOKINE RELEASE SYNDROME,1
AU,DEAFNESS UNILATERAL,1
AU,DEBRIDEMENT,1
AU,DECREASED INTEREST,1
AU,DELAYED ENGRAFTMENT,1
AU,DELIRIUM,1
AU,DERMAL CYST,1
AU,DERMATITIS ALLERGIC,1
AU,DERMATITIS ATOPIC,1
AU,DEVICE DEPENDENCE,1
AU,DIABETES INSIPIDUS,1
AU,DIABETES MELLITUS INADEQUATE CONTROL,1
AU,DIABETIC KETOACIDOSIS,1
AU,DIALYSIS,1
AU,DIAPHRAGMATIC PARALYSIS,1
AU,DIARRHOEA INFECTIOUS,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DISCOMFORT,1
AU,DISEASE COMPLICATION,1
AU,DISSEMINATED TUBERCULOSIS,1
AU,DOUBLE STRANDED DNA ANTIBODY POSITIVE,1
AU,DRUG CLEARANCE DECREASED,1
AU,DRUG EFFECT DELAYED,1
AU,DRUG ERUPTION,1
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
AU,DRUG USE DISORDER,1
AU,DUODENOSTOMY,1
AU,DYSKINESIA,1
AU,DYSPLASIA,1
AU,EAR DISCOMFORT,1
AU,EAR INFECTION,1
AU,ECHINOCOCCIASIS,1
AU,ECTOPIC PREGNANCY,1
AU,EJECTION FRACTION DECREASED,1
AU,ELECTROCARDIOGRAM AMBULATORY ABNORMAL,1
AU,ELECTROCARDIOGRAM T WAVE INVERSION,1
AU,EMPHYSEMA,1
AU,ENCEPHALITIS,1
AU,ENCEPHALITIS VIRAL,1
AU,ENCEPHALOMYELITIS,1
AU,ENCEPHALOPATHY,1
AU,ENDOCARDITIS,1
AU,ENDOMETRIAL CANCER,1
AU,ENTERITIS,1
AU,ENTERITIS INFECTIOUS,1
AU,ENTEROCOCCAL INFECTION,1
AU,ENTEROCUTANEOUS FISTULA,1
AU,ENTHESOPATHY,1
AU,EPIDEMIC POLYARTHRITIS,1
AU,EPIDERMAL NECROSIS,1
AU,ERYTHRODERMIC PSORIASIS,1
AU,ESCHERICHIA SEPSIS,1
AU,EXCORIATION,1
AU,EXPOSED BONE IN JAW,1
AU,EXTRADURAL ABSCESS,1
AU,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
AU,EYE DISCHARGE,1
AU,EYE INFLAMMATION,1
AU,EYE IRRITATION,1
AU,EYE OEDEMA,1
AU,EYE PAIN,1
AU,EYE ULCER,1
AU,FACE OEDEMA,1
AU,FACIAL PAIN,1
AU,FACTOR V DEFICIENCY,1
AU,FAECALOMA,1
AU,FAECES DISCOLOURED,1
AU,FELTY^S SYNDROME,1
AU,FIBROMYALGIA,1
AU,FIBULA FRACTURE,1
AU,FINE MOTOR SKILL DYSFUNCTION,1
AU,FINGER DEFORMITY,1
AU,FISTULA,1
AU,FISTULA OF SMALL INTESTINE,1
AU,FLUID OVERLOAD,1
AU,FOLLICULITIS,1
AU,FOOD POISONING,1
AU,FOOT DEFORMITY,1
AU,FORCED EXPIRATORY VOLUME DECREASED,1
AU,FOREARM FRACTURE,1
AU,FORMICATION,1
AU,FUNGAL SEPSIS,1
AU,FUNGAL SKIN INFECTION,1
AU,GALLBLADDER CANCER METASTATIC,1
AU,GAMMA-GLUTAMYLTRANSFERASE DECREASED,1
AU,GASTRECTOMY,1
AU,GASTRIC HAEMORRHAGE,1
AU,GASTRIC HYPOMOTILITY,1
AU,GASTRIC MUCOSAL HYPERTROPHY,1
AU,GASTRIC STAPLING,1
AU,GASTROINTESTINAL ANASTOMOTIC COMPLICATION,1
AU,GASTROINTESTINAL MOTILITY DISORDER,1
AU,GASTROINTESTINAL NEOPLASM,1
AU,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
AU,GENERALISED OEDEMA,1
AU,GENITAL BLISTER,1
AU,GIARDIASIS,1
AU,GINGIVAL ABSCESS,1
AU,GINGIVAL BLEEDING,1
AU,GINGIVAL PAIN,1
AU,GLAUCOMA,1
AU,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
AU,GOITRE,1
AU,GRAFT COMPLICATION,1
AU,GRAFT VERSUS HOST DISEASE IN LIVER,1
AU,GRANULOMATOSIS WITH POLYANGIITIS,1
AU,GROIN PAIN,1
AU,GYNAECOMASTIA,1
AU,HAEMATEMESIS,1
AU,HAEMOGLOBIN ABNORMAL,1
AU,HAEMOLYSIS,1
AU,HAEMOPHILUS TEST POSITIVE,1
AU,HAIR DISORDER,1
AU,HAND DEFORMITY,1
AU,HAND-FOOT-AND-MOUTH DISEASE,1
AU,HEAD DISCOMFORT,1
AU,HEAD INJURY,1
AU,HEAD TITUBATION,1
AU,HEART RATE INCREASED,1
AU,HEART VALVE INCOMPETENCE,1
AU,HELICOBACTER INFECTION,1
AU,HEPATIC CANCER,1
AU,HEPATIC ENCEPHALOPATHY,1
AU,HEPATIC FIBROSIS,1
AT,RESPIRATORY TRACT INFECTION,14
AT,ADVERSE EVENT,9
AT,DEAFNESS,9
AT,PYREXIA,8
AT,ERYSIPELAS,7
AT,ATRIAL FIBRILLATION,6
AT,PNEUMONIA,6
AT,DIARRHOEA,5
AT,SUDDEN HEARING LOSS,5
AT,ARTHRALGIA,4
AT,CAROTID ARTERY STENOSIS,4
AT,DRUG INEFFECTIVE,4
AT,ENTEROCOLITIS,4
AT,GASTROOESOPHAGEAL REFLUX DISEASE,4
AT,HERPES ZOSTER,4
AT,PNEUMONITIS,4
AT,SEPSIS,4
AT,TRANSIENT ISCHAEMIC ATTACK,4
AT,APPENDICITIS PERFORATED,3
AT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
AT,COLITIS,3
AT,DEATH,3
AT,GRAFT VERSUS HOST DISEASE IN SKIN,3
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
AT,NAUSEA,3
AT,PRODUCT USE ISSUE,3
AT,REFEEDING SYNDROME,3
AT,SEIZURE,3
AT,STOMATITIS,3
AT,TONSILLITIS,3
AT,VOMITING,3
AT,ACUTE RESPIRATORY DISTRESS SYNDROME,2
AT,AGRANULOCYTOSIS,2
AT,ALCOHOLISM,2
AT,ANKYLOSING SPONDYLITIS,2
AT,BASAL GANGLIA HAEMORRHAGE,2
AT,CHOLANGITIS SCLEROSING,2
AT,COLECTOMY,2
AT,COLON ADENOMA,2
AT,CONDITION AGGRAVATED,2
AT,CUSHING^S SYNDROME,2
AT,DYSPNOEA,2
AT,FALL,2
AT,FEBRILE NEUTROPENIA,2
AT,FRACTURE,2
AT,GASTROENTERITIS,2
AT,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
AT,HAEMORRHAGE,2
AT,HISTIOCYTOSIS HAEMATOPHAGIC,2
AT,IMPAIRED HEALING,2
AT,INFLUENZA,2
AT,INFLUENZA LIKE ILLNESS,2
AT,INJECTION RELATED REACTION,2
AT,JOINT INSTABILITY,2
AT,LIVER DISORDER,2
AT,LUPUS-LIKE SYNDROME,2
AT,METASTASES TO LIVER,2
AT,MULTI-ORGAN FAILURE,2
AT,ORGANISING PNEUMONIA,2
AT,OSTEOPENIA,2
AT,PARONYCHIA,2
AT,PRODUCT USE IN UNAPPROVED INDICATION,2
AT,PSORIASIS,2
AT,RADIUS FRACTURE,2
AT,SECONDARY ADRENOCORTICAL INSUFFICIENCY,2
AT,SKIN TOXICITY,2
AT,SKIN ULCER,2
AT,SMALL INTESTINE CARCINOMA,2
AT,SYNCOPE,2
AT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
AT,TINNITUS,2
AT,TRANSAMINASES INCREASED,2
AT,TREATMENT FAILURE,2
AT,TYPE 2 DIABETES MELLITUS,2
AT,ULNA FRACTURE,2
AT,UPPER LIMB FRACTURE,2
AT,URINARY TRACT INFECTION,2
AT,UVEITIS,2
AT,VAGINAL HAEMORRHAGE,2
AT,ABDOMINAL PAIN,1
AT,ABDOMINAL PAIN UPPER,1
AT,ABORTION,1
AT,ABORTION SPONTANEOUS,1
AT,ABSCESS LIMB,1
AT,ACCIDENTAL EXPOSURE TO PRODUCT,1
AT,ACCIDENTAL OVERDOSE,1
AT,ACUTE MYOCARDIAL INFARCTION,1
AT,ACUTE PRERENAL FAILURE,1
AT,ANGINA PECTORIS,1
AT,APOPTOSIS,1
AT,ARRHYTHMIA,1
AT,ARTERIAL DISORDER,1
AT,ARTHRITIS,1
AT,ARTHROPATHY,1
AT,ASPARTATE AMINOTRANSFERASE INCREASED,1
AT,ATRIAL TACHYCARDIA,1
AT,ATYPICAL TERATOID/RHABDOID TUMOUR OF CNS,1
AT,B-CELL LYMPHOMA,1
AT,BACTERAEMIA,1
AT,BASAL CELL CARCINOMA,1
AT,BILIARY COLIC,1
AT,BLAU SYNDROME,1
AT,BLINDNESS,1
AT,BLOOD BILIRUBIN INCREASED,1
AT,BONE PAIN,1
AT,BRAIN OEDEMA,1
AT,BRONCHIAL NEOPLASM,1
AT,BURSITIS,1
AT,C-REACTIVE PROTEIN INCREASED,1
AT,CATARACT,1
AT,CEREBRAL ARTERY EMBOLISM,1
AT,CERVICAL RADICULOPATHY,1
AT,CHOLECYSTECTOMY,1
AT,CIRCULATORY COLLAPSE,1
AT,COLONOSCOPY ABNORMAL,1
AT,COMPLETED SUICIDE,1
AT,CONJUNCTIVAL NEOPLASM,1
AT,CONJUNCTIVITIS,1
AT,CONSTIPATION,1
AT,CORNEOCONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA,1
AT,COUGH,1
AT,CYTOMEGALOVIRUS INFECTION,1
AT,DECREASED APPETITE,1
AT,DEHYDRATION,1
AT,DEVICE RELATED INFECTION,1
AT,DIARRHOEA HAEMORRHAGIC,1
AT,DISEASE PROGRESSION,1
AT,DISTURBANCE IN ATTENTION,1
AT,DIVERTICULITIS,1
AT,DOUBLE STRANDED DNA ANTIBODY,1
AT,DRUG HYPERSENSITIVITY,1
AT,DRUG INTOLERANCE,1
AT,DYSBACTERIOSIS,1
AT,DYSPNOEA EXERTIONAL,1
AT,EMBOLIC CEREBRAL INFARCTION,1
AT,ENDOMETRITIS,1
AT,EPICONDYLITIS,1
AT,EPILEPSY,1
AT,EROSIVE DUODENITIS,1
AT,ESCHERICHIA INFECTION,1
AT,EWING^S SARCOMA,1
AT,FATIGUE,1
AT,FEBRILE INFECTION,1
AT,FEEDING DISORDER,1
AT,FEELING ABNORMAL,1
AT,FEELING HOT,1
AT,GASTROENTERITIS NOROVIRUS,1
AT,GASTROINTESTINAL INFLAMMATION,1
AT,GENERAL PHYSICAL HEALTH DETERIORATION,1
AT,GENITAL HERPES,1
AT,GENITOURINARY TRACT INFECTION,1
AT,GRAFT LOSS,1
AT,GRAFT VERSUS HOST DISEASE,1
AT,GRAFT VERSUS HOST DISEASE IN LIVER,1
AT,GRANULOCYTOPENIA,1
AT,GRANULOMATOSIS WITH POLYANGIITIS,1
AT,HAEMANGIOMA OF SKIN,1
AT,HAEMATOCHEZIA,1
AT,HAEMATOMA,1
AT,HELICOBACTER GASTRITIS,1
AT,HEPATIC ENZYME INCREASED,1
AT,HEPATIC FUNCTION ABNORMAL,1
AT,HEPATITIS B,1
AT,HERPES ZOSTER INFECTION NEUROLOGICAL,1
AT,HISTOLOGY ABNORMAL,1
AT,HYPERCALCAEMIA,1
AT,HYPERTENSION,1
AT,HYPERTENSIVE CRISIS,1
AT,HYPERTRIGLYCERIDAEMIA,1
AT,HYPONATRAEMIA,1
AT,IATROGENIC INJURY,1
AT,ILL-DEFINED DISORDER,1
AT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AT,INCORRECT DRUG ADMINISTRATION DURATION,1
AT,INFECTION,1
AT,INFESTATION,1
AT,INJECTION SITE ERYTHEMA,1
AT,INJURY,1
AT,INTERSTITIAL LUNG DISEASE,1
AT,INTERVERTEBRAL DISC PROTRUSION,1
AT,INTRAVENTRICULAR HAEMORRHAGE,1
AT,JAUNDICE,1
AT,JOINT SWELLING,1
AT,JUVENILE IDIOPATHIC ARTHRITIS,1
AT,LEUKOCYTOSIS,1
AT,LEUKOPENIA,1
AT,LOWER LIMB FRACTURE,1
AT,LUPUS HEPATITIS,1
AT,LYMPHOCYTOSIS,1
AT,MALIGNANT MELANOMA STAGE I,1
AT,MALIGNANT NEOPLASM PROGRESSION,1
AT,MANTLE CELL LYMPHOMA,1
AT,MATERNAL EXPOSURE DURING PREGNANCY,1
AT,MICROANGIOPATHY,1
AT,MUCOSAL INFLAMMATION,1
AT,MUCOUS MEMBRANE DISORDER,1
AT,MUSCLE STRAIN,1
AT,MUSCLE TIGHTNESS,1
AT,MUSCULOSKELETAL DISCOMFORT,1
AT,MUSCULOSKELETAL PAIN,1
AT,MYALGIA,1
AT,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
AT,MYOCARDIAL ISCHAEMIA,1
AT,MYOCARDITIS,1
AT,NASOPHARYNGITIS,1
AT,NEUROTOXICITY,1
AT,NEUTROPENIA,1
AT,NYSTAGMUS,1
AT,OESOPHAGOGASTRODUODENOSCOPY ABNORMAL,1
AT,OSTEOCHONDROSIS,1
AT,OSTEOMYELITIS,1
AT,OSTEONECROSIS OF JAW,1
AT,OVERDOSE,1
AT,PANCREATITIS,1
AT,PANNICULITIS,1
AT,PAO2/FIO2 RATIO DECREASED,1
AT,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
AT,PLEURAL EFFUSION,1
AT,PLEURISY,1
AT,POLYARTHRITIS,1
AT,POLYMYOSITIS,1
AT,PRERENAL FAILURE,1
AT,PRURITUS,1
AT,PUBIS FRACTURE,1
AT,PULMONARY EMBOLISM,1
AT,PULMONARY HAEMORRHAGE,1
AT,PULMONARY OEDEMA,1
AT,PURULENT PERICARDITIS,1
AT,RENAL FAILURE,1
AT,RENAL IMPAIRMENT,1
AT,RESPIRATORY DISTRESS,1
AT,RHINITIS,1
AT,RIB FRACTURE,1
AT,SACROILIITIS,1
AT,SALPINGO-OOPHORITIS,1
AT,SINUSITIS,1
AT,SKIN EXFOLIATION,1
AT,SPINAL DISORDER,1
AT,STAPHYLOCOCCAL SEPSIS,1
AT,SYSTEMIC CANDIDA,1
AT,TENDERNESS,1
AT,THERAPEUTIC RESPONSE DECREASED,1
AT,THERAPY CESSATION,1
AT,TOOTH EXTRACTION,1
AT,TOXICITY TO VARIOUS AGENTS,1
AT,TRANSFUSION-RELATED ACUTE LUNG INJURY,1
AT,TRANSITIONAL CELL CARCINOMA,1
AT,TREMOR,1
AT,VENOOCCLUSIVE DISEASE,1
AT,VENTRICULAR ARRHYTHMIA,1
AT,VENTRICULAR FIBRILLATION,1
AT,VENTRICULAR TACHYCARDIA,1
AT,VERTIGO,1
AT,VISUAL ACUITY REDUCED,1
AT,WEIGHT INCREASED,1
BH,ACUTE KIDNEY INJURY,2
BH,ACUTE MYOCARDIAL INFARCTION,2
BH,CARDIOPULMONARY FAILURE,2
BH,DIARRHOEA,2
BH,PANCYTOPENIA,2
BH,ANAEMIA,1
BD,INFECTION,6
BD,ABDOMINAL PAIN,3
BD,ACARODERMATITIS,3
BD,PIGMENTATION DISORDER,3
BD,SKIN STRIAE,3
BD,SWELLING FACE,3
BD,TYPE 2 LEPRA REACTION,3
BD,WEIGHT INCREASED,3
BY,SEPSIS,2
BY,CALCULUS URINARY,1
BY,DIARRHOEA HAEMORRHAGIC,1
BY,GASTROINTESTINAL DISORDER,1
BY,HISTIOCYTOSIS HAEMATOPHAGIC,1
BY,PYELONEPHRITIS ACUTE,1
BE,OTOTOXICITY,17
BE,RENAL CELL CARCINOMA,17
BE,CATARACT,14
BE,FEBRILE NEUTROPENIA,13
BE,PYREXIA,13
BE,PRODUCT USE ISSUE,12
BE,DIABETES MELLITUS,9
BE,DRUG INEFFECTIVE,9
BE,DRUG-INDUCED LIVER INJURY,9
BE,HIP FRACTURE,9
BE,ILEUS PARALYTIC,9
BE,KERATITIS,9
BE,OESOPHAGEAL ULCER,9
BE,PANCYTOPENIA,9
BE,STOMATITIS,9
BE,KERATOPATHY,8
BE,AMYLOIDOSIS,7
BE,APHTHOUS ULCER,7
BE,CROHN^S DISEASE,7
BE,DISEASE PROGRESSION,7
BE,GASTROOESOPHAGEAL REFLUX DISEASE,7
BE,INTERVERTEBRAL DISCITIS,7
BE,MIGRAINE,7
BE,SLEEP APNOEA SYNDROME,7
BE,GASTROINTESTINAL INFLAMMATION,6
BE,NEUTROPENIC SEPSIS,6
BE,ARTHRALGIA,5
BE,ENDOCARDITIS,5
BE,UVEITIS,5
BE,WEIGHT DECREASED,5
BE,DEATH,4
BE,HERPES ZOSTER,4
BE,MALIGNANT MELANOMA,4
BE,MALIGNANT NEOPLASM PROGRESSION,4
BE,METASTASES TO LUNG,4
BE,NODULAR REGENERATIVE HYPERPLASIA,4
BE,PNEUMONIA,4
BE,PRODUCT USE IN UNAPPROVED INDICATION,4
BE,SEPTIC EMBOLUS,4
BE,ABDOMINAL ABSCESS,3
BE,ANAL ABSCESS,3
BE,BREAST CANCER,3
BE,CHEST PAIN,3
BE,DIABETIC HYPEROSMOLAR COMA,3
BE,DIVERTICULITIS,3
BE,DRUG RESISTANCE,3
BE,EOSINOPHILIA,3
BE,INFECTION,3
BE,INFLAMMATORY PAIN,3
BE,INTERSTITIAL LUNG DISEASE,3
BE,METASTASES TO BONE,3
BE,MUCOSAL INFLAMMATION,3
BE,MYALGIA,3
BE,OBESITY,3
BE,PAIN,3
BE,POLYCHONDRITIS,3
BE,PORTAL HYPERTENSION,3
BE,PULMONARY EMBOLISM,3
BE,RASH,3
BE,RESPIRATORY FAILURE,3
BE,RHEUMATOID ARTHRITIS,3
BE,SEPTIC SHOCK,3
BE,ACUTE GRAFT VERSUS HOST DISEASE,2
BE,ANAEMIA,2
BE,ARTHRITIS,2
BE,ATYPICAL MYCOBACTERIAL INFECTION,2
BE,B-CELL LYMPHOMA,2
BE,BLISTER,2
BE,BONE MARROW FAILURE,2
BE,CARDIAC FAILURE,2
BE,CEREBROVASCULAR ACCIDENT,2
BE,CERVICAL DYSPLASIA,2
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
BE,COLITIS ULCERATIVE,2
BE,COMA,2
BE,DECREASED APPETITE,2
BE,DISEASE RECURRENCE,2
BE,DRUG EFFECT INCOMPLETE,2
BE,DRUG INTOLERANCE,2
BE,DRUG LEVEL DECREASED,2
BE,DRUG SPECIFIC ANTIBODY PRESENT,2
BE,ELECTROCARDIOGRAM QT PROLONGED,2
BE,EPSTEIN-BARR VIRUS INFECTION,2
BE,FOLLICULITIS,2
BE,GENERAL PHYSICAL HEALTH DETERIORATION,2
BE,GRAFT VERSUS HOST DISEASE,2
BE,HEADACHE,2
BE,HEPATOCELLULAR INJURY,2
BE,HYPOTENSION,2
BE,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BE,INFUSION RELATED REACTION,2
BE,INTESTINAL OBSTRUCTION,2
BE,JUVENILE IDIOPATHIC ARTHRITIS,2
BE,LIVER FUNCTION TEST ABNORMAL,2
BE,LYMPHOCYTIC LEUKAEMIA,2
BE,LYMPHOPROLIFERATIVE DISORDER,2
BE,MENINGOENCEPHALITIS VIRAL,2
BE,METASTASES TO LIVER,2
BE,MYOCARDIAL INFARCTION,2
BE,NEUTROPENIA,2
BE,NON-HODGKIN^S LYMPHOMA,2
BE,ORAL HERPES,2
BE,OSTEOARTHRITIS,2
BE,OVARIAN FAILURE,2
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
BE,PSORIASIS,2
BE,PSYCHOTIC DISORDER,2
BE,RENAL FAILURE,2
BE,RESPIRATORY DISTRESS,2
BE,RESPIRATORY TRACT INFECTION,2
BE,ROSACEA,2
BE,SALPINGO-OOPHORITIS,2
BE,STAPHYLOCOCCAL INFECTION,2
BE,SUBCUTANEOUS ABSCESS,2
BE,SUDDEN DEATH,2
BE,THERAPEUTIC RESPONSE DECREASED,2
BE,THROMBOCYTOPENIA,2
BE,TREATMENT NONCOMPLIANCE,2
BE,URINARY TRACT INFECTION,2
BE,VERTIGO,2
BE,ABDOMINAL PAIN,1
BE,ABDOMINAL PAIN UPPER,1
BE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
BE,ADENOCARCINOMA OF COLON,1
BE,ADRENAL GLAND TUBERCULOSIS,1
BE,ADRENAL INSUFFICIENCY,1
BE,AGRANULOCYTOSIS,1
BE,ALOPECIA,1
BE,AMENORRHOEA,1
BE,ANAL FISTULA,1
BE,ANGINA PECTORIS,1
BE,ANGLE CLOSURE GLAUCOMA,1
BE,AORTIC VALVE INCOMPETENCE,1
BE,APHASIA,1
BE,APPENDICEAL ABSCESS,1
BE,APPENDICITIS,1
BE,ARTERIOSCLEROSIS,1
BE,ARTHRODESIS,1
BE,ARTHROPATHY,1
BE,ATRIAL FIBRILLATION,1
BE,BACTERIAL INFECTION,1
BE,BALANCE DISORDER,1
BE,BASAL CELL CARCINOMA,1
BE,BASOSQUAMOUS CARCINOMA,1
BE,BLINDNESS,1
BE,BLOOD COUNT ABNORMAL,1
BE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
BE,BLOOD GONADOTROPHIN INCREASED,1
BE,BRONCHOPULMONARY ASPERGILLOSIS,1
BE,BURSITIS INFECTIVE,1
BE,C-REACTIVE PROTEIN INCREASED,1
BE,CALCULUS BLADDER,1
BE,CARDIAC SARCOIDOSIS,1
BE,CARDIOGENIC SHOCK,1
BE,CARPAL TUNNEL SYNDROME,1
BE,CELLULITIS,1
BE,CEREBRAL ARTERY EMBOLISM,1
BE,CHEST DISCOMFORT,1
BE,CHRONIC GRAFT VERSUS HOST DISEASE,1
BE,CHRONIC MYELOID LEUKAEMIA,1
BE,CLEAR CELL RENAL CELL CARCINOMA,1
BE,COLITIS ISCHAEMIC,1
BE,COLON ADENOMA,1
BE,COLON DYSPLASIA,1
BE,CONDITION AGGRAVATED,1
BE,CONTRAINDICATED PRODUCT ADMINISTERED,1
BE,CONTUSION,1
BE,COUGH,1
BE,CUTANEOUS VASCULITIS,1
BE,CYTOMEGALOVIRUS INFECTION,1
BE,DEAFNESS NEUROSENSORY,1
BE,DEEP VEIN THROMBOSIS,1
BE,DEFAECATION URGENCY,1
BE,DEFORMITY,1
BE,DENTAL PROSTHESIS PLACEMENT,1
BE,DEPRESSION,1
BE,DERMATITIS EXFOLIATIVE,1
BE,DEVICE RELATED INFECTION,1
BE,DIARRHOEA,1
BE,DISSEMINATED TUBERCULOSIS,1
BE,DIVERTICULAR PERFORATION,1
BE,DIZZINESS,1
BE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
BE,DRUG CLEARANCE DECREASED,1
BE,DRUG HYPERSENSITIVITY,1
BE,DRUG LEVEL INCREASED,1
BE,DYSGEUSIA,1
BE,DYSPEPSIA,1
BE,DYSPNOEA,1
BE,ECCHYMOSIS,1
BE,ENCEPHALITIS AUTOIMMUNE,1
BE,ENCEPHALOPATHY,1
BE,ENDOMETRIAL ADENOCARCINOMA,1
BE,ENTEROCOCCAL SEPSIS,1
BE,ERYSIPELAS,1
BE,ERYTHEMA,1
BE,ESCHERICHIA SEPSIS,1
BE,EXOMPHALOS,1
BE,EXOSTOSIS,1
BE,EYE PAIN,1
BE,EYE PRURITUS,1
BE,FALL,1
BE,FATIGUE,1
BE,FEELING COLD,1
BE,FIBROSIS,1
BE,FLANK PAIN,1
BE,FOCAL NODULAR HYPERPLASIA,1
BE,GAIT DISTURBANCE,1
BE,GASTROENTERITIS BACTERIAL,1
BE,GASTROINTESTINAL TOXICITY,1
BE,GASTROINTESTINAL ULCER HAEMORRHAGE,1
BE,GINGIVAL DISORDER,1
BE,GLIOMA,1
BE,GRANULOMATOUS LIVER DISEASE,1
BE,GROIN ABSCESS,1
BE,HAEMANGIOMA OF LIVER,1
BE,HAEMATOMA,1
BE,HAEMOLYTIC ANAEMIA,1
BE,HAEMORRHOIDS,1
BE,HAND DEFORMITY,1
BE,HEMIPARESIS,1
BE,HEPATIC CIRRHOSIS,1
BE,HEPATIC ENZYME INCREASED,1
BE,HEPATIC MASS,1
BE,HEPATITIS,1
BE,HEPATITIS TOXIC,1
BE,HEPATOSPLENOMEGALY,1
BE,HERPES ZOSTER OPHTHALMIC,1
BE,HIP SURGERY,1
BE,HISTIOCYTOSIS HAEMATOPHAGIC,1
BE,HOSPITALISATION,1
BE,HUMERUS FRACTURE,1
BE,HYPERCALCAEMIA,1
BE,HYPERCHOLESTEROLAEMIA,1
BE,HYPEROSMOLAR STATE,1
BE,HYPERTHERMIA,1
BE,HYPERTHYROIDISM,1
BE,HYPERTROPHIC CARDIOMYOPATHY,1
BE,HYPERVENTILATION,1
BE,HYPOAESTHESIA,1
BE,ILEAL STENOSIS,1
BE,IMPAIRED HEALING,1
BE,INCISIONAL HERNIA,1
BE,INCREASED INSULIN REQUIREMENT,1
BE,INFARCTION,1
BE,INFLAMMATION,1
BE,INFLUENZA LIKE ILLNESS,1
BE,INGUINAL MASS,1
BE,INJECTION SITE BRUISING,1
BE,INJECTION SITE ERYTHEMA,1
BE,INJECTION SITE INDURATION,1
BE,INJURY,1
BE,INSOMNIA,1
BE,INTESTINAL POLYP,1
BE,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
BE,INVASIVE DUCTAL BREAST CARCINOMA,1
BE,IRON DEFICIENCY ANAEMIA,1
BE,ISCHAEMIC STROKE,1
BE,JOINT SWELLING,1
BE,KIDNEY INFECTION,1
BE,LARGE INTESTINAL STENOSIS,1
BE,LARGE INTESTINE PERFORATION,1
BE,LARGE INTESTINE POLYP,1
BE,LATENT TUBERCULOSIS,1
BE,LEGIONELLA INFECTION,1
BE,LEIOMYOSARCOMA,1
BE,LEUKOCYTOSIS,1
BE,LIMB DISCOMFORT,1
BE,LIVER DISORDER,1
BE,LUMBAR SPINAL STENOSIS,1
BE,LUNG ABSCESS,1
BE,LUNG INFECTION,1
BE,LUNG INFECTION PSEUDOMONAL,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LYMPH NODE TUBERCULOSIS,1
BE,LYMPHADENITIS,1
BE,LYMPHOCYTOSIS,1
BE,MALAISE,1
BE,MENINGITIS,1
BE,MENINGITIS PNEUMOCOCCAL,1
BE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
BE,METASTASES TO LYMPH NODES,1
BE,METASTASES TO THE MEDIASTINUM,1
BE,METASTATIC NEOPLASM,1
BE,MITRAL VALVE INCOMPETENCE,1
BE,MOBILITY DECREASED,1
BE,MUSCLE TIGHTNESS,1
BE,MUSCULAR WEAKNESS,1
BE,MUSCULOSKELETAL STIFFNESS,1
BE,MYCOSIS FUNGOIDES,1
BE,NASAL SEPTAL OPERATION,1
BE,NAUSEA,1
BE,NECK MASS,1
BE,NEOPLASM MALIGNANT,1
BE,NEOPLASM PROSTATE,1
BE,NEPHROTIC SYNDROME,1
BE,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
BE,NEUROLOGICAL DECOMPENSATION,1
BE,NON-SMALL CELL LUNG CANCER,1
BE,ORAL NEOPLASM,1
BE,OSTEITIS,1
BE,OSTEONECROSIS,1
BE,OVERDOSE,1
BE,PAIN IN EXTREMITY,1
BE,PALLOR,1
BE,PANCREATITIS ACUTE,1
BE,PATHOLOGICAL FRACTURE,1
BE,PELVI-URETERIC OBSTRUCTION,1
BE,PELVIC FRACTURE,1
BE,PELVIC INFLAMMATORY DISEASE,1
BE,PERINEAL ABSCESS,1
BE,PERIPHERAL SWELLING,1
BE,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
BE,PERITONITIS,1
BE,PNEUMOMEDIASTINUM,1
BE,PNEUMONITIS,1
BE,PNEUMOPERITONEUM,1
BE,POLYARTHRITIS,1
BE,POST PROCEDURAL PNEUMONIA,1
BE,PREMATURE MENOPAUSE,1
BE,PRESCRIBED UNDERDOSE,1
BE,PRURITUS,1
BE,PSEUDOMONAL SEPSIS,1
BE,PULMONARY OEDEMA,1
BE,PYODERMA GANGRENOSUM,1
BE,PYONEPHROSIS,1
BE,RADICAL PROSTATECTOMY,1
BE,RASH MACULO-PAPULAR,1
BE,RASH PUSTULAR,1
BE,RECTAL HAEMORRHAGE,1
BE,SACROILIITIS,1
BE,SARCOIDOSIS,1
BE,SCARLET FEVER,1
BE,SCEDOSPORIUM INFECTION,1
BE,SECRETION DISCHARGE,1
BE,SEMINOMA,1
BE,SEPSIS,1
BE,SERUM AMYLOID A PROTEIN INCREASED,1
BE,SKIN DISORDER,1
BE,SKIN INFECTION,1
BE,SKIN REACTION,1
BE,SOCIAL PROBLEM,1
BE,SPINAL COMPRESSION FRACTURE,1
BE,SPLENOMEGALY,1
BE,SPLINTER,1
BE,SPONDYLITIS,1
BE,SQUAMOUS CELL CARCINOMA,1
BE,SQUAMOUS CELL CARCINOMA OF SKIN,1
BE,STEVENS-JOHNSON SYNDROME,1
BE,SUBILEUS,1
BE,SUICIDE ATTEMPT,1
BE,SUTURE INSERTION,1
BE,SYNOVITIS,1
BE,SYSTEMIC MYCOSIS,1
BE,T-CELL LYMPHOMA RECURRENT,1
BE,TENDON RUPTURE,1
BE,THERAPEUTIC RESPONSE UNEXPECTED,1
BE,TONGUE ULCERATION,1
BE,TOOTH ABSCESS,1
BE,TOOTHACHE,1
BE,TOXICITY TO VARIOUS AGENTS,1
BE,TRANSIENT ISCHAEMIC ATTACK,1
BE,TRANSPLANT,1
BE,TUBERCULIN TEST POSITIVE,1
BE,TUBERCULOSIS,1
BE,UPPER RESPIRATORY TRACT INFECTION,1
BE,VARICELLA,1
BE,VENTRICULAR TACHYCARDIA,1
BE,VESTIBULAR DISORDER,1
BE,VOMITING,1
BO,DEATH,1
BA,ANGINA PECTORIS,1
BA,C-REACTIVE PROTEIN INCREASED,1
BA,CONDITION AGGRAVATED,1
BA,DERMATOMYOSITIS,1
BA,DISEASE RECURRENCE,1
BA,ERYTHEMA,1
BA,EYELID RASH,1
BA,HAEMOGLOBIN DECREASED,1
BA,JUVENILE IDIOPATHIC ARTHRITIS,1
BA,MYOCARDIAL INFARCTION,1
BA,MYOSITIS,1
BA,NASAL OEDEMA,1
BA,PRODUCT USE ISSUE,1
BA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BA,SKIN ATROPHY,1
BA,ULCER,1
BA,URTICARIA,1
BR,PAIN,576
BR,ARTHRALGIA,536
BR,DRUG INEFFECTIVE,393
BR,PAIN IN EXTREMITY,376
BR,INFLUENZA,252
BR,RHEUMATOID ARTHRITIS,247
BR,GAIT DISTURBANCE,246
BR,URINARY TRACT INFECTION,235
BR,MALAISE,226
BR,PNEUMONIA,215
BR,WEIGHT DECREASED,201
BR,HEADACHE,197
BR,PERIPHERAL SWELLING,196
BR,FALL,175
BR,JOINT SWELLING,173
BR,DYSPNOEA,167
BR,INJECTION SITE PAIN,162
BR,PYREXIA,162
BR,HYPERTENSION,151
BR,ARTHROPATHY,150
BR,HYPERSENSITIVITY,148
BR,IMMUNODEFICIENCY,146
BR,SWELLING,139
BR,ASTHENIA,138
BR,FATIGUE,138
BR,WEIGHT INCREASED,138
BR,COUGH,137
BR,OSTEOARTHRITIS,133
BR,NAUSEA,127
BR,ARTHRITIS,120
BR,BACK PAIN,119
BR,DIZZINESS,114
BR,ANAEMIA,110
BR,DEPRESSION,110
BR,INFECTION,106
BR,PRURITUS,104
BR,SINUSITIS,103
BR,VOMITING,100
BR,ABASIA,99
BR,INJECTION SITE ERYTHEMA,96
BR,DRUG DOSE OMISSION,91
BR,ERYTHEMA,91
BR,DIARRHOEA,87
BR,DIABETES MELLITUS,84
BR,NASOPHARYNGITIS,79
BR,INFLAMMATION,78
BR,MEMORY IMPAIRMENT,76
BR,INJECTION SITE PRURITUS,73
BR,WOUND,73
BR,HYPOAESTHESIA,72
BR,MOBILITY DECREASED,71
BR,INSOMNIA,69
BR,CATARACT,67
BR,SPINAL PAIN,66
BR,FOOT DEFORMITY,64
BR,CHEST PAIN,63
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,63
BR,PSORIASIS,63
BR,DECREASED APPETITE,62
BR,MUSCULOSKELETAL STIFFNESS,61
BR,ABDOMINAL PAIN UPPER,60
BR,BLOOD CHOLESTEROL INCREASED,60
BR,DENGUE FEVER,60
BR,ALOPECIA,59
BR,CARDIAC DISORDER,59
BR,MUSCULOSKELETAL PAIN,59
BR,BLOOD PRESSURE INCREASED,58
BR,OROPHARYNGEAL PAIN,58
BR,FEELING ABNORMAL,55
BR,DEATH,53
BR,OSTEOPOROSIS,53
BR,SYNCOPE,53
BR,SOMNOLENCE,52
BR,ANXIETY,51
BR,ARRHYTHMIA,51
BR,TUBERCULOSIS,51
BR,DECREASED IMMUNE RESPONSIVENESS,50
BR,ABDOMINAL PAIN,49
BR,INTERVERTEBRAL DISC PROTRUSION,49
BR,NEPHROLITHIASIS,49
BR,SKIN DISCOLOURATION,49
BR,LUNG DISORDER,48
BR,VISUAL IMPAIRMENT,47
BR,BONE DISORDER,46
BR,DYSPHONIA,46
BR,BURNING SENSATION,45
BR,DEVICE MALFUNCTION,45
BR,NECK PAIN,45
BR,PRODUCT USE ISSUE,45
BR,BEDRIDDEN,44
BR,TREMOR,44
BR,HAND DEFORMITY,42
BR,PHARYNGITIS,42
BR,THERAPEUTIC RESPONSE DECREASED,42
BR,CHOLELITHIASIS,41
BR,CONDITION AGGRAVATED,41
BR,INJECTION SITE SWELLING,41
BR,THROMBOSIS,41
BR,MYOCARDIAL INFARCTION,40
BR,NERVOUSNESS,40
BR,HAEMORRHAGE,39
BR,BLOOD CHOLESTEROL ABNORMAL,38
BR,BONE PAIN,38
BR,CEREBROVASCULAR ACCIDENT,38
BR,FEMUR FRACTURE,38
BR,FINGER DEFORMITY,38
BR,LOCAL SWELLING,38
BR,MUSCULAR WEAKNESS,38
BR,SPINAL DISORDER,38
BR,FEELING HOT,37
BR,HYPOTENSION,37
BR,PARAESTHESIA,37
BR,SEPSIS,37
BR,VIRAL INFECTION,37
BR,INFUSION RELATED REACTION,36
BR,LUNG INFECTION,36
BR,RASH,35
BR,DYSSTASIA,34
BR,LIMB INJURY,34
BR,MASS,34
BR,RASH MACULAR,34
BR,DRUG EFFECT INCOMPLETE,33
BR,INFARCTION,33
BR,LABYRINTHITIS,33
BR,NODULE,33
BR,GASTRITIS,32
BR,LIVER DISORDER,32
BR,MUSCLE SPASMS,32
BR,RHINITIS,32
BR,STRESS,32
BR,INJECTION SITE MASS,31
BR,OEDEMA PERIPHERAL,31
BR,HYPERHIDROSIS,30
BR,INJECTION SITE WARMTH,30
BR,JOINT STIFFNESS,30
BR,LOCALISED INFECTION,30
BR,VISION BLURRED,30
BR,BRONCHITIS,29
BR,HERPES VIRUS INFECTION,29
BR,INJECTION SITE DISCOLOURATION,29
BR,JOINT RANGE OF MOTION DECREASED,29
BR,PLATELET COUNT DECREASED,29
BR,RENAL DISORDER,29
BR,ANKYLOSING SPONDYLITIS,28
BR,DRUG HYPERSENSITIVITY,28
BR,DRY MOUTH,28
BR,GASTRIC DISORDER,28
BR,HYPOPHAGIA,28
BR,JOINT INJURY,28
BR,TACHYCARDIA,28
BR,TENDON RUPTURE,28
BR,ABDOMINAL DISTENSION,27
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,27
BR,BLISTER,27
BR,PULMONARY OEDEMA,27
BR,HERPES ZOSTER,26
BR,MOVEMENT DISORDER,26
BR,PRURITUS GENERALISED,26
BR,PULMONARY EMBOLISM,26
BR,PULMONARY MASS,26
BR,ROAD TRAFFIC ACCIDENT,26
BR,TENDONITIS,26
BR,TOOTH DISORDER,26
BR,UNEVALUABLE EVENT,26
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,26
BR,BLOOD GLUCOSE INCREASED,25
BR,CHILLS,25
BR,EAR INFECTION,25
BR,PLEURAL EFFUSION,25
BR,THROAT IRRITATION,25
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,25
BR,BLOOD PRESSURE DECREASED,24
BR,DRUG EFFECT DECREASED,24
BR,THYROID DISORDER,24
BR,VARICOSE VEIN,24
BR,BLOOD PRESSURE FLUCTUATION,23
BR,CHONDROPATHY,23
BR,DRUG-INDUCED LIVER INJURY,23
BR,DRY SKIN,23
BR,EXOSTOSIS,23
BR,INJECTION SITE HAEMATOMA,23
BR,JOINT EFFUSION,23
BR,OCULAR HYPERAEMIA,23
BR,RHEUMATIC DISORDER,23
BR,STOMATITIS,23
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,23
BR,UPPER LIMB FRACTURE,23
BR,AMNESIA,22
BR,CYST,22
BR,DEPRESSED MOOD,22
BR,DEVICE DISLOCATION,22
BR,DRY EYE,22
BR,DYSURIA,22
BR,GASTROINTESTINAL DISORDER,22
BR,GASTROOESOPHAGEAL REFLUX DISEASE,22
BR,GLAUCOMA,22
BR,HEPATIC STEATOSIS,22
BR,JOINT DISLOCATION,22
BR,NEUTROPENIA,22
BR,PSORIATIC ARTHROPATHY,22
BR,SWELLING FACE,22
BR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,21
BR,FIBROMYALGIA,21
BR,LEUKOPENIA,21
BR,POST PROCEDURAL COMPLICATION,21
BR,SURGERY,21
BR,EMOTIONAL DISORDER,20
BR,IMPAIRED HEALING,20
BR,KIDNEY INFECTION,20
BR,KNEE ARTHROPLASTY,20
BR,LOWER LIMB FRACTURE,20
BR,SPEECH DISORDER,20
BR,BLINDNESS,19
BR,BURSITIS,19
BR,CARDIAC ARREST,19
BR,CONFUSIONAL STATE,19
BR,CONJUNCTIVITIS,19
BR,EPISTAXIS,19
BR,EYE DISORDER,19
BR,GAIT INABILITY,19
BR,HAEMATOMA,19
BR,KNEE OPERATION,19
BR,LARYNGEAL OEDEMA,19
BR,MUSCULOSKELETAL DISORDER,19
BR,TOXICITY TO VARIOUS AGENTS,19
BR,ASTHMA,18
BR,ATROPHY,18
BR,BACTERIAL INFECTION,18
BR,BLOOD PRESSURE ABNORMAL,18
BR,ERYSIPELAS,18
BR,EYE PAIN,18
BR,IMMUNOSUPPRESSION,18
BR,LIGAMENT SPRAIN,18
BR,LOSS OF CONSCIOUSNESS,18
BR,MEDICATION ERROR,18
BR,OSTEOPENIA,18
BR,SPINAL OSTEOARTHRITIS,18
BR,URTICARIA,18
BR,VITAMIN D DECREASED,18
BR,BODY HEIGHT DECREASED,17
BR,BONE EROSION,17
BR,CARDIOMEGALY,17
BR,CARTILAGE INJURY,17
BR,DEAFNESS,17
BR,DYSGEUSIA,17
BR,EATING DISORDER,17
BR,EXPOSURE DURING PREGNANCY,17
BR,FOOT FRACTURE,17
BR,GALLBLADDER DISORDER,17
BR,HEART RATE INCREASED,17
BR,ILL-DEFINED DISORDER,17
BR,KNEE DEFORMITY,17
BR,PRODUCT QUALITY ISSUE,17
BR,SEPTIC SHOCK,17
BR,SKIN EXFOLIATION,17
BR,TOOTH INFECTION,17
BR,ARTHRITIS INFECTIVE,16
BR,CELLULITIS,16
BR,CRYING,16
BR,DERMATITIS ALLERGIC,16
BR,DISEASE PROGRESSION,16
BR,DIVERTICULITIS,16
BR,DYSPEPSIA,16
BR,EAR PAIN,16
BR,FEELING COLD,16
BR,HIP ARTHROPLASTY,16
BR,LIMB DEFORMITY,16
BR,RENAL FAILURE,16
BR,RENAL IMPAIRMENT,16
BR,RESPIRATORY FAILURE,16
BR,SKIN DISORDER,16
BR,THROAT TIGHTNESS,16
BR,ACCIDENT,15
BR,BREAST CANCER,15
BR,CANDIDA INFECTION,15
BR,CATARRH,15
BR,COMA,15
BR,DEHYDRATION,15
BR,EYE IRRITATION,15
BR,HIP FRACTURE,15
BR,HOSPITALISATION,15
BR,IMMUNE SYSTEM DISORDER,15
BR,INJECTION SITE HYPERSENSITIVITY,15
BR,IRIS ADHESIONS,15
BR,LABORATORY TEST ABNORMAL,15
BR,POST PROCEDURAL INFECTION,15
BR,PRODUCT AVAILABILITY ISSUE,15
BR,PULMONARY FIBROSIS,15
BR,RENAL PAIN,15
BR,RETCHING,15
BR,SCIATICA,15
BR,SECRETION DISCHARGE,15
BR,VISUAL ACUITY REDUCED,15
BR,VITAMIN D DEFICIENCY,15
BR,BLOOD GLUCOSE ABNORMAL,14
BR,CROHN^S DISEASE,14
BR,DYSPHAGIA,14
BR,GASTROINTESTINAL INFECTION,14
BR,HEPATITIS,14
BR,HIATUS HERNIA,14
BR,LIMB OPERATION,14
BR,MYALGIA,14
BR,PALPITATIONS,14
BR,PANCYTOPENIA,14
BR,PERICARDIAL EFFUSION,14
BR,PROCEDURAL PAIN,14
BR,SEIZURE,14
BR,SKIN LESION,14
BR,TINNITUS,14
BR,TOOTH FRACTURE,14
BR,UVEITIS,14
BR,ANKLE FRACTURE,13
BR,BLOOD TRIGLYCERIDES INCREASED,13
BR,CARPAL TUNNEL SYNDROME,13
BR,CHIKUNGUNYA VIRUS INFECTION,13
BR,FLUID RETENTION,13
BR,FURUNCLE,13
BR,HEAD INJURY,13
BR,HYPERGLYCAEMIA,13
BR,HYPOACUSIS,13
BR,INCORRECT PRODUCT STORAGE,13
BR,LEIOMYOMA,13
BR,LYMPHOMA,13
BR,MIGRAINE,13
BR,MOUTH INJURY,13
BR,NERVOUS SYSTEM DISORDER,13
BR,ORAL HERPES,13
BR,PULMONARY TUBERCULOSIS,13
BR,RHEUMATOID FACTOR INCREASED,13
BR,SKIN IRRITATION,13
BR,SKIN ULCER,13
BR,SPINAL FRACTURE,13
BR,SYNOVITIS,13
BR,ABDOMINAL DISCOMFORT,12
BR,BLOOD TEST ABNORMAL,12
BR,C-REACTIVE PROTEIN INCREASED,12
BR,CARDIAC FAILURE,12
BR,CARDIOVASCULAR DISORDER,12
BR,CORONARY ARTERY OCCLUSION,12
BR,DEVICE RELATED INFECTION,12
BR,FEBRILE NEUTROPENIA,12
BR,FEEDING DISORDER,12
BR,FORMICATION,12
BR,GRIP STRENGTH DECREASED,12
BR,HAEMATOCHEZIA,12
BR,HAEMORRHOIDS,12
BR,HERNIA,12
BR,INCORRECT DOSE ADMINISTERED,12
BR,INTENTIONAL PRODUCT MISUSE,12
BR,LACERATION,12
BR,MENISCUS INJURY,12
BR,MENORRHAGIA,12
BR,MENTAL DISORDER,12
BR,MUSCLE ATROPHY,12
BR,NASAL CONGESTION,12
BR,OVARIAN CYST,12
BR,POSTOPERATIVE WOUND INFECTION,12
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,12
BR,THERAPEUTIC RESPONSE UNEXPECTED,12
BR,TUBERCULIN TEST POSITIVE,12
BR,URINARY INCONTINENCE,12
BR,UTERINE LEIOMYOMA,12
BR,VENOUS OCCLUSION,12
BR,AGITATION,11
BR,ALANINE AMINOTRANSFERASE INCREASED,11
BR,ANAPHYLACTIC SHOCK,11
BR,APHONIA,11
BR,APPLICATION SITE ERYTHEMA,11
BR,ASPARTATE AMINOTRANSFERASE INCREASED,11
BR,BALANCE DISORDER,11
BR,BLOOD TRIGLYCERIDES ABNORMAL,11
BR,BREAST MASS,11
BR,CONSTIPATION,11
BR,FEAR,11
BR,HYPERKERATOSIS,11
BR,HYPOGLYCAEMIA,11
BR,HYPOKINESIA,11
BR,HYPOTHYROIDISM,11
BR,INJECTION SITE INDURATION,11
BR,INJECTION SITE REACTION,11
BR,IRRITABILITY,11
BR,LIMB DISCOMFORT,11
BR,NEUROPATHY PERIPHERAL,11
BR,OSTEOMYELITIS,11
BR,PANIC DISORDER,11
BR,PHARYNGEAL DISORDER,11
BR,PYELONEPHRITIS,11
BR,RESPIRATORY TRACT INFECTION,11
BR,RIB FRACTURE,11
BR,UMBILICAL HERNIA,11
BR,ANGIOPATHY,10
BR,ARTERIAL OCCLUSIVE DISEASE,10
BR,CHEST DISCOMFORT,10
BR,DISCOMFORT,10
BR,EMPHYSEMA,10
BR,HEAD DISCOMFORT,10
BR,INJECTION SITE HAEMORRHAGE,10
BR,JOINT LOCK,10
BR,MUCOSAL INFLAMMATION,10
BR,NEOPLASM,10
BR,NOSOCOMIAL INFECTION,10
BR,PALLOR,10
BR,POLLAKIURIA,10
BR,SLEEP DISORDER,10
BR,VAGINAL HAEMORRHAGE,10
BR,VASCULITIS,10
BR,WEIGHT FLUCTUATION,10
BR,WHEEZING,10
BR,ACCIDENTAL EXPOSURE TO PRODUCT,9
BR,ACUTE MYOCARDIAL INFARCTION,9
BR,APPENDICITIS,9
BR,ARTHROPOD BITE,9
BR,C-REACTIVE PROTEIN ABNORMAL,9
BR,DEAFNESS UNILATERAL,9
BR,DEEP VEIN THROMBOSIS,9
BR,HEPATIC ENZYME INCREASED,9
BR,INTERVERTEBRAL DISC DISORDER,9
BR,LEUKOCYTOSIS,9
BR,MUSCLE RIGIDITY,9
BR,OSTEONECROSIS,9
BR,PATIENT-DEVICE INCOMPATIBILITY,9
BR,PRODUCTIVE COUGH,9
BR,RASH ERYTHEMATOUS,9
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,9
BR,SENSORY LOSS,9
BR,SKIN HYPERTROPHY,9
BR,SLUGGISHNESS,9
BR,SNEEZING,9
BR,SUICIDAL IDEATION,9
BR,SYNOVIAL CYST,9
BR,TENDON DISORDER,9
BR,THYROID MASS,9
BR,TOOTHACHE,9
BR,VEIN DISORDER,9
BR,WHITE BLOOD CELL COUNT DECREASED,9
BR,WRIST FRACTURE,9
BR,ADVERSE EVENT,8
BR,ALLERGIC COUGH,8
BR,COAGULOPATHY,8
BR,COLITIS,8
BR,CYSTITIS,8
BR,DEFORMITY,8
BR,DYSENTERY,8
BR,EYE HAEMORRHAGE,8
BR,FOOT OPERATION,8
BR,GINGIVAL BLEEDING,8
BR,HEMIPLEGIA,8
BR,HORMONE LEVEL ABNORMAL,8
BR,INGUINAL HERNIA,8
BR,INJECTION SITE OEDEMA,8
BR,JUVENILE IDIOPATHIC ARTHRITIS,8
BR,MUSCULOSKELETAL CHEST PAIN,8
BR,PARALYSIS,8
BR,PHARYNGEAL INFLAMMATION,8
BR,PHARYNGEAL OEDEMA,8
BR,POISONING,8
BR,PRODUCT USE IN UNAPPROVED INDICATION,8
BR,PURULENT DISCHARGE,8
BR,RHEUMATOID NODULE,8
BR,RHINITIS ALLERGIC,8
BR,SENSORY DISTURBANCE,8
BR,THROMBOCYTOPENIA,8
BR,THYROID NEOPLASM,8
BR,TOOTH EXTRACTION,8
BR,TOOTH LOSS,8
BR,ULCER,8
BR,VIRAL UPPER RESPIRATORY TRACT INFECTION,8
BR,ABORTION SPONTANEOUS,7
BR,ANGINA PECTORIS,7
BR,APHASIA,7
BR,ASTHMATIC CRISIS,7
BR,BLINDNESS UNILATERAL,7
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,7
BR,BLOOD URIC ACID INCREASED,7
BR,BONE MARROW DISORDER,7
BR,BRONCHOPNEUMONIA,7
BR,BRONCHOSPASM,7
BR,CHRONIC SINUSITIS,7
BR,CONTUSION,7
BR,CONVULSION,7
BR,DEVICE BREAKAGE,7
BR,DISEASE RECURRENCE,7
BR,DRY THROAT,7
BR,EYE SWELLING,7
BR,FUNGAL INFECTION,7
BR,GASTROENTERITIS,7
BR,GASTROINTESTINAL PAIN,7
BR,GENERALISED OEDEMA,7
BR,GLUCOSE TOLERANCE IMPAIRED,7
BR,HEPATIC CIRRHOSIS,7
BR,HEPATOMEGALY,7
BR,INJURY,7
BR,INTERVERTEBRAL DISC DEGENERATION,7
BR,LEPROSY,7
BR,LIMB ASYMMETRY,7
BR,LIMB MASS,7
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,7
BR,MATERNAL EXPOSURE DURING PREGNANCY,7
BR,MULTI-ORGAN FAILURE,7
BR,NEOPLASM MALIGNANT,7
BR,NERVE COMPRESSION,7
BR,ORAL DISCOMFORT,7
BR,ORAL DISORDER,7
BR,ORAL PAIN,7
BR,OSTEITIS,7
BR,PANCREATITIS,7
BR,PANCREATITIS ACUTE,7
BR,PHLEBITIS,7
BR,PLEURITIC PAIN,7
BR,PROCEDURAL COMPLICATION,7
BR,RENAL CYST,7
BR,RETINAL DETACHMENT,7
BR,SJOGREN^S SYNDROME,7
BR,SKIN CANCER,7
BR,SKIN WOUND,7
BR,SPINAL DEFORMITY,7
BR,UTERINE DISORDER,7
BR,ACNE,6
BR,APPLICATION SITE PAIN,6
BR,BLINDNESS TRANSIENT,6
BR,BLOOD URINE PRESENT,6
BR,BONE FRAGMENTATION,6
BR,BONE LOSS,6
BR,BONE MARROW FAILURE,6
BR,CARDIO-RESPIRATORY ARREST,6
BR,CYANOSIS,6
BR,DRUG ADMINISTRATION ERROR,6
BR,DYSLIPIDAEMIA,6
BR,ENDOMETRIOSIS,6
BR,FRACTURE,6
BR,GASTRIC HAEMORRHAGE,6
BR,GASTRIC ULCER,6
BR,GINGIVITIS,6
BR,HEPATIC NEOPLASM,6
BR,INTESTINAL PERFORATION,6
BR,ISCHAEMIA,6
BR,JOINT CREPITATION,6
BR,LACRIMATION INCREASED,6
BR,LIGAMENT RUPTURE,6
BR,MOUTH ULCERATION,6
BR,MUCOCUTANEOUS LEISHMANIASIS,6
BR,NAIL DISORDER,6
BR,NIGHT SWEATS,6
BR,OBESITY,6
BR,ONYCHOCLASIS,6
BR,ORAL CANDIDIASIS,6
BR,PAIN IN JAW,6
BR,POST PROCEDURAL INFLAMMATION,6
BR,PRODUCT STORAGE ERROR,6
BR,PRURITUS ALLERGIC,6
BR,PSYCHIATRIC SYMPTOM,6
BR,PULMONARY CALCIFICATION,6
BR,RASH PUSTULAR,6
BR,RESPIRATORY DISORDER,6
BR,ROTATOR CUFF SYNDROME,6
BR,SENSITIVITY TO WEATHER CHANGE,6
BR,SPINAL OPERATION,6
BR,SPONDYLITIS,6
BR,SUFFOCATION FEELING,6
BR,TIBIA FRACTURE,6
BR,TONSILLITIS,6
BR,UTERINE INFECTION,6
BR,VEIN RUPTURE,6
BR,VERTIGO,6
BR,WEIGHT LOSS POOR,6
BR,ABDOMINAL HERNIA,5
BR,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,5
BR,APHAGIA,5
BR,APPLICATION SITE PRURITUS,5
BR,ARTERIOSCLEROSIS,5
BR,ARTHRITIS BACTERIAL,5
BR,BACK DISORDER,5
BR,BLADDER DISORDER,5
BR,BONE CYST,5
BR,BONE DEFORMITY,5
BR,BRONCHIECTASIS,5
BR,CALCIUM DEFICIENCY,5
BR,CATARACT OPERATION,5
BR,CHOKING SENSATION,5
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,5
BR,COLD SWEAT,5
BR,COLITIS ULCERATIVE,5
BR,CUTANEOUS LEISHMANIASIS,5
BR,DENTAL CARIES,5
BR,DENTAL IMPLANTATION,5
BR,DERMATITIS,5
BR,DEVICE FAILURE,5
BR,DIARRHOEA HAEMORRHAGIC,5
BR,DIPLOPIA,5
BR,DRUG DEPENDENCE,5
BR,DRUG INTOLERANCE,5
BR,DRUG PRESCRIBING ERROR,5
BR,DYSPNOEA EXERTIONAL,5
BR,EAR DISCOMFORT,5
BR,ELBOW DEFORMITY,5
BR,EMBOLISM,5
BR,EMOTIONAL DISTRESS,5
BR,EYE INFLAMMATION,5
BR,EYELID DISORDER,5
BR,FACE INJURY,5
BR,FEELING OF DESPAIR,5
BR,FLATULENCE,5
BR,FLAVIVIRUS INFECTION,5
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
BR,GASTROINTESTINAL HAEMORRHAGE,5
BR,GENERAL PHYSICAL HEALTH DETERIORATION,5
BR,GINGIVAL DISORDER,5
BR,GROIN PAIN,5
BR,HAEMATEMESIS,5
BR,HAEMOGLOBIN DECREASED,5
BR,HYPERAEMIA,5
BR,HYPERAESTHESIA,5
BR,HYPERSOMNIA,5
BR,HYPERTENSIVE CRISIS,5
BR,IMMOBILE,5
BR,INCISION SITE PAIN,5
BR,INFLAMMATORY MARKER INCREASED,5
BR,INJECTION SITE PAPULE,5
BR,INTERSTITIAL LUNG DISEASE,5
BR,INTESTINAL HAEMORRHAGE,5
BR,INTESTINAL OBSTRUCTION,5
BR,LIPOMA,5
BR,LOOSE TOOTH,5
BR,LUMBAR VERTEBRAL FRACTURE,5
BR,LUPUS-LIKE SYNDROME,5
BR,LYMPHADENOPATHY,5
BR,MEDICAL DEVICE COMPLICATION,5
BR,MOUTH HAEMORRHAGE,5
BR,MYELODYSPLASTIC SYNDROME,5
BR,MYOPIA,5
BR,OCULAR HYPERTENSION,5
BR,OCULAR VASCULAR DISORDER,5
BR,ODYNOPHAGIA,5
BR,OEDEMA,5
BR,OESOPHAGITIS,5
BR,OVERWEIGHT,5
BR,OXYGEN SATURATION DECREASED,5
BR,PAPULE,5
BR,PELVIC FRACTURE,5
BR,PERITONITIS,5
BR,PNEUMONIA BACTERIAL,5
BR,POOR PERIPHERAL CIRCULATION,5
BR,PRESYNCOPE,5
BR,PULMONARY HYPERTENSION,5
BR,PULMONARY SEPSIS,5
BR,RED BLOOD CELL COUNT DECREASED,5
BR,RESPIRATORY ARREST,5
BR,RHEUMATIC FEVER,5
BR,RHINORRHOEA,5
BR,SCAR,5
BR,SCIATIC NERVE NEUROPATHY,5
BR,SERUM FERRITIN INCREASED,5
BR,SKIN FISSURES,5
BR,SKIN INFECTION,5
BR,SKIN MASS,5
BR,SKIN PAPILLOMA,5
BR,SKIN PLAQUE,5
BR,SKIN REACTION,5
BR,THERAPY NON-RESPONDER,5
BR,THIRST,5
BR,THYROID FUNCTION TEST ABNORMAL,5
BR,UNDERDOSE,5
BR,URINE ABNORMALITY,5
BR,VAGINAL DISCHARGE,5
BR,VASCULAR RUPTURE,5
BR,VIITH NERVE PARALYSIS,5
BR,WOUND HAEMORRHAGE,5
BR,ABNORMAL BEHAVIOUR,4
BR,ACUTE RESPIRATORY FAILURE,4
BR,AGEUSIA,4
BR,ALANINE AMINOTRANSFERASE ABNORMAL,4
BR,ALLERGY TO CHEMICALS,4
BR,ANAL HAEMORRHAGE,4
BR,ANTINUCLEAR ANTIBODY POSITIVE,4
BR,AORTIC ANEURYSM,4
BR,APHTHOUS ULCER,4
BR,APNOEA,4
BR,APPLICATION SITE SWELLING,4
BR,ARTERIAL DISORDER,4
BR,ARTERIOSCLEROSIS CORONARY ARTERY,4
BR,ARTHRODESIS,4
BR,ATRIAL FIBRILLATION,4
BR,AXILLARY MASS,4
BR,BENIGN BREAST NEOPLASM,4
BR,BLOOD DISORDER,4
BR,BLOOD GLUCOSE DECREASED,4
BR,BLOOD POTASSIUM ABNORMAL,4
BR,BLOOD POTASSIUM DECREASED,4
BR,BLOOD UREA INCREASED,4
BR,BODY TEMPERATURE DECREASED,4
BR,BONE MARROW OEDEMA,4
BR,BREAST PAIN,4
BR,BRONCHITIS CHRONIC,4
BR,BRONCHOPULMONARY ASPERGILLOSIS,4
BR,CARDIAC FAILURE CONGESTIVE,4
BR,CARDIAC OPERATION,4
BR,CAROTID ARTERY OCCLUSION,4
BR,CARTILAGE ATROPHY,4
BR,CEREBRAL DISORDER,4
BR,CERVICAL RADICULOPATHY,4
BR,CERVIX CARCINOMA,4
BR,CHOKING,4
BR,CHOLECYSTECTOMY,4
BR,CHOLECYSTITIS,4
BR,COCCYDYNIA,4
BR,CONJUNCTIVITIS BACTERIAL,4
BR,DIABETES MELLITUS INADEQUATE CONTROL,4
BR,EAR DISORDER,4
BR,ENDODONTIC PROCEDURE,4
BR,ERYTHEMA MULTIFORME,4
BR,EYE PRURITUS,4
BR,GASTROINTESTINAL CARCINOMA,4
BR,H1N1 INFLUENZA,4
BR,HAEMATOTOXICITY,4
BR,HALLUCINATION,4
BR,HEPATIC ENZYME ABNORMAL,4
BR,HEPATIC INFECTION,4
BR,HEPATOTOXICITY,4
BR,HYPERTHYROIDISM,4
BR,HYPOTHERMIA,4
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
BR,INCREASED UPPER AIRWAY SECRETION,4
BR,INFLUENZA LIKE ILLNESS,4
BR,INGROWING NAIL,4
BR,INJECTION SITE BRUISING,4
BR,INJECTION SITE RASH,4
BR,INJECTION SITE URTICARIA,4
BR,INTRAOCULAR PRESSURE INCREASED,4
BR,IRON DEFICIENCY ANAEMIA,4
BR,JAUNDICE,4
BR,JOINT INSTABILITY,4
BR,JOINT WARMTH,4
BR,LIGAMENT DISORDER,4
BR,LIP OEDEMA,4
BR,LIVER INJURY,4
BR,LUNG NEOPLASM MALIGNANT,4
BR,LYMPH NODE TUBERCULOSIS,4
BR,MACULAR OEDEMA,4
BR,MALIGNANT MELANOMA,4
BR,MONOPLEGIA,4
BR,MOOD ALTERED,4
BR,MUSCULOSKELETAL DISCOMFORT,4
BR,MYOCARDITIS,4
BR,NAIL INFECTION,4
BR,NASAL PRURITUS,4
BR,NERVE INJURY,4
BR,NEURALGIA,4
BR,NEUROMA,4
BR,OBSTRUCTIVE AIRWAYS DISORDER,4
BR,OESOPHAGEAL CANDIDIASIS,4
BR,ONYCHOMADESIS,4
BR,OSTEOSCLEROSIS,4
BR,PERIPHERAL COLDNESS,4
BR,PETECHIAE,4
BR,PIGMENTATION DISORDER,4
BR,PLATELET COUNT INCREASED,4
BR,PNEUMONITIS,4
BR,POLYARTHRITIS,4
BR,PRE-EXISTING CONDITION IMPROVED,4
BR,PULMONARY CAVITATION,4
BR,PULMONARY PAIN,4
BR,PULMONARY THROMBOSIS,4
BR,PURULENCE,4
BR,RENAL COLIC,4
BR,RHEUMATOID LUNG,4
BR,SENSATION OF FOREIGN BODY,4
BR,SKIN BURNING SENSATION,4
BR,SKIN INDURATION,4
BR,SKIN SENSITISATION,4
BR,SUBCUTANEOUS ABSCESS,4
BR,TACHYPNOEA,4
BR,TENDON INJURY,4
BR,THERAPEUTIC RESPONSE SHORTENED,4
BR,TONGUE DISORDER,4
BR,TRANSAMINASES INCREASED,4
BR,TREATMENT NONCOMPLIANCE,4
BR,TYPE 2 DIABETES MELLITUS,4
BR,URINE ANALYSIS ABNORMAL,4
BR,UTERINE HAEMORRHAGE,4
BR,UTERINE NEOPLASM,4
BR,UTERINE POLYP,4
BR,VAGINAL INFECTION,4
BR,VARICOSE VEIN RUPTURED,4
BR,WHEELCHAIR USER,4
BR,WOUND COMPLICATION,4
BR,WOUND INFECTION,4
BR,WOUND SECRETION,4
BR,ABNORMAL FAECES,3
BR,ABSCESS,3
BR,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,3
BR,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,3
BR,ACUTE LYMPHOCYTIC LEUKAEMIA,3
BR,ADVERSE DRUG REACTION,3
BR,AGGRESSION,3
BR,ALLERGIC RESPIRATORY SYMPTOM,3
BR,ANAL SQUAMOUS CELL CARCINOMA,3
BR,ANEURYSM,3
BR,ANIMAL BITE,3
BR,AORTIC DILATATION,3
BR,APATHY,3
BR,ASCITES,3
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,3
BR,ASPERGILLUS INFECTION,3
BR,ASPHYXIA,3
BR,ATELECTASIS,3
BR,BLADDER OPERATION,3
BR,BLADDER PROLAPSE,3
BR,BLOOD CREATININE ABNORMAL,3
BR,BLOOD CREATININE INCREASED,3
BR,BLOOD GLUCOSE FLUCTUATION,3
BR,BONE ATROPHY,3
BR,BONE DECALCIFICATION,3
BR,BONE GRAFT,3
BR,BONE TUBERCULOSIS,3
BR,BRAIN ABSCESS,3
BR,BRAIN HERNIATION,3
BR,BREAST DISORDER,3
BR,BREATH ODOUR,3
BR,BUNDLE BRANCH BLOCK LEFT,3
BR,CARDIAC FAILURE CHRONIC,3
BR,CARDIAC TAMPONADE,3
BR,CATARACT SUBCAPSULAR,3
BR,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,3
BR,CEREBRAL ISCHAEMIA,3
BR,CEREBRAL THROMBOSIS,3
BR,CERVICAL VERTEBRAL FRACTURE,3
BR,CHRONIC GASTRITIS,3
BR,CHRONIC KIDNEY DISEASE,3
BR,CLAVICLE FRACTURE,3
BR,CNS VENTRICULITIS,3
BR,COLON CANCER,3
BR,CONCOMITANT DISEASE AGGRAVATED,3
BR,CONGESTIVE CARDIOMYOPATHY,3
BR,COORDINATION ABNORMAL,3
BR,CORNEAL DISORDER,3
BR,CORONARY ARTERY DISEASE,3
BR,CUSHING^S SYNDROME,3
BR,CUTANEOUS TUBERCULOSIS,3
BR,DAYDREAMING,3
BR,DEMENTIA ALZHEIMER^S TYPE,3
BR,DENTAL OPERATION,3
BR,DENTAL PROSTHESIS PLACEMENT,3
BR,DERMATITIS CONTACT,3
BR,DEVICE LOOSENING,3
BR,DISABILITY,3
BR,DISEASE COMPLICATION,3
BR,DRUG EFFECT DELAYED,3
BR,DUODENAL ULCER,3
BR,ENCEPHALITIS VIRAL,3
BR,ENDOMETRITIS,3
BR,EPISCLERITIS,3
BR,EYE ALLERGY,3
BR,EYE INFECTION,3
BR,EYE INFECTION TOXOPLASMAL,3
BR,FIBROSIS,3
BR,FLUID INTAKE REDUCED,3
BR,FOETAL DEATH,3
BR,FOOD POISONING,3
BR,FULL BLOOD COUNT ABNORMAL,3
BR,GALLBLADDER POLYP,3
BR,GASTROINTESTINAL INFLAMMATION,3
BR,GASTROINTESTINAL MOTILITY DISORDER,3
BR,GENERALISED ERYTHEMA,3
BR,GINGIVAL SWELLING,3
BR,HAEMANGIOMA OF BONE,3
BR,HAEMATOCRIT DECREASED,3
BR,HAEMOPTYSIS,3
BR,HALLUCINATION_ VISUAL,3
BR,HAND FRACTURE,3
BR,HEART RATE DECREASED,3
BR,HEART RATE IRREGULAR,3
BR,HEPATIC CANCER,3
BR,HEPATIC FUNCTION ABNORMAL,3
BR,HEPATIC PAIN,3
BR,HERPES SIMPLEX,3
BR,HISTIOCYTOSIS HAEMATOPHAGIC,3
BR,HOT FLUSH,3
BR,HUMERUS FRACTURE,3
BR,HYPERCHOLESTEROLAEMIA,3
BR,ILEUS PARALYTIC,3
BR,INCISION SITE INFLAMMATION,3
BR,INCREASED APPETITE,3
BR,INFLAMMATION OF WOUND,3
BR,INJECTION SITE DRYNESS,3
BR,INJECTION SITE EXTRAVASATION,3
BR,INJECTION SITE INFECTION,3
BR,INJECTION SITE INJURY,3
BR,INTERVERTEBRAL DISC SPACE NARROWING,3
BR,INTERVERTEBRAL DISCITIS,3
BR,INTESTINAL STENOSIS,3
BR,LACTOSE INTOLERANCE,3
BR,LARYNGITIS,3
BR,LIP DISORDER,3
BR,LIVE BIRTH,3
BR,LIVER FUNCTION TEST ABNORMAL,3
BR,LORDOSIS,3
BR,LOWER EXTREMITY MASS,3
BR,LUNG INFILTRATION,3
BR,LYMPHADENITIS BACTERIAL,3
BR,MALNUTRITION,3
BR,MASTITIS,3
BR,MENINGIOMA,3
BR,MENOPAUSE,3
BR,MENSTRUAL DISORDER,3
BR,MENSTRUATION IRREGULAR,3
BR,MITRAL VALVE DISEASE,3
BR,MUSCLE TWITCHING,3
BR,MYDRIASIS,3
BR,NASAL DISCOMFORT,3
BR,NECROSIS,3
BR,NEEDLE ISSUE,3
BR,NEPHRITIS,3
BR,NEURITIS,3
BR,NONINFECTIVE GINGIVITIS,3
BR,OESOPHAGEAL DISORDER,3
BR,ORAL PRURITUS,3
BR,OSTEONECROSIS OF JAW,3
BR,OVERDOSE,3
BR,PAIN OF SKIN,3
BR,PARKINSON^S DISEASE,3
BR,PELVIC PAIN,3
BR,PERIODONTITIS,3
BR,PERIPHERAL ARTERY OCCLUSION,3
BR,PERIPHERAL VASCULAR DISORDER,3
BR,PETIT MAL EPILEPSY,3
BR,PLANTAR FASCIITIS,3
BR,PLATELET DISORDER,3
BR,PNEUMOTHORAX,3
BR,POOR QUALITY DRUG ADMINISTERED,3
BR,POST PROCEDURAL SWELLING,3
BR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
BR,PRIMARY HYPOGONADISM,3
BR,PROSTATE CANCER,3
BR,PROSTHESIS IMPLANTATION,3
BR,PROTEIN URINE PRESENT,3
BR,PULMONARY HAEMORRHAGE,3
BR,RADIUS FRACTURE,3
BR,RASH GENERALISED,3
BR,RECTAL HAEMORRHAGE,3
BR,RECTAL NEOPLASM,3
BR,REFLUX GASTRITIS,3
BR,RENAL FAILURE ACUTE,3
BR,RENAL NEOPLASM,3
BR,SACROILIITIS,3
BR,SCOLIOSIS,3
BR,SHOULDER OPERATION,3
BR,SKIN ATROPHY,3
BR,SKIN DEPIGMENTATION,3
BR,SKIN HAEMORRHAGE,3
BR,SKIN INJURY,3
BR,SKIN TOXICITY,3
BR,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,3
BR,SNORING,3
BR,SPINAL CORD DISORDER,3
BR,SPLENOMEGALY,3
BR,SUICIDE ATTEMPT,3
BR,TENOSYNOVITIS,3
BR,THROMBOCYTOSIS,3
BR,TOOTH ABSCESS,3
BR,TOOTH INJURY,3
BR,TOOTH SOCKET HAEMORRHAGE,3
BR,TRANSIENT ISCHAEMIC ATTACK,3
BR,TRANSPLANT REJECTION,3
BR,TREATMENT FAILURE,3
BR,TRIGGER FINGER,3
BR,TUMOUR LYSIS SYNDROME,3
BR,UNINTENDED PREGNANCY,3
BR,UPPER EXTREMITY MASS,3
BR,URINARY RETENTION,3
BR,URINARY TRACT INFECTION BACTERIAL,3
BR,UTERINE CYST,3
BR,VERTEBRAL OSTEOPHYTE,3
BR,VITAMIN B12 DEFICIENCY,3
BR,VOCAL CORD DISORDER,3
BR,VOCAL CORD PARALYSIS,3
BR,WALKING DISABILITY,3
BR,WHITE BLOOD CELL COUNT INCREASED,3
BR,YELLOW SKIN,3
BR,ABNORMAL SENSATION IN EYE,2
BR,ABORTION,2
BR,ABSCESS LIMB,2
BR,ABSCESS RUPTURE,2
BR,ACUTE GRAFT VERSUS HOST DISEASE,2
BR,ACUTE KIDNEY INJURY,2
BR,ADVERSE REACTION,2
BR,AGRANULOCYTOSIS,2
BR,AMERICAN TRYPANOSOMIASIS,2
BR,ANGINA UNSTABLE,2
BR,ANKLE DEFORMITY,2
BR,APPARENT DEATH,2
BR,APPLICATION SITE HAEMORRHAGE,2
BR,APTYALISM,2
BR,ASTIGMATISM,2
BR,AUTOIMMUNE THYROIDITIS,2
BR,BACTERIAL TEST POSITIVE,2
BR,BARTHOLIN^S CYST,2
BR,BENIGN NEOPLASM,2
BG,ARTHRALGIA,5
BG,NEUROPATHY PERIPHERAL,4
BG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
BG,PYREXIA,4
BG,BONE MARROW FAILURE,3
BG,COUGH,3
BG,PANCYTOPENIA,3
BG,STAPHYLOCOCCAL INFECTION,3
BG,TOXICITY TO VARIOUS AGENTS,3
BG,ABDOMINAL PAIN,2
BG,ACUTE RESPIRATORY FAILURE,2
BG,ANAEMIA,2
BG,APHTHOUS STOMATITIS,2
BG,APLASTIC ANAEMIA,2
BG,BURSITIS,2
BG,CYTOPENIA,2
BG,DEATH,2
BG,ECCHYMOSIS,2
BG,FATIGUE,2
BG,GENERALISED TONIC-CLONIC SEIZURE,2
BG,HEPATOSPLENOMEGALY,2
BG,HYPOALBUMINAEMIA,2
BG,NECROSIS,2
BG,OVERDOSE,2
BG,PNEUMONITIS,2
BG,PYODERMA,2
BG,RENAL FAILURE ACUTE,2
BG,SKIN EROSION,2
BG,SKIN LESION,2
BG,SKIN ULCER,2
BG,SOMNOLENCE,2
BG,STAPHYLOCOCCAL SKIN INFECTION,2
BG,STOMATITIS,2
BG,TACHYPNOEA,2
BG,TUBERCULOSIS,2
BG,ABNORMAL FAECES,1
BG,ACUTE LEUKAEMIA,1
BG,AGRANULOCYTOSIS,1
BG,ALOPECIA,1
BG,ANURIA,1
BG,ASTHENIA,1
BG,BACK PAIN,1
BG,BASAL CELL CARCINOMA,1
BG,BICYTOPENIA,1
BG,BLADDER CANCER,1
BG,BLISTER,1
BG,BODY TEMPERATURE INCREASED,1
BG,CHANGE OF BOWEL HABIT,1
BG,CHEMICAL POISONING,1
BG,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
BG,COLON CANCER,1
BG,CONCOMITANT DISEASE AGGRAVATED,1
BG,CONDITION AGGRAVATED,1
BG,CONSTIPATION,1
BG,DECREASED APPETITE,1
BG,DEHYDRATION,1
BG,DERMATOMYOSITIS,1
BG,DIARRHOEA,1
BG,DISEASE RECURRENCE,1
BG,DRUG ABUSE,1
BG,DRUG EFFECT DECREASED,1
BG,DRUG INTOLERANCE,1
BG,DRUG LEVEL DECREASED,1
BG,DYSGEUSIA,1
BG,DYSPNOEA,1
BG,ERYTHEMA,1
BG,EYELID OEDEMA,1
BG,FLUID INTAKE REDUCED,1
BG,GASTRITIS,1
BG,HAEMORRHAGIC STROKE,1
BG,HEADACHE,1
BG,HEMIPLEGIA,1
BG,HEPATIC FAILURE,1
BG,HEPATITIS TOXIC,1
BG,HODGKIN^S DISEASE,1
BG,HYPERHIDROSIS,1
BG,HYPERSENSITIVITY,1
BG,HYPOPHAGIA,1
BG,HYPOTENSION,1
BG,HYPOTONIA,1
BG,INCORRECT DRUG ADMINISTRATION RATE,1
BG,INFECTION,1
BG,INFLAMMATION,1
BG,INFLAMMATORY PAIN,1
BG,INTERSTITIAL LUNG DISEASE,1
BG,INTESTINAL MUCOSAL ATROPHY,1
BG,INTESTINAL OBSTRUCTION,1
BG,INTESTINAL ULCER,1
BG,ISCHAEMIC STROKE,1
BG,JOINT SWELLING,1
BG,KERNIG^S SIGN,1
BG,LATENT TUBERCULOSIS,1
BG,LEUKOPENIA,1
BG,LIP SWELLING,1
BG,LOSS OF CONSCIOUSNESS,1
BG,LYMPHADENOPATHY,1
BG,MEGACOLON,1
BG,MELAENA,1
BG,METASTASES TO BONE,1
BG,METASTASES TO LIVER,1
BG,METASTASES TO LUNG,1
BG,METASTASES TO LYMPH NODES,1
BG,MOBILITY DECREASED,1
BG,MUSCLE SPASMS,1
BG,MUSCULOSKELETAL CHEST PAIN,1
BG,MUSCULOSKELETAL STIFFNESS,1
BG,MYALGIA,1
BG,MYOCARDIAL INFARCTION,1
BG,MYOCARDITIS,1
BG,NEOPLASM MALIGNANT,1
BG,NEUTROPENIA,1
BG,NON-HODGKIN^S LYMPHOMA,1
BG,NUCHAL RIGIDITY,1
BG,OESOPHAGITIS,1
BG,PARTIAL SEIZURES,1
BG,PHARYNGITIS,1
BG,PLEURISY,1
BG,PNEUMONIA,1
BG,PRODUCTIVE COUGH,1
BG,PUSTULAR PSORIASIS,1
BG,RASH,1
BG,RASH ERYTHEMATOUS,1
BG,RECTAL CANCER,1
BG,RHEUMATOID FACTOR INCREASED,1
BG,SALIVARY GLAND CANCER STAGE I,1
BG,SKIN EXFOLIATION,1
BG,STATUS EPILEPTICUS,1
BG,SWELLING FACE,1
BG,TACHYARRHYTHMIA,1
BG,TACHYCARDIA,1
BG,THROMBOCYTOPENIA,1
BG,THYROID CANCER,1
BG,TIBIA FRACTURE,1
BG,UNEVALUABLE EVENT,1
BG,URETEROLITHIASIS,1
BG,UTERINE CANCER,1
BG,UVEITIS,1
BG,VERTIGO,1
BG,VIRAL INFECTION,1
BG,VOMITING,1
BG,WHITE BLOOD CELL COUNT DECREASED,1
CM,DRUG INEFFECTIVE,2
CM,HEADACHE,2
CM,ABDOMINAL DISCOMFORT,1
CM,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CM,COELIAC DISEASE,1
CM,COLITIS ULCERATIVE,1
CM,CONDITION AGGRAVATED,1
CM,GASTROINTESTINAL DISORDER,1
CM,GRIP STRENGTH DECREASED,1
CM,INFECTION,1
CM,INJECTION SITE REACTION,1
CM,MOBILITY DECREASED,1
CM,NAIL DISORDER,1
CM,NAUSEA,1
CM,ONYCHOMADESIS,1
CM,ONYCHOMYCOSIS,1
CM,PNEUMOTHORAX,1
CM,SPINAL FRACTURE,1
CM,VOMITING,1
CA,DRUG INEFFECTIVE,6680
CA,RHEUMATOID ARTHRITIS,4011
CA,PAIN,2264
CA,ARTHRALGIA,2128
CA,DRUG INTOLERANCE,1804
CA,JOINT SWELLING,1772
CA,NAUSEA,1736
CA,FATIGUE,1690
CA,CONDITION AGGRAVATED,1261
CA,HEADACHE,1168
CA,PAIN IN EXTREMITY,1125
CA,DIARRHOEA,1049
CA,TREATMENT FAILURE,1041
CA,PERIPHERAL SWELLING,1009
CA,DRUG HYPERSENSITIVITY,948
CA,MALAISE,933
CA,RASH,887
CA,SYNOVITIS,881
CA,WEIGHT DECREASED,822
CA,PNEUMONIA,820
CA,DRUG EFFECT DECREASED,819
CA,ARTHROPATHY,812
CA,ABDOMINAL DISCOMFORT,799
CA,VOMITING,786
CA,NASOPHARYNGITIS,756
CA,MUSCULOSKELETAL STIFFNESS,716
CA,INFECTION,686
CA,DYSPNOEA,681
CA,FALL,657
CA,DRUG EFFECT INCOMPLETE,652
CA,SWELLING,623
CA,ALOPECIA,607
CA,INFUSION RELATED REACTION,567
CA,COUGH,558
CA,DIZZINESS,558
CA,GAIT DISTURBANCE,552
CA,WEIGHT INCREASED,550
CA,BLOOD PRESSURE INCREASED,535
CA,ASTHENIA,522
CA,MOBILITY DECREASED,509
CA,ARTHRITIS,503
CA,HEPATIC ENZYME INCREASED,497
CA,BACK PAIN,479
CA,MUSCULOSKELETAL PAIN,461
CA,ABDOMINAL PAIN,453
CA,HYPERTENSION,448
CA,HYPERSENSITIVITY,447
CA,C-REACTIVE PROTEIN ABNORMAL,433
CA,PYREXIA,431
CA,SINUSITIS,427
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,414
CA,PRURITUS,410
CA,INSOMNIA,387
CA,ABDOMINAL PAIN UPPER,373
CA,URINARY TRACT INFECTION,372
CA,OSTEOARTHRITIS,370
CA,INFLUENZA,369
CA,LOWER RESPIRATORY TRACT INFECTION,364
CA,BRONCHITIS,356
CA,HERPES ZOSTER,355
CA,C-REACTIVE PROTEIN INCREASED,341
CA,PSORIASIS,334
CA,DECREASED APPETITE,311
CA,GASTROINTESTINAL DISORDER,310
CA,INFLAMMATION,307
CA,KNEE ARTHROPLASTY,295
CA,PRODUCT USE ISSUE,295
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,293
CA,CHEST PAIN,286
CA,HYPOAESTHESIA,284
CA,THERAPEUTIC RESPONSE DECREASED,283
CA,ERYTHEMA,281
CA,OROPHARYNGEAL PAIN,277
CA,DEPRESSION,272
CA,CROHN^S DISEASE,269
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,268
CA,HAND DEFORMITY,260
CA,HYPOTENSION,251
CA,DIVERTICULITIS,244
CA,MYOCARDIAL INFARCTION,244
CA,URTICARIA,240
CA,LUNG DISORDER,237
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,234
CA,ANXIETY,231
CA,CONTRAINDICATED PRODUCT ADMINISTERED,230
CA,EAR INFECTION,229
CA,PEMPHIGUS,225
CA,CATARACT,220
CA,FIBROMYALGIA,218
CA,OXYGEN SATURATION DECREASED,218
CA,NEPHROLITHIASIS,217
CA,OSTEOPOROSIS,215
CA,PARAESTHESIA,215
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,211
CA,DIABETES MELLITUS,209
CA,NECK PAIN,206
CA,JOINT STIFFNESS,204
CA,SLEEP DISORDER,204
CA,STRESS,204
CA,PSORIATIC ARTHROPATHY,202
CA,BONE EROSION,201
CA,FEELING ABNORMAL,200
CA,MUSCLE SPASMS,200
CA,CYSTITIS,198
CA,EYE DISORDER,197
CA,FOOT DEFORMITY,196
CA,PHARYNGITIS,196
CA,RHEUMATOID FACTOR POSITIVE,196
CA,ANAEMIA,195
CA,MUSCULOSKELETAL DISORDER,192
CA,DEATH,186
CA,HEART RATE INCREASED,186
CA,INTERSTITIAL LUNG DISEASE,186
CA,STOMATITIS,186
CA,IMPAIRED WORK ABILITY,185
CA,CONTUSION,183
CA,LOCALISED INFECTION,181
CA,OEDEMA PERIPHERAL,181
CA,WHITE BLOOD CELL COUNT DECREASED,181
CA,DYSPEPSIA,179
CA,BLOOD PRESSURE FLUCTUATION,173
CA,GLOSSODYNIA,171
CA,LUNG INFECTION,167
CA,RHINORRHOEA,166
CA,SKIN ULCER,166
CA,MIGRAINE,165
CA,ALANINE AMINOTRANSFERASE INCREASED,162
CA,SEPSIS,161
CA,DRUG DOSE OMISSION,160
CA,HEART RATE DECREASED,160
CA,INJECTION SITE REACTION,159
CA,JOINT RANGE OF MOTION DECREASED,159
CA,RENAL FAILURE,159
CA,LIVER FUNCTION TEST INCREASED,158
CA,LIVER DISORDER,157
CA,BLOOD CHOLESTEROL INCREASED,156
CA,CELLULITIS,156
CA,DISABILITY,156
CA,NEOPLASM MALIGNANT,156
CA,HIP ARTHROPLASTY,155
CA,GENERAL PHYSICAL HEALTH DETERIORATION,154
CA,MYALGIA,154
CA,HAEMOGLOBIN DECREASED,152
CA,ADVERSE DRUG REACTION,150
CA,PRODUCTIVE COUGH,150
CA,HAEMATOCHEZIA,148
CA,LOSS OF CONSCIOUSNESS,148
CA,IMPAIRED HEALING,147
CA,SOMNOLENCE,147
CA,PULMONARY FIBROSIS,146
CA,MUSCULAR WEAKNESS,143
CA,NODULE,143
CA,BASAL CELL CARCINOMA,142
CA,CHILLS,142
CA,WOUND,142
CA,BURNING SENSATION,141
CA,NEUTROPENIA,137
CA,PULMONARY MASS,137
CA,RENAL IMPAIRMENT,136
CA,ASPARTATE AMINOTRANSFERASE INCREASED,134
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,134
CA,BREAST CANCER,132
CA,GRIP STRENGTH DECREASED,132
CA,NASAL CONGESTION,131
CA,VISUAL IMPAIRMENT,131
CA,JOINT INJURY,130
CA,CEREBROVASCULAR ACCIDENT,129
CA,ANAPHYLACTIC REACTION,126
CA,TREMOR,126
CA,FEMUR FRACTURE,124
CA,MOUTH ULCERATION,124
CA,GASTRIC DISORDER,123
CA,CHEST DISCOMFORT,122
CA,INFLUENZA LIKE ILLNESS,122
CA,LIVER FUNCTION TEST ABNORMAL,122
CA,PULMONARY EMBOLISM,121
CA,SURGERY,121
CA,THROMBOSIS,120
CA,HEPATITIS,119
CA,PALPITATIONS,119
CA,TOXICITY TO VARIOUS AGENTS,117
CA,ASTHMA,115
CA,HYPERHIDROSIS,115
CA,FUNGAL INFECTION,113
CA,ORAL HERPES,113
CA,HEPATOTOXICITY,112
CA,VIRAL INFECTION,110
CA,DEAFNESS,109
CA,LIMB DISCOMFORT,109
CA,MEMORY IMPAIRMENT,109
CA,INJECTION SITE PAIN,108
CA,LYMPHADENOPATHY,108
CA,UPPER LIMB FRACTURE,108
CA,GLAUCOMA,107
CA,LOCAL SWELLING,107
CA,RHEUMATOID NODULE,107
CA,AMNESIA,106
CA,HOT FLUSH,105
CA,LEUKOPENIA,105
CA,ATRIAL FIBRILLATION,104
CA,DISEASE PROGRESSION,103
CA,SWELLING FACE,103
CA,NAIL DISORDER,102
CA,PNEUMONITIS,102
CA,TENDERNESS,102
CA,SCIATICA,101
CA,ABASIA,100
CA,ADVERSE EVENT,100
CA,CONSTIPATION,99
CA,FINGER DEFORMITY,99
CA,SHOULDER ARTHROPLASTY,99
CA,BLOOD PRESSURE SYSTOLIC INCREASED,98
CA,BLOOD PRESSURE DIASTOLIC DECREASED,96
CA,CARPAL TUNNEL SYNDROME,96
CA,PAIN IN JAW,95
CA,TYPE 2 DIABETES MELLITUS,93
CA,UPPER RESPIRATORY TRACT INFECTION,93
CA,ABDOMINAL DISTENSION,92
CA,EPISTAXIS,92
CA,GASTROINTESTINAL PAIN,92
CA,GASTROOESOPHAGEAL REFLUX DISEASE,92
CA,SPINAL COLUMN STENOSIS,92
CA,DYSPHONIA,91
CA,FOOT FRACTURE,91
CA,INTESTINAL OBSTRUCTION,91
CA,DRUG ERUPTION,90
CA,KIDNEY INFECTION,90
CA,VISION BLURRED,90
CA,FINE MOTOR SKILL DYSFUNCTION,89
CA,ILL-DEFINED DISORDER,89
CA,SENSITIVITY TO WEATHER CHANGE,88
CA,SEPTIC SHOCK,87
CA,COLITIS ULCERATIVE,86
CA,CYST,85
CA,MASS,85
CA,POST PROCEDURAL INFECTION,85
CA,DEHYDRATION,84
CA,HERNIA,84
CA,BODY TEMPERATURE DECREASED,83
CA,DRY EYE,82
CA,FEELING HOT,82
CA,GAIT INABILITY,82
CA,DRY MOUTH,80
CA,SYNCOPE,80
CA,THERAPY NON-RESPONDER,80
CA,DYSPHAGIA,79
CA,FOOT OPERATION,79
CA,HEPATIC CIRRHOSIS,79
CA,IMMOBILE,79
CA,CLOSTRIDIUM DIFFICILE INFECTION,78
CA,COELIAC DISEASE,78
CA,FREQUENT BOWEL MOVEMENTS,78
CA,UNEVALUABLE EVENT,78
CA,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,77
CA,DEEP VEIN THROMBOSIS,77
CA,INJECTION SITE ERYTHEMA,77
CA,WOUND INFECTION,77
CA,MALIGNANT MELANOMA,76
CA,BLOOD CREATININE INCREASED,75
CA,BONE DISORDER,75
CA,HYPOPHAGIA,75
CA,BACTERIAL INFECTION,73
CA,CHOLELITHIASIS,73
CA,FEEDING DISORDER,73
CA,INJECTION SITE BRUISING,73
CA,LACERATION,73
CA,ONYCHOMYCOSIS,73
CA,PHARYNGEAL OEDEMA,73
CA,SKIN DISCOLOURATION,73
CA,ULCER,73
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,73
CA,BONE PAIN,72
CA,HEPATIC STEATOSIS,72
CA,LIMB INJURY,72
CA,NON-HODGKIN^S LYMPHOMA,72
CA,TOOTH INFECTION,72
CA,HAEMORRHAGE,71
CA,LYMPHOMA,71
CA,POOR VENOUS ACCESS,71
CA,RASH PRURITIC,71
CA,SYNOVIAL CYST,71
CA,THROAT IRRITATION,71
CA,CARDIAC DISORDER,70
CA,OSTEOMYELITIS,70
CA,INJECTION SITE SWELLING,69
CA,TOOTH ABSCESS,69
CA,VERTIGO,69
CA,ACNE,68
CA,JOINT EFFUSION,68
CA,PULMONARY OEDEMA,68
CA,RECTAL HAEMORRHAGE,68
CA,RENAL DISORDER,68
CA,HOSPITALISATION,66
CA,CONFUSIONAL STATE,65
CA,SKIN LESION,65
CA,ABSCESS,64
CA,BLOOD PRESSURE DECREASED,64
CA,EYE PAIN,64
CA,MUSCULOSKELETAL DISCOMFORT,64
CA,NIGHT SWEATS,64
CA,OBESITY,64
CA,NEUROPATHY PERIPHERAL,63
CA,PLATELET COUNT DECREASED,63
CA,SECRETION DISCHARGE,63
CA,SEIZURE,63
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,62
CA,DEFORMITY,62
CA,FLUSHING,62
CA,HIP FRACTURE,62
CA,LOWER LIMB FRACTURE,62
CA,SINUS CONGESTION,62
CA,SPINAL FRACTURE,62
CA,BALANCE DISORDER,61
CA,DISCOMFORT,61
CA,LUNG NEOPLASM MALIGNANT,61
CA,RIB FRACTURE,61
CA,THYROID DISORDER,61
CA,WHEEZING,61
CA,BLOOD GLUCOSE INCREASED,60
CA,EXPOSURE DURING PREGNANCY,60
CA,JOINT DISLOCATION,60
CA,COLITIS,59
CA,PLEURAL EFFUSION,59
CA,DEPRESSED MOOD,58
CA,DRUG DEPENDENCE,58
CA,NERVE INJURY,58
CA,BLISTER,57
CA,DERMATITIS ALLERGIC,57
CA,RESPIRATORY TRACT INFECTION,57
CA,TENDONITIS,57
CA,CANDIDA INFECTION,56
CA,INTERVERTEBRAL DISC PROTRUSION,56
CA,MATERNAL EXPOSURE DURING PREGNANCY,56
CA,BLOOD IRON ABNORMAL,55
CA,EAR PAIN,55
CA,LABORATORY TEST ABNORMAL,55
CA,ROAD TRAFFIC ACCIDENT,55
CA,TACHYCARDIA,55
CA,TENOSYNOVITIS,55
CA,BODY TEMPERATURE INCREASED,54
CA,COLITIS MICROSCOPIC,54
CA,GASTRIC ULCER,54
CA,JUVENILE IDIOPATHIC ARTHRITIS,54
CA,SKIN DISORDER,54
CA,TOOTH DISORDER,54
CA,WHITE BLOOD CELL COUNT INCREASED,54
CA,ANKYLOSING SPONDYLITIS,53
CA,GALLBLADDER DISORDER,53
CA,PANCREATITIS,53
CA,PANNICULITIS,53
CA,APPARENT DEATH,52
CA,EYE INFECTION,52
CA,OEDEMA,52
CA,RESPIRATORY TRACT CONGESTION,52
CA,SKIN CANCER,52
CA,THROMBOCYTOPENIA,52
CA,BURSITIS,51
CA,CRYING,51
CA,DEAFNESS TRANSITORY,51
CA,HEART RATE IRREGULAR,51
CA,HYPERCALCAEMIA,51
CA,PANCYTOPENIA,51
CA,ADVERSE REACTION,50
CA,BACK INJURY,50
CA,BONE DENSITY DECREASED,50
CA,DRY SKIN,50
CA,INJECTION SITE PRURITUS,50
CA,INTESTINAL RESECTION,50
CA,OCULAR HYPERAEMIA,50
CA,PNEUMONIA VIRAL,50
CA,STAPHYLOCOCCAL INFECTION,50
CA,ANKLE FRACTURE,49
CA,BACK DISORDER,49
CA,BLOOD PRESSURE DIASTOLIC INCREASED,49
CA,HYPOACUSIS,49
CA,ANGINA PECTORIS,48
CA,DYSSTASIA,48
CA,NEURALGIA,48
CA,ORAL CANDIDIASIS,48
CA,CARDIAC FAILURE CONGESTIVE,47
CA,JOINT ARTHROPLASTY,47
CA,DYSPNOEA EXERTIONAL,46
CA,GASTROENTERITIS,46
CA,POST PROCEDURAL COMPLICATION,46
CA,RESPIRATORY DISORDER,46
CA,SKIN EXFOLIATION,46
CA,IMMUNE SYSTEM DISORDER,45
CA,OSTEOPENIA,45
CA,PERICARDITIS,45
CA,PHOTOPHOBIA,45
CA,PRURITUS GENERALISED,45
CA,RASH ERYTHEMATOUS,45
CA,WALKING AID USER,45
CA,CARDIAC FAILURE,44
CA,ENCEPHALITIS,44
CA,GASTROINTESTINAL HAEMORRHAGE,44
CA,HYPOTHYROIDISM,44
CA,LIVER INJURY,44
CA,MULTIPLE SCLEROSIS,44
CA,RESPIRATORY RATE INCREASED,44
CA,SCAR,44
CA,SKIN REACTION,44
CA,ARTHRITIS INFECTIVE,43
CA,DRUG RESISTANCE,43
CA,HEPATIC ENZYME ABNORMAL,43
CA,MOVEMENT DISORDER,43
CA,POSTOPERATIVE WOUND INFECTION,43
CA,BEDRIDDEN,42
CA,BLOOD TEST ABNORMAL,42
CA,DYSGEUSIA,42
CA,FISTULA,42
CA,FLATULENCE,42
CA,INCORRECT DOSE ADMINISTERED,42
CA,ORAL PAIN,42
CA,POLLAKIURIA,42
CA,POLYARTHRITIS,42
CA,SKIN INFECTION,42
CA,SUICIDAL IDEATION,42
CA,ARTHRODESIS,41
CA,BLOOD PARATHYROID HORMONE DECREASED,41
CA,CLOSTRIDIUM DIFFICILE COLITIS,41
CA,GASTROENTERITIS VIRAL,41
CA,IMMUNODEFICIENCY,41
CA,SKIN NECROSIS,41
CA,WRIST DEFORMITY,41
CA,ADRENAL INSUFFICIENCY,40
CA,APHONIA,40
CA,DISEASE RECURRENCE,40
CA,EYE HAEMORRHAGE,40
CA,HEPATIC FUNCTION ABNORMAL,40
CA,LACRIMATION INCREASED,40
CA,LARYNGITIS,40
CA,PROSTATE CANCER,40
CA,PULMONARY TOXICITY,40
CA,WEIGHT FLUCTUATION,40
CA,BREAST CANCER STAGE III,39
CA,ENTHESOPATHY,39
CA,PHARYNGITIS STREPTOCOCCAL,39
CA,RETINAL TOXICITY,39
CA,SPINAL DISORDER,39
CA,SPUTUM DISCOLOURED,39
CA,TREATMENT NONCOMPLIANCE,39
CA,JOINT DESTRUCTION,38
CA,RED BLOOD CELL COUNT DECREASED,38
CA,WRIST FRACTURE,38
CA,ACUTE KIDNEY INJURY,37
CA,DYSURIA,37
CA,ECZEMA,37
CA,HUMAN HERPESVIRUS 6 INFECTION,37
CA,INTESTINAL PERFORATION,37
CA,NERVOUS SYSTEM DISORDER,37
CA,NERVOUSNESS,37
CA,RESPIRATORY FAILURE,37
CA,TOOTHACHE,37
CA,TRANSIENT ISCHAEMIC ATTACK,37
CA,BRONCHITIS CHRONIC,36
CA,PELVIC FRACTURE,36
CA,BLOOD URINE PRESENT,35
CA,EPICONDYLITIS,35
CA,FRACTURE,35
CA,INJECTION SITE HAEMORRHAGE,35
CA,KNEE OPERATION,35
CA,MYCOBACTERIUM CHELONAE INFECTION,35
CA,SLEEP APNOEA SYNDROME,35
CA,TOOTH FRACTURE,35
CA,TUBERCULOSIS,35
CA,APHTHOUS ULCER,34
CA,BLOOD PRESSURE ABNORMAL,34
CA,BRONCHIECTASIS,34
CA,GRANULOMA SKIN,34
CA,HAEMATOMA,34
CA,HYPERSOMNIA,34
CA,INJURY,34
CA,IRRITABLE BOWEL SYNDROME,34
CA,MOOD SWINGS,34
CA,NECK MASS,34
CA,PULMONARY THROMBOSIS,34
CA,THYROID NEOPLASM,34
CA,TONGUE DISORDER,34
CA,UVEITIS,34
CA,ANKLE DEFORMITY,33
CA,EMOTIONAL DISORDER,33
CA,FURUNCLE,33
CA,LIGAMENT SPRAIN,33
CA,NO ADVERSE EVENT,33
CA,ONYCHOMADESIS,33
CA,SPINAL PAIN,33
CA,TUBERCULIN TEST POSITIVE,33
CA,ABDOMINAL PAIN LOWER,32
CA,ANGIOEDEMA,32
CA,BODY HEIGHT BELOW NORMAL,32
CA,ELBOW DEFORMITY,32
CA,HEAD INJURY,32
CA,HYPOKINESIA,32
CA,POOR QUALITY SLEEP,32
CA,PROCEDURAL PAIN,32
CA,SPEECH DISORDER,32
CA,TOOTH LOSS,32
CA,CARDIOVASCULAR DISORDER,31
CA,ENTERITIS,31
CA,GINGIVAL BLEEDING,31
CA,IMMUNOSUPPRESSION,31
CA,INTESTINAL STENOSIS,31
CA,LUPUS-LIKE SYNDROME,31
CA,MUCOSAL INFLAMMATION,31
CA,OVARIAN CYST,31
CA,SOFT TISSUE DISORDER,31
CA,TENDON DISORDER,31
CA,THROAT TIGHTNESS,31
CA,BLOOD IRON DECREASED,30
CA,BLOOD POTASSIUM DECREASED,30
CA,CATARACT OPERATION,30
CA,EATING DISORDER,30
CA,HAEMOPTYSIS,30
CA,HEPATIC FIBROSIS,30
CA,LIMB DEFORMITY,30
CA,MUSCLE STRAIN,30
CA,MUSCULOSKELETAL CHEST PAIN,30
CA,ROTATOR CUFF SYNDROME,30
CA,THYROID CANCER,30
CA,TINNITUS,30
CA,ANAPHYLACTIC SHOCK,29
CA,DEMYELINATION,29
CA,DRUG-INDUCED LIVER INJURY,29
CA,FEELING COLD,29
CA,GENERALISED OEDEMA,29
CA,HAEMATOCRIT DECREASED,29
CA,HELICOBACTER INFECTION,29
CA,HUMAN ANTICHIMERIC ANTIBODY POSITIVE,29
CA,HYPERAESTHESIA,29
CA,IMPAIRED GASTRIC EMPTYING,29
CA,PALLOR,29
CA,SINUS DISORDER,29
CA,SPINAL OSTEOARTHRITIS,29
CA,SQUAMOUS CELL CARCINOMA,29
CA,ACCIDENT,28
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,28
CA,CORONARY ARTERY OCCLUSION,28
CA,DELIRIUM,28
CA,DENTAL CARIES,28
CA,EPIGASTRIC DISCOMFORT,28
CA,FLUID RETENTION,28
CA,GASTROINTESTINAL INFLAMMATION,28
CA,GENERALISED ERYTHEMA,28
CA,PARAINFLUENZAE VIRUS INFECTION,28
CA,PHOTOSENSITIVITY REACTION,28
CA,PRESYNCOPE,28
CA,PYELONEPHRITIS,28
CA,SWOLLEN TONGUE,28
CA,ARTHRITIS BACTERIAL,27
CA,BRONCHOSPASM,27
CA,CHRONIC SINUSITIS,27
CA,DEAFNESS NEUROSENSORY,27
CA,DIARRHOEA HAEMORRHAGIC,27
CA,FEAR OF INJECTION,27
CA,LIMB OPERATION,27
CA,LYME DISEASE,27
CA,MOTOR DYSFUNCTION,27
CA,NEUTROPHIL COUNT DECREASED,27
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,27
CA,SMALL INTESTINAL OBSTRUCTION,27
CA,SPINAL COMPRESSION FRACTURE,27
CA,TENDON RUPTURE,27
CA,URINARY INCONTINENCE,27
CA,BLOOD PRESSURE SYSTOLIC DECREASED,26
CA,BRAIN NEOPLASM,26
CA,CONJUNCTIVITIS,26
CA,EMPHYSEMA,26
CA,EXOSTOSIS,26
CA,EYE IRRITATION,26
CA,EYE OPERATION,26
CA,FAECES SOFT,26
CA,GROIN PAIN,26
CA,INTERNATIONAL NORMALISED RATIO FLUCTUATION,26
CA,MIDDLE INSOMNIA,26
CA,PRESBYACUSIS,26
CA,SARCOIDOSIS,26
CA,X-RAY ABNORMAL,26
CA,ALANINE AMINOTRANSFERASE ABNORMAL,25
CA,BLINDNESS,25
CA,DISLOCATION OF VERTEBRA,25
CA,HIP SURGERY,25
CA,MACULAR DEGENERATION,25
CA,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,25
CA,ORAL DISORDER,25
CA,PUSTULAR PSORIASIS,25
CA,VISUAL ACUITY REDUCED,25
CA,APHASIA,24
CA,ARRHYTHMIA,24
CA,BONE MARROW FAILURE,24
CA,DRUG SPECIFIC ANTIBODY PRESENT,24
CA,INJECTION SITE EXTRAVASATION,24
CA,INTESTINAL POLYP,24
CA,INTRAOCULAR PRESSURE INCREASED,24
CA,LETHARGY,24
CA,NERVE COMPRESSION,24
CA,ORAL MUCOSAL EXFOLIATION,24
CA,PLANTAR FASCIITIS,24
CA,PLEURAL FIBROSIS,24
CA,PLEURISY,24
CA,PRODUCT USE IN UNAPPROVED INDICATION,24
CA,PURULENT DISCHARGE,24
CA,SEASONAL ALLERGY,24
CA,SKIN FISSURES,24
CA,TOOTH EXTRACTION,24
CA,VEIN RUPTURE,24
CA,EXERCISE TOLERANCE DECREASED,23
CA,EYE PRURITUS,23
CA,GASTRITIS,23
CA,GLOMERULAR FILTRATION RATE DECREASED,23
CA,HYPERCHOLESTEROLAEMIA,23
CA,INTERVERTEBRAL DISC DEGENERATION,23
CA,IRRITABILITY,23
CA,ONYCHOCLASIS,23
CA,RHEUMATOID FACTOR NEGATIVE,23
CA,SKIN PAPILLOMA,23
CA,SNEEZING,23
CA,SPINAL OPERATION,23
CA,VAGINAL INFECTION,23
CA,ABSCESS LIMB,22
CA,ANKLE OPERATION,22
CA,ATELECTASIS,22
CA,BLOOD ALBUMIN DECREASED,22
CA,COMA,22
CA,CREPITATIONS,22
CA,CUTANEOUS VASCULITIS,22
CA,DERMATITIS,22
CA,DIVERTICULUM,22
CA,EYE DISCHARGE,22
CA,GASTRIC HAEMORRHAGE,22
CA,HYSTERECTOMY,22
CA,INJECTION SITE MASS,22
CA,INTENTIONAL PRODUCT MISUSE,22
CA,INTERVERTEBRAL DISC COMPRESSION,22
CA,MENTAL DISORDER,22
CA,OVARIAN NEOPLASM,22
CA,PNEUMOTHORAX,22
CA,PSEUDOMONAL SEPSIS,22
CA,RASH GENERALISED,22
CA,RASH MACULAR,22
CA,ROSACEA,22
CA,SCRATCH,22
CA,SJOGREN^S SYNDROME,22
CA,SLE ARTHRITIS,22
CA,TRANSAMINASES INCREASED,22
CA,UPPER-AIRWAY COUGH SYNDROME,22
CA,URINARY TRACT DISORDER,22
CA,ABORTION SPONTANEOUS,21
CA,ARTHROPOD BITE,21
CA,BRONCHOPULMONARY ASPERGILLOSIS,21
CA,CHONDROPATHY,21
CA,DRUG USE DISORDER,21
CA,GASTROINTESTINAL INFECTION,21
CA,HAND FRACTURE,21
CA,IRITIS,21
CA,JOINT CREPITATION,21
CA,LATENT TUBERCULOSIS,21
CA,MEDICATION ERROR,21
CA,NASAL ULCER,21
CA,OESOPHAGEAL CANDIDIASIS,21
CA,PAIN OF SKIN,21
CA,PANIC ATTACK,21
CA,PRERENAL FAILURE,21
CA,RENAL PAIN,21
CA,RETINOPATHY,21
CA,SHOULDER OPERATION,21
CA,SKIN ABRASION,21
CA,THROMBOCYTOSIS,21
CA,ACNE CYSTIC,20
CA,ANAL FISSURE,20
CA,BONE CYST,20
CA,BONE DENSITY ABNORMAL,20
CA,CARDIOMYOPATHY,20
CA,EMOTIONAL DISTRESS,20
CA,ENTEROBACTER INFECTION,20
CA,FEAR,20
CA,HUMAN BOCAVIRUS INFECTION,20
CA,INCORRECT DOSAGE ADMINISTERED,20
CA,JAUNDICE,20
CA,JOINT LAXITY,20
CA,LOWER RESPIRATORY TRACT CONGESTION,20
CA,OBSTRUCTIVE AIRWAYS DISORDER,20
CA,OVARIAN CANCER,20
CA,PERICARDIAL EFFUSION,20
CA,PRODUCT QUALITY ISSUE,20
CA,SCAB,20
CA,SKIN BURNING SENSATION,20
CA,STRESS FRACTURE,20
CA,WOUND SECRETION,20
CA,ABDOMINAL HERNIA,19
CA,ASCITES,19
CA,CONCUSSION,19
CA,CORONA VIRUS INFECTION,19
CA,CYTOMEGALOVIRUS CHORIORETINITIS,19
CA,DEVICE RELATED INFECTION,19
CA,DRUG ADMINISTRATION ERROR,19
CA,EYE SWELLING,19
CA,FEBRILE NEUTROPENIA,19
CA,FLANK PAIN,19
CA,HAEMATEMESIS,19
CA,HERPES VIRUS INFECTION,19
CA,HYPERKERATOSIS,19
CA,INCISION SITE INFECTION,19
CA,INFECTED SKIN ULCER,19
CA,INJECTION SITE RASH,19
CA,MUSCLE SPASTICITY,19
CA,PLATELET COUNT INCREASED,19
CA,PNEUMATOSIS INTESTINALIS,19
CA,PNEUMOCYSTIS JIROVECII PNEUMONIA,19
CA,PULMONARY CONGESTION,19
CA,QUALITY OF LIFE DECREASED,19
CA,RED CELL DISTRIBUTION WIDTH INCREASED,19
CA,RETINITIS,19
CA,RHINITIS,19
CA,RHINOVIRUS INFECTION,19
CA,SECONDARY IMMUNODEFICIENCY,19
CA,THERAPY PARTIAL RESPONDER,19
CA,THIRST,19
CA,URINARY RETENTION,19
CA,UROSEPSIS,19
CA,VASCULITIS,19
CA,WRIST SURGERY,19
CA,ANAL ABSCESS,18
CA,ANGER,18
CA,BLADDER DISORDER,18
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,18
CA,BLOODY DISCHARGE,18
CA,COLON CANCER,18
CA,DIPLOPIA,18
CA,DRUG EFFECT DELAYED,18
CA,DRY THROAT,18
CA,EAR DISCOMFORT,18
CA,ECCHYMOSIS,18
CA,FACIAL PARALYSIS,18
CA,GASTROINTESTINAL TOXICITY,18
CA,HEPATIC FAILURE,18
CA,HUMERUS FRACTURE,18
CA,INGUINAL HERNIA,18
CA,INTERVERTEBRAL DISC DISORDER,18
CA,LIP SWELLING,18
CA,MELANOCYTIC NAEVUS,18
CA,MENINGITIS,18
CA,MENOPAUSE,18
CA,MENORRHAGIA,18
CA,MULTIPLE ALLERGIES,18
CA,NECK DEFORMITY,18
CA,POLYP,18
CA,PRECANCEROUS CELLS PRESENT,18
CA,TONGUE ULCERATION,18
CA,UNDERDOSE,18
CA,UTERINE LEIOMYOMA,18
CA,ANAL FISTULA,17
CA,ANTIBODY TEST POSITIVE,17
CA,AORTIC ANEURYSM,17
CA,ASPERGILLUS INFECTION,17
CA,CYTOMEGALOVIRUS VIRAEMIA,17
CA,DECREASED ACTIVITY,17
CA,GOUT,17
CA,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,17
CA,HAEMATURIA,17
CA,MULTIPLE FRACTURES,17
CA,NEOPLASM,17
CA,PHLEBITIS,17
CA,PLEURAL THICKENING,17
CA,PLEURITIC PAIN,17
CA,RENAL CYST,17
CA,RESTLESS LEGS SYNDROME,17
CA,SCOLIOSIS,17
CA,SKIN HAEMORRHAGE,17
CA,SPINAL FUSION SURGERY,17
CA,STENT PLACEMENT,17
CA,VEIN DISORDER,17
CA,WHEELCHAIR USER,17
CA,ABDOMINAL ADHESIONS,16
CA,AGGRESSION,16
CA,ANIMAL BITE,16
CA,APPENDICITIS,16
CA,ARTERIAL OCCLUSIVE DISEASE,16
CA,BILE DUCT OBSTRUCTION,16
CA,BLADDER CANCER,16
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,16
CA,BREAST PAIN,16
CA,CARDIAC ARREST,16
CA,CHOLECYSTITIS,16
CA,CUSHINGOID,16
CA,EPILEPSY,16
CA,GINGIVITIS,16
CA,HALLUCINATION,16
CA,HEAD DISCOMFORT,16
CA,HERPES SIMPLEX OESOPHAGITIS,16
CA,HYPOGLYCAEMIA,16
CA,INTENTIONAL PRODUCT USE ISSUE,16
CA,INTERVERTEBRAL DISC SPACE NARROWING,16
CA,JOINT LOCK,16
CA,LIGAMENT RUPTURE,16
CA,MALIGNANT NEOPLASM PROGRESSION,16
CA,NEUROTOXICITY,16
CA,NO THERAPEUTIC RESPONSE,16
CA,OSTEONECROSIS,16
CA,PARKINSON^S DISEASE,16
CA,RHEUMATIC FEVER,16
CA,SKIN PLAQUE,16
CA,TERMINAL STATE,16
CA,TONSILLITIS,16
CA,AGITATION,15
CA,BONE SWELLING,15
CA,BREAST MASS,15
CA,C-REACTIVE PROTEIN DECREASED,15
CA,CARDIAC MURMUR,15
CA,CHOLECYSTECTOMY,15
CA,CYSTITIS BACTERIAL,15
CA,DIFFUSE ALVEOLAR DAMAGE,15
CA,DRUG PRESCRIBING ERROR,15
CA,EXTREMITY CONTRACTURE,15
CA,FEELING JITTERY,15
CA,GASTRIC INFECTION,15
CA,HEART VALVE INCOMPETENCE,15
CA,INCREASED APPETITE,15
CA,INFLAMMATORY MARKER INCREASED,15
CA,IRON DEFICIENCY,15
CA,LIMB MASS,15
CA,ORAL SURGERY,15
CA,PAINFUL RESPIRATION,15
CA,PERIPHERAL COLDNESS,15
CA,SKIN ATROPHY,15
CA,SKIN MASS,15
CA,SKIN WARM,15
CA,SUBCUTANEOUS ABSCESS,15
CA,TEMPERATURE INTOLERANCE,15
CA,TOE AMPUTATION,15
CA,BLADDER TRANSITIONAL CELL CARCINOMA,14
CA,BLOOD COUNT ABNORMAL,14
CA,EMBOLISM,14
CA,ENDODONTIC PROCEDURE,14
CA,EYE INFLAMMATION,14
CA,FOETAL EXPOSURE DURING PREGNANCY,14
CA,GRAFT VERSUS HOST DISEASE,14
CA,GUILLAIN-BARRE SYNDROME,14
CA,HAEMORRHOIDS,14
CA,HEPATOMEGALY,14
CA,HEPATOSPLENIC T-CELL LYMPHOMA,14
CA,HIATUS HERNIA,14
CA,HYPOKALAEMIA,14
CA,HYPOXIA,14
CA,INCREASED TENDENCY TO BRUISE,14
CA,INJECTION SITE URTICARIA,14
CA,INTERNAL HAEMORRHAGE,14
CA,JOINT ANKYLOSIS,14
CA,LYMPHOEDEMA,14
CA,NOROVIRUS TEST POSITIVE,14
CA,OVERDOSE,14
CA,PERIARTHRITIS,14
CA,POST PROCEDURAL DISCHARGE,14
CA,RESPIRATORY ARREST,14
CA,SENSORY LOSS,14
CA,SERUM FERRITIN DECREASED,14
CA,THROAT CANCER,14
CA,TRANSAMINASES ABNORMAL,14
CA,TYMPANIC MEMBRANE PERFORATION,14
CA,URINE ABNORMALITY,14
CA,UTERINE DISORDER,14
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,14
CA,ABSCESS BACTERIAL,13
CA,ADENOVIRUS INFECTION,13
CA,ANGIOPATHY,13
CA,ANKLE ARTHROPLASTY,13
CA,BLADDER PROLAPSE,13
CA,BRADYCARDIA,13
CA,BREAST NEOPLASM,13
CA,BUNION OPERATION,13
CA,CHROMATURIA,13
CA,CYTOMEGALOVIRUS INFECTION,13
CA,DEVICE BREAKAGE,13
CA,DEVICE DISLOCATION,13
CA,DISEASE SUSCEPTIBILITY,13
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,13
CA,EAR PRURITUS,13
CA,ENTERITIS INFECTIOUS,13
CA,FUNGAL SKIN INFECTION,13
CA,GINGIVAL PAIN,13
CA,GOITRE,13
CA,GRAFT VERSUS HOST DISEASE IN SKIN,13
CA,HEPATIC CANCER,13
CA,HEPATIC PAIN,13
CA,HYPOAESTHESIA ORAL,13
CA,LARYNGITIS FUNGAL,13
CA,MENISCUS INJURY,13
CA,MENOPAUSAL SYMPTOMS,13
CA,ORAL INFECTION,13
CA,OSTEOPOROTIC FRACTURE,13
CA,PSYCHIATRIC SYMPTOM,13
CA,ROTATOR CUFF REPAIR,13
CA,SPLENOMEGALY,13
CA,STREPTOCOCCAL INFECTION,13
CA,TENDON PAIN,13
CA,THERMAL BURN,13
CA,THYROID MASS,13
CA,TINEA PEDIS,13
CA,VIRAEMIA,13
CA,ABDOMINAL ABSCESS,12
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,12
CA,AFFECT LABILITY,12
CA,ANAL INCONTINENCE,12
CA,ANTINUCLEAR ANTIBODY POSITIVE,12
CA,BLOOD BILIRUBIN INCREASED,12
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,12
CA,BLOOD POTASSIUM INCREASED,12
CA,C-REACTIVE PROTEIN,12
CA,CARDIAC VALVE DISEASE,12
CA,CARDIOTOXICITY,12
CA,CEREBRAL DISORDER,12
CA,COLD SWEAT,12
CA,CORONARY ARTERY DISEASE,12
CA,CYTOPENIA,12
CA,DERMATITIS PSORIASIFORM,12
CA,DISORIENTATION,12
CA,DRUG TOLERANCE DECREASED,12
CA,DYSARTHRIA,12
CA,ENCEPHALOPATHY,12
CA,FIBULA FRACTURE,12
CA,FUNCTIONAL GASTROINTESTINAL DISORDER,12
CA,HEPATIC NECROSIS,12
CA,HERPES OPHTHALMIC,12
CA,ILEAL STENOSIS,12
CA,INGROWING NAIL,12
CA,INJECTION SITE INFLAMMATION,12
CA,INVESTIGATION ABNORMAL,12
CA,LYMPHOCYTE COUNT DECREASED,12
CA,MENIERE^S DISEASE,12
CA,MOUTH HAEMORRHAGE,12
CA,MUCORMYCOSIS,12
CA,MUSCLE ATROPHY,12
CA,MUSCLE DISORDER,12
CA,ORAL DISCOMFORT,12
CA,OSTEOSCLEROSIS,12
CA,PANCREATIC CARCINOMA,12
CA,PARALYSIS,12
CA,PELVIC PAIN,12
CA,PERIPHERAL VENOUS DISEASE,12
CA,PSYCHOMOTOR HYPERACTIVITY,12
CA,RENAL FUNCTION TEST ABNORMAL,12
CA,RESPIRATORY DISTRESS,12
CA,SCLERITIS,12
CA,SKIN IRRITATION,12
CA,SPINAL COLUMN INJURY,12
CA,STRESS AT WORK,12
CA,VAGINAL HAEMORRHAGE,12
CA,VENOUS THROMBOSIS,12
CA,ABDOMINAL MASS,11
CA,ABSCESS INTESTINAL,11
CA,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,11
CA,BACTERIAL SEPSIS,11
CA,BLOOD MAGNESIUM INCREASED,11
CA,BONE GRAFT,11
CA,BREAST CANCER FEMALE,11
CA,CARDIAC FLUTTER,11
CA,CEREBRAL HAEMORRHAGE,11
CA,COLECTOMY,11
CA,CONVULSION,11
CA,CYSTITIS INTERSTITIAL,11
CA,DEMENTIA,11
CA,DEPENDENCE,11
CA,DIABETES MELLITUS INADEQUATE CONTROL,11
CA,ERYTHEMA NODOSUM,11
CA,FEELING DRUNK,11
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,11
CA,GENITAL HERPES,11
CA,HLA MARKER STUDY POSITIVE,11
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,11
CA,INFLAMMATORY BOWEL DISEASE,11
CA,LARYNGEAL DISORDER,11
CA,LENNOX-GASTAUT SYNDROME,11
CA,LIP ULCERATION,11
CA,LOOSE BODY IN JOINT,11
CA,LOOSE TOOTH,11
CA,MEAN CELL HAEMOGLOBIN INCREASED,11
CA,MONOCYTE COUNT INCREASED,11
CA,MYOPATHY,11
CA,NEUROGENIC BLADDER,11
CA,OBLITERATIVE BRONCHIOLITIS,11
CA,PAPILLARY THYROID CANCER,11
CA,PERIPHERAL VASCULAR DISORDER,11
CA,PHARYNGEAL ULCERATION,11
CA,PRESCRIBED OVERDOSE,11
CA,PYODERMA GANGRENOSUM,11
CA,RALES,11
CA,RASH PUSTULAR,11
CA,RHEUMATOID LUNG,11
CA,SERONEGATIVE ARTHRITIS,11
CA,SKIN DEPIGMENTATION,11
CA,SKIN SWELLING,11
CA,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,11
CA,SMEAR CERVIX ABNORMAL,11
CA,STAPHYLOCOCCAL BACTERAEMIA,11
CA,TENOSYNOVITIS STENOSANS,11
CA,THERAPEUTIC RESPONSE SHORTENED,11
CA,VIITH NERVE PARALYSIS,11
CA,VITAMIN D DEFICIENCY,11
CL,DRUG INEFFECTIVE,16
CL,ARTHRALGIA,9
CL,DIARRHOEA,9
CL,PAIN,9
CL,SWELLING,8
CL,ARTHRITIS,7
CL,DIZZINESS,7
CL,FALL,7
CL,MALAISE,7
CL,PAIN IN EXTREMITY,7
CL,VOMITING,7
CL,INFLAMMATION,6
CL,DRUG DOSE OMISSION,5
CL,GASTRITIS,5
CL,HEADACHE,5
CL,NASOPHARYNGITIS,5
CL,NAUSEA,5
CL,PNEUMONIA,5
CL,PYREXIA,5
CL,VERTIGO,5
CL,BACK PAIN,4
CL,COLITIS,4
CL,FATIGUE,4
CL,IMMUNE SYSTEM DISORDER,4
CL,INFECTION,4
CL,JOINT SWELLING,4
CL,PERIPHERAL SWELLING,4
CL,URINARY TRACT INFECTION,4
CL,VARICELLA ZOSTER VIRUS INFECTION,4
CL,ASTHENIA,3
CL,BLOOD TEST ABNORMAL,3
CL,BONE DISORDER,3
CL,BRONCHITIS,3
CL,DEPRESSION,3
CL,IMMUNODEFICIENCY,3
CL,SEPSIS,3
CL,ABDOMINAL PAIN,2
CL,AMNESIA,2
CL,ASTHMA,2
CL,BACTERIAL INFECTION,2
CL,BLOOD CHOLESTEROL INCREASED,2
CL,CATARACT,2
CL,COLITIS ULCERATIVE,2
CL,CROHN^S DISEASE,2
CL,CUSHING^S SYNDROME,2
CL,CYTOMEGALOVIRUS CHORIORETINITIS,2
CL,CYTOMEGALOVIRUS INFECTION,2
CL,DECREASED APPETITE,2
CL,DEEP VEIN THROMBOSIS,2
CL,ERYTHEMA,2
CL,EYE DISORDER,2
CL,FOOT DEFORMITY,2
CL,FOOT FRACTURE,2
CL,GAIT DISTURBANCE,2
CL,HAEMATOCHEZIA,2
CL,HAEMATOCRIT DECREASED,2
CL,HEPATIC STEATOSIS,2
CL,HERPES ZOSTER,2
CL,INFLUENZA,2
CL,INJECTION SITE PAIN,2
CL,INSOMNIA,2
CL,INTESTINAL PERFORATION,2
CL,LIGAMENT SPRAIN,2
CL,MUSCULAR WEAKNESS,2
CL,OCULAR HYPERAEMIA,2
CL,ORAL INFECTION,2
CL,PARAESTHESIA,2
CL,PRURITUS,2
CL,PULMONARY EMBOLISM,2
CL,PULMONARY FIBROSIS,2
CL,RECTAL POLYP,2
CL,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
CL,SEPTIC SHOCK,2
CL,SJOGREN^S SYNDROME,2
CL,STRESS,2
CL,TACHYCARDIA,2
CL,THROMBOSIS,2
CL,UPPER RESPIRATORY TRACT INFECTION,2
CL,WEIGHT DECREASED,2
CL,ABASIA,1
CL,ABSCESS LIMB,1
CL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
CL,ACUTE MYOCARDIAL INFARCTION,1
CL,ACUTE PULMONARY OEDEMA,1
CL,ADNEXA UTERI CYST,1
CL,ADVERSE EVENT,1
CL,ALOPECIA,1
CL,ANAEMIA,1
CL,ANAL ABSCESS,1
CL,ANAL FISTULA,1
CL,ANAL HAEMORRHAGE,1
CL,ANAL PROLAPSE,1
CL,ANAPHYLACTIC SHOCK,1
CL,ANKLE FRACTURE,1
CL,ANORECTAL SWELLING,1
CL,ANXIETY,1
CL,ARTHROPATHY,1
CL,ARTHROPOD BITE,1
CL,ASTHMATIC CRISIS,1
CL,BENIGN NEOPLASM OF SKIN,1
CL,BENIGN NEOPLASM OF THYROID GLAND,1
CL,BLISTER,1
CL,BLOOD GLUCOSE INCREASED,1
CL,BLOOD PRESSURE INCREASED,1
CL,BLOOD TRIGLYCERIDES INCREASED,1
CL,BLOOD URINE PRESENT,1
CL,BONE MARROW FAILURE,1
CL,BONE MARROW OEDEMA,1
CL,BONE PAIN,1
CL,BREAST PAIN,1
CL,BRONCHIECTASIS,1
CL,BURNING SENSATION,1
CL,CARDIAC FAILURE,1
CL,CARDIO-RESPIRATORY ARREST,1
CL,CARTILAGE INJURY,1
CL,CHILLS,1
CL,CHOKING SENSATION,1
CL,CHOLECYSTITIS ACUTE,1
CL,CHOLELITHIASIS,1
CL,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
CL,COMPLEMENT FACTOR C3 DECREASED,1
CL,COMPLEMENT FACTOR C4 DECREASED,1
CL,CONDITION AGGRAVATED,1
CL,CONTUSION,1
CL,CYST,1
CL,DEATH,1
CL,DEHYDRATION,1
CL,DEPRESSED MOOD,1
CL,DEVELOPMENTAL HIP DYSPLASIA,1
CL,DIABETES MELLITUS,1
CL,DIABETIC COMA,1
CL,DIARRHOEA HAEMORRHAGIC,1
CL,DISCOMFORT,1
CL,DISEASE PROGRESSION,1
CL,DISEASE RECURRENCE,1
CL,DIVERTICULITIS,1
CL,DIVERTICULUM,1
CL,DRUG ADMINISTRATION ERROR,1
CL,DRUG EFFECT INCOMPLETE,1
CL,DRUG LEVEL INCREASED,1
CL,DRUG-INDUCED LIVER INJURY,1
CL,DYSPEPSIA,1
CL,DYSSTASIA,1
CL,EATING DISORDER,1
CL,ELBOW DEFORMITY,1
CL,ENDOMETRIAL HYPERPLASIA,1
CL,EPICONDYLITIS,1
CL,EPISCLERITIS,1
CL,EYE INFLAMMATION,1
CL,FACIAL PARALYSIS,1
CL,FEELING ABNORMAL,1
CL,FEELING HOT,1
CL,FIBROMYALGIA,1
CL,FINGER DEFORMITY,1
CL,FRACTURED COCCYX,1
CL,FREQUENT BOWEL MOVEMENTS,1
CL,GALLBLADDER DISORDER,1
CL,GASTRIC DISORDER,1
CL,GASTROINTESTINAL DISORDER,1
CL,GASTROINTESTINAL NECROSIS,1
CL,GASTROINTESTINAL OEDEMA,1
CL,GASTROINTESTINAL PAIN,1
CL,GASTROINTESTINAL SOUNDS ABNORMAL,1
CL,GENERAL PHYSICAL HEALTH DETERIORATION,1
CL,GENITAL ULCERATION,1
CL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
CL,GROIN PAIN,1
CL,GYNAECOMASTIA,1
CL,HAEMORRHAGE,1
CL,HAEMORRHOIDS,1
CL,HAND DEFORMITY,1
CL,HAND FRACTURE,1
CL,HEPATOTOXICITY,1
CL,HIP FRACTURE,1
CL,HOSPITALISATION,1
CL,HYPERHIDROSIS,1
CL,HYPERSENSITIVITY,1
CL,HYPERTENSIVE CRISIS,1
CL,HYPOAESTHESIA,1
CL,HYPOGLYCAEMIA,1
CL,HYPOTENSION,1
CL,IMMOBILE,1
CL,IMMUNOGLOBULINS DECREASED,1
CL,INCREASED BRONCHIAL SECRETION,1
CL,INJECTION SITE HAEMORRHAGE,1
CL,INJURY,1
CL,INTERVERTEBRAL DISC PROTRUSION,1
CL,INTESTINAL HAEMORRHAGE,1
CL,INTESTINAL OBSTRUCTION,1
CL,INTESTINAL STENOSIS,1
CL,INTRAOCULAR PRESSURE INCREASED,1
CL,IRRITABLE BOWEL SYNDROME,1
CL,JOINT DISLOCATION,1
CL,JUVENILE IDIOPATHIC ARTHRITIS,1
CL,JUVENILE PSORIATIC ARTHRITIS,1
CL,KELOID SCAR,1
CL,KIDNEY INFECTION,1
CL,LEUKOENCEPHALOPATHY,1
CL,LIGAMENT DISORDER,1
CL,LIGAMENT INJURY,1
CL,LIGAMENT RUPTURE,1
CL,LIMB OPERATION,1
CL,LIPOMA,1
CL,LIVER DISORDER,1
CL,LOCAL SWELLING,1
CL,LOCALISED INFECTION,1
CL,LOWER RESPIRATORY TRACT INFECTION,1
CL,LUNG DISORDER,1
CL,LYMPHADENITIS,1
CL,LYMPHATIC SYSTEM NEOPLASM,1
CL,MENINGIOMA,1
CL,MENOMETRORRHAGIA,1
CL,MENSTRUATION IRREGULAR,1
CL,MOUTH ULCERATION,1
CL,MOVEMENT DISORDER,1
CL,MUCOSAL INFLAMMATION,1
CL,MUSCLE ATROPHY,1
CL,MUSCLE FATIGUE,1
CL,MUSCLE HYPERTROPHY,1
CL,MUSCLE RUPTURE,1
CL,MUSCLE SPASMS,1
CL,MUSCULOSKELETAL STIFFNESS,1
CL,MYALGIA,1
CL,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
CL,MYOSITIS,1
CL,NASAL ULCER,1
CL,NERVOUSNESS,1
CL,NEUTROPENIA,1
CL,NODULE,1
CL,OBSTRUCTIVE AIRWAYS DISORDER,1
CL,OEDEMA PERIPHERAL,1
CL,ONYCHOMYCOSIS,1
CL,ORAL MUCOSAL BLISTERING,1
CL,OROPHARYNGEAL PAIN,1
CL,OTITIS MEDIA,1
CL,PANCREATIC DISORDER,1
CL,PERITONEAL TUBERCULOSIS,1
CL,PHARYNGITIS,1
CL,PHOTOPHOBIA,1
CL,PLATELET COUNT DECREASED,1
CL,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
CL,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,1
CL,PNEUMONITIS,1
CL,POLYARTERITIS NODOSA,1
CL,POLYP,1
CL,POST HERPETIC NEURALGIA,1
CL,POST PROCEDURAL COMPLICATION,1
CL,POST PROCEDURAL HAEMORRHAGE,1
CL,POSTMENOPAUSAL HAEMORRHAGE,1
CL,PROCEDURAL INTESTINAL PERFORATION,1
CL,PROTEINURIA,1
CL,PSEUDOLYMPHOMA,1
CL,PSORIASIS,1
CL,PULMONARY MASS,1
CL,PYELONEPHRITIS ACUTE,1
CL,RASH,1
CL,RED BLOOD CELL COUNT DECREASED,1
CL,RENAL CYST,1
CL,RENAL DISORDER,1
CL,RESPIRATORY DISORDER,1
CL,RESPIRATORY DISTRESS,1
CL,RESPIRATORY FAILURE,1
CL,RESPIRATORY TRACT INFECTION VIRAL,1
CL,RHINITIS,1
CL,RHINOVIRUS INFECTION,1
CL,SCAR,1
CL,SEIZURE,1
CL,SINUSITIS,1
CL,SKIN DISCOLOURATION,1
CL,SKIN INFECTION,1
CL,SKIN ULCER,1
CL,SKIN WARM,1
CL,SMALL INTESTINAL STENOSIS,1
CL,SPINAL DEFORMITY,1
CL,SPINAL OPERATION,1
CL,STAPHYLOCOCCAL INFECTION,1
CL,STEVENS-JOHNSON SYNDROME,1
CL,STOMA SITE PAIN,1
CL,SUICIDAL IDEATION,1
CL,SUPERINFECTION,1
CL,SYNCOPE,1
CL,SYNOVIAL FLUID ANALYSIS ABNORMAL,1
CL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CL,TENDON PAIN,1
CL,TENDONITIS,1
CL,THERAPEUTIC RESPONSE DECREASED,1
CL,THERAPY NON-RESPONDER,1
CL,THIRST,1
CL,THYROID DISORDER,1
CL,THYROID HORMONES INCREASED,1
CL,THYROID MASS,1
CL,TOOTH DISORDER,1
CL,TOOTH INJURY,1
CL,TREMOR,1
CL,ULTRASOUND ABDOMEN ABNORMAL,1
CL,UMBILICAL HERNIA,1
CL,URTICARIA,1
CL,UVEITIS,1
CL,VARICELLA,1
CL,VIITH NERVE PARALYSIS,1
CL,VIRAL INFECTION,1
CL,VIRAL LOAD INCREASED,1
CL,VISION BLURRED,1
CL,VISUAL IMPAIRMENT,1
CL,VITAMIN D DECREASED,1
CL,VULVOVAGINAL MYCOTIC INFECTION,1
CL,VULVOVAGINAL SWELLING,1
CL,WEIGHT LOSS POOR,1
CL,WHITE BLOOD CELL COUNT DECREASED,1
CL,WHITE BLOOD CELL COUNT INCREASED,1
CN,ACUTE GRAFT VERSUS HOST DISEASE,67
CN,BONE MARROW FAILURE,57
CN,NEUTROPENIA,56
CN,THROMBOCYTOPENIA,46
CN,LUNG INFECTION,44
CN,INFECTION,38
CN,PYREXIA,38
CN,VOMITING,36
CN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,34
CN,PNEUMONIA,33
CN,TOXICITY TO VARIOUS AGENTS,33
CN,GRAFT VERSUS HOST DISEASE,32
CN,FEBRILE NEUTROPENIA,30
CN,CYSTITIS HAEMORRHAGIC,29
CN,DECREASED APPETITE,29
CN,FATIGUE,28
CN,GASTROINTESTINAL HAEMORRHAGE,28
CN,COMPLICATIONS OF BONE MARROW TRANSPLANT,26
CN,DRUG INEFFECTIVE,26
CN,MUSCULOSKELETAL DISORDER,25
CN,PRODUCT USE IN UNAPPROVED INDICATION,25
CN,DEATH,23
CN,SEPSIS,23
CN,DIARRHOEA,22
CN,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,21
CN,ALANINE AMINOTRANSFERASE INCREASED,21
CN,CYTOMEGALOVIRUS INFECTION,20
CN,MUCOSAL INFLAMMATION,20
CN,NAUSEA,20
CN,NEUROTOXICITY,20
CN,EPILEPSY,19
CN,LEUKOPENIA,19
CN,MOUTH ULCERATION,19
CN,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,18
CN,CHRONIC GRAFT VERSUS HOST DISEASE,17
CN,NEUTROPENIC INFECTION,17
CN,RESPIRATORY FAILURE,17
CN,ANAEMIA,15
CN,PRODUCT USE ISSUE,15
CN,LIVER INJURY,14
CN,ASPARTATE AMINOTRANSFERASE INCREASED,13
CN,BLOOD BILIRUBIN INCREASED,13
CN,KLEBSIELLA INFECTION,13
CN,PLATELET COUNT DECREASED,13
CN,DRUG RESISTANCE,12
CN,HEPATITIS B,12
CN,HEPATOTOXICITY,12
CN,MULTI-ORGAN FAILURE,12
CN,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,12
CN,WHITE BLOOD CELL COUNT DECREASED,12
CN,ACUTE MYELOID LEUKAEMIA RECURRENT,11
CN,DYSPNOEA,11
CN,EPSTEIN-BARR VIRUS INFECTION,11
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,11
CN,HEPATIC FUNCTION ABNORMAL,11
CN,RASH,11
CN,SEPTIC SHOCK,11
CN,THERAPY NON-RESPONDER,11
CN,ABDOMINAL PAIN,10
CN,ASCITES,10
CN,COUGH,10
CN,ELECTROLYTE IMBALANCE,10
CN,STOMATITIS,10
CN,VENOOCCLUSIVE LIVER DISEASE,10
CN,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,9
CN,BREAST CANCER RECURRENT,9
CN,DRUG LEVEL INCREASED,9
CN,INTESTINAL ATRESIA,9
CN,METASTASES TO MENINGES,9
CN,RENAL IMPAIRMENT,9
CN,ACUTE KIDNEY INJURY,8
CN,ACUTE MYELOID LEUKAEMIA,8
CN,ASTHENIA,8
CN,CHOLECYSTITIS ACUTE,8
CN,GENERALISED TONIC-CLONIC SEIZURE,8
CN,VENOOCCLUSIVE DISEASE,8
CN,ARTHRALGIA,7
CN,COMA,7
CN,DIZZINESS,7
CN,EPSTEIN-BARR VIRAEMIA,7
CN,FUNGAL INFECTION,7
CN,GRAFT VERSUS HOST DISEASE IN SKIN,7
CN,HEADACHE,7
CN,IDIOPATHIC PNEUMONIA SYNDROME,7
CN,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,7
CN,INTERSTITIAL LUNG DISEASE,7
CN,LEUKAEMIA RECURRENT,7
CN,LEUKOENCEPHALOPATHY,7
CN,LIVER DISORDER,7
CN,LOSS OF CONSCIOUSNESS,7
CN,PATHOGEN RESISTANCE,7
CN,THERAPEUTIC RESPONSE DECREASED,7
CN,URINARY TRACT INFECTION,7
CN,BLOOD CREATININE INCREASED,6
CN,CEREBRAL HAEMORRHAGE,6
CN,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,6
CN,DISEASE PROGRESSION,6
CN,DUODENAL OBSTRUCTION,6
CN,HEPATOMEGALY,6
CN,HYPOAESTHESIA,6
CN,PULMONARY ALVEOLAR HAEMORRHAGE,6
CN,RENAL FAILURE ACUTE,6
CN,RHABDOMYOLYSIS,6
CN,SECONDARY HYPERTENSION,6
CN,SOFT TISSUE INFECTION,6
CN,TRANSPLANT FAILURE,6
CN,TUBERCULOSIS,6
CN,TUMOUR LYSIS SYNDROME,6
CN,WEIGHT INCREASED,6
CN,AGRANULOCYTOSIS,5
CN,BACTERIAL INFECTION,5
CN,BLINDNESS,5
CN,CARDIAC FAILURE,5
CN,CYTOMEGALOVIRUS VIRAEMIA,5
CN,DRUG EFFECT INCOMPLETE,5
CN,GASTROINTESTINAL DISORDER,5
CN,HEPATITIS B DNA INCREASED,5
CN,HYPERTENSION,5
CN,INFUSION RELATED REACTION,5
CN,LYMPHOMA,5
CN,MULTIPLE-DRUG RESISTANCE,5
CN,MYALGIA,5
CN,OROPHARYNGEAL PAIN,5
CN,PRURITUS,5
CN,PULMONARY TUBERCULOSIS,5
CN,RHEUMATOID ARTHRITIS,5
CN,THROMBOTIC MICROANGIOPATHY,5
CN,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,4
CN,ACUTE PULMONARY OEDEMA,4
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,4
CN,CARDIOMYOPATHY,4
CN,DIFFUSE LARGE B-CELL LYMPHOMA,4
CN,GASTROINTESTINAL INFECTION,4
CN,GASTROINTESTINAL INJURY,4
CN,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,4
CN,GRAFT VERSUS HOST DISEASE IN LIVER,4
CN,GRANULOCYTOPENIA,4
CN,HAEMOPTYSIS,4
CN,HEPATITIS B REACTIVATION,4
CN,HEPATOCELLULAR INJURY,4
CN,HYPERPYREXIA,4
CN,JAUNDICE,4
CN,LUNG NEOPLASM MALIGNANT,4
CN,MALIGNANT NEOPLASM PROGRESSION,4
CN,MATERNAL EXPOSURE DURING PREGNANCY,4
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
CN,NEPHROPATHY TOXIC,4
CN,PALPITATIONS,4
CN,PNEUMONIA KLEBSIELLA,4
CN,PULMONARY OEDEMA,4
CN,RENAL INJURY,4
CN,SHOCK,4
CN,SKIN INFECTION,4
CN,TRANSAMINASES ABNORMAL,4
CN,TRANSAMINASES INCREASED,4
CN,URINARY INCONTINENCE,4
CN,VISION BLURRED,4
CN,ABDOMINAL TENDERNESS,3
CN,ACUTE MONOCYTIC LEUKAEMIA,3
CN,ASTHMA,3
CN,BK VIRUS INFECTION,3
CN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
CN,BLOOD URIC ACID INCREASED,3
CN,C-REACTIVE PROTEIN INCREASED,3
CN,CENTRAL NERVOUS SYSTEM FUNGAL INFECTION,3
CN,CHEST PAIN,3
CN,CONDITION AGGRAVATED,3
CN,CONVULSION,3
CN,DIABETES MELLITUS,3
CN,DISEASE RECURRENCE,3
CN,DISSEMINATED INTRAVASCULAR COAGULATION,3
CN,DRUG HYPERSENSITIVITY,3
CN,DRUG-INDUCED LIVER INJURY,3
CN,DYSPHAGIA,3
CN,EPISTAXIS,3
CN,FLUSHING,3
CN,HAEMATOCHEZIA,3
CN,HAEMORRHAGE,3
CN,HISTIOCYTOSIS HAEMATOPHAGIC,3
CN,HYPERSENSITIVITY,3
CN,ILEUS PARALYTIC,3
CN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CN,LYMPHOID TISSUE HYPERPLASIA,3
CN,MEMORY IMPAIRMENT,3
CN,MENINGITIS CHEMICAL,3
CN,METASTASES TO BONE,3
CN,MUSCULAR WEAKNESS,3
CN,NEUTROPHIL COUNT DECREASED,3
CN,OBLITERATIVE BRONCHIOLITIS,3
CN,OSTEONECROSIS,3
CN,PAIN,3
CN,PANCREATITIS,3
CN,PANCYTOPENIA,3
CN,PARTIAL SEIZURES,3
CN,PLEURAL EFFUSION,3
CN,PNEUMONIA BACTERIAL,3
CN,PNEUMONIA CYTOMEGALOVIRAL,3
CN,PNEUMONIA FUNGAL,3
CN,PNEUMONITIS,3
CN,POSTPARTUM HAEMORRHAGE,3
CN,RESPIRATORY TRACT INFECTION,3
CN,SEIZURE,3
CN,SERUM FERRITIN INCREASED,3
CN,TRAUMATIC LUNG INJURY,3
CN,TREATMENT FAILURE,3
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,3
CN,ABORTION INDUCED,2
CN,ACINETOBACTER INFECTION,2
CN,ACUTE HEPATIC FAILURE,2
CN,AGITATION,2
CN,ALTERED STATE OF CONSCIOUSNESS,2
CN,ANAL INFECTION,2
CN,ANAPHYLACTIC REACTION,2
CN,ANAPHYLACTIC SHOCK,2
CN,ANAPLASTIC LARGE-CELL LYMPHOMA,2
CN,APHASIA,2
CN,APPENDICITIS,2
CN,ARRHYTHMIA,2
CN,AUTOMATISM EPILEPTIC,2
CN,BACK PAIN,2
CN,BACTERAEMIA,2
CN,BLISTER,2
CN,BLOOD BILIRUBIN ABNORMAL,2
CN,BREATH SOUNDS ABNORMAL,2
CN,CACHEXIA,2
CN,CANDIDA INFECTION,2
CN,CARDIAC ARREST,2
CN,CARDIOTOXICITY,2
CN,CEREBRAL INFARCTION,2
CN,CHEST DISCOMFORT,2
CN,CHILLS,2
CN,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,2
CN,CORNEAL DISORDER,2
CN,CORONARY ARTERY DISEASE,2
CN,CYTOMEGALOVIRUS CHORIORETINITIS,2
CN,CYTOMEGALOVIRUS TEST POSITIVE,2
CN,DEAFNESS,2
CN,DEMYELINATION,2
CN,DERMATITIS EXFOLIATIVE,2
CN,DIFFUSE LARGE B-CELL LYMPHOMA STAGE II,2
CN,DISSEMINATED TUBERCULOSIS,2
CN,DRUG ADMINISTRATION ERROR,2
CN,DRUG CLEARANCE DECREASED,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DYSPHORIA,2
CN,ENGRAFT FAILURE,2
CN,ENTERITIS,2
CN,ESCHERICHIA INFECTION,2
CN,EXPOSURE DURING PREGNANCY,2
CN,EXTRAPULMONARY TUBERCULOSIS,2
CN,FAECES DISCOLOURED,2
CN,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
CN,FOETAL DEATH,2
CN,GASTRIC HAEMORRHAGE,2
CN,HAEMATOTOXICITY,2
CN,HAEMATURIA,2
CN,HAEMOGLOBIN ABNORMAL,2
CN,HAEMOGLOBIN DECREASED,2
CN,HAEMOLYSIS,2
CN,HAEMORRHAGIC CEREBRAL INFARCTION,2
CN,HEART RATE INCREASED,2
CN,HEPATIC ENZYME INCREASED,2
CN,HEPATIC FAILURE,2
CN,HERPES VIRUS INFECTION,2
CN,HYPERBILIRUBINAEMIA,2
CN,HYPERHIDROSIS,2
CN,HYPONATRAEMIA,2
CN,HYPOPROTEINAEMIA,2
CN,HYPOTENSION,2
CN,HYPOXIA,2
CN,INCORRECT DOSE ADMINISTERED,2
CN,INJECTION SITE PAIN,2
CN,LABORATORY TEST ABNORMAL,2
CN,LARYNGEAL OEDEMA,2
CN,LEFT VENTRICULAR FAILURE,2
CN,LEUKAEMIA,2
CN,LUNG DISORDER,2
CN,LUPUS-LIKE SYNDROME,2
CN,LYMPH NODE TUBERCULOSIS,2
CN,LYMPHADENOPATHY,2
CN,LYMPHOPROLIFERATIVE DISORDER,2
CN,MALAISE,2
CN,METASTASIS,2
CN,MUCOSAL EROSION,2
CN,MYELOPATHY,2
CN,NERVOUS SYSTEM DISORDER,2
CN,OCCULT BLOOD POSITIVE,2
CN,OESOPHAGEAL CANDIDIASIS,2
CN,ORAL HERPES,2
CN,PERICARDIAL EFFUSION,2
CN,PETIT MAL EPILEPSY,2
CN,PLASMABLASTIC LYMPHOMA,2
CN,PLATELET DISORDER,2
CN,PNEUMONIA VIRAL,2
CN,PNEUMOTHORAX,2
CN,POOR QUALITY SLEEP,2
CN,PRODUCTIVE COUGH,2
CN,PULMONARY HAEMORRHAGE,2
CN,PULMONARY MASS,2
CN,PULMONARY MYCOSIS,2
CN,PUPILLARY REFLEX IMPAIRED,2
CN,RASH ERYTHEMATOUS,2
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
CN,RENAL FAILURE,2
CN,RETINAL DEGENERATION,2
CN,SCAB,2
CN,SKIN EXFOLIATION,2
CN,SKIN LESION,2
CN,SKIN ULCER,2
CN,SPEECH DISORDER,2
CN,STEM CELL TRANSPLANT,2
CN,SUPERIOR SAGITTAL SINUS THROMBOSIS,2
CN,SWELLING FACE,2
CN,TEMPORAL LOBE EPILEPSY,2
CN,TONIC CLONIC MOVEMENTS,2
CN,TONSILLITIS,2
CN,URINARY RETENTION,2
CN,VISUAL ACUITY REDUCED,2
CN,VITREOUS OPACITIES,2
CN,ABASIA,1
CN,ABDOMINAL DISCOMFORT,1
CN,ABDOMINAL DISTENSION,1
CN,ABDOMINAL PAIN UPPER,1
CN,ABNORMAL FAECES,1
CN,ACINETOBACTER BACTERAEMIA,1
CN,ACNE,1
CN,ACQUIRED HAEMOPHILIA,1
CN,ACQUIRED TRACHEO-OESOPHAGEAL FISTULA,1
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CN,ACUTE INTERSTITIAL PNEUMONITIS,1
CN,ACUTE LYMPHOCYTIC LEUKAEMIA,1
CN,ACUTE MYOCARDIAL INFARCTION,1
CN,ADENOIDAL DISORDER,1
CN,ADVERSE DRUG REACTION,1
CN,ALOPECIA,1
CN,AMENORRHOEA,1
CN,AMNESIA,1
CN,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
CN,ANAL HAEMORRHAGE,1
CN,ANAL INCONTINENCE,1
CN,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
CN,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT,1
CN,ANGINA UNSTABLE,1
CN,APATHY,1
CN,APLASTIC ANAEMIA,1
CN,APPENDICECTOMY,1
CN,ARTERIOSCLEROSIS,1
CN,ATAXIA,1
CN,ATRIOVENTRICULAR BLOCK,1
CN,B-CELL LYMPHOMA RECURRENT,1
CN,BACTERIAL TEST POSITIVE,1
CN,BLOOD COUNT ABNORMAL,1
CN,BLOOD DISORDER,1
CN,BLOOD FIBRINOGEN DECREASED,1
CN,BLOOD FIBRINOGEN INCREASED,1
CN,BLOOD GLUCOSE ABNORMAL,1
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CN,BLOOD PRESSURE DECREASED,1
CN,BLOOD UREA INCREASED,1
CN,BODY TEMPERATURE INCREASED,1
CN,BONE MARROW TRANSPLANT REJECTION,1
CN,BRAIN HERNIATION,1
CN,BRAIN INJURY,1
CN,BRAIN OEDEMA,1
CN,BRONCHOPULMONARY ASPERGILLOSIS,1
CN,BRONCHOSPASM,1
CN,BUTTERFLY RASH,1
CN,CARDIAC DISORDER,1
CN,CARDIAC FAILURE ACUTE,1
CN,CARDIAC NEOPLASM UNSPECIFIED,1
CN,CARDIO-RESPIRATORY ARREST,1
CN,CENTRAL NERVOUS SYSTEM LESION,1
CN,CEREBRAL ARTERY OCCLUSION,1
CN,CEREBRAL DISORDER,1
CN,CEREBRAL FUNGAL INFECTION,1
CN,CEREBROVASCULAR DISORDER,1
CN,CEREBROVASCULAR INSUFFICIENCY,1
CN,CERVIX CARCINOMA,1
CN,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,1
CN,CHLOROMA,1
CN,CHOKING,1
CN,CHOLECYSTITIS,1
CN,CHOLESTEROSIS,1
CN,CHROMATURIA,1
CN,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,1
CN,CHRONIC KIDNEY DISEASE,1
CN,CHRONIC MYELOID LEUKAEMIA,1
CN,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CN,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
CN,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
CN,CHYLOTHORAX,1
CN,CIRCULATORY COLLAPSE,1
CN,COAGULOPATHY,1
CN,COGNITIVE DISORDER,1
CN,COLITIS,1
CN,CONCOMITANT DISEASE AGGRAVATED,1
CN,CONFUSIONAL STATE,1
CN,CONSTIPATION,1
CN,CONTUSION,1
CN,CREATININE RENAL CLEARANCE INCREASED,1
CN,CROHN^S DISEASE,1
CN,CSF CELL COUNT INCREASED,1
CN,CSF PROTEIN INCREASED,1
CN,CUSHINGOID,1
CN,CYSTITIS VIRAL,1
CN,CYTOMEGALOVIRUS SYNDROME,1
CN,DEEP VEIN THROMBOSIS,1
CN,DEHYDRATION,1
CN,DERMATITIS,1
CN,DIET REFUSAL,1
CN,DIPLEGIA,1
CN,DISORIENTATION,1
CN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CN,DRUG LEVEL ABOVE THERAPEUTIC,1
CN,DRY MOUTH,1
CN,DRY THROAT,1
CN,DUODENAL ULCER HAEMORRHAGE,1
CN,DYSCALCULIA,1
CN,DYSGEUSIA,1
CN,DYSKINESIA,1
CN,EAR PAIN,1
CN,ECCHYMOSIS,1
CN,EMBOLISM ARTERIAL,1
CN,ENCEPHALITIS,1
CN,ENCEPHALITIS VIRAL,1
CN,ENDOCARDITIS,1
CN,ENGRAFTMENT SYNDROME,1
CN,EPILEPTIC AURA,1
CN,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
CN,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
CN,ERYTHEMA,1
CN,ERYTHROLEUKAEMIA,1
CN,EXTENSOR PLANTAR RESPONSE,1
CN,EXTRADURAL HAEMATOMA,1
CN,EYE HAEMORRHAGE,1
CN,FAECAL INCONTINENCE,1
CN,FAECES HARD,1
CN,FEEDING DISORDER,1
CN,FEELING ABNORMAL,1
CN,FULL BLOOD COUNT DECREASED,1
CN,FUNGAL OESOPHAGITIS,1
CN,FUSARIUM INFECTION,1
CN,GASTRIC ULCER,1
CN,GASTRITIS,1
CN,GASTROENTERITIS,1
CN,GASTROENTERITIS NOROVIRUS,1
CN,GASTROINTESTINAL MUCOSAL EXFOLIATION,1
CN,GASTROINTESTINAL SOUNDS ABNORMAL,1
CN,GENERAL PHYSICAL HEALTH DETERIORATION,1
CN,GENERALISED ERYTHEMA,1
CN,GENERALISED OEDEMA,1
CN,GINGIVAL BLEEDING,1
CN,GINGIVAL ULCERATION,1
CN,GINGIVITIS,1
CN,GOITRE,1
CN,GOUTY ARTHRITIS,1
CN,GRAFT VERSUS HOST DISEASE IN LUNG,1
CN,GRANULOCYTE COUNT DECREASED,1
CN,GRANULOMA,1
CN,GUILLAIN-BARRE SYNDROME,1
CN,HAEMATOLOGICAL MALIGNANCY,1
CN,HAEMOLYTIC ANAEMIA,1
CN,HALLUCINATION_ AUDITORY,1
CN,HALLUCINATION_ VISUAL,1
CN,HEART INJURY,1
CN,HELICOBACTER INFECTION,1
CN,HEMIPARESIS,1
CN,HEMIPLEGIA,1
CN,HENOCH-SCHONLEIN PURPURA,1
CN,HEPATIC CIRRHOSIS,1
CN,HEPATIC CYST,1
CN,HEPATIC ENCEPHALOPATHY,1
CN,HEPATIC LESION,1
CN,HEPATIC STEATOSIS,1
CN,HEPATIC VEIN OCCLUSION,1
CN,HEPATITIS,1
CN,HEPATITIS VIRAL,1
CN,HEPATOSPLENOMEGALY,1
CN,HERPES SIMPLEX MENINGOENCEPHALITIS,1
CN,HERPES ZOSTER,1
CN,HICCUPS,1
CN,HIPPOCAMPAL SCLEROSIS,1
CN,HUMAN HERPESVIRUS 6 INFECTION,1
CN,HYPERCHOLESTEROLAEMIA,1
CN,HYPOGAMMAGLOBULINAEMIA,1
CN,HYPOPHAGIA,1
CN,HYPOTHYROIDISM,1
CN,IMMUNOSUPPRESSION,1
CN,INCONTINENCE,1
CN,INCREASED APPETITE,1
CN,INFECTED SKIN ULCER,1
CN,INFECTIOUS PLEURAL EFFUSION,1
CN,INJECTION SITE BRUISING,1
CN,INTESTINAL OBSTRUCTION,1
CN,INTRACRANIAL PRESSURE INCREASED,1
CN,IRIDOCYCLITIS,1
CN,IRITIS,1
CN,IRON METABOLISM DISORDER,1
CN,IRRITABILITY,1
CN,JOINT CONTRACTURE,1
CN,KLEBSIELLA SEPSIS,1
CN,LACUNAR INFARCTION,1
CN,LANGUAGE DISORDER,1
CN,LARYNGOTRACHEITIS OBSTRUCTIVE,1
CN,LATENT TUBERCULOSIS,1
CN,LEUKAEMIC INFILTRATION EXTRAMEDULLARY,1
CN,LEUKAEMIC LYMPHOMA,1
CN,LEUKOCYTOSIS,1
CN,LIMBIC ENCEPHALITIS,1
CN,LIP SWELLING,1
CN,LISTERIOSIS,1
CN,LOCAL SWELLING,1
CN,LUNG ADENOCARCINOMA,1
CN,LUNG INFILTRATION,1
CN,LYMPH NODE PALPABLE,1
CN,LYMPHADENITIS,1
CN,LYMPHATIC DISORDER,1
CN,LYMPHOCYTIC LEUKAEMIA,1
CN,LYMPHOPENIA,1
CN,MARROW HYPERPLASIA,1
CN,MASTOIDITIS,1
CN,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
CN,MEASLES,1
CN,MENINGITIS,1
CN,MENTAL DISORDER,1
CN,MENTAL IMPAIRMENT,1
CN,MENTAL STATUS CHANGES,1
CN,METASTASES TO LIVER,1
CN,METASTASES TO LUNG,1
CN,METASTASES TO LYMPH NODES,1
CN,METASTASES TO PLEURA,1
CN,MICTURITION URGENCY,1
CN,MIOSIS,1
CN,MONOPLEGIA,1
CN,MOUTH SWELLING,1
CN,MUCORMYCOSIS,1
CN,MUCOUS MEMBRANE DISORDER,1
CN,MULTI-ORGAN DISORDER,1
CN,MURPHY^S SIGN POSITIVE,1
CN,MUSCLE INJURY,1
CN,MUSCLE RIGIDITY,1
CN,MUSCULOSKELETAL STIFFNESS,1
CN,MYCOSIS FUNGOIDES,1
CN,MYELODYSPLASTIC SYNDROME TRANSFORMATION,1
CN,MYOCARDIAL INFARCTION,1
CN,MYOCARDIAL ISCHAEMIA,1
CN,NASAL CONGESTION,1
CN,NASOPHARYNGITIS,1
CN,NATURAL KILLER CELL COUNT DECREASED,1
CN,NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA,1
CN,NEOPLASM,1
CN,NEOPLASM RECURRENCE,1
CN,NEPHROLITHIASIS,1
CN,NEPHROTIC SYNDROME,1
CN,NEUROLOGICAL SYMPTOM,1
CN,NEUTROPHIL COUNT,1
CN,NEUTROPHIL COUNT ABNORMAL,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,NO ADVERSE EVENT,1
CN,NON-HODGKIN^S LYMPHOMA,1
CN,OCULAR TOXICITY,1
CN,ODYNOPHAGIA,1
CN,OEDEMA,1
CN,OEDEMA PERIPHERAL,1
CN,OLIGURIA,1
CN,OPTIC ISCHAEMIC NEUROPATHY,1
CN,ORAL FUNGAL INFECTION,1
CN,ORAL PAIN,1
CN,ORAL TOXICITY,1
CN,ORGAN FAILURE,1
CN,OSTEOARTHRITIS,1
CN,OSTEOPENIA,1
CN,OVARIAN EPITHELIAL CANCER,1
CN,OVERDOSE,1
CN,OXYGEN SATURATION DECREASED,1
CN,PACHYDERMOPERIOSTOSIS,1
CN,PAIN IN EXTREMITY,1
CN,PANCREATIC ENZYMES INCREASED,1
CN,PARAESTHESIA,1
CN,PARALYSIS,1
CN,PERICARDITIS,1
CN,PERINEAL INFECTION,1
CN,PETECHIAE,1
CN,PHARYNGEAL INFLAMMATION,1
CN,PHARYNGEAL OEDEMA,1
CN,PLASMA CELL MYELOMA,1
CN,PLEURAL THICKENING,1
CN,PNEUMONIA STAPHYLOCOCCAL,1
CN,PROCALCITONIN INCREASED,1
CN,PROCTALGIA,1
CN,PROTEINURIA,1
CN,PSEUDOMONAL SEPSIS,1
CN,PSORIASIS,1
CN,PULMONARY FIBROSIS,1
CN,PURPURA,1
CN,RADIATION PNEUMONITIS,1
CN,RECTAL CANCER,1
CN,RECURRENT CANCER,1
CN,RED BLOOD CELL ANALYSIS ABNORMAL,1
CN,RED BLOOD CELL COUNT DECREASED,1
CN,RENAL CYST,1
CN,RESPIRATORY ARREST,1
CN,RESPIRATORY RATE INCREASED,1
CN,RESPIRATORY TRACT INFECTION FUNGAL,1
CN,RETINAL HAEMORRHAGE,1
CN,RETINAL INFILTRATES,1
CN,RIB FRACTURE,1
CN,SCROTAL PAIN,1
CN,SELF-MEDICATION,1
CN,SERUM SICKNESS,1
CN,SHOCK HAEMORRHAGIC,1
CN,SINUS TACHYCARDIA,1
CN,SINUSITIS,1
CN,SINUSITIS BACTERIAL,1
CN,SKIN DISORDER,1
CN,SKIN MASS,1
CN,SOFT TISSUE HAEMORRHAGE,1
CN,SOMNOLENCE,1
CN,SPINAL CORD DISORDER,1
CN,SPINAL CORD INJURY,1
CN,SPINAL SHOCK,1
CN,SPUTUM ABNORMAL,1
CN,STARING,1
CN,SYNCOPE,1
CN,SYNOVIAL CYST,1
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CN,T-CELL LYMPHOMA RECURRENT,1
CN,TACHYCARDIA,1
CN,TACHYPNOEA,1
CN,TETANY,1
CN,THALASSAEMIA BETA,1
CN,THERMAL BURN,1
CN,TIBIA FRACTURE,1
CN,TONSILLITIS BACTERIAL,1
CN,TRACHEO-OESOPHAGEAL FISTULA,1
CN,TRANSFUSION REACTION,1
CN,TRANSPLANT REJECTION,1
CN,TUBERCULOSIS GASTROINTESTINAL,1
CN,TUBERCULOUS PLEURISY,1
CN,TYPE IV HYPERSENSITIVITY REACTION,1
CN,ULCER,1
CN,UNEVALUABLE EVENT,1
CN,UNINTENDED PREGNANCY,1
CN,UPPER RESPIRATORY TRACT INFECTION,1
CN,URINARY BLADDER HAEMORRHAGE,1
CN,UTERINE PERFORATION,1
CN,VAGINAL HAEMORRHAGE,1
CN,VASCULITIS,1
CN,VENTRICULAR EXTRASYSTOLES,1
CN,VIRAEMIA,1
CN,VIRAL INFECTION,1
CN,VIRAL LOAD INCREASED,1
CN,VIRAL MYELITIS,1
CN,VISUAL IMPAIRMENT,1
CN,VITRITIS,1
CN,WEIGHT DECREASED,1
CN,WHITE BLOOD CELL COUNT INCREASED,1
CN,WHITE BLOOD CELL DISORDER,1
CN,WHITE MATTER LESION,1
CN,XANTHOCHROMIA,1
CO,ARTHRALGIA,111
CO,PAIN IN EXTREMITY,61
CO,PYREXIA,61
CO,HEADACHE,59
CO,PAIN,54
CO,URINARY TRACT INFECTION,52
CO,DRUG INEFFECTIVE,47
CO,INFLAMMATION,47
CO,MALAISE,45
CO,VOMITING,44
CO,INFLUENZA,39
CO,ABDOMINAL PAIN,33
CO,DIZZINESS,33
CO,FALL,33
CO,GAIT DISTURBANCE,33
CO,ARTHRITIS,32
CO,OSTEOARTHRITIS,31
CO,COUGH,30
CO,ARTHROPATHY,29
CO,MOBILITY DECREASED,29
CO,PNEUMONIA,28
CO,NAUSEA,27
CO,FOOT DEFORMITY,25
CO,JOINT SWELLING,23
CO,DYSPNOEA,22
CO,FATIGUE,22
CO,ASTHENIA,21
CO,RHEUMATOID ARTHRITIS,21
CO,DECREASED APPETITE,19
CO,BACK PAIN,18
CO,ERYTHEMA,18
CO,RESPIRATORY DISTRESS,18
CO,DIARRHOEA,17
CO,OSTEOPOROSIS,17
CO,ABDOMINAL PAIN UPPER,16
CO,PERIPHERAL SWELLING,16
CO,PSORIASIS,16
CO,BRONCHITIS,15
CO,CHEST PAIN,15
CO,HYPERTENSION,15
CO,OEDEMA PERIPHERAL,15
CO,WEIGHT DECREASED,15
CO,CONDITION AGGRAVATED,14
CO,LOSS OF CONSCIOUSNESS,14
CO,ROAD TRAFFIC ACCIDENT,14
CO,DYSURIA,13
CO,ANAEMIA,12
CO,BLOOD PRESSURE INCREASED,12
CO,CHOLELITHIASIS,12
CO,DISCOMFORT,12
CO,HYPERSENSITIVITY,12
CO,LIMB INJURY,12
CO,CARDIO-RESPIRATORY ARREST,11
CO,CATARACT,11
CO,GASTRITIS,11
CO,INJECTION SITE ERYTHEMA,11
CO,INJECTION SITE PAIN,11
CO,JOINT DISLOCATION,11
CO,PRURITUS,11
CO,SOMNOLENCE,11
CO,TOXICITY TO VARIOUS AGENTS,11
CO,VISION BLURRED,11
CO,ABDOMINAL DISTENSION,10
CO,DEPRESSION,10
CO,DIABETES MELLITUS,10
CO,FEELING ABNORMAL,10
CO,HYPERHIDROSIS,10
CO,JOINT RANGE OF MOTION DECREASED,10
CO,PSORIATIC ARTHROPATHY,10
CO,RASH,10
CO,TACHYCARDIA,10
CO,TUBERCULIN TEST POSITIVE,10
CO,TUBERCULOSIS,10
CO,CEREBROVASCULAR ACCIDENT,9
CO,EPISTAXIS,9
CO,HYPOAESTHESIA,9
CO,LUNG DISORDER,9
CO,PROCEDURAL PAIN,9
CO,SPINAL PAIN,9
CO,SYNCOPE,9
CO,UTERINE LEIOMYOMA,9
CO,VAGINAL HAEMORRHAGE,9
CO,CHILLS,8
CO,DEPRESSED MOOD,8
CO,DRUG DOSE OMISSION,8
CO,GLAUCOMA,8
CO,INJECTION SITE SWELLING,8
CO,LOCAL SWELLING,8
CO,NASAL CONGESTION,8
CO,NEPHROLITHIASIS,8
CO,SINUSITIS,8
CO,SWELLING,8
CO,VERTIGO,8
CO,VISUAL ACUITY REDUCED,8
CO,ABASIA,7
CO,APPENDICITIS,7
CO,FLUID RETENTION,7
CO,IMMUNE SYSTEM DISORDER,7
CO,INGUINAL HERNIA,7
CO,JOINT INJURY,7
CO,MUSCLE SPASMS,7
CO,MUSCULOSKELETAL PAIN,7
CO,MUSCULOSKELETAL STIFFNESS,7
CO,NECK PAIN,7
CO,PELVIC PAIN,7
CO,PRODUCTIVE COUGH,7
CO,SPINAL DISORDER,7
CO,ABDOMINAL DISCOMFORT,6
CO,ABDOMINAL PAIN LOWER,6
CO,AMNESIA,6
CO,BLINDNESS,6
CO,BLOOD GLUCOSE INCREASED,6
CO,CARDIAC ARREST,6
CO,CARDIAC DISORDER,6
CO,COMA,6
CO,DEAFNESS,6
CO,DECREASED IMMUNE RESPONSIVENESS,6
CO,DYSPEPSIA,6
CO,EYE INFECTION,6
CO,GAIT INABILITY,6
CO,HEAD INJURY,6
CO,HEMIPARESIS,6
CO,HERPES VIRUS INFECTION,6
CO,HYPOTENSION,6
CO,INFARCTION,6
CO,INFECTION,6
CO,INJECTION SITE PRURITUS,6
CO,JOINT STIFFNESS,6
CO,LIMB DISCOMFORT,6
CO,MENISCUS INJURY,6
CO,OROPHARYNGEAL PAIN,6
CO,PARAESTHESIA,6
CO,POSTOPERATIVE WOUND INFECTION,6
CO,PRODUCT QUALITY ISSUE,6
CO,RESPIRATORY ARREST,6
CO,SUBCUTANEOUS ABSCESS,6
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,6
CO,THROMBOSIS,6
CO,TOOTH DISORDER,6
CO,VAGINAL DISCHARGE,6
CO,VIITH NERVE PARALYSIS,6
CO,ACCIDENT,5
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,5
CO,ACUTE MYOCARDIAL INFARCTION,5
CO,ANXIETY,5
CO,ARRHYTHMIA,5
CO,ASPHYXIA,5
CO,BONE PAIN,5
CO,BREAST MASS,5
CO,CARPAL TUNNEL SYNDROME,5
CO,CELLULITIS,5
CO,CHEST DISCOMFORT,5
CO,CONTUSION,5
CO,DRUG INTOLERANCE,5
CO,DRY SKIN,5
CO,DYSARTHRIA,5
CO,DYSPHONIA,5
CO,EYE DISORDER,5
CO,EYE PAIN,5
CO,FACIAL PAIN,5
CO,FEELING HOT,5
CO,FIBROMYALGIA,5
CO,FINGER DEFORMITY,5
CO,FURUNCLE,5
CO,HAEMATOMA,5
CO,HAND DEFORMITY,5
CO,HERPES ZOSTER,5
CO,HYPOXIA,5
CO,INCREASED UPPER AIRWAY SECRETION,5
CO,INSOMNIA,5
CO,KIDNEY INFECTION,5
CO,LIVER DISORDER,5
CO,LYMPHOMA,5
CO,MUSCULAR WEAKNESS,5
CO,MYOCARDIAL INFARCTION,5
CO,PLATELET COUNT DECREASED,5
CO,PRURITUS GENERALISED,5
CO,PTERYGIUM,5
CO,PULMONARY GRANULOMA,5
CO,PULMONARY MASS,5
CO,RENAL FAILURE,5
CO,RESPIRATORY DISORDER,5
CO,SEIZURE,5
CO,SJOGREN^S SYNDROME,5
CO,SKIN ULCER,5
CO,SPEECH DISORDER,5
CO,SPINAL OSTEOARTHRITIS,5
CO,TOOTH EXTRACTION,5
CO,TOOTH FRACTURE,5
CO,TOOTHACHE,5
CO,TRANSAMINASES INCREASED,5
CO,UVEITIS,5
CO,VIRAL INFECTION,5
CO,WOUND INFECTION,5
CO,ABSCESS LIMB,4
CO,ALOPECIA,4
CO,ANKLE FRACTURE,4
CO,ASTHMATIC CRISIS,4
CO,BENIGN BREAST NEOPLASM,4
CO,CALCULUS URINARY,4
CO,CHOLECYSTITIS,4
CO,CONJUNCTIVITIS,4
CO,CONVULSION,4
CO,CYSTOCELE,4
CO,DEATH,4
CO,DENTAL CARIES,4
CO,DEVICE RELATED INFECTION,4
CO,DYSPHAGIA,4
CO,ECZEMA,4
CO,ENDOMETRIOSIS,4
CO,ERYSIPELAS,4
CO,FOOT FRACTURE,4
CO,GASTROENTERITIS,4
CO,GENERAL PHYSICAL HEALTH DETERIORATION,4
CO,HAND FRACTURE,4
CO,HEPATIC FAILURE,4
CO,HEPATOTOXICITY,4
CO,HYPERGLYCAEMIA,4
CO,HYPERKERATOSIS,4
CO,HYPOACUSIS,4
CO,HYPOGLYCAEMIA,4
CO,IMMUNOSUPPRESSION,4
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
CO,INJECTION SITE BRUISING,4
CO,INJURY,4
CO,IRIDOCYCLITIS,4
CO,LYMPHADENOPATHY,4
CO,MEMORY IMPAIRMENT,4
CO,MYELOPATHY,4
CO,NERVOUSNESS,4
CO,NODULE,4
CO,OEDEMA,4
CO,PLEURAL EFFUSION,4
CO,POLLAKIURIA,4
CO,POST PROCEDURAL INFECTION,4
CO,PRODUCT USE ISSUE,4
CO,RASH GENERALISED,4
CO,RENAL DISORDER,4
CO,SEPSIS,4
CO,SKIN INFECTION,4
CO,SPINAL FRACTURE,4
CO,TENDONITIS,4
CO,THROAT IRRITATION,4
CO,TIBIA FRACTURE,4
CO,TOOTH LOSS,4
CO,TYMPANIC MEMBRANE PERFORATION,4
CO,URTICARIA,4
CO,UTERINE DISORDER,4
CO,UTERINE HAEMORRHAGE,4
CO,WEIGHT INCREASED,4
CO,ANIMAL BITE,3
CO,ANKLE DEFORMITY,3
CO,ASCITES,3
CO,BLOOD CHOLESTEROL INCREASED,3
CO,BONE CYST,3
CO,BONE DECALCIFICATION,3
CO,BONE MARROW OEDEMA,3
CO,BURNING SENSATION,3
CO,C-REACTIVE PROTEIN DECREASED,3
CO,CANDIDA INFECTION,3
CO,CARTILAGE INJURY,3
CO,CHIKUNGUNYA VIRUS INFECTION,3
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
CO,CONSTIPATION,3
CO,DEHYDRATION,3
CO,DISLOCATION OF VERTEBRA,3
CO,DISORIENTATION,3
CO,DYSSTASIA,3
CO,EAR INFECTION,3
CO,EAR PAIN,3
CO,EXPOSURE DURING PREGNANCY,3
CO,EYE IRRITATION,3
CO,EYE PRURITUS,3
CO,FACE OEDEMA,3
CO,GALLBLADDER DISORDER,3
CO,GASTRIC ULCER,3
CO,GASTROINTESTINAL INFLAMMATION,3
CO,GASTROOESOPHAGEAL REFLUX DISEASE,3
CO,GENERALISED OEDEMA,3
CO,GOITRE,3
CO,HAEMORRHAGE,3
CO,HEART RATE INCREASED,3
CO,HIATUS HERNIA,3
CO,HIP FRACTURE,3
CO,HYPERTHERMIA,3
CO,INFLUENZA LIKE ILLNESS,3
CO,INJECTION SITE HAEMORRHAGE,3
CO,JOINT EFFUSION,3
CO,JUVENILE IDIOPATHIC ARTHRITIS,3
CO,LABORATORY TEST ABNORMAL,3
CO,LACERATION,3
CO,LIVER INJURY,3
CO,LOCALISED INFECTION,3
CO,LUNG INFECTION,3
CO,LYMPHADENITIS,3
CO,MALNUTRITION,3
CO,MOVEMENT DISORDER,3
CO,MYALGIA,3
CO,NEUTROPENIA,3
CO,OCULAR HYPERAEMIA,3
CO,ORAL HERPES,3
CO,OSTEOPENIA,3
CO,OVARIAN CYST,3
CO,PAIN IN JAW,3
CO,PAIN OF SKIN,3
CO,PALLOR,3
CO,PANCREATITIS,3
CO,PEAU D^ORANGE,3
CO,PERIPHERAL COLDNESS,3
CO,PHARYNGITIS,3
CO,POISONING,3
CO,PRODUCT USE IN UNAPPROVED INDICATION,3
CO,PROSTATIC DISORDER,3
CO,PURULENT DISCHARGE,3
CO,RADIUS FRACTURE,3
CO,RETINAL DETACHMENT,3
CO,RHINORRHOEA,3
CO,SKIN DEPIGMENTATION,3
CO,SKIN INJURY,3
CO,SKIN PAPILLOMA,3
CO,STOMATITIS,3
CO,SURGICAL FAILURE,3
CO,THORACIC VERTEBRAL FRACTURE,3
CO,THYROID DISORDER,3
CO,TONSILLAR DISORDER,3
CO,TOXIC SKIN ERUPTION,3
CO,ULCERATIVE KERATITIS,3
CO,UMBILICAL HERNIA,3
CO,WHEEZING,3
CO,WOUND,3
CO,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
CO,ABDOMINAL MASS,2
CO,ABSCESS,2
CO,ABSCESS NECK,2
CO,ACETABULUM FRACTURE,2
CO,ACNE,2
CO,ALANINE AMINOTRANSFERASE INCREASED,2
CO,ANGINA UNSTABLE,2
CO,ANKYLOSING SPONDYLITIS,2
CO,APHONIA,2
CO,ARTERIAL OCCLUSIVE DISEASE,2
CO,ARTHRITIS BACTERIAL,2
CO,ARTHRITIS INFECTIVE,2
CO,ASPARTATE AMINOTRANSFERASE INCREASED,2
CO,ATYPICAL PNEUMONIA,2
CO,BACTERAEMIA,2
CO,BACTERIAL INFECTION,2
CO,BALANCE DISORDER,2
CO,BASAL CELL CARCINOMA,2
CO,BLOOD CHOLESTEROL ABNORMAL,2
CO,BLOOD CREATININE INCREASED,2
CO,BLOOD PRESSURE DECREASED,2
CO,BLOOD TRIGLYCERIDES INCREASED,2
CO,BLOOD URIC ACID INCREASED,2
CO,BLOODY DISCHARGE,2
CO,BONE CANCER,2
CO,BONE DEFORMITY,2
CO,BONE DISORDER,2
CO,BRAIN NEOPLASM,2
CO,BREAST CALCIFICATIONS,2
CO,BREAST DISCHARGE,2
CO,BREAST PAIN,2
CO,BRONCHITIS BACTERIAL,2
CO,BRONCHOPNEUMONIA,2
CO,C-REACTIVE PROTEIN INCREASED,2
CO,CEREBRAL HAEMORRHAGE,2
CO,CEREBRAL INFARCTION,2
CO,CHONDROPATHY,2
CO,COAGULOPATHY,2
CO,CONFUSIONAL STATE,2
CO,CONJUNCTIVAL HAEMORRHAGE,2
CO,CORONARY ARTERY OCCLUSION,2
CO,CRYING,2
CO,CUSHING^S SYNDROME,2
CO,CYANOSIS,2
CO,CYST,2
CO,DEEP VEIN THROMBOSIS,2
CO,DENGUE FEVER,2
CO,DERMATITIS EXFOLIATIVE,2
CO,DEVICE DISLOCATION,2
CO,DISEASE PROGRESSION,2
CO,DISEASE RECURRENCE,2
CO,DIVERTICULITIS,2
CO,DRUG ADMINISTRATION ERROR,2
CO,DRUG DEPENDENCE,2
CO,DRUG PRESCRIBING ERROR,2
CO,DRY EYE,2
CO,ENCEPHALITIS,2
CO,EPIPHYSEAL FRACTURE,2
CO,EXOSTOSIS,2
CO,EYE DISCHARGE,2
CO,EYE INFLAMMATION,2
CO,FLATULENCE,2
CO,FUNGAL SKIN INFECTION,2
CO,GASTRIC CANCER,2
CO,GASTRIC INFECTION,2
CO,GASTROINTESTINAL DISORDER,2
CO,GASTROINTESTINAL HAEMORRHAGE,2
CO,GASTROINTESTINAL INFECTION,2
CO,GROIN PAIN,2
CO,HAEMATEMESIS,2
CO,HAEMATOCHEZIA,2
CO,HAEMATURIA,2
CO,HAEMORRHOIDS,2
CO,HEPATIC STEATOSIS,2
CO,HEPATITIS,2
CO,HEPATOMEGALY,2
CO,HORMONE LEVEL ABNORMAL,2
CO,HUMERUS FRACTURE,2
CO,HYPERTENSIVE CRISIS,2
CO,HYPERTHYROIDISM,2
CO,HYPOAESTHESIA ORAL,2
CO,HYPOCALCAEMIA,2
CO,HYPOTHYROIDISM,2
CO,IMMOBILE,2
CO,IMMUNODEFICIENCY,2
CO,INCISION SITE PAIN,2
CO,INCORRECT DOSE ADMINISTERED,2
CO,INCORRECT PRODUCT STORAGE,2
CO,INFLAMMATION OF WOUND,2
CO,INJECTION SITE HAEMATOMA,2
CO,INJECTION SITE RASH,2
CO,INJECTION SITE URTICARIA,2
CO,INNER EAR INFLAMMATION,2
CO,INTERSTITIAL LUNG DISEASE,2
CO,INTRAOCULAR LENS IMPLANT,2
CO,JOINT WARMTH,2
CO,LACRIMATION INCREASED,2
CO,LEFT VENTRICULAR HYPERTROPHY,2
CO,LEIOMYOMA,2
CO,LIPOMA,2
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,2
CO,LOWER LIMB FRACTURE,2
CO,LUNG INFILTRATION,2
CO,MAMMARY DUCT ECTASIA,2
CO,MAMMOGRAM ABNORMAL,2
CO,MELANOCYTIC NAEVUS,2
CO,MENOPAUSE,2
CO,MENSTRUATION IRREGULAR,2
CO,MIGRAINE,2
CO,MUCOSAL INFLAMMATION,2
CO,MULTIPLE INJURIES,2
CO,MYOSITIS,2
CO,NEOPLASM,2
CO,NERVOUS SYSTEM DISORDER,2
CO,NIPPLE DISORDER,2
CO,OBSTRUCTIVE AIRWAYS DISORDER,2
CO,OCULAR HYPERTENSION,2
CO,ODYNOPHAGIA,2
CO,OESOPHAGITIS,2
CO,ORAL PAIN,2
CO,OTORRHOEA,2
CO,OVARIAN MASS,2
CO,OVARIAN NEOPLASM,2
CO,OXYGEN SATURATION DECREASED,2
CO,PATIENT-DEVICE INCOMPATIBILITY,2
CO,PNEUMONIA BACTERIAL,2
CO,POLYCYSTIC OVARIES,2
CO,POLYNEUROPATHY,2
CO,POLYURIA,2
CO,POST PROCEDURAL INFLAMMATION,2
CO,PREGNANCY,2
CO,PROCEDURAL COMPLICATION,2
CO,PROCEDURAL DIZZINESS,2
CO,PSYCHIATRIC SYMPTOM,2
CO,PULMONARY CALCIFICATION,2
CO,PULMONARY OEDEMA,2
CO,PULMONARY THROMBOSIS,2
CO,PULMONARY TUBERCULOSIS,2
CO,RADICULOPATHY,2
CO,RASH ERYTHEMATOUS,2
CO,RASH MACULAR,2
CO,REFLUX GASTRITIS,2
CO,RENAL PAIN,2
CO,RHINITIS,2
CO,ROTATOR CUFF SYNDROME,2
CO,SARCOIDOSIS,2
CO,SCAR,2
CO,SENSORY LOSS,2
CO,SKIN BURNING SENSATION,2
CO,SKIN CANCER,2
CO,SKIN DISCOLOURATION,2
CO,SKIN DISORDER,2
CO,SKIN EXFOLIATION,2
CO,SKIN LESION,2
CO,SKIN WOUND,2
CO,SLEEP APNOEA SYNDROME,2
CO,SPINAL COLUMN INJURY,2
CO,SPINAL OPERATION,2
CO,SPONDYLOLISTHESIS,2
CO,STRESS URINARY INCONTINENCE,2
CO,SUICIDAL IDEATION,2
CO,TENDON RUPTURE,2
CO,THYROID MASS,2
CO,TONGUE INJURY,2
CO,TONSILLITIS,2
CO,TOOTH INFECTION,2
CO,TRANSAMINASES ABNORMAL,2
CO,TREATMENT FAILURE,2
CO,TREATMENT NONCOMPLIANCE,2
CO,TREMOR,2
CO,UNEVALUABLE EVENT,2
CO,UPPER LIMB FRACTURE,2
CO,URETEROLITHIASIS,2
CO,UTERINE CANCER,2
CO,VARICOSE VEIN RUPTURED,2
CO,VIRAL UVEITIS,2
CO,VISUAL FIELD DEFECT,2
CO,VISUAL IMPAIRMENT,2
CO,VITRITIS,2
CO,WALKING DISABILITY,2
CO,WOUND COMPLICATION,2
CO,WOUND HAEMORRHAGE,2
CO,ABDOMINAL INFECTION,1
CO,ABORTION INDUCED,1
CO,ABORTION MISSED,1
CO,ABORTION SPONTANEOUS,1
CO,ABSCESS ORAL,1
CO,ACCESSORY BREAST,1
CO,ACCIDENT AT WORK,1
CO,ACCIDENTAL EXPOSURE TO PRODUCT,1
CO,ACTINIC ELASTOSIS,1
CO,ACTINIC KERATOSIS,1
CO,ACUTE KIDNEY INJURY,1
CO,ADENOIDAL DISORDER,1
CO,ADENOIDITIS,1
CO,ADENOMYOSIS,1
CO,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
CO,ALLERGIC COUGH,1
CO,ALOPECIA AREATA,1
CO,AMERICAN TRYPANOSOMIASIS,1
CO,AMYLASE INCREASED,1
CO,ANDROGEN DEFICIENCY,1
CO,ANGINA PECTORIS,1
CO,ANGIOPLASTY,1
CO,ANOGENITAL DYSPLASIA,1
CO,ANTIPHOSPHOLIPID SYNDROME,1
CO,ANURIA,1
CO,AORTIC ARTERIOSCLEROSIS,1
CO,AORTIC VALVE INCOMPETENCE,1
CO,AORTIC VALVE STENOSIS,1
CO,AORTITIS,1
CO,APHAGIA,1
CO,APPENDIX DISORDER,1
CO,ARTERIOSCLEROSIS CORONARY ARTERY,1
CO,ARTHRODESIS,1
CO,ARTHROPOD BITE,1
CO,ARTHROPOD STING,1
CO,ASTHMA,1
CO,ASTIGMATISM,1
CO,ATELECTASIS,1
CO,ATRIAL FIBRILLATION,1
CO,ATRIAL FLUTTER,1
CO,ATRIAL SEPTAL DEFECT,1
CO,ATRIOVENTRICULAR BLOCK,1
CO,AUTISM,1
CO,AXILLARY MASS,1
CO,BACK DISORDER,1
CO,BACTERIURIA,1
CO,BEDRIDDEN,1
CO,BENIGN BONE NEOPLASM,1
CO,BENIGN LUNG NEOPLASM,1
CO,BENIGN NEOPLASM OF CERVIX UTERI,1
CO,BENIGN NEOPLASM OF SKIN,1
CO,BENIGN SPLEEN TUMOUR,1
CO,BILE DUCT STONE,1
CO,BIOPSY,1
CO,BIOPSY VAGINA ABNORMAL,1
CO,BIPOLAR DISORDER,1
CO,BLADDER GRANULOMA,1
CO,BLADDER INJURY,1
CO,BLINDNESS UNILATERAL,1
CO,BLISTER,1
CO,BLISTER INFECTED,1
CO,BLOOD CORTISOL INCREASED,1
CO,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
CO,BLOOD DISORDER,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD POTASSIUM DECREASED,1
CO,BLOOD PRESSURE ABNORMAL,1
CO,BLOOD UREA ABNORMAL,1
CO,BONE ATROPHY,1
CO,BONE EROSION,1
CO,BONE FISSURE,1
CO,BONE LESION,1
CO,BONE LOSS,1
CO,BONE NEOPLASM,1
CO,BONE OPERATION,1
CO,BOREDOM,1
CO,BRAIN OEDEMA,1
CO,BREAST ABSCESS,1
CO,BREAST CANCER,1
CO,BREAST CANCER FEMALE,1
CO,BREAST CELLULITIS,1
CO,BREAST CYST,1
CO,BREAST FIBROSIS,1
CO,BREAST INFLAMMATION,1
CO,BREAST RECONSTRUCTION,1
CO,BREAST TENDERNESS,1
CO,BROMHIDROSIS,1
CO,BRONCHIAL NEOPLASM BENIGN,1
CO,BRONCHIAL OBSTRUCTION,1
CO,BRONCHIECTASIS,1
CO,BRONCHOSPASM,1
CO,BUNION,1
CO,CARDIAC FAILURE,1
CO,CARDIAC MURMUR,1
CO,CARTILAGE ATROPHY,1
CO,CATARACT OPERATION,1
CO,CATHETER SITE HAEMORRHAGE,1
CO,CEREBRAL HAEMATOMA,1
CO,CEREBRAL MICROANGIOPATHY,1
CO,CEREBRAL THROMBOSIS,1
CO,CEREBRAL VENTRICLE DILATATION,1
CO,CEREBROVASCULAR DISORDER,1
CO,CERVICAL DYSPLASIA,1
CO,CERVIX CARCINOMA,1
CO,CHEST X-RAY ABNORMAL,1
CO,CHOKING SENSATION,1
CO,CHOLECYSTECTOMY,1
CO,CHOLECYSTITIS ACUTE,1
CO,CHOLECYSTITIS CHRONIC,1
CO,CHORIORETINOPATHY,1
CO,CHROMATURIA,1
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CO,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
CO,CLAVICLE FRACTURE,1
CO,COITAL BLEEDING,1
CO,COLITIS,1
CO,COMMINUTED FRACTURE,1
CO,CONCOMITANT DISEASE AGGRAVATED,1
CO,CORNEOCONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA,1
CO,CORONARY ARTERY DISEASE,1
CO,CROHN^S DISEASE,1
CO,CUTANEOUS CALCIFICATION,1
CO,CUTANEOUS TUBERCULOSIS,1
CO,CYTOGENETIC ANALYSIS ABNORMAL,1
CO,DACTYLITIS,1
CO,DEAFNESS BILATERAL,1
CO,DEAFNESS UNILATERAL,1
CO,DECUBITUS ULCER,1
CO,DEMENTIA,1
CO,DEMENTIA ALZHEIMER^S TYPE,1
CO,DENTAL IMPLANTATION,1
CO,DENTAL PULP DISORDER,1
CO,DEPRESSIVE SYMPTOM,1
CO,DERMATITIS,1
CO,DERMATITIS ATOPIC,1
CO,DERMATITIS CONTACT,1
CO,DERMATITIS PSORIASIFORM,1
CO,DEVICE BREAKAGE,1
CO,DEVICE FASTENER ISSUE,1
CO,DEVICE ISSUE,1
CO,DEVICE MATERIAL ISSUE,1
CO,DEVICE OCCLUSION,1
CO,DIABETIC FOOT,1
CO,DIARRHOEA HAEMORRHAGIC,1
CO,DILATATION ATRIAL,1
CO,DISABILITY,1
CO,DISEASE COMPLICATION,1
CO,DISTURBANCE IN ATTENTION,1
CO,DRUG DISPENSING ERROR,1
CO,DRUG LEVEL INCREASED,1
CO,DRUG RESISTANCE,1
CO,DRUG USE DISORDER,1
CO,DRUG-INDUCED LIVER INJURY,1
CO,DRY MOUTH,1
CO,DRY THROAT,1
CO,DYSPAREUNIA,1
CO,DYSPNOEA EXERTIONAL,1
CO,EAR HAEMORRHAGE,1
CO,EAR INJURY,1
CO,EAR NEOPLASM MALIGNANT,1
CO,EATING DISORDER,1
CO,ECCHYMOSIS,1
CO,EJECTION FRACTION ABNORMAL,1
CO,EJECTION FRACTION DECREASED,1
CO,ELBOW DEFORMITY,1
CO,EMOTIONAL DISORDER,1
CO,ENCEPHALITIC INFECTION,1
CO,ENDOMETRIAL HYPERPLASIA,1
CO,ENDOPHTHALMITIS,1
CO,ENZYME ABNORMALITY,1
CO,EOSINOPHIL COUNT INCREASED,1
CO,EPISCLERITIS,1
CO,ERUCTATION,1
CO,ERYTHEMA MULTIFORME,1
CO,ERYTHEMA NODOSUM,1
CO,ERYTHEMA OF EYELID,1
CO,ESCHERICHIA INFECTION,1
CO,ESCHERICHIA URINARY TRACT INFECTION,1
CO,EXTREMITY NECROSIS,1
CO,EYE PENETRATION,1
CO,EYELID INJURY,1
CO,EYELID PAIN,1
CO,FAT INTOLERANCE,1
CO,FAT TISSUE INCREASED,1
CO,FEEDING DISORDER,1
CO,FEELING COLD,1
CO,FEMORAL NECK FRACTURE,1
CO,FEMUR FRACTURE,1
CO,FIBROADENOMA OF BREAST,1
CO,FIBULA FRACTURE,1
CO,FISTULA,1
CO,FISTULA DISCHARGE,1
CO,FLANK PAIN,1
CO,FLUSHING,1
CO,FOETAL DEATH,1
CO,FOETAL EXPOSURE DURING PREGNANCY,1
CO,FOREIGN BODY SENSATION IN EYES,1
CO,GALLBLADDER ENLARGEMENT,1
CO,GALLBLADDER PAIN,1
CO,GASTRIC DISORDER,1
CO,GASTRITIS EROSIVE,1
CO,GASTRODUODENAL ULCER,1
CO,GASTROINTESTINAL BACTERIAL INFECTION,1
CO,GASTROLITHIASIS,1
CO,GENITAL DISCHARGE,1
CO,GENITAL INFECTION,1
CO,GINGIVAL BLEEDING,1
CO,GLIOSIS,1
CO,GLOMERULONEPHRITIS,1
CO,GLUCOSE TOLERANCE IMPAIRED,1
CO,GOUT,1
CO,GRANULOMA,1
CO,GRANULOMA SKIN,1
CO,GRANULOMATOUS LIVER DISEASE,1
CO,GUN SHOT WOUND,1
CO,GUTTATE PSORIASIS,1
CO,HAEMANGIOMA OF BONE,1
CO,HAEMODYNAMIC INSTABILITY,1
CO,HAEMOGLOBIN DECREASED,1
CO,HAEMORRHAGE INTRACRANIAL,1
CO,HAEMORRHAGIC OVARIAN CYST,1
CO,HALLUCINATION,1
CO,HALLUCINATIONS_ MIXED,1
CO,HELICOBACTER GASTRITIS,1
CO,HEMIPLEGIA,1
CO,HEPATIC CANCER,1
CO,HEPATIC CIRRHOSIS,1
CO,HEPATIC ENZYME INCREASED,1
CO,HEPATIC LESION,1
CO,HEPATIC MASS,1
CO,HEPATIC PAIN,1
CO,HEPATITIS ACUTE,1
CO,HEPATITIS B,1
CO,HERPES SIMPLEX MENINGITIS,1
CO,HIP ARTHROPLASTY,1
CO,HIP DEFORMITY,1
CO,HIP SURGERY,1
CO,HISTOPLASMOSIS,1
CO,HIV TEST POSITIVE,1
CO,HYPERPARATHYROIDISM,1
CO,HYPERTENSIVE HEART DISEASE,1
CO,HYPERTROPHIC SCAR,1
CO,HYPOGAMMAGLOBULINAEMIA,1
CO,HYPOKINESIA,1
CO,HYPONATRAEMIA,1
CO,HYPOPITUITARISM,1
CO,HYPOTHALAMO-PITUITARY DISORDER,1
CO,HYSTERECTOMY,1
CO,IDIOSYNCRATIC DRUG REACTION,1
CO,IMPAIRED HEALING,1
CO,INCISION SITE INFLAMMATION,1
CO,INCORRECT DRUG ADMINISTRATION RATE,1
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CO,INFECTED BITE,1
CO,INFECTION SUSCEPTIBILITY INCREASED,1
CO,INFECTIVE THROMBOSIS,1
CO,INFLAMMATORY MARKER INCREASED,1
CO,INFUSION RELATED REACTION,1
CO,INGROWING NAIL,1
CO,INJECTION SITE HYPERSENSITIVITY,1
CO,INJECTION SITE INFECTION,1
CO,INJECTION SITE INJURY,1
CO,INJECTION SITE OEDEMA,1
CO,INJECTION SITE REACTION,1
CO,INJECTION SITE WARMTH,1
CO,INTERVERTEBRAL DISC COMPRESSION,1
CO,INTERVERTEBRAL DISC DEGENERATION,1
CO,INTERVERTEBRAL DISC DISORDER,1
CO,INTERVERTEBRAL DISC PROTRUSION,1
CO,INTESTINAL MASS,1
CO,INTESTINAL OBSTRUCTION,1
CO,INTRACARDIAC THROMBUS,1
CO,INTRACRANIAL ANEURYSM,1
CO,INVESTIGATION,1
CO,INVESTIGATION ABNORMAL,1
CO,IRRITABLE BOWEL SYNDROME,1
CO,ISCHAEMIA,1
CO,ISCHAEMIC STROKE,1
CO,JAW CYST,1
CO,JAW FRACTURE,1
CO,JOINT ABSCESS,1
CO,JOINT CONTRACTURE,1
CO,JOINT CREPITATION,1
CO,JOINT DESTRUCTION,1
CO,JOINT DISLOCATION POSTOPERATIVE,1
CO,JOINT INJECTION,1
CO,JOINT INSTABILITY,1
CO,JOINT LOCK,1
CO,KNEE ARTHROPLASTY,1
CO,KYPHOSIS,1
CO,LACUNAR INFARCTION,1
CO,LAPAROSCOPY,1
CO,LARGE INTESTINAL STENOSIS,1
CO,LARGE INTESTINE POLYP,1
CO,LARYNGEAL CANCER,1
CO,LARYNGITIS,1
CO,LATENT TUBERCULOSIS,1
CO,LAZINESS,1
CO,LEUKOCYTOSIS,1
CO,LEUKOPENIA,1
CO,LIGAMENT INJURY,1
CO,LIGAMENTITIS,1
CO,LIMB CRUSHING INJURY,1
CO,LIMB DEFORMITY,1
CO,LIP ULCERATION,1
CO,LIPASE INCREASED,1
CO,LIPOSUCTION,1
CO,LIVER ABSCESS,1
CO,LIVER FUNCTION TEST INCREASED,1
CO,LOCALISED OEDEMA,1
CO,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
CO,LOW BIRTH WEIGHT BABY,1
CO,LOWER RESPIRATORY TRACT INFECTION,1
CO,LUMBAR VERTEBRAL FRACTURE,1
CO,LUNG NEOPLASM,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LYMPHOCYTE COUNT INCREASED,1
CO,MACULAR DEGENERATION,1
CO,MACULAR HOLE,1
CO,MACULE,1
CO,MAJOR DEPRESSION,1
CO,MALIGNANT MESENTERIC NEOPLASM,1
CO,MASS,1
CO,MEDICAL DEVICE REMOVAL,1
CO,MEDICAL INDUCTION OF COMA,1
CO,MELAENA,1
CO,MENINGITIS,1
CO,MENINGITIS BACTERIAL,1
CO,MENINGITIS CRYPTOCOCCAL,1
CO,MENINGOENCEPHALITIS HERPETIC,1
CO,MENORRHAGIA,1
CO,MENTAL DISORDER,1
CO,METASTASIS,1
CO,METRORRHAGIA,1
CO,MICTURITION DISORDER,1
CO,MIDDLE EAR EFFUSION,1
CO,MOUTH ULCERATION,1
CO,MULTI-ORGAN FAILURE,1
CO,MULTIPLE FRACTURES,1
CO,MUSCULOSKELETAL DISORDER,1
CO,MYCOBACTERIAL INFECTION,1
CO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
CO,NAIL OPERATION,1
CO,NAIL PSORIASIS,1
CO,NASAL DISORDER,1
CO,NASAL POLYPS,1
CO,NASAL ULCER,1
CO,NASOPHARYNGITIS,1
CO,NEOPLASM MALIGNANT,1
CO,NEOPLASM RECURRENCE,1
CO,NEPHROPATHY,1
CO,NERVE COMPRESSION,1
CO,NEUROLOGICAL DECOMPENSATION,1
CO,NEUTROPHIL COUNT DECREASED,1
CO,NIGHT BLINDNESS,1
CO,NIGHT SWEATS,1
CO,NOCTURIA,1
CO,NON-HODGKIN^S LYMPHOMA,1
CO,NUCLEAR MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL,1
CO,NYSTAGMUS,1
CO,OBESITY,1
CO,OBLITERATIVE BRONCHIOLITIS,1
CO,OCULAR DISCOMFORT,1
CO,OCULAR NEOPLASM,1
CO,OEDEMA GENITAL,1
CO,OEDEMA MOUTH,1
CO,ONYCHOLYSIS,1
CO,ONYCHOMYCOSIS,1
CO,OPHTHALMIC HERPES SIMPLEX,1
CO,OPTIC NERVE DISORDER,1
CO,OPTIC NEURITIS,1
CO,ORAL DISORDER,1
CO,ORAL INFECTION,1
CO,ORAL NEOPLASM,1
CO,OSTEOMYELITIS,1
CO,OSTEONECROSIS,1
CO,OSTEOPOROTIC FRACTURE,1
CO,OSTEOSARCOMA,1
CO,OVARIAN DISORDER,1
CO,OVERDOSE,1
CO,PANCREATIC CARCINOMA,1
CO,PANCYTOPENIA,1
CO,PAPULE,1
CO,PARALYSIS,1
CO,PARANASAL SINUS HYPERSECRETION,1
CO,PARASITIC GASTROENTERITIS,1
CO,PARATHYROID DISORDER,1
CO,PARKINSON^S DISEASE,1
CO,PAROTID GLAND ENLARGEMENT,1
CO,PATELLA FRACTURE,1
CO,PELVIC DISCOMFORT,1
CO,PELVIC MASS,1
CO,PERICARDITIS,1
CO,PERIORBITAL CELLULITIS,1
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CO,PERIPHERAL VENOUS DISEASE,1
CO,PHARYNGEAL HAEMORRHAGE,1
CO,PHARYNGEAL INFLAMMATION,1
CO,PHARYNGOTONSILLITIS,1
CO,PHOTOPHOBIA,1
CO,PHOTOPSIA,1
CO,PLATELET COUNT INCREASED,1
CO,PLEURAL DECORTICATION,1
CO,PNEUMONIA ASPIRATION,1
CO,PNEUMONIA STAPHYLOCOCCAL,1
CO,PNEUMONITIS,1
CO,POLYCYTHAEMIA VERA,1
CO,POLYMYALGIA RHEUMATICA,1
CO,POOR QUALITY SLEEP,1
CO,POST PROCEDURAL COMPLICATION,1
CO,POST PROCEDURAL DISCHARGE,1
CO,POST PROCEDURAL HAEMORRHAGE,1
CO,POST PROCEDURAL SEPSIS,1
CO,POST-TRAUMATIC HEADACHE,1
CO,POSTOPERATIVE THROMBOSIS,1
CO,POUCHITIS,1
CO,PREMATURE BABY,1
CO,PREMATURE SEPARATION OF PLACENTA,1
CO,PROCEDURAL HAEMORRHAGE,1
CO,PROCTALGIA,1
CO,PRODUCT ADMINISTERED AT INAPPROPRIATE SITE,1
CO,PROSTATITIS,1
CO,PROSTATOMEGALY,1
CO,PSEUDARTHROSIS,1
CO,PUBIC PAIN,1
CO,PULMONARY FIBROSIS,1
CO,PULMONARY HYPERTENSION,1
CO,PURULENCE,1
CO,QUALITY OF LIFE DECREASED,1
CO,RECTOCELE,1
CO,REMISSION NOT ACHIEVED,1
CO,RENAL ARTERY OCCLUSION,1
CO,RENAL CYST,1
CO,RENAL FAILURE CHRONIC,1
CO,RENAL IMPAIRMENT,1
CO,RESPIRATORY DEPRESSION,1
CO,RESPIRATORY FAILURE,1
CO,RESPIRATORY TRACT INFECTION FUNGAL,1
CO,RETINAL HAEMORRHAGE,1
CO,RETINAL TEAR,1
CO,RETINITIS PIGMENTOSA,1
CO,RETINOPEXY,1
CO,RETROPERITONEAL HAEMORRHAGE,1
CO,RHEUMATIC FEVER,1
CO,RHEUMATOID FACTOR POSITIVE,1
CO,RHEUMATOID NODULE,1
CO,RIB FRACTURE,1
CO,RIGHT ATRIAL DILATATION,1
CO,SCIATIC NERVE INJURY,1
CO,SCIATIC NERVE NEUROPATHY,1
CO,SCLERODERMA,1
CO,SCOLIOSIS,1
CO,SEPTIC SHOCK,1
CO,SINUS BRADYCARDIA,1
CO,SINUS CONGESTION,1
CO,SKIN ADHESION,1
CO,SKIN HYPERPIGMENTATION,1
CO,SKIN MASS,1
CO,SLEEP DISORDER,1
CO,SMALLPOX,1
CO,SNEEZING,1
CO,SNORING,1
CO,SPINAL DEFORMITY,1
CO,SPINE MALFORMATION,1
CO,SPLENOMEGALY,1
CO,SPUTUM RETENTION,1
CO,SQUAMOUS CELL CARCINOMA OF SKIN,1
CO,SQUAMOUS CELL CARCINOMA OF THE CERVIX,1
CO,STOMATITIS NECROTISING,1
CO,STRESS,1
CO,STUPOR,1
CO,SUPERINFECTION,1
CO,SURGERY,1
CO,SWELLING FACE,1
CO,SYNOVIAL CYST,1
CO,SYNOVIAL FLUID ANALYSIS ABNORMAL,1
CO,SYNOVITIS,1
CO,TAKAYASU^S ARTERITIS,1
CO,TENOSYNOVITIS,1
CO,THERAPEUTIC RESPONSE UNEXPECTED,1
CO,THORACOTOMY,1
CO,THROMBOCYTOPENIA,1
CO,THROMBOPHLEBITIS,1
CO,THYMECTOMY,1
CO,THYMUS ENLARGEMENT,1
CR,DIZZINESS,4
CR,EXPOSURE DURING PREGNANCY,3
CR,OSTEOARTHRITIS,3
CR,THROMBOSIS,3
CR,BLOOD CHOLESTEROL INCREASED,2
CR,DRUG EFFECT INCOMPLETE,2
CR,DRUG INTOLERANCE,2
CR,DYSPNOEA,2
CR,FATIGUE,2
CR,HEADACHE,2
CR,OEDEMA,2
CR,OTITIS MEDIA,2
CR,SKIN LESION,2
CR,ABDOMINAL DISTENSION,1
CR,ABORTION,1
CR,ACUTE MYELOID LEUKAEMIA,1
CR,ACUTE MYOCARDIAL INFARCTION,1
CR,ACUTE PULMONARY OEDEMA,1
CR,AMPUTATION,1
CR,ANAEMIA,1
CR,ANGIOEDEMA,1
CR,ANXIETY,1
CR,ARRHYTHMIA,1
CR,ARTERIAL INSUFFICIENCY,1
CR,ARTHRALGIA,1
CR,ARTHRITIS BACTERIAL,1
CR,ASCITES,1
CR,ASPARTATE AMINOTRANSFERASE INCREASED,1
CR,ASTHENIA,1
CR,ATRIOVENTRICULAR BLOCK,1
CR,BEDRIDDEN,1
CR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CR,BLOOD TEST ABNORMAL,1
CR,BLOOD TRIGLYCERIDES INCREASED,1
CR,BLOOD UREA INCREASED,1
CR,BODY HEIGHT DECREASED,1
CR,CEREBRAL INFARCTION,1
CR,CEREBROVASCULAR ACCIDENT,1
CR,CHRONIC GASTRITIS,1
CR,CHRONIC HEPATIC FAILURE,1
CR,COLORECTAL CANCER METASTATIC,1
CR,DECREASED APPETITE,1
CR,DELIVERY,1
CR,DEVICE RELATED INFECTION,1
CR,DIARRHOEA,1
CR,DISCOMFORT,1
CR,DRUG HYPERSENSITIVITY,1
CR,DRUG INEFFECTIVE,1
CR,DRY MOUTH,1
CR,DYSARTHRIA,1
CR,DYSPHAGIA,1
CR,DYSSTASIA,1
CR,ERYTHEMA,1
CR,EYE INFECTION TOXOPLASMAL,1
CR,FACE OEDEMA,1
CR,FALL,1
CR,FEBRILE NEUTROPENIA,1
CR,FEMUR FRACTURE,1
CR,FURUNCLE,1
CR,GAIT DISTURBANCE,1
CR,GLAUCOMA,1
CR,HAEMATOCRIT DECREASED,1
CR,HAEMOGLOBIN DECREASED,1
CR,HAEMORRHOIDS,1
CR,HEART RATE DECREASED,1
CR,HELICOBACTER INFECTION,1
CR,HEPATIC CANCER,1
CR,HEPATIC STEATOSIS,1
CR,HEPATOMEGALY,1
CR,HIGH DENSITY LIPOPROTEIN DECREASED,1
CR,HYPERAEMIA,1
CR,HYPOAESTHESIA,1
CR,HYPOTENSION,1
CR,INSOMNIA,1
CR,JOINT EFFUSION,1
CR,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
CR,LEUKAEMIA,1
CR,LYMPHOCYTE PERCENTAGE INCREASED,1
CR,LYMPHOCYTOSIS,1
CR,MALAISE,1
CR,MALIGNANT MELANOMA,1
CR,MOBILITY DECREASED,1
CR,MONOCYTE PERCENTAGE INCREASED,1
CR,MUSCLE ATROPHY,1
CR,MUSCLE DISORDER,1
CR,MYALGIA,1
CR,MYELOFIBROSIS,1
CR,MYOCARDIAL INFARCTION,1
CR,NASOPHARYNGITIS,1
CR,NEUTROPENIA,1
CR,OCCULT BLOOD POSITIVE,1
CR,OSTEONECROSIS,1
CR,PAPILLOMA,1
CR,PERIPHERAL SWELLING,1
CR,PLEURAL EFFUSION,1
CR,PNEUMONIA,1
CR,POLYP,1
CR,POST PROCEDURAL COMPLICATION,1
CR,PREMATURE LABOUR,1
CR,PROCEDURAL COMPLICATION,1
CR,RECTAL HAEMORRHAGE,1
CR,RECTAL ULCER,1
CR,RENAL FAILURE,1
CR,RHEUMATOID ARTHRITIS,1
CR,RIB FRACTURE,1
CR,SEIZURE,1
CR,SPINAL CORD COMPRESSION,1
CR,SPINAL FRACTURE,1
CR,STOMATITIS,1
CR,SWELLING FACE,1
CR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CR,THROMBOCYTOPENIA,1
CR,URINARY TRACT INFECTION,1
CR,UROSEPSIS,1
CR,VERTIGO,1
CR,WEIGHT DECREASED,1
CR,WHITE BLOOD CELL COUNT DECREASED,1
HR,DRUG INEFFECTIVE,6
HR,C-REACTIVE PROTEIN INCREASED,5
HR,RHEUMATOID ARTHRITIS,5
HR,ACUTE PROMYELOCYTIC LEUKAEMIA,4
HR,ARTHRALGIA,4
HR,DISEASE PROGRESSION,4
HR,HAEMATURIA,4
HR,IGA NEPHROPATHY,4
HR,MYELODYSPLASTIC SYNDROME,4
HR,RENAL FAILURE,4
HR,SARCOIDOSIS,4
HR,BURSITIS,3
HR,DYSPNOEA,3
HR,LOSS OF CONSCIOUSNESS,3
HR,METASTASES TO BONE,3
HR,PYREXIA,3
HR,QUADRIPLEGIA,3
HR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
HR,TINNITUS,3
HR,ABDOMINAL PAIN,2
HR,ACUTE CORONARY SYNDROME,2
HR,ALOPECIA,2
HR,ANAL INCONTINENCE,2
HR,ARTHROPATHY,2
HR,BASAL CELL CARCINOMA,2
HR,BLOOD PRESSURE INCREASED,2
HR,COUGH,2
HR,DIPLOPIA,2
HR,DIVERTICULITIS,2
HR,FATIGUE,2
HR,HAEMATOCHEZIA,2
HR,HEADACHE,2
HR,HYPERHIDROSIS,2
HR,HYPERSENSITIVITY,2
HR,INSOMNIA,2
HR,INTESTINAL PERFORATION,2
HR,JOINT EFFUSION,2
HR,JOINT SWELLING,2
HR,LEUKOPENIA,2
HR,LYMPHADENOPATHY,2
HR,MALIGNANT MELANOMA,2
HR,MALIGNANT NEOPLASM PROGRESSION,2
HR,MENINGITIS CHEMICAL,2
HR,MYOCARDIAL INFARCTION,2
HR,NEUROLOGICAL SYMPTOM,2
HR,NON-HODGKIN^S LYMPHOMA REFRACTORY,2
HR,PALLOR,2
HR,PANCYTOPENIA,2
HR,PLEURAL EFFUSION,2
HR,POLYARTHRITIS,2
HR,PSORIASIS,2
HR,PULMONARY HYPERTENSION,2
HR,RESPIRATORY FAILURE,2
HR,RHEUMATIC DISORDER,2
HR,SPINAL CORD COMPRESSION,2
HR,SYNOVIAL CYST,2
HR,SYNOVIAL RUPTURE,2
HR,TRANSAMINASES INCREASED,2
HR,TREMOR,2
HR,URINARY INCONTINENCE,2
HR,VISUAL FIELD DEFECT,2
HR,ABDOMINAL WALL NEOPLASM BENIGN,1
HR,AGEUSIA,1
HR,AGITATION,1
HR,ANAEMIA MEGALOBLASTIC,1
HR,ANAPHYLACTIC REACTION,1
HR,ANGIOEDEMA,1
HR,ANKYLOSING SPONDYLITIS,1
HR,ANTINUCLEAR ANTIBODY,1
HR,ANTINUCLEAR ANTIBODY POSITIVE,1
HR,APNOEA,1
HR,ARTHRITIS,1
HR,ATAXIA,1
HR,BACK PAIN,1
HR,BILIARY ADENOMA,1
HR,BLOOD FOLATE DECREASED,1
HR,BLOOD URIC ACID INCREASED,1
HR,BONE PAIN,1
HR,BRADYCARDIA,1
HR,BRONCHIAL OBSTRUCTION,1
HR,BRONCHOSPASM,1
HR,CARDIAC VALVE SCLEROSIS,1
HR,CELLULITIS,1
HR,CHEILITIS,1
HR,CHEST DISCOMFORT,1
HR,CHILLS,1
HR,CHOKING,1
HR,CONDITION AGGRAVATED,1
HR,CONFUSIONAL STATE,1
HR,CONNECTIVE TISSUE DISORDER,1
HR,COORDINATION ABNORMAL,1
HR,CORONARY ARTERY OCCLUSION,1
HR,CROHN^S DISEASE,1
HR,CYTOTOXIC OEDEMA,1
HR,DECREASED APPETITE,1
HR,DEEP VEIN THROMBOSIS,1
HR,DEMYELINATION,1
HR,DIARRHOEA,1
HR,DISEASE RECURRENCE,1
HR,DISORIENTATION,1
HR,DRUG INTOLERANCE,1
HR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
HR,ELECTROCARDIOGRAM T WAVE INVERSION,1
HR,ENTEROCOLITIS,1
HR,EOSINOPHILIA,1
HR,ERYTHEMA,1
HR,EYE MOVEMENT DISORDER,1
HR,FEELING ABNORMAL,1
HR,GAIT DISTURBANCE,1
HR,GASTRIC POLYPS,1
HR,GASTROOESOPHAGEAL REFLUX DISEASE,1
HR,GENERALISED TONIC-CLONIC SEIZURE,1
HR,HAEMATOMA,1
HR,HAEMORRHOIDS,1
HR,HEPATIC ADENOMA,1
HR,HEPATIC CYST,1
HR,HEPATOTOXICITY,1
HR,HERPES ZOSTER,1
HR,HIATUS HERNIA,1
HR,HUMERUS FRACTURE,1
HR,HYPERSENSITIVITY VASCULITIS,1
HR,HYPERTENSION,1
HR,HYPOAESTHESIA,1
HR,HYPOTENSION,1
HR,HYPOTONIA,1
HR,INCORRECT DOSE ADMINISTERED,1
HR,INFLAMMATION,1
HR,INFUSION RELATED REACTION,1
HR,INJECTION SITE PAIN,1
HR,INTERSTITIAL LUNG DISEASE,1
HR,IRRITABILITY,1
HR,JOINT RANGE OF MOTION DECREASED,1
HR,JOINT STIFFNESS,1
HR,LEFT VENTRICULAR HYPERTROPHY,1
HR,LIPOMA,1
HR,LIVER INJURY,1
HR,LUNG DISORDER,1
HR,LUNG NEOPLASM MALIGNANT,1
HR,MEDICATION ERROR,1
HR,MENINGISM,1
HR,MENOMETRORRHAGIA,1
HR,MOTOR DYSFUNCTION,1
HR,MUCOSAL DRYNESS,1
HR,MUSCLE HYPERTROPHY,1
HR,MUSCULAR WEAKNESS,1
HR,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
HR,NASOPHARYNGITIS,1
HR,NAUSEA,1
HR,NEUROLOGICAL DECOMPENSATION,1
HR,NOSOCOMIAL INFECTION,1
HR,OEDEMA,1
HR,OPHTHALMIC HERPES ZOSTER,1
HR,OPTIC NEURITIS,1
HR,OXYGEN SATURATION DECREASED,1
HR,PAIN,1
HR,PALPITATIONS,1
HR,PANCREATIC CYST,1
HR,PARAESTHESIA,1
HR,PAROTID GLAND ENLARGEMENT,1
HR,PERIPHERAL SWELLING,1
HR,PNEUMONIA,1
HR,PNEUMONIA LEGIONELLA,1
HR,POLLAKIURIA,1
HR,POST LUMBAR PUNCTURE SYNDROME,1
HR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
HR,PRURITUS,1
HR,PULMONARY EMBOLISM,1
HR,PULMONARY FIBROSIS,1
HR,PULMONARY MASS,1
HR,RASH,1
HR,RASH MACULO-PAPULAR,1
HR,RESPIRATORY DISTRESS,1
HR,RESPIRATORY TRACT INFECTION,1
HR,RHEUMATOID FACTOR INCREASED,1
HR,SCAB,1
HR,SKIN EXFOLIATION,1
HR,SKIN ULCER,1
HR,STAPHYLOCOCCAL SCALDED SKIN SYNDROME,1
HR,SYNCOPE,1
HR,TACHYCARDIA,1
HR,TACHYPNOEA,1
HR,THIRST,1
HR,THROAT IRRITATION,1
HR,TRAUMATIC FRACTURE,1
HR,TROPONIN INCREASED,1
HR,VERTIGO,1
HR,VISUAL IMPAIRMENT,1
HR,VOMITING,1
HR,WEIGHT DECREASED,1
HR,WHEEZING,1
CY,ACUTE KIDNEY INJURY,1
CY,BREAST CANCER STAGE II,1
CY,CEREBRAL ARTERY EMBOLISM,1
CY,CHOLECYSTITIS,1
CY,DEAFNESS,1
CY,ENDOCARDITIS,1
CY,GUILLAIN-BARRE SYNDROME,1
CY,LUMBAR VERTEBRAL FRACTURE,1
CY,NEUROPATHY PERIPHERAL,1
CY,PANCREATITIS,1
CY,POLYNEUROPATHY,1
CY,PSEUDOCYST,1
CY,UTERINE CANCER,1
CZ,SEPSIS,22
CZ,PANCYTOPENIA,17
CZ,FEBRILE NEUTROPENIA,15
CZ,INFECTION,11
CZ,DRUG INEFFECTIVE,10
CZ,HAEMATOTOXICITY,10
CZ,MUCOSAL TOXICITY,10
CZ,PNEUMONIA,10
CZ,SKIN TOXICITY,10
CZ,HEADACHE,9
CZ,PSYCHOMOTOR HYPERACTIVITY,8
CZ,ACUTE MONOCYTIC LEUKAEMIA,7
CZ,PSORIASIS,7
CZ,ANAEMIA,6
CZ,DYSPNOEA,6
CZ,HAEMODYNAMIC INSTABILITY,6
CZ,POLYNEUROPATHY,6
CZ,RASH,6
CZ,STOMATITIS,6
CZ,TOXICITY TO VARIOUS AGENTS,6
CZ,VOMITING,6
CZ,BREAST CANCER,5
CZ,GASTRITIS,5
CZ,GASTROINTESTINAL TOXICITY,5
CZ,LATENT TUBERCULOSIS,5
CZ,LIVER DISORDER,5
CZ,SWELLING FACE,5
CZ,CIRCULATORY COLLAPSE,4
CZ,DEATH,4
CZ,DIARRHOEA,4
CZ,HEPATOTOXICITY,4
CZ,MUCOSAL INFLAMMATION,4
CZ,MYOCARDIAL INFARCTION,4
CZ,NEUROTOXICITY,4
CZ,NEUTROPENIA,4
CZ,ODYNOPHAGIA,4
CZ,PYREXIA,4
CZ,RENAL FAILURE,4
CZ,SUBILEUS,4
CZ,ABDOMINAL PAIN,3
CZ,ACUTE MYOCARDIAL INFARCTION,3
CZ,ALANINE AMINOTRANSFERASE INCREASED,3
CZ,ASTHENIA,3
CZ,CHEST PAIN,3
CZ,COUGH,3
CZ,DRUG ERUPTION,3
CZ,DRUG-INDUCED LIVER INJURY,3
CZ,HEPATIC STEATOSIS,3
CZ,HYPOTENSION,3
CZ,IDIOSYNCRATIC DRUG REACTION,3
CZ,INTESTINAL HAEMORRHAGE,3
CZ,METASTASES TO BONE,3
CZ,PLEURAL EFFUSION,3
CZ,PULMONARY EMBOLISM,3
CZ,RENAL CANCER,3
CZ,ACUTE MYELOID LEUKAEMIA,2
CZ,APHTHOUS STOMATITIS,2
CZ,ARTHRALGIA,2
CZ,B-CELL LYMPHOMA,2
CZ,BLOOD CREATININE INCREASED,2
CZ,BONE MARROW FAILURE,2
CZ,BRONCHOPNEUMONIA,2
CZ,CARDIAC FAILURE,2
CZ,CARDIOTOXICITY,2
CZ,CERVIX CARCINOMA,2
CZ,CHOLELITHIASIS,2
CZ,CLEAR CELL RENAL CELL CARCINOMA,2
CZ,CONDITION AGGRAVATED,2
CZ,DEHYDRATION,2
CZ,DERMATITIS EXFOLIATIVE,2
CZ,DIVERTICULITIS,2
CZ,ERYSIPELAS,2
CZ,ERYTHEMA,2
CZ,FALL,2
CZ,FATIGUE,2
CZ,HYDROTHORAX,2
CZ,HYPERSENSITIVITY,2
CZ,HYPERTENSION,2
CZ,INFLAMMATORY MARKER INCREASED,2
CZ,INTERSTITIAL LUNG DISEASE,2
CZ,LEUKOPENIA,2
CZ,LUNG NEOPLASM MALIGNANT,2
CZ,NAUSEA,2
CZ,PAIN,2
CZ,PHARYNGITIS,2
CZ,PROSTATE CANCER,2
CZ,PYELONEPHRITIS,2
CZ,RASH GENERALISED,2
CZ,RHEUMATOID ARTHRITIS,2
CZ,SKIN EXFOLIATION,2
CZ,SPINAL PAIN,2
CZ,SYPHILIS,2
CZ,THROMBOSIS,2
CZ,URINARY TRACT INFECTION,2
CZ,ABDOMINAL DISTENSION,1
CZ,ABORTION,1
CZ,ACUTE RESPIRATORY FAILURE,1
CZ,ADENOCARCINOMA OF COLON,1
CZ,ADVERSE REACTION,1
CZ,ALANINE AMINOTRANSFERASE ABNORMAL,1
CZ,AMAUROSIS,1
CZ,ANAEMIA OF CHRONIC DISEASE,1
CZ,ANAPHYLACTIC REACTION,1
CZ,ANGINA PECTORIS,1
CZ,AORTITIS,1
CZ,APHTHOUS ULCER,1
CZ,APPENDICITIS,1
CZ,APPENDICITIS PERFORATED,1
CZ,ARTERIOSCLEROSIS CORONARY ARTERY,1
CZ,ARTHRITIS,1
CZ,ARTHRITIS BACTERIAL,1
CZ,ARTHROPATHY,1
CZ,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CZ,ASTHMA,1
CZ,ATRIAL FIBRILLATION,1
CZ,BACK PAIN,1
CZ,BILE DUCT CANCER STAGE IV,1
CZ,BILE DUCT OBSTRUCTION,1
CZ,BILE DUCT STENOSIS,1
CZ,BLADDER TRANSITIONAL CELL CARCINOMA,1
CZ,BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT,1
CZ,BLOOD BILIRUBIN ABNORMAL,1
CZ,BLOOD BILIRUBIN INCREASED,1
CZ,BLOOD COUNT ABNORMAL,1
CZ,BLOOD UREA INCREASED,1
CZ,BONE PAIN,1
CZ,BONE RESORPTION TEST ABNORMAL,1
CZ,BOWEN^S DISEASE,1
CZ,BREAST CANCER FEMALE,1
CZ,BRONCHIAL CARCINOMA,1
CZ,BRONCHITIS,1
CZ,BURSITIS,1
CZ,C-REACTIVE PROTEIN INCREASED,1
CZ,CAMPYLOBACTER GASTROENTERITIS,1
CZ,CANDIDA INFECTION,1
CZ,CARDIAC ARREST,1
CZ,CARDIAC SEPTAL HYPERTROPHY,1
CZ,CARDIOVASCULAR DISORDER,1
CZ,CATARACT,1
CZ,CELLULITIS,1
CZ,CEREBRAL DISORDER,1
CZ,CEREBROVASCULAR ACCIDENT,1
CZ,CHILLS,1
CZ,CHOLESTASIS,1
CZ,CHRONIC HEPATITIS,1
CZ,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
CZ,COLITIS,1
CZ,COLITIS ULCERATIVE,1
CZ,COMPLETED SUICIDE,1
CZ,CONTUSION,1
CZ,COORDINATION ABNORMAL,1
CZ,CREATININE RENAL CLEARANCE ABNORMAL,1
CZ,CROHN^S DISEASE,1
CZ,CYST,1
CZ,CYSTITIS,1
CZ,CYTOMEGALOVIRUS INFECTION,1
CZ,DACTYLITIS,1
CZ,DEEP VEIN THROMBOSIS,1
CZ,DERMATITIS ALLERGIC,1
CZ,DIABETES MELLITUS,1
CZ,DISEASE PROGRESSION,1
CZ,DISEASE RECURRENCE,1
CZ,DISSEMINATED TUBERCULOSIS,1
CZ,DIZZINESS,1
CZ,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CZ,DUODENAL ULCER,1
CZ,DYSLIPIDAEMIA,1
CZ,DYSPEPSIA,1
CZ,DYSPNOEA EXERTIONAL,1
CZ,DYSURIA,1
CZ,ENCEPHALOPATHY,1
CZ,ENDOMETRIAL ADENOCARCINOMA,1
CZ,EPILEPSY,1
CZ,ERYTHEMA MULTIFORME,1
CZ,ERYTHEMA NODOSUM,1
CZ,ESCHERICHIA INFECTION,1
CZ,ESCHERICHIA URINARY TRACT INFECTION,1
CZ,EXTRADURAL ABSCESS,1
CZ,FACE OEDEMA,1
CZ,FEELING ABNORMAL,1
CZ,FEMORAL NECK FRACTURE,1
CZ,FEMUR FRACTURE,1
CZ,FORMICATION,1
CZ,GASTRIC DISORDER,1
CZ,GASTRIC ULCER,1
CZ,GASTROENTERITIS ROTAVIRUS,1
CZ,GASTROENTERITIS SALMONELLA,1
CZ,GASTROINTESTINAL DISORDER,1
CZ,GASTROINTESTINAL HAEMORRHAGE,1
CZ,GASTROINTESTINAL INFLAMMATION,1
CZ,GENERAL PHYSICAL CONDITION ABNORMAL,1
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
CZ,GLIOBLASTOMA,1
CZ,GOITRE,1
CZ,H1N1 INFLUENZA,1
CZ,HAEMATOMA,1
CZ,HAEMOGLOBIN DECREASED,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HEPATIC FAILURE,1
CZ,HEPATIC STEATO-FIBROSIS,1
CZ,HEPATITIS C,1
CZ,HEPATOSPLENOMEGALY,1
CZ,HERPES ZOSTER,1
CZ,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
CZ,HODGKIN^S DISEASE,1
CZ,HYPERGLYCAEMIA,1
CZ,HYPERKALAEMIA,1
CZ,HYPERPYREXIA,1
CZ,HYPERURICAEMIA,1
CZ,HYPOMAGNESAEMIA,1
CZ,HYSTERECTOMY,1
CZ,IMMUNOGLOBULIN G4 RELATED DISEASE,1
CZ,IMPAIRED GASTRIC EMPTYING,1
CZ,IMPAIRED HEALING,1
CZ,INCARCERATED HERNIA,1
CZ,INFLUENZA,1
CZ,INFUSION RELATED REACTION,1
CZ,INJURY,1
CZ,INTERFERON GAMMA LEVEL,1
CZ,INTERVERTEBRAL DISCITIS,1
CZ,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
CZ,INVASIVE DUCTAL BREAST CARCINOMA,1
CZ,INVASIVE LOBULAR BREAST CARCINOMA,1
CZ,IRON DEFICIENCY ANAEMIA,1
CZ,JAUNDICE CHOLESTATIC,1
CZ,JOINT SWELLING,1
CZ,LABORATORY TEST ABNORMAL,1
CZ,LARYNGEAL PAIN,1
CZ,LARYNGEAL POLYP,1
CZ,LARYNGITIS,1
CZ,LENS EXTRACTION,1
CZ,LEUKOENCEPHALOPATHY,1
CZ,LIVER FUNCTION TEST ABNORMAL,1
CZ,LUNG ADENOCARCINOMA,1
CZ,LUNG CANCER METASTATIC,1
CZ,LUNG INFILTRATION,1
CZ,LUNG NEOPLASM,1
CZ,LYMPHOEDEMA,1
CZ,LYMPHOMA,1
CZ,LYMPHOPENIA,1
CZ,MALIGNANT MELANOMA,1
CZ,MALNUTRITION,1
CZ,MEDULLOBLASTOMA RECURRENT,1
CZ,MENINGIOMA,1
CZ,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CZ,METASTASES TO LIVER,1
CZ,METASTASES TO LUNG,1
CZ,METASTASES TO PERITONEUM,1
CZ,METASTASIS,1
CZ,METRORRHAGIA,1
CZ,MINERAL DEFICIENCY,1
CZ,MUCOSAL HAEMORRHAGE,1
CZ,MULTI-ORGAN FAILURE,1
CZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CZ,MUSCULOSKELETAL STIFFNESS,1
CZ,MYALGIA,1
CZ,MYOPATHY,1
CZ,MYOSITIS,1
CZ,NAIL DYSTROPHY,1
CZ,NASOPHARYNGITIS,1
CZ,NEPHROPATHY TOXIC,1
CZ,NEUROBORRELIOSIS,1
CZ,NEUTROPENIC SEPSIS,1
CZ,NEUTROPHIL COUNT DECREASED,1
CZ,NON-HODGKIN^S LYMPHOMA,1
CZ,NON-SMALL CELL LUNG CANCER,1
CZ,OBESITY,1
CZ,OESOPHAGEAL CARCINOMA,1
CZ,OOPHORITIS,1
CZ,ORAL CANDIDIASIS,1
CZ,ORAL FIBROMA,1
CZ,ORTHOSTATIC HYPOTENSION,1
CZ,OSTEOARTHRITIS,1
CZ,OSTEOPOROSIS,1
CZ,OSTEOSARCOMA,1
CZ,OTITIS EXTERNA,1
CZ,OTITIS MEDIA,1
CZ,OVARIAN CYST,1
CZ,OVARIAN EPITHELIAL CANCER,1
CZ,OVERDOSE,1
CZ,PAIN IN EXTREMITY,1
CZ,PANCREATIC CARCINOMA METASTATIC,1
CZ,PANCREATIC ENLARGEMENT,1
CZ,PANCREATIC NEOPLASM,1
CZ,PELVIC ABSCESS,1
CZ,PEPTIC ULCER,1
CZ,PERITONEAL HAEMORRHAGE,1
CZ,PERITONITIS,1
CZ,PHAEOCHROMOCYTOMA,1
CZ,PLATELET COUNT DECREASED,1
CZ,PNEUMONIA KLEBSIELLA,1
CZ,POLYMYOSITIS,1
CZ,PRESYNCOPE,1
CZ,PRODUCT SOLUBILITY ABNORMAL,1
CZ,PRODUCT USE IN UNAPPROVED INDICATION,1
CZ,PRODUCT USE ISSUE,1
CZ,PRODUCTIVE COUGH,1
CZ,PULMONARY ARTERIAL HYPERTENSION,1
CZ,PULMONARY FIBROSIS,1
CZ,PULMONARY OEDEMA,1
CZ,PULMONARY TOXICITY,1
CZ,PYELONEPHRITIS ACUTE,1
CZ,RALES,1
CZ,RESPIRATORY FAILURE,1
CZ,RESPIRATORY TRACT INFECTION,1
CZ,RETROPERITONEAL FIBROSIS,1
CZ,RHEUMATOID LUNG,1
CZ,RHEUMATOID NODULE,1
CZ,RICHTER^S HERNIA,1
CZ,SALIVARY GLAND NEOPLASM,1
CZ,SALMONELLA SEPSIS,1
CZ,SALMONELLA TEST POSITIVE,1
CZ,SICK SINUS SYNDROME,1
CZ,SINUSITIS,1
CZ,SKIN ULCER,1
CZ,SPUTUM PURULENT,1
CZ,STAPHYLOCOCCAL INFECTION,1
CZ,STEATOHEPATITIS,1
CZ,STEVENS-JOHNSON SYNDROME,1
CZ,STRANGULATED HERNIA,1
CZ,STRESS CARDIOMYOPATHY,1
CZ,SUBCUTANEOUS HAEMATOMA,1
CZ,SUBDIAPHRAGMATIC ABSCESS,1
CZ,SYNCOPE,1
CZ,SYNOVECTOMY,1
CZ,TACHYCARDIA,1
CZ,THERAPY CESSATION,1
CZ,THROAT IRRITATION,1
CZ,THROMBOCYTOPENIA,1
CZ,TOE AMPUTATION,1
CZ,TONGUE DISCOLOURATION,1
CZ,TONGUE DRY,1
CZ,TONSILLITIS STREPTOCOCCAL,1
CZ,TRANSAMINASES INCREASED,1
CZ,TRANSFUSION,1
CZ,TREATMENT FAILURE,1
CZ,TUBERCULIN TEST POSITIVE,1
CZ,UNEVALUABLE EVENT,1
CZ,UPPER RESPIRATORY TRACT INFECTION,1
CZ,URETHRAL STRICTURE POST INFECTION,1
CZ,UROSEPSIS,1
CZ,UTERINE PROLAPSE,1
CZ,VAGINAL HAEMORRHAGE,1
CZ,VAGINAL PROLAPSE,1
CZ,VARICOSE VEIN,1
CZ,VASCULAR RESISTANCE PULMONARY INCREASED,1
CZ,VENTRICULAR DYSFUNCTION,1
CZ,VERTIGO,1
CZ,WEIGHT INCREASED,1
DK,VENOOCCLUSIVE LIVER DISEASE,145
DK,METASTASIS,52
DK,FATIGUE,27
DK,ANAEMIA,22
DK,DYSPNOEA,22
DK,WEIGHT DECREASED,22
DK,LUNG NEOPLASM MALIGNANT,21
DK,COUGH,19
DK,PNEUMONIA,18
DK,PYREXIA,18
DK,PULMONARY FIBROSIS,15
DK,RESPIRATORY SYMPTOM,15
DK,PANCYTOPENIA,14
DK,DISEASE PROGRESSION,13
DK,DRUG INEFFECTIVE,13
DK,DISTURBANCE IN ATTENTION,12
DK,MYELODYSPLASTIC SYNDROME,12
DK,HAEMOGLOBIN DECREASED,11
DK,MALIGNANT RESPIRATORY TRACT NEOPLASM,11
DK,SPLENOMEGALY,11
DK,RESPIRATORY FAILURE,10
DK,BRONCHOPULMONARY ASPERGILLOSIS,9
DK,HYPERHIDROSIS,9
DK,INSOMNIA,9
DK,INTERSTITIAL LUNG DISEASE,9
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
DK,PARAESTHESIA,9
DK,ARTHRALGIA,8
DK,ARTHRITIS,8
DK,DIARRHOEA,8
DK,HAEMATURIA,8
DK,LUNG ADENOCARCINOMA,8
DK,MALAISE,8
DK,NEUROTOXICITY,8
DK,OESOPHAGEAL CARCINOMA,8
DK,PRURITUS,8
DK,THROMBOCYTOPENIA,8
DK,TREMOR,8
DK,AMNESIA,7
DK,ANORGASMIA,7
DK,ANXIETY,7
DK,BONE DISORDER,7
DK,CARDIAC DISORDER,7
DK,CARTILAGE ATROPHY,7
DK,DYSKINESIA,7
DK,GAIT DISTURBANCE,7
DK,HEPATIC STEATOSIS,7
DK,HOT FLUSH,7
DK,MYALGIA,7
DK,NEUTROPENIA,7
DK,NIGHTMARE,7
DK,PRODUCT USE IN UNAPPROVED INDICATION,7
DK,SYNOVITIS,7
DK,TOXICITY TO VARIOUS AGENTS,7
DK,ALANINE AMINOTRANSFERASE INCREASED,6
DK,BASAL CELL CARCINOMA,6
DK,BONE ATROPHY,6
DK,COLITIS,6
DK,DIZZINESS,6
DK,ENCEPHALITIS,6
DK,ENDOMETRIAL CANCER,6
DK,HEADACHE,6
DK,LYMPHOPENIA,6
DK,METASTASES TO REPRODUCTIVE ORGAN,6
DK,MUSCULAR WEAKNESS,6
DK,NAUSEA,6
DK,NECROTISING COLITIS,6
DK,NEUTROPHIL COUNT DECREASED,6
DK,OEDEMA PERIPHERAL,6
DK,PLATELET COUNT DECREASED,6
DK,PNEUMONITIS,6
DK,PROSTATE CANCER,6
DK,PULMONARY FUNCTION TEST DECREASED,6
DK,VOMITING,6
DK,WHITE BLOOD CELL COUNT DECREASED,6
DK,ABDOMINAL PAIN,5
DK,AMOEBIC COLITIS,5
DK,BALANCE DISORDER,5
DK,BLADDER TRANSITIONAL CELL CARCINOMA STAGE II,5
DK,BONE MARROW TOXICITY,5
DK,CONSTIPATION,5
DK,DRUG RESISTANCE,5
DK,FACIAL PARESIS,5
DK,INFECTION,5
DK,LIVER DISORDER,5
DK,LUNG LOBECTOMY,5
DK,MEMORY IMPAIRMENT,5
DK,NEURALGIA,5
DK,PERIPHERAL SENSORY NEUROPATHY,5
DK,RENAL CANCER,5
DK,STOMATITIS,5
DK,VISUAL IMPAIRMENT,5
DK,WOUND,5
DK,ABDOMINAL DISCOMFORT,4
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,4
DK,ALVEOLITIS ALLERGIC,4
DK,BILIARY CIRRHOSIS,4
DK,BLOOD ALBUMIN DECREASED,4
DK,BLOOD CREATININE INCREASED,4
DK,CEREBRAL THROMBOSIS,4
DK,COLON CANCER,4
DK,DERMATITIS,4
DK,DIVERTICULUM,4
DK,FEBRILE NEUTROPENIA,4
DK,GASTRIC ULCER,4
DK,GASTROINTESTINAL INFLAMMATION,4
DK,HAEMORRHAGE,4
DK,HEPATOTOXICITY,4
DK,IMMUNOSUPPRESSION,4
DK,KNEE OPERATION,4
DK,LIBIDO DECREASED,4
DK,LUNG INFILTRATION,4
DK,MALIGNANT MELANOMA,4
DK,PAIN,4
DK,PAIN IN EXTREMITY,4
DK,PAIN IN JAW,4
DK,PRODUCT USE ISSUE,4
DK,PSORIASIS,4
DK,RASH,4
DK,SENSORY DISTURBANCE,4
DK,ABDOMINAL PAIN LOWER,3
DK,ABDOMINAL PAIN UPPER,3
DK,ACUTE MYOCARDIAL INFARCTION,3
DK,AMOEBIASIS,3
DK,ASCITES,3
DK,ATAXIA,3
DK,BLADDER CANCER,3
DK,BONE MARROW FAILURE,3
DK,C-REACTIVE PROTEIN INCREASED,3
DK,CHOLANGITIS SCLEROSING,3
DK,CHRONIC HEPATIC FAILURE,3
DK,COGNITIVE DISORDER,3
DK,CONTUSION,3
DK,DECREASED APPETITE,3
DK,DEHYDRATION,3
DK,DIARRHOEA HAEMORRHAGIC,3
DK,DIPLOPIA,3
DK,DRUG EFFECT DECREASED,3
DK,DYSARTHRIA,3
DK,DYSENTERY,3
DK,DYSGEUSIA,3
DK,DYSPHAGIA,3
DK,DYSPNOEA EXERTIONAL,3
DK,ECZEMA INFECTED,3
DK,EYE HAEMORRHAGE,3
DK,GASTRIC CANCER,3
DK,HEMIPARESIS,3
DK,HEPATIC CIRRHOSIS,3
DK,HYPERSENSITIVITY VASCULITIS,3
DK,JOINT SWELLING,3
DK,LEUKOPENIA,3
DK,LOSS OF LIBIDO,3
DK,MULTIPLE SCLEROSIS,3
DK,NECK PAIN,3
DK,NEOBLADDER SURGERY,3
DK,PANCREATIC CARCINOMA,3
DK,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
DK,PULMONARY EMBOLISM,3
DK,SCINTILLATING SCOTOMA,3
DK,SEIZURE,3
DK,SEPSIS,3
DK,SKIN PLAQUE,3
DK,THROAT IRRITATION,3
DK,THROMBOSIS,3
DK,URINARY CYSTECTOMY,3
DK,URTICARIA,3
DK,VARICELLA,3
DK,VARICELLA ZOSTER PNEUMONIA,3
DK,VARICES OESOPHAGEAL,3
DK,ABDOMINAL COMPARTMENT SYNDROME,2
DK,ABDOMINAL TENDERNESS,2
DK,ACCIDENT,2
DK,ACUTE ABDOMEN,2
DK,ADENOVIRUS INFECTION,2
DK,ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY,2
DK,ALOPECIA,2
DK,ALVEOLITIS,2
DK,AMOEBIC DYSENTERY,2
DK,ASTHENIA,2
DK,AUTOIMMUNE DISORDER,2
DK,BILIARY CIRRHOSIS PRIMARY,2
DK,BLADDER DISORDER,2
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,2
DK,BREAST CANCER,2
DK,BRONCHIECTASIS,2
DK,CARDIAC FAILURE,2
DK,CEREBRAL HAEMORRHAGE,2
DK,CHEST PAIN,2
DK,CHOLELITHIASIS,2
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
DK,COLITIS ULCERATIVE,2
DK,COMA,2
DK,CONDITION AGGRAVATED,2
DK,CONGENITAL INTESTINAL MALFORMATION,2
DK,CROHN^S DISEASE,2
DK,CYSTITIS,2
DK,CYSTITIS HAEMORRHAGIC,2
DK,DEMYELINATION,2
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,2
DK,DIFFUSE LARGE B-CELL LYMPHOMA,2
DK,DISCOMFORT,2
DK,DISSEMINATED INTRAVASCULAR COAGULATION,2
DK,DRUG-INDUCED LIVER INJURY,2
DK,ELECTROENCEPHALOGRAM ABNORMAL,2
DK,ENCEPHALOPATHY,2
DK,ENDOTRACHEAL INTUBATION,2
DK,ERYSIPELAS,2
DK,FEMUR FRACTURE,2
DK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
DK,GASTROINTESTINAL ANASTOMOTIC LEAK,2
DK,GENERAL PHYSICAL HEALTH DETERIORATION,2
DK,GLIOSIS,2
DK,GRAFT VERSUS HOST DISEASE IN SKIN,2
DK,GROIN PAIN,2
DK,HALLUCINATION,2
DK,HEARING IMPAIRED,2
DK,HEMIPLEGIA,2
DK,HERPES ZOSTER,2
DK,HIDRADENITIS,2
DK,HIP ARTHROPLASTY,2
DK,HYDRONEPHROSIS,2
DK,HYPERSENSITIVITY,2
DK,HYPOAESTHESIA,2
DK,HYPOGAMMAGLOBULINAEMIA,2
DK,HYPOXIA,2
DK,IMPAIRED HEALING,2
DK,INFLAMMATION,2
DK,INFLUENZA LIKE ILLNESS,2
DK,INFUSION RELATED REACTION,2
DK,INJURY,2
DK,IRITIS,2
DK,IRON DEFICIENCY,2
DK,JOINT INJURY,2
DK,LEUKOCYTOSIS,2
DK,LUNG INFECTION,2
DK,LYMPHADENOPATHY,2
DK,LYMPHOCYTOSIS,2
DK,METASTASES TO LUNG,2
DK,METASTASES TO LYMPH NODES,2
DK,METASTASES TO PERITONEUM,2
DK,MYCOBACTERIUM CHELONAE INFECTION,2
DK,NEUROPATHY PERIPHERAL,2
DK,NO ADVERSE EVENT,2
DK,NON-HODGKIN^S LYMPHOMA,2
DK,OPTIC NEURITIS,2
DK,OPTIC NEUROPATHY,2
DK,ORAL INFECTION,2
DK,ORAL MUCOSAL BLISTERING,2
DK,OSTEOMYELITIS,2
DK,OSTEONECROSIS,2
DK,PALPITATIONS,2
DK,PARALYSIS,2
DK,PARAPLEGIA,2
DK,PERIPHERAL MOTOR NEUROPATHY,2
DK,PHARYNGEAL OEDEMA,2
DK,PLEURAL EFFUSION,2
DK,PROCEDURAL PAIN,2
DK,PUBIS FRACTURE,2
DK,PULMONARY FUNCTION TEST ABNORMAL,2
DK,PURPURA,2
DK,PUSTULAR PSORIASIS,2
DK,RASH PUSTULAR,2
DK,RENAL IMPAIRMENT,2
DK,RHEUMATOID ARTHRITIS,2
DK,SECOND PRIMARY MALIGNANCY,2
DK,SENSORY LOSS,2
DK,SERUM PROCOLLAGEN TYPE III N-TERMINAL PROPEPTIDE INCREASED,2
DK,SERUM SICKNESS,2
DK,SHORT-BOWEL SYNDROME,2
DK,SPINAL OSTEOARTHRITIS,2
DK,URINARY RETENTION,2
DK,URINARY TRACT INFECTION,2
DK,VISUAL ACUITY REDUCED,2
DK,VISUAL FIELD DEFECT,2
DK,ABDOMINAL DISTENSION,1
DK,ABDOMINAL NEOPLASM,1
DK,ABDOMINAL RIGIDITY,1
DK,ABNORMAL BEHAVIOUR,1
DK,ABNORMAL FAECES,1
DK,ABSCESS LIMB,1
DK,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
DK,ACUTE INTERSTITIAL PNEUMONITIS,1
DK,ACUTE LEUKAEMIA,1
DK,ACUTE LYMPHOCYTIC LEUKAEMIA,1
DK,ACUTE POLYNEUROPATHY,1
DK,ADENOCARCINOMA GASTRIC,1
DK,ADVERSE EVENT,1
DK,AGITATION,1
DK,AMYLASE INCREASED,1
DK,ANAL INCONTINENCE,1
DK,ANAPHYLACTIC REACTION,1
DK,ANKYLOSING SPONDYLITIS,1
DK,APHASIA,1
DK,AREFLEXIA,1
DK,ARTHRITIS BACTERIAL,1
DK,ARTHROPATHY,1
DK,ATAXIA TELANGIECTASIA,1
DK,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
DK,AUTOIMMUNE HEPATITIS,1
DK,AXILLARY PAIN,1
DK,BACK PAIN,1
DK,BACTERAEMIA,1
DK,BASAL GANGLIA HAEMORRHAGE,1
DK,BLADDER PAIN,1
DK,BLADDER TRANSITIONAL CELL CARCINOMA STAGE I,1
DK,BLINDNESS,1
DK,BLOOD CALCIUM INCREASED,1
DK,BLOOD ELECTROLYTES ABNORMAL,1
DK,BLOOD PRESSURE INCREASED,1
DK,BLOOD TRIGLYCERIDES INCREASED,1
DK,BLOOD UREA INCREASED,1
DK,BODY MASS INDEX DECREASED,1
DK,BONE DENSITY INCREASED,1
DK,BONE GIANT CELL TUMOUR,1
DK,BONE LOSS,1
DK,BONE MARROW DISORDER,1
DK,BRAIN MASS,1
DK,BRAIN STEM THROMBOSIS,1
DK,CANCER SURGERY,1
DK,CARDIAC ARREST,1
DK,CARDIAC HYPERTROPHY,1
DK,CARDIOGENIC SHOCK,1
DK,CARDIOMEGALY,1
DK,CARDIOVASCULAR DISORDER,1
DK,CARTILAGE INJURY,1
DK,CENTRAL NERVOUS SYSTEM LESION,1
DK,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
DK,CEREBRAL INFARCTION,1
DK,CEREBROVASCULAR ACCIDENT,1
DK,CHEST DISCOMFORT,1
DK,CHOLESTASIS,1
DK,CLINICALLY ISOLATED SYNDROME,1
DK,COAGULATION FACTOR DECREASED,1
DK,COLITIS MICROSCOPIC,1
DK,COLON DYSPLASIA,1
DK,CONFUSIONAL STATE,1
DK,CONJUNCTIVITIS,1
DK,CONNECTIVE TISSUE DISORDER,1
DK,CONTRAINDICATION TO VACCINATION,1
DK,CULTURE URINE POSITIVE,1
DK,CYTOMEGALOVIRUS INFECTION,1
DK,CYTOPENIA,1
DK,DEAFNESS NEUROSENSORY,1
DK,DEATH,1
DK,DEVICE RELATED INFECTION,1
DK,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,1
DK,DILATATION VENTRICULAR,1
DK,DISORIENTATION,1
DK,DIZZINESS POSTURAL,1
DK,DRUG ADMINISTRATION ERROR,1
DK,DRUG EFFECT INCOMPLETE,1
DK,DRUG ERUPTION,1
DK,DRUG HYPERSENSITIVITY,1
DK,DRY EYE,1
DK,DYSPHONIA,1
DK,EAR PAIN,1
DK,ECCHYMOSIS,1
DK,EJECTION FRACTION DECREASED,1
DK,EMPHYSEMA,1
DK,ENDOCARDITIS STAPHYLOCOCCAL,1
DK,ENTEROCOCCAL BACTERAEMIA,1
DK,EPILEPSY,1
DK,EPSTEIN-BARR VIRUS INFECTION,1
DK,ERYTHEMA,1
DK,ERYTHROPENIA,1
DK,EXERCISE TOLERANCE DECREASED,1
DK,EXPOSED BONE IN JAW,1
DK,EYE DISORDER,1
DK,EYE MOVEMENT DISORDER,1
DK,EYE PAIN,1
DK,EYE PRURITUS,1
DK,EYELID PTOSIS,1
DK,FACIAL PARALYSIS,1
DK,FAECAL INCONTINENCE,1
DK,FAECALOMA,1
DK,FALL,1
DK,FAT NECROSIS,1
DK,FEELING COLD,1
DK,FINE MOTOR SKILL DYSFUNCTION,1
DK,FLUSHING,1
DK,FUNCTIONAL GASTROINTESTINAL DISORDER,1
DK,FUNGAL SEPSIS,1
DK,GASTRIC ULCER HAEMORRHAGE,1
DK,GASTRITIS,1
DK,GASTROINTESTINAL DISORDER,1
DK,GASTROINTESTINAL NECROSIS,1
DK,GASTROINTESTINAL STOMA COMPLICATION,1
DK,GASTROINTESTINAL TOXICITY,1
DK,GASTROINTESTINAL WALL THICKENING,1
DK,GENERALISED TONIC-CLONIC SEIZURE,1
DK,GENITAL RASH,1
DK,GLOMERULAR FILTRATION RATE DECREASED,1
DK,GOITRE,1
DK,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
DK,GRAFT VERSUS HOST DISEASE IN INTESTINE,1
DK,GRAFT VERSUS HOST DISEASE IN LIVER,1
DK,GUILLAIN-BARRE SYNDROME,1
DK,HAEMATOLOGICAL MALIGNANCY,1
DK,HAEMATOMA,1
DK,HAEMORRHAGIC DISORDER,1
DK,HAIRY CELL LEUKAEMIA,1
DK,HEAD AND NECK CANCER,1
DK,HEMIANOPIA HOMONYMOUS,1
DK,HEPATIC ENZYME INCREASED,1
DK,HEPATIC FAILURE,1
DK,HEPATIC NECROSIS,1
DK,HEPATITIS,1
DK,HODGKIN^S DISEASE,1
DK,HODGKIN^S DISEASE LYMPHOCYTE DEPLETION TYPE STAGE IV,1
DK,HUMAN HERPESVIRUS 6 INFECTION,1
DK,HYPERAESTHESIA,1
DK,HYPERKALAEMIA,1
DK,IGA NEPHROPATHY,1
DK,ILEAL STENOSIS,1
DK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
DK,INCORRECT DOSE ADMINISTERED,1
DK,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
DK,INFECTIVE TENOSYNOVITIS,1
DK,INFLUENZA,1
DK,INJECTION SITE PAIN,1
DK,INJECTION SITE REACTION,1
DK,INJECTION SITE SWELLING,1
DK,INTENSIVE CARE,1
DK,INTERNATIONAL NORMALISED RATIO INCREASED,1
DK,INTRACRANIAL ANEURYSM,1
DK,INTRACRANIAL PRESSURE INCREASED,1
DK,INVASIVE DUCTAL BREAST CARCINOMA,1
DK,ISCHAEMIC NEUROPATHY,1
DK,JOINT RANGE OF MOTION DECREASED,1
DK,JOINT STIFFNESS,1
DK,LACTIC ACIDOSIS,1
DK,LEFT VENTRICULAR FAILURE,1
DK,LEUKOCYTOCLASTIC VASCULITIS,1
DK,LHERMITTE^S SIGN,1
DK,LIP NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
DK,LUNG DISORDER,1
DK,LYMPHADENOPATHY MEDIASTINAL,1
DK,LYMPHOCYTE COUNT DECREASED,1
DK,LYMPHOCYTIC INFILTRATION,1
DK,LYMPHOEDEMA,1
DK,MALIGNANT NEOPLASM PROGRESSION,1
DK,MASTICATION DISORDER,1
DK,MATERNAL EXPOSURE BEFORE PREGNANCY,1
DK,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
DK,MEDIASTINAL FIBROSIS,1
DK,MEDICATION ERROR,1
DK,MEGACOLON,1
DK,MENINGITIS,1
DK,MENINGITIS LISTERIA,1
DK,MENINGITIS TUBERCULOUS,1
DK,MENTAL DISORDER,1
DK,METASTASES TO ADRENALS,1
DK,METASTASES TO BONE,1
DK,METASTASES TO CENTRAL NERVOUS SYSTEM,1
DK,METASTASES TO DIAPHRAGM,1
DK,METASTASES TO LIVER,1
DK,METASTASES TO NERVOUS SYSTEM,1
DK,METASTATIC MALIGNANT MELANOMA,1
DK,MILLER FISHER SYNDROME,1
DK,MOBILITY DECREASED,1
DK,MONOPARESIS,1
DK,MOUTH ULCERATION,1
DK,MOVEMENT DISORDER,1
DK,MUCOUS MEMBRANE DISORDER,1
DK,MUSCLE CONTRACTIONS INVOLUNTARY,1
DK,MUSCLE DISORDER,1
DK,MUSCLE FATIGUE,1
DK,MUSCLE TIGHTNESS,1
DK,MUSCULOSKELETAL PAIN,1
DK,MUSCULOSKELETAL STIFFNESS,1
DK,MYELITIS,1
DK,MYELOFIBROSIS,1
DK,MYELOPATHY,1
DK,MYOCARDIAL ISCHAEMIA,1
DK,NASOPHARYNGITIS,1
DK,NEOPLASM MALIGNANT,1
DK,NEUROENDOCRINE TUMOUR,1
DK,NEUROLOGICAL SYMPTOM,1
DK,NON-SMALL CELL LUNG CANCER,1
DK,OCULAR TOXICITY,1
DK,OPPORTUNISTIC INFECTION,1
DK,ORAL CANDIDIASIS,1
DK,ORAL FUNGAL INFECTION,1
DK,ORAL PAIN,1
DK,OROPHARYNGEAL PAIN,1
DK,OSTEOARTHRITIS,1
DK,OSTEONECROSIS OF JAW,1
DK,OSTEOPENIA,1
DK,OSTEOPOROSIS,1
DK,OXYGEN CONSUMPTION DECREASED,1
DK,PANCREATITIS,1
DK,PANCREATITIS ACUTE,1
DK,PANCREATITIS HAEMORRHAGIC,1
DK,PAPILLOEDEMA,1
DK,PARAPARESIS,1
DK,PARKINSONISM,1
DK,PERIODONTITIS,1
DK,PERIPHERAL ARTERY THROMBOSIS,1
DK,PERIPHERAL SWELLING,1
DK,PERITONITIS,1
DK,PITUITARY TUMOUR BENIGN,1
DK,PLATELET COUNT ABNORMAL,1
DK,PLEURAL FIBROSIS,1
DK,PNEUMONIA KLEBSIELLA,1
DK,POLYDACTYLY,1
DK,POLYMYALGIA RHEUMATICA,1
DK,POLYNEUROPATHY,1
DK,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
DK,PROCEDURAL HAEMORRHAGE,1
DK,PRODUCT QUALITY ISSUE,1
DK,PRODUCT SUBSTITUTION,1
DK,PROSTATOMEGALY,1
DK,PRURITUS GENERALISED,1
DK,PSEUDOMONAS INFECTION,1
DK,PSEUDOPOLYP,1
DK,PSORIATIC ARTHROPATHY,1
DK,PULMONARY HYPERTENSION,1
DK,PULMONARY VENO-OCCLUSIVE DISEASE,1
DK,PURULENT DISCHARGE,1
DK,QUADRIPLEGIA,1
DK,RADICULITIS,1
DK,RALES,1
DK,RECTAL CANCER,1
DK,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
DK,RENAL CELL CARCINOMA,1
DK,RENAL FAILURE,1
DK,RETROPERITONEAL LYMPHADENOPATHY,1
DK,RETROPERITONEAL MASS,1
DK,SARCOMA,1
DK,SENSORIMOTOR DISORDER,1
DK,SEPTIC SHOCK,1
DK,SEQUESTRECTOMY,1
DK,SKIN DISCOLOURATION,1
DK,SKIN DISORDER,1
DK,SKIN NEOPLASM EXCISION,1
DK,SKIN WOUND,1
DK,SLEEP DISORDER,1
DK,SLOW SPEECH,1
DK,SPEECH DISORDER,1
DK,SPINAL FRACTURE,1
DK,SPINDLE CELL SARCOMA,1
DK,SPLINTER HAEMORRHAGES,1
DK,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
DK,STAPHYLOCOCCAL SEPSIS,1
DK,STREPTOCOCCAL SEPSIS,1
DK,STRESS CARDIOMYOPATHY,1
DK,SUBARACHNOID HAEMORRHAGE,1
DK,SUPERINFECTION,1
DK,SWELLING,1
DK,SYSTOLIC DYSFUNCTION,1
DK,T-LYMPHOCYTE COUNT INCREASED,1
DK,TACHYCARDIA,1
DK,TEMPERATURE INTOLERANCE,1
DK,TESTIS CANCER,1
DK,THROAT TIGHTNESS,1
DK,TONGUE MOVEMENT DISTURBANCE,1
DK,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
DK,TRACHEOSTOMY,1
DK,TRICUSPID VALVE INCOMPETENCE,1
DK,TUBERCULOSIS,1
DK,UPPER RESPIRATORY TRACT CONGESTION,1
DK,URINARY INCONTINENCE,1
DK,VENTRICULAR HYPERKINESIA,1
DK,VIRAEMIA,1
DK,VISION BLURRED,1
DK,WALKING DISABILITY,1
DK,WEIGHT INCREASED,1
DK,WHITE MATTER LESION,1
DK,YELLOW FEVER,1
DO,ARTHRALGIA,2
DO,BACK PAIN,2
DO,DYSURIA,2
DO,INFLUENZA,2
DO,OSTEOARTHRITIS,2
DO,PNEUMONIA,2
DO,POST PROCEDURAL COMPLICATION,2
DO,PULMONARY OEDEMA,2
DO,URINARY TRACT INFECTION,2
DO,UTERINE LEIOMYOMA,2
DO,VISION BLURRED,2
DO,ABDOMINAL DISCOMFORT,1
DO,ABDOMINAL DISTENSION,1
DO,ABDOMINAL HERNIA,1
DO,ABDOMINAL PAIN,1
DO,ABORTION SPONTANEOUS,1
DO,ADMINISTRATION SITE PAIN,1
DO,ANAL FISSURE,1
DO,ATELECTASIS,1
DO,AXILLARY MASS,1
DO,BLINDNESS,1
DO,BLOOD PRESSURE ABNORMAL,1
DO,BREAST DISCOMFORT,1
DO,BREATH SOUNDS ABNORMAL,1
DO,CHEST DISCOMFORT,1
DO,CHEST PAIN,1
DO,COUGH,1
DO,DIABETES MELLITUS,1
DO,DIZZINESS,1
DO,DYSMENORRHOEA,1
DO,DYSSTASIA,1
DO,ESCHERICHIA URINARY TRACT INFECTION,1
DO,EXPOSURE DURING PREGNANCY,1
DO,FALL,1
DO,FATIGUE,1
DO,FOETAL DEATH,1
DO,GAIT DISTURBANCE,1
DO,GALLBLADDER NECROSIS,1
DO,GALLBLADDER OEDEMA,1
DO,HEADACHE,1
DO,HYPERGLYCAEMIA,1
DO,HYPERHIDROSIS,1
DO,HYPOTENSION,1
DO,INJECTION SITE REACTION,1
DO,INSOMNIA,1
DO,JOINT RANGE OF MOTION DECREASED,1
DO,JOINT SWELLING,1
DO,JOINT WARMTH,1
DO,KIDNEY ENLARGEMENT,1
DO,LACRIMATION INCREASED,1
DO,LIPOMA,1
DO,MICTURITION URGENCY,1
DO,MOBILITY DECREASED,1
DO,NAUSEA,1
DO,OCULAR HYPERAEMIA,1
DO,OEDEMA MUCOSAL,1
DO,OEDEMATOUS KIDNEY,1
DO,PAINFUL DEFAECATION,1
DO,PELVIC PAIN,1
DO,POLYDIPSIA,1
DO,POLYURIA,1
DO,PROCEDURAL COMPLICATION,1
DO,PROCTALGIA,1
DO,PRURITUS,1
DO,PYREXIA,1
DO,RASH ERYTHEMATOUS,1
DO,RECTAL PROLAPSE,1
DO,RESPIRATORY DISTRESS,1
DO,RESPIRATORY FAILURE,1
DO,RESPIRATORY TRACT CONGESTION,1
DO,RHINITIS,1
DO,SENSORY LOSS,1
DO,SKIN LESION,1
DO,SKIN REACTION,1
DO,STRIDOR,1
DO,T-CELL LYMPHOMA,1
DO,THYROID MASS,1
DO,TUBERCULIN TEST POSITIVE,1
DO,UPPER LIMB FRACTURE,1
DO,VAGINAL HAEMORRHAGE,1
EC,DRUG INEFFECTIVE,2
EC,DYSPNOEA,2
EC,OSMOTIC DEMYELINATION SYNDROME,2
EC,PARKINSONISM,2
EC,ABORTION,1
EC,ABORTION INDUCED,1
EC,ANAEMIA,1
EC,ANGIOEDEMA,1
EC,ARTHRALGIA,1
EC,ARTHRITIS,1
EC,ARTHROPATHY,1
EC,BRONCHOSPASM,1
EC,BURNING FEET SYNDROME,1
EC,CHOKING SENSATION,1
EC,COUGH,1
EC,DRUG EFFECT INCOMPLETE,1
EC,EXPOSURE DURING PREGNANCY,1
EC,FACE OEDEMA,1
EC,HAEMATOCRIT DECREASED,1
EC,HEPATIC STEATOSIS,1
EC,HYPOAESTHESIA,1
EC,HYPOCALCAEMIA,1
EC,INFUSION RELATED REACTION,1
EC,INGUINAL HERNIA,1
EC,INTERVERTEBRAL DISC PROTRUSION,1
EC,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
EC,MUSCLE SPASMS,1
EC,NAUSEA,1
EC,NECK PAIN,1
EC,OEDEMA PERIPHERAL,1
EC,POSTOPERATIVE WOUND INFECTION,1
EC,PROCEDURAL PAIN,1
EC,RESPIRATORY TRACT INFECTION,1
EC,RHEUMATOID ARTHRITIS,1
EC,SECRETION DISCHARGE,1
EC,SPINAL PAIN,1
EC,SWELLING FACE,1
EC,TACHYCARDIA,1
EC,URINARY TRACT INFECTION,1
EC,VAGINAL HAEMORRHAGE,1
EG,FEBRILE NEUTROPENIA,8
EG,MUCOSAL INFLAMMATION,8
EG,ANAL HAEMORRHAGE,6
EG,HEPATIC FUNCTION ABNORMAL,6
EG,MELAENA,6
EG,MULTI-ORGAN DISORDER,6
EG,RENAL IMPAIRMENT,6
EG,TOXIC EPIDERMAL NECROLYSIS,6
EG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
EG,PRODUCT USE ISSUE,4
EG,SEPSIS,4
EG,BONE MARROW FAILURE,3
EG,GENERAL PHYSICAL HEALTH DETERIORATION,3
EG,LEUKOPENIA,3
EG,THROMBOCYTOPENIA,3
EG,CHEST PAIN,2
EG,DRUG INEFFECTIVE,2
EG,INCORRECT DOSE ADMINISTERED,2
EG,INFECTION,2
EG,SEIZURE,2
EG,ABDOMINAL DISCOMFORT,1
EG,ACCIDENTAL EXPOSURE TO PRODUCT,1
EG,ACNE,1
EG,ACUTE GRAFT VERSUS HOST DISEASE,1
EG,ACUTE MYOCARDIAL INFARCTION,1
EG,ADVERSE EVENT,1
EG,ALOPECIA,1
EG,ALTERED STATE OF CONSCIOUSNESS,1
EG,ANAEMIA,1
EG,ANAPHYLACTOID REACTION,1
EG,ATROPHIC GLOSSITIS,1
EG,BLOOD CHOLESTEROL INCREASED,1
EG,BONE INFARCTION,1
EG,CALCINOSIS,1
EG,CARDIOMEGALY,1
EG,CARDIOTOXICITY,1
EG,CELLULITIS,1
EG,CEREBRAL HAEMORRHAGE,1
EG,CEREBRAL INFARCTION,1
EG,CHEST DISCOMFORT,1
EG,COMA,1
EG,CUTANEOUS LEISHMANIASIS,1
EG,CYANOSIS,1
EG,DERMATITIS,1
EG,DERMATITIS ACNEIFORM,1
EG,DERMATITIS ALLERGIC,1
EG,DIABETES MELLITUS,1
EG,DISCOMFORT,1
EG,DYSKINESIA,1
EG,DYSPNOEA,1
EG,EMPHYSEMA,1
EG,EXTRAVASATION,1
EG,FEELING HOT,1
EG,GASTROENTERITIS,1
EG,GASTROOESOPHAGEAL REFLUX DISEASE,1
EG,HAEMOLYTIC ANAEMIA,1
EG,HAEMORRHAGE,1
EG,HEART RATE INCREASED,1
EG,HYPERTENSION,1
EG,HYPOAESTHESIA,1
EG,HYPOTENSION,1
EG,INJECTION SITE HAEMATOMA,1
EG,INJECTION SITE HAEMORRHAGE,1
EG,INJECTION SITE OEDEMA,1
EG,INJECTION SITE PAIN,1
EG,LOSS OF CONSCIOUSNESS,1
EG,LOWER RESPIRATORY TRACT INFECTION,1
EG,LYMPH GLAND INFECTION,1
EG,LYMPHOEDEMA,1
EG,NAIL DISORDER,1
EG,NAIL PIGMENTATION,1
EG,NAUSEA,1
EG,NEUTROPENIA,1
EG,NON-HODGKIN^S LYMPHOMA,1
EG,OROPHARYNGEAL PAIN,1
EG,OSTEONECROSIS,1
EG,OSTEOPENIA,1
EG,PAIN IN EXTREMITY,1
EG,PANCREATIC DISORDER,1
EG,PAPILLARY MUSCLE RUPTURE,1
EG,PARANEOPLASTIC SYNDROME,1
EG,PATHOLOGICAL FRACTURE,1
EG,PERIPHERAL SWELLING,1
EG,PIGMENTATION DISORDER,1
EG,PLANTAR ERYTHEMA,1
EG,PNEUMOTHORAX,1
EG,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA RECURRENT,1
EG,PRODUCTIVE COUGH,1
EG,PULMONARY CALCIFICATION,1
EG,PULMONARY FIBROSIS,1
EG,PULMONARY TOXICITY,1
EG,PYREXIA,1
EG,RHEUMATOID ARTHRITIS,1
EG,SKIN ATROPHY,1
EG,SKIN ULCER,1
EG,STEVENS-JOHNSON SYNDROME,1
EG,SWELLING,1
EG,THROMBOSIS,1
EG,TOXICITY TO VARIOUS AGENTS,1
EG,TYPE I HYPERSENSITIVITY,1
EG,ULCERATIVE KERATITIS,1
EG,VIRAL INFECTION,1
EG,VISION BLURRED,1
EG,VOMITING,1
SV,DIARRHOEA,1
SV,DYSPNOEA,1
SV,INFLAMMATION,1
SV,RESPIRATORY DISORDER,1
EE,HAEMATOMA,3
EE,FATIGUE,2
EE,ABDOMINAL PAIN LOWER,1
EE,ACCIDENTAL OVERDOSE,1
EE,AGITATION,1
EE,APHTHOUS ULCER,1
EE,ASTHENIA,1
EE,BLOOD CREATININE INCREASED,1
EE,BLOOD IMMUNOGLOBULIN A DECREASED,1
EE,C-REACTIVE PROTEIN INCREASED,1
EE,CARPAL TUNNEL SYNDROME,1
EE,CHOLECYSTITIS ACUTE,1
EE,DERMATITIS BULLOUS,1
EE,DIZZINESS,1
EE,DRUG INEFFECTIVE,1
EE,DYSPEPSIA,1
EE,GASTROINTESTINAL WALL THICKENING,1
EE,HAEMATOCHEZIA,1
EE,HEADACHE,1
EE,HERPES ZOSTER,1
EE,HISTIOCYTOSIS HAEMATOPHAGIC,1
EE,HYDRONEPHROSIS,1
EE,HYPERACUSIS,1
EE,HYPERAESTHESIA,1
EE,HYPOAESTHESIA,1
EE,IMMUNOSUPPRESSION,1
EE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
EE,INITIAL INSOMNIA,1
EE,INTERSTITIAL LUNG DISEASE,1
EE,LEUKOPENIA,1
EE,MENINGITIS,1
EE,MUCOSAL INFLAMMATION,1
EE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
EE,NAUSEA,1
EE,NUCHAL RIGIDITY,1
EE,OSTEONECROSIS OF JAW,1
EE,PAIN,1
EE,PANCYTOPENIA,1
EE,PHOTOPHOBIA,1
EE,PNEUMONIA,1
EE,PYREXIA,1
EE,RENAL FAILURE,1
EE,SYNCOPE,1
EE,URINARY TRACT INFECTION,1
EE,VIRAL INFECTION,1
ET,COUGH,2
ET,ABDOMINAL PAIN UPPER,1
ET,ACUTE HEPATITIS B,1
ET,ANAEMIA,1
ET,CARDIO-RESPIRATORY ARREST,1
ET,DIABETIC KETOACIDOSIS,1
ET,DYSPNOEA,1
ET,EPISTAXIS,1
ET,HEPATOSPLENOMEGALY,1
ET,HERPES ZOSTER,1
ET,MULTI-ORGAN FAILURE,1
ET,NIGHT SWEATS,1
ET,PLEURISY,1
ET,PNEUMONIA,1
ET,PULMONARY TUBERCULOSIS,1
ET,PYREXIA,1
ET,SEPSIS,1
ET,SEPTIC SHOCK,1
ET,THROMBOCYTOPENIA,1
ET,TUBERCULOSIS,1
ET,WEIGHT DECREASED,1
FI,NEUTROPENIA,20
FI,INFECTION,19
FI,PYREXIA,14
FI,SEPSIS,12
FI,DRUG EFFECT INCOMPLETE,11
FI,ANAEMIA,10
FI,PNEUMONIA,9
FI,ACUTE GRAFT VERSUS HOST DISEASE,8
FI,C-REACTIVE PROTEIN INCREASED,8
FI,CHRONIC GRAFT VERSUS HOST DISEASE,8
FI,DEEP VEIN THROMBOSIS,8
FI,MUCOSAL INFLAMMATION,8
FI,ASCITES,7
FI,CYTOPENIA,7
FI,DRUG PRESCRIBING ERROR,7
FI,FATIGUE,7
FI,ORAL PAIN,7
FI,ARTHRITIS,6
FI,DRUG INEFFECTIVE,6
FI,INTERSTITIAL LUNG DISEASE,6
FI,THROMBOCYTOPENIA,6
FI,CARDIAC FAILURE,5
FI,CATARACT,5
FI,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,5
FI,DYSPNOEA,5
FI,FALL,5
FI,GENERAL PHYSICAL HEALTH DETERIORATION,5
FI,HEPATITIS C,5
FI,INFLUENZA,5
FI,IRITIS,5
FI,ARTHRALGIA,4
FI,ARTHROPATHY,4
FI,DRUG EFFECT DECREASED,4
FI,HEADACHE,4
FI,LIVER FUNCTION TEST INCREASED,4
FI,LUNG DISORDER,4
FI,LYMPHOPENIA,4
FI,NAUSEA,4
FI,PRODUCT USE ISSUE,4
FI,SEXUALLY TRANSMITTED DISEASE,4
FI,TONSILLITIS,4
FI,URINARY TRACT INFECTION,4
FI,CEREBRAL INFARCTION,3
FI,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,3
FI,COUGH,3
FI,DISEASE PROGRESSION,3
FI,DRUG SPECIFIC ANTIBODY PRESENT,3
FI,GRAFT VERSUS HOST DISEASE IN LUNG,3
FI,HEPATIC ENZYME INCREASED,3
FI,LUNG INFILTRATION,3
FI,PAIN,3
FI,PRODUCT USE IN UNAPPROVED INDICATION,3
FI,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
FI,SINUSITIS,3
FI,UPPER RESPIRATORY TRACT INFECTION,3
FI,WEIGHT INCREASED,3
FI,WHITE BLOOD CELL COUNT DECREASED,3
FI,ACCIDENTAL OVERDOSE,2
FI,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
FI,ADVERSE EVENT,2
FI,ALANINE AMINOTRANSFERASE ABNORMAL,2
FI,ALANINE AMINOTRANSFERASE INCREASED,2
FI,ANTERIOR CHAMBER CELL,2
FI,ARTHRITIS BACTERIAL,2
FI,ASPERGILLUS INFECTION,2
FI,CENTRAL NERVOUS SYSTEM LYMPHOMA,2
FI,DEATH,2
FI,DERMATITIS PSORIASIFORM,2
FI,DISEASE RECURRENCE,2
FI,DRUG SPECIFIC ANTIBODY,2
FI,EXPOSURE DURING PREGNANCY,2
FI,GAIT DISTURBANCE,2
FI,GAMBLING DISORDER,2
FI,GRAFT VERSUS HOST DISEASE IN SKIN,2
FI,H1N1 INFLUENZA,2
FI,HAEMOGLOBIN DECREASED,2
FI,HYPERSENSITIVITY,2
FI,ILEAL ULCER,2
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FI,INTRAOCULAR PRESSURE INCREASED,2
FI,ISCHAEMIC STROKE,2
FI,JOINT EFFUSION,2
FI,JUVENILE IDIOPATHIC ARTHRITIS,2
FI,LETHARGY,2
FI,LEUKOPENIA,2
FI,MACROCYTOSIS,2
FI,MENINGITIS,2
FI,MENTAL DISORDER,2
FI,MIGRAINE,2
FI,MITRAL VALVE INCOMPETENCE,2
FI,MUSCULOSKELETAL STIFFNESS,2
FI,NERVOUS SYSTEM DISORDER,2
FI,OPPORTUNISTIC INFECTION,2
FI,PSORIASIS,2
FI,PSYCHOTIC DISORDER,2
FI,PULMONARY HAEMORRHAGE,2
FI,RASH,2
FI,RHEUMATOID ARTHRITIS,2
FI,SARCOIDOSIS,2
FI,SEIZURE,2
FI,STAPHYLOCOCCAL SEPSIS,2
FI,TENDONITIS,2
FI,TUBERCULOSIS,2
FI,UVEITIS,2
FI,VASCULITIS,2
FI,VERTIGO,2
FI,WEIGHT DECREASED,2
FI,ABDOMINAL NEOPLASM,1
FI,ABDOMINAL PAIN UPPER,1
FI,ACTINOMYCOSIS,1
FI,ACTIVITIES OF DAILY LIVING IMPAIRED,1
FI,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
FI,ADENOCARCINOMA GASTRIC,1
FI,ADRENAL GLAND INJURY,1
FI,AGRANULOCYTOSIS,1
FI,ALOPECIA,1
FI,AMNESIA,1
FI,ANAPHYLACTIC REACTION,1
FI,ANGIOTENSIN CONVERTING ENZYME INCREASED,1
FI,ANKLE DEFORMITY,1
FI,ANKLE FRACTURE,1
FI,ANTERIOR CHAMBER DISORDER,1
FI,ANTINUCLEAR ANTIBODY INCREASED,1
FI,APHASIA,1
FI,APPENDICITIS,1
FI,ARTERIOSCLEROSIS,1
FI,ASTHMA,1
FI,ATYPICAL MYCOBACTERIAL INFECTION,1
FI,BACK PAIN,1
FI,BACTERIAL SEPSIS,1
FI,BK VIRUS INFECTION,1
FI,BLOOD CHOLESTEROL INCREASED,1
FI,BLOOD CREATININE INCREASED,1
FI,BLOOD IMMUNOGLOBULIN G INCREASED,1
FI,BLOOD PRESSURE DECREASED,1
FI,BLOOD PRESSURE INCREASED,1
FI,BLOOD TEST ABNORMAL,1
FI,BLOOD URIC ACID INCREASED,1
FI,BONE EROSION,1
FI,BREAST CANCER,1
FI,BREAST CANCER METASTATIC,1
FI,BRONCHIECTASIS,1
FI,BRONCHITIS,1
FI,CARDIOMYOPATHY,1
FI,CEREBRAL HAEMORRHAGE,1
FI,CHOLELITHIASIS,1
FI,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,1
FI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FI,COGNITIVE DISORDER,1
FI,COLITIS ULCERATIVE,1
FI,COMPLICATIONS OF TRANSPLANTED LUNG,1
FI,CONDITION AGGRAVATED,1
FI,CONJUNCTIVITIS,1
FI,CONJUNCTIVITIS ALLERGIC,1
FI,CONNECTIVE TISSUE DISORDER,1
FI,CONSTIPATION,1
FI,CONTUSION,1
FI,CORONARY ARTERY DISEASE,1
FI,CROHN^S DISEASE,1
FI,CYTOMEGALOVIRUS COLITIS,1
FI,CYTOMEGALOVIRUS VIRAEMIA,1
FI,DEAFNESS,1
FI,DELIRIUM,1
FI,DEPRESSION,1
FI,DERMATITIS,1
FI,DERMATITIS INFECTED,1
FI,DEVICE FAILURE,1
FI,DIARRHOEA,1
FI,DISORIENTATION,1
FI,DISSEMINATED TUBERCULOSIS,1
FI,DOUBLE STRANDED DNA ANTIBODY,1
FI,DRUG DISPENSING ERROR,1
FI,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
FI,DRUG INTOLERANCE,1
FI,DRUG LEVEL BELOW THERAPEUTIC,1
FI,EAR INFECTION,1
FI,ECTOPIC PREGNANCY,1
FI,ECZEMA,1
FI,EMBOLISM ARTERIAL,1
FI,EOSINOPHILIA,1
FI,EPILEPSY,1
FI,ERYTHEMA,1
FI,EXPOSURE TO TOXIC AGENT,1
FI,EXTREMITY NECROSIS,1
FI,FAECAL CALPROTECTIN ABNORMAL,1
FI,FALLOPIAN TUBE CANCER,1
FI,FALSE POSITIVE INVESTIGATION RESULT,1
FI,FEELING HOT,1
FI,FRACTURE,1
FI,FURUNCLE,1
FI,GASTROENTERITIS,1
FI,GASTROINTESTINAL INFLAMMATION,1
FI,GASTROINTESTINAL TOXICITY,1
FI,GLAUCOMA,1
FI,GOUT,1
FI,GRAFT VERSUS HOST DISEASE,1
FI,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
FI,GRAFT VERSUS HOST DISEASE IN LIVER,1
FI,HAEMATEMESIS,1
FI,HAEMATOTOXICITY,1
FI,HAEMATURIA,1
FI,HAEMORRHAGE,1
FI,HEAD INJURY,1
FI,HEMIPARESIS,1
FI,HENOCH-SCHONLEIN PURPURA,1
FI,HEPATIC CIRRHOSIS,1
FI,HEPATIC FIBROSIS,1
FI,HER-2 POSITIVE BREAST CANCER,1
FI,HERPES SIMPLEX,1
FI,HERPES ZOSTER,1
FI,HODGKIN^S DISEASE RECURRENT,1
FI,HYPERGLYCAEMIA,1
FI,HYPERTENSION,1
FI,HYPERURICAEMIA,1
FI,IGA NEPHROPATHY,1
FI,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
FI,IMMUNOSUPPRESSION,1
FI,IMPAIRED HEALING,1
FI,INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT,1
FI,INCORRECT PRODUCT STORAGE,1
FI,INFLAMMATORY BOWEL DISEASE,1
FI,INFUSION RELATED REACTION,1
FI,INJECTION SITE REACTION,1
FI,INTESTINAL OBSTRUCTION,1
FI,INTRACARDIAC THROMBUS,1
FI,IRIS ADHESIONS,1
FI,JOINT ARTHROPLASTY,1
FI,JOINT DESTRUCTION,1
FI,JOINT INJURY,1
FI,JOINT RANGE OF MOTION DECREASED,1
FI,JOINT SWELLING,1
FI,LARGE INTESTINAL STENOSIS,1
FI,LICHEN PLANUS,1
FI,LUNG INFECTION,1
FI,LYMPHANGITIS,1
FI,LYSOZYME INCREASED,1
FI,MALIGNANT MELANOMA IN SITU,1
FI,MEMORY IMPAIRMENT,1
FI,METASTASES TO CENTRAL NERVOUS SYSTEM,1
FI,METASTASES TO SKIN,1
FI,METATARSALGIA,1
FI,MOLLUSCUM CONTAGIOSUM,1
FI,MULTIPLE USE OF SINGLE-USE PRODUCT,1
FI,MUSCLE TIGHTNESS,1
FI,MUSCULOSKELETAL PAIN,1
FI,MYALGIA,1
FI,MYCOSIS FUNGOIDES RECURRENT,1
FI,MYOCARDIAL INFARCTION,1
FI,MYOTONIA,1
FI,NAIL BED INFLAMMATION,1
FI,NAIL DISORDER,1
FI,NASOPHARYNGITIS,1
FI,NECK PAIN,1
FI,NEOPLASM MALIGNANT,1
FI,NEUROFIBROMATOSIS,1
FI,NEUROLOGICAL SYMPTOM,1
FI,NEUTROPENIC INFECTION,1
FI,NEUTROPENIC SEPSIS,1
FI,NO THERAPEUTIC RESPONSE,1
FI,OBLITERATIVE BRONCHIOLITIS,1
FI,OESOPHAGEAL ADENOCARCINOMA,1
FI,ORGANISING PNEUMONIA,1
FI,OROPHARYNGEAL PAIN,1
FI,OSTEOMYELITIS BACTERIAL,1
FI,OSTEOPENIA,1
FI,OSTEOPOROSIS,1
FI,OTITIS MEDIA,1
FI,OXYGEN SATURATION DECREASED,1
FI,PAIN IN EXTREMITY,1
FI,PALPITATIONS,1
FI,PANCREATIC CARCINOMA,1
FI,PANCREATITIS,1
FI,PANCYTOPENIA,1
FI,PERIPHERAL ISCHAEMIA,1
FI,PNEUMOCYSTIS JIROVECII INFECTION,1
FI,PNEUMONIA CYTOMEGALOVIRAL,1
FI,PNEUMONITIS CHEMICAL,1
FI,PNEUMOTHORAX,1
FI,POISONING,1
FI,POLYARTHRITIS,1
FI,PRODUCT LABEL ISSUE,1
FI,PRODUCT QUALITY ISSUE,1
FI,PRURITUS,1
FI,PSORIATIC ARTHROPATHY,1
FI,PULMONARY CONGESTION,1
FI,PULMONARY EMBOLISM,1
FI,PULMONARY SARCOIDOSIS,1
FI,PUPILLARY DISORDER,1
FI,RASH PAPULAR,1
FI,RED BLOOD CELL MACROCYTES PRESENT,1
FI,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
FI,RENAL CANCER,1
FI,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
FI,REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME,1
FI,RHABDOMYOLYSIS,1
FI,RIGHT VENTRICULAR FAILURE,1
FI,SJOGREN^S SYNDROME,1
FI,SKIN DISORDER,1
FI,SKIN INFECTION,1
FI,SKIN LESION,1
FI,SKIN PAPILLOMA,1
FI,SPINAL COMPRESSION FRACTURE,1
FI,SPINAL FRACTURE,1
FI,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
FI,SUBDURAL EFFUSION,1
FI,SWELLING FACE,1
FI,SYNCOPE,1
FI,SYSTEMIC LUPUS ERYTHEMATOSUS,1
FI,TENDON SHEATH DISORDER,1
FI,THERAPEUTIC RESPONSE DECREASED,1
FI,THERAPEUTIC RESPONSE UNEXPECTED,1
FI,THERAPY NON-RESPONDER,1
FI,THROMBOPHLEBITIS SUPERFICIAL,1
FI,THROMBOSIS,1
FI,THYROID CANCER,1
FI,TINEA VERSICOLOUR,1
FI,TOE AMPUTATION,1
FI,TONSILLAR HYPERTROPHY,1
FI,TONSILLITIS STREPTOCOCCAL,1
FI,TOOTH INFECTION,1
FI,TRANSCRIPTION MEDICATION ERROR,1
FI,TREATMENT NONCOMPLIANCE,1
FI,UNDERDOSE,1
FI,UNEVALUABLE EVENT,1
FI,UROSEPSIS,1
FI,VARICELLA,1
FI,VERTIGO POSITIONAL,1
FI,VISION BLURRED,1
FI,WHEELCHAIR USER,1
FI,WOUND,1
FI,WOUND INFECTION,1
FR,FEBRILE BONE MARROW APLASIA,364
FR,HEPATOCELLULAR INJURY,203
FR,PYREXIA,145
FR,ACUTE KIDNEY INJURY,125
FR,NEUTROPENIA,122
FR,DRUG INEFFECTIVE,120
FR,MUCOSAL INFLAMMATION,118
FR,DIARRHOEA,105
FR,PRODUCT USE ISSUE,104
FR,HYPOFIBRINOGENAEMIA,102
FR,SEPTIC SHOCK,101
FR,SEPSIS,98
FR,THROMBOCYTOPENIA,94
FR,BRONCHITIS,93
FR,ASTHENIA,81
FR,INFECTION,76
FR,PANCYTOPENIA,75
FR,VOMITING,75
FR,ANAEMIA,74
FR,TOXICITY TO VARIOUS AGENTS,74
FR,HEADACHE,72
FR,BONE MARROW FAILURE,71
FR,HYPERTRIGLYCERIDAEMIA,70
FR,FEBRILE NEUTROPENIA,69
FR,INFUSION RELATED REACTION,69
FR,PNEUMONIA,67
FR,CHOLESTASIS,65
FR,DYSPNOEA,61
FR,RENAL FAILURE,61
FR,MATERNAL EXPOSURE BEFORE PREGNANCY,57
FR,PRODUCT USE IN UNAPPROVED INDICATION,56
FR,PSORIASIS,55
FR,ABDOMINAL PAIN,54
FR,HYPERBILIRUBINAEMIA,54
FR,LUNG INFECTION,54
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,53
FR,LYMPHOPENIA,51
FR,LEUKOPENIA,50
FR,LUNG DISORDER,50
FR,URINARY TRACT INFECTION,50
FR,ALANINE AMINOTRANSFERASE INCREASED,49
FR,NAUSEA,48
FR,COUGH,47
FR,ARTHRALGIA,46
FR,WEIGHT DECREASED,46
FR,CARDIAC FAILURE,45
FR,BASAL CELL CARCINOMA,44
FR,PULMONARY EMBOLISM,44
FR,DEATH,43
FR,ENCEPHALOPATHY,42
FR,HYPERTENSION,42
FR,FALL,41
FR,RENAL FAILURE ACUTE,41
FR,GENERAL PHYSICAL HEALTH DETERIORATION,40
FR,CONDITION AGGRAVATED,39
FR,HYPERSENSITIVITY,39
FR,INTERSTITIAL LUNG DISEASE,38
FR,PANCREATITIS,38
FR,SINUSITIS,38
FR,DIABETES MELLITUS,37
FR,DEPRESSION,36
FR,CONFUSIONAL STATE,35
FR,AGRANULOCYTOSIS,34
FR,DEHYDRATION,34
FR,HYPOTENSION,34
FR,DRUG HYPERSENSITIVITY,33
FR,RHEUMATOID ARTHRITIS,33
FR,PARAESTHESIA,32
FR,ERYTHEMA,31
FR,FATIGUE,31
FR,HEPATITIS,31
FR,KAPOSI^S SARCOMA,31
FR,SKIN LESION,31
FR,MALAISE,30
FR,RASH,30
FR,PRURITUS,29
FR,RESPIRATORY DISTRESS,29
FR,PAIN IN EXTREMITY,28
FR,PLEURAL EFFUSION,28
FR,RHINITIS,28
FR,SKIN ULCER,28
FR,EPSTEIN-BARR VIRUS INFECTION,27
FR,BRONCHOPNEUMONIA,26
FR,GASTROENTERITIS,26
FR,SEIZURE,26
FR,BREAST CANCER,25
FR,DEEP VEIN THROMBOSIS,25
FR,TACHYCARDIA,25
FR,APHASIA,24
FR,APLASIA,24
FR,BACK PAIN,24
FR,DECREASED APPETITE,24
FR,DRUG LEVEL INCREASED,24
FR,HERPES ZOSTER,24
FR,LEUKOENCEPHALOPATHY,24
FR,PERICARDITIS,24
FR,POTENTIATING DRUG INTERACTION,24
FR,PYELONEPHRITIS,24
FR,SQUAMOUS CELL CARCINOMA,24
FR,STAPHYLOCOCCAL INFECTION,24
FR,COLITIS,23
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,23
FR,STOMATITIS,23
FR,VERTIGO,23
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,22
FR,COMA,22
FR,EPISTAXIS,22
FR,ESCHERICHIA SEPSIS,22
FR,HYPOKALAEMIA,22
FR,NEUROPATHY PERIPHERAL,22
FR,OEDEMA PERIPHERAL,22
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,22
FR,ARTHRITIS,21
FR,ISCHAEMIC STROKE,21
FR,NASOPHARYNGITIS,21
FR,PAIN,21
FR,ABDOMINAL PAIN UPPER,20
FR,ACUTE MYELOID LEUKAEMIA,20
FR,CARDIOGENIC SHOCK,20
FR,HISTIOCYTOSIS HAEMATOPHAGIC,20
FR,HYPERLIPIDAEMIA,20
FR,MULTI-ORGAN FAILURE,20
FR,MYELODYSPLASTIC SYNDROME,20
FR,OVERDOSE,20
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,20
FR,TRANSAMINASES INCREASED,20
FR,URTICARIA,20
FR,ANAEMIA MACROCYTIC,19
FR,ENCEPHALITIS,19
FR,MYOCARDIAL INFARCTION,19
FR,SUPERINFECTION,19
FR,ANAPHYLACTIC SHOCK,18
FR,CEREBRAL VENOUS THROMBOSIS,18
FR,CHEST PAIN,18
FR,CHILLS,18
FR,CYSTITIS,18
FR,DISEASE PROGRESSION,18
FR,INFLAMMATION,18
FR,PANCREATITIS ACUTE,18
FR,ADENOCARCINOMA OF COLON,17
FR,ALOPECIA,17
FR,BLOOD BILIRUBIN INCREASED,17
FR,CONSTIPATION,17
FR,CROHN^S DISEASE,17
FR,DEVICE RELATED INFECTION,17
FR,EJECTION FRACTION DECREASED,17
FR,MALIGNANT MELANOMA,17
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,17
FR,MYALGIA,17
FR,TREATMENT FAILURE,17
FR,ACUTE CORONARY SYNDROME,16
FR,ATRIAL FIBRILLATION,16
FR,BLOOD CREATININE INCREASED,16
FR,HYPOALBUMINAEMIA,16
FR,INFLUENZA,16
FR,LUNG NEOPLASM MALIGNANT,16
FR,LYMPHADENOPATHY,16
FR,METASTASES TO LIVER,16
FR,OSTEOARTHRITIS,16
FR,PERICARDIAL EFFUSION,16
FR,RASH ERYTHEMATOUS,16
FR,RECTAL HAEMORRHAGE,16
FR,CARDIO-RESPIRATORY ARREST,15
FR,CATARACT,15
FR,CELLULITIS,15
FR,DIABETES MELLITUS INADEQUATE CONTROL,15
FR,EAR INFECTION,15
FR,GASTROINTESTINAL DISORDER,15
FR,HAEMATURIA,15
FR,HYPOGAMMAGLOBULINAEMIA,15
FR,INVASIVE DUCTAL BREAST CARCINOMA,15
FR,PULMONARY FIBROSIS,15
FR,RESPIRATORY FAILURE,15
FR,TOOTH ABSCESS,15
FR,TOXIC SKIN ERUPTION,15
FR,CEREBRAL THROMBOSIS,14
FR,HEPATOTOXICITY,14
FR,HERPES SIMPLEX,14
FR,HODGKIN^S DISEASE,14
FR,HYPERTHERMIA,14
FR,HYPONATRAEMIA,14
FR,MALNUTRITION,14
FR,MOUTH ULCERATION,14
FR,PERITONITIS,14
FR,PHLEBITIS,14
FR,POLYNEUROPATHY,14
FR,PRODUCTIVE COUGH,14
FR,SLEEP DISORDER,14
FR,TUBERCULOSIS,14
FR,VIITH NERVE PARALYSIS,14
FR,VIRAL INFECTION,14
FR,ARTHROPATHY,13
FR,B-CELL LYMPHOMA,13
FR,BACTERIAL INFECTION,13
FR,CARDIAC FAILURE ACUTE,13
FR,CHOLECYSTITIS,13
FR,CONVULSION,13
FR,DERMATITIS BULLOUS,13
FR,DRUG INTOLERANCE,13
FR,FOETAL EXPOSURE DURING PREGNANCY,13
FR,HAEMATOMA,13
FR,ISOSPORIASIS,13
FR,LIPASE INCREASED,13
FR,METABOLIC ACIDOSIS,13
FR,MIGRAINE,13
FR,SARCOIDOSIS,13
FR,STAPHYLOCOCCAL SEPSIS,13
FR,WEIGHT INCREASED,13
FR,ANGIOEDEMA,12
FR,ASPARTATE AMINOTRANSFERASE INCREASED,12
FR,BACTERAEMIA,12
FR,CARDIAC DISORDER,12
FR,CEREBROVASCULAR ACCIDENT,12
FR,CONJUNCTIVITIS,12
FR,CYTOMEGALOVIRUS INFECTION,12
FR,DISEASE RECURRENCE,12
FR,HAEMATOTOXICITY,12
FR,HAEMOPTYSIS,12
FR,HERPES VIRUS INFECTION,12
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,12
FR,MEDICATION ERROR,12
FR,MOLLUSCUM CONTAGIOSUM,12
FR,NEURALGIA,12
FR,PUSTULAR PSORIASIS,12
FR,RASH MACULO-PAPULAR,12
FR,RENAL COLIC,12
FR,SCIATICA,12
FR,SKIN NECROSIS,12
FR,ABSCESS,11
FR,ACUTE PULMONARY OEDEMA,11
FR,ANAPHYLACTIC REACTION,11
FR,ANXIETY,11
FR,ASCITES,11
FR,BALANCE DISORDER,11
FR,CANDIDA INFECTION,11
FR,CEREBELLAR SYNDROME,11
FR,CHOLELITHIASIS,11
FR,ERYSIPELAS,11
FR,ESCHERICHIA URINARY TRACT INFECTION,11
FR,FUNGAL INFECTION,11
FR,GASTROINTESTINAL HAEMORRHAGE,11
FR,HEPATIC STEATOSIS,11
FR,HUMAN HERPESVIRUS 8 INFECTION,11
FR,HYPOGLYCAEMIA,11
FR,HYPOXIA,11
FR,LOSS OF CONSCIOUSNESS,11
FR,MENINGITIS ASEPTIC,11
FR,MYOCLONUS,11
FR,PHARYNGITIS,11
FR,PSEUDOMONAS INFECTION,11
FR,RENAL IMPAIRMENT,11
FR,SHOCK,11
FR,TREMOR,11
FR,ABORTION SPONTANEOUS,10
FR,ACUTE RESPIRATORY FAILURE,10
FR,AGGRESSION,10
FR,ANTITHROMBIN III,10
FR,APHTHOUS ULCER,10
FR,APLASTIC ANAEMIA,10
FR,ARTHRITIS INFECTIVE,10
FR,CELL-MEDIATED IMMUNE DEFICIENCY,10
FR,CEREBRAL HAEMORRHAGE,10
FR,CHRONIC KIDNEY DISEASE,10
FR,COAGULOPATHY,10
FR,DIFFUSE LARGE B-CELL LYMPHOMA,10
FR,DIZZINESS,10
FR,DRUG-INDUCED LIVER INJURY,10
FR,EMBOLISM,10
FR,FOLATE DEFICIENCY,10
FR,GAIT DISTURBANCE,10
FR,INTRACARDIAC THROMBUS,10
FR,IRON DEFICIENCY ANAEMIA,10
FR,LUNG ADENOCARCINOMA,10
FR,MELAENA,10
FR,NEOPLASM MALIGNANT,10
FR,OEDEMA,10
FR,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,10
FR,RENAL TUBULAR NECROSIS,10
FR,RHEUMATOID NODULE,10
FR,SUBCUTANEOUS ABSCESS,10
FR,SUBDURAL HAEMATOMA,10
FR,TOXIC EPIDERMAL NECROLYSIS,10
FR,VISUAL ACUITY REDUCED,10
FR,ALVEOLITIS,9
FR,ANGINA PECTORIS,9
FR,ANKYLOSING SPONDYLITIS,9
FR,ANTEROGRADE AMNESIA,9
FR,ASPERGILLUS INFECTION,9
FR,AXONAL NEUROPATHY,9
FR,BLOOD FIBRINOGEN DECREASED,9
FR,BURSITIS,9
FR,CARDIAC ARREST,9
FR,CELL DEATH,9
FR,CEREBRAL ISCHAEMIA,9
FR,CLOSTRIDIUM DIFFICILE INFECTION,9
FR,COLON CANCER,9
FR,DERMATITIS EXFOLIATIVE,9
FR,DYSPHAGIA,9
FR,ECZEMA,9
FR,EXPOSURE DURING PREGNANCY,9
FR,HYPERHIDROSIS,9
FR,LEUKOCYTOSIS,9
FR,MYOCARDITIS,9
FR,NECK PAIN,9
FR,OTITIS MEDIA ACUTE,9
FR,PERINEAL INFECTION,9
FR,PLEURISY,9
FR,PRURIGO,9
FR,PSORIATIC ARTHROPATHY,9
FR,SKIN INFECTION,9
FR,TENOSYNOVITIS,9
FR,TONSILLITIS,9
FR,UPPER RESPIRATORY TRACT INFECTION,9
FR,ACUTE PRERENAL FAILURE,8
FR,ANTITHROMBIN III DECREASED,8
FR,CHEST DISCOMFORT,8
FR,CONGESTIVE CARDIOMYOPATHY,8
FR,DEAFNESS,8
FR,DISORIENTATION,8
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,8
FR,DYSLIPIDAEMIA,8
FR,DYSPNOEA EXERTIONAL,8
FR,DYSURIA,8
FR,FOLLICULITIS,8
FR,HEMIPARESIS,8
FR,HEPATIC ENZYME INCREASED,8
FR,HEPATITIS E,8
FR,HOT FLUSH,8
FR,HYPOAESTHESIA,8
FR,HYPOVOLAEMIC SHOCK,8
FR,INFLUENZA LIKE ILLNESS,8
FR,INTESTINAL PERFORATION,8
FR,LIVER DISORDER,8
FR,LIVER FUNCTION TEST ABNORMAL,8
FR,MEMORY IMPAIRMENT,8
FR,NECROSIS,8
FR,NEPHROLITHIASIS,8
FR,NEUROTOXICITY,8
FR,OPTIC NERVE DISORDER,8
FR,ORAL HERPES,8
FR,OROPHARYNGEAL PAIN,8
FR,PALPITATIONS,8
FR,PARONYCHIA,8
FR,PERIORBITAL INFECTION,8
FR,PROSTATE CANCER,8
FR,PULMONARY MASS,8
FR,PULMONARY TOXICITY,8
FR,PURPURA,8
FR,RENAL TUBULAR DISORDER,8
FR,RHABDOMYOLYSIS,8
FR,RHINORRHOEA,8
FR,RIB FRACTURE,8
FR,STATUS EPILEPTICUS,8
FR,THROMBOTIC MICROANGIOPATHY,8
FR,TINNITUS,8
FR,UVEITIS,8
FR,ABNORMAL BEHAVIOUR,7
FR,ALTERED STATE OF CONSCIOUSNESS,7
FR,ARACHNOIDITIS,7
FR,BRONCHIAL DISORDER,7
FR,CARDIOMYOPATHY,7
FR,CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC,7
FR,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,7
FR,COAGULATION FACTOR V LEVEL DECREASED,7
FR,CYSTITIS HAEMORRHAGIC,7
FR,DRUG ADMINISTRATION ERROR,7
FR,DRUG DEPENDENCE,7
FR,DRUG EFFECT INCOMPLETE,7
FR,DYSARTHRIA,7
FR,EOSINOPHILIA,7
FR,EPILEPSY,7
FR,FACE OEDEMA,7
FR,FEMUR FRACTURE,7
FR,GASTROINTESTINAL INFECTION,7
FR,HAEMATEMESIS,7
FR,HAEMORRHAGE,7
FR,HEPATIC CIRRHOSIS,7
FR,HEPATIC FAILURE,7
FR,HEPATOMEGALY,7
FR,HYPERCHOLESTEROLAEMIA,7
FR,HYPOTHERMIA,7
FR,ILEUS PARALYTIC,7
FR,IMMUNE-MEDIATED NECROTISING MYOPATHY,7
FR,INTERVERTEBRAL DISCITIS,7
FR,LARYNGITIS,7
FR,LEFT VENTRICULAR FAILURE,7
FR,LUNG ABSCESS,7
FR,MALIGNANT NEOPLASM PROGRESSION,7
FR,METASTASES TO BONE,7
FR,MOTOR DYSFUNCTION,7
FR,MUCORMYCOSIS,7
FR,MUSCULOSKELETAL PAIN,7
FR,MYELITIS,7
FR,NON-HODGKIN^S LYMPHOMA,7
FR,OSTEITIS,7
FR,OSTEONECROSIS,7
FR,OSTEOPOROSIS,7
FR,PELVIC FRACTURE,7
FR,PHAEHYPHOMYCOSIS,7
FR,PLASMA CELL MYELOMA RECURRENT,7
FR,PNEUMOTHORAX,7
FR,POST LUMBAR PUNCTURE SYNDROME,7
FR,PYELONEPHRITIS ACUTE,7
FR,PYOPNEUMOTHORAX,7
FR,QUADRIPLEGIA,7
FR,RASH PUSTULAR,7
FR,REBOUND EFFECT,7
FR,RED BLOOD CELL COUNT DECREASED,7
FR,SJOGREN^S SYNDROME,7
FR,SKIN PLAQUE,7
FR,SOMNOLENCE,7
FR,SUICIDAL IDEATION,7
FR,SYNOVITIS,7
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,7
FR,THERAPEUTIC RESPONSE DECREASED,7
FR,URINARY INCONTINENCE,7
FR,VENOUS THROMBOSIS LIMB,7
FR,VITAMIN B12 DEFICIENCY,7
FR,ABSCESS LIMB,6
FR,ACCIDENTAL OVERDOSE,6
FR,ACUTE LYMPHOCYTIC LEUKAEMIA,6
FR,ANGIOCENTRIC LYMPHOMA,6
FR,ANURIA,6
FR,ARTHRITIS BACTERIAL,6
FR,BICYTOPENIA,6
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
FR,C-REACTIVE PROTEIN INCREASED,6
FR,CENTRAL NERVOUS SYSTEM LYMPHOMA,6
FR,CHOLANGITIS,6
FR,CHOLANGITIS INFECTIVE,6
FR,CHOLECYSTITIS ACUTE,6
FR,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,6
FR,CIRCULATORY COLLAPSE,6
FR,CONTRAINDICATED PRODUCT ADMINISTERED,6
FR,CRYPTOCOCCOSIS,6
FR,CYTOPENIA,6
FR,DEAFNESS BILATERAL,6
FR,DEVICE DISLOCATION,6
FR,DIPLOPIA,6
FR,DISSEMINATED LARGE CELL LYMPHOMA,6
FR,DIVERTICULITIS,6
FR,DIVERTICULUM INTESTINAL,6
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,6
FR,DYSKINESIA,6
FR,FOOT DEFORMITY,6
FR,GASTROINTESTINAL LYMPHOMA,6
FR,GENITOURINARY TRACT INFECTION,6
FR,GLIOBLASTOMA,6
FR,GRAFT VERSUS HOST DISEASE,6
FR,HELICOBACTER INFECTION,6
FR,HEPATOCELLULAR CARCINOMA,6
FR,HERPES SIMPLEX ENCEPHALITIS,6
FR,HERPES ZOSTER MENINGOENCEPHALITIS,6
FR,HISTOPLASMOSIS DISSEMINATED,6
FR,HYPERGLYCAEMIA,6
FR,HYPERKERATOSIS,6
FR,HYPERLEUKOCYTOSIS,6
FR,HYPOCALCAEMIA,6
FR,INCORRECT DOSE ADMINISTERED,6
FR,INJECTION SITE REACTION,6
FR,INTESTINAL OBSTRUCTION,6
FR,INTRADUCTAL PROLIFERATIVE BREAST LESION,6
FR,JOINT EFFUSION,6
FR,LARGE INTESTINE PERFORATION,6
FR,LIGAMENT SPRAIN,6
FR,MONOCLONAL GAMMOPATHY,6
FR,MUCOSAL HAEMORRHAGE,6
FR,MUSCLE SPASMS,6
FR,MYCOBACTERIAL INFECTION,6
FR,ODYNOPHAGIA,6
FR,OSTEOMYELITIS,6
FR,PARADOXICAL DRUG REACTION,6
FR,PLASMA CELL MYELOMA,6
FR,PNEUMONIA CYTOMEGALOVIRAL,6
FR,PNEUMONIA PSEUDOMONAL,6
FR,PROTHROMBIN LEVEL DECREASED,6
FR,PSEUDOMONAL SEPSIS,6
FR,PULMONARY OEDEMA,6
FR,PULMONARY TUBERCULOSIS,6
FR,RALES,6
FR,SKIN TOXICITY,6
FR,SPINAL FRACTURE,6
FR,SQUAMOUS CELL CARCINOMA OF LUNG,6
FR,SUBILEUS,6
FR,SUICIDE ATTEMPT,6
FR,SUPERIOR SAGITTAL SINUS THROMBOSIS,6
FR,TRANSVERSE SINUS THROMBOSIS,6
FR,VARICELLA,6
FR,VULVOVAGINAL MYCOTIC INFECTION,6
FR,WOUND,6
FR,ABORTION INDUCED,5
FR,ACUTE MYELOMONOCYTIC LEUKAEMIA,5
FR,ADVERSE EVENT,5
FR,ANGIODYSPLASIA,5
FR,ANOSMIA,5
FR,APHTHOUS STOMATITIS,5
FR,APOPTOTIC COLONOPATHY,5
FR,ARRHYTHMIA,5
FR,ARTHRODESIS,5
FR,ASPHYXIA,5
FR,ASTHMA,5
FR,BLADDER TRANSITIONAL CELL CARCINOMA,5
FR,BLISTER,5
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,5
FR,BREAKTHROUGH PAIN,5
FR,BRONCHOPULMONARY ASPERGILLOSIS,5
FR,CARDIOTOXICITY,5
FR,CARPAL TUNNEL SYNDROME,5
FR,CEREBROSPINAL FLUID LEAKAGE,5
FR,CHEST X-RAY ABNORMAL,5
FR,CLOSTRIDIUM DIFFICILE COLITIS,5
FR,COLITIS ULCERATIVE,5
FR,DISTURBANCE IN ATTENTION,5
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
FR,DRY EYE,5
FR,DYSPEPSIA,5
FR,ENDOCARDITIS,5
FR,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,5
FR,ESCHAR,5
FR,EYE PAIN,5
FR,FALLOT^S TETRALOGY,5
FR,FEELING ABNORMAL,5
FR,FLUSHING,5
FR,FRACTURE,5
FR,GANGRENE,5
FR,GILBERT^S SYNDROME,5
FR,GROIN ABSCESS,5
FR,HALLUCINATION,5
FR,HALLUCINATION_ VISUAL,5
FR,HYPERKALAEMIA,5
FR,HYPOPHOSPHATAEMIA,5
FR,IMMUNOSUPPRESSION,5
FR,INFECTIOUS COLITIS,5
FR,INTENTIONAL PRODUCT USE ISSUE,5
FR,JUGULAR VEIN THROMBOSIS,5
FR,LARGE INTESTINE POLYP,5
FR,MATERNAL EXPOSURE DURING PREGNANCY,5
FR,MYCOSIS FUNGOIDES,5
FR,NERVOUS SYSTEM DISORDER,5
FR,NIGHT SWEATS,5
FR,OBLITERATIVE BRONCHIOLITIS,5
FR,OLIGOHYDRAMNIOS,5
FR,PANCREATIC CARCINOMA METASTATIC,5
FR,PAPILLOMA VIRAL INFECTION,5
FR,PAPULE,5
FR,PARTIAL SEIZURES,5
FR,PNEUMONIA VIRAL,5
FR,POLLAKIURIA,5
FR,POSTOPERATIVE WOUND INFECTION,5
FR,PREMATURE DELIVERY,5
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
FR,PULMONARY ARTERIAL HYPERTENSION,5
FR,RASH PAPULAR,5
FR,RESPIRATORY DISORDER,5
FR,RESPIRATORY TRACT INFECTION,5
FR,RHEUMATOID LUNG,5
FR,SECOND PRIMARY MALIGNANCY,5
FR,SKIN DISORDER,5
FR,SKIN EROSION,5
FR,SKIN EXFOLIATION,5
FR,SPINAL COMPRESSION FRACTURE,5
FR,SQUAMOUS CELL CARCINOMA OF SKIN,5
FR,TENDON RUPTURE,5
FR,THERAPEUTIC RESPONSE UNEXPECTED,5
FR,TOOTH EXTRACTION,5
FR,TOOTH INFECTION,5
FR,TRANSIENT ISCHAEMIC ATTACK,5
FR,ULCERATIVE KERATITIS,5
FR,VASCULITIS,5
FR,VENOOCCLUSIVE DISEASE,5
FR,VENOUS THROMBOSIS,5
FR,VISION BLURRED,5
FR,ABDOMINAL WALL HAEMATOMA,4
FR,ACARODERMATITIS,4
FR,ACTINIC KERATOSIS,4
FR,ACTINOMYCOTIC PULMONARY INFECTION,4
FR,AMENORRHOEA,4
FR,ANAPHYLACTOID REACTION,4
FR,ANGIOPATHY,4
FR,ARTHRITIS VIRAL,4
FR,ATAXIA,4
FR,ATRIAL FLUTTER,4
FR,ATRIOVENTRICULAR BLOCK COMPLETE,4
FR,BLINDNESS,4
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,4
FR,BONE PAIN,4
FR,BRAIN ABSCESS,4
FR,BREAST CANCER METASTATIC,4
FR,BRONCHIAL CARCINOMA,4
FR,BRONCHIECTASIS,4
FR,CAMPYLOBACTER GASTROENTERITIS,4
FR,CAMPYLOBACTER INFECTION,4
FR,CARDIOMYOPATHY ACUTE,4
FR,CEREBRAL VENTRICLE DILATATION,4
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,4
FR,CHRONIC SINUSITIS,4
FR,CUSHING^S SYNDROME,4
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,4
FR,CUTANEOUS VASCULITIS,4
FR,CYST,4
FR,CYTOMEGALOVIRUS COLITIS,4
FR,DERMO-HYPODERMITIS,4
FR,DIARRHOEA HAEMORRHAGIC,4
FR,DISSEMINATED TUBERCULOSIS,4
FR,DIVERTICULAR PERFORATION,4
FR,DRUG CLEARANCE DECREASED,4
FR,DRUG EFFECT DECREASED,4
FR,DRUG RESISTANCE,4
FR,DYSGEUSIA,4
FR,ENDOMETRIOSIS,4
FR,ENTEROBACTER INFECTION,4
FR,ESCHERICHIA INFECTION,4
FR,FACIAL SPASM,4
FR,FOETAL DEATH,4
FR,FOETAL EXPOSURE TIMING UNSPECIFIED,4
FR,FURUNCLE,4
FR,GASTRIC ULCER,4
FR,GASTRITIS,4
FR,GASTROENTERITIS VIRAL,4
FR,GASTROINTESTINAL TOXICITY,4
FR,GENERAL PHYSICAL CONDITION ABNORMAL,4
FR,GENITAL HERPES,4
FR,HAEMODYNAMIC INSTABILITY,4
FR,HEMIPLEGIA,4
FR,HENOCH-SCHONLEIN PURPURA,4
FR,HEPATITIS ACUTE,4
FR,HEPATITIS CHOLESTATIC,4
FR,HEPATITIS FULMINANT,4
FR,HIDRADENITIS,4
FR,HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE III,4
FR,HYDRONEPHROSIS,4
FR,HYPERLACTACIDAEMIA,4
FR,HYPERPLASIA,4
FR,HYPERTENSIVE CRISIS,4
FR,ILL-DEFINED DISORDER,4
FR,INJECTION SITE PAIN,4
FR,INTENTIONAL OVERDOSE,4
FR,INTERNATIONAL NORMALISED RATIO INCREASED,4
FR,IRRITABILITY,4
FR,JOINT ARTHROPLASTY,4
FR,JOINT INJURY,4
FR,JOINT SWELLING,4
FR,KNEE ARTHROPLASTY,4
FR,LEUKAEMIA,4
FR,LIPOMA,4
FR,LIVER INJURY,4
FR,LOCALISED INFECTION,4
FR,LUMBAR SPINAL STENOSIS,4
FR,MAJOR DEPRESSION,4
FR,MENINGITIS ENTEROCOCCAL,4
FR,MENINGORRHAGIA,4
FR,METASTASES TO LYMPH NODES,4
FR,MIOSIS,4
FR,MUCOCUTANEOUS ULCERATION,4
FR,MUSCULAR WEAKNESS,4
FR,MUSCULOSKELETAL DISORDER,4
FR,MUSCULOSKELETAL STIFFNESS,4
FR,NEOPLASM,4
FR,NEOPLASM PROGRESSION,4
FR,NEPHRITIS,4
FR,NEPHROPATHY TOXIC,4
FR,NEUROLOGICAL DECOMPENSATION,4
FR,NEUTROPHIL COUNT DECREASED,4
FR,NUTRITIONAL CONDITION ABNORMAL,4
FR,ONYCHOMYCOSIS,4
FR,ORAL FUNGAL INFECTION,4
FR,ORGANISING PNEUMONIA,4
FR,OSTEOPOROTIC FRACTURE,4
FR,OVARIAN CYST,4
FR,OVARIAN FAILURE,4
FR,OXYGEN SATURATION DECREASED,4
FR,PARAPARESIS,4
FR,PARAPLEGIA,4
FR,PATHOLOGICAL FRACTURE,4
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
FR,PERIPHERAL SENSORY NEUROPATHY,4
FR,PETECHIAE,4
FR,PHOTOSENSITIVITY REACTION,4
FR,PNEUMOCYSTIS JIROVECII INFECTION,4
FR,PNEUMONIA BACTERIAL,4
FR,PNEUMONIA LEGIONELLA,4
FR,PNEUMONIA PNEUMOCOCCAL,4
FR,PREMATURE RUPTURE OF MEMBRANES,4
FR,PRESYNCOPE,4
FR,PSEUDOSTROKE,4
FR,PULMONARY ALVEOLAR HAEMORRHAGE,4
FR,PURULENT DISCHARGE,4
FR,RADICULAR PAIN,4
FR,RASH MACULAR,4
FR,RECTAL ADENOCARCINOMA,4
FR,RENAL CYST,4
FR,RENAL NEOPLASM,4
FR,RIGHT VENTRICULAR FAILURE,4
FR,ROTATOR CUFF SYNDROME,4
FR,SCAB,4
FR,SHOCK HAEMORRHAGIC,4
FR,SLEEP APNOEA SYNDROME,4
FR,SPEECH DISORDER,4
FR,STEVENS-JOHNSON SYNDROME,4
FR,STRESS FRACTURE,4
FR,STRONGYLOIDIASIS,4
FR,SYNCOPE,4
FR,TENDON DISORDER,4
FR,THROMBOPHLEBITIS SUPERFICIAL,4
FR,THROMBOSIS,4
FR,TOOTHACHE,4
FR,TRANSITIONAL CELL CARCINOMA,4
FR,TYPE 2 DIABETES MELLITUS,4
FR,VARICES OESOPHAGEAL,4
FR,VENTRICULAR HYPOKINESIA,4
FR,VISUAL IMPAIRMENT,4
FR,VITREOUS DETACHMENT,4
FR,VULVITIS,4
FR,ABASIA,3
FR,ABDOMINAL DISTENSION,3
FR,ABDOMINAL PAIN LOWER,3
FR,ACNE,3
FR,ACTIVITIES OF DAILY LIVING IMPAIRED,3
FR,ACUTE POLYNEUROPATHY,3
FR,ADENOCARCINOMA GASTRIC,3
FR,ADVERSE DRUG REACTION,3
FR,AFFECTIVE DISORDER,3
FR,AGEUSIA,3
FR,ANAL ABSCESS,3
FR,ANAL INCONTINENCE,3
FR,ANGIODERMATITIS,3
FR,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,3
FR,ANKLE FRACTURE,3
FR,AORTIC VALVE INCOMPETENCE,3
FR,BACTERIAL TEST POSITIVE,3
FR,BEHCET^S SYNDROME,3
FR,BILE DUCT STONE,3
FR,BK VIRUS INFECTION,3
FR,BLOOD ALBUMIN DECREASED,3
FR,BLOOD PRESSURE INCREASED,3
FR,BRADYCARDIA,3
FR,BRAIN INJURY,3
FR,BREAST NEOPLASM,3
FR,BRONCHITIS BACTERIAL,3
FR,BRONCHOPNEUMOPATHY,3
FR,BRONCHOSPASM,3
FR,CARDIOPULMONARY FAILURE,3
FR,CAUDA EQUINA SYNDROME,3
FR,CENTRAL NERVOUS SYSTEM LESION,3
FR,CEREBRAL TOXOPLASMOSIS,3
FR,CERVICAL DYSPLASIA,3
FR,CHEILITIS,3
FR,CHOLANGIOCARCINOMA,3
FR,CHOLECYSTECTOMY,3
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
FR,CLEAR CELL RENAL CELL CARCINOMA,3
FR,COLON ADENOMA,3
FR,COMA SCALE ABNORMAL,3
FR,CONGENITAL MULTIPLEX ARTHROGRYPOSIS,3
FR,CORONARY ARTERY STENOSIS,3
FR,CREATININE RENAL CLEARANCE DECREASED,3
FR,CSF PROTEIN INCREASED,3
FR,DEAFNESS NEUROSENSORY,3
FR,DELIRIUM,3
FR,DERMATOPHYTOSIS,3
FR,DRUG DISPENSING ERROR,3
FR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,3
FR,ELECTROENCEPHALOGRAM ABNORMAL,3
FR,EMPHYSEMA,3
FR,ENCOPRESIS,3
FR,ENTEROCUTANEOUS FISTULA,3
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,3
FR,ESCHERICHIA PYELONEPHRITIS,3
FR,ESCHERICHIA TEST POSITIVE,3
FR,EXTRAPYRAMIDAL DISORDER,3
FR,EXTREMITY NECROSIS,3
FR,EYE PRURITUS,3
FR,EYELID OEDEMA,3
FR,EYELID PTOSIS,3
FR,FACIAL PARALYSIS,3
FR,FOOT FRACTURE,3
FR,FOOT OPERATION,3
FR,FUNGAEMIA,3
FR,GAMBLING,3
FR,GASTROINTESTINAL INFLAMMATION,3
FR,GENERALISED OEDEMA,3
FR,GINGIVITIS,3
FR,GLYCOSURIA,3
FR,GRAFT VERSUS HOST DISEASE IN INTESTINE,3
FR,GRANULOMATOUS LIVER DISEASE,3
FR,GROIN PAIN,3
FR,GROWTH RETARDATION,3
FR,GUILLAIN-BARRE SYNDROME,3
FR,GUTTATE PSORIASIS,3
FR,HAEMOGLOBIN DECREASED,3
FR,HAEMOLYTIC URAEMIC SYNDROME,3
FR,HAEMORRHAGIC ANAEMIA,3
FR,HAEMORRHOIDS,3
FR,HEPATIC ENCEPHALOPATHY,3
FR,HEPATIC FIBROSIS,3
FR,HEPATIC LESION,3
FR,HEPATITIS B,3
FR,HIATUS HERNIA,3
FR,HIP ARTHROPLASTY,3
FR,HOSPITALISATION,3
FR,HUMAN HERPES VIRUS 8 TEST POSITIVE,3
FR,HUMERUS FRACTURE,3
FR,HYPERAMMONAEMIA,3
FR,HYPERCALCAEMIA,3
FR,HYPOACUSIS,3
FR,IIIRD NERVE PARALYSIS,3
FR,ILEUS,3
FR,IMPAIRED HEALING,3
FR,INFECTION REACTIVATION,3
FR,INFECTION SUSCEPTIBILITY INCREASED,3
FR,INFERTILITY,3
FR,INGUINAL HERNIA,3
FR,INJECTION SITE PRURITUS,3
FR,INTESTINAL ISCHAEMIA,3
FR,INTRA-ABDOMINAL HAEMATOMA,3
FR,INTRACRANIAL VENOUS SINUS THROMBOSIS,3
FR,JAUNDICE,3
FR,JAUNDICE CHOLESTATIC,3
FR,JOINT DISLOCATION,3
FR,KERATITIS,3
FR,LACERATION,3
FR,LEUKOCYTURIA,3
FR,LEWIS-SUMNER SYNDROME,3
FR,LICHEN PLANUS,3
FR,LICHENOID KERATOSIS,3
FR,LIP ULCERATION,3
FR,LISTERIOSIS,3
FR,LOSS OF LIBIDO,3
FR,LUNG CANCER METASTATIC,3
FR,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,3
FR,LYME DISEASE,3
FR,LYMPHOEDEMA,3
FR,LYMPHOMA,3
FR,MACULAR OEDEMA,3
FR,MANTLE CELL LYMPHOMA,3
FR,MEAN CELL VOLUME INCREASED,3
FR,MENINGIOMA,3
FR,MENINGITIS,3
FR,MENINGITIS HAEMOPHILUS,3
FR,MENTAL DISORDER,3
FR,METABOLIC DISORDER,3
FR,METASTASES TO CENTRAL NERVOUS SYSTEM,3
FR,MIDDLE INSOMNIA,3
FR,MOBILITY DECREASED,3
FR,MONOCYTOPENIA,3
FR,MOOD ALTERED,3
FR,MUSCLE DISORDER,3
FR,MYOPATHY,3
FR,MYOSITIS,3
FR,NASAL CONGESTION,3
FR,NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA,3
FR,NEOPLASM RECURRENCE,3
FR,NEPHROCALCINOSIS,3
FR,NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC,3
FR,NEUTROPENIC COLITIS,3
FR,NEUTROPENIC INFECTION,3
FR,NODULE,3
FR,OCULAR HYPERAEMIA,3
FR,OEDEMATOUS PANCREATITIS,3
FR,OESOPHAGEAL CARCINOMA,3
FR,OESOPHAGITIS,3
FR,ORAL CANDIDIASIS,3
FR,ORTHOPNOEA,3
FR,OSTEONECROSIS OF JAW,3
FR,OTOTOXICITY,3
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
FR,PANCREATIC CARCINOMA,3
FR,PARALYSIS,3
FR,PARANOIA,3
FR,PEMPHIGOID,3
FR,PERINEAL NECROSIS,3
FR,PERITONEAL HAEMORRHAGE,3
FR,PERSECUTORY DELUSION,3
FR,PETIT MAL EPILEPSY,3
FR,PNEUMONIA ASPIRATION,3
FR,PNEUMONITIS,3
FR,PNEUMOPERITONEUM,3
FR,PREMATURE BABY,3
FR,PROSTATITIS,3
FR,PRURITUS GENERALISED,3
FR,PULMONARY INFARCTION,3
FR,RECTAL CANCER,3
FR,RENAL CELL CARCINOMA,3
FR,RHEUMATIC DISORDER,3
FR,SCLERITIS,3
FR,SENSORY LOSS,3
FR,SINUS BRADYCARDIA,3
FR,SKIN DISCOLOURATION,3
FR,SKIN HYPERPIGMENTATION,3
FR,SKIN IRRITATION,3
FR,SKIN NEOPLASM EXCISION,3
FR,SKIN PAPILLOMA,3
FR,SMALL INTESTINAL PERFORATION,3
FR,SPINAL CORD INFECTION,3
FR,SQUAMOUS CELL CARCINOMA OF THE CERVIX,3
FR,STAPHYLOCOCCAL BACTERAEMIA,3
FR,STAPHYLOCOCCUS TEST POSITIVE,3
FR,STERNAL FRACTURE,3
FR,STREPTOCOCCAL BACTERAEMIA,3
FR,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,3
FR,SUPERIOR VENA CAVA SYNDROME,3
FR,SUPRAVENTRICULAR TACHYCARDIA,3
FR,SWELLING,3
FR,SWELLING FACE,3
FR,SYNOVIAL RUPTURE,3
FR,TACHYPNOEA,3
FR,THERAPY NON-RESPONDER,3
FR,THROMBOPHLEBITIS,3
FR,THYROID NEOPLASM,3
FR,TIBIA FRACTURE,3
FR,TINEA VERSICOLOUR,3
FR,TRACHEITIS,3
FR,TREATMENT NONCOMPLIANCE,3
FR,URINARY TRACT INFECTION BACTERIAL,3
FR,UROSEPSIS,3
FR,UTERINE CANCER,3
FR,VARICELLA ZOSTER VIRUS INFECTION,3
FR,VESTIBULAR NEURONITIS,3
FR,VISUAL FIELD DEFECT,3
FR,WOUND INFECTION,3
FR,WRIST FRACTURE,3
FR,WRONG DOSE,3
FR,ABDOMINAL ABSCESS,2
FR,ABDOMINAL DISCOMFORT,2
FR,ABDOMINAL MASS,2
FR,ABDOMINAL TENDERNESS,2
FR,ACCIDENTAL UNDERDOSE,2
FR,ACINETOBACTER BACTERAEMIA,2
FR,ACINETOBACTER INFECTION,2
FR,ACOUSTIC NEUROMA,2
FR,ACQUIRED HAEMOPHILIA,2
FR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
FR,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
FR,ACUTE MYOCARDIAL INFARCTION,2
FR,ACUTE SINUSITIS,2
FR,ACUTE VESTIBULAR SYNDROME,2
FR,AGITATION,2
FR,ALANINE AMINOTRANSFERASE ABNORMAL,2
FR,AMNESIA,2
FR,AMYLASE INCREASED,2
FR,AMYLOIDOSIS,2
FR,AMYOTROPHY,2
FR,ANAL FISSURE,2
FR,ANGULAR CHEILITIS,2
FR,ANKLE ARTHROPLASTY,2
FR,ANOGENITAL WARTS,2
FR,ANTINUCLEAR ANTIBODY POSITIVE,2
FR,AORTIC VALVE DISEASE,2
FR,AORTIC VALVE STENOSIS,2
FR,APLASIA PURE RED CELL,2
FR,ARTERIAL DISORDER,2
FR,ARTHRITIS FUNGAL,2
FR,ARTHROPOD BITE,2
FR,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
FR,ASTROCYTOMA,2
FR,AUTOIMMUNE THYROIDITIS,2
FR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
FR,AZOOSPERMIA,2
FR,BACILLUS INFECTION,2
FR,BACTERIAL DISEASE CARRIER,2
FR,BACTERIAL PYELONEPHRITIS,2
FR,BACTERIAL SEPSIS,2
FR,BARTHOLINITIS,2
FR,BASEDOW^S DISEASE,2
FR,BEDRIDDEN,2
FR,BILIRUBIN CONJUGATED INCREASED,2
FR,BLOOD CREATINE INCREASED,2
FR,BLOOD CREATININE ABNORMAL,2
FR,BLOOD CULTURE POSITIVE,2
FR,BLOOD IMMUNOGLOBULIN G DECREASED,2
FR,BLOOD TRIGLYCERIDES INCREASED,2
FR,BONE FISSURE,2
FR,BREAST CALCIFICATIONS,2
FR,BREAST CANCER FEMALE,2
FR,BREAST CANCER IN SITU,2
FR,BREAST DISORDER,2
FR,BREAST NECROSIS,2
FR,BRONCHIOLITIS,2
FR,BURNING SENSATION,2
FR,CALCINOSIS,2
FR,CALCULUS BLADDER,2
FR,CALCULUS URETERIC,2
FR,CAROTID ARTERY STENOSIS,2
FR,CATARACT OPERATION,2
FR,CENTRAL VENOUS CATHETER REMOVAL,2
FR,CENTRAL VENOUS CATHETERISATION,2
FR,CEREBELLAR ATAXIA,2
FR,CEREBRAL ATROPHY,2
FR,CEREBRAL HAEMATOMA,2
FR,CEREBRAL INFARCTION,2
FR,CHALAZION,2
FR,CHILLBLAINS,2
FR,CHORIORETINITIS,2
FR,CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS,2
FR,CHRONIC MYELOID LEUKAEMIA,2
FR,CHRONIC RESPIRATORY FAILURE,2
FR,COLONIC ABSCESS,2
FR,CORONARY ARTERIAL STENT INSERTION,2
GE,ANAEMIA,1
GE,DIFFUSE LARGE B-CELL LYMPHOMA,1
GE,GASTROINTESTINAL HAEMORRHAGE,1
GE,INFUSION RELATED REACTION,1
GE,LEUKOPENIA,1
GE,LIPIDS ABNORMAL,1
GE,NEPHROPATHY TOXIC,1
GE,PANCYTOPENIA,1
GE,PNEUMONIA,1
GE,SEPSIS,1
GE,SUBCUTANEOUS ABSCESS,1
GE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
GE,UPPER RESPIRATORY TRACT INFECTION,1
DE,PNEUMONIA,124
DE,RHEUMATOID ARTHRITIS,98
DE,DRUG INEFFECTIVE,93
DE,ARTHRALGIA,85
DE,NAUSEA,81
DE,GENERAL PHYSICAL HEALTH DETERIORATION,80
DE,PYREXIA,71
DE,SEPSIS,67
DE,DEATH,66
DE,OSTEOARTHRITIS,63
DE,PAIN,63
DE,PANCYTOPENIA,63
DE,INFECTION,59
DE,BRONCHITIS,53
DE,IMPAIRED HEALING,51
DE,NASOPHARYNGITIS,50
DE,PULMONARY EMBOLISM,49
DE,DIARRHOEA,47
DE,DYSPNOEA,46
DE,FALL,46
DE,VOMITING,46
DE,PAIN IN EXTREMITY,43
DE,URINARY TRACT INFECTION,43
DE,LEUKOPENIA,42
DE,BASAL CELL CARCINOMA,40
DE,ATRIAL FIBRILLATION,39
DE,CARDIAC FAILURE,39
DE,WEIGHT DECREASED,39
DE,ANAEMIA,38
DE,CEREBROVASCULAR ACCIDENT,38
DE,FOETAL EXPOSURE DURING PREGNANCY,38
DE,HERPES ZOSTER,38
DE,MUCOSAL INFLAMMATION,38
DE,MYOCARDIAL INFARCTION,38
DE,FATIGUE,37
DE,FEBRILE NEUTROPENIA,37
DE,PLEURAL EFFUSION,37
DE,ABDOMINAL PAIN,36
DE,DIZZINESS,36
DE,HEADACHE,36
DE,PSORIASIS,33
DE,SYNCOPE,33
DE,ARTHROPATHY,32
DE,HYPERTENSION,32
DE,THROMBOCYTOPENIA,32
DE,INTERVERTEBRAL DISC PROTRUSION,30
DE,JOINT SWELLING,30
DE,ARTHRITIS,29
DE,C-REACTIVE PROTEIN INCREASED,29
DE,DRUG EFFECT DECREASED,29
DE,RESPIRATORY TRACT INFECTION,29
DE,ACUTE KIDNEY INJURY,28
DE,ASTHENIA,28
DE,CONDITION AGGRAVATED,28
DE,GASTRITIS,28
DE,HYPOKALAEMIA,28
DE,PULMONARY FIBROSIS,27
DE,SEPTIC SHOCK,27
DE,CHILLS,26
DE,CORONARY ARTERY DISEASE,26
DE,DRUG INTOLERANCE,26
DE,HYPERTENSIVE CRISIS,26
DE,POLYNEUROPATHY,26
DE,NEUTROPENIA,25
DE,PRODUCT USE ISSUE,25
DE,RHEUMATOID NODULE,25
DE,BACK PAIN,24
DE,CHOLELITHIASIS,24
DE,CROHN^S DISEASE,24
DE,DIVERTICULITIS,24
DE,ERYTHEMA,24
DE,FOOT DEFORMITY,24
DE,OSTEOPOROSIS,24
DE,TENDON RUPTURE,24
DE,MULTI-ORGAN FAILURE,23
DE,RENAL FAILURE,23
DE,COLITIS,22
DE,HEPATOTOXICITY,22
DE,STOMATITIS,22
DE,DEPRESSION,21
DE,HAEMATURIA,21
DE,RESPIRATORY FAILURE,21
DE,CIRCULATORY COLLAPSE,20
DE,COUGH,20
DE,DEHYDRATION,20
DE,HAEMATOTOXICITY,20
DE,HEMIPARESIS,20
DE,HEPATIC ENZYME INCREASED,20
DE,ABDOMINAL PAIN UPPER,19
DE,ABSCESS,19
DE,ALOPECIA,19
DE,CHEST PAIN,19
DE,DIABETES MELLITUS,19
DE,DISEASE RECURRENCE,19
DE,HYPOAESTHESIA,19
DE,INFLUENZA,19
DE,PERICARDIAL EFFUSION,19
DE,PRURITUS,19
DE,RASH,19
DE,SYNOVIAL CYST,19
DE,ACTINIC KERATOSIS,18
DE,ANGINA PECTORIS,18
DE,HAEMORRHAGE,18
DE,HEPATIC STEATOSIS,18
DE,INFLAMMATION,18
DE,KNEE ARTHROPLASTY,18
DE,LYMPHADENOPATHY,18
DE,MUSCULOSKELETAL STIFFNESS,18
DE,UPPER RESPIRATORY TRACT INFECTION,18
DE,UROSEPSIS,18
DE,BREAST CANCER,17
DE,GAIT DISTURBANCE,17
DE,MUSCULOSKELETAL PAIN,17
DE,PARAESTHESIA,17
DE,TRANSAMINASES INCREASED,17
DE,VERTIGO,17
DE,ARRHYTHMIA,16
DE,ASCITES,16
DE,BURSITIS,16
DE,CEREBRAL INFARCTION,16
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,16
DE,CONSTIPATION,16
DE,DECREASED APPETITE,16
DE,DEEP VEIN THROMBOSIS,16
DE,HYPERSENSITIVITY,16
DE,INFLUENZA LIKE ILLNESS,16
DE,INTERSTITIAL LUNG DISEASE,16
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,16
DE,PERIPHERAL SWELLING,16
DE,PSORIATIC ARTHROPATHY,16
DE,RHEUMATIC DISORDER,16
DE,SEIZURE,16
DE,SKIN TOXICITY,16
DE,SYNOVITIS,16
DE,ACUTE MYOCARDIAL INFARCTION,15
DE,ANAPHYLACTIC REACTION,15
DE,CHEST DISCOMFORT,15
DE,EPISTAXIS,15
DE,ERYSIPELAS,15
DE,GASTROENTERITIS,15
DE,HAEMATOMA,15
DE,LUNG INFILTRATION,15
DE,PRODUCT USE IN UNAPPROVED INDICATION,15
DE,SKIN ULCER,15
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,14
DE,CARDIAC DISORDER,14
DE,CARDIOVASCULAR DISORDER,14
DE,CONTRAINDICATED PRODUCT ADMINISTERED,14
DE,INFLAMMATORY MARKER INCREASED,14
DE,MYALGIA,14
DE,MYELODYSPLASTIC SYNDROME,14
DE,STAPHYLOCOCCAL INFECTION,14
DE,CATARACT,13
DE,DRUG EFFECT INCOMPLETE,13
DE,EXPOSURE DURING PREGNANCY,13
DE,FISTULA,13
DE,GASTROINTESTINAL INFLAMMATION,13
DE,HAEMOGLOBIN DECREASED,13
DE,JOINT EFFUSION,13
DE,NEUTROPENIC SEPSIS,13
DE,PANCREATITIS,13
DE,PANCREATITIS ACUTE,13
DE,PNEUMOCYSTIS JIROVECII PNEUMONIA,13
DE,ROTATOR CUFF SYNDROME,13
DE,SPINAL OSTEOARTHRITIS,13
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,13
DE,TACHYCARDIA,13
DE,UVEITIS,13
DE,ALANINE AMINOTRANSFERASE INCREASED,12
DE,ALVEOLITIS,12
DE,BLOOD PRESSURE INCREASED,12
DE,BLOOD TEST ABNORMAL,12
DE,CHOLECYSTITIS,12
DE,CYSTITIS,12
DE,DIVERTICULUM INTESTINAL,12
DE,DYSPNOEA EXERTIONAL,12
DE,GENERALISED TONIC-CLONIC SEIZURE,12
DE,ILEUS,12
DE,LIVER FUNCTION TEST ABNORMAL,12
DE,MALAISE,12
DE,MALIGNANT MELANOMA,12
DE,METASTASES TO LUNG,12
DE,OEDEMA PERIPHERAL,12
DE,ORAL HERPES,12
DE,PLEURISY,12
DE,PULMONARY OEDEMA,12
DE,RENAL IMPAIRMENT,12
DE,SKIN CANCER,12
DE,VASCULITIS,12
DE,ACUTE LYMPHOCYTIC LEUKAEMIA,11
DE,ARTHRODESIS,11
DE,ATRIAL SEPTAL DEFECT,11
DE,BONE MARROW FAILURE,11
DE,DISEASE PROGRESSION,11
DE,ENCEPHALITIS,11
DE,EPSTEIN-BARR VIRUS INFECTION,11
DE,GASTROINTESTINAL HAEMORRHAGE,11
DE,HEPATIC CIRRHOSIS,11
DE,HYPERHIDROSIS,11
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,11
DE,JOINT DISLOCATION,11
DE,MUSCULAR WEAKNESS,11
DE,NON-HODGKIN^S LYMPHOMA,11
DE,OPTIC NEURITIS,11
DE,PNEUMONITIS,11
DE,PROSTATE CANCER,11
DE,SINUSITIS,11
DE,TOXICITY TO VARIOUS AGENTS,11
DE,WOUND,11
DE,ABDOMINAL DISCOMFORT,10
DE,ABDOMINAL PAIN LOWER,10
DE,ACCIDENTAL OVERDOSE,10
DE,AGRANULOCYTOSIS,10
DE,ASPERGILLUS INFECTION,10
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
DE,BRONCHOPNEUMONIA,10
DE,CARPAL TUNNEL SYNDROME,10
DE,EMPYEMA,10
DE,ENDOCARDITIS,10
DE,FLATULENCE,10
DE,FOOT FRACTURE,10
DE,HISTIOCYTOSIS HAEMATOPHAGIC,10
DE,HYPERKERATOSIS,10
DE,INGUINAL HERNIA,10
DE,JOINT RANGE OF MOTION DECREASED,10
DE,LIVER DISORDER,10
DE,LOCAL SWELLING,10
DE,MALIGNANT NEOPLASM PROGRESSION,10
DE,MATERNAL EXPOSURE DURING PREGNANCY,10
DE,MENISCUS INJURY,10
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,10
DE,PERITONITIS,10
DE,PNEUMONIA ESCHERICHIA,10
DE,RENAL CYST,10
DE,RENAL FUNCTION TEST ABNORMAL,10
DE,SPINAL DISORDER,10
DE,SURGERY,10
DE,SYNOVECTOMY,10
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,10
DE,VENTRICULAR FIBRILLATION,10
DE,WEIGHT INCREASED,10
DE,ABORTION INDUCED,9
DE,ARTHRITIS INFECTIVE,9
DE,ASPARTATE AMINOTRANSFERASE INCREASED,9
DE,BLOOD CREATININE INCREASED,9
DE,BOWEN^S DISEASE,9
DE,BRONCHIAL CARCINOMA,9
DE,CAROTID ARTERY STENOSIS,9
DE,CYTOMEGALOVIRUS INFECTION,9
DE,DERMATITIS ALLERGIC,9
DE,DRUG-INDUCED LIVER INJURY,9
DE,DRY MOUTH,9
DE,DYSARTHRIA,9
DE,DYSPHAGIA,9
DE,EPILEPSY,9
DE,FACIAL PARESIS,9
DE,FEMORAL NECK FRACTURE,9
DE,FRACTURE,9
DE,FUNGAL INFECTION,9
DE,HIP ARTHROPLASTY,9
DE,KERATOACANTHOMA,9
DE,LEUKOENCEPHALOPATHY,9
DE,LUMBAR SPINAL STENOSIS,9
DE,LYMPHOPENIA,9
DE,NEPHROLITHIASIS,9
DE,POLYARTHRITIS,9
DE,RIB FRACTURE,9
DE,SCIATICA,9
DE,STRESS,9
DE,TENOSYNOVITIS,9
DE,THROMBOSIS,9
DE,TIBIA FRACTURE,9
DE,TINNITUS,9
DE,TOOTH DISORDER,9
DE,TYPE 2 DIABETES MELLITUS,9
DE,VISUAL IMPAIRMENT,9
DE,ABORTION SPONTANEOUS,8
DE,ABSCESS LIMB,8
DE,ANKLE FRACTURE,8
DE,ANXIETY,8
DE,ARTERIOSCLEROSIS,8
DE,ATELECTASIS,8
DE,B-CELL LYMPHOMA,8
DE,BLINDNESS UNILATERAL,8
DE,BRAIN OEDEMA,8
DE,CELLULITIS,8
DE,CERVICAL DYSPLASIA,8
DE,COLITIS ULCERATIVE,8
DE,CONJUNCTIVITIS,8
DE,DRUG PRESCRIBING ERROR,8
DE,ESCHERICHIA URINARY TRACT INFECTION,8
DE,FIBROMYALGIA,8
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
DE,GASTRIC ULCER,8
DE,GLAUCOMA,8
DE,HYPERGLYCAEMIA,8
DE,HYPERTENSIVE HEART DISEASE,8
DE,INFECTIOUS COLITIS,8
DE,INFUSION RELATED REACTION,8
DE,INTESTINAL HAEMORRHAGE,8
DE,JUVENILE IDIOPATHIC ARTHRITIS,8
DE,LOSS OF CONSCIOUSNESS,8
DE,MOBILITY DECREASED,8
DE,MUCOSAL TOXICITY,8
DE,MYELITIS,8
DE,OSTEITIS,8
DE,PALPITATIONS,8
DE,PERIPHERAL SENSORY NEUROPATHY,8
DE,PNEUMONIA LEGIONELLA,8
DE,PULMONARY SEPSIS,8
DE,PUSTULAR PSORIASIS,8
DE,PYELONEPHRITIS,8
DE,REHABILITATION THERAPY,8
DE,RENAL FAILURE ACUTE,8
DE,RHINITIS,8
DE,SINUS TACHYCARDIA,8
DE,SKIN DISORDER,8
DE,SOMNOLENCE,8
DE,SPINAL COLUMN STENOSIS,8
DE,SUDDEN HEARING LOSS,8
DE,TONSILLITIS,8
DE,VULVAL CANCER,8
DE,WHIPPLE^S DISEASE,8
DE,WHITE BLOOD CELL COUNT DECREASED,8
DE,BILE DUCT STONE,7
DE,BLOOD BILIRUBIN INCREASED,7
DE,BLOOD GLUCOSE INCREASED,7
DE,CARDIOMYOPATHY,7
DE,CARDIOTOXICITY,7
DE,CEREBRAL ISCHAEMIA,7
DE,DERMATITIS,7
DE,DIFFUSE LARGE B-CELL LYMPHOMA,7
DE,DYSURIA,7
DE,FEBRILE INFECTION,7
DE,GASTROINTESTINAL PAIN,7
DE,HEPATIC FAILURE,7
DE,HYPOTENSION,7
DE,ILEAL STENOSIS,7
DE,ILL-DEFINED DISORDER,7
DE,INJECTION SITE ERYTHEMA,7
DE,INJECTION SITE SWELLING,7
DE,LIVER FUNCTION TEST INCREASED,7
DE,LUMBAR VERTEBRAL FRACTURE,7
DE,LUNG DISORDER,7
DE,LYMPHOPROLIFERATIVE DISORDER,7
DE,METASTATIC BRONCHIAL CARCINOMA,7
DE,MITRAL VALVE INCOMPETENCE,7
DE,MULTIPLE FRACTURES,7
DE,NEUROTOXICITY,7
DE,OSTEONECROSIS OF JAW,7
DE,PATENT DUCTUS ARTERIOSUS,7
DE,PLATELET COUNT DECREASED,7
DE,PNEUMONIA CYTOMEGALOVIRAL,7
DE,POST PROCEDURAL COMPLICATION,7
DE,POST PROCEDURAL HAEMORRHAGE,7
DE,PREMATURE BABY,7
DE,PRODUCT CONTAMINATION MICROBIAL,7
DE,PROSTATITIS,7
DE,RETINAL DETACHMENT,7
DE,RHABDOMYOLYSIS,7
DE,RHEUMATOID LUNG,7
DE,SCOLIOSIS,7
DE,SPINAL FRACTURE,7
DE,STAPHYLOCOCCAL SEPSIS,7
DE,SUBCUTANEOUS ABSCESS,7
DE,SWELLING,7
DE,THROMBOPHLEBITIS,7
DE,URTICARIA,7
DE,VIRAL INFECTION,7
DE,WOUND INFECTION,7
DE,ABDOMINAL DISTENSION,6
DE,APLASTIC ANAEMIA,6
DE,APPENDICITIS,6
DE,ASTHMA,6
DE,ATAXIA,6
DE,BLOOD IMMUNOGLOBULIN M DECREASED,6
DE,BRONCHITIS BACTERIAL,6
DE,CARDIAC ARREST,6
DE,CARDIOMEGALY,6
DE,CAUDAL REGRESSION SYNDROME,6
DE,CEREBRAL HAEMORRHAGE,6
DE,COAGULOPATHY,6
DE,CONGESTIVE CARDIOMYOPATHY,6
DE,DEAFNESS,6
DE,DIABETES MELLITUS INADEQUATE CONTROL,6
DE,DYSGEUSIA,6
DE,DYSPEPSIA,6
DE,ENTERITIS,6
DE,GASTRITIS EROSIVE,6
DE,GASTROINTESTINAL ULCER,6
DE,GLIOSIS,6
DE,GOITRE,6
DE,GRAND MAL CONVULSION,6
DE,HELICOBACTER GASTRITIS,6
DE,HIATUS HERNIA,6
DE,HYPERCOAGULATION,6
DE,HYPOGLYCAEMIA,6
DE,HYPONATRAEMIA,6
DE,HYPOXIA,6
DE,INCISIONAL HERNIA,6
DE,INJECTION SITE REACTION,6
DE,IRON DEFICIENCY,6
DE,JOINT DESTRUCTION,6
DE,JOINT STIFFNESS,6
DE,LEFT VENTRICULAR DYSFUNCTION,6
DE,LEG AMPUTATION,6
DE,LUPUS-LIKE SYNDROME,6
DE,MALIGNANT MELANOMA STAGE I,6
DE,MATERNAL DRUGS AFFECTING FOETUS,6
DE,METASTASES TO LIVER,6
DE,MUSCLE SPASMS,6
DE,NECROTISING RETINITIS,6
DE,NERVOUS SYSTEM DISORDER,6
DE,NEUROENDOCRINE TUMOUR,6
DE,OESOPHAGEAL CANDIDIASIS,6
DE,OESOPHAGITIS,6
DE,OROPHARYNGEAL PAIN,6
DE,OSTEOMYELITIS,6
DE,OSTEONECROSIS,6
DE,OVERDOSE,6
DE,PANCREATIC CARCINOMA,6
DE,PELVIC FRACTURE,6
DE,PHOTOSENSITIVITY REACTION,6
DE,PNEUMONIA ASPIRATION,6
DE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,6
DE,PRODUCTIVE COUGH,6
DE,PSYCHOTIC DISORDER,6
DE,PULMONARY MASS,6
DE,RECTAL STENOSIS,6
DE,RECTOCELE,6
DE,RENAL CELL CARCINOMA,6
DE,RENAL DISORDER,6
DE,RENAL TRANSPLANT FAILURE,6
DE,RHINORRHOEA,6
DE,SARCOIDOSIS,6
DE,SKIN REACTION,6
DE,SLEEP DISORDER,6
DE,SPEECH DISORDER,6
DE,SPINAL PAIN,6
DE,SQUAMOUS CELL CARCINOMA,6
DE,STRESS FRACTURE,6
DE,THERAPY NON-RESPONDER,6
DE,TOOTH EXTRACTION,6
DE,ULNA FRACTURE,6
DE,UPPER LIMB FRACTURE,6
DE,VARICOSE VEIN,6
DE,VENOOCCLUSIVE DISEASE,6
DE,VENOUS THROMBOSIS,6
DE,VERTEBRAL FORAMINAL STENOSIS,6
DE,VISION BLURRED,6
DE,VISUAL ACUITY REDUCED,6
DE,VITAMIN B12 DEFICIENCY,6
DE,ABDOMINAL ADHESIONS,5
DE,ACUTE GRAFT VERSUS HOST DISEASE,5
DE,ADENOVIRUS INFECTION,5
DE,ALVEOLITIS ALLERGIC,5
DE,ANAL ABSCESS,5
DE,ANAL PROLAPSE,5
DE,ANGIOEDEMA,5
DE,ANKYLOSING SPONDYLITIS,5
DE,AORTIC ARTERIOSCLEROSIS,5
DE,APHASIA,5
DE,BALANCE DISORDER,5
DE,BENIGN PROSTATIC HYPERPLASIA,5
DE,BILIARY COLIC,5
DE,BLADDER CANCER,5
DE,BLADDER TRANSITIONAL CELL CARCINOMA,5
DE,BLOOD PRESSURE DECREASED,5
DE,BRONCHIOLITIS,5
DE,BRONCHITIS CHRONIC,5
DE,BUNDLE BRANCH BLOCK RIGHT,5
DE,CENTRAL NERVOUS SYSTEM LESION,5
DE,CHEST X-RAY ABNORMAL,5
DE,CHOLANGITIS,5
DE,CHOLESTASIS,5
DE,COLON CANCER,5
DE,COMPLEMENT FACTOR C3 DECREASED,5
DE,CONVULSION,5
DE,CYSTITIS HAEMORRHAGIC,5
DE,DEVICE RELATED INFECTION,5
DE,DIABETIC FOOT,5
DE,DIASTOLIC DYSFUNCTION,5
DE,DISORIENTATION,5
DE,DRUG LEVEL INCREASED,5
DE,EMBOLISM,5
DE,EMPHYSEMA,5
DE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,5
DE,EYE DISORDER,5
DE,FLUSHING,5
DE,FREQUENT BOWEL MOVEMENTS,5
DE,GASTRIC DISORDER,5
DE,GINGIVITIS,5
DE,GLOMERULONEPHRITIS CHRONIC,5
DE,GRANULOCYTOPENIA,5
DE,GROIN PAIN,5
DE,HAEMOPTYSIS,5
DE,HEART DISEASE CONGENITAL,5
DE,HEPATIC FUNCTION ABNORMAL,5
DE,HEPATITIS E,5
DE,HYPERLIPIDAEMIA,5
DE,HYPOTHERMIA,5
DE,IMMUNOSUPPRESSION,5
DE,INJECTION SITE PAIN,5
DE,INJECTION SITE PRURITUS,5
DE,INTENTIONAL PRODUCT USE ISSUE,5
DE,INTRAOCULAR PRESSURE INCREASED,5
DE,LARGE INTESTINE PERFORATION,5
DE,LARYNGITIS,5
DE,MALIGNANT NEOPLASM OF CONJUNCTIVA,5
DE,MATERNAL EXPOSURE BEFORE PREGNANCY,5
DE,MENINGITIS ASEPTIC,5
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,5
DE,MONOCLONAL GAMMOPATHY,5
DE,NAIL DISORDER,5
DE,NECROSIS,5
DE,NEPHROPATHY TOXIC,5
DE,NEUROPATHY PERIPHERAL,5
DE,NUTRITIONAL CONDITION ABNORMAL,5
DE,OEDEMA,5
DE,OSTEOCHONDROSIS,5
DE,PANCREATIC NEOPLASM,5
DE,PARONYCHIA,5
DE,PAROTITIS,5
DE,POSTOPERATIVE WOUND INFECTION,5
DE,PRESCRIBED UNDERDOSE,5
DE,PROSTATIC ADENOMA,5
DE,PROTHROMBIN TIME PROLONGED,5
DE,PSEUDOMONAS INFECTION,5
DE,RADIUS FRACTURE,5
DE,RASH PUSTULAR,5
DE,RESTLESS LEGS SYNDROME,5
DE,SMALL FOR DATES BABY,5
DE,SPLENOMEGALY,5
DE,SPONDYLOLISTHESIS,5
DE,THERAPEUTIC RESPONSE DECREASED,5
DE,TRANSIENT ISCHAEMIC ATTACK,5
DE,TRANSURETHRAL PROSTATECTOMY,5
DE,UNEVALUABLE EVENT,5
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,5
DE,VAGINAL HAEMORRHAGE,5
DE,VENTRICULAR SEPTAL DEFECT,5
DE,WRIST FRACTURE,5
DE,ACUTE ABDOMEN,4
DE,ACUTE CORONARY SYNDROME,4
DE,ACUTE DISSEMINATED ENCEPHALOMYELITIS,4
DE,ACUTE LUNG INJURY,4
DE,ACUTE MYELOID LEUKAEMIA,4
DE,ACUTE MYELOID LEUKAEMIA RECURRENT,4
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,4
DE,ADVERSE EVENT,4
DE,AMPUTATION,4
DE,AORTIC ANEURYSM,4
DE,AORTIC VALVE INCOMPETENCE,4
DE,APATHY,4
DE,ARTERIOSCLEROSIS CORONARY ARTERY,4
DE,ARTHRITIS BACTERIAL,4
DE,ASPIRATION,4
DE,ATROPHY,4
DE,BLADDER DILATATION,4
DE,BODY TEMPERATURE INCREASED,4
DE,BRADYCARDIA,4
DE,BRAIN HERNIATION,4
DE,BURSA DISORDER,4
DE,CENTRAL NERVOUS SYSTEM NECROSIS,4
DE,CERVIX CARCINOMA STAGE 0,4
DE,CHRONIC GRAFT VERSUS HOST DISEASE,4
DE,COLITIS ISCHAEMIC,4
DE,CONGENITAL CYSTIC LUNG,4
DE,CUSHING^S SYNDROME,4
DE,CYST,4
DE,DECUBITUS ULCER,4
DE,DEMENTIA,4
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,4
DE,DEVICE DISLOCATION,4
DE,DIFFUSE LARGE B-CELL LYMPHOMA STAGE II,4
DE,DISSEMINATED INTRAVASCULAR COAGULATION,4
DE,DISSEMINATED TUBERCULOSIS,4
DE,DIVERTICULAR PERFORATION,4
DE,DRUG HYPERSENSITIVITY,4
DE,EAR NEOPLASM MALIGNANT,4
DE,ECTOPIC KIDNEY,4
DE,EMBOLIC CEREBRAL INFARCTION,4
DE,ENCEPHALOPATHY,4
DE,EPENDYMOMA MALIGNANT,4
DE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,4
DE,ERYTHEMA MIGRANS,4
DE,EYE INFLAMMATION,4
DE,FEELING ABNORMAL,4
DE,FIBRIN D DIMER INCREASED,4
DE,FOREARM FRACTURE,4
DE,FUNGAL SEPSIS,4
DE,FURUNCLE,4
DE,GASTROINTESTINAL DISORDER,4
DE,GASTROOESOPHAGEAL REFLUX DISEASE,4
DE,GASTROSCHISIS,4
DE,GINGIVAL BLEEDING,4
DE,GLOMERULAR FILTRATION RATE DECREASED,4
DE,HAEMATOCHEZIA,4
DE,HEAD DISCOMFORT,4
DE,HEARING IMPAIRED,4
DE,HEPATIC CYST,4
DE,HEPATIC LESION,4
DE,HEPATITIS,4
DE,HEPATOSPLENOMEGALY,4
DE,HOLOPROSENCEPHALY,4
DE,HUMERUS FRACTURE,4
DE,HYPERBILIRUBINAEMIA,4
DE,ILEUS PARALYTIC,4
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
DE,INCORRECT DOSE ADMINISTERED,4
DE,INTESTINAL STENOSIS,4
DE,INVASIVE DUCTAL BREAST CARCINOMA,4
DE,IRON DEFICIENCY ANAEMIA,4
DE,JOINT INJURY,4
DE,LACRIMATION INCREASED,4
DE,LEUKAEMIA RECURRENT,4
DE,LISTLESS,4
DE,LIVER INJURY,4
DE,LUNG NEOPLASM MALIGNANT,4
DE,MELANOMA RECURRENT,4
DE,MENISCUS OPERATION,4
DE,MENTAL DISORDER,4
DE,METASTATIC RENAL CELL CARCINOMA,4
DE,MITRAL VALVE DISEASE,4
DE,MYELOPATHY,4
DE,MYOCARDIAL ISCHAEMIA,4
DE,MYOCARDIAL NECROSIS MARKER INCREASED,4
DE,MYOCARDITIS,4
DE,MYOSITIS,4
DE,NEOPLASM MALIGNANT,4
DE,NEPHRITIC SYNDROME,4
DE,NEURALGIA,4
DE,NEUROLOGICAL SYMPTOM,4
DE,NIGHT SWEATS,4
DE,NOCTURIA,4
DE,OBSTRUCTIVE AIRWAYS DISORDER,4
DE,OLIGURIA,4
DE,OMENTAL NECROSIS,4
DE,OPHTHALMIC HERPES ZOSTER,4
DE,ORAL DISORDER,4
DE,OROPHARYNGEAL DISCOLOURATION,4
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
DE,PANCREATIC CALCIFICATION,4
DE,PANCREATIC DUCT STENOSIS,4
DE,PANCREATIC MASS,4
DE,PANCREATITIS CHRONIC,4
DE,PARESIS,4
DE,PHARYNGITIS,4
DE,PNEUMONITIS CHEMICAL,4
DE,PNEUMOTHORAX,4
DE,POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME,4
DE,PRE-ECLAMPSIA,4
DE,PSEUDARTHROSIS,4
DE,PSOAS ABSCESS,4
DE,PULMONARY HAEMORRHAGE,4
DE,PULMONARY HYPERTENSION,4
DE,PULMONARY TUBERCULOSIS,4
DE,PURULENCE,4
DE,QUADRIPARESIS,4
DE,RECTAL HAEMORRHAGE,4
DE,RENAL APLASIA,4
DE,RENAL PAIN,4
DE,RESPIRATORY DISORDER,4
DE,RESPIRATORY DISTRESS,4
DE,RHEUMATOID FACTOR INCREASED,4
DE,SCLERAL DISORDER,4
DE,SENSORY DISTURBANCE,4
DE,SJOGREN^S SYNDROME,4
DE,SKIN MASS,4
DE,SKIN NECROSIS,4
DE,SLEEP APNOEA SYNDROME,4
DE,SMALL CELL LUNG CANCER,4
DE,STAPHYLOCOCCUS TEST POSITIVE,4
DE,STENT PLACEMENT,4
DE,SUICIDAL IDEATION,4
DE,SYMBLEPHARON,4
DE,TACHYARRHYTHMIA,4
DE,TENDONITIS,4
DE,THORACIC VERTEBRAL FRACTURE,4
DE,TOOTHACHE,4
DE,TREMOR,4
DE,TRICUSPID VALVE INCOMPETENCE,4
DE,TUBERCULOSIS,4
DE,URINARY RETENTION,4
DE,UTERINE LEIOMYOMA,4
DE,UTERINE POLYP,4
DE,VERTIGO POSITIONAL,4
DE,VESTIBULAR DISORDER,4
DE,WHITE BLOOD CELL COUNT INCREASED,4
DE,ABORTION MISSED,3
DE,ACCESSORY AURICLE,3
DE,ACCIDENT,3
DE,ACCIDENTAL POISONING,3
DE,ACNE,3
DE,ACUTE HEPATIC FAILURE,3
DE,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,3
DE,ADRENOCORTICAL CARCINOMA,3
DE,ADVERSE DRUG REACTION,3
DE,AGGRESSION,3
DE,ALLERGIC OEDEMA,3
DE,AMNESIA,3
DE,ANAEMIA POSTOPERATIVE,3
DE,ANAL HAEMORRHAGE,3
DE,ANGIOPATHY,3
DE,ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ANTIBODIES POSITIVE,3
DE,ANTINUCLEAR ANTIBODY POSITIVE,3
DE,AORTIC DILATATION,3
DE,AORTIC STENOSIS,3
DE,APHTHOUS STOMATITIS,3
DE,APHTHOUS ULCER,3
DE,ARTHROSCOPY,3
DE,ATRIOVENTRICULAR SEPTAL DEFECT,3
DE,BACTERIAL INFECTION,3
DE,BLISTER,3
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,3
DE,BLOOD BILIRUBIN ABNORMAL,3
DE,BLOOD TRIGLYCERIDES INCREASED,3
DE,BLOOD URINE PRESENT,3
DE,BREAST MASS,3
DE,BUNDLE BRANCH BLOCK LEFT,3
DE,BURNS SECOND DEGREE,3
DE,CARDIAC FAILURE CONGESTIVE,3
DE,CARDIAC VALVE DISEASE,3
DE,CARTILAGE INJURY,3
DE,CATARACT CONGENITAL,3
DE,CEREBELLAR SYNDROME,3
DE,CHOLECYSTECTOMY,3
DE,CHROMATURIA,3
DE,CHROMOSOMAL DELETION,3
DE,CLOSTRIDIUM DIFFICILE COLITIS,3
DE,CLOSTRIDIUM DIFFICILE INFECTION,3
DE,COLON ADENOMA,3
DE,CONCUSSION,3
DE,CONFUSIONAL STATE,3
DE,CONGENITAL SCOLIOSIS,3
DE,CONTUSION,3
DE,CORONARY ARTERIAL STENT INSERTION,3
DE,CORONARY ARTERY STENOSIS,3
DE,CYSTITIS NONINFECTIVE,3
DE,CYSTOID MACULAR OEDEMA,3
DE,DEAFNESS CONGENITAL,3
DE,DEAFNESS UNILATERAL,3
DE,DEMYELINATION,3
DE,DIABETIC FOOT INFECTION,3
DE,DIARRHOEA HAEMORRHAGIC,3
DE,DIPLOPIA,3
DE,DISCOMFORT,3
DE,DIVERTICULUM,3
DE,DRUG ERUPTION,3
DE,DUODENITIS,3
DE,DYSMORPHISM,3
DE,EJECTION FRACTION DECREASED,3
DE,ELECTROCARDIOGRAM T WAVE INVERSION,3
DE,EOSINOPHILIC PNEUMONIA,3
DE,ESCHERICHIA INFECTION,3
DE,EXOMPHALOS,3
DE,EXOSTOSIS,3
DE,EXPOSURE VIA PARTNER,3
DE,FEELING COLD,3
DE,FEMUR FRACTURE,3
DE,FLANK PAIN,3
DE,FOLATE DEFICIENCY,3
DE,FOLLICULITIS,3
DE,FOOD INTOLERANCE,3
DE,GALLBLADDER DISORDER,3
DE,GASTRIC CYST,3
DE,GASTRIC MUCOSA ERYTHEMA,3
DE,GASTRIC ULCER HAEMORRHAGE,3
DE,GASTRITIS BACTERIAL,3
DE,GENITAL INFECTION FUNGAL,3
DE,GRAFT VERSUS HOST DISEASE,3
DE,GROIN ABSCESS,3
DE,GUILLAIN-BARRE SYNDROME,3
DE,HAEMANGIOMA,3
DE,HAEMARTHROSIS,3
DE,HAND DEFORMITY,3
DE,HAND FRACTURE,3
DE,HERPES SIMPLEX,3
DE,HOSPITALISATION,3
DE,HYPERKALAEMIA,3
DE,HYPERTHYROIDISM,3
DE,HYPOCALCAEMIA,3
DE,HYPOCHROMIC ANAEMIA,3
DE,HYPOFIBRINOGENAEMIA,3
DE,HYPOTONIA NEONATAL,3
DE,HYSTERECTOMY,3
DE,INFECTIOUS PLEURAL EFFUSION,3
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,3
DE,INSOMNIA,3
DE,INTESTINAL ISCHAEMIA,3
DE,INTESTINAL PERFORATION,3
DE,IRIDOCYCLITIS,3
DE,IRIS ADHESIONS,3
DE,ISCHAEMIA,3
DE,ISCHAEMIC CARDIOMYOPATHY,3
DE,ISCHAEMIC STROKE,3
DE,KETOACIDOSIS,3
DE,LARGE FOR DATES BABY,3
DE,LATENT TUBERCULOSIS,3
DE,LEFT VENTRICULAR HYPERTROPHY,3
DE,LEUKOCYTOSIS,3
DE,LIPASE INCREASED,3
DE,LOCALISED INFECTION,3
DE,LOWER LIMB FRACTURE,3
DE,LUNG ADENOCARCINOMA,3
DE,LUNG INFECTION,3
DE,LYMPHANGITIS,3
DE,MEMORY IMPAIRMENT,3
DE,MENINGITIS,3
DE,MENINGOMYELOCELE,3
DE,METABOLIC ACIDOSIS,3
DE,METATARSALGIA,3
DE,MOTOR DYSFUNCTION,3
DE,MOUTH ULCERATION,3
DE,MOVEMENT DISORDER,3
DE,MULTIPLE SCLEROSIS,3
DE,MUSCLE ATROPHY,3
DE,NASAL POLYPS,3
DE,NEOPLASM,3
DE,NEUROENDOCRINE CARCINOMA METASTATIC,3
DE,NEUROMYELITIS OPTICA SPECTRUM DISORDER,3
DE,NEUTROPENIC INFECTION,3
DE,NON-HODGKIN^S LYMPHOMA RECURRENT,3
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
DE,OESOPHAGEAL SQUAMOUS CELL CARCINOMA STAGE III,3
DE,OLIGODENDROGLIOMA,3
DE,ORAL CANDIDIASIS,3
DE,ORTHOSTATIC INTOLERANCE,3
DE,OSTEOPOROTIC FRACTURE,3
DE,OTITIS MEDIA,3
DE,OVARIAN CYST,3
DE,PAIN OF SKIN,3
DE,PANCREATIC INJURY,3
DE,PANCREATIC STEATOSIS,3
DE,PANIC ATTACK,3
DE,PARTIAL SEIZURES,3
DE,PATELLA FRACTURE,3
DE,PELVI-URETERIC OBSTRUCTION,3
DE,PILONIDAL CYST,3
DE,PLASMA CELL MYELOMA,3
DE,POST PROCEDURAL INFECTION,3
DE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
DE,POSTOPERATIVE ABSCESS,3
DE,PREMATURE DELIVERY,3
DE,PREMATURE LABOUR,3
DE,PREMATURE RUPTURE OF MEMBRANES,3
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
DE,PULMONARY ARTERY STENOSIS CONGENITAL,3
DE,PULMONARY GRANULOMA,3
DE,PULMONARY TOXICITY,3
DE,PYELOCALIECTASIS,3
DE,PYOPNEUMOTHORAX,3
DE,RADICULOPATHY,3
DE,RASH GENERALISED,3
DE,RAYNAUD^S PHENOMENON,3
DE,REACTIVE GASTROPATHY,3
DE,RECTAL CANCER,3
DE,RED BLOOD CELL COUNT DECREASED,3
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
DE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
DE,RIGHT VENTRICULAR FAILURE,3
DE,ROAD TRAFFIC ACCIDENT,3
DE,ROTAVIRUS INFECTION,3
DE,SENSATION OF FOREIGN BODY,3
DE,SEROMA,3
DE,SERUM FERRITIN INCREASED,3
DE,SKIN DISCOLOURATION,3
DE,SKIN EROSION,3
DE,SKIN EXFOLIATION,3
DE,SKIN NEOPLASM EXCISION,3
DE,SOFT TISSUE INFECTION,3
DE,SOFT TISSUE INJURY,3
DE,SPINAL INSTABILITY,3
DE,SPONDYLITIS,3
DE,STEVENS-JOHNSON SYNDROME,3
DE,STREPTOCOCCAL INFECTION,3
DE,SUPRAVENTRICULAR TACHYCARDIA,3
DE,SWELLING FACE,3
DE,TEMPORAL ARTERITIS,3
DE,TENDON DISORDER,3
DE,THERAPEUTIC RESPONSE SHORTENED,3
DE,THERMAL BURN,3
DE,THYROID DISORDER,3
DE,THYROID NEOPLASM,3
DE,TONGUE COATED,3
DE,TOXIC EPIDERMAL NECROLYSIS,3
DE,TREATMENT FAILURE,3
DE,TROPONIN INCREASED,3
DE,UMBILICAL HERNIA,3
DE,URINARY TRACT DISORDER,3
DE,URINARY TRACT INFECTION ENTEROCOCCAL,3
DE,UTERINE HAEMORRHAGE,3
DE,VARICES OESOPHAGEAL,3
DE,VENOUS THROMBOSIS LIMB,3
DE,VESTIBULAR NEURONITIS,3
DE,WOUND DEHISCENCE,3
DE,WOUND INFECTION BACTERIAL,3
DE,ABDOMINAL RIGIDITY,2
DE,ABDOMINAL WALL HAEMATOMA,2
DE,ABORTION,2
DE,ACCIDENTAL EXPOSURE TO PRODUCT,2
DE,ACQUIRED CLAW TOE,2
DE,ACUTE HEPATITIS B,2
DE,ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION),2
DE,ACUTE TONSILLITIS,2
DE,ADRENOCORTICAL INSUFFICIENCY ACUTE,2
DE,ALTERED STATE OF CONSCIOUSNESS,2
DE,AMENORRHOEA,2
DE,ANAL ATRESIA,2
DE,ANAL FISSURE,2
DE,ANAPHYLACTIC SHOCK,2
DE,ANOGENITAL WARTS,2
DE,ANORECTAL AGENESIS,2
DE,ANTINUCLEAR ANTIBODY INCREASED,2
DE,AORTIC DISSECTION,2
DE,AORTIC VALVE STENOSIS,2
DE,AREFLEXIA,2
DE,ARTERIAL OCCLUSIVE DISEASE,2
DE,ARTERIOGRAM CORONARY,2
DE,ARTHROPOD STING,2
DE,ASTHENOPIA,2
DE,ATRIOVENTRICULAR BLOCK COMPLETE,2
DE,BEDRIDDEN,2
DE,BILE DUCT CANCER STAGE II,2
DE,BLADDER NEOPLASM,2
DE,BLEPHARITIS,2
DE,BLOOD CALCIUM INCREASED,2
DE,BLOOD CHOLINESTERASE INCREASED,2
DE,BLOOD IRON DECREASED,2
DE,BLOOD POTASSIUM INCREASED,2
DE,BLOOD PRESSURE ABNORMAL,2
DE,BLOOD PRESSURE FLUCTUATION,2
DE,BLOOD UREA INCREASED,2
DE,BONE INFARCTION,2
DE,BONE MARROW TOXICITY,2
DE,BONE PAIN,2
DE,BORRELIA INFECTION,2
DE,BREAST ABSCESS,2
DE,BREAST CANCER FEMALE,2
DE,BRONCHIECTASIS,2
DE,BRONCHOSPASM,2
DE,BUNION OPERATION,2
DE,BURKITT^S LYMPHOMA STAGE IV,2
DE,BURNING SENSATION,2
DE,CAESAREAN SECTION,2
DE,CALCIPHYLAXIS,2
DE,CALCULUS URETERIC,2
DE,CANDIDA SEPSIS,2
DE,CARDIAC DEATH,2
DE,CARDIAC FLUTTER,2
DE,CARDIOVASCULAR INSUFFICIENCY,2
DE,CARDITIS,2
DE,CAROTID ARTERIOSCLEROSIS,2
DE,CENTRAL NERVOUS SYSTEM FUNGAL INFECTION,2
DE,CEREBELLAR INFARCTION,2
DE,CEREBRAL ASPERGILLOSIS,2
DE,CEREBRAL HYPOPERFUSION,2
DE,CEREBRAL MICROANGIOPATHY,2
DE,CERVICAL SPINAL STENOSIS,2
DE,CERVIX CARCINOMA,2
DE,CHOLANGITIS INFECTIVE,2
DE,CHOLECYSTITIS ACUTE,2
DE,CHONDROPATHY,2
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
DE,CHRONIC RESPIRATORY FAILURE,2
DE,CHRONIC SINUSITIS,2
DE,CLOSTRIDIUM COLITIS,2
DE,COELIAC ARTERY COMPRESSION SYNDROME,2
DE,COGNITIVE DISORDER,2
DE,COLD SWEAT,2
DE,COLON CANCER METASTATIC,2
DE,COLON NEOPLASM,2
DE,COLONIC ABSCESS,2
DE,COMA,2
DE,COMPLEX REGIONAL PAIN SYNDROME,2
DE,CONGENITAL DIAPHRAGMATIC HERNIA,2
DE,CONGENITAL NEUROLOGICAL DISORDER,2
DE,CONGENITAL PULMONARY HYPERTENSION,2
DE,CONNECTIVE TISSUE DISORDER,2
DE,CORONA VIRUS INFECTION,2
DE,CORONARY ARTERY BYPASS,2
DE,CORONARY ARTERY OCCLUSION,2
DE,CUBITAL TUNNEL SYNDROME,2
DE,CYTOPENIA,2
DE,DEBRIDEMENT,2
DE,DELIRIUM,2
DE,DERMAL CYST,2
DE,DERMATITIS BULLOUS,2
DE,DEVICE MALFUNCTION,2
DE,DIFFUSE LARGE B-CELL LYMPHOMA STAGE III,2
DE,DOUBLE STRANDED DNA ANTIBODY POSITIVE,2
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
DE,DRUG RESISTANCE,2
DE,DRUG SPECIFIC ANTIBODY PRESENT,2
DE,DRUG WITHDRAWAL SYNDROME,2
DE,DRY SKIN,2
DE,DUODENAL ULCER,2
DE,DYSAESTHESIA,2
GR,FEBRILE NEUTROPENIA,16
GR,PYREXIA,14
GR,DRUG INEFFECTIVE,13
GR,MALIGNANT NEOPLASM PROGRESSION,12
GR,URINARY TRACT INFECTION,11
GR,BREAST CANCER,10
GR,DYSPNOEA,10
GR,PAIN,10
GR,PSORIASIS,10
GR,RESPIRATORY TRACT INFECTION,9
GR,CONDITION AGGRAVATED,8
GR,DISEASE PROGRESSION,8
GR,FALL,8
GR,HYPERTENSION,8
GR,PSORIATIC ARTHROPATHY,8
GR,EPSTEIN-BARR VIRUS INFECTION,7
GR,VISCERAL LEISHMANIASIS,7
GR,BLOOD PRESSURE INCREASED,6
GR,BONE MARROW OEDEMA,6
GR,C-REACTIVE PROTEIN INCREASED,6
GR,HYPOAESTHESIA,6
GR,IMMOBILE,6
GR,JOINT EFFUSION,6
GR,METASTASES TO LIVER,6
GR,OSTEONECROSIS OF JAW,6
GR,OSTEOPOROTIC FRACTURE,6
GR,PAIN IN EXTREMITY,6
GR,PLATELET COUNT DECREASED,6
GR,RASH,6
GR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,6
GR,SACROILIITIS,6
GR,WHITE BLOOD CELL COUNT DECREASED,6
GR,HAEMATOCRIT DECREASED,5
GR,HEADACHE,5
GR,HEPATIC ENZYME INCREASED,5
GR,HYPERSENSITIVITY,5
GR,METASTASES TO BONE,5
GR,NEUTROPENIA,5
GR,OEDEMA PERIPHERAL,5
GR,PANCYTOPENIA,5
GR,PRODUCT USE IN UNAPPROVED INDICATION,5
GR,SQUAMOUS CELL CARCINOMA,5
GR,BACK PAIN,4
GR,BLOOD CREATININE INCREASED,4
GR,BONE MARROW TOXICITY,4
GR,CHEST PAIN,4
GR,DIARRHOEA,4
GR,DISEASE RECURRENCE,4
GR,DIZZINESS,4
GR,FATIGUE,4
GR,HEPATIC STEATOSIS,4
GR,HISTIOCYTOSIS HAEMATOPHAGIC,4
GR,INFECTION,4
GR,INVASIVE DUCTAL BREAST CARCINOMA,4
GR,LEUKOPENIA,4
GR,LOWER RESPIRATORY TRACT INFECTION,4
GR,LYMPHADENOPATHY,4
GR,MYCOSIS FUNGOIDES STAGE I,4
GR,OSTEOPOROSIS,4
GR,PLATELET COUNT INCREASED,4
GR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
GR,PRODUCT USE ISSUE,4
GR,RHEUMATOID ARTHRITIS,4
GR,THERAPEUTIC RESPONSE DECREASED,4
GR,THROMBOCYTOPENIA,4
GR,VOMITING,4
GR,ACUTE LYMPHOCYTIC LEUKAEMIA,3
GR,ACUTE MYELOMONOCYTIC LEUKAEMIA,3
GR,ARTHRITIS,3
GR,ATAXIA,3
GR,BACTERIAL SEPSIS,3
GR,BREAST CANCER METASTATIC,3
GR,COUGH,3
GR,CROHN^S DISEASE,3
GR,DECREASED APPETITE,3
GR,DIABETES MELLITUS,3
GR,GAIT DISTURBANCE,3
GR,HAEMATOMA,3
GR,HEPATOTOXICITY,3
GR,INTERSTITIAL LUNG DISEASE,3
GR,LEISHMANIASIS,3
GR,LUNG NEOPLASM MALIGNANT,3
GR,LUPUS NEPHRITIS,3
GR,LYMPHOMA,3
GR,MALAISE,3
GR,METASTASES TO CHEST WALL,3
GR,METASTASES TO LUNG,3
GR,MYELODYSPLASTIC SYNDROME,3
GR,OSTEONECROSIS,3
GR,PANCREATITIS ACUTE,3
GR,PNEUMONIA,3
GR,PRURITUS,3
GR,RADICULOPATHY,3
GR,RESPIRATORY FAILURE,3
GR,SEIZURE,3
GR,SEPSIS,3
GR,SKIN MASS,3
GR,TRANSAMINASES INCREASED,3
GR,ABASIA,2
GR,ABDOMINAL PAIN,2
GR,ABDOMINAL PAIN UPPER,2
GR,ABORTION INDUCED,2
GR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,2
GR,ANURIA,2
GR,ARTHRALGIA,2
GR,ARTHROPATHY,2
GR,ASTHENOPIA,2
GR,AUTOIMMUNE HEPATITIS,2
GR,BLOOD LACTATE DEHYDROGENASE INCREASED,2
GR,BLOOD PRESSURE ABNORMAL,2
GR,CARDIAC DISORDER,2
GR,CARDIAC FAILURE,2
GR,DACTYLITIS,2
GR,DEATH,2
GR,DERMATITIS EXFOLIATIVE,2
GR,DRUG DOSE OMISSION,2
GR,DRUG INTOLERANCE,2
GR,DRUG RESISTANCE,2
GR,DUODENAL FISTULA,2
GR,EXPOSURE DURING PREGNANCY,2
GR,GASTROINTESTINAL DISORDER,2
GR,GINGIVAL HYPERPLASIA,2
GR,GUILLAIN-BARRE SYNDROME,2
GR,HAEMOGLOBIN DECREASED,2
GR,HAEMOLYSIS,2
GR,HEAD DISCOMFORT,2
GR,HEPATOSPLENOMEGALY,2
GR,HODGKIN^S DISEASE,2
GR,HYPERCALCAEMIA,2
GR,HYPERGAMMAGLOBULINAEMIA,2
GR,HYPOREFLEXIA,2
GR,ILL-DEFINED DISORDER,2
GR,INVASIVE BREAST CARCINOMA,2
GR,IRIDOCYCLITIS,2
GR,LEUKAEMIA RECURRENT,2
GR,LIMB INJURY,2
GR,LUNG DISORDER,2
GR,LUNG INFECTION,2
GR,METASTASES TO LYMPH NODES,2
GR,METASTASES TO SKIN,2
GR,MICROLITHIASIS,2
GR,MULTIPLE SCLEROSIS,2
GR,MUSCULAR WEAKNESS,2
GR,MUSCULOSKELETAL PAIN,2
GR,NAUSEA,2
GR,NEOPLASM MALIGNANT,2
GR,NEPHROLITHIASIS,2
GR,NEUROPATHY PERIPHERAL,2
GR,NEUTROPHIL COUNT DECREASED,2
GR,NO THERAPEUTIC RESPONSE,2
GR,OESTROGEN RECEPTOR POSITIVE BREAST CANCER,2
GR,OVARIAN CYST,2
GR,PARESIS,2
GR,PERIPHERAL SENSORY NEUROPATHY,2
GR,PROSTATE CANCER,2
GR,PROTEINURIA,2
GR,PSEUDOMONAL SEPSIS,2
GR,PULMONARY EMBOLISM,2
GR,RECURRENT CANCER,2
GR,RENAL CANCER,2
GR,RESPIRATORY DISTRESS,2
GR,SERRATIA SEPSIS,2
GR,STOMATITIS,2
GR,TACHYCARDIA,2
GR,TOXICITY TO VARIOUS AGENTS,2
GR,TRANSIENT ISCHAEMIC ATTACK,2
GR,TUBERCULOSIS,2
GR,TUMOUR LYSIS SYNDROME,2
GR,UPPER RESPIRATORY TRACT INFECTION,2
GR,VERTEBRAL COLUMN MASS,2
GR,VERTIGO,2
GR,WEIGHT DECREASED,2
GR,ACCIDENTAL OVERDOSE,1
GR,ACNE,1
GR,ACUTE MYOCARDIAL INFARCTION,1
GR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
GR,ADVERSE EVENT,1
GR,AEROMONAS INFECTION,1
GR,ALBUMIN CSF INCREASED,1
GR,ALLERGY TO ARTHROPOD STING,1
GR,ALOPECIA,1
GR,ALPHA-2 MACROGLOBULIN INCREASED,1
GR,ANAEMIA,1
GR,ANAL FISSURE,1
GR,ANAPHYLACTIC REACTION,1
GR,ANGIOEDEMA,1
GR,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
GR,ANGIOPATHY,1
GR,ANTINUCLEAR ANTIBODY POSITIVE,1
GR,APLASTIC ANAEMIA,1
GR,ASPERGILLUS INFECTION,1
GR,ASTHENIA,1
GR,ATYPICAL FEMUR FRACTURE,1
GR,B-CELL LYMPHOMA,1
GR,BACTERAEMIA,1
GR,BACTERIAL INFECTION,1
GR,BASAL CELL CARCINOMA,1
GR,BENIGN INTRACRANIAL HYPERTENSION,1
GR,BLOOD ALBUMIN DECREASED,1
GR,BLOOD BILIRUBIN INCREASED,1
GR,BLOOD CALCIUM ABNORMAL,1
GR,BLOOD CHOLESTEROL INCREASED,1
GR,BLOOD GLUCOSE DECREASED,1
GR,BLOOD IRON DECREASED,1
GR,BLOOD POTASSIUM DECREASED,1
GR,BLOOD SODIUM DECREASED,1
GR,BLOOD URIC ACID INCREASED,1
GR,BONE MARROW LEUKAEMIC CELL INFILTRATION,1
GR,BRAIN NEOPLASM BENIGN,1
GR,BREAST CANCER RECURRENT,1
GR,BREAST MASS,1
GR,BRONCHIECTASIS,1
GR,BRONCHOSPASM,1
GR,BUTTERFLY RASH,1
GR,CARCINOID TUMOUR PULMONARY,1
GR,CARDIAC ARREST,1
GR,CARDIAC MURMUR,1
GR,CATARACT,1
GR,CELLULITIS,1
GR,CEREBELLAR TUMOUR,1
GR,CEREBRAL ARTERY THROMBOSIS,1
GR,CEREBRAL ASPERGILLOSIS,1
GR,CEREBRAL VENOUS THROMBOSIS,1
GR,CEREBROVASCULAR ACCIDENT,1
GR,CERVICAL MYELOPATHY,1
GR,CHILLS,1
GR,CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS,1
GR,CHRONIC HEPATITIS,1
GR,CHRONIC MYELOID LEUKAEMIA,1
GR,CLEAR CELL RENAL CELL CARCINOMA,1
GR,COLECTOMY,1
GR,COLITIS,1
GR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
GR,CONGENITAL HYDROCEPHALUS,1
GR,CONSTIPATION,1
GR,CONTUSION,1
GR,COORDINATION ABNORMAL,1
GR,CORONARY ARTERY DISEASE,1
GR,CRYING,1
GR,CSF CELL COUNT ABNORMAL,1
GR,CSF IMMUNOGLOBULIN INCREASED,1
GR,CSF TEST ABNORMAL,1
GR,CYSTITIS HAEMORRHAGIC,1
GR,CYTOMEGALOVIRUS TEST POSITIVE,1
GR,DEMENTIA,1
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GR,DERMATITIS ACNEIFORM,1
GR,DERMATOPATHIC LYMPHADENOPATHY,1
GR,DIFFUSE LARGE B-CELL LYMPHOMA,1
GR,DILATATION VENTRICULAR,1
GR,DISSEMINATED INTRAVASCULAR COAGULATION,1
GR,DRUG EFFECT INCOMPLETE,1
GR,DRUG HYPERSENSITIVITY,1
GR,DRUG TOLERANCE,1
GR,DRY MOUTH,1
GR,DYSPHAGIA,1
GR,DYSPHONIA,1
GR,DYSPNOEA EXERTIONAL,1
GR,EAR PAIN,1
GR,EATING DISORDER,1
GR,ECTOPIC PREGNANCY,1
GR,ENDOCARDITIS BACTERIAL,1
GR,ENDOMETRIOSIS,1
GR,EPIDIDYMITIS,1
GR,EPILEPSY,1
GR,ERYSIPELAS,1
GR,ERYTHRODERMIC PSORIASIS,1
GR,ESCHERICHIA INFECTION,1
GR,EYE DISORDER,1
GR,EYE PAIN,1
GR,FAECALOMA,1
GR,FALLOPIAN TUBE CYST,1
GR,FEELING OF BODY TEMPERATURE CHANGE,1
GR,FLUSHING,1
GR,FOLLICULAR THYROID CANCER,1
GR,GAIT INABILITY,1
GR,GASTRIC PERFORATION,1
GR,GASTROINTESTINAL CARCINOMA,1
GR,GASTROINTESTINAL HAEMORRHAGE,1
GR,GASTROINTESTINAL INFLAMMATION,1
GR,GENERAL PHYSICAL HEALTH DETERIORATION,1
GR,GENERALISED TONIC-CLONIC SEIZURE,1
GR,GLAUCOMA,1
GR,GLOMERULONEPHRITIS,1
GR,GYNAECOMASTIA,1
GR,HAEMATOCHEZIA,1
GR,HAEMATURIA,1
GR,HAEMOGLOBIN ABNORMAL,1
GR,HEMIPARESIS,1
GR,HEPATIC FIBROSIS,1
GR,HEPATITIS B,1
GR,HEPATOCELLULAR CARCINOMA,1
GR,HEPATOMEGALY,1
GR,HER-2 POSITIVE BREAST CANCER,1
GR,HERNIA,1
GR,HISTOPLASMOSIS,1
GR,HODGKIN^S DISEASE MIXED CELLULARITY STAGE III,1
GR,HODGKIN^S DISEASE MIXED CELLULARITY STAGE UNSPECIFIED,1
GR,HYDROCEPHALUS,1
GR,HYPERAMYLASAEMIA,1
GR,HYPOCAPNIA,1
GR,HYPOCHROMIC ANAEMIA,1
GR,HYPOGAMMAGLOBULINAEMIA,1
GR,HYPONATRAEMIA,1
GR,HYPOPHAGIA,1
GR,HYPOPHARYNGEAL NEOPLASM,1
GR,HYPORESPONSIVE TO STIMULI,1
GR,HYPOTONIA,1
GR,HYPOXIA,1
GR,ILEAL STENOSIS,1
GR,ILEUS PARALYTIC,1
GR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
GR,IMMUNE THROMBOCYTOPENIC PURPURA,1
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
GR,INCORRECT DOSE ADMINISTERED,1
GR,INFECTIOUS MONONUCLEOSIS,1
GR,INFLAMMATION,1
GR,INJECTION SITE ERYTHEMA,1
GR,INJECTION SITE HYPERSENSITIVITY,1
GR,INJECTION SITE OEDEMA,1
GR,INTERVERTEBRAL DISC PROTRUSION,1
GR,INTERVERTEBRAL DISCITIS,1
GR,INTESTINAL TUBERCULOSIS,1
GR,INTRACRANIAL PRESSURE INCREASED,1
GR,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
GR,IRRITABILITY,1
GR,JUGULAR VEIN DISTENSION,1
GR,LARYNGEAL OEDEMA,1
GR,LARYNGITIS,1
GR,LEFT ATRIAL DILATATION,1
GR,LEUKOENCEPHALOPATHY,1
GR,LIMB IMMOBILISATION,1
GR,LIVER FUNCTION TEST ABNORMAL,1
GR,LIVER PALPABLE,1
GR,LOSS OF CONSCIOUSNESS,1
GR,LOW DENSITY LIPOPROTEIN INCREASED,1
GR,LUNG ADENOCARCINOMA,1
GR,LUNG CANCER METASTATIC,1
GR,LYMPHANGITIS,1
GR,LYMPHOPENIA,1
GR,MAJOR DEPRESSION,1
GR,MALIGNANT MELANOMA,1
GR,MASS,1
GR,MATERNAL EXPOSURE BEFORE PREGNANCY,1
GR,MEMORY IMPAIRMENT,1
GR,MENINGITIS TUBERCULOUS,1
GR,MENORRHAGIA,1
GR,MERALGIA PARAESTHETICA,1
GR,METABOLIC ACIDOSIS,1
GR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GR,METASTASES TO MENINGES,1
GR,METASTATIC NEOPLASM,1
GR,MOLLUSCUM CONTAGIOSUM,1
GR,MOUTH ULCERATION,1
GR,MUCOSAL INFLAMMATION,1
GR,MULTIPLE FRACTURES,1
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GR,MYCOBACTERIAL INFECTION,1
GR,MYELODYSPLASTIC SYNDROME TRANSFORMATION,1
GR,MYELOFIBROSIS,1
GR,MYOCARDITIS,1
GR,MYOPATHY,1
GR,NAIL DISORDER,1
GR,NAIL PSORIASIS,1
GR,NECROSIS,1
GR,NERVOUS SYSTEM DISORDER,1
GR,NEUTROPHIL COUNT ABNORMAL,1
GR,NIPPLE PAIN,1
GR,NON-HODGKIN^S LYMPHOMA,1
GR,OCULAR HYPERAEMIA,1
GR,OEDEMA,1
GR,OLIGURIA,1
GR,ORAL DISORDER,1
GR,ORGAN FAILURE,1
GR,OROPHARYNGEAL PAIN,1
GR,OSTEOARTHRITIS,1
GR,OSTEOLYSIS,1
GR,OSTEOPENIA,1
GR,OTITIS MEDIA ACUTE,1
GR,PALPITATIONS,1
GR,PANCREATITIS,1
GR,PAPILLARY THYROID CANCER,1
GR,PARASPINAL ABSCESS,1
GR,PERICARDITIS TUBERCULOUS,1
GR,PHARYNGEAL DISORDER,1
GR,PLATELET COUNT ABNORMAL,1
GR,POLYDIPSIA,1
GR,POLYURIA,1
GR,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA,1
GR,PROCTALGIA,1
GR,PRODUCTIVE COUGH,1
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
GR,PROTEIN TOTAL INCREASED,1
GR,PSEUDOMONAS INFECTION,1
GR,PSEUDOMONAS TEST POSITIVE,1
GR,PULMONARY TUBERCULOSIS,1
GR,PUSTULAR PSORIASIS,1
GR,PYOMYOSITIS,1
GR,RALES,1
GR,RASH GENERALISED,1
GR,RECTAL ADENOCARCINOMA,1
GR,RENAL CANCER METASTATIC,1
GR,RENAL DISORDER,1
GR,RENAL FAILURE,1
GR,RENAL IMPAIRMENT,1
GR,RENAL PAPILLARY NECROSIS,1
GR,ROAD TRAFFIC ACCIDENT,1
GR,SARCOIDOSIS,1
GR,SCIATICA,1
GR,SEPTIC SHOCK,1
GR,SINUSITIS,1
GR,SKIN CANCER,1
GR,SKIN EXFOLIATION,1
GR,SKIN REACTION,1
GR,SKIN ULCER,1
GR,SMALL INTESTINAL OBSTRUCTION,1
GR,SPLEEN PALPABLE,1
GR,SPLENOMEGALY,1
GR,STAPHYLOCOCCUS TEST POSITIVE,1
GR,STILL^S DISEASE ADULT ONSET,1
GR,STRESS,1
GR,SUBACUTE ENDOCARDITIS,1
GR,SUBCUTANEOUS ABSCESS,1
GR,SUICIDAL IDEATION,1
GR,SYNCOPE,1
GR,SYNOVITIS,1
GR,TACHYPNOEA,1
GR,THERAPEUTIC PRODUCT INEFFECTIVE,1
GR,THERAPY RESPONDER,1
GR,THYROID CANCER,1
GR,TINNITUS,1
GR,TONGUE ULCERATION,1
GR,TONSILLAR HYPERTROPHY,1
GR,TOOTH DISORDER,1
GR,TOOTH FRACTURE,1
GR,TOOTH HYPOPLASIA,1
GR,TREATMENT NONCOMPLIANCE,1
GR,TUMOUR MARKER INCREASED,1
GR,ULCERATIVE KERATITIS,1
GR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GR,URINARY SEDIMENT PRESENT,1
GR,UTERINE POLYP,1
GR,VASCULITIS,1
GR,VENOOCCLUSIVE LIVER DISEASE,1
GR,VISUAL ACUITY REDUCED,1
GR,VISUAL IMPAIRMENT,1
GR,VULVOVAGINAL MYCOTIC INFECTION,1
GR,VULVOVAGINAL PAIN,1
GR,WHITE BLOOD CELL COUNT INCREASED,1
GR,WHITE BLOOD CELL DISORDER,1
GU,ANAEMIA,1
GU,DEHYDRATION,1
GU,DERMATITIS ACNEIFORM,1
GU,FATIGUE,1
GU,HYPERCALCAEMIA,1
GU,MUCOSAL INFLAMMATION,1
GU,NO THERAPEUTIC RESPONSE,1
GU,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
GT,ABDOMINAL PAIN,1
GT,ABORTION SPONTANEOUS,1
GT,ESCHERICHIA INFECTION,1
GT,EXPOSURE DURING PREGNANCY,1
GT,FALL,1
GT,FOETAL DEATH,1
GT,LUNG NEOPLASM MALIGNANT,1
GT,PNEUMONIA,1
GT,URINARY TRACT DISORDER,1
GT,WOUND,1
HN,ABASIA,1
HN,DEMYELINATION,1
HN,LUNG INFECTION,1
HN,MIGRAINE,1
HN,PLEURAL EFFUSION,1
HN,RENAL NEOPLASM,1
HN,TREMOR,1
HN,TUBERCULIN TEST POSITIVE,1
HN,VOMITING,1
HK,DISEASE PROGRESSION,10
HK,APPENDICITIS,7
HK,PERITONITIS,7
HK,DISEASE RECURRENCE,6
HK,DIARRHOEA HAEMORRHAGIC,4
HK,DRUG INEFFECTIVE,4
HK,FEBRILE NEUTROPENIA,4
HK,GESTATIONAL TROPHOBLASTIC TUMOUR,4
HK,MUCOSAL INFLAMMATION,4
HK,PANCYTOPENIA,4
HK,PELVIC ABSCESS,4
HK,ABSCESS,3
HK,APPENDICITIS PERFORATED,3
HK,SUBCUTANEOUS ABSCESS,3
HK,HEPATIC FAILURE,2
HK,INFECTION,2
HK,NEUROPATHY PERIPHERAL,2
HK,PNEUMONIA,2
HK,RENAL FAILURE,2
HK,RESPIRATORY FAILURE,2
HK,SEPTIC SHOCK,2
HK,TOXICITY TO VARIOUS AGENTS,2
HK,ABORTION INDUCED,1
HK,ABSCESS BACTERIAL,1
HK,ACUTE GRAFT VERSUS HOST DISEASE,1
HK,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
HK,ACUTE KIDNEY INJURY,1
HK,ANGIOEDEMA,1
HK,AORTITIS SALMONELLA,1
HK,CACHEXIA,1
HK,CELLULITIS,1
HK,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
HK,CLOSTRIDIUM DIFFICILE INFECTION,1
HK,COLON CANCER,1
HK,CYTOMEGALOVIRUS CHORIORETINITIS,1
HK,CYTOMEGALOVIRUS INFECTION,1
HK,DEPRESSION,1
HK,DIARRHOEA,1
HK,DISSEMINATED TUBERCULOSIS,1
HK,DRUG RESISTANCE,1
HK,EMPYEMA,1
HK,ENCEPHALITIS CYTOMEGALOVIRUS,1
HK,FOETAL DEATH,1
HK,GENERAL PHYSICAL HEALTH DETERIORATION,1
HK,HEPATOSPLENOMEGALY,1
HK,HISTIOCYTOSIS HAEMATOPHAGIC,1
HK,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
HK,INFECTIVE ANEURYSM,1
HK,LOWER RESPIRATORY TRACT INFECTION,1
HK,LUNG INFECTION,1
HK,METABOLIC ACIDOSIS,1
HK,MYELOPATHY,1
HK,NEOPLASM MALIGNANT,1
HK,NEUTROPENIA,1
HK,NOROVIRUS TEST POSITIVE,1
HK,PEPTIC ULCER PERFORATION,1
HK,PITYRIASIS RUBRA PILARIS,1
HK,PNEUMOPERITONEUM,1
HK,POLYMYALGIA RHEUMATICA,1
HK,POOR VENOUS ACCESS,1
HK,PYREXIA,1
HK,RENAL FAILURE ACUTE,1
HK,SEPSIS,1
HK,SHOCK,1
HK,TUMOUR LYSIS SYNDROME,1
HK,VIRAL INFECTION,1
HU,DRUG INEFFECTIVE,7
HU,HEPATIC ENZYME INCREASED,6
HU,BENIGN PROSTATIC HYPERPLASIA,5
HU,DISEASE RECURRENCE,5
HU,DIZZINESS,5
HU,GRANULOMATOSIS WITH POLYANGIITIS,5
HU,HEPATITIS B,5
HU,PRODUCT USE IN UNAPPROVED INDICATION,5
HU,DIARRHOEA,4
HU,EPISCLERITIS,4
HU,GASTROINTESTINAL DISORDER,4
HU,OSTEOPOROSIS,4
HU,PNEUMONIA,4
HU,TESTICULAR ATROPHY,4
HU,THERAPY NON-RESPONDER,4
HU,VASCULITIS,4
HU,BONE MARROW TOXICITY,3
HU,GAIT DISTURBANCE,3
HU,HERPES ZOSTER,3
HU,INFECTION,3
HU,NEOPLASM RECURRENCE,3
HU,PANCYTOPENIA,3
HU,PNEUMONIA INFLUENZAL,3
HU,SEPSIS,3
HU,SEPTIC SHOCK,3
HU,THROMBOCYTOPENIA,3
HU,ABSCESS,2
HU,ANAL ABSCESS,2
HU,ATRIOVENTRICULAR BLOCK COMPLETE,2
HU,CARDIAC ARREST,2
HU,CARDIOMYOPATHY,2
HU,DYSPNOEA,2
HU,ELECTROCARDIOGRAM QT PROLONGED,2
HU,ENTEROCUTANEOUS FISTULA,2
HU,ESCHERICHIA SEPSIS,2
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
HU,JAUNDICE,2
HU,LEUKOPENIA,2
HU,MUSCULAR WEAKNESS,2
HU,NAUSEA,2
HU,OVERDOSE,2
HU,PAIN IN EXTREMITY,2
HU,PRODUCT USE ISSUE,2
HU,RHEUMATOID ARTHRITIS,2
HU,RHEUMATOID NODULE,2
HU,SKIN NECROSIS,2
HU,TORSADE DE POINTES,2
HU,UPPER RESPIRATORY TRACT INFECTION,2
HU,VENTRICULAR FIBRILLATION,2
HU,ABDOMINAL DISTENSION,1
HU,ABDOMINAL MASS,1
HU,ABDOMINAL PAIN,1
HU,ABDOMINAL PAIN UPPER,1
HU,ABORTION SPONTANEOUS,1
HU,ALANINE AMINOTRANSFERASE INCREASED,1
HU,ANAEMIA,1
HU,ANAL FISSURE,1
HU,ANAL FISTULA,1
HU,ANOGENITAL DYSPLASIA,1
HU,APLASIA,1
HU,APPENDICITIS,1
HU,ARTHRALGIA,1
HU,ARTHRITIS,1
HU,ASPARTATE AMINOTRANSFERASE INCREASED,1
HU,ASPERGILLUS INFECTION,1
HU,ASTHENIA,1
HU,ASTHMA,1
HU,AXILLARY PAIN,1
HU,B-CELL LYMPHOMA,1
HU,BASAL CELL CARCINOMA,1
HU,BIOPSY MUSCLE ABNORMAL,1
HU,BLISTER,1
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HU,BLOOD GLUCOSE INCREASED,1
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
HU,BODY TEMPERATURE INCREASED,1
HU,BONE MARROW FAILURE,1
HU,BRADYCARDIA,1
HU,BRAIN NATRIURETIC PEPTIDE INCREASED,1
HU,BRONCHOPNEUMONIA,1
HU,BRONCHOPULMONARY ASPERGILLOSIS,1
HU,CARDIAC FAILURE,1
HU,CARDIOMEGALY,1
HU,CARPAL TUNNEL SYNDROME,1
HU,CARTILAGE INJURY,1
HU,CATARRH,1
HU,CELLULITIS,1
HU,CEREBROVASCULAR ACCIDENT,1
HU,CHEST X-RAY ABNORMAL,1
HU,CHILLS,1
HU,COMPLEX REGIONAL PAIN SYNDROME,1
HU,CONDITION AGGRAVATED,1
HU,CONFUSIONAL STATE,1
HU,CUSHINGOID,1
HU,CUTANEOUS SYMPTOM,1
HU,DESMOID TUMOUR,1
HU,DISSEMINATED INTRAVASCULAR COAGULATION,1
HU,DIVERTICULUM INTESTINAL,1
HU,DYSGEUSIA,1
HU,DYSPHAGIA,1
HU,DYSPHONIA,1
HU,ECHOCARDIOGRAM ABNORMAL,1
HU,ECZEMA,1
HU,ENGRAFTMENT SYNDROME,1
HU,ENTERITIS LEUKOPENIC,1
HU,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,1
HU,ERYSIPELAS,1
HU,EXPOSURE DURING PREGNANCY,1
HU,EYE INFLAMMATION,1
HU,FEBRILE BONE MARROW APLASIA,1
HU,FEBRILE NEUTROPENIA,1
HU,FEMUR FRACTURE,1
HU,FOETAL EXPOSURE DURING PREGNANCY,1
HU,FOETAL GROWTH RESTRICTION,1
HU,GALLBLADDER DISORDER,1
HU,GASTROENTERITIS SALMONELLA,1
HU,GASTROINTESTINAL TOXICITY,1
HU,GLOMERULAR FILTRATION RATE INCREASED,1
HU,GRAFT COMPLICATION,1
HU,GRANULOCYTOPENIA,1
HU,GUILLAIN-BARRE SYNDROME,1
HU,HAEMATOCHEZIA,1
HU,HAEMOGLOBIN DECREASED,1
HU,HEPATIC CYST,1
HU,HEPATIC FUNCTION ABNORMAL,1
HU,HEPATIC STEATOSIS,1
HU,HEPATITIS B E ANTIGEN POSITIVE,1
HU,HEPATITIS C VIRUS TEST POSITIVE,1
HU,HEPATOMEGALY,1
HU,HERPES OPHTHALMIC,1
HU,HYPERSENSITIVITY,1
HU,HYPERSENSITIVITY VASCULITIS,1
HU,HYPERTENSION,1
HU,HYPOTENSION,1
HU,IDIOPATHIC PULMONARY FIBROSIS,1
HU,IMMUNODEFICIENCY,1
HU,IMPETIGO,1
HU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
HU,INFESTATION,1
HU,INFLAMMATORY BOWEL DISEASE,1
HU,INJECTION SITE RASH,1
HU,INTERNATIONAL NORMALISED RATIO INCREASED,1
HU,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
HU,INVASIVE DUCTAL BREAST CARCINOMA,1
HU,IRIDOCYCLITIS,1
HU,IRRITABLE BOWEL SYNDROME,1
HU,JOINT SWELLING,1
HU,LATENT TUBERCULOSIS,1
HU,LEIOMYOMA,1
HU,LIMB MALFORMATION,1
HU,LIMB OPERATION,1
HU,LOSS OF CONSCIOUSNESS,1
HU,LUNG ADENOCARCINOMA,1
HU,LUNG CANCER METASTATIC,1
HU,LUNG DISORDER,1
HU,LUNG NEOPLASM MALIGNANT,1
HU,LYMPHOPENIA,1
HU,LYMPHOPROLIFERATIVE DISORDER,1
HU,MALAISE,1
HU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
HU,METASTASES TO LIVER,1
HU,MONOCYTOSIS,1
HU,MUCOSAL INFLAMMATION,1
HU,MYOCARDIAL INFARCTION,1
HU,MYOPATHY,1
HU,NASOPHARYNGITIS,1
HU,NECK PAIN,1
HU,NEONATAL INFECTION,1
HU,NEUTROPENIA,1
HU,NO THERAPEUTIC RESPONSE,1
HU,NON-HODGKIN^S LYMPHOMA,1
HU,OEDEMA,1
HU,ORAL HERPES,1
HU,OROPHARYNGEAL PAIN,1
HU,OTITIS MEDIA,1
HU,OVERLAP SYNDROME,1
HU,PAPULE,1
HU,PATHOGEN RESISTANCE,1
HU,PLEURISY,1
HU,PREGNANCY,1
HU,PREMATURE BABY,1
HU,PREMATURE DELIVERY,1
HU,PREMATURE RUPTURE OF MEMBRANES,1
HU,PRESCRIBED OVERDOSE,1
HU,PROCTITIS,1
HU,PRURITUS,1
HU,PSEUDOMONAL BACTERAEMIA,1
HU,PSEUDOMONAS INFECTION,1
HU,PSEUDOMONAS TEST POSITIVE,1
HU,PULMONARY FIBROSIS,1
HU,PULMONARY OEDEMA,1
HU,PYELONEPHRITIS,1
HU,PYELONEPHRITIS ACUTE,1
HU,PYURIA,1
HU,RADICULOPATHY,1
HU,RASH,1
HU,RASH ERYTHEMATOUS,1
HU,RASH PRURITIC,1
HU,RASH PUSTULAR,1
HU,RASH VESICULAR,1
HU,RECTAL ADENOCARCINOMA,1
HU,RECTAL NEOPLASM,1
HU,RENAL IMPAIRMENT,1
HU,RENAL NEOPLASM,1
HU,RESPIRATORY DISTRESS,1
HU,RESPIRATORY FAILURE,1
HU,RETINOPATHY,1
HU,RIB FRACTURE,1
HU,ROSACEA,1
HU,SARCOIDOSIS,1
HU,SKIN DISORDER,1
HU,SKIN LESION,1
HU,SKIN MASS,1
HU,SKIN ULCER,1
HU,TACHYCARDIA,1
HU,THYROIDITIS,1
HU,TIBIA FRACTURE,1
HU,TOE AMPUTATION,1
HU,TOXIC SHOCK SYNDROME STREPTOCOCCAL,1
HU,TREMOR,1
HU,ULCER,1
HU,UMBILICAL HERNIA,1
HU,URTICARIA,1
HU,VAGINAL CANCER METASTATIC,1
HU,VITREOUS HAEMORRHAGE,1
HU,VOMITING,1
HU,WEIGHT DECREASED,1
HU,WEIGHT INCREASED,1
IS,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IS,JOINT SWELLING,1
IS,LUPUS-LIKE SYNDROME,1
IS,SHRINKING LUNG SYNDROME,1
IN,PANCYTOPENIA,34
IN,TOXICITY TO VARIOUS AGENTS,31
IN,PYREXIA,23
IN,VOMITING,23
IN,MUCOSAL INFLAMMATION,20
IN,DISEASE PROGRESSION,16
IN,NEUTROPENIA,15
IN,CHORIORETINOPATHY,13
IN,DRUG INEFFECTIVE,13
IN,INCORRECT DOSAGE ADMINISTERED,12
IN,THROMBOCYTOPENIA,12
IN,BLOOD CREATININE INCREASED,11
IN,BONE MARROW FAILURE,11
IN,DISSEMINATED TUBERCULOSIS,11
IN,HEPATOTOXICITY,11
IN,HISTIOCYTOSIS HAEMATOPHAGIC,11
IN,FEBRILE NEUTROPENIA,10
IN,SEPSIS,10
IN,DEATH,9
IN,DISEASE RECURRENCE,9
IN,HYPERTENSION,9
IN,HYPERLIPIDAEMIA,8
IN,LUNG INFECTION,8
IN,PSORIASIS,8
IN,ANAEMIA,7
IN,PNEUMONITIS,7
IN,SKIN ULCER,7
IN,BLISTER,6
IN,DERMATITIS BULLOUS,6
IN,DIABETES MELLITUS,6
IN,HEPATIC ENZYME INCREASED,6
IN,MELAENA,6
IN,MOUTH ULCERATION,6
IN,NEUROPATHY PERIPHERAL,6
IN,APLASTIC ANAEMIA,5
IN,CELLULITIS,5
IN,CEREBRAL VENOUS THROMBOSIS,5
IN,CUSHINGOID,5
IN,CYTOMEGALOVIRUS INFECTION,5
IN,DEEP VEIN THROMBOSIS,5
IN,DIARRHOEA,5
IN,ENDOPHTHALMITIS,5
IN,ERYTHEMA,5
IN,LYMPHADENOPATHY,5
IN,MYCOSIS FUNGOIDES,5
IN,MYELODYSPLASTIC SYNDROME,5
IN,NAUSEA,5
IN,PULMONARY TUBERCULOSIS,5
IN,RENAL IMPAIRMENT,5
IN,SKIN LESION,5
IN,STOMATITIS,5
IN,TACHYCARDIA,5
IN,ASCITES,4
IN,DERMATITIS EXFOLIATIVE,4
IN,DRUG INTOLERANCE,4
IN,DYSPHAGIA,4
IN,DYSPNOEA,4
IN,HEADACHE,4
IN,HEPATIC FIBROSIS,4
IN,HYPOTENSION,4
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
IN,INTENTIONAL PRODUCT MISUSE,4
IN,KLEBSIELLA INFECTION,4
IN,LEPROMATOUS LEPROSY,4
IN,LIVER FUNCTION TEST ABNORMAL,4
IN,LIVER FUNCTION TEST INCREASED,4
IN,LYMPHOCYTIC INFILTRATION,4
IN,MUCORMYCOSIS,4
IN,MYOCARDITIS,4
IN,NEUROTOXICITY,4
IN,ORAL MUCOSA EROSION,4
IN,OVERDOSE,4
IN,PORPHYRIA NON-ACUTE,4
IN,PRURITUS,4
IN,RASH,4
IN,RASH ERYTHEMATOUS,4
IN,SEIZURE,4
IN,SHOCK,4
IN,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,4
IN,STEVENS-JOHNSON SYNDROME,4
IN,URINARY TRACT INFECTION,4
IN,URTICARIA,4
IN,ABDOMINAL DISTENSION,3
IN,ACINETOBACTER INFECTION,3
IN,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,3
IN,BLINDNESS,3
IN,CARDIAC ARREST,3
IN,CARDIOMEGALY,3
IN,CEREBRAL HAEMORRHAGE,3
IN,CONDITION AGGRAVATED,3
IN,CONJUNCTIVAL HAEMORRHAGE,3
IN,COUGH,3
IN,DISORIENTATION,3
IN,DISSEMINATED INTRAVASCULAR COAGULATION,3
IN,DRUG RESISTANCE,3
IN,ENCEPHALITIS,3
IN,EXPOSURE DURING PREGNANCY,3
IN,FACE OEDEMA,3
IN,FAILURE TO THRIVE,3
IN,GASTRITIS,3
IN,GENERALISED ERYTHEMA,3
IN,HAEMOGLOBIN DECREASED,3
IN,HEMIPARESIS,3
IN,HIRSUTISM,3
IN,HYPERKALAEMIA,3
IN,HYPERTRIGLYCERIDAEMIA,3
IN,HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION,3
IN,LEUKOENCEPHALOPATHY,3
IN,MEDICATION ERROR,3
IN,MENINGOENCEPHALITIS AMOEBIC,3
IN,MOLLUSCUM CONTAGIOSUM,3
IN,MUSCULAR WEAKNESS,3
IN,PIGMENTATION DISORDER,3
IN,PRODUCT USE IN UNAPPROVED INDICATION,3
IN,PRODUCT USE ISSUE,3
IN,PUSTULAR PSORIASIS,3
IN,RESPIRATORY FAILURE,3
IN,SOMNOLENCE,3
IN,STATUS EPILEPTICUS,3
IN,SUBARACHNOID HAEMORRHAGE,3
IN,THROMBOSIS,3
IN,THROMBOTIC MICROANGIOPATHY,3
IN,TRANSAMINASES INCREASED,3
IN,TUBERCULOSIS,3
IN,ABDOMINAL PAIN,2
IN,ACCIDENTAL OVERDOSE,2
IN,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
IN,ACUTE KIDNEY INJURY,2
IN,ACUTE MYELOID LEUKAEMIA,2
IN,ALANINE AMINOTRANSFERASE INCREASED,2
IN,ALOPECIA,2
IN,ANGIOEDEMA,2
IN,ANTITHROMBIN III DECREASED,2
IN,AORTIC VALVE INCOMPETENCE,2
IN,APATHY,2
IN,APHASIA,2
IN,APHTHOUS STOMATITIS,2
IN,ASPARTATE AMINOTRANSFERASE INCREASED,2
IN,ASPERGILLUS INFECTION,2
IN,BENIGN INTRACRANIAL HYPERTENSION,2
IN,BLOOD IMMUNOGLOBULIN G DECREASED,2
IN,CANCER PAIN,2
IN,CANDIDIASIS,2
IN,CATARACT,2
IN,CENTRAL NERVOUS SYSTEM LESION,2
IN,CHILLS,2
IN,CHRONIC GRAFT VERSUS HOST DISEASE,2
IN,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,2
IN,COAGULOPATHY,2
IN,COLITIS,2
IN,CREPITATIONS,2
IN,CYSTITIS HAEMORRHAGIC,2
IN,DECREASED APPETITE,2
IN,DEMYELINATION,2
IN,DEPRESSION,2
IN,DIZZINESS,2
IN,DRUG ADMINISTRATION ERROR,2
IN,FUNGAL INFECTION,2
IN,GASTROINTESTINAL INFECTION,2
IN,GENERAL PHYSICAL HEALTH DETERIORATION,2
IN,GENERALISED TONIC-CLONIC SEIZURE,2
IN,GLOSSITIS,2
IN,GRAFT VERSUS HOST DISEASE,2
IN,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
IN,GRAFT VERSUS HOST DISEASE IN SKIN,2
IN,HAEMOLYTIC ANAEMIA,2
IN,HAEMOPTYSIS,2
IN,HEPATIC NECROSIS,2
IN,HEPATITIS,2
IN,HEPATOSPLENOMEGALY,2
IN,HOSPITALISATION,2
IN,HYPERBILIRUBINAEMIA,2
IN,HYPERCOAGULATION,2
IN,HYPERSENSITIVITY,2
IN,INFLUENZA LIKE ILLNESS,2
IN,INTESTINAL OBSTRUCTION,2
IN,INTRACRANIAL PRESSURE INCREASED,2
IN,INTRAVENTRICULAR HAEMORRHAGE,2
IN,IRRITABILITY,2
IN,JAUNDICE,2
IN,LETHARGY,2
IN,LEUKOCYTOSIS,2
IN,LEUKOPENIA,2
IN,LOCALISED INTRAABDOMINAL FLUID COLLECTION,2
IN,LOSS OF CONSCIOUSNESS,2
IN,LOWER RESPIRATORY TRACT INFECTION,2
IN,LYMPHOPROLIFERATIVE DISORDER,2
IN,MALAISE,2
IN,MATERNAL EXPOSURE DURING PREGNANCY,2
IN,MITRAL VALVE STENOSIS,2
IN,MONONEUROPATHY MULTIPLEX,2
IN,MULTI-ORGAN FAILURE,2
IN,NEPHROPATHY TOXIC,2
IN,NEUTROPENIC COLITIS,2
IN,ODYNOPHAGIA,2
IN,OEDEMA PERIPHERAL,2
IN,OROPHARYNGEAL CANDIDIASIS,2
IN,PALLOR,2
IN,PLATELET COUNT DECREASED,2
IN,PLEURAL EFFUSION,2
IN,PNEUMONIA,2
IN,PNEUMONIA ASPIRATION,2
IN,PORTAL VEIN THROMBOSIS,2
IN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
IN,PRODUCT QUALITY ISSUE,2
IN,PROTEIN S DECREASED,2
IN,PSORIATIC ARTHROPATHY,2
IN,PSYCHOTIC DISORDER,2
IN,PULMONARY HAEMORRHAGE,2
IN,QUADRIPLEGIA,2
IN,RASH MACULO-PAPULAR,2
IN,RASH PUSTULAR,2
IN,RENAL FAILURE,2
IN,RENAL FUNCTION TEST ABNORMAL,2
IN,RESPIRATORY TRACT INFECTION,2
IN,RHEUMATIC HEART DISEASE,2
IN,SELF-MEDICATION,2
IN,SKIN EROSION,2
IN,SKIN EXFOLIATION,2
IN,SKIN PAPILLOMA,2
IN,SKIN PLAQUE,2
IN,SUPERIOR SAGITTAL SINUS THROMBOSIS,2
IN,THERAPEUTIC RESPONSE DECREASED,2
IN,THROMBOCYTOSIS,2
IN,TOXIC EPIDERMAL NECROLYSIS,2
IN,VARICELLA,2
IN,VISION BLURRED,2
IN,WHITE BLOOD CELL COUNT DECREASED,2
IN,ABDOMINAL ADHESIONS,1
IN,ABDOMINAL RIGIDITY,1
IN,ABNORMAL BEHAVIOUR,1
IN,ABORTION INDUCED,1
IN,ACANTHAMOEBA INFECTION,1
IN,ACANTHOSIS,1
IN,ACQUIRED PIGMENTED RETINOPATHY,1
IN,ACUTE GRAFT VERSUS HOST DISEASE,1
IN,ACUTE HEPATIC FAILURE,1
IN,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
IN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IN,ACUTE RESPIRATORY FAILURE,1
IN,ADENOVIRUS INFECTION,1
IN,AGITATION,1
IN,AMOEBIC LUNG ABSCESS,1
IN,ANAL FISTULA,1
IN,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
IN,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES STAGE III,1
IN,ANAPLASTIC LARGE-CELL LYMPHOMA,1
IN,ARTHRALGIA,1
IN,ASPERGILLOMA,1
IN,ASTHENIA,1
IN,ATAXIA,1
IN,BACK PAIN,1
IN,BACTERIAL INFECTION,1
IN,BACTERIAL SEPSIS,1
IN,BICYTOPENIA,1
IN,BIOPSY SKIN ABNORMAL,1
IN,BLOOD COUNT ABNORMAL,1
IN,BLOOD GLUCOSE INCREASED,1
IN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IN,BLOOD POTASSIUM ABNORMAL,1
IN,BONE MARROW DISORDER,1
IN,BONE MARROW TOXICITY,1
IN,BRAIN INJURY,1
IN,BRONCHOPULMONARY ASPERGILLOSIS,1
IN,CANDIDA INFECTION,1
IN,CARDIAC FAILURE,1
IN,CARDIOTOXICITY,1
IN,CATARACT SUBCAPSULAR,1
IN,CENTRAL NERVOUS SYSTEM LEUKAEMIA,1
IN,CENTRAL OBESITY,1
IN,CEREBRAL TOXOPLASMOSIS,1
IN,CHROMATURIA,1
IN,CHRONIC GRANULOMATOUS DISEASE,1
IN,CHRONIC MYELOID LEUKAEMIA,1
IN,CONSTIPATION,1
IN,CONTUSION,1
IN,CONVULSION,1
IN,CRYPTOSPORIDIOSIS INFECTION,1
IN,CSF PRESSURE INCREASED,1
IN,CUSHING^S SYNDROME,1
IN,CUTANEOUS SPOROTRICHOSIS,1
IN,CYTOMEGALOVIRUS CHORIORETINITIS,1
IN,CYTOPENIA,1
IN,CYTOTOXIC OEDEMA,1
IN,DEAFNESS,1
IN,DEFORMITY,1
IN,DELIRIUM,1
IN,DIARRHOEA HAEMORRHAGIC,1
IN,DIFFUSE ALVEOLAR DAMAGE,1
IN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
IN,DRUG EFFECT INCOMPLETE,1
IN,DRUG HYPERSENSITIVITY,1
IN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IN,DYSPEPSIA,1
IN,DYSPNOEA EXERTIONAL,1
IN,ECCHYMOSIS,1
IN,END STAGE RENAL DISEASE,1
IN,ENDOCARDITIS,1
IN,ENGRAFTMENT SYNDROME,1
IN,ENTEROCUTANEOUS FISTULA,1
IN,EOSINOPHILIA,1
IN,EPIDERMAL NECROSIS,1
IN,ERYTHEMA MULTIFORME,1
IN,ERYTHRODERMIC PSORIASIS,1
IN,ERYTHROLEUKAEMIA,1
IN,ESCHERICHIA URINARY TRACT INFECTION,1
IN,FATIGUE,1
IN,GAIT DISTURBANCE,1
IN,GASTROENTERITIS,1
IN,GASTROENTERITIS STAPHYLOCOCCAL,1
IN,GASTROINTESTINAL FISTULA,1
IN,GENERALISED OEDEMA,1
IN,GRAFT VERSUS HOST DISEASE IN LIVER,1
IN,GRAFT VERSUS HOST DISEASE IN LUNG,1
IN,GRAND MAL CONVULSION,1
IN,GYNAECOMASTIA,1
IN,HAEMATEMESIS,1
IN,HAEMATURIA,1
IN,HAEMORRHAGE INTRACRANIAL,1
IN,HAIR DISORDER,1
IN,HALLUCINATION_ AUDITORY,1
IN,HALLUCINATION_ VISUAL,1
IN,HEMIPLEGIA,1
IN,HEPATIC FUNCTION ABNORMAL,1
IN,HEPATIC STEATOSIS,1
IN,HEPATITIS A,1
IN,HEPATITIS ACUTE,1
IN,HUMAN CHORIONIC GONADOTROPIN INCREASED,1
IN,HYPERFERRITINAEMIA,1
IN,HYPERSENSITIVITY VASCULITIS,1
IN,HYPERTRICHOSIS,1
IN,HYPERURICAEMIA,1
IN,HYPOKALAEMIA,1
IN,HYPONATRAEMIA,1
IN,HYPOXIA,1
IN,ILEAL PERFORATION,1
IN,ILEAL ULCER,1
IN,ILEUS,1
IN,IMMUNOSUPPRESSION,1
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IN,INCORRECT DOSE ADMINISTERED,1
IN,INCREASED UPPER AIRWAY SECRETION,1
IN,INFUSION RELATED REACTION,1
IN,INSOMNIA,1
IN,INTERVERTEBRAL DISCITIS,1
IN,INTRAOCULAR PRESSURE INCREASED,1
IN,JOINT SWELLING,1
IN,KNEE DEFORMITY,1
IN,LARYNGEAL STENOSIS,1
IN,LARYNGEAL ULCERATION,1
IN,LEFT VENTRICULAR DYSFUNCTION,1
IN,LIMB AMPUTATION,1
IN,LIMB RECONSTRUCTIVE SURGERY,1
IN,LUNG ADENOCARCINOMA METASTATIC,1
IN,LYMPH NODE TUBERCULOSIS,1
IN,LYMPHOCYTE COUNT DECREASED,1
IN,MACULE,1
IN,MALIGNANT GLIOMA,1
IN,MASTICATION DISORDER,1
IN,MEGAKARYOCYTES ABNORMAL,1
IN,MENSTRUATION NORMAL,1
IN,METABOLIC SYNDROME,1
IN,METAL POISONING,1
IN,METASTASES TO CENTRAL NERVOUS SYSTEM,1
IN,METASTASES TO LIVER,1
IN,METASTASES TO LUNG,1
IN,MUCOEPIDERMOID CARCINOMA,1
IN,MUCOSAL ATROPHY,1
IN,MUCOSAL EROSION,1
IN,MUCOSAL ULCERATION,1
IN,MULTIPLE FRACTURES,1
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IN,MYELOPATHY,1
IN,MYOPATHY,1
IN,MYXOEDEMA COMA,1
IN,NAIL DISCOLOURATION,1
IN,NAIL RIDGING,1
IN,NASAL DISORDER,1
IN,NECK MASS,1
IN,NEUTROPENIC SEPSIS,1
IN,NEUTROPHIL COUNT DECREASED,1
IN,NOCARDIOSIS,1
IN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
IN,NOSE DEFORMITY,1
IN,NUCHAL RIGIDITY,1
IN,OCULOGYRIC CRISIS,1
IN,OPTIC NERVE DISORDER,1
IN,ORAL CANDIDIASIS,1
IN,ORAL DISORDER,1
IN,OSTEONECROSIS,1
IN,OSTEONECROSIS OF JAW,1
IN,OSTEOPOROSIS,1
IN,PACHYMENINGITIS,1
IN,PAIN,1
IN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IN,PAPILLOEDEMA,1
IN,PAPULE,1
IN,PARAKERATOSIS,1
IN,PAROTITIS,1
IN,PHOTOSENSITIVITY REACTION,1
IN,PORPHYRINS URINE INCREASED,1
IN,PORTAL FIBROSIS,1
IN,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA,1
IN,PREMATURE MENOPAUSE,1
IN,PRODUCT CONTAMINATION,1
IN,PRODUCT CONTAMINATION MICROBIAL,1
IN,PROTEINURIA,1
IN,PRURITUS GENERALISED,1
IN,PULMONARY TOXICITY,1
IN,RASH PAPULAR,1
IN,REFRACTORY CANCER,1
IN,RENAL INJURY,1
IN,RESPIRATORY ALKALOSIS,1
IN,RESPIRATORY DISTRESS,1
IN,RETCHING,1
IN,RETINAL ARTERY OCCLUSION,1
IN,RETINOPATHY,1
IN,RHEUMATOID ARTHRITIS,1
IN,RHINORRHOEA,1
IN,SECOND PRIMARY MALIGNANCY,1
IN,SECONDARY HYPOGONADISM,1
IN,SENSATION OF FOREIGN BODY,1
IN,SEPTIC SHOCK,1
IN,SINUS DISORDER,1
IN,SINUSITIS,1
IN,SKIN ATROPHY,1
IN,SKIN DEPIGMENTATION,1
IN,SKIN DYSTROPHY,1
IN,SKIN HYPERPIGMENTATION,1
IN,SKIN HYPERPLASIA,1
IN,SKIN MASS,1
IN,SKIN STRIAE,1
IN,SLEEP DISORDER,1
IN,SMALL INTESTINAL PERFORATION,1
IN,SPEECH DISORDER,1
IN,SPINAL COMPRESSION FRACTURE,1
IN,SPLENIC LESION,1
IN,SPLENOMEGALY,1
IN,STAPHYLOCOCCAL SEPSIS,1
IN,STAPHYLOCOCCAL SKIN INFECTION,1
IN,SURGERY,1
IN,SWELLING FACE,1
IN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
IN,TACHYPNOEA,1
IN,TENDERNESS,1
IN,TESTICULAR DISORDER,1
IN,THERAPEUTIC RESPONSE UNEXPECTED,1
IN,TOXIC DILATATION OF INTESTINE,1
IN,TOXIC LEUKOENCEPHALOPATHY,1
IN,TREATMENT NONCOMPLIANCE,1
IN,TREMOR,1
IN,TRISMUS,1
IN,TUMOUR NECROSIS,1
IN,ULCER,1
IN,UPPER RESPIRATORY TRACT INFECTION,1
IN,URINE OUTPUT DECREASED,1
IN,VASCULITIC ULCER,1
IN,VASCULITIS,1
IN,VIRAL INFECTION,1
IN,VISUAL IMPAIRMENT,1
IN,WEIGHT INCREASED,1
IN,WOUND,1
ID,SEPSIS,29
ID,PYREXIA,22
ID,CARDIOGENIC SHOCK,2
ID,HAEMORRHAGE INTRACRANIAL,2
ID,ALANINE AMINOTRANSFERASE ABNORMAL,1
ID,ANAPHYLACTIC SHOCK,1
ID,ARTHRALGIA,1
ID,ARTHROPATHY,1
ID,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
ID,CORONARY VASCULAR GRAFT OCCLUSION,1
ID,DEATH,1
ID,DIARRHOEA,1
ID,DISSEMINATED INTRAVASCULAR COAGULATION,1
ID,DRUG INEFFECTIVE,1
ID,GAIT DISTURBANCE,1
ID,HYPOTENSION,1
ID,HYPOVOLAEMIC SHOCK,1
ID,JOINT DESTRUCTION,1
ID,MOUTH ULCERATION,1
ID,MULTI-ORGAN DISORDER,1
ID,MUSCULOSKELETAL STIFFNESS,1
ID,OSTEOPOROSIS,1
ID,PAIN,1
ID,PAIN IN EXTREMITY,1
ID,PSEUDOMONAS INFECTION,1
ID,REBOUND EFFECT,1
ID,VARICELLA,1
ID,VASCULITIS,1
ID,VENOUS OCCLUSION,1
IR,NAUSEA,8
IR,VOMITING,8
IR,ASTHENIA,6
IR,NEUTROPENIA,6
IR,PYREXIA,6
IR,DECUBITUS ULCER,5
IR,EMBOLISM VENOUS,5
IR,TACHYCARDIA,5
IR,THROMBOCYTOPENIA,5
IR,TOXICITY TO VARIOUS AGENTS,4
IR,FLUSHING,3
IR,MENINGITIS CRYPTOCOCCAL,3
IR,RENAL FUNCTION TEST ABNORMAL,3
IR,ABDOMINAL PAIN,2
IR,ACCIDENTAL OVERDOSE,2
IR,ACCIDENTAL POISONING,2
IR,ACNE,2
IR,ANAPHYLACTIC REACTION,2
IR,BACTERIAL SEPSIS,2
IR,BLOOD CREATININE INCREASED,2
IR,BLOOD UREA INCREASED,2
IR,CHEST DISCOMFORT,2
IR,DIZZINESS,2
IR,DRUG HYPERSENSITIVITY,2
IR,DRUG INEFFECTIVE,2
IR,DYSPNOEA,2
IR,EOSINOPHILIA,2
IR,FACE OEDEMA,2
IR,GENERALISED TONIC-CLONIC SEIZURE,2
IR,JUGULAR VEIN THROMBOSIS,2
IR,LIVER FUNCTION TEST INCREASED,2
IR,MEDICATION ERROR,2
IR,MUSCLE SPASMS,2
IR,PRURITUS,2
IR,PULMONARY HAEMORRHAGE,2
IR,SHOCK,2
IR,SKIN EROSION,2
IR,TREMOR,2
IR,UTERINE FISTULA,2
IR,UTERINE NECROSIS,2
IR,VERTIGO POSITIONAL,2
IR,WRONG DRUG ADMINISTERED,2
IR,ACUTE GRAFT VERSUS HOST DISEASE,1
IR,ALANINE AMINOTRANSFERASE INCREASED,1
IR,AMENORRHOEA,1
IR,ANAEMIA,1
IR,ARTHRALGIA,1
IR,ARTHRITIS,1
IR,ASPARTATE AMINOTRANSFERASE INCREASED,1
IR,BACTERIAL INFECTION,1
IR,BLOOD PRESSURE DECREASED,1
IR,CEREBRAL THROMBOSIS,1
IR,CONVULSION,1
IR,CUTANEOUS TUBERCULOSIS,1
IR,CYTOMEGALOVIRUS INFECTION,1
IR,DEATH,1
IR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IR,DYSPEPSIA,1
IR,EPISTAXIS,1
IR,FACIAL PARALYSIS,1
IR,FUNGAL INFECTION,1
IR,GAIT DISTURBANCE,1
IR,GENERALISED ERYTHEMA,1
IR,GUILLAIN-BARRE SYNDROME,1
IR,HAEMOGLOBIN DECREASED,1
IR,HAEMORRHAGE,1
IR,HEART RATE INCREASED,1
IR,HERPES VIRUS INFECTION,1
IR,HYPERSENSITIVITY,1
IR,HYPERTENSION,1
IR,HYPOKINESIA,1
IR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
IR,INFECTION,1
IR,INFUSION RELATED REACTION,1
IR,INTERCEPTED PRODUCT SELECTION ERROR,1
IR,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
IR,JOINT SWELLING,1
IR,LETHARGY,1
IR,LICHENOID KERATOSIS,1
IR,LIVER FUNCTION TEST ABNORMAL,1
IR,LUNG INFECTION,1
IR,MATERNAL EXPOSURE DURING PREGNANCY,1
IR,MESENTERIC HAEMORRHAGE,1
IR,MOUTH ULCERATION,1
IR,MUCOSAL INFLAMMATION,1
IR,MUSCLE HAEMORRHAGE,1
IR,NECK PAIN,1
IR,PAIN,1
IR,PALPITATIONS,1
IR,PARAESTHESIA,1
IR,PAROTID GLAND ENLARGEMENT,1
IR,PLATELET COUNT DECREASED,1
IR,PRODUCT NAME CONFUSION,1
IR,PULMONARY MASS,1
IR,RASH MACULO-PAPULAR,1
IR,RASH PRURITIC,1
IR,RECTAL HAEMORRHAGE,1
IR,RESPIRATORY RATE INCREASED,1
IR,RETROPERITONEAL HAEMORRHAGE,1
IR,RHEUMATOID ARTHRITIS,1
IR,SKIN LESION,1
IR,T-CELL TYPE ACUTE LEUKAEMIA,1
IR,THERAPEUTIC RESPONSE UNEXPECTED,1
IR,THROMBOSIS,1
IR,TRANSAMINASES INCREASED,1
IR,TUBERCULOSIS,1
IR,UTERINE RUPTURE,1
IR,VAGINAL HAEMORRHAGE,1
IR,WEIGHT INCREASED,1
IR,WHITE BLOOD CELL COUNT DECREASED,1
IR,WHITE BLOOD CELL COUNT INCREASED,1
IQ,ARTHRITIS BACTERIAL,4
IQ,PYREXIA,3
IQ,ARTHRITIS,2
IQ,JOINT EFFUSION,2
IQ,ABDOMINAL DISTENSION,1
IQ,ALANINE AMINOTRANSFERASE INCREASED,1
IQ,ANTINUCLEAR ANTIBODY POSITIVE,1
IQ,ASPARTATE AMINOTRANSFERASE INCREASED,1
IQ,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IQ,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IQ,CHEST X-RAY ABNORMAL,1
IQ,CHOLELITHIASIS,1
IQ,DYSPNOEA EXERTIONAL,1
IQ,ERYTHEMA,1
IQ,ERYTHRODERMIC PSORIASIS,1
IQ,FATIGUE,1
IQ,HYPERHIDROSIS,1
IQ,JOINT SWELLING,1
IQ,LUPUS-LIKE SYNDROME,1
IQ,MUSCULAR WEAKNESS,1
IQ,MYCOSIS FUNGOIDES,1
IQ,NEOPLASM,1
IQ,NEUTROPHILIA,1
IQ,OEDEMA PERIPHERAL,1
IQ,PAPULE,1
IQ,RASH,1
IQ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IQ,SKIN FIBROSIS,1
IQ,SLEEP DISORDER,1
IQ,STAPHYLOCOCCUS TEST POSITIVE,1
IQ,SYNCOPE,1
IQ,WHITE BLOOD CELL COUNT INCREASED,1
IE,LOWER RESPIRATORY TRACT INFECTION,35
IE,DRUG INEFFECTIVE,12
IE,OROPHARYNGEAL PAIN,12
IE,INFECTION,11
IE,MALAISE,9
IE,MUCOSAL INFLAMMATION,9
IE,PRODUCT USE ISSUE,9
IE,RHEUMATOID ARTHRITIS,9
IE,DYSPHAGIA,8
IE,SEPSIS,8
IE,ASTHENIA,7
IE,DIARRHOEA,7
IE,DYSPNOEA,7
IE,FATIGUE,7
IE,HEADACHE,7
IE,KIDNEY INFECTION,7
IE,NAUSEA,7
IE,URINARY TRACT INFECTION,7
IE,DEATH,6
IE,FALL,6
IE,INFUSION RELATED REACTION,6
IE,PRODUCT USE IN UNAPPROVED INDICATION,6
IE,PSORIASIS,6
IE,VOMITING,6
IE,ABDOMINAL PAIN UPPER,5
IE,COUGH,5
IE,IMPAIRED HEALING,5
IE,INFLUENZA,5
IE,JOINT SWELLING,5
IE,NECROTISING FASCIITIS,5
IE,PAIN,5
IE,PAIN IN EXTREMITY,5
IE,PYREXIA,5
IE,ABDOMINAL PAIN,4
IE,ARTHRALGIA,4
IE,B-CELL LYMPHOMA,4
IE,CUSHINGOID,4
IE,DISSEMINATED VARICELLA ZOSTER VACCINE VIRUS INFECTION,4
IE,HERPES ZOSTER,4
IE,ILL-DEFINED DISORDER,4
IE,INJECTION SITE ERYTHEMA,4
IE,INJECTION SITE PAIN,4
IE,LEUKOPENIA,4
IE,LYMPHOMA,4
IE,PHARYNGITIS,4
IE,SINUSITIS,4
IE,SKIN ATROPHY,4
IE,ACUTE KIDNEY INJURY,3
IE,ADVERSE EVENT,3
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,3
IE,BLOOD GLUCOSE INCREASED,3
IE,BRONCHITIS,3
IE,CHEST DISCOMFORT,3
IE,CONDITION AGGRAVATED,3
IE,CROHN^S DISEASE,3
IE,DISCOLOURED VOMIT,3
IE,DIZZINESS,3
IE,ERYTHEMA,3
IE,FACIAL PARALYSIS,3
IE,FAECES DISCOLOURED,3
IE,FEELING ABNORMAL,3
IE,FLUSHING,3
IE,GAIT DISTURBANCE,3
IE,HEPATIC FUNCTION ABNORMAL,3
IE,HEPATIC STEATOSIS,3
IE,HYPOAESTHESIA,3
IE,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
IE,INJECTION SITE SWELLING,3
IE,INTERNAL HAEMORRHAGE,3
IE,LUNG DISORDER,3
IE,MOBILITY DECREASED,3
IE,MYALGIA,3
IE,POST STREPTOCOCCAL GLOMERULONEPHRITIS,3
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
IE,PSYCHOMOTOR HYPERACTIVITY,3
IE,PULMONARY MASS,3
IE,RASH ERYTHEMATOUS,3
IE,RESPIRATORY TRACT INFECTION,3
IE,SQUAMOUS CELL CARCINOMA,3
IE,SYNCOPE,3
IE,TOOTH ABSCESS,3
IE,WHEEZING,3
IE,WHITE BLOOD CELL COUNT INCREASED,3
IE,ACCIDENTAL EXPOSURE TO PRODUCT,2
IE,ACCIDENTAL OVERDOSE,2
IE,ARTHRITIS,2
IE,BASAL CELL CARCINOMA,2
IE,BLOOD UREA INCREASED,2
IE,BODY MASS INDEX INCREASED,2
IE,CARDIAC FAILURE,2
IE,CELLULITIS,2
IE,CHEST PAIN,2
IE,CHILLS,2
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
IE,DRUG EFFECT DECREASED,2
IE,EAR INFECTION,2
IE,ENCEPHALITIS,2
IE,FREQUENT BOWEL MOVEMENTS,2
IE,GASTROINTESTINAL DISORDER,2
IE,GRANULOMATOUS LIVER DISEASE,2
IE,HAEMOGLOBIN DECREASED,2
IE,HERPES ZOSTER MENINGOENCEPHALITIS,2
IE,HYPERHIDROSIS,2
IE,HYPOXIA,2
IE,JOINT DISLOCATION,2
IE,LEUKOCYTOSIS,2
IE,LIVER DISORDER,2
IE,LUNG INFECTION,2
IE,MALIGNANT MELANOMA,2
IE,METASTATIC RENAL CELL CARCINOMA,2
IE,MUSCULOSKELETAL PAIN,2
IE,MUSCULOSKELETAL STIFFNESS,2
IE,MYOCARDIAL INFARCTION,2
IE,NASOPHARYNGITIS,2
IE,NECROTISING FASCIITIS STAPHYLOCOCCAL,2
IE,NEPHROLITHIASIS,2
IE,NEURODERMATITIS,2
IE,NODULE,2
IE,OSTEONECROSIS,2
IE,PANCYTOPENIA,2
IE,PARKINSONISM,2
IE,PLEURAL EFFUSION,2
IE,PNEUMONIA,2
IE,PNEUMONIA KLEBSIELLA,2
IE,PNEUMONIA LEGIONELLA,2
IE,POST HERPETIC NEURALGIA,2
IE,PRURITUS,2
IE,Q FEVER,2
IE,RECTAL ADENOCARCINOMA,2
IE,RHEUMATOID VASCULITIS,2
IE,SERUM FERRITIN INCREASED,2
IE,SWELLING,2
IE,TONSILLITIS,2
IE,ABDOMINAL TENDERNESS,1
IE,ABORTION SPONTANEOUS,1
IE,ABSCESS,1
IE,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
IE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IE,ADENOVIRUS INFECTION,1
IE,ADVERSE DRUG REACTION,1
IE,ADVERSE REACTION,1
IE,ALANINE AMINOTRANSFERASE DECREASED,1
IE,ALOPECIA,1
IE,ANAEMIA MEGALOBLASTIC,1
IE,ANAL ABSCESS,1
IE,ANAL FISTULA,1
IE,ANAL INJURY,1
IE,ANKLE FRACTURE,1
IE,ANORECTAL CELLULITIS,1
IE,APRAXIA,1
IE,ARTHROPATHY,1
IE,ASPERGILLUS INFECTION,1
IE,ATRIAL FIBRILLATION,1
IE,BACK PAIN,1
IE,BARRETT^S OESOPHAGUS,1
IE,BEHCET^S SYNDROME,1
IE,BLADDER TRANSITIONAL CELL CARCINOMA,1
IE,BLINDNESS UNILATERAL,1
IE,BLOOD CALCIUM DECREASED,1
IE,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
IE,BLOOD CREATININE INCREASED,1
IE,BLOOD FOLATE INCREASED,1
IE,BLOOD TEST ABNORMAL,1
IE,BLOOD THYROID STIMULATING HORMONE DECREASED,1
IE,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IE,BLOOD URINE PRESENT,1
IE,BODY TEMPERATURE INCREASED,1
IE,BONE PAIN,1
IE,BREAST CANCER,1
IE,BRONCHIAL NEOPLASM,1
IE,BRONCHIECTASIS,1
IE,C-REACTIVE PROTEIN INCREASED,1
IE,CARCINOID TUMOUR PULMONARY,1
IE,CARDIAC MURMUR,1
IE,CATARACT,1
IE,CATARACT CONGENITAL,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CERVIX CANCER METASTATIC,1
IE,CHEST X-RAY ABNORMAL,1
IE,CHOLECYSTITIS,1
IE,CHOLELITHIASIS,1
IE,CHRONIC SINUSITIS,1
IE,COLITIS,1
IE,COLORECTAL CANCER METASTATIC,1
IE,COLOUR BLINDNESS ACQUIRED,1
IE,COMA,1
IE,CONTUSION,1
IE,CORONARY ARTERY DISEASE,1
IE,CYST,1
IE,DEEP VEIN THROMBOSIS,1
IE,DEFAECATION URGENCY,1
IE,DENTAL CARIES,1
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IE,DIABETES MELLITUS,1
IE,DIPLEGIA,1
IE,DIPLOPIA,1
IE,DISORIENTATION,1
IE,DIVERTICULITIS,1
IE,DIVERTICULUM INTESTINAL,1
IE,DRUG CLEARANCE INCREASED,1
IE,DRUG EFFECT INCOMPLETE,1
IE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IE,ECZEMA,1
IE,EMOTIONAL DISTRESS,1
IE,EMPYEMA,1
IE,ESCHERICHIA INFECTION,1
IE,EXPOSURE DURING PREGNANCY,1
IE,EYE DISORDER,1
IE,EYE INFLAMMATION,1
IE,EYE PAIN,1
IE,EYE SWELLING,1
IE,FACIAL PAIN,1
IE,FAECAL INCONTINENCE,1
IE,FEAR OF INJECTION,1
IE,FEEDING DISORDER,1
IE,FEELING HOT,1
IE,FEMALE GENITAL TRACT FISTULA,1
IE,FOETAL EXPOSURE DURING PREGNANCY,1
IE,FOETAL GROWTH RESTRICTION,1
IE,FOLATE DEFICIENCY,1
IE,FUNGAL INFECTION,1
IE,GASTROENTERITIS VIRAL,1
IE,GENERALISED ERYTHEMA,1
IE,GRAFT VERSUS HOST DISEASE IN LIVER,1
IE,HAEMARTHROSIS,1
IE,HAEMATOCRIT DECREASED,1
IE,HAEMATOMA,1
IE,HAEMATOTOXICITY,1
IE,HAEMATURIA,1
IE,HAEMORRHAGE,1
IE,HEARING IMPAIRED,1
IE,HEART RATE INCREASED,1
IE,HEMIPARESIS,1
IE,HEPATIC FAILURE,1
IE,HEPATOTOXICITY,1
IE,HERPES ZOSTER OTICUS,1
IE,HIP ARTHROPLASTY,1
IE,HOSPITALISATION,1
IE,HUMAN POLYOMAVIRUS INFECTION,1
IE,HYPERCHOLESTEROLAEMIA,1
IE,HYPERSENSITIVITY,1
IE,HYPERTONIA,1
IE,HYPOMAGNESAEMIA,1
IE,HYPOTONY OF EYE,1
IE,IMMUNODEFICIENCY,1
IE,IMPAIRED WORK ABILITY,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INCORRECT PRODUCT STORAGE,1
IE,INFECTION SUSCEPTIBILITY INCREASED,1
IE,INFECTIVE TENOSYNOVITIS,1
IE,INFLUENZA LIKE ILLNESS,1
IE,INTENTIONAL PRODUCT USE ISSUE,1
IE,INTERVERTEBRAL DISC PROTRUSION,1
IE,INTERVERTEBRAL DISCITIS,1
IE,JOINT RANGE OF MOTION DECREASED,1
IE,JOINT STIFFNESS,1
IE,KNEE ARTHROPLASTY,1
IE,KNEE OPERATION,1
IE,LATENT TUBERCULOSIS,1
IE,LEG AMPUTATION,1
IE,LETHARGY,1
IE,LIMB INJURY,1
IE,LIVEDO RETICULARIS,1
IE,LOCAL SWELLING,1
IE,LOWER LIMB FRACTURE,1
IE,LUMBAR SPINAL STENOSIS,1
IE,LUNG CANCER METASTATIC,1
IE,LYMPHADENOPATHY,1
IE,LYMPHADENOPATHY MEDIASTINAL,1
IE,LYMPHOMATOID PAPULOSIS,1
IE,LYMPHOPENIA,1
IE,MASS,1
IE,MASTECTOMY,1
IE,MEMORY IMPAIRMENT,1
IE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
IE,METASTASES TO LUNG,1
IE,METASTATIC MALIGNANT MELANOMA,1
IE,METASTATIC NEOPLASM,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MONOCYTE COUNT INCREASED,1
IE,MOUTH ULCERATION,1
IE,MUSCLE INJURY,1
IE,MYCOSIS FUNGOIDES STAGE II,1
IE,NASAL CONGESTION,1
IE,NECROTISING FASCIITIS STREPTOCOCCAL,1
IE,NEEDLE ISSUE,1
IE,NEOPLASM MALIGNANT,1
IE,NEPHROPATHY,1
IE,NERVE COMPRESSION,1
IE,NEURALGIA,1
IE,NEUROTOXICITY,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,NIGHT SWEATS,1
IE,NODULAR MELANOMA,1
IE,NON-SMALL CELL LUNG CANCER,1
IE,OPTIC NEUROPATHY,1
IE,ORAL CANDIDIASIS,1
IE,ORAL HERPES,1
IE,ORAL MUCOSAL BLISTERING,1
IE,OSTEOARTHRITIS,1
IE,OSTEONECROSIS OF JAW,1
IE,OVERDOSE,1
IE,OXYGEN SATURATION DECREASED,1
IE,PANCREATITIS,1
IE,PARAESTHESIA,1
IE,PARAESTHESIA ORAL,1
IE,PERINEURIAL CYST,1
IE,PERIPHERAL ARTERY THROMBOSIS,1
IE,PERONEAL NERVE PALSY,1
IE,PHARYNGEAL OEDEMA,1
IE,PHARYNGITIS STREPTOCOCCAL,1
IE,PLEURITIC PAIN,1
IE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
IE,PNEUMONITIS,1
IE,PROCTOCOLECTOMY,1
IE,PRODUCT QUALITY ISSUE,1
IE,PRODUCT SIZE ISSUE,1
IE,PROSTATE CANCER,1
IE,PROTHROMBIN TIME PROLONGED,1
IE,PSORIATIC ARTHROPATHY,1
IE,PULMONARY CAVITATION,1
IE,PULMONARY EMBOLISM,1
IE,PURULENT DISCHARGE,1
IE,RALES,1
IE,RASH PRURITIC,1
IE,RECTAL HAEMORRHAGE,1
IE,RED BLOOD CELL COUNT DECREASED,1
IE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IE,RED CELL DISTRIBUTION WIDTH INCREASED,1
IE,RESTLESS LEGS SYNDROME,1
IE,RHEUMATOID NODULE,1
IE,SARCOIDOSIS,1
IE,SARCOMA,1
IE,SARCOMA METASTATIC,1
IE,SCAB,1
IE,SCLERAL DISORDER,1
IE,SECOND PRIMARY MALIGNANCY,1
IE,SEIDEL TEST POSITIVE,1
IE,SENSATION OF PRESSURE,1
IE,SENSORY DISTURBANCE,1
IE,SKIN EXFOLIATION,1
IE,SKIN FISSURES,1
IE,SKIN LESION,1
IE,SKIN PAPILLOMA,1
IE,SKIN ULCER,1
IE,SMALL CELL LUNG CANCER,1
IE,SPONDYLITIS,1
IE,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
IE,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
IE,STOMATITIS,1
IE,SWELLING FACE,1
IE,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,1
IE,THROAT TIGHTNESS,1
IE,TINEA PEDIS,1
IE,TOXIC ENCEPHALOPATHY,1
IE,TREMOR,1
IE,TUBERCULOSIS,1
IE,TUBULOINTERSTITIAL NEPHRITIS,1
IE,UPPER LIMB FRACTURE,1
IE,URINARY BLADDER HAEMORRHAGE,1
IE,URTICARIA,1
IE,VAGINAL HAEMORRHAGE,1
IE,VENOOCCLUSIVE DISEASE,1
IE,VIRAL INFECTION,1
IE,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IE,VISION BLURRED,1
IE,VISUAL ACUITY REDUCED,1
IE,VISUAL FIELD DEFECT,1
IE,WEIGHT DECREASED,1
IE,WRIST FRACTURE,1
IL,TOXICITY TO VARIOUS AGENTS,57
IL,PANCYTOPENIA,54
IL,MUCOSAL INFLAMMATION,43
IL,SEPSIS,22
IL,DRUG INEFFECTIVE,21
IL,PYREXIA,16
IL,HEPATOTOXICITY,15
IL,PNEUMONITIS,15
IL,PAIN,14
IL,ARTHRALGIA,12
IL,NEUTROPENIA,12
IL,PNEUMONIA,11
IL,INFECTION,10
IL,PRURITUS,9
IL,THROMBOCYTOPENIA,8
IL,ASTHENIA,7
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
IL,PAIN IN EXTREMITY,7
IL,ABDOMINAL PAIN,6
IL,BREAST CANCER,6
IL,CONDITION AGGRAVATED,6
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
IL,JOINT SWELLING,6
IL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,6
IL,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,5
IL,ARTHRITIS,5
IL,BACK PAIN,5
IL,DIARRHOEA,5
IL,DYSPNOEA,5
IL,MYELITIS TRANSVERSE,5
IL,PRODUCT USE IN UNAPPROVED INDICATION,5
IL,SEPTIC SHOCK,5
IL,CHEST PAIN,4
IL,FATIGUE,4
IL,GAIT DISTURBANCE,4
IL,HYPERTENSION,4
IL,INCORRECT DOSE ADMINISTERED,4
IL,INFLAMMATORY MARKER INCREASED,4
IL,MULTI-ORGAN FAILURE,4
IL,MUSCULOSKELETAL PAIN,4
IL,NEPHROPATHY TOXIC,4
IL,ORAL CANDIDIASIS,4
IL,PSORIASIS,4
IL,PSORIATIC ARTHROPATHY,4
IL,VARICELLA ZOSTER PNEUMONIA,4
IL,WHITE BLOOD CELL COUNT DECREASED,4
IL,ANAEMIA,3
IL,ASCITES,3
IL,AZOOSPERMIA,3
IL,CEREBROVASCULAR ACCIDENT,3
IL,DIZZINESS,3
IL,DRUG EFFECT DECREASED,3
IL,DRUG HYPERSENSITIVITY,3
IL,ESCHERICHIA SEPSIS,3
IL,FEELING ABNORMAL,3
IL,GASTROENTERITIS,3
IL,HEADACHE,3
IL,HYPONATRAEMIA,3
IL,JUVENILE IDIOPATHIC ARTHRITIS,3
IL,LEUKOPENIA,3
IL,LUPUS-LIKE SYNDROME,3
IL,MYOCARDIAL INFARCTION,3
IL,OROPHARYNGEAL PAIN,3
IL,PERIPHERAL SWELLING,3
IL,PRODUCT USE ISSUE,3
IL,RASH,3
IL,RASH MACULO-PAPULAR,3
IL,RENAL FAILURE ACUTE,3
IL,RESPIRATORY FAILURE,3
IL,SEIZURE,3
IL,SKIN EXFOLIATION,3
IL,WEIGHT DECREASED,3
IL,WEIGHT INCREASED,3
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,2
IL,ACUTE GRAFT VERSUS HOST DISEASE,2
IL,ACUTE KIDNEY INJURY,2
IL,ACUTE MYELOID LEUKAEMIA,2
IL,ANKYLOSING SPONDYLITIS,2
IL,ARTHROPATHY,2
IL,ATRIAL FIBRILLATION,2
IL,B-CELL LYMPHOMA,2
IL,BACTERAEMIA,2
IL,BONE MARROW TOXICITY,2
IL,BREAST CANCER METASTATIC,2
IL,BRONCHIECTASIS,2
IL,BURNING SENSATION,2
IL,CATARACT,2
IL,CELLULITIS,2
IL,CENTRAL NERVOUS SYSTEM ENTEROVIRAL INFECTION,2
IL,COUGH,2
IL,CROHN^S DISEASE,2
IL,CYTOMEGALOVIRUS INFECTION,2
IL,DERMATITIS,2
IL,DISEASE PROGRESSION,2
IL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
IL,ERYTHEMA,2
IL,FEBRILE NEUTROPENIA,2
IL,GALLBLADDER DISORDER,2
IL,GRAFT VERSUS HOST DISEASE,2
IL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
IL,GRAFT VERSUS HOST DISEASE IN LIVER,2
IL,HAEMOGLOBIN DECREASED,2
IL,HEPATIC FUNCTION ABNORMAL,2
IL,HERPES VIRUS INFECTION,2
IL,HYPOXIA,2
IL,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
IL,INFLUENZA,2
IL,INFUSION RELATED REACTION,2
IL,INJECTION SITE PAIN,2
IL,INTERSTITIAL LUNG DISEASE,2
IL,INTRACRANIAL ANEURYSM,2
IL,MUSCULOSKELETAL STIFFNESS,2
IL,MYALGIA,2
IL,ORAL PAIN,2
IL,ORGAN FAILURE,2
IL,PERICARDIAL EFFUSION,2
IL,PHARYNGEAL INFLAMMATION,2
IL,SPONDYLITIS,2
IL,STILL^S DISEASE,2
IL,THERAPEUTIC RESPONSE DECREASED,2
IL,TREATMENT NONCOMPLIANCE,2
IL,TRISMUS,2
IL,URTICARIA,2
IL,UTERINE MASS,2
IL,UVEITIS,2
IL,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
IL,VOMITING,2
IL,ABASIA,1
IL,ABDOMINAL DISTENSION,1
IL,ABDOMINAL PAIN UPPER,1
IL,ABDOMINAL TENDERNESS,1
IL,ABORTION SPONTANEOUS,1
IL,ABSCESS,1
IL,ACCIDENTAL EXPOSURE TO PRODUCT,1
IL,ACCIDENTAL OVERDOSE,1
IL,AGITATION,1
IL,ALLODYNIA,1
IL,ANAL ABSCESS,1
IL,ANAPHYLACTIC SHOCK,1
IL,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
IL,ANTINUCLEAR ANTIBODY POSITIVE,1
IL,ATYPICAL PNEUMONIA,1
IL,AUTOIMMUNE HEPATITIS,1
IL,BACTERIAL INFECTION,1
IL,BEDRIDDEN,1
IL,BLISTER,1
IL,BLOOD BILIRUBIN INCREASED,1
IL,BLOOD CALCIUM DECREASED,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD PRESSURE ABNORMAL,1
IL,BLOOD TEST ABNORMAL,1
IL,BONE PAIN,1
IL,BURSITIS,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CALCIUM DEFICIENCY,1
IL,CAMPYLOBACTER TEST POSITIVE,1
IL,CARDIAC ARREST,1
IL,CARDIAC DISORDER,1
IL,CATHETER SITE PAIN,1
IL,CHOLANGITIS SCLEROSING,1
IL,CHOLECYSTECTOMY,1
IL,CHONDROPATHY,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,CITROBACTER TEST POSITIVE,1
IL,COLECTOMY,1
IL,COLITIS,1
IL,CONSTIPATION,1
IL,CSF PROTEIN INCREASED,1
IL,DEATH,1
IL,DECUBITUS ULCER,1
IL,DEEP VEIN THROMBOSIS,1
IL,DEVICE ISSUE,1
IL,DEVICE OCCLUSION,1
IL,DIABETES MELLITUS,1
IL,DISEASE RECURRENCE,1
IL,DISSEMINATED TUBERCULOSIS,1
IL,DRUG ERUPTION,1
IL,DRUG LEVEL DECREASED,1
IL,DRUG SPECIFIC ANTIBODY PRESENT,1
IL,DRY MOUTH,1
IL,DYSPEPSIA,1
IL,DYSPNOEA AT REST,1
IL,DYSURIA,1
IL,EATING DISORDER,1
IL,EPILEPSY,1
IL,ESCHERICHIA INFECTION,1
IL,EXPOSURE DURING PREGNANCY,1
IL,FACIAL PARALYSIS,1
IL,FALL,1
IL,FEELING COLD,1
IL,FELTY^S SYNDROME,1
IL,FISTULA,1
IL,FUNGAL INFECTION,1
IL,GALLBLADDER ADENOCARCINOMA,1
IL,GANGRENE,1
IL,GASTRODUODENAL ULCER,1
IL,GASTROINTESTINAL DISORDER,1
IL,GASTROINTESTINAL INFLAMMATION,1
IL,GASTROINTESTINAL OEDEMA,1
IL,GENERAL PHYSICAL HEALTH DETERIORATION,1
IL,GENERAL SYMPTOM,1
IL,GRAFT VERSUS HOST DISEASE IN SKIN,1
IL,GRANULOCYTOPENIA,1
IL,GRANULOMATOSIS WITH POLYANGIITIS,1
IL,HAEMATOCHEZIA,1
IL,HAEMOLYTIC ANAEMIA,1
IL,HAEMORRHOIDS,1
IL,HAND FRACTURE,1
IL,HEAD INJURY,1
IL,HEART VALVE INCOMPETENCE,1
IL,HEMIPARESIS,1
IL,HEPATIC ENZYME INCREASED,1
IL,HEPATIC FAILURE,1
IL,HEPATITIS B,1
IL,HEPATITIS TOXIC,1
IL,HEPATOMEGALY,1
IL,HERPES ZOSTER DISSEMINATED,1
IL,HYPERAESTHESIA,1
IL,HYPERCHOLESTEROLAEMIA,1
IL,HYPERLIPIDAEMIA,1
IL,HYPERTRIGLYCERIDAEMIA,1
IL,HYPOALBUMINAEMIA,1
IL,HYPOREFLEXIA,1
IL,IMMUNOSUPPRESSION,1
IL,INFERTILITY,1
IL,INFERTILITY MALE,1
IL,INFLAMMATION,1
IL,INFLAMMATORY BOWEL DISEASE,1
IL,INJECTION SITE HAEMORRHAGE,1
IL,INSOMNIA,1
IL,KETONURIA,1
IL,LEUKAEMIA,1
IL,LEUKAEMIA RECURRENT,1
IL,LIVER FUNCTION TEST ABNORMAL,1
IL,LIVER FUNCTION TEST INCREASED,1
IL,LOSS OF CONSCIOUSNESS,1
IL,LUPUS NEPHRITIS,1
IL,LYMPHOMA,1
IL,MATERNAL EXPOSURE DURING PREGNANCY,1
IL,MEDICAL DEVICE SITE PAIN,1
IL,MEDICATION ERROR,1
IL,MENINGITIS HAEMOPHILUS,1
IL,MENINGOENCEPHALITIS VIRAL,1
IL,MICROCYTIC ANAEMIA,1
IL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IL,MUSCULAR WEAKNESS,1
IL,MUSCULOSKELETAL DISCOMFORT,1
IL,MYELITIS,1
IL,MYELOID LEUKAEMIA,1
IL,MYOSITIS,1
IL,NASOPHARYNGITIS,1
IL,NAUSEA,1
IL,NERVOUS SYSTEM DISORDER,1
IL,NEUROLOGICAL DECOMPENSATION,1
IL,NEUROPATHY PERIPHERAL,1
IL,NEUTROPHIL COUNT DECREASED,1
IL,NON-HODGKIN^S LYMPHOMA RECURRENT,1
IL,OEDEMA,1
IL,OEDEMA PERIPHERAL,1
IL,OSTEITIS,1
IL,OSTEOPOROTIC FRACTURE,1
IL,OVARIAN FAILURE,1
IL,OVERDOSE,1
IL,PALLOR,1
IL,PARAESTHESIA,1
IL,PARALYSIS,1
IL,PELVIC PAIN,1
IL,PERIPORTAL OEDEMA,1
IL,PHOTOSENSITIVITY REACTION,1
IL,PLATELET COUNT ABNORMAL,1
IL,PLATELET COUNT DECREASED,1
IL,PLEURAL EFFUSION,1
IL,PLEUROPERICARDITIS,1
IL,POST PROCEDURAL COMPLICATION,1
IL,POST PROCEDURAL SEPSIS,1
IL,POUCHITIS,1
IL,PRESCRIBED OVERDOSE,1
IL,PROSTATE CANCER,1
IL,PULMONARY ARTERIAL HYPERTENSION,1
IL,PULMONARY ARTERIAL PRESSURE INCREASED,1
IL,PULMONARY EMBOLISM,1
IL,PULMONARY FUNCTION TEST ABNORMAL,1
IL,PULMONARY OEDEMA,1
IL,RALES,1
IL,RASH PAPULAR,1
IL,RASH PUSTULAR,1
IL,RASH VESICULAR,1
IL,RENAL CYST,1
IL,RENAL FAILURE,1
IL,RENAL IMPAIRMENT,1
IL,RHEUMATOID ARTHRITIS,1
IL,SCAB,1
IL,SENSORY DISTURBANCE,1
IL,SEROSITIS,1
IL,SEROUS CYSTADENOCARCINOMA OVARY,1
IL,SKIN DISCOLOURATION,1
IL,SKIN LESION,1
IL,SOMNOLENCE,1
IL,SPINAL DISORDER,1
IL,SPINAL PAIN,1
IL,SPLENOMEGALY,1
IL,STAPHYLOCOCCAL INFECTION,1
IL,STEM CELL TRANSPLANT,1
IL,STOMATITIS,1
IL,STREPTOCOCCAL URINARY TRACT INFECTION,1
IL,SUFFOCATION FEELING,1
IL,SUPERIOR VENA CAVA SYNDROME,1
IL,SYSTEMIC CANDIDA,1
IL,TACHYPNOEA,1
IL,TENDON PAIN,1
IL,TENDON RUPTURE,1
IL,TERMINAL STATE,1
IL,THERAPY CHANGE,1
IL,THROMBOSIS,1
IL,THROMBOTIC MICROANGIOPATHY,1
IL,TOOTH INFECTION,1
IL,TREATMENT FAILURE,1
IL,TUBERCULIN TEST POSITIVE,1
IL,TUBERCULOSIS,1
IL,UNDERDOSE,1
IL,URINARY SEDIMENT PRESENT,1
IL,URINARY TRACT INFECTION,1
IL,URINE OUTPUT DECREASED,1
IL,VASCULAR INJURY,1
IL,VENOOCCLUSIVE LIVER DISEASE,1
IL,VENTRICULAR TACHYCARDIA,1
IL,WHITE MATTER LESION,1
IT,HYPERTENSION,92
IT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,92
IT,PRODUCT USE IN UNAPPROVED INDICATION,73
IT,PYREXIA,72
IT,NEUTROPENIA,71
IT,DRUG INEFFECTIVE,57
IT,PNEUMONIA,54
IT,THROMBOCYTOPENIA,50
IT,DEATH,48
IT,NAUSEA,45
IT,DISEASE PROGRESSION,44
IT,SEIZURE,40
IT,SEPSIS,37
IT,TOXICITY TO VARIOUS AGENTS,35
IT,VOMITING,32
IT,ANAEMIA,29
IT,CHRONIC GRAFT VERSUS HOST DISEASE,29
IT,PANCYTOPENIA,29
IT,VENOOCCLUSIVE LIVER DISEASE,29
IT,ACUTE GRAFT VERSUS HOST DISEASE,28
IT,CONDITION AGGRAVATED,28
IT,DIARRHOEA,28
IT,DYSPNOEA,28
IT,MUCOSAL INFLAMMATION,28
IT,ALANINE AMINOTRANSFERASE INCREASED,27
IT,HEADACHE,27
IT,NON-HODGKIN^S LYMPHOMA RECURRENT,27
IT,NEUROTOXICITY,26
IT,ABDOMINAL PAIN,25
IT,HEPATOTOXICITY,25
IT,ASTHENIA,24
IT,COUGH,24
IT,NEPHROPATHY TOXIC,24
IT,FEBRILE NEUTROPENIA,23
IT,ASPARTATE AMINOTRANSFERASE INCREASED,22
IT,SALIVARY GLAND CANCER,22
IT,SEPTIC SHOCK,22
IT,PARAESTHESIA,21
IT,PRODUCT USE ISSUE,21
IT,COMA,20
IT,HAEMATURIA,20
IT,CONFUSIONAL STATE,19
IT,GRAFT VERSUS HOST DISEASE IN SKIN,19
IT,HYPOTENSION,19
IT,PULMONARY MASS,19
IT,TRANSAMINASES INCREASED,19
IT,ASPERGILLUS INFECTION,18
IT,MYELODYSPLASTIC SYNDROME,18
IT,ATRIAL FIBRILLATION,17
IT,BRONCHITIS,17
IT,CHOLECYSTITIS ACUTE,17
IT,ERYTHEMA,17
IT,INFECTION,17
IT,LEUKOPENIA,17
IT,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,16
IT,PRURITUS,16
IT,RENAL FAILURE,16
IT,STOMATITIS,16
IT,TREATMENT FAILURE,16
IT,URTICARIA,16
IT,ARTHRITIS,15
IT,CYTOMEGALOVIRUS INFECTION,15
IT,THERAPEUTIC RESPONSE DECREASED,15
IT,BONE MARROW FAILURE,14
IT,FATIGUE,14
IT,NERVOUS SYSTEM DISORDER,14
IT,HAEMATOTOXICITY,13
IT,HYPOGLYCAEMIA,13
IT,MALAISE,13
IT,NEUROPATHY PERIPHERAL,13
IT,PLEURISY,13
IT,ACUTE KIDNEY INJURY,12
IT,CARDIAC FAILURE,12
IT,CHILLS,12
IT,HEPATITIS B REACTIVATION,12
IT,INFUSION RELATED REACTION,12
IT,METASTASES TO BREAST,12
IT,PSORIASIS,12
IT,ABDOMINAL PAIN UPPER,11
IT,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,11
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,11
IT,ALOPECIA,11
IT,ASCITES,11
IT,BRONCHOPULMONARY ASPERGILLOSIS,11
IT,DYSPHAGIA,11
IT,ENDOPHTHALMITIS,11
IT,JUVENILE MELANOMA BENIGN,11
IT,KLEBSIELLA INFECTION,11
IT,PLATELET COUNT DECREASED,11
IT,PNEUMONITIS,11
IT,PULMONARY EMBOLISM,11
IT,ARTHRALGIA,10
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,10
IT,BLINDNESS,10
IT,DYSARTHRIA,10
IT,ESCHERICHIA INFECTION,10
IT,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,10
IT,HERPES SIMPLEX,10
IT,MALIGNANT NEOPLASM PROGRESSION,10
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,10
IT,NEPHROLITHIASIS,10
IT,OSTEONECROSIS OF JAW,10
IT,RESPIRATORY FAILURE,10
IT,RHEUMATOID ARTHRITIS,10
IT,URINARY TRACT INFECTION,10
IT,VERTIGO,10
IT,WHIPPLE^S DISEASE,10
IT,ARRHYTHMIA,9
IT,B-CELL LYMPHOMA,9
IT,BACTERIAL SEPSIS,9
IT,BASAL CELL CARCINOMA,9
IT,CELLULITIS,9
IT,CEREBRAL HAEMORRHAGE,9
IT,FUNGAL SEPSIS,9
IT,FUSARIUM INFECTION,9
IT,GASTROINTESTINAL DISORDER,9
IT,GENERAL PHYSICAL HEALTH DETERIORATION,9
IT,LEUKOENCEPHALOPATHY,9
IT,MALIGNANT MELANOMA,9
IT,METASTASIS,9
IT,PETECHIAE,9
IT,PLEURAL EFFUSION,9
IT,RENAL IMPAIRMENT,9
IT,SYNCOPE,9
IT,BLADDER CANCER,8
IT,BONE FISTULA,8
IT,BREAST CANCER,8
IT,CANDIDA INFECTION,8
IT,CHEST PAIN,8
IT,CYSTITIS HAEMORRHAGIC,8
IT,HEPATIC FAILURE,8
IT,HEPATIC STEATOSIS,8
IT,HYPERTRANSAMINASAEMIA,8
IT,MORPHOEA,8
IT,OSTEONECROSIS,8
IT,PNEUMOTHORAX,8
IT,PULMONARY TUBERCULOSIS,8
IT,RECURRENT CANCER,8
IT,SEROTONIN SYNDROME,8
IT,WEIGHT DECREASED,8
IT,ACUTE MYELOID LEUKAEMIA,7
IT,ACUTE MYOCARDIAL INFARCTION,7
IT,ALTERED STATE OF CONSCIOUSNESS,7
IT,BLOOD BILIRUBIN INCREASED,7
IT,CHOLANGIOCARCINOMA,7
IT,CHOLANGITIS,7
IT,COLITIS,7
IT,CYTOKINE RELEASE SYNDROME,7
IT,DECREASED APPETITE,7
IT,DISORIENTATION,7
IT,ENTEROCOCCAL INFECTION,7
IT,GROWTH RETARDATION,7
IT,HAEMOGLOBIN DECREASED,7
IT,HYPERSENSITIVITY,7
IT,HYPONATRAEMIA,7
IT,INFLUENZA,7
IT,INTERSTITIAL LUNG DISEASE,7
IT,KAPOSI^S SARCOMA,7
IT,MEDICATION ERROR,7
IT,MYCOBACTERIAL INFECTION,7
IT,MYOCARDIAL INFARCTION,7
IT,NO THERAPEUTIC RESPONSE,7
IT,OSTEOPENIA,7
IT,PULMONARY FIBROSIS,7
IT,RASH,7
IT,SHOCK HAEMORRHAGIC,7
IT,THERAPY NON-RESPONDER,7
IT,THROAT IRRITATION,7
IT,ABSCESS LIMB,6
IT,AGITATION,6
IT,ATAXIA,6
IT,ATRIAL FLUTTER,6
IT,BRONCHOPNEUMONIA,6
IT,CAMPYLOBACTER INFECTION,6
IT,CANDIDA ENDOPHTHALMITIS,6
IT,CARDIOTOXICITY,6
IT,COAGULOPATHY,6
IT,CROHN^S DISEASE,6
IT,CYTOPENIA,6
IT,DISEASE RECURRENCE,6
IT,DIZZINESS,6
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,6
IT,DRUG INTOLERANCE,6
IT,ENCEPHALOPATHY,6
IT,EPSTEIN-BARR VIRUS INFECTION,6
IT,GLOMERULAR FILTRATION RATE DECREASED,6
IT,HEPATITIS ACUTE,6
IT,HEPATITIS B,6
IT,HYPERHIDROSIS,6
IT,HYPERSENSITIVITY VASCULITIS,6
IT,HYPOGLYCAEMIC COMA,6
IT,INVASIVE DUCTAL BREAST CARCINOMA,6
IT,LIVER TENDERNESS,6
IT,LOSS OF CONSCIOUSNESS,6
IT,LUNG ADENOCARCINOMA,6
IT,LUNG INFECTION,6
IT,LYMPHADENOPATHY,6
IT,MATERNAL EXPOSURE DURING PREGNANCY,6
IT,MELAENA,6
IT,METASTASES TO LIVER,6
IT,MUCOSAL INFECTION,6
IT,OLIGURIA,6
IT,ORTHOSTATIC HYPOTENSION,6
IT,PAIN,6
IT,PANNICULITIS,6
IT,PERITONITIS,6
IT,PHARYNGITIS,6
IT,POLYP,6
IT,PSORIATIC ARTHROPATHY,6
IT,Q FEVER,6
IT,RHINITIS,6
IT,SALIVARY GLAND NEOPLASM,6
IT,SKIN LESION,6
IT,SOPOR,6
IT,THROAT TIGHTNESS,6
IT,VISUAL IMPAIRMENT,6
IT,VULVOVAGINAL CANDIDIASIS,6
IT,WEIGHT INCREASED,6
IT,ACUTE RESPIRATORY FAILURE,5
IT,ANXIETY,5
IT,AUTONOMIC NERVOUS SYSTEM IMBALANCE,5
IT,AZOOSPERMIA,5
IT,BREAST MASS,5
IT,BRONCHOSPASM,5
IT,CARDIAC TAMPONADE,5
IT,CATARACT,5
IT,CHOLESTASIS,5
IT,CHRONIC GASTRITIS,5
IT,CONJUNCTIVITIS,5
IT,CULTURE STOOL POSITIVE,5
IT,DEEP VEIN THROMBOSIS,5
IT,DELIRIUM,5
IT,DRUG EFFECT INCOMPLETE,5
IT,DYSPEPSIA,5
IT,ERYSIPELAS,5
IT,EXPOSURE DURING PREGNANCY,5
IT,GASTROINTESTINAL TOXICITY,5
IT,HEPATOMEGALY,5
IT,HYPOKALAEMIA,5
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,5
IT,LARYNGEAL OEDEMA,5
IT,LEUKOCYTOSIS,5
IT,LUNG DISORDER,5
IT,LYME DISEASE,5
IT,LYMPHOPENIA,5
IT,MENINGITIS ASEPTIC,5
IT,MUCOSAL NECROSIS,5
IT,MULTI-ORGAN FAILURE,5
IT,NEOPLASM,5
IT,NEUROFIBROMATOSIS,5
IT,NEUTROPHIL COUNT DECREASED,5
IT,NON-HODGKIN^S LYMPHOMA,5
IT,ORAL DISORDER,5
IT,OSTEOPOROSIS,5
IT,PARAPLEGIA,5
IT,PERICARDITIS,5
IT,PHARYNGOTONSILLITIS,5
IT,PORTAL HYPERTENSION,5
IT,PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT,5
IT,RENAL FAILURE ACUTE,5
IT,RESPIRATORY DISTRESS,5
IT,RESTRICTIVE PULMONARY DISEASE,5
IT,SECOND PRIMARY MALIGNANCY,5
IT,SQUAMOUS CELL CARCINOMA OF SKIN,5
IT,STAPHYLOCOCCAL INFECTION,5
IT,SUDDEN DEATH,5
IT,SWELLING,5
IT,TACHYCARDIA,5
IT,TOXIC EPIDERMAL NECROLYSIS,5
IT,TREMOR,5
IT,UPPER RESPIRATORY TRACT INFECTION,5
IT,VISUAL ACUITY REDUCED,5
IT,VULVOVAGINAL PRURITUS,5
IT,WERNICKE^S ENCEPHALOPATHY,5
IT,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,4
IT,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,4
IT,ADVERSE DRUG REACTION,4
IT,AMNESIA,4
IT,ANGIOEDEMA,4
IT,BACTERIAL INFECTION,4
IT,BEHCET^S SYNDROME,4
IT,BLOOD CREATININE INCREASED,4
IT,BRADYCARDIA,4
IT,CARDIOGENIC SHOCK,4
IT,CATARRH,4
IT,CEREBROVASCULAR ACCIDENT,4
IT,COLON CANCER,4
IT,CONSTIPATION,4
IT,CUTANEOUS TUBERCULOSIS,4
IT,DEPRESSED MOOD,4
IT,DEVICE RELATED INFECTION,4
IT,DIVERTICULITIS,4
IT,DRUG ABUSE,4
IT,DRUG RESISTANCE,4
IT,DYSURIA,4
IT,ELECTROLYTE IMBALANCE,4
IT,ENDOCARDITIS,4
IT,EPILEPSY,4
IT,EYE PAIN,4
IT,GAIT DISTURBANCE,4
IT,GASTRITIS EROSIVE,4
IT,GASTROINTESTINAL HAEMORRHAGE,4
IT,GRAFT VERSUS HOST DISEASE,4
IT,HAEMATOMA,4
IT,HAEMORRHAGE,4
IT,HAND DERMATITIS,4
IT,HYPERGLYCAEMIA,4
IT,HYPERKERATOSIS,4
IT,HYPERPYREXIA,4
IT,HYPOALBUMINAEMIA,4
IT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
IT,IMMUNOSUPPRESSION,4
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
IT,INFECTION MASKED,4
IT,INFLAMMATORY BOWEL DISEASE,4
IT,INTENTIONAL PRODUCT MISUSE,4
IT,INTESTINAL OBSTRUCTION,4
IT,INTESTINAL PERFORATION,4
IT,JAUNDICE,4
IT,JOINT SWELLING,4
IT,LARGE INTESTINE PERFORATION,4
IT,LETHARGY,4
IT,LOSS OF PROPRIOCEPTION,4
IT,LUPUS-LIKE SYNDROME,4
IT,MALIGNANT MELANOMA IN SITU,4
IT,MENTAL STATUS CHANGES,4
IT,METASTASES TO LUNG,4
IT,MUCOEPIDERMOID CARCINOMA OF SALIVARY GLAND,4
IT,MUSCLE SPASMS,4
IT,NAIL DISORDER,4
IT,NASOPHARYNGITIS,4
IT,NODULE,4
IT,OSTEOMYELITIS,4
IT,OXYGEN SATURATION DECREASED,4
IT,PALMAR ERYTHEMA,4
IT,PLASMA CELL MYELOMA,4
IT,PLEUROPERICARDITIS,4
IT,POLYPECTOMY,4
IT,PORPHYROMONAS INFECTION,4
IT,PURULENT PERICARDITIS,4
IT,PUSTULAR PSORIASIS,4
IT,RECTAL HAEMORRHAGE,4
IT,RESPIRATORY DISORDER,4
IT,SARCOMA,4
IT,SKIN ATROPHY,4
IT,SLEEP APNOEA SYNDROME,4
IT,SOMNOLENCE,4
IT,THYROID CANCER,4
IT,TOOTH ABSCESS,4
IT,TOXIC LEUKOENCEPHALOPATHY,4
IT,TOXOPLASMOSIS,4
IT,TRAUMATIC LUNG INJURY,4
IT,TRISOMY 18,4
IT,TUBERCULOSIS,4
IT,VASOPLEGIA SYNDROME,4
IT,VULVOVAGINITIS TRICHOMONAL,4
IT,ABORTION,3
IT,ABORTION SPONTANEOUS,3
IT,ACUTE ABDOMEN,3
IT,ADVERSE EVENT,3
IT,AMENORRHOEA,3
IT,APLASIA,3
IT,APRAXIA,3
IT,BLINDNESS CORTICAL,3
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,3
IT,C-REACTIVE PROTEIN INCREASED,3
IT,CARDIAC FAILURE ACUTE,3
IT,COLON CANCER STAGE II,3
IT,CYTOGENETIC ANALYSIS ABNORMAL,3
IT,DEPRESSION,3
IT,DIARRHOEA HAEMORRHAGIC,3
IT,DRUG CLEARANCE DECREASED,3
IT,DUODENAL ULCER,3
IT,DYSKINESIA,3
IT,DYSPHONIA,3
IT,ENCEPHALITIS,3
IT,ENCEPHALITIS FUNGAL,3
IT,EPISTAXIS,3
IT,ERYTHRODERMIC PSORIASIS,3
IT,FACE OEDEMA,3
IT,FISTULA,3
IT,FLUSHING,3
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
IT,GASTRIC POLYPS,3
IT,GENERALISED TONIC-CLONIC SEIZURE,3
IT,GLAUCOMA,3
IT,HAEMATEMESIS,3
IT,HAEMATOCHEZIA,3
IT,HAEMOCHROMATOSIS,3
IT,HALLUCINATION,3
IT,HEMIANOPIA,3
IT,HEMIPARESIS,3
IT,HEPATIC CIRRHOSIS,3
IT,HEPATIC ENZYME INCREASED,3
IT,HERPES ZOSTER,3
IT,HERPES ZOSTER INFECTION NEUROLOGICAL,3
IT,HODGKIN^S DISEASE,3
IT,HYDROCEPHALUS,3
IT,HYPERAEMIA,3
IT,HYPERTENSIVE CRISIS,3
IT,HYPOACUSIS,3
IT,HYPOCALCAEMIA,3
IT,HYPOTONIA,3
IT,INCORRECT DOSE ADMINISTERED,3
IT,IRIDOCYCLITIS,3
IT,LEGIONELLA INFECTION,3
IT,LEUKAEMIA RECURRENT,3
IT,LIVER ABSCESS,3
IT,LOCALISED OEDEMA,3
IT,LYMPHANGIOSIS CARCINOMATOSA,3
IT,LYMPHANGITIS,3
IT,MEDIASTINITIS,3
IT,MEMORY IMPAIRMENT,3
IT,MENINGIOMA,3
IT,MENINGOENCEPHALITIS BACTERIAL,3
IT,METAPLASTIC BREAST CARCINOMA,3
IT,MOUTH ULCERATION,3
IT,MUCORMYCOSIS,3
IT,MULTIPLE-DRUG RESISTANCE,3
IT,MUSCULOSKELETAL PAIN,3
IT,MYALGIA,3
IT,MYELOID LEUKAEMIA,3
IT,MYELOPROLIFERATIVE DISORDER,3
IT,ORAL PAIN,3
IT,OVERDOSE,3
IT,PAIN IN EXTREMITY,3
IT,PANCREATITIS,3
IT,PARAPARESIS,3
IT,PERICARDITIS CONSTRICTIVE,3
IT,PERIPHERAL MOTOR NEUROPATHY,3
IT,PERIPHERAL SENSORY NEUROPATHY,3
IT,PERIPHERAL SWELLING,3
IT,PNEUMONIA CYTOMEGALOVIRAL,3
IT,PSEUDOMONAL SEPSIS,3
IT,PSEUDOMONAS INFECTION,3
IT,RASH MACULO-PAPULAR,3
IT,RENAL CANCER,3
IT,RENAL CELL CARCINOMA,3
IT,RESPIRATORY TRACT INFECTION FUNGAL,3
IT,SKIN TOXICITY,3
IT,SLEEP DISORDER,3
IT,SPINAL FRACTURE,3
IT,STAPHYLOCOCCAL SEPSIS,3
IT,STREPTOCOCCAL INFECTION,3
IT,THROMBOSIS,3
IT,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,3
IT,TRANSPLANTATION COMPLICATION,3
IT,TREATMENT NONCOMPLIANCE,3
IT,UVEITIS,3
IT,VENOOCCLUSIVE DISEASE,3
IT,VENOUS THROMBOSIS,3
IT,VITRECTOMY,3
IT,ABSCESS JAW,2
IT,ACCIDENTAL OVERDOSE,2
IT,ACQUIRED GENE MUTATION,2
IT,ACTINOMYCOSIS,2
IT,ADENOCARCINOMA OF COLON,2
IT,ALANINE AMINOTRANSFERASE ABNORMAL,2
IT,AMERICAN TRYPANOSOMIASIS,2
IT,AMYLASE ABNORMAL,2
IT,AMYOTROPHY,2
IT,ANAPHYLACTIC REACTION,2
IT,ANAPHYLACTIC SHOCK,2
IT,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,2
IT,ANGIOSARCOMA,2
IT,ANTIPHOSPHOLIPID SYNDROME,2
IT,AORTIC ANEURYSM RUPTURE,2
IT,APHASIA,2
IT,APHTHOUS ULCER,2
IT,APPENDICITIS,2
IT,ARTHRITIS BACTERIAL,2
IT,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
IT,AZOTAEMIA,2
IT,BACTERAEMIA,2
IT,BALANCE DISORDER,2
IT,BENIGN BREAST NEOPLASM,2
IT,BILIARY CIRRHOSIS PRIMARY,2
IT,BILIARY HAMARTOMA,2
IT,BLOOD BILIRUBIN ABNORMAL,2
IT,BLOOD CHOLESTEROL INCREASED,2
IT,BLOOD FIBRINOGEN DECREASED,2
IT,BLOOD TRIGLYCERIDES INCREASED,2
IT,BODY TEMPERATURE INCREASED,2
IT,BONE PAIN,2
IT,BREAST CANCER RECURRENT,2
IT,BURSITIS,2
IT,BURSITIS INFECTIVE,2
IT,CANDIDA SEPSIS,2
IT,CAUDA EQUINA SYNDROME,2
IT,CEREBRAL ISCHAEMIA,2
IT,CEREBRAL TOXOPLASMOSIS,2
IT,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,2
IT,CHEST DISCOMFORT,2
IT,CHOLANGITIS SCLEROSING,2
IT,CHOLECYSTITIS,2
IT,CHORIORETINAL DISORDER,2
IT,COGNITIVE DISORDER,2
IT,CONJUNCTIVAL OEDEMA,2
IT,CRANIAL NERVE INFECTION,2
IT,CRANIOFACIAL DYSOSTOSIS,2
IT,CUSHING^S SYNDROME,2
IT,CYANOSIS,2
IT,CYSTITIS,2
IT,DERMATITIS,2
IT,DERMO-HYPODERMITIS,2
IT,DIABETES MELLITUS,2
IT,DIABETIC FOOT,2
IT,DILATATION ATRIAL,2
IT,DIPLOPIA,2
IT,DIVERTICULAR PERFORATION,2
IT,DRUG HYPERSENSITIVITY,2
IT,DRUG-INDUCED LIVER INJURY,2
IT,EMPHYSEMA,2
IT,ENTEROCOCCAL BACTERAEMIA,2
IT,ESCHERICHIA SEPSIS,2
IT,EWING^S SARCOMA,2
IT,EYE ABSCESS,2
IT,EYELID OEDEMA,2
IT,FALL,2
IT,FEMALE GENITAL TRACT FISTULA,2
IT,FOLLICULITIS,2
IT,FUNGAL INFECTION,2
IT,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,2
IT,GASTRIC CANCER,2
IT,GASTROENTERITIS,2
IT,GENERALISED ERYTHEMA,2
IT,GENITAL INFECTION,2
IT,GLIOBLASTOMA,2
IT,GRAFT VERSUS HOST DISEASE IN LIVER,2
IT,GUILLAIN-BARRE SYNDROME,2
IT,HAEMORRHAGE INTRACRANIAL,2
IT,HAEMORRHAGIC ANAEMIA,2
IT,HEMIPLEGIA,2
IT,HEPATIC FUNCTION ABNORMAL,2
IT,HEPATITIS B VIRUS TEST POSITIVE,2
IT,HIGH DENSITY LIPOPROTEIN INCREASED,2
IT,HYPERCREATININAEMIA,2
IT,HYPOAESTHESIA,2
IT,HYPOPNOEA,2
IT,IMPETIGO,2
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
IT,INFLUENZA LIKE ILLNESS,2
IT,INFUSION SITE OEDEMA,2
IT,INTENTIONAL OVERDOSE,2
IT,INTESTINAL POLYP,2
IT,INTRAOCULAR PRESSURE INCREASED,2
IT,INVASIVE LOBULAR BREAST CARCINOMA,2
IT,IRIS ADHESIONS,2
IT,IRREGULAR BREATHING,2
IT,LIPASE ABNORMAL,2
IT,LISTERIA ENCEPHALITIS,2
IT,LIVER FUNCTION TEST INCREASED,2
IT,LOCAL SWELLING,2
IT,LUNG NEOPLASM MALIGNANT,2
IT,METABOLIC DISORDER,2
IT,METASTATIC NEOPLASM,2
IT,MIGRAINE,2
IT,MILLER FISHER SYNDROME,2
IT,MONOCLONAL B-CELL LYMPHOCYTOSIS,2
IT,MOTOR DYSFUNCTION,2
IT,MULTIPLE FRACTURES,2
IT,MUSCLE RIGIDITY,2
IT,MUSCULAR WEAKNESS,2
IT,MUSCULOSKELETAL STIFFNESS,2
IT,MYELOPATHY,2
IT,MYOSITIS,2
IT,NECROSIS,2
IT,NEOPLASM MALIGNANT,2
IT,NEOPLASM PROGRESSION,2
IT,NEPHROTIC SYNDROME,2
IT,NO ADVERSE EVENT,2
IT,NOCARDIOSIS,2
IT,NON-HODGKIN^S LYMPHOMA REFRACTORY,2
IT,OESOPHAGITIS,2
IT,ORAL INFECTION,2
IT,ORAL MUCOSAL ERYTHEMA,2
IT,ORGAN FAILURE,2
IT,OROPHARYNGEAL PAIN,2
IT,OROPHARYNGITIS FUNGAL,2
IT,OSTEOARTHRITIS,2
IT,OSTEOMYELITIS BACTERIAL,2
IT,OSTEOSARCOMA,2
IT,PANCREATIC NEOPLASM,2
IT,PANCREATITIS ACUTE,2
IT,PAPILLARY THYROID CANCER,2
IT,PENILE SQUAMOUS CELL CARCINOMA,2
IT,PLEOCYTOSIS,2
IT,POLYMYOSITIS,2
IT,PREGNANCY,2
IT,PREMATURE MENOPAUSE,2
IT,PRESYNCOPE,2
IT,PRODUCTIVE COUGH,2
IT,PROTEINURIA,2
IT,PRURITUS GENERALISED,2
IT,PSEUDOMONAS BRONCHITIS,2
IT,PSYCHOMOTOR RETARDATION,2
IT,PSYCHOTIC DISORDER,2
IT,PULMONARY SEPSIS,2
IT,RESPIRATORY TRACT INFECTION,2
IT,ROSEOLA,2
IT,SALIVARY GLAND CANCER RECURRENT,2
IT,SCROTAL ABSCESS,2
IT,SENSORY LOSS,2
IT,SKIN NECROSIS,2
IT,SPLENOMEGALY,2
IT,SPUTUM DISCOLOURED,2
IT,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,2
IT,STATUS EPILEPTICUS,2
IT,STENOTROPHOMONAS SEPSIS,2
IT,STOMATITIS NECROTISING,2
IT,STREPTOCOCCAL SEPSIS,2
IT,SUICIDE ATTEMPT,2
IT,SUPERINFECTION,2
IT,SUPERINFECTION FUNGAL,2
IT,SWELLING FACE,2
IT,SYNOVITIS,2
IT,SYSTEMIC LUPUS ERYTHEMATOSUS,2
IT,TENDONITIS,2
IT,TRACHEOBRONCHITIS,2
IT,TRANSIENT ISCHAEMIC ATTACK,2
IT,TRANSITIONAL CELL CARCINOMA,2
IT,TRISMUS,2
IT,TROPONIN I INCREASED,2
IT,TUMOUR LYSIS SYNDROME,2
IT,URINARY INCONTINENCE,2
IT,URINARY RETENTION,2
IT,URINARY TRACT INFECTION BACTERIAL,2
IT,UTERINE POLYP,2
IT,VASCULITIS,2
IT,VITREOUS FLOATERS,2
IT,VITRITIS,2
IT,WHITE BLOOD CELL COUNT DECREASED,2
IT,ABASIA,1
IT,ABDOMINAL DISTENSION,1
IT,ABDOMINAL INFECTION,1
IT,ABDOMINAL MASS,1
IT,ABDOMINAL TENDERNESS,1
IT,ABSCESS BACTERIAL,1
IT,ACINIC CELL CARCINOMA OF SALIVARY GLAND,1
IT,ACTINIC CHEILITIS,1
IT,ACUTE CORONARY SYNDROME,1
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
IT,ACUTE SINUSITIS,1
IT,ADENOCARCINOMA,1
IT,ADENOMA BENIGN,1
IT,ADENOVIRUS INFECTION,1
IT,ADNEXA UTERI CYST,1
IT,AEROMONA INFECTION,1
IT,AEROMONAS INFECTION,1
IT,ALLERGIC OEDEMA,1
IT,AMYOTROPHIC LATERAL SCLEROSIS,1
IT,ANAEMIA HAEMOLYTIC AUTOIMMUNE,1
IT,ANAEMIA MACROCYTIC,1
IT,ANGINA UNSTABLE,1
IT,ANISOCYTOSIS,1
IT,ANOSMIA,1
IT,ANTISYNTHETASE SYNDROME,1
IT,AORTIC VALVE INCOMPETENCE,1
IT,APHONIA,1
IT,APPARENT LIFE THREATENING EVENT,1
IT,ARTERIOSCLEROSIS,1
IT,ARTHRITIS INFECTIVE,1
IT,ARTHROPATHY,1
IT,ARTHROPOD BITE,1
IT,ASPERGILLUS TEST POSITIVE,1
IT,ASPIRATION TRACHEAL,1
IT,ASTHMATIC CRISIS,1
IT,ASTRINGENT THERAPY,1
IT,ASYMPTOMATIC BACTERIURIA,1
IT,ATELECTASIS,1
IT,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
IT,AUTOIMMUNE NEUTROPENIA,1
IT,BACK PAIN,1
IT,BECKER^S NAEVUS,1
IT,BENIGN SALIVARY GLAND NEOPLASM,1
IT,BETA 2 MICROGLOBULIN INCREASED,1
IT,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
IT,BILIARY COLIC,1
IT,BLADDER MASS,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLAST CELL COUNT INCREASED,1
IT,BLAST CELL CRISIS,1
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IT,BLOOD COUNT ABNORMAL,1
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE MB,1
IT,BLOOD IMMUNOGLOBULIN E INCREASED,1
IT,BLOOD IRON DECREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD PRESSURE FLUCTUATION,1
IT,BLOOD PRESSURE INCREASED,1
IT,BLOOD TEST ABNORMAL,1
IT,BLOOD URIC ACID INCREASED,1
IT,BLOOD URINE PRESENT,1
IT,BONE EROSION,1
IT,BONE LESION,1
IT,BONE MARROW DISORDER,1
IT,BRAIN INJURY,1
IT,BRAIN OEDEMA,1
IT,BREAST CANCER FEMALE,1
IT,BREAST CANCER METASTATIC,1
IT,BREAST CANCER STAGE II,1
IT,BRONCHOGENIC CYST,1
IT,BRONCHOSTENOSIS,1
IT,BRUCELLOSIS,1
IT,CACHEXIA,1
IT,CAESAREAN SECTION,1
IT,CALCULUS URETERIC,1
IT,CAMPYLOBACTER SEPSIS,1
IT,CANDIDA TEST POSITIVE,1
IT,CARDIAC DISORDER,1
IT,CARDIAC DYSFUNCTION,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CAROTID ARTERY ANEURYSM,1
IT,CEREBRAL ARTERIOSCLEROSIS,1
IT,CEREBRAL ATROPHY,1
IT,CEREBRAL FUNGAL INFECTION,1
IT,CEREBROVASCULAR DISORDER,1
IT,CERVICAL CYST,1
IT,CERVICAL DYSPLASIA,1
IT,CHALAZION,1
IT,CHOREA,1
IT,CHROMOSOMAL MUTATION,1
IT,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
IT,CLEAR CELL RENAL CELL CARCINOMA,1
IT,CLONIC CONVULSION,1
IT,CLOSTRIDIUM DIFFICILE INFECTION,1
IT,COLECTOMY,1
IT,COLITIS ULCERATIVE,1
IT,COLON NEOPLASM,1
IT,COLORECTAL CANCER,1
IT,COMPLETED SUICIDE,1
IT,COMPLICATIONS OF BONE MARROW TRANSPLANT,1
IT,CONGENITAL DYSKERATOSIS,1
IT,CONJUNCTIVAL HAEMORRHAGE,1
IT,CONJUNCTIVITIS BACTERIAL,1
IT,CONTUSION,1
IT,CONVULSION,1
IT,CORONARY ARTERY DISEASE,1
IT,CORONARY ARTERY STENOSIS,1
IT,CRANIAL NERVE PARALYSIS,1
IT,CSF GLUCOSE ABNORMAL,1
IT,CSF PROTEIN INCREASED,1
IT,CYCLIC VOMITING SYNDROME,1
IT,CYSTITIS ESCHERICHIA,1
IT,CYTOMEGALOVIRUS COLITIS,1
IT,CYTOMEGALOVIRUS VIRAEMIA,1
IT,DEHYDRATION,1
IT,DEPENDENCE,1
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IT,DEPRESSION SUICIDAL,1
IT,DERMATITIS ALLERGIC,1
IT,DERMATOMYOSITIS,1
IT,DESMOPLASTIC MELANOMA,1
IT,DIARRHOEA INFECTIOUS,1
IT,DIFFUSE LARGE B-CELL LYMPHOMA,1
IT,DILATATION INTRAHEPATIC DUCT ACQUIRED,1
IT,DILATATION VENTRICULAR,1
IT,DISABILITY,1
IT,DISCOMFORT,1
IT,DISSEMINATED INTRAVASCULAR COAGULATION,1
IT,DIVERTICULUM INTESTINAL,1
IT,DROP ATTACKS,1
IT,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
IT,DRUG DEPENDENCE,1
IT,DRUG ERUPTION,1
IT,DRUG LEVEL INCREASED,1
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IT,DRUG USE DISORDER,1
IT,DRUG WITHDRAWAL SYNDROME,1
IT,DUODENAL PERFORATION,1
IT,DYSAESTHESIA,1
IT,DYSGEUSIA,1
IT,DYSLEXIA,1
IT,DYSPHORIA,1
IT,EAR HAEMORRHAGE,1
IT,ECZEMA NUMMULAR,1
IT,EJECTION FRACTION DECREASED,1
IT,EMBOLISM,1
IT,EMPTY SELLA SYNDROME,1
IT,ENCEPHALITIS CYTOMEGALOVIRUS,1
IT,ENCEPHALITIS HERPES,1
IT,ENCEPHALITIS VIRAL,1
IT,ENDOCARDITIS Q FEVER,1
IT,ENDOCRINE DISORDER,1
IT,ENTERITIS,1
IT,ENTEROCOLITIS,1
IT,ENTEROCOLITIS INFECTIOUS,1
IT,EOSINOPHILIA,1
IT,EPIDERMOLYSIS,1
IT,EPIGASTRIC DISCOMFORT,1
IT,ERUCTATION,1
IT,ERYTHEMA NODOSUM,1
IT,ERYTHROLEUKAEMIA,1
IT,ESCHERICHIA BACTERAEMIA,1
IT,ESCHERICHIA TEST POSITIVE,1
IT,ESCHERICHIA URINARY TRACT INFECTION,1
IT,EVANS SYNDROME,1
IT,EXECUTIVE DYSFUNCTION,1
IT,EXOPHTHALMOS,1
IT,EXTRAOCULAR MUSCLE PARESIS,1
IT,EXTRAPYRAMIDAL DISORDER,1
IT,EXTRAVASATION BLOOD,1
IT,EYE INFECTION,1
IT,EYE SWELLING,1
IT,EYELID PAIN,1
IT,EYELIDS PRURITUS,1
IT,FACIAL PARALYSIS,1
IT,FALSE POSITIVE INVESTIGATION RESULT,1
IT,FANCONI SYNDROME ACQUIRED,1
IT,FEELING HOT,1
IT,FEELING OF BODY TEMPERATURE CHANGE,1
IT,FIBROMYALGIA,1
IT,FIBROSARCOMA,1
IT,FLUID RETENTION,1
IT,FUSOBACTERIUM INFECTION,1
IT,GALLBLADDER ABSCESS,1
IT,GALLBLADDER DISORDER,1
IT,GASTRIC DISORDER,1
IT,GASTRIC MUCOSA ERYTHEMA,1
IT,GASTRIC OPERATION,1
IT,GASTRIC ULCER,1
IT,GASTROINTESTINAL NEOPLASM,1
IT,GASTROINTESTINAL PAIN,1
IT,GASTROOESOPHAGEAL REFLUX DISEASE,1
IT,GINGIVAL DISORDER,1
IT,GINGIVITIS,1
IT,GLOMERULONEPHRITIS,1
IT,GLOSSITIS,1
IT,GRANULOCYTOPENIA,1
IT,GRANULOMA,1
IT,HAEMANGIOMA OF LIVER,1
IT,HAEMOPHILUS INFECTION,1
IT,HAEMOPTYSIS,1
IT,HAEMORRHAGIC DISORDER,1
IT,HALLUCINATION_ VISUAL,1
IT,HAND DEFORMITY,1
IT,HEPATECTOMY,1
IT,HEPATIC CYST,1
IT,HEPATIC ENZYME ABNORMAL,1
IT,HEPATIC FIBROSIS,1
IT,HEPATIC LESION,1
IT,HEPATIC NEOPLASM,1
IT,HEPATITIS C,1
IT,HEPATOCELLULAR CARCINOMA,1
IT,HEPATOSPLENOMEGALY,1
IT,HIATUS HERNIA,1
IT,HISTIOCYTOSIS HAEMATOPHAGIC,1
IT,HISTOLOGY ABNORMAL,1
IT,HOMICIDE,1
IT,HUMAN HERPESVIRUS 6 INFECTION,1
IT,HUMAN HERPESVIRUS 7 INFECTION,1
IT,HYDRONEPHROSIS,1
IT,HYPERBILIRUBINAEMIA,1
IT,HYPERCREATINAEMIA,1
IT,HYPERNATRAEMIA,1
IT,HYPERPROLACTINAEMIA,1
IT,HYPERREFLEXIA,1
IT,HYPOCHROMASIA,1
IT,HYPOGAMMAGLOBULINAEMIA,1
IT,HYPOKINESIA,1
IT,HYPOPHAGIA,1
IT,ILEAL STENOSIS,1
IT,ILEUS,1
IT,ILEUS PARALYTIC,1
IT,INCREASED BRONCHIAL SECRETION,1
IT,INFARCTION,1
IT,INFECTED FISTULA,1
IT,INFERTILITY,1
IT,INFLAMMATION,1
IT,INFLAMMATORY MARKER INCREASED,1
IT,INJECTION SITE ERYTHEMA,1
IT,INJECTION SITE REACTION,1
IT,INSOMNIA,1
IT,INTENTIONAL DRUG MISUSE,1
IT,INTENTIONAL SELF-INJURY,1
IT,INTERNATIONAL NORMALISED RATIO INCREASED,1
IT,INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED,1
IT,INTESTINAL RESECTION,1
IT,INTESTINAL VILLI ATROPHY,1
IT,INTRADUCTAL PAPILLARY BREAST NEOPLASM,1
IT,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
IT,IRON DEFICIENCY,1
IT,ISCHAEMIC STROKE,1
IT,JOINT EFFUSION,1
IT,JUVENILE IDIOPATHIC ARTHRITIS,1
IT,KLEBSIELLA SEPSIS,1
IT,LACERATION,1
IT,LARYNGITIS,1
IT,LARYNGOSPASM,1
IT,LATENT TUBERCULOSIS,1
IT,LEFT VENTRICULAR HYPERTROPHY,1
IT,LEG AMPUTATION,1
IT,LEUKOCYTURIA,1
IT,LI-FRAUMENI SYNDROME,1
IT,LICHENOID KERATOSIS,1
IT,LIMBIC ENCEPHALITIS,1
IT,LIP OEDEMA,1
IT,LIPOSARCOMA,1
IT,LISTERIOSIS,1
IT,LIVE BIRTH,1
IT,LIVER DISORDER,1
IT,LIVER FUNCTION TEST ABNORMAL,1
IT,LOBULAR BREAST CARCINOMA IN SITU,1
IT,LOWER RESPIRATORY TRACT INFECTION,1
IT,LUMBAR HERNIA,1
IT,LUMBAR PUNCTURE ABNORMAL,1
IT,LUMBAR VERTEBRAL FRACTURE,1
IT,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,1
IT,LUNG NEOPLASM,1
IT,LUPUS NEPHRITIS,1
IT,LYMPHANGIECTASIA INTESTINAL,1
IT,LYMPHOCYTIC INFILTRATION,1
IT,LYMPHOID TISSUE HYPERPLASIA,1
IT,LYMPHOMA CUTIS,1
IT,MASTICATION DISORDER,1
IT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
IT,MEASLES,1
IT,MENINGISM,1
IT,MENINGITIS,1
IT,MENSTRUATION IRREGULAR,1
IT,MENTALLY LATE DEVELOPER,1
IT,METABOLIC ACIDOSIS,1
IT,METASTASES TO GASTROINTESTINAL TRACT,1
IT,METASTASES TO LYMPH NODES,1
IT,METASTASES TO OVARY,1
IT,METASTATIC LYMPHOMA,1
IT,METASTATIC MALIGNANT MELANOMA,1
IT,MIOSIS,1
IT,MITRAL VALVE INCOMPETENCE,1
IT,MOUTH HAEMORRHAGE,1
IT,MOVEMENT DISORDER,1
IT,MUCOSAL HAEMORRHAGE,1
IT,MUSCLE ENZYME INCREASED,1
IT,MUSCLE INJURY,1
IT,MYASTHENIA GRAVIS,1
IT,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
IT,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
IT,MYCOSIS FUNGOIDES,1
IT,MYDRIASIS,1
IT,MYOCARDIAL ISCHAEMIA,1
IT,NASAL CYST,1
IT,NECROTISING FASCIITIS,1
IT,NERVE INJURY,1
IT,NEUROENDOCRINE TUMOUR,1
IT,NEUROLOGIC NEGLECT SYNDROME,1
IT,NEUROLOGICAL SYMPTOM,1
IT,NEUTROPHILIA,1
IT,NODULAR MELANOMA,1
IT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
IT,NYSTAGMUS,1
IT,OBSTRUCTIVE AIRWAYS DISORDER,1
IT,OBSTRUCTIVE UROPATHY,1
IT,ODYNOPHAGIA,1
IT,OEDEMA,1
IT,OEDEMA MUCOSAL,1
IT,OEDEMA PERIPHERAL,1
IT,OPEN FRACTURE,1
IT,OPPORTUNISTIC INFECTION,1
IT,OPTIC NEURITIS,1
IT,OROPHARYNGEAL PLAQUE,1
IT,OSTEITIS,1
IT,OSTEOLYSIS,1
IT,OVARIAN CANCER,1
IT,PALATAL SWELLING,1
IT,PALLOR,1
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IT,PALPITATIONS,1
IT,PANCREATITIS RELAPSING,1
IT,PANIC ATTACK,1
IT,PARATYPHOID FEVER,1
IT,PAROTID GLAND ENLARGEMENT,1
IT,PARTIAL SEIZURES,1
IT,PEMPHIGUS,1
IT,PEPTIC ULCER HAEMORRHAGE,1
IT,PERICARDITIS INFECTIVE,1
IT,PERINEAL PAIN,1
IT,PERIODONTITIS,1
IT,PERIPHERAL NERVE OPERATION,1
IT,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
IT,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT,1
IT,PETIT MAL EPILEPSY,1
IT,PHARYNGEAL OEDEMA,1
IT,PLASMINOGEN ACTIVATOR INHIBITOR INCREASED,1
IT,PLATELET COUNT INCREASED,1
IT,PLEURAL DISORDER,1
IT,PNEUMOCYSTIS JIROVECI INFECTION,1
IT,PNEUMONIA ADENOVIRAL,1
IT,PNEUMONIA ASPIRATION,1
IT,PNEUMONIA FUNGAL,1
IT,PNEUMONIA LEGIONELLA,1
IT,PNEUMONIA PSEUDOMONAL,1
IT,PNEUMONIA STAPHYLOCOCCAL,1
IT,POLLAKIURIA,1
IT,POLYURIA,1
IT,POROKERATOSIS,1
IT,PORTAL VEIN PHLEBITIS,1
IT,PORTAL VEIN THROMBOSIS,1
JM,CARDIAC ARREST,1
JM,HYPERSENSITIVITY,1
JM,PAIN IN EXTREMITY,1
JM,URTICARIA,1
JP,DRUG INEFFECTIVE,375
JP,ACUTE GRAFT VERSUS HOST DISEASE,244
JP,PYREXIA,240
JP,LYMPHOPROLIFERATIVE DISORDER,233
JP,PNEUMONIA,215
JP,INTERSTITIAL LUNG DISEASE,208
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,181
JP,FEBRILE NEUTROPENIA,178
JP,HEPATIC FUNCTION ABNORMAL,135
JP,DIFFUSE LARGE B-CELL LYMPHOMA,123
JP,PANCYTOPENIA,120
JP,SEPSIS,118
JP,CHRONIC GRAFT VERSUS HOST DISEASE,113
JP,PLATELET COUNT DECREASED,113
JP,ANAEMIA,112
JP,BONE MARROW FAILURE,112
JP,NEUTROPENIA,107
JP,EPSTEIN-BARR VIRUS INFECTION,106
JP,RENAL IMPAIRMENT,100
JP,DIARRHOEA,95
JP,STOMATITIS,95
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,94
JP,DISSEMINATED INTRAVASCULAR COAGULATION,92
JP,LEUKOPENIA,85
JP,CYTOMEGALOVIRUS INFECTION,83
JP,WHITE BLOOD CELL COUNT DECREASED,83
JP,HERPES ZOSTER,81
JP,NAUSEA,80
JP,THROMBOTIC MICROANGIOPATHY,76
JP,LIVER DISORDER,74
JP,LYMPHOMA,73
JP,GRAFT VERSUS HOST DISEASE,72
JP,DECREASED APPETITE,67
JP,HISTIOCYTOSIS HAEMATOPHAGIC,63
JP,THROMBOCYTOPENIA,63
JP,RASH,62
JP,CELLULITIS,60
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,60
JP,RHEUMATOID ARTHRITIS,60
JP,NEUTROPHIL COUNT DECREASED,59
JP,SEPTIC SHOCK,59
JP,INFECTION,55
JP,PNEUMONIA BACTERIAL,55
JP,CYTOMEGALOVIRUS TEST POSITIVE,53
JP,ORGANISING PNEUMONIA,53
JP,VOMITING,53
JP,RESPIRATORY FAILURE,52
JP,ARTHRALGIA,51
JP,CARDIAC FAILURE,50
JP,CONDITION AGGRAVATED,47
JP,DEATH,47
JP,DIABETES MELLITUS,47
JP,MYELODYSPLASTIC SYNDROME,46
JP,OSTEONECROSIS OF JAW,46
JP,RENAL DISORDER,46
JP,FALL,44
JP,HYPERTENSION,44
JP,PLEURAL EFFUSION,44
JP,CYTOMEGALOVIRUS VIRAEMIA,43
JP,C-REACTIVE PROTEIN INCREASED,42
JP,HODGKIN^S DISEASE,41
JP,MALAISE,41
JP,ABDOMINAL PAIN,40
JP,ACUTE MYELOID LEUKAEMIA,40
JP,INFUSION RELATED REACTION,38
JP,DISEASE PROGRESSION,37
JP,RENAL FAILURE,37
JP,ALANINE AMINOTRANSFERASE INCREASED,36
JP,BREAST CANCER,36
JP,CEREBRAL INFARCTION,36
JP,HEADACHE,36
JP,ANGIOCENTRIC LYMPHOMA,35
JP,CYSTITIS HAEMORRHAGIC,35
JP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,34
JP,VENOOCCLUSIVE LIVER DISEASE,33
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,32
JP,ALTERED STATE OF CONSCIOUSNESS,32
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,32
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,31
JP,BRONCHOPULMONARY ASPERGILLOSIS,31
JP,DYSPNOEA,31
JP,HEPATITIS B,31
JP,PERITONITIS,31
JP,ASPARTATE AMINOTRANSFERASE INCREASED,30
JP,NASOPHARYNGITIS,30
JP,PAIN,30
JP,PRODUCT USE ISSUE,30
JP,CYTOMEGALOVIRUS CHORIORETINITIS,29
JP,DRUG-INDUCED LIVER INJURY,29
JP,GRAFT VERSUS HOST DISEASE IN SKIN,29
JP,LUNG DISORDER,29
JP,MUCOUS MEMBRANE DISORDER,29
JP,ACUTE KIDNEY INJURY,28
JP,BLOOD CREATININE INCREASED,28
JP,LUNG NEOPLASM MALIGNANT,28
JP,COUGH,27
JP,GASTRIC CANCER,27
JP,GASTROINTESTINAL HAEMORRHAGE,27
JP,ASCITES,26
JP,STAPHYLOCOCCAL SEPSIS,26
JP,COLON CANCER,25
JP,DRUG LEVEL INCREASED,25
JP,ERYTHEMA,25
JP,GASTRIC ULCER,25
JP,MALIGNANT NEOPLASM PROGRESSION,25
JP,OEDEMA,25
JP,STAPHYLOCOCCAL INFECTION,25
JP,LYMPHADENOPATHY,24
JP,MUSCULAR WEAKNESS,24
JP,SECOND PRIMARY MALIGNANCY,24
JP,DRUG RESISTANCE,23
JP,GAIT DISTURBANCE,23
JP,HYPOGAMMAGLOBULINAEMIA,23
JP,HYPONATRAEMIA,23
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,23
JP,BRONCHITIS,22
JP,CEREBRAL HAEMORRHAGE,22
JP,ENGRAFTMENT SYNDROME,22
JP,OEDEMA PERIPHERAL,22
JP,OSTEOMYELITIS,22
JP,ARTHRITIS BACTERIAL,21
JP,DISSEMINATED TUBERCULOSIS,21
JP,LYMPHOPENIA,21
JP,NON-ALCOHOLIC STEATOHEPATITIS,21
JP,PNEUMONIA ASPIRATION,21
JP,PULMONARY TUBERCULOSIS,21
JP,SKIN ULCER,21
JP,ASTHENIA,20
JP,DEHYDRATION,20
JP,ENCEPHALOPATHY,20
JP,FEMUR FRACTURE,20
JP,GASTROINTESTINAL PERFORATION,20
JP,HEPATIC FAILURE,20
JP,HYPOKALAEMIA,20
JP,LEUKOENCEPHALOPATHY,20
JP,PRURITUS,20
JP,PYELONEPHRITIS,20
JP,CELL MARKER INCREASED,19
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,19
JP,EPSTEIN-BARR VIRUS TEST POSITIVE,19
JP,INTESTINAL PERFORATION,19
JP,PAIN IN EXTREMITY,19
JP,TOXICITY TO VARIOUS AGENTS,19
JP,ARTHRITIS,18
JP,CONSTIPATION,18
JP,FATIGUE,18
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA,17
JP,HYPERGLYCAEMIA,17
JP,HYPOAESTHESIA,17
JP,MUCOSAL INFLAMMATION,17
JP,MYCOBACTERIAL INFECTION,17
JP,PLEURISY,17
JP,PNEUMATOSIS INTESTINALIS,17
JP,SPINAL COMPRESSION FRACTURE,17
JP,BACK PAIN,16
JP,BACTERAEMIA,16
JP,BLOOD PRESSURE INCREASED,16
JP,CYTOPENIA,16
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,16
JP,DIZZINESS,16
JP,HAEMOGLOBIN DECREASED,16
JP,HAEMORRHAGE,16
JP,ILEUS,16
JP,SEIZURE,16
JP,SUBDURAL HAEMATOMA,16
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,16
JP,THERAPEUTIC RESPONSE DECREASED,16
JP,URINARY TRACT INFECTION,16
JP,WEIGHT DECREASED,16
JP,B-CELL LYMPHOMA,15
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,15
JP,CONVULSION,15
JP,DEVICE RELATED INFECTION,15
JP,HAEMATOCHEZIA,15
JP,HEPATIC ENZYME INCREASED,15
JP,IMMUNOSUPPRESSION,15
JP,INSOMNIA,15
JP,MYELOPATHY,15
JP,OROPHARYNGEAL PAIN,15
JP,PNEUMONIA CYTOMEGALOVIRAL,15
JP,RENAL FAILURE ACUTE,15
JP,WHITE BLOOD CELL COUNT INCREASED,15
JP,ACUTE MYELOID LEUKAEMIA RECURRENT,14
JP,ALOPECIA,14
JP,ASPERGILLUS INFECTION,14
JP,CYSTITIS VIRAL,14
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,14
JP,GASTROENTERITIS,14
JP,HAEMATOTOXICITY,14
JP,HYPOALBUMINAEMIA,14
JP,IMMUNODEFICIENCY,14
JP,NEUROPATHY PERIPHERAL,14
JP,PNEUMOTHORAX,14
JP,PULMONARY ALVEOLAR HAEMORRHAGE,14
JP,PULMONARY HAEMORRHAGE,14
JP,SOMNOLENCE,14
JP,SUBARACHNOID HAEMORRHAGE,14
JP,TUBERCULOSIS,14
JP,VIRAL HAEMORRHAGIC CYSTITIS,14
JP,ABDOMINAL PAIN UPPER,13
JP,ADENOVIRUS INFECTION,13
JP,BLOOD BILIRUBIN INCREASED,13
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,13
JP,BLOOD PRESSURE DECREASED,13
JP,CATARACT,13
JP,DEEP VEIN THROMBOSIS,13
JP,FUNGAL INFECTION,13
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,13
JP,LIVER ABSCESS,13
JP,MULTI-ORGAN FAILURE,13
JP,POST TRANSPLANT DISTAL LIMB SYNDROME,13
JP,PRODUCT USE IN UNAPPROVED INDICATION,13
JP,PULMONARY MYCOSIS,13
JP,RESPIRATORY DISORDER,13
JP,UPPER RESPIRATORY TRACT INFLAMMATION,13
JP,URTICARIA,13
JP,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,12
JP,ANTITHROMBIN III DECREASED,12
JP,BACTERIAL INFECTION,12
JP,BLOOD BETA-D-GLUCAN INCREASED,12
JP,CHRONIC MYELOID LEUKAEMIA,12
JP,DEPRESSION,12
JP,ENGRAFT FAILURE,12
JP,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,12
JP,GRAFT VERSUS HOST DISEASE IN INTESTINE,12
JP,HAEMATURIA,12
JP,HYPERSENSITIVITY,12
JP,JOINT SWELLING,12
JP,LIVER FUNCTION TEST ABNORMAL,12
JP,MATERNAL EXPOSURE DURING PREGNANCY,12
JP,OSTEONECROSIS,12
JP,PERICARDIAL EFFUSION,12
JP,PULMONARY EMBOLISM,12
JP,PULMONARY FIBROSIS,12
JP,SHOCK,12
JP,SHOCK HAEMORRHAGIC,12
JP,SKIN MASS,12
JP,TOXIC ENCEPHALOPATHY,12
JP,VIRAL INFECTION,12
JP,ARTHROPATHY,11
JP,ASTHMA,11
JP,ATYPICAL MYCOBACTERIAL INFECTION,11
JP,BK VIRUS INFECTION,11
JP,BRONCHOPNEUMONIA,11
JP,CHOLECYSTITIS ACUTE,11
JP,DELIRIUM,11
JP,DRUG ERUPTION,11
JP,DYSPHAGIA,11
JP,EXPOSURE DURING PREGNANCY,11
JP,HELICOBACTER INFECTION,11
JP,HEPATITIS B REACTIVATION,11
JP,HYDROCEPHALUS,11
JP,HYPERBILIRUBINAEMIA,11
JP,LYMPHOCYTE COUNT DECREASED,11
JP,MELAENA,11
JP,MYOCARDIAL INFARCTION,11
JP,NEOPLASM MALIGNANT,11
JP,ORAL DISORDER,11
JP,OXYGEN SATURATION DECREASED,11
JP,PANCREATITIS ACUTE,11
JP,PSEUDOMONAS INFECTION,11
JP,APPENDICITIS,10
JP,ATRIAL FIBRILLATION,10
JP,BACTERIAL SEPSIS,10
JP,BRAIN HERNIATION,10
JP,CARDIO-RESPIRATORY ARREST,10
JP,CHEST X-RAY ABNORMAL,10
JP,CHILLS,10
JP,ENCEPHALITIS,10
JP,ENTERITIS INFECTIOUS,10
JP,EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER,10
JP,EPSTEIN-BARR VIRAEMIA,10
JP,FEMORAL NECK FRACTURE,10
JP,GASTRITIS EROSIVE,10
JP,GENERAL PHYSICAL HEALTH DETERIORATION,10
JP,GRAFT VERSUS HOST DISEASE IN LIVER,10
JP,HAEMORRHAGE INTRACRANIAL,10
JP,HEPATIC STEATOSIS,10
JP,HYDRONEPHROSIS,10
JP,INFLUENZA,10
JP,INTENTIONAL UNDERDOSE,10
JP,METASTASES TO LIVER,10
JP,METASTASES TO LUNG,10
JP,OBLITERATIVE BRONCHIOLITIS,10
JP,PNEUMOCYSTIS JIROVECI PNEUMONIA,10
JP,PSORIASIS,10
JP,PULMONARY OEDEMA,10
JP,RHABDOMYOLYSIS,10
JP,SWEAT GLAND TUMOUR,10
JP,TRANSAMINASES INCREASED,10
JP,VIRAL VASCULITIS,10
JP,ACUTE RESPIRATORY FAILURE,9
JP,AUTOIMMUNE HEPATITIS,9
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,9
JP,BRONCHIECTASIS,9
JP,CARDIAC FAILURE ACUTE,9
JP,CARDIAC FAILURE CONGESTIVE,9
JP,CARDIAC TAMPONADE,9
JP,CHEST PAIN,9
JP,CHOLECYSTITIS,9
JP,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,9
JP,CIRCULATORY COLLAPSE,9
JP,CONTUSION,9
JP,DISEASE RECURRENCE,9
JP,ENDOCARDITIS,9
JP,FOETAL EXPOSURE DURING PREGNANCY,9
JP,FOETAL GROWTH RESTRICTION,9
JP,GASTRIC ULCER PERFORATION,9
JP,GASTRITIS,9
JP,HUMAN HERPESVIRUS 6 INFECTION,9
JP,ILEAL PERFORATION,9
JP,ILEUS PARALYTIC,9
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,9
JP,LUPUS-LIKE SYNDROME,9
JP,METASTASES TO LYMPH NODES,9
JP,PANCREATITIS,9
JP,PHARYNGITIS,9
JP,SKIN LESION,9
JP,SYSTEMIC CANDIDA,9
JP,TENDON RUPTURE,9
JP,TREATMENT FAILURE,9
JP,TUBERCULOUS PLEURISY,9
JP,VASCULITIS,9
JP,ABDOMINAL DISTENSION,8
JP,ACUTE LYMPHOCYTIC LEUKAEMIA,8
JP,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,8
JP,ANAPHYLACTIC REACTION,8
JP,AORTIC ANEURYSM RUPTURE,8
JP,BLISTER,8
JP,CENTRAL NERVOUS SYSTEM LYMPHOMA,8
JP,CHOLELITHIASIS,8
JP,CLOSTRIDIUM DIFFICILE COLITIS,8
JP,COAGULOPATHY,8
JP,COLITIS ULCERATIVE,8
JP,DRUG HYPERSENSITIVITY,8
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,8
JP,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),8
JP,FRACTURE,8
JP,HAEMANGIOMA,8
JP,HEPATIC NEOPLASM,8
JP,HEPATITIS ACUTE,8
JP,HEPATITIS FULMINANT,8
JP,HEPATOSPLENOMEGALY,8
JP,HEPATOTOXICITY,8
JP,HERPES SIMPLEX,8
JP,HERPES VIRUS INFECTION,8
JP,HERPES ZOSTER DISSEMINATED,8
JP,HYPOMAGNESAEMIA,8
JP,HYPOPHAGIA,8
JP,JUVENILE IDIOPATHIC ARTHRITIS,8
JP,LARGE INTESTINE PERFORATION,8
JP,LUNG ADENOCARCINOMA,8
JP,MENINGOENCEPHALITIS HERPETIC,8
JP,METASTASES TO BONE,8
JP,MOUTH ULCERATION,8
JP,MYALGIA,8
JP,NERVOUS SYSTEM DISORDER,8
JP,NOCARDIOSIS,8
JP,PERICARDITIS,8
JP,PROTEINURIA,8
JP,PULMONARY HYPERTENSION,8
JP,PULMONARY MASS,8
JP,PYELONEPHRITIS ACUTE,8
JP,SENSORY DISTURBANCE,8
JP,SERUM FERRITIN INCREASED,8
JP,SKIN EXFOLIATION,8
JP,TREMOR,8
JP,UTERINE CANCER,8
JP,UTERINE LEIOMYOMA,8
JP,VARICELLA ZOSTER VIRUS INFECTION,8
JP,VENOOCCLUSIVE DISEASE,8
JP,ABDOMINAL DISCOMFORT,7
JP,ALVEOLITIS ALLERGIC,7
JP,AMENORRHOEA,7
JP,APLASTIC ANAEMIA,7
JP,BASAL CELL CARCINOMA,7
JP,BLOOD UREA INCREASED,7
JP,CANDIDA INFECTION,7
JP,CARDIAC DISORDER,7
JP,CARDIOMYOPATHY,7
JP,CAUDAL REGRESSION SYNDROME,7
JP,COLITIS,7
JP,DEAFNESS,7
JP,DRUG EFFECT DECREASED,7
JP,DRUG EFFECT INCOMPLETE,7
JP,EWING^S SARCOMA,7
JP,FOOD ALLERGY,7
JP,GENERALISED OEDEMA,7
JP,GINGIVAL ULCERATION,7
JP,HENOCH-SCHONLEIN PURPURA,7
JP,HEPATIC CIRRHOSIS,7
JP,HYPERAMMONAEMIA,7
JP,HYPOCALCAEMIA,7
JP,IMMUNE THROMBOCYTOPENIC PURPURA,7
JP,INFECTIOUS PLEURAL EFFUSION,7
JP,INFLAMMATORY MYOFIBROBLASTIC TUMOUR,7
JP,INTESTINAL OBSTRUCTION,7
JP,JAUNDICE,7
JP,LEUKAEMIA RECURRENT,7
JP,LUNG INFECTION,7
JP,MENINGITIS,7
JP,METASTASIS,7
JP,MICROANGIOPATHY,7
JP,MUCORMYCOSIS,7
JP,MUSCULOSKELETAL STIFFNESS,7
JP,NECROTISING FASCIITIS,7
JP,NEPHROTIC SYNDROME,7
JP,NEUROTOXICITY,7
JP,NON-HODGKIN^S LYMPHOMA,7
JP,PAPILLARY THYROID CANCER,7
JP,PERITONEAL TUBERCULOSIS,7
JP,PNEUMONIA CRYPTOCOCCAL,7
JP,PNEUMONIA LEGIONELLA,7
JP,PROSTATE CANCER,7
JP,PYODERMA GANGRENOSUM,7
JP,SCLERODERMA RENAL CRISIS,7
JP,THYROID CANCER,7
JP,TONGUE DISCOLOURATION,7
JP,TUMOUR LYSIS SYNDROME,7
JP,VASCULITIS CEREBRAL,7
JP,WEIGHT INCREASED,7
JP,ABSCESS,6
JP,AMYLASE INCREASED,6
JP,AORTIC ANEURYSM,6
JP,AORTIC DISSECTION,6
JP,ARRHYTHMIA,6
JP,BLADDER CANCER,6
JP,BLOOD CHOLESTEROL INCREASED,6
JP,BODY HEIGHT BELOW NORMAL,6
JP,BRADYCARDIA,6
JP,CHEST DISCOMFORT,6
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,6
JP,CYTOMEGALOVIRUS COLITIS,6
JP,CYTOMEGALOVIRUS ENTERITIS,6
JP,DUODENAL ULCER,6
JP,FACIAL PARALYSIS,6
JP,GASTRIC ANTRAL VASCULAR ECTASIA,6
JP,HAEMORRHAGE SUBCUTANEOUS,6
JP,HEPATOMEGALY,6
JP,HERPES ZOSTER OTICUS,6
JP,HYPERCALCAEMIA,6
JP,HYPOGLYCAEMIA,6
JP,HYPOTENSION,6
JP,HYPOTHYROIDISM,6
JP,IMPAIRED HEALING,6
JP,INJECTION SITE PAIN,6
JP,INTENTIONAL DRUG MISUSE,6
JP,LARGE INTESTINAL ULCER,6
JP,LISTERIOSIS,6
JP,LIVER INJURY,6
JP,LOSS OF CONSCIOUSNESS,6
JP,LYMPH NODE TUBERCULOSIS,6
JP,LYMPHADENITIS,6
JP,MAJOR DEPRESSION,6
JP,MUSCLE SPASMS,6
JP,MYCOBACTERIUM MARINUM INFECTION,6
JP,MYELITIS TRANSVERSE,6
JP,NEOPLASM,6
JP,NEPHRITIS,6
JP,NEUROENDOCRINE TUMOUR,6
JP,OLIGURIA,6
JP,ORAL CANDIDIASIS,6
JP,ORAL HERPES,6
JP,OVARIAN CANCER,6
JP,PALPITATIONS,6
JP,PANCREATIC CARCINOMA,6
JP,PANNICULITIS,6
JP,PLASMA CELL MYELOMA,6
JP,PNEUMONIA PSEUDOMONAL,6
JP,POLYMYOSITIS,6
JP,PRODUCTIVE COUGH,6
JP,PUSTULAR PSORIASIS,6
JP,RED BLOOD CELL COUNT DECREASED,6
JP,RENAL CANCER,6
JP,SKIN EROSION,6
JP,SMALL INTESTINAL HAEMORRHAGE,6
JP,SQUAMOUS CELL CARCINOMA,6
JP,STILL^S DISEASE ADULT ONSET,6
JP,SWELLING,6
JP,TOXIC SKIN ERUPTION,6
JP,UPPER RESPIRATORY TRACT INFECTION,6
JP,VISUAL ACUITY REDUCED,6
JP,VISUAL IMPAIRMENT,6
JP,ABASIA,5
JP,ABORTION SPONTANEOUS,5
JP,ACUTE MYOCARDIAL INFARCTION,5
JP,ADENOVIRAL HAEMORRHAGIC CYSTITIS,5
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA RECURRENT,5
JP,AGRANULOCYTOSIS,5
JP,ANAPHYLACTIC SHOCK,5
JP,ANURIA,5
JP,ANXIETY,5
JP,APPENDICITIS PERFORATED,5
JP,ARTHRITIS INFECTIVE,5
JP,ARTICULAR CALCIFICATION,5
JP,BEHCET^S SYNDROME,5
JP,BLINDNESS,5
JP,BLOOD DISORDER,5
JP,BLOOD GLUCOSE INCREASED,5
JP,CARDIAC ARREST,5
JP,CENTRAL NERVOUS SYSTEM LESION,5
JP,CHLOROMA,5
JP,COLITIS ISCHAEMIC,5
JP,COMPRESSION FRACTURE,5
JP,CONJUNCTIVITIS,5
JP,CROHN^S DISEASE,5
JP,CYSTITIS,5
JP,CYTOKINE STORM,5
JP,DEMENTIA,5
JP,DRUG CLEARANCE DECREASED,5
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
JP,DYSAESTHESIA,5
JP,DYSGEUSIA,5
JP,DYSPNOEA EXERTIONAL,5
JP,DYSURIA,5
JP,ENTEROCOCCAL INFECTION,5
JP,ENTEROCOCCAL SEPSIS,5
JP,EOSINOPHIL COUNT INCREASED,5
JP,ERYTHEMA INDURATUM,5
JP,ESCHERICHIA INFECTION,5
JP,GASTROENTERITIS NOROVIRUS,5
JP,GASTROINTESTINAL DISORDER,5
JP,GLUCOSE TOLERANCE IMPAIRED,5
JP,HYPERKALAEMIA,5
JP,HYPERLIPIDAEMIA,5
JP,HYPERSENSITIVITY VASCULITIS,5
JP,HYPOXIA,5
JP,IDIOPATHIC PNEUMONIA SYNDROME,5
JP,INFLAMMATION,5
JP,JOINT ARTHROPLASTY,5
JP,LUNG INFILTRATION,5
JP,MASS,5
JP,MOUTH HAEMORRHAGE,5
JP,MYASTHENIA GRAVIS,5
JP,NERVOUSNESS,5
JP,OSTEOPOROSIS,5
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
JP,PARADOXICAL DRUG REACTION,5
JP,PARAPLEGIA,5
JP,PNEUMONIA FUNGAL,5
JP,PNEUMONIA PNEUMOCOCCAL,5
JP,PNEUMONITIS,5
JP,PSEUDOMEMBRANOUS COLITIS,5
JP,PURPURA,5
JP,RADICULOPATHY,5
JP,RASH GENERALISED,5
JP,RAYNAUD^S PHENOMENON,5
JP,RECTAL CANCER,5
JP,RENAL TUBULAR DISORDER,5
JP,RHEUMATOID VASCULITIS,5
JP,RHINORRHOEA,5
JP,SPONDYLITIS,5
JP,STAPHYLOCOCCAL BACTERAEMIA,5
JP,STAPHYLOCOCCUS TEST POSITIVE,5
JP,SUBCUTANEOUS ABSCESS,5
JP,SURGERY,5
JP,SWELLING FACE,5
JP,TAKAYASU^S ARTERITIS,5
JP,TEMPORAL LOBE EPILEPSY,5
JP,THROMBOSIS,5
JP,TRICHOSPORON INFECTION,5
JP,ULCER,5
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,5
JP,VERTIGO,5
JP,VIITH NERVE PARALYSIS,5
JP,VIRAEMIA,5
JP,VIRAL UPPER RESPIRATORY TRACT INFECTION,5
JP,ZYGOMYCOSIS,5
JP,ABDOMINAL PAIN LOWER,4
JP,ACUTE DISSEMINATED ENCEPHALOMYELITIS,4
JP,ADRENAL INSUFFICIENCY,4
JP,ANGINA PECTORIS,4
JP,ANORECTAL DISORDER,4
JP,ANTISYNTHETASE SYNDROME,4
JP,ARTERIOSCLEROSIS,4
JP,ASPHYXIA,4
JP,ATELECTASIS,4
JP,ATYPICAL FEMUR FRACTURE,4
JP,BLADDER DISORDER,4
JP,BLOOD ALBUMIN DECREASED,4
JP,BLOOD POTASSIUM DECREASED,4
JP,BLOOD TEST ABNORMAL,4
JP,CAPNOCYTOPHAGA INFECTION,4
JP,COGNITIVE DISORDER,4
JP,CORYNEBACTERIUM SEPSIS,4
JP,CRYPTOCOCCOSIS,4
JP,CYTOMEGALOVIRUS GASTROENTERITIS,4
JP,DERMATITIS ALLERGIC,4
JP,DERMATOMYOSITIS,4
JP,DIFFUSE ALVEOLAR DAMAGE,4
JP,DISORIENTATION,4
JP,DISSEMINATED CRYPTOCOCCOSIS,4
JP,DUODENAL PERFORATION,4
JP,DYSPEPSIA,4
JP,DYSSTASIA,4
JP,ECZEMA,4
JP,ENCEPHALITIS AUTOIMMUNE,4
JP,ENTEROCOLITIS,4
JP,ENTEROCOLITIS VIRAL,4
JP,EPILEPSY,4
JP,ESCHERICHIA SEPSIS,4
JP,EYELID OEDEMA,4
JP,FACE OEDEMA,4
JP,FAECES DISCOLOURED,4
JP,GASTRIC MUCOSAL LESION,4
JP,GASTROENTERITIS VIRAL,4
JP,GASTROOESOPHAGEAL REFLUX DISEASE,4
JP,GENITAL HAEMORRHAGE,4
JP,GERM CELL CANCER,4
JP,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,4
JP,HAEMATOCOLPOS,4
JP,HAEMOLYTIC ANAEMIA,4
JP,HEPATIC FIBROSIS,4
JP,HIPPOCAMPAL SCLEROSIS,4
JP,HUMERUS FRACTURE,4
JP,HYPERAMYLASAEMIA,4
JP,HYPERNATRAEMIA,4
JP,HYPERTRIGLYCERIDAEMIA,4
JP,HYPOCOMPLEMENTAEMIA,4
JP,ILEAL ULCER,4
JP,IMMUNE RECOVERY UVEITIS,4
JP,INJECTION SITE REACTION,4
JP,INJURY,4
JP,INTENTIONAL PRODUCT MISUSE,4
JP,INTERLEUKIN-2 RECEPTOR INCREASED,4
JP,INTERVERTEBRAL DISC PROTRUSION,4
JP,INTESTINAL TUBERCULOSIS,4
JP,INTRACRANIAL ANEURYSM,4
JP,INVASIVE DUCTAL BREAST CARCINOMA,4
JP,IRIDOCYCLITIS,4
JP,IRON DEFICIENCY ANAEMIA,4
JP,JOINT DISLOCATION,4
JP,KLEBSIELLA SEPSIS,4
JP,LEFT VENTRICULAR DYSFUNCTION,4
JP,LIMB DISCOMFORT,4
JP,LISTERIA SEPSIS,4
JP,LOBAR PNEUMONIA,4
JP,LOW BIRTH WEIGHT BABY,4
JP,LUMBAR SPINAL STENOSIS,4
JP,LUMBAR VERTEBRAL FRACTURE,4
JP,LUPUS NEPHRITIS,4
JP,MALNUTRITION,4
JP,MENINGITIS ASEPTIC,4
JP,MENINGITIS BACTERIAL,4
JP,MENINGITIS TUBERCULOUS,4
JP,MYCOBACTERIUM AVIUM COMPLEX INFECTION,4
JP,MYELITIS,4
JP,NECROTISING RETINITIS,4
JP,NEURALGIA,4
JP,NODULE,4
JP,OESOPHAGEAL CANDIDIASIS,4
JP,ORAL INFECTION,4
JP,OSTEOSARCOMA,4
JP,OTITIS MEDIA,4
JP,OVERDOSE,4
JP,PATHOGEN RESISTANCE,4
JP,PIGMENTATION DISORDER,4
JP,PLATELET COUNT INCREASED,4
JP,PNEUMONIA STAPHYLOCOCCAL,4
JP,PNEUMONIA STREPTOCOCCAL,4
JP,PNEUMONIA VIRAL,4
JP,POLYARTERITIS NODOSA,4
JP,POLYCHONDRITIS,4
JP,POLYMYALGIA RHEUMATICA,4
JP,POLYNEUROPATHY,4
JP,PORTAL VENOUS GAS,4
JP,PROTEIN URINE PRESENT,4
JP,PSEUDOMONAL SEPSIS,4
JP,PSORIATIC ARTHROPATHY,4
JP,PULMONARY AIR LEAKAGE,4
JP,PULMONARY ARTERIAL HYPERTENSION,4
JP,RENAL INFARCT,4
JP,RENAL TUBULAR NECROSIS,4
JP,RESPIRATORY SYNCYTIAL VIRUS INFECTION,4
JP,RESPIRATORY TRACT INFECTION,4
JP,RESTLESSNESS,4
JP,RHEUMATOID LUNG,4
JP,RHINITIS ALLERGIC,4
JP,RIB FRACTURE,4
JP,SEBACEOUS CARCINOMA,4
JP,SINUSITIS,4
JP,SKIN INFECTION,4
JP,SMALL CELL LUNG CANCER,4
JP,SMALL INTESTINAL PERFORATION,4
JP,SPLENOMEGALY,4
JP,STATUS EPILEPTICUS,4
JP,STEVENS-JOHNSON SYNDROME,4
JP,STREPTOCOCCAL INFECTION,4
JP,STRESS CARDIOMYOPATHY,4
JP,SUPERIOR SAGITTAL SINUS THROMBOSIS,4
JP,SYSTEMIC MYCOSIS,4
JP,TACHYCARDIA,4
JP,TIBIA FRACTURE,4
JP,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,4
JP,TONGUE ULCERATION,4
JP,TOOTHACHE,4
JP,TOXIC EPIDERMAL NECROLYSIS,4
JP,TRANSPLANT FAILURE,4
JP,TUBULOINTERSTITIAL NEPHRITIS,4
JP,ULNA FRACTURE,4
JP,UPPER LIMB FRACTURE,4
JP,URETEROLITHIASIS,4
JP,URINARY RETENTION,4
JP,VARICELLA,4
JP,VENTRICULAR ARRHYTHMIA,4
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
JP,ABDOMINAL ADHESIONS,3
JP,ABSCESS LIMB,3
JP,ACUTE HEPATIC FAILURE,3
JP,ACUTE HEPATITIS B,3
JP,ACUTE SINUSITIS,3
JP,ADENOCARCINOMA GASTRIC,3
JP,ADENOCARCINOMA OF COLON,3
JP,ADENOVIRAL HEPATITIS,3
JP,ADMINISTRATION RELATED REACTION,3
JP,AGITATION,3
JP,AMYLOIDOSIS,3
JP,ANAEMIA MACROCYTIC,3
JP,ANAPLASTIC LARGE-CELL LYMPHOMA,3
JP,ANGINA UNSTABLE,3
JP,ANTIPHOSPHOLIPID SYNDROME,3
JP,AREFLEXIA,3
JP,ARTERIAL THROMBOSIS,3
JP,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
JP,BILIRUBIN CONJUGATED INCREASED,3
JP,BLOOD SODIUM DECREASED,3
JP,BLOOD URIC ACID INCREASED,3
JP,BONE MARROW DISORDER,3
JP,BRAIN ABSCESS,3
JP,BRAIN OEDEMA,3
JP,BURKITT^S LYMPHOMA RECURRENT,3
JP,CALCULUS URETERIC,3
JP,CANDIDA TEST POSITIVE,3
JP,CAPILLARY LEAK SYNDROME,3
JP,CARDIAC HYPERTROPHY,3
JP,CARDIOMEGALY,3
JP,CERVIX CARCINOMA,3
JP,CHEILITIS,3
JP,CHRONIC GASTRITIS,3
JP,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,3
JP,COLD TYPE HAEMOLYTIC ANAEMIA,3
JP,CYANOSIS,3
JP,CYTOMEGALOVIRUS GASTRITIS,3
JP,CYTOMEGALOVIRUS GASTROINTESTINAL ULCER,3
JP,DENTAL CARIES,3
JP,DERMATITIS,3
JP,DERMATITIS PSORIASIFORM,3
JP,DIVERTICULITIS,3
JP,DNA ANTIBODY POSITIVE,3
JP,DRUG SPECIFIC ANTIBODY PRESENT,3
JP,DRY EYE,3
JP,DYSARTHRIA,3
JP,DYSLALIA,3
JP,DYSPHONIA,3
JP,ENCEPHALOMYELITIS,3
JP,ENTERITIS,3
JP,EPIGASTRIC DISCOMFORT,3
JP,EPISTAXIS,3
JP,EYE DISORDER,3
JP,EYE PAIN,3
JP,FEELING ABNORMAL,3
JP,FIBRIN D DIMER INCREASED,3
JP,FIBRIN DEGRADATION PRODUCTS INCREASED,3
JP,FOLATE DEFICIENCY,3
JP,GASTRIC ULCER HAEMORRHAGE,3
JP,GASTROENTERITIS EOSINOPHILIC,3
JP,GASTROINTESTINAL MUCOSAL NECROSIS,3
JP,GASTROINTESTINAL ULCER,3
JP,GENE MUTATION,3
JP,GENERALISED ERYTHEMA,3
JP,GENERALISED TONIC-CLONIC SEIZURE,3
JP,GLAUCOMA,3
JP,GRAFT VERSUS HOST DISEASE IN LUNG,3
JP,GRANULOMA,3
JP,GUILLAIN-BARRE SYNDROME,3
JP,HAEMATOMA,3
JP,HAEMOPTYSIS,3
JP,HAEMORRHAGIC DIATHESIS,3
JP,HALLUCINATION_ AUDITORY,3
JP,HEAT ILLNESS,3
JP,HEMIPLEGIA,3
JP,HEPATIC NECROSIS,3
JP,HEPATOBILIARY DISEASE,3
JP,HERPES SIMPLEX MENINGOENCEPHALITIS,3
JP,HICCUPS,3
JP,HODGKIN^S DISEASE NODULAR SCLEROSIS,3
JP,HOT FLUSH,3
JP,HYPERURICAEMIA,3
JP,ILEAL ULCER PERFORATION,3
JP,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
JP,IMMUNE-MEDIATED NECROTISING MYOPATHY,3
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
JP,INFECTION REACTIVATION,3
JP,INGUINAL HERNIA,3
JP,JOINT DESTRUCTION,3
JP,LARGE INTESTINAL STENOSIS,3
JP,LEIOMYOMA,3
JP,LEUKAEMIA,3
JP,LIP HAEMORRHAGE,3
JP,LYMPHOCYTE MORPHOLOGY ABNORMAL,3
JP,LYMPHOCYTIC INFILTRATION,3
JP,MALIGNANT ASCITES,3
JP,MEMORY IMPAIRMENT,3
JP,MENINGITIS CRYPTOCOCCAL,3
JP,METABOLIC ACIDOSIS,3
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,3
JP,MIGRAINE,3
JP,MILK ALLERGY,3
JP,MOVEMENT DISORDER,3
JP,MULTIPLE SCLEROSIS,3
JP,MUSCLE ABSCESS,3
JP,MUSCULOSKELETAL PAIN,3
JP,MYCOBACTERIUM CHELONAE INFECTION,3
JP,MYOCARDIAL ISCHAEMIA,3
JP,NECROSIS,3
JP,NEOPLASM PROGRESSION,3
JP,NEPHROGENIC ANAEMIA,3
JP,NEPHROPATHY,3
JP,NEPHROPATHY TOXIC,3
JP,NO THERAPEUTIC RESPONSE,3
JP,OESOPHAGEAL STENOSIS,3
JP,OESOPHAGEAL ULCER,3
JP,OPHTHALMOPLEGIA,3
JP,OSTEITIS,3
JP,PALATAL ULCER,3
JP,PAPULE,3
JP,PERIODONTITIS,3
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,3
JP,PERIPHERAL MOTOR NEUROPATHY,3
JP,PERIPHERAL SENSORY NEUROPATHY,3
JP,PERITONEAL DISORDER,3
JP,PHARYNGEAL OEDEMA,3
JP,PLASMACYTOMA,3
JP,POST PROCEDURAL INFECTION,3
JP,PREMATURE BABY,3
JP,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
JP,QUADRIPLEGIA,3
JP,RADIUS FRACTURE,3
JP,RASH PAPULAR,3
JP,RASH PRURITIC,3
JP,RENAL FAILURE CHRONIC,3
JP,RENAL INJURY,3
JP,RESPIRATORY ARREST,3
JP,RETINAL HAEMORRHAGE,3
JP,RETINAL VEIN OCCLUSION,3
JP,ROAD TRAFFIC ACCIDENT,3
JP,SARCOIDOSIS,3
JP,SHOCK SYMPTOM,3
JP,SINUSITIS FUNGAL,3
JP,SKIN DISORDER,3
JP,SKIN NECROSIS,3
JP,SMALL INTESTINE ULCER,3
JP,SPINAL OSTEOARTHRITIS,3
JP,STEM CELL TRANSPLANT,3
JP,STENOSIS,3
JP,STREPTOCOCCAL SEPSIS,3
JP,SUICIDAL IDEATION,3
JP,SUICIDE ATTEMPT,3
JP,SUPRAVENTRICULAR TACHYCARDIA,3
JP,SYNOVITIS,3
JP,T-CELL TYPE ACUTE LEUKAEMIA,3
JP,TENOSYNOVITIS,3
JP,TONSILLITIS,3
JP,TOXOPLASMOSIS,3
JP,TRANSIENT ISCHAEMIC ATTACK,3
JP,TRANSITIONAL CELL CARCINOMA,3
JP,TUBERCULOSIS GASTROINTESTINAL,3
JP,TUMOUR EMBOLISM,3
JP,URINARY INCONTINENCE,3
JP,URINE OUTPUT DECREASED,3
JP,UTERINE HAEMORRHAGE,3
JP,UVEITIS,3
JP,VASCULAR PSEUDOANEURYSM,3
JP,VENTRICULAR TACHYCARDIA,3
JP,VOCAL CORD PARALYSIS,3
JP,WHITE MATTER LESION,3
JP,WOUND INFECTION,3
JP,ABDOMINAL ABSCESS,2
JP,ABNORMAL SENSATION IN EYE,2
JP,ABORTION INDUCED,2
JP,ABSCESS DRAINAGE,2
JP,ACNE,2
JP,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
JP,ACUTE MONOCYTIC LEUKAEMIA,2
JP,ACUTE MYELOMONOCYTIC LEUKAEMIA,2
JP,ADMINISTRATION SITE REACTION,2
JP,ADRENOCORTICAL INSUFFICIENCY ACUTE,2
JP,ADVERSE DRUG REACTION,2
JP,ADVERSE EVENT,2
JP,AGE-RELATED MACULAR DEGENERATION,2
JP,ANAESTHESIA,2
JP,ANAPHYLACTOID REACTION,2
JP,ANEURYSM RUPTURED,2
JP,ANGIOPATHY,2
JP,ANKLE FRACTURE,2
JP,ANKYLOSING SPONDYLITIS,2
JP,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,2
JP,APHASIA,2
JP,APLASIA PURE RED CELL,2
JP,ARTERIAL OCCLUSIVE DISEASE,2
JP,ASPERGILLOSIS,2
JP,ATAXIA,2
JP,ATRIAL FLUTTER,2
JP,ATYPICAL PNEUMONIA,2
JP,BACTEROIDES INFECTION,2
JP,BALANOPOSTHITIS,2
JP,BASEDOW^S DISEASE,2
JP,BENIGN NEOPLASM OF CHOROID,2
JP,BILIARY CIRRHOSIS PRIMARY,2
JP,BLOOD FIBRINOGEN DECREASED,2
JP,BLOOD HIV RNA INCREASED,2
JP,BLOOD IMMUNOGLOBULIN E INCREASED,2
JP,BLOOD IMMUNOGLOBULIN G DECREASED,2
JP,BLOOD PRESSURE FLUCTUATION,2
JP,BLOOD TRIGLYCERIDES INCREASED,2
JP,BONE CANCER,2
JP,BONE MARROW TRANSPLANT,2
JP,BONE TUBERCULOSIS,2
JP,BOWEN^S DISEASE,2
JP,BREAST CANCER METASTATIC,2
JP,BREAST MASS,2
JP,BREAST SWELLING,2
JP,BURKITT^S LYMPHOMA,2
JP,C-REACTIVE PROTEIN ABNORMAL,2
JP,CALCULUS URINARY,2
JP,CANCER PAIN,2
JP,CANDIDIASIS,2
JP,CARDIAC NEOPLASM UNSPECIFIED,2
JP,CARDIOVASCULAR DISORDER,2
JP,CENTRAL NERVOUS SYSTEM LEUKAEMIA,2
JP,CENTRAL OBESITY,2
JP,CEREBRAL TOXOPLASMOSIS,2
JP,CEREBROVASCULAR ACCIDENT,2
JP,CERVICAL DYSPLASIA,2
JP,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,2
JP,CHIMERISM,2
JP,CHLAMYDIA TEST POSITIVE,2
JP,CHOLANGITIS,2
JP,CHROMOSOME ANALYSIS ABNORMAL,2
JP,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,2
JP,CHRONIC KIDNEY DISEASE,2
JP,CLAVICLE FRACTURE,2
JP,COLON CANCER METASTATIC,2
JP,COMA,2
JP,COMPLETED SUICIDE,2
JP,CONGESTIVE CARDIOMYOPATHY,2
JP,CONNECTIVE TISSUE DISORDER,2
JP,CONTRAINDICATED PRODUCT ADMINISTERED,2
JP,CSF CELL COUNT INCREASED,2
JP,CSF PROTEIN INCREASED,2
JP,CUSHINGOID,2
JP,CYTOKINE RELEASE SYNDROME,2
JP,DEAFNESS UNILATERAL,2
JP,DECREASED VIBRATORY SENSE,2
JP,DELUSION,2
JP,DEMYELINATION,2
JP,DERMATITIS EXFOLIATIVE,2
JP,DIABETES INSIPIDUS,2
JP,DIARRHOEA HAEMORRHAGIC,2
JP,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,2
JP,DIPLEGIA,2
JP,DIPLOPIA,2
JP,DISCOMFORT,2
JP,DISLOCATION OF VERTEBRA,2
JP,DIVERTICULUM INTESTINAL,2
JP,DRUG INTOLERANCE,2
JP,DRUG PRESCRIBING ERROR,2
JP,DRY MOUTH,2
JP,DRY SKIN,2
JP,DUODENAL STENOSIS,2
JP,DUODENAL ULCER HAEMORRHAGE,2
JP,DUODENITIS,2
JP,EJECTION FRACTION DECREASED,2
JP,EMPHYSEMA,2
JP,ENCEPHALITIS CYTOMEGALOVIRUS,2
JP,ENCEPHALITIS HERPES,2
JP,ENCEPHALITIS VIRAL,2
JP,ENDOMETRIOSIS,2
JP,ENDOTOXAEMIA,2
JP,ENTEROCOCCAL BACTERAEMIA,2
JP,ENTEROCOLITIS HAEMORRHAGIC,2
JP,EOSINOPHILIA,2
JP,EPIGLOTTITIS,2
JP,EPSTEIN-BARR VIRUS ANTIGEN POSITIVE,2
JP,ERYTHEMA MULTIFORME,2
JP,EXTENSOR PLANTAR RESPONSE,2
JP,EXTRANODAL NK/T-CELL LYMPHOMA_ NASAL TYPE,2
JP,EYE SWELLING,2
JP,FAECAL INCONTINENCE,2
JP,FAMILIAL MEDITERRANEAN FEVER,2
JP,FAT NECROSIS,2
JP,FEELING HOT,2
JP,FIBROSIS,2
JP,FINGER DEFORMITY,2
JP,FISTULA,2
JP,FLANK PAIN,2
JP,FLATULENCE,2
JO,NEUTROPHIL COUNT INCREASED,3
JO,ACUTE MYELOID LEUKAEMIA,1
JO,CRANIOPHARYNGIOMA,1
JO,EYE PAIN,1
JO,FATIGUE,1
JO,HAEMATURIA,1
JO,HEADACHE,1
JO,HEPATITIS,1
JO,HYPERSENSITIVITY,1
JO,PANCREATITIS ACUTE,1
JO,PANCREATITIS RELAPSING,1
JO,PANCYTOPENIA,1
JO,PYREXIA,1
JO,RENAL IMPAIRMENT,1
JO,VISION BLURRED,1
KZ,BODY TEMPERATURE INCREASED,1
KZ,CERVIX CARCINOMA,1
KZ,DRUG EFFECT DECREASED,1
KZ,FIBROADENOMA OF BREAST,1
KZ,HEPATIC CIRRHOSIS,1
KZ,NAUSEA,1
KZ,PHARYNGITIS BACTERIAL,1
KZ,PURULENT DISCHARGE,1
KZ,RHEUMATOID ARTHRITIS,1
KZ,RHEUMATOID NODULE,1
KZ,SKIN LESION,1
KZ,VOMITING,1
KE,ALOPECIA,1
KE,ANAEMIA,1
KE,CONSTIPATION,1
KE,DIARRHOEA,1
KE,DIZZINESS,1
KE,DRUG DOSE OMISSION,1
KE,GASTRIC ULCER,1
KE,HYPERCHLORHYDRIA,1
KE,MOUTH ULCERATION,1
KE,NAIL PIGMENTATION,1
KE,NEUTROPENIA,1
KE,OVERDOSE,1
KE,PAIN IN EXTREMITY,1
KE,PARAESTHESIA,1
KE,PIGMENTATION DISORDER,1
KE,PRODUCT USE ISSUE,1
KE,UNDERDOSE,1
KE,VOMITING,1
KP,CEREBRAL SALT-WASTING SYNDROME,3
KP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
KP,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
KP,BK VIRUS INFECTION,1
KP,CONDITION AGGRAVATED,1
KP,CYTOMEGALOVIRUS VIRAEMIA,1
KP,DEATH,1
KP,DERMATITIS BULLOUS,1
KP,ENCEPHALITIS VIRAL,1
KP,KLEBSIELLA INFECTION,1
KP,LEUKOENCEPHALOPATHY,1
KP,MENINGITIS ASEPTIC,1
KP,METASTASES TO CENTRAL NERVOUS SYSTEM,1
KP,METASTASES TO LUNG,1
KP,METASTASES TO LYMPH NODES,1
KP,METASTASES TO OVARY,1
KP,PNEUMONIA,1
KP,PNEUMONIA ASPIRATION,1
KP,PNEUMONIA FUNGAL,1
KP,RASH,1
KP,SEPSIS,1
KP,TOXICITY TO VARIOUS AGENTS,1
KR,TREATMENT FAILURE,28
KR,PNEUMONIA,25
KR,SEPSIS,17
KR,FEBRILE NEUTROPENIA,16
KR,PYREXIA,12
KR,DRUG INEFFECTIVE,11
KR,CHRONIC GRAFT VERSUS HOST DISEASE,10
KR,CYSTITIS HAEMORRHAGIC,10
KR,HYPERTENSION,10
KR,NEUTROPENIA,10
KR,ASTHENIA,9
KR,GRAFT VERSUS HOST DISEASE,9
KR,ARTHRALGIA,8
KR,CONDITION AGGRAVATED,8
KR,DISEASE RECURRENCE,8
KR,HEADACHE,8
KR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,7
KR,APPENDICITIS,7
KR,CONVULSION,7
KR,DIARRHOEA,7
KR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,7
KR,ACUTE GRAFT VERSUS HOST DISEASE,6
KR,NAUSEA,6
KR,PYELONEPHRITIS ACUTE,6
KR,ACUTE MYELOID LEUKAEMIA,5
KR,C-REACTIVE PROTEIN INCREASED,5
KR,DEATH,5
KR,DISEASE PROGRESSION,5
KR,THROMBOCYTOPENIA,5
KR,VENOOCCLUSIVE DISEASE,5
KR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,4
KR,ALANINE AMINOTRANSFERASE INCREASED,4
KR,CONFUSIONAL STATE,4
KR,ESCHERICHIA BACTERAEMIA,4
KR,HAEMOGLOBIN DECREASED,4
KR,INFUSION RELATED REACTION,4
KR,INTERSTITIAL LUNG DISEASE,4
KR,MALIGNANT NEOPLASM PROGRESSION,4
KR,METASTASES TO LUNG,4
KR,MYELOPATHY,4
KR,NEUTROPHIL COUNT DECREASED,4
KR,ORAL CANDIDIASIS,4
KR,OSTEOSARCOMA,4
KR,PANCYTOPENIA,4
KR,PNEUMATOSIS INTESTINALIS,4
KR,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
KR,PROTHROMBIN TIME PROLONGED,4
KR,PULMONARY TUBERCULOSIS,4
KR,RASH,4
KR,RESPIRATORY FAILURE,4
KR,STEM CELL TRANSPLANT,4
KR,TUBERCULOSIS,4
KR,VOMITING,4
KR,ABDOMINAL PAIN,3
KR,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,3
KR,ANAEMIA,3
KR,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE III,3
KR,ASPERGILLUS INFECTION,3
KR,ATYPICAL FEMUR FRACTURE,3
KR,BRONCHIECTASIS,3
KR,CUTANEOUS CALCIFICATION,3
KR,CYTOMEGALOVIRUS CHORIORETINITIS,3
KR,CYTOMEGALOVIRUS INFECTION,3
KR,DERMATITIS BULLOUS,3
KR,DYSPNOEA,3
KR,ENCEPHALITIS,3
KR,EPILEPSY,3
KR,ERYTHEMA,3
KR,GENERALISED OEDEMA,3
KR,HAEMORRHAGE,3
KR,HEPATIC ENZYME INCREASED,3
KR,HERPES ZOSTER,3
KR,INFECTION,3
KR,INFECTION REACTIVATION,3
KR,INTERVERTEBRAL DISC PROTRUSION,3
KR,PAIN IN EXTREMITY,3
KR,PLATELET COUNT DECREASED,3
KR,PNEUMONIA ASPIRATION,3
KR,PRODUCT USE ISSUE,3
KR,PROTEINURIA,3
KR,RENAL INFARCT,3
KR,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
KR,RETINAL DETACHMENT,3
KR,RHEUMATOID ARTHRITIS,3
KR,SECOND PRIMARY MALIGNANCY,3
KR,SEPTIC SHOCK,3
KR,THERAPEUTIC RESPONSE DECREASED,3
KR,THERAPY NON-RESPONDER,3
KR,URINARY TRACT INFECTION,3
KR,VENOOCCLUSIVE LIVER DISEASE,3
KR,ABDOMINAL DISCOMFORT,2
KR,ABDOMINAL DISTENSION,2
KR,ACTINIC KERATOSIS,2
KR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
KR,ANGIOPATHY,2
KR,ARTHRITIS BACTERIAL,2
KR,ASPARTATE AMINOTRANSFERASE INCREASED,2
KR,ATAXIA,2
KR,BACTERIAL INFECTION,2
KR,BASAL CELL CARCINOMA,2
KR,BK VIRUS INFECTION,2
KR,BLAST CELLS PRESENT,2
KR,BLISTER,2
KR,BLOOD ALBUMIN DECREASED,2
KR,BLOOD STEM CELL TRANSPLANT FAILURE,2
KR,BREAST CANCER,2
KR,CEREBRAL HAEMORRHAGE,2
KR,CEREBRAL VASOCONSTRICTION,2
KR,COMPLICATIONS OF BONE MARROW TRANSPLANT,2
KR,CONSTIPATION,2
KR,CYTOMEGALOVIRUS COLITIS,2
KR,DECREASED APPETITE,2
KR,DELIRIUM,2
KR,DIFFUSE LARGE B-CELL LYMPHOMA,2
KR,DIZZINESS,2
KR,DRUG RESISTANCE,2
KR,DYSARTHRIA,2
KR,DYSPHAGIA,2
KR,EWING^S SARCOMA,2
KR,EXTRAVASATION,2
KR,FEMUR FRACTURE,2
KR,GASTROOESOPHAGEAL REFLUX DISEASE,2
KR,GENERAL PHYSICAL HEALTH DETERIORATION,2
KR,GLOMERULONEPHRITIS MEMBRANOUS,2
KR,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
KR,GRAFT VERSUS HOST DISEASE IN INTESTINE,2
KR,HAEMATOCHEZIA,2
KR,HAEMATOMA,2
KR,HEPATITIS,2
KR,HYPOAESTHESIA,2
KR,HYPOTHYROIDISM,2
KR,INFLAMMATION,2
KR,INFLUENZA LIKE ILLNESS,2
KR,INSOMNIA,2
KR,INTENTION TREMOR,2
KR,LEUKAEMIA RECURRENT,2
KR,LEUKOENCEPHALOPATHY,2
KR,LEUKOPENIA,2
KR,LUNG NEOPLASM MALIGNANT,2
KR,LYMPHADENOPATHY,2
KR,MALAISE,2
KR,MATERNAL EXPOSURE DURING PREGNANCY,2
KR,MUSCULAR WEAKNESS,2
KR,MYELODYSPLASTIC SYNDROME,2
KR,MYOCARDIAL INFARCTION,2
KR,NASOPHARYNGITIS,2
KR,NEUTROPENIC SEPSIS,2
KR,NYSTAGMUS,2
KR,OESOPHAGITIS,2
KR,OSTEOARTHRITIS,2
KR,OTITIS MEDIA,2
KR,PAIN,2
KR,PERITONEAL TUBERCULOSIS,2
KR,PNEUMONIA FUNGAL,2
KR,PNEUMONITIS,2
KR,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
KR,PRODUCT USE IN UNAPPROVED INDICATION,2
KR,PULMONARY EMBOLISM,2
KR,PULMONARY OEDEMA,2
KR,RHINITIS,2
KR,SKIN LESION,2
KR,SMALL INTESTINAL OBSTRUCTION,2
KR,SOMNOLENCE,2
KR,SPINAL COLUMN STENOSIS,2
KR,SQUAMOUS CELL CARCINOMA,2
KR,SURGERY,2
KR,TOXICITY TO VARIOUS AGENTS,2
KR,UPPER RESPIRATORY TRACT INFECTION,2
KR,URINARY TRACT DISORDER,2
KR,UTERINE LEIOMYOMA,2
KR,VAGINAL HAEMORRHAGE,2
KR,VIITH NERVE PARALYSIS,2
KR,ABASIA,1
KR,ABDOMINAL PAIN LOWER,1
KR,ABDOMINAL RIGIDITY,1
KR,ABDOMINAL TENDERNESS,1
KR,ABSCESS,1
KR,ABSCESS INTESTINAL,1
KR,ACTINOMYCOSIS,1
KR,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
KR,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
KR,ACUTE KIDNEY INJURY,1
KR,ACUTE LYMPHOCYTIC LEUKAEMIA,1
KR,ACUTE RESPIRATORY FAILURE,1
KR,ADENOCARCINOMA GASTRIC,1
KR,ADENOCARCINOMA OF COLON,1
KR,ADENOMYOSIS,1
KR,ADRENAL INSUFFICIENCY,1
KR,AMNESIA,1
KR,ANAL ABSCESS,1
KR,ANAL FISTULA,1
KR,ANAPHYLACTOID REACTION,1
KR,ANORECTAL DISORDER,1
KR,APLASIA PURE RED CELL,1
KR,AREFLEXIA,1
KR,ARRHYTHMIA,1
KR,ASCITES,1
KR,ATYPICAL MYCOBACTERIAL INFECTION,1
KR,AUTOIMMUNE DISORDER,1
KR,B-CELL LYMPHOMA,1
KR,BENIGN PROSTATIC HYPERPLASIA,1
KR,BLOOD CREATININE INCREASED,1
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
KR,BLOOD OSMOLARITY DECREASED,1
KR,BLOOD PRESSURE INCREASED,1
KR,BLOOD PRESSURE SYSTOLIC INCREASED,1
KR,BONE DENSITY DECREASED,1
KR,BRONCHOPULMONARY ASPERGILLOSIS,1
KR,BURNING SENSATION,1
KR,CARDIAC AMYLOIDOSIS,1
KR,CARDIAC ARREST,1
KR,CARDIAC FAILURE,1
KR,CARDIOVASCULAR DISORDER,1
KR,CAUDA EQUINA SYNDROME,1
KR,CELLULITIS,1
KR,CEREBELLAR SYNDROME,1
KR,CEREBRAL DISORDER,1
KR,CEREBRAL INFARCTION,1
KR,CERVIX CARCINOMA,1
KR,CHEST DISCOMFORT,1
KR,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,1
KR,CHRONIC KIDNEY DISEASE,1
KR,CLOSED FRACTURE MANIPULATION,1
KR,CLUMSINESS,1
KR,COLITIS,1
KR,COLITIS ISCHAEMIC,1
KR,COLON CANCER,1
KR,COLORECTAL CANCER,1
KR,COMPLEMENT FACTOR C3 DECREASED,1
KR,COMPLEMENT FACTOR C4 DECREASED,1
KR,CORONARY ARTERY DISEASE,1
KR,CRANIAL NERVE PARALYSIS,1
KR,CREATININE URINE DECREASED,1
KR,CROHN^S DISEASE,1
KR,CRYPTOCOCCOSIS,1
KR,CRYPTOCOCCUS TEST POSITIVE,1
KR,CYTOMEGALOVIRUS DUODENITIS,1
KR,CYTOMEGALOVIRUS TEST POSITIVE,1
KR,CYTOMEGALOVIRUS VIRAEMIA,1
KR,DEAFNESS NEUROSENSORY,1
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KR,DEPRESSED MOOD,1
KR,DIABETIC COMPLICATION,1
KR,DISORIENTATION,1
KR,DRUG ERUPTION,1
KR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
KR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KR,DRUG SPECIFIC ANTIBODY PRESENT,1
KR,DUODENAL PERFORATION,1
KR,DUODENAL ULCER,1
KR,DYSKINESIA,1
KR,DYSPEPSIA,1
KR,DYSPHONIA,1
KR,DYSSTASIA,1
KR,DYSURIA,1
KR,ENCEPHALITIS VIRAL,1
KR,ENTEROBACTER BACTERAEMIA,1
KR,EPIDIDYMITIS,1
KR,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
KR,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
KR,ESCHERICHIA INFECTION,1
KR,EXPOSURE DURING PREGNANCY,1
KR,FALL,1
KR,FATIGUE,1
KR,FEMORAL NECK FRACTURE,1
KR,FIBROMYALGIA,1
KR,FLUID RETENTION,1
KR,FOOT FRACTURE,1
KR,FRACTURE NONUNION,1
KR,GALLBLADDER PERFORATION,1
KR,GASTRIC ULCER HAEMORRHAGE,1
KR,GASTROENTERITIS,1
KR,GASTROINTESTINAL OBSTRUCTION,1
KR,GENERAL PHYSICAL CONDITION ABNORMAL,1
KR,GENITAL EROSION,1
KR,GRAFT VERSUS HOST DISEASE IN EYE,1
KR,GRAFT VERSUS HOST DISEASE IN LIVER,1
KR,GRAFT VERSUS HOST DISEASE IN LUNG,1
KR,HAEMATURIA,1
KR,HAEMOLYTIC URAEMIC SYNDROME,1
KR,HALLUCINATION,1
KR,HENOCH-SCHONLEIN PURPURA,1
KR,HEPATIC VEIN OCCLUSION,1
KR,HEPATITIS B,1
KR,HEPATITIS B DNA INCREASED,1
KR,HEPATOTOXICITY,1
KR,HERPES SIMPLEX,1
KR,HERPES VIRUS INFECTION,1
KR,HIPPOCAMPAL SCLEROSIS,1
KR,HUMAN CHORIONIC GONADOTROPIN POSITIVE,1
KR,HYDROCEPHALUS,1
KR,HYPERSENSITIVITY VASCULITIS,1
KR,HYPONATRAEMIA,1
KR,IDIOPATHIC PULMONARY FIBROSIS,1
KR,INFECTIOUS COLITIS,1
KR,INFLUENZA,1
KR,INGUINAL HERNIA,1
KR,INTERVERTEBRAL DISC DISORDER,1
KR,INTESTINAL FISTULA,1
KR,INTESTINAL OBSTRUCTION,1
KR,INTRAMEDULLARY ROD INSERTION,1
KR,IRRITABLE BOWEL SYNDROME,1
KR,JEJUNAL PERFORATION,1
KR,JOINT EFFUSION,1
KR,JOINT RANGE OF MOTION DECREASED,1
KR,JOINT SWELLING,1
KR,KIDNEY FIBROSIS,1
KR,LACUNAR INFARCTION,1
KR,LARYNGEAL DISORDER,1
KR,LATENT TUBERCULOSIS,1
KR,LEUKAEMIA,1
KR,LEUKAEMIC INFILTRATION EXTRAMEDULLARY,1
KR,LIGAMENT DISORDER,1
KR,LIVER FUNCTION TEST ABNORMAL,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LOSS OF PROPRIOCEPTION,1
KR,LOWER RESPIRATORY TRACT INFECTION,1
KR,LUMBAR SPINAL STENOSIS,1
KR,LUNG ADENOCARCINOMA METASTATIC,1
KR,LUNG INFILTRATION,1
KR,LYMPHADENOPATHY MEDIASTINAL,1
KR,LYMPHOMA,1
KR,LYMPHOPENIA,1
KR,MECHANICAL ILEUS,1
KR,MENINGITIS VIRAL,1
KR,MENISCUS INJURY,1
KR,MENTAL DISORDER,1
KR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
KR,METASTASES TO LYMPH NODES,1
KR,METASTASES TO OVARY,1
KR,METASTASES TO PERITONEUM,1
KR,MUCOSAL INFLAMMATION,1
KR,MULTI-ORGAN FAILURE,1
KR,MUSCLE CONTRACTURE,1
KR,MUSCULOSKELETAL CHEST PAIN,1
KR,MYALGIA,1
KR,MYCOBACTERIAL INFECTION,1
KR,MYELOPROLIFERATIVE DISORDER,1
KR,NECROTISING FASCIITIS,1
KR,NEPHROPATHY TOXIC,1
KR,NEPHROTIC SYNDROME,1
KR,NEUROGENIC BLADDER,1
KR,NEUROGENIC BOWEL,1
KR,NEUROLOGICAL SYMPTOM,1
KR,NEUROPATHY PERIPHERAL,1
KR,NEUROTOXICITY,1
KR,NO THERAPEUTIC RESPONSE,1
KR,OEDEMA,1
KR,OESOPHAGEAL HAEMORRHAGE,1
KR,ORAL ADMINISTRATION COMPLICATION,1
KR,ORAL MUCOSA EROSION,1
KR,ORGAN FAILURE,1
KR,ORGANISING PNEUMONIA,1
KR,OSTEOPOROSIS,1
KR,OTITIS MEDIA CHRONIC,1
KR,OVARIAN CANCER,1
KR,OVARIAN CYST,1
KR,OVERDOSE,1
KR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KR,PALPABLE PURPURA,1
KR,PANCREATITIS ACUTE,1
KR,PAPILLARY THYROID CANCER,1
KR,PARAESTHESIA,1
KR,PARALYSIS FLACCID,1
KR,PATHOLOGICAL FRACTURE,1
KR,PERINEAL ERYTHEMA,1
KR,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
KR,PERIPHERAL SWELLING,1
KR,PERITONEAL HAEMORRHAGE,1
KR,PERITONITIS,1
KR,PERITONITIS BACTERIAL,1
KR,PHARYNGEAL ERYTHEMA,1
KR,PLASMA CELL MYELOMA,1
KR,PNEUMOMEDIASTINUM,1
KR,PNEUMONIA KLEBSIELLA,1
KR,POST PROCEDURAL COMPLICATION,1
KR,POST PROCEDURAL INFLAMMATION,1
KR,PRINZMETAL ANGINA,1
KR,PRURITUS,1
KR,PSEUDOCYST,1
KR,PSEUDOMEMBRANOUS COLITIS,1
KR,PUBIS FRACTURE,1
KR,PULMONARY ALVEOLAR HAEMORRHAGE,1
KR,PULMONARY HAEMORRHAGE,1
KR,PULMONARY MASS,1
KR,PULMONARY TOXICITY,1
KR,PUSTULAR PSORIASIS,1
KR,PYELOCALIECTASIS,1
KR,RADICULOPATHY,1
KR,RALES,1
KR,RASH ERYTHEMATOUS,1
KR,RASH GENERALISED,1
KR,RASH MACULO-PAPULAR,1
KR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
KR,RENAL ABSCESS,1
KR,RENAL DISORDER,1
KR,RENAL IMPAIRMENT,1
KR,RENAL NECROSIS,1
KR,RETROPERITONEAL ABSCESS,1
KR,RETROPERITONEAL LYMPHADENOPATHY,1
KR,RHABDOMYOLYSIS,1
KR,SCLERITIS,1
KR,SKIN BURNING SENSATION,1
KR,SKIN EXFOLIATION,1
KR,SKIN PLAQUE,1
KR,SLOW RESPONSE TO STIMULI,1
KR,SMALL INTESTINAL HAEMORRHAGE,1
KR,SOFT TISSUE NECROSIS,1
KR,SPEECH DISORDER,1
KR,SPINAL COMPRESSION FRACTURE,1
KR,SPINAL CORD COMPRESSION,1
KR,SPLENIC ABSCESS,1
KR,STAPHYLOCOCCUS TEST POSITIVE,1
KR,STILL^S DISEASE,1
KR,STREPTOCOCCAL BACTERAEMIA,1
KR,STUPOR,1
KR,SUBARACHNOID HAEMORRHAGE,1
KR,SUBDURAL HAEMATOMA,1
KR,SUICIDAL IDEATION,1
KR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
KR,TACHYCARDIA,1
KR,TACHYPNOEA,1
KR,THROMBOTIC MICROANGIOPATHY,1
KR,THYROID CANCER,1
KR,TOXIC SKIN ERUPTION,1
KR,TRANSAMINASES INCREASED,1
KR,TRANSPLANT FAILURE,1
KR,TREMOR,1
KR,TUBERCULOUS PLEURISY,1
KR,TUMOUR NECROSIS,1
KR,URETHRITIS,1
KR,UTERINE HAEMORRHAGE,1
KR,VASCULITIS,1
KR,VIRAL HAEMORRHAGIC CYSTITIS,1
KR,VIRAL RASH,1
KR,VISUAL IMPAIRMENT,1
KR,WEIGHT INCREASED,1
KR,WERNICKE^S ENCEPHALOPATHY,1
KR,WHITE MATTER LESION,1
KW,5Q MINUS SYNDROME,3
KW,LOWER RESPIRATORY TRACT INFECTION,3
KW,PANCYTOPENIA,3
KW,DRUG INEFFECTIVE,2
KW,ACUTE RESPIRATORY DISTRESS SYNDROME,1
KW,ANAEMIA,1
KW,ASTHENIA,1
KW,BLOOD DISORDER,1
KW,BREAST MASS,1
KW,DEATH,1
KW,DEPRESSION,1
KW,DIFFUSE ALOPECIA,1
KW,DRUG RESISTANCE,1
KW,DYSHIDROTIC ECZEMA,1
KW,DYSURIA,1
KW,ECZEMA,1
KW,GASTROENTERITIS ESCHERICHIA COLI,1
KW,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
KW,GRAFT VERSUS HOST DISEASE IN LIVER,1
KW,GRAFT VERSUS HOST DISEASE IN SKIN,1
KW,HAEMOPTYSIS,1
KW,INFECTION,1
KW,JC VIRUS TEST POSITIVE,1
KW,LICHEN PLANUS,1
KW,MASTITIS,1
KW,MULTIPLE SCLEROSIS,1
KW,MYELODYSPLASTIC SYNDROME,1
KW,ORAL MUCOSAL ERYTHEMA,1
KW,PALLOR,1
KW,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KW,PARONYCHIA,1
KW,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
KW,PRODUCT USE IN UNAPPROVED INDICATION,1
KW,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
KW,PROSTATIC DISORDER,1
KW,PROSTATIC PAIN,1
KW,PYREXIA,1
KW,RENAL INJURY,1
KW,SCLERITIS,1
KW,SCLERODERMA-LIKE REACTION,1
LV,ARTHRALGIA,2
LV,ABDOMINAL PAIN,1
LV,ABSCESS LIMB,1
LV,AGITATION,1
LV,APPENDICITIS,1
LV,ASTHENIA,1
LV,CELLULITIS,1
LV,CHILLS,1
LV,CHOLANGIOCARCINOMA,1
LV,COUGH,1
LV,CRYING,1
LV,DIARRHOEA,1
LV,DIVERTICULITIS,1
LV,DRUG INEFFECTIVE,1
LV,EPISTAXIS,1
LV,GASTROINTESTINAL PERFORATION,1
LV,HEPATITIS,1
LV,HYPERAEMIA,1
LV,HYPERSENSITIVITY VASCULITIS,1
LV,HYPERTENSIVE CRISIS,1
LV,IRRITABILITY,1
LV,LATENT TUBERCULOSIS,1
LV,LYMPHADENITIS,1
LV,LYMPHADENOPATHY,1
LV,MALAISE,1
LV,MUSCULOSKELETAL STIFFNESS,1
LV,NASAL INFLAMMATION,1
LV,NECK PAIN,1
LV,PAIN,1
LV,PERITONITIS,1
LV,PNEUMONIA,1
LV,PNEUMONIA LEGIONELLA,1
LV,PRURITUS,1
LV,PURULENT DISCHARGE,1
LV,PYREXIA,1
LV,RECTAL HAEMORRHAGE,1
LV,SKIN DISORDER,1
LV,SPONDYLOARTHROPATHY,1
LV,TRANSAMINASES INCREASED,1
LB,CHRONIC GRAFT VERSUS HOST DISEASE,9
LB,PYREXIA,9
LB,ACUTE GRAFT VERSUS HOST DISEASE,8
LB,SEPTIC SHOCK,6
LB,NEUTROPENIA,5
LB,TOXICITY TO VARIOUS AGENTS,5
LB,ANAEMIA,4
LB,ARTHRITIS BACTERIAL,4
LB,ASTHENIA,4
LB,BONE MARROW FAILURE,4
LB,GROWTH RETARDATION,4
LB,HEADACHE,4
LB,OVERDOSE,4
LB,SALMONELLA BACTERAEMIA,4
LB,CONDITION AGGRAVATED,3
LB,GASTROINTESTINAL NECROSIS,3
LB,HAEMATOTOXICITY,3
LB,HYPOTHYROIDISM,3
LB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
LB,MUCOCUTANEOUS ULCERATION,3
LB,PAIN,3
LB,STOMATITIS,3
LB,TACHYCARDIA,3
LB,ADENOCARCINOMA GASTRIC,2
LB,C-REACTIVE PROTEIN INCREASED,2
LB,CANDIDA INFECTION,2
LB,DIARRHOEA,2
LB,DRUG INEFFECTIVE,2
LB,DRUG RESISTANCE,2
LB,FEBRILE NEUTROPENIA,2
LB,GASTROINTESTINAL INFECTION,2
LB,GRAFT VERSUS HOST DISEASE,2
LB,GRAFT VERSUS HOST DISEASE IN SKIN,2
LB,LETHARGY,2
LB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
LB,MUSCULAR WEAKNESS,2
LB,NEUTROPHIL COUNT INCREASED,2
LB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
LB,PSORIASIS,2
LB,SKIN PLAQUE,2
LB,SPEECH DISORDER,2
LB,STAPHYLOCOCCAL INFECTION,2
LB,ABSCESS,1
LB,ABSCESS BACTERIAL,1
LB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
LB,ADVERSE DRUG REACTION,1
LB,ALTERED STATE OF CONSCIOUSNESS,1
LB,APHASIA,1
LB,APHONIA,1
LB,ARTHRALGIA,1
LB,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
LB,BLINDNESS,1
LB,BLOOD CREATINE INCREASED,1
LB,BLOOD PRESSURE ABNORMAL,1
LB,BLOOD PRESSURE INCREASED,1
LB,CARDIAC ARREST,1
LB,CEREBROVASCULAR ACCIDENT,1
LB,CHRONIC MYELOID LEUKAEMIA,1
LB,CLONUS,1
LB,DEAFNESS UNILATERAL,1
LB,DEATH,1
LB,DISEASE PROGRESSION,1
LB,DRUG DOSE OMISSION,1
LB,DRUG HYPERSENSITIVITY,1
LB,DRUG INTOLERANCE,1
LB,DYSPHAGIA,1
LB,DYSPHONIA,1
LB,EYE ABSCESS,1
LB,FALL,1
LB,GAIT INABILITY,1
LB,GENERAL PHYSICAL HEALTH DETERIORATION,1
LB,GRAND MAL CONVULSION,1
LB,HAEMOGLOBIN DECREASED,1
LB,HAEMORRHAGE,1
LB,HEPATIC ENZYME INCREASED,1
LB,HYPERTENSIVE ENCEPHALOPATHY,1
LB,HYPOKINESIA,1
LB,HYPOTENSION,1
LB,HYPOTONIA,1
LB,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
LB,INTERSTITIAL LUNG DISEASE,1
LB,JOINT RANGE OF MOTION DECREASED,1
LB,JOINT STIFFNESS,1
LB,LIVER DISORDER,1
LB,LYMPHOMA,1
LB,MASTECTOMY,1
LB,METASTASES TO PERITONEUM,1
LB,MOUTH HAEMORRHAGE,1
LB,MOUTH ULCERATION,1
LB,MULTI-ORGAN FAILURE,1
LB,NEOPLASM MALIGNANT,1
LB,OEDEMA PERIPHERAL,1
LB,OESOPHAGITIS,1
LB,ORAL ADMINISTRATION COMPLICATION,1
LB,ORAL DISORDER,1
LB,ORAL MUCOSA EROSION,1
LB,ORAL MUCOSAL ERYTHEMA,1
LB,ORAL PAIN,1
LB,OSTEOPOROSIS,1
LB,OVARIAN CANCER,1
LB,OVARIAN CYST,1
LB,PAIN IN EXTREMITY,1
LB,PALLOR,1
LB,PANCYTOPENIA,1
LB,PARAESTHESIA,1
LB,PERIPHERAL EMBOLISM,1
LB,PERIPHERAL SWELLING,1
LB,PLATELET COUNT DECREASED,1
LB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
LB,PULMONARY EMBOLISM,1
LB,PUSTULAR PSORIASIS,1
LB,RASH,1
LB,RASH PUSTULAR,1
LB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
LB,RENAL FAILURE,1
LB,SACROILIITIS,1
LB,SKIN DISCOLOURATION,1
LB,SKIN LESION,1
LB,SKIN ULCER,1
LB,SPLENOMEGALY,1
LB,STOMATITIS NECROTISING,1
LB,SUBCUTANEOUS ABSCESS,1
LB,SYNCOPE,1
LB,TENDERNESS,1
LB,THERAPEUTIC RESPONSE DECREASED,1
LB,THROMBOSIS,1
LB,TONGUE EXFOLIATION,1
LB,TONGUE INJURY,1
LB,TOXIC ENCEPHALOPATHY,1
LB,TREATMENT NONCOMPLIANCE,1
LB,VAGINAL HAEMORRHAGE,1
LB,VASCULITIS,1
LB,VITILIGO,1
LB,WEIGHT DECREASED,1
LB,WHITE BLOOD CELL COUNT DECREASED,1
LY,UPPER RESPIRATORY TRACT CONGESTION,2
LY,COUGH,1
LY,DECREASED APPETITE,1
LY,FLUSHING,1
LY,HEADACHE,1
LY,NIGHT SWEATS,1
LY,THROAT IRRITATION,1
LY,TUBERCULOSIS,1
LT,NEUROENDOCRINE CARCINOMA OF THE SKIN,7
LT,CARDIOVASCULAR INSUFFICIENCY,4
LT,DRUG INEFFECTIVE,3
LT,FATIGUE,3
LT,PNEUMONIA,3
LT,DYSPNOEA,2
LT,METASTASES TO PANCREAS,2
LT,PSEUDOLYMPHOMA,2
LT,PULMONARY TUBERCULOSIS,2
LT,ANEURYSM,1
LT,ANGIOEDEMA,1
LT,ARTHRALGIA,1
LT,BRONCHITIS,1
LT,BURSITIS,1
LT,C-REACTIVE PROTEIN INCREASED,1
LT,CATARACT,1
LT,COLON CANCER,1
LT,DIEULAFOY^S VASCULAR MALFORMATION,1
LT,DIZZINESS,1
LT,DYSPHAGIA,1
LT,FUNGAL SKIN INFECTION,1
LT,GASTRIC HAEMORRHAGE,1
LT,HAEMATOMA,1
LT,HAEMORRHAGIC STROKE,1
LT,HYPERAEMIA,1
LT,INFLUENZA,1
LT,INFUSION RELATED REACTION,1
LT,LUNG ADENOCARCINOMA,1
LT,LUNG NEOPLASM,1
LT,LYMPHOMA,1
LT,METASTASES TO SOFT TISSUE,1
LT,MOVEMENT DISORDER,1
LT,MYOCARDIAL INFARCTION,1
LT,NAUSEA,1
LT,NEUROENDOCRINE CARCINOMA METASTATIC,1
LT,OEDEMA,1
LT,ONYCHOMYCOSIS,1
LT,OVARIAN CYST,1
LT,PANCREATITIS CHRONIC,1
LT,PERITONSILLAR ABSCESS,1
LT,RASH,1
LT,RASH MACULAR,1
LT,RASH PUSTULAR,1
LT,SCLERODERMA,1
LT,SKIN DISCOLOURATION,1
LT,SKIN MASS,1
LT,SPEECH DISORDER,1
LT,SYNCOPE,1
LT,TACHYCARDIA,1
LT,TACHYPNOEA,1
LT,TOOTH INFECTION,1
LT,UVEITIS,1
LT,WHITE BLOOD CELL COUNT DECREASED,1
LT,WHITE BLOOD CELL COUNT INCREASED,1
LU,ANAPHYLACTIC REACTION,1
LU,ANAPHYLACTOID REACTION,1
LU,ERYTHEMA,1
LU,HYPOTENSION,1
LU,PERIORBITAL OEDEMA,1
MO,ANTIBODY TEST ABNORMAL,2
MO,HEPATITIS B E ANTIBODY POSITIVE,2
MO,LIVER FUNCTION TEST ABNORMAL,2
MO,LOSS OF CONSCIOUSNESS,1
MO,PYREXIA,1
MW,LEUKOPENIA,1
MW,PRODUCT USE IN UNAPPROVED INDICATION,1
MW,SEPSIS,1
MY,NEUTROPENIC SEPSIS,11
MY,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,8
MY,DEEP VEIN THROMBOSIS,7
MY,STAPHYLOCOCCAL SEPSIS,7
MY,HYPERTENSION,5
MY,PNEUMONIA,5
MY,ACUTE MYELOID LEUKAEMIA,4
MY,HEADACHE,3
MY,HEPATITIS ACUTE,3
MY,MYELODYSPLASTIC SYNDROME,3
MY,NEUTROPENIA,3
MY,PLEURAL EFFUSION,3
MY,ACUTE KIDNEY INJURY,2
MY,ACUTE RESPIRATORY DISTRESS SYNDROME,2
MY,ALANINE AMINOTRANSFERASE INCREASED,2
MY,DRUG-INDUCED LIVER INJURY,2
MY,FOETAL EXPOSURE DURING PREGNANCY,2
MY,HEPATIC ENZYME INCREASED,2
MY,MYELOPROLIFERATIVE NEOPLASM,2
MY,OEDEMA PERIPHERAL,2
MY,PANCYTOPENIA,2
MY,PRODUCT USE ISSUE,2
MY,SEIZURE,2
MY,THROMBOCYTOPENIA,2
MY,TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA,2
MY,TUBERCULOSIS,2
MY,TUBERCULOUS PLEURISY,2
MY,WHITE BLOOD CELL COUNT DECREASED,2
MY,ABDOMINAL PAIN,1
MY,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
MY,ANAPHYLACTIC SHOCK,1
MY,BACK PAIN,1
MY,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
MY,BLOOD PRESSURE INCREASED,1
MY,BREAST CANCER STAGE III,1
MY,BRONCHOPULMONARY ASPERGILLOSIS,1
MY,CEREBROVASCULAR ACCIDENT,1
MY,CHROMATURIA,1
MY,DISEASE PROGRESSION,1
MY,DISEASE RECURRENCE,1
MY,DISSEMINATED TUBERCULOSIS,1
MY,DIZZINESS,1
MY,DRUG INEFFECTIVE,1
MY,DRY SKIN,1
MY,ERYTHEMA,1
MY,EXPOSURE VIA FATHER,1
MY,FACIAL PARALYSIS,1
MY,FATIGUE,1
MY,FEBRILE NEUTROPENIA,1
MY,HEMIPARESIS,1
MY,HEPATIC FAILURE,1
MY,HEPATITIS,1
MY,HERPES ZOSTER,1
MY,HERPES ZOSTER OTICUS,1
MY,HYPERSENSITIVITY,1
MY,INFECTION,1
MY,INFUSION RELATED REACTION,1
MY,INJECTION SITE ERYTHEMA,1
MY,INTRADUCTAL PAPILLOMA OF BREAST,1
MY,INTRAVENTRICULAR HAEMORRHAGE,1
MY,JAUNDICE,1
MY,JAUNDICE NEONATAL,1
MY,KARYOTYPE ANALYSIS ABNORMAL,1
MY,LEUKOPENIA,1
MY,LOW BIRTH WEIGHT BABY,1
MY,LUNG ABSCESS,1
MY,LYMPHADENOPATHY,1
MY,MALIGNANT HYPERTENSION,1
MY,MORGANELLA INFECTION,1
MY,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
MY,NIGHT SWEATS,1
MY,PAIN,1
MY,PERIORBITAL OEDEMA,1
MY,PHOTOSENSITIVITY REACTION,1
MY,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
MY,PNEUMONITIS,1
MY,PRODUCT USE IN UNAPPROVED INDICATION,1
MY,PRURITUS,1
MY,PULMONARY TUBERCULOSIS,1
MY,PYREXIA,1
MY,RECTAL ABSCESS,1
MY,RESPIRATORY FAILURE,1
MY,RHEUMATOID ARTHRITIS,1
MY,SECOND PRIMARY MALIGNANCY,1
MY,SEPSIS,1
MY,SEPTIC SHOCK,1
MY,SUBCUTANEOUS ABSCESS,1
MY,SWELLING FACE,1
MY,SYSTEMIC LUPUS ERYTHEMATOSUS,1
MY,THALAMUS HAEMORRHAGE,1
MY,THERAPEUTIC RESPONSE DECREASED,1
MY,TOXICITY TO VARIOUS AGENTS,1
MY,TUMOUR LYSIS SYNDROME,1
MY,URINE OUTPUT DECREASED,1
MY,URTICARIA,1
MY,VAGINAL HAEMORRHAGE,1
MY,WEIGHT DECREASED,1
MT,NEUTROPENIC SEPSIS,6
MT,TOXICITY TO VARIOUS AGENTS,6
MT,INJECTION SITE PAIN,2
MT,ACUTE KIDNEY INJURY,1
MT,ADRENAL INSUFFICIENCY,1
MT,ANAL ATRESIA,1
MT,ATRIAL FIBRILLATION,1
MT,ATYPICAL FRACTURE,1
MT,BASAL CELL CARCINOMA,1
MT,BLADDER TRANSITIONAL CELL CARCINOMA STAGE II,1
MT,CARDIOVASCULAR DISORDER,1
MT,COLON CANCER,1
MT,DEATH,1
MT,DISEASE PROGRESSION,1
MT,DRUG EFFECT DELAYED,1
MT,DYSPEPSIA,1
MT,EMBOLISM,1
MT,ENDOCARDITIS,1
MT,ERYTHEMA,1
MT,HAEMATURIA,1
MT,HIP FRACTURE,1
MT,HYPERSENSITIVITY,1
MT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
MT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
MT,METASTASES TO ADRENALS,1
MT,MOBILITY DECREASED,1
MT,MUSCULAR WEAKNESS,1
MT,PARAESTHESIA,1
MT,POLYP,1
MT,POST PROCEDURAL COMPLICATION,1
MT,PROSTATE CANCER STAGE III,1
MT,PSORIASIS,1
MT,PSORIATIC ARTHROPATHY,1
MT,RIGHT ATRIAL DILATATION,1
MT,RIGHT VENTRICULAR DILATATION,1
MT,RIGHT VENTRICULAR DYSFUNCTION,1
MT,SWELLING FACE,1
MT,THERAPY RESPONDER,1
MT,TRANSITIONAL CELL CARCINOMA,1
MT,TRISOMY 21,1
MX,FEBRILE NEUTROPENIA,32
MX,ARTHRALGIA,25
MX,HEADACHE,16
MX,PNEUMONIA,15
MX,PAIN,13
MX,DRUG INEFFECTIVE,11
MX,FATIGUE,11
MX,PAIN IN EXTREMITY,11
MX,COUGH,10
MX,WEIGHT DECREASED,10
MX,PYREXIA,9
MX,SEPTIC SHOCK,9
MX,DIARRHOEA,8
MX,FALL,8
MX,MALAISE,8
MX,MUCOSAL INFLAMMATION,8
MX,ORAL CANDIDIASIS,8
MX,ANXIETY,7
MX,CARDIO-RESPIRATORY ARREST,7
MX,DIZZINESS,7
MX,EXTRAPULMONARY TUBERCULOSIS,7
MX,GAIT DISTURBANCE,7
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
MX,INFLAMMATION,7
MX,PLATELET COUNT DECREASED,7
MX,ARTHRITIS,6
MX,BACK PAIN,6
MX,DYSPNOEA,6
MX,INSOMNIA,6
MX,NECK PAIN,6
MX,VOMITING,6
MX,ANAEMIA,5
MX,ASTHENIA,5
MX,BACTERAEMIA,5
MX,BONE PAIN,5
MX,CONGESTIVE CARDIOMYOPATHY,5
MX,CONSTIPATION,5
MX,HEPATIC FUNCTION ABNORMAL,5
MX,HYPERSENSITIVITY,5
MX,HYPOAESTHESIA,5
MX,HYPOTENSION,5
MX,INFLUENZA,5
MX,LYMPHOCYTE COUNT DECREASED,5
MX,MUCOSAL ATROPHY,5
MX,MUSCULOSKELETAL PAIN,5
MX,MUSCULOSKELETAL STIFFNESS,5
MX,PALLOR,5
MX,PARAESTHESIA,5
MX,RESPIRATORY FAILURE,5
MX,STOMATITIS,5
MX,WEIGHT INCREASED,5
MX,WHITE BLOOD CELL COUNT DECREASED,5
MX,ABDOMINAL PAIN,4
MX,BLOOD TRIGLYCERIDES INCREASED,4
MX,CHEST PAIN,4
MX,COAGULOPATHY,4
MX,DECREASED APPETITE,4
MX,ERYTHEMA,4
MX,GASTRITIS,4
MX,HAEMORRHAGE,4
MX,HERPES ZOSTER,4
MX,IMMUNOSUPPRESSION,4
MX,INTENTIONAL PRODUCT MISUSE,4
MX,MALNUTRITION,4
MX,MOBILITY DECREASED,4
MX,NAUSEA,4
MX,PRODUCT USE ISSUE,4
MX,RETINOIC ACID SYNDROME,4
MX,RHEUMATOID ARTHRITIS,4
MX,SEPSIS,4
MX,TACHYCARDIA,4
MX,TENDON RUPTURE,4
MX,TOXICITY TO VARIOUS AGENTS,4
MX,URINARY TRACT INFECTION,4
MX,VITAMIN B12 ABNORMAL,4
MX,ABASIA,3
MX,ABORTION SPONTANEOUS,3
MX,ANAPHYLACTIC REACTION,3
MX,ANGINA UNSTABLE,3
MX,APLASTIC ANAEMIA,3
MX,BLOOD CHOLESTEROL INCREASED,3
MX,BLOOD PRESSURE DECREASED,3
MX,CEREBRAL HAEMORRHAGE,3
MX,CHEILITIS,3
MX,CHONDROPATHY,3
MX,CHRONIC GRAFT VERSUS HOST DISEASE,3
MX,DEHYDRATION,3
MX,DEPRESSED MOOD,3
MX,DEPRESSION,3
MX,DEVICE RELATED INFECTION,3
MX,DISEASE PROGRESSION,3
MX,DISSEMINATED TUBERCULOSIS,3
MX,DRUG HYPERSENSITIVITY,3
MX,DRY THROAT,3
MX,EXPOSURE DURING PREGNANCY,3
MX,FEELING ABNORMAL,3
MX,GASTROOESOPHAGEAL REFLUX DISEASE,3
MX,GRAFT VERSUS HOST DISEASE,3
MX,HEPATIC CIRRHOSIS,3
MX,HEPATOTOXICITY,3
MX,HERPES VIRUS INFECTION,3
MX,HYPERTENSION,3
MX,INFECTION,3
MX,INFUSION RELATED REACTION,3
MX,INTESTINAL PERFORATION,3
MX,JOINT SWELLING,3
MX,LIGAMENT SPRAIN,3
MX,MENINGITIS TUBERCULOUS,3
MX,MOVEMENT DISORDER,3
MX,MUSCLE RIGIDITY,3
MX,MYALGIA,3
MX,MYOCARDIAL INFARCTION,3
MX,NUTRITIONAL CONDITION ABNORMAL,3
MX,OROPHARYNGEAL PAIN,3
MX,PERIPHERAL SWELLING,3
MX,POST INFLAMMATORY PIGMENTATION CHANGE,3
MX,PRODUCT USE IN UNAPPROVED INDICATION,3
MX,SJOGREN^S SYNDROME,3
MX,SOMNOLENCE,3
MX,THROAT IRRITATION,3
MX,ABDOMINAL DISCOMFORT,2
MX,ABDOMINAL DISTENSION,2
MX,ABDOMINAL PAIN UPPER,2
MX,ACTIVITIES OF DAILY LIVING IMPAIRED,2
MX,ACUTE KIDNEY INJURY,2
MX,ARTHRITIS BACTERIAL,2
MX,BLOOD PRESSURE INCREASED,2
MX,BONE MARROW FAILURE,2
MX,BURNING MOUTH SYNDROME,2
MX,BURNING SENSATION,2
MX,CANDIDA INFECTION,2
MX,CARDIOTOXICITY,2
MX,CHILLS,2
MX,COCCIDIOIDOMYCOSIS,2
MX,CONFUSIONAL STATE,2
MX,CYANOSIS,2
MX,DEATH,2
MX,DISORIENTATION,2
MX,DIVERTICULITIS,2
MX,DRUG ADMINISTRATION ERROR,2
MX,DRUG DOSE OMISSION,2
MX,DRUG EFFECT INCOMPLETE,2
MX,DRUG PRESCRIBING ERROR,2
MX,DYSKINESIA,2
MX,DYSSTASIA,2
MX,EATING DISORDER,2
MX,ERYTHRODERMIC PSORIASIS,2
MX,EYE PAIN,2
MX,FLATULENCE,2
MX,GALLBLADDER DISORDER,2
MX,GASTRIC INFECTION,2
MX,GOITRE,2
MX,HAEMOGLOBIN DECREASED,2
MX,HEPATIC STEATOSIS,2
MX,HYPERHIDROSIS,2
MX,HYPONATRAEMIA,2
MX,INJECTION SITE ERYTHEMA,2
MX,INJECTION SITE INDURATION,2
MX,INJECTION SITE PRURITUS,2
MX,INTERVERTEBRAL DISC PROTRUSION,2
MX,IRRITABLE BOWEL SYNDROME,2
MX,JOINT RANGE OF MOTION DECREASED,2
MX,JOINT STIFFNESS,2
MX,LACTOSE INTOLERANCE,2
MX,LEUKAEMIA RECURRENT,2
MX,LEUKOCYTOSIS,2
MX,LEUKOENCEPHALOPATHY,2
MX,LIVER FUNCTION TEST ABNORMAL,2
MX,LIVER INJURY,2
MX,LOCAL SWELLING,2
MX,LYMPHOMA,2
MX,MEDICATION ERROR,2
MX,MEMORY IMPAIRMENT,2
MX,METABOLIC ACIDOSIS,2
MX,MOUTH ULCERATION,2
MX,MUSCLE SPASMS,2
MX,MUSCULAR WEAKNESS,2
MX,MYCOBACTERIAL INFECTION,2
MX,NERVE INJURY,2
MX,NEUROBORRELIOSIS,2
MX,OSTEOARTHRITIS,2
MX,OVERDOSE,2
MX,PAIN IN JAW,2
MX,PALPABLE PURPURA,2
MX,PHARYNGITIS,2
MX,PNEUMONITIS,2
MX,PROCEDURAL PAIN,2
MX,PRURITUS,2
MX,PULMONARY EMBOLISM,2
MX,PULMONARY TUBERCULOSIS,2
MX,RASH,2
MX,RASH PUSTULAR,2
MX,RENAL ABSCESS,2
MX,RENAL FAILURE,2
MX,ROAD TRAFFIC ACCIDENT,2
MX,SCOLIOSIS,2
MX,SENSATION OF FOREIGN BODY,2
MX,SPINAL PAIN,2
MX,STEROID THERAPY,2
MX,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,2
MX,SWELLING,2
MX,SWELLING FACE,2
MX,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
MX,TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,2
MX,TUBERCULOSIS,2
MX,UPPER RESPIRATORY TRACT INFECTION,2
MX,URTICARIA,2
MX,VARICELLA,2
MX,WOUND INFECTION,2
MX,ABNORMAL WEIGHT GAIN,1
MX,ACCIDENT,1
MX,ACID PEPTIC DISEASE,1
MX,ACUTE HEPATIC FAILURE,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,ADRENAL GLAND INJURY,1
MX,ADRENAL SUPPRESSION,1
MX,ADVERSE EVENT,1
MX,ALANINE AMINOTRANSFERASE INCREASED,1
MX,ALOPECIA,1
MX,ANAPHYLACTIC SHOCK,1
MX,ANGIOPATHY,1
MX,ANIMAL BITE,1
MX,ANIMAL SCRATCH,1
MX,ANOGENITAL WARTS,1
MX,ANTICIPATORY ANXIETY,1
MX,APATHY,1
MX,APHTHOUS ULCER,1
MX,APPENDICITIS,1
MX,APPENDICITIS PERFORATED,1
MX,APPLICATION SITE BRUISE,1
MX,APPLICATION SITE PAIN,1
MX,ARRHYTHMIA,1
MX,ARTERIAL OCCLUSIVE DISEASE,1
MX,ARTHROPATHY,1
MX,ASCITES,1
MX,ASPARTATE AMINOTRANSFERASE INCREASED,1
MX,ASTHMATIC CRISIS,1
MX,BACTERIAL INFECTION,1
MX,BENIGN INTRACRANIAL HYPERTENSION,1
MX,BLADDER PROLAPSE,1
MX,BLOOD CORTISOL,1
MX,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MX,BONE DEFORMITY,1
MX,BONE DISORDER,1
MX,BONE MARROW DISORDER,1
MX,BONE TUBERCULOSIS,1
MX,BRAIN HERNIATION,1
MX,BRAIN STEM SYNDROME,1
MX,BREAST ABSCESS,1
MX,BREAST CANCER,1
MX,BREAST CANCER FEMALE,1
MX,BREAST MASS,1
MX,BREAST PAIN,1
MX,BURKHOLDERIA CEPACIA COMPLEX INFECTION,1
MX,BURSITIS INFECTIVE,1
MX,C-REACTIVE PROTEIN INCREASED,1
MX,CAFE AU LAIT SPOTS,1
MX,CARDIOMEGALY,1
MX,CARPAL TUNNEL SYNDROME,1
MX,CARTILAGE ATROPHY,1
MX,CARTILAGE INJURY,1
MX,CELLULITIS,1
MX,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
MX,CEREBELLAR ATROPHY,1
MX,CEREBRAL ARTERY EMBOLISM,1
MX,CEREBRAL ASPERGILLOSIS,1
MX,CEREBRAL ATROPHY,1
MX,CEREBRAL CALCIFICATION,1
MX,CEREBRAL VENTRICLE DILATATION,1
MX,CEREBROVASCULAR ACCIDENT,1
MX,CHEMICAL POISONING,1
MX,CHOLELITHIASIS,1
MX,CLAVICLE FRACTURE,1
MX,CLOSTRIDIUM DIFFICILE INFECTION,1
MX,COLON CANCER,1
MX,CONDITION AGGRAVATED,1
MX,CONJUNCTIVAL ULCER,1
MX,CONJUNCTIVITIS,1
MX,CONTUSION,1
MX,CSF OLIGOCLONAL BAND ABSENT,1
MX,CUTANEOUS TUBERCULOSIS,1
MX,DEAFNESS,1
MX,DECUBITUS ULCER,1
MX,DEMENTIA,1
MX,DERMATITIS ATOPIC,1
MX,DERMATOSIS,1
MX,DEVICE MALFUNCTION,1
MX,DIABETES MELLITUS,1
MX,DIFFUSE VASCULITIS,1
MX,DISCOMFORT,1
MX,DISEASE RECURRENCE,1
MX,DIVERTICULUM,1
MX,DRUG ABUSE,1
MX,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
MX,DRUG CLEARANCE DECREASED,1
MX,DRUG DEPENDENCE,1
MX,DYSMENORRHOEA,1
MX,DYSPEPSIA,1
MX,ELBOW DEFORMITY,1
MX,ENCEPHALOPATHY,1
MX,ENTERITIS INFECTIOUS,1
MX,ENTEROCOCCAL INFECTION,1
MX,EPISTAXIS,1
MX,ESCHERICHIA URINARY TRACT INFECTION,1
MX,EYE ABSCESS,1
MX,EYE DISCHARGE,1
MX,EYE INFECTION,1
MX,FACE OEDEMA,1
MX,FAHR^S DISEASE,1
MX,FEMUR FRACTURE,1
MX,FLANK PAIN,1
MX,FLUSHING,1
MX,FOETAL DEATH,1
MX,FOOT FRACTURE,1
MX,FUNGAL INFECTION,1
MX,GASTRIC ULCER,1
MX,GASTROENTERITIS,1
MX,GASTROINTESTINAL DISORDER,1
MX,GASTROINTESTINAL HAEMORRHAGE,1
MX,GASTROINTESTINAL HYPERMOTILITY,1
MX,GASTROINTESTINAL SOUNDS ABNORMAL,1
MX,GENERAL PHYSICAL HEALTH DETERIORATION,1
MX,GENERALISED ERYTHEMA,1
MX,GENERALISED OEDEMA,1
MX,GLOMUS TUMOUR,1
MX,GLUTEN SENSITIVITY,1
MX,GRANULOMATOSIS WITH POLYANGIITIS,1
MX,HAEMATOCHEZIA,1
MX,HAEMORRHAGIC ANAEMIA,1
MX,HAEMORRHOIDS,1
MX,HAND DEFORMITY,1
MX,HEPATIC CANCER,1
MX,HEPATIC ENZYME INCREASED,1
MX,HEPATIC VEIN THROMBOSIS,1
MX,HEPATITIS A,1
MX,HEPATITIS C,1
MX,HERPES ZOSTER DISSEMINATED,1
MX,HIATUS HERNIA,1
MX,HISTIOCYTOSIS HAEMATOPHAGIC,1
MX,HISTOPLASMOSIS,1
MX,HODGKIN^S DISEASE,1
MX,HYPERCHOLESTEROLAEMIA,1
MX,HYPERGLYCAEMIA,1
MX,HYPERTRIGLYCERIDAEMIA,1
MX,HYPERURICAEMIA,1
MX,HYPOKINESIA,1
MX,HYPOTHYROIDISM,1
MX,HYPOTONIA,1
MX,HYPOXIA,1
MX,IMMINENT ABORTION,1
MX,IMMUNODEFICIENCY,1
MX,IMPAIRED FASTING GLUCOSE,1
MX,INCORRECT DOSE ADMINISTERED,1
MX,INCREASED APPETITE,1
MX,INSULIN RESISTANCE,1
MX,INTENTIONAL DRUG MISUSE,1
MX,INTERCEPTED MEDICATION ERROR,1
MX,INTERSTITIAL LUNG DISEASE,1
MX,INTERVERTEBRAL DISCITIS,1
MX,INTESTINAL OBSTRUCTION,1
MX,ISCHAEMIC STROKE,1
MX,JOINT EFFUSION,1
MX,JUVENILE IDIOPATHIC ARTHRITIS,1
MX,KNEE ARTHROPLASTY,1
MX,KNEE DEFORMITY,1
MX,KNEE OPERATION,1
MX,LACERATION,1
MX,LACRIMATION INCREASED,1
MX,LARGE INTESTINE PERFORATION,1
MX,LATENT TUBERCULOSIS,1
MX,LATERAL MEDULLARY SYNDROME,1
MX,LEUKAEMIA,1
MX,LIGAMENT DISORDER,1
MX,LIMB ASYMMETRY,1
MX,LIMB IMMOBILISATION,1
MX,LOBAR PNEUMONIA,1
MX,LOCALISED INFECTION,1
MX,LUNG DISORDER,1
MX,LUNG INFILTRATION,1
MX,LUPUS-LIKE SYNDROME,1
MX,LYMPHADENOPATHY,1
MX,LYMPHOPROLIFERATIVE DISORDER,1
MX,MAJOR DEPRESSION,1
MX,MELAENA,1
MX,MENTAL IMPAIRMENT,1
MX,METASTASES TO CENTRAL NERVOUS SYSTEM,1
MX,METASTASES TO LIVER,1
MX,MICTURITION URGENCY,1
MX,MIGRAINE,1
MX,MOOD ALTERED,1
MX,MOOD SWINGS,1
MX,MOTOR DYSFUNCTION,1
MX,MOUTH HAEMORRHAGE,1
MX,MUCORMYCOSIS,1
MX,MUSCLE INJURY,1
MX,MUSCULOSKELETAL CHEST PAIN,1
MX,MYELITIS TRANSVERSE,1
MX,NASOPHARYNGITIS,1
MX,NEOPLASM PROGRESSION,1
MX,NEPHROLITHIASIS,1
MX,NERVOUS SYSTEM DISORDER,1
MX,NEURITIS,1
MX,NEUROBLASTOMA,1
MX,NEUROMA,1
MX,NEUROTRANSMITTER LEVEL ALTERED,1
MX,NEUTROPENIA,1
MX,NEUTROPHIL COUNT DECREASED,1
MX,NIGHT SWEATS,1
MX,NIGHTMARE,1
MX,NODULE,1
MX,NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT,1
MX,NUCHAL RIGIDITY,1
MX,OBSESSIVE THOUGHTS,1
MX,OCULAR HYPERAEMIA,1
MX,OEDEMA PERIPHERAL,1
MX,OESOPHAGEAL HAEMORRHAGE,1
MX,ORAL DISCOMFORT,1
MX,ORAL DISORDER,1
MX,ORAL HERPES,1
MX,ORAL INFECTION,1
MX,ORAL PAIN,1
MX,OROPHARYNGEAL DISCOMFORT,1
MX,OSTEOCHONDROSIS,1
MX,OSTEONECROSIS,1
MX,OSTEOPENIA,1
MX,OVERLAP SYNDROME,1
MX,PACKED RED BLOOD CELL TRANSFUSION,1
MX,PALPITATIONS,1
MX,PANCREATIC CARCINOMA,1
MX,PAPILLARY THYROID CANCER,1
MX,PARALYSIS,1
MX,PATHOGEN RESISTANCE,1
MX,PELVIC INFLAMMATORY DISEASE,1
MX,PEPTIC ULCER,1
MX,PERIPHERAL VASCULAR DISORDER,1
MX,PERITONITIS,1
MX,PHARYNGEAL DISORDER,1
MX,PHARYNGEAL INFLAMMATION,1
MX,PHARYNGEAL OEDEMA,1
MX,PHARYNGOTONSILLITIS,1
MX,PLEURAL EFFUSION,1
MX,PNEUMONIA BACTERIAL,1
MX,POLLAKIURIA,1
MX,POLYARTHRITIS,1
MX,POLYURIA,1
MX,POST PROCEDURAL HAEMATOMA,1
MX,POSTOPERATIVE ABSCESS,1
MX,POSTOPERATIVE WOUND INFECTION,1
MX,PREGNANCY,1
MX,PREGNANCY ON CONTRACEPTIVE,1
MX,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
MX,PRODUCT QUALITY ISSUE,1
MX,PRODUCTIVE COUGH,1
MX,PROTEIN DEFICIENCY,1
MX,PRURITUS GENERALISED,1
MX,PSORIASIS,1
MX,PSORIATIC ARTHROPATHY,1
MX,PULMONARY HAEMORRHAGE,1
MX,PULMONARY MASS,1
MX,PURULENT DISCHARGE,1
MX,RADIUS FRACTURE,1
MX,RASH ERYTHEMATOUS,1
MX,RASH GENERALISED,1
MX,RASH MACULO-PAPULAR,1
MX,RASH PAPULAR,1
MX,RENAL FAILURE ACUTE,1
MX,RESPIRATORY DISORDER,1
MX,RESPIRATORY DISTRESS,1
MX,RESPIRATORY TRACT INFECTION,1
MX,RETINOPATHY,1
MX,RHEUMATOID FACTOR INCREASED,1
MX,RIB FRACTURE,1
MX,SALPINGO-OOPHORITIS,1
MX,SARCOIDOSIS,1
MX,SCLERITIS,1
MX,SEIZURE,1
MX,SERRATIA SEPSIS,1
MX,SHOULDER OPERATION,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SKIN IRRITATION,1
MX,SKIN PAPILLOMA,1
MX,SKIN ULCER,1
MX,SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,1
MX,SPINAL COLUMN INJURY,1
MX,SQUAMOUS CELL CARCINOMA,1
MX,STATUS EPILEPTICUS,1
MX,STENOSIS,1
MX,STEVENS-JOHNSON SYNDROME,1
MX,STRESS,1
MX,SUBDURAL HAEMATOMA,1
MX,SUDDEN VISUAL LOSS,1
MX,SUICIDAL BEHAVIOUR,1
MX,SUPRAVENTRICULAR TACHYCARDIA,1
MX,SURGERY,1
MX,SUSPECTED COUNTERFEIT PRODUCT,1
MX,TEMPERATURE INTOLERANCE,1
MX,TEMPERATURE REGULATION DISORDER,1
MX,THERAPEUTIC RESPONSE DECREASED,1
MX,THERAPY NON-RESPONDER,1
MX,THROAT TIGHTNESS,1
MX,THROMBOCYTOPENIA,1
MX,THROMBOCYTOPENIC PURPURA,1
MX,THROMBOCYTOSIS,1
MX,THROMBOSIS,1
MX,THYROID NEOPLASM,1
MX,THYROIDITIS,1
MX,TINNITUS,1
MX,TOOTH INFECTION,1
MX,TOXIC EPIDERMAL NECROLYSIS,1
MX,TRANSAMINASES INCREASED,1
MX,TRANSFUSION,1
MX,TREATMENT NONCOMPLIANCE,1
MX,TUBERCULOMA OF CENTRAL NERVOUS SYSTEM,1
MX,TUBERCULOSIS LIVER,1
MX,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,1
MX,UNEVALUABLE EVENT,1
MX,UPPER LIMB FRACTURE,1
MX,URINARY INCONTINENCE,1
MX,UTERINE CYST,1
MX,UTERINE HAEMORRHAGE,1
MX,VAGINAL DISORDER,1
MX,VARICOSE VEIN,1
MX,VENOUS THROMBOSIS,1
MX,VISION BLURRED,1
MX,VISUAL ACUITY REDUCED,1
MX,WALKING DISABILITY,1
MX,WHITE BLOOD CELL COUNT INCREASED,1
MX,WOUND COMPLICATION,1
MX,WOUND DEHISCENCE,1
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
MX,XEROPHTHALMIA,1
MD,BLOOD PRESSURE INCREASED,1
MD,PYREXIA,1
MD,SEIZURE,1
MD,VOMITING,1
MC,CHOLESTASIS,1
MC,COLITIS,1
MC,DEFAECATION URGENCY,1
MC,DIARRHOEA,1
MC,DIVERTICULUM INTESTINAL,1
MC,ERYSIPELAS,1
MC,ESCHERICHIA INFECTION,1
MC,GASTROENTERITIS,1
MC,HEPATOCELLULAR INJURY,1
MC,HYPERTHERMIA,1
MC,INFLUENZA,1
MC,INFUSION RELATED REACTION,1
MC,MICTURITION URGENCY,1
MC,NEUTROPENIC COLITIS,1
MC,PROCTITIS,1
MC,PSORIASIS,1
MC,PULMONARY FIBROSIS,1
MC,SHOCK,1
MC,STAPHYLOCOCCAL INFECTION,1
MC,TOXIC SKIN ERUPTION,1
MC,URINARY TRACT INFECTION,1
MC,VENOOCCLUSIVE LIVER DISEASE,1
ME,COUGH,2
ME,PULMONARY TUBERCULOSIS,2
ME,ABDOMINAL PAIN,1
ME,BODY TEMPERATURE INCREASED,1
ME,BREATH SOUNDS ABNORMAL,1
ME,BRONCHIECTASIS,1
ME,DIARRHOEA,1
ME,DRUG INEFFECTIVE,1
ME,HAEMATOCHEZIA,1
ME,HEPATIC FAILURE,1
ME,HEPATOTOXICITY,1
ME,INFECTIOUS PLEURAL EFFUSION,1
ME,INTESTINAL STENOSIS,1
ME,PNEUMONIA,1
ME,PRODUCTIVE COUGH,1
ME,SEPSIS,1
ME,SKIN DISORDER,1
MA,SEPTIC SHOCK,7
MA,DIABETES MELLITUS,4
MA,HAEMATOTOXICITY,3
MA,MUCOSAL TOXICITY,3
MA,RENAL FAILURE,3
MA,TOXICITY TO VARIOUS AGENTS,3
MA,APLASIA,2
MA,COLITIS,2
MA,HEPATOCELLULAR INJURY,2
MA,HEPATOSPLENOMEGALY,2
MA,INFECTION,2
MA,MELANODERMA,2
MA,TREATMENT FAILURE,2
MA,ACUTE ABDOMEN,1
MA,BACTERIAL INFECTION,1
MA,BODY HEIGHT BELOW NORMAL,1
MA,C-REACTIVE PROTEIN INCREASED,1
MA,CHEILITIS,1
MA,CUSHINGOID,1
MA,DEHYDRATION,1
MA,DIARRHOEA,1
MA,DISEASE PROGRESSION,1
MA,ELECTROLYTE IMBALANCE,1
MA,GASTROENTERITIS VIRAL,1
MA,HEPATIC FAILURE,1
MA,HISTIOCYTOSIS HAEMATOPHAGIC,1
MA,JOINT DESTRUCTION,1
MA,LUNG DISORDER,1
MA,LUNG INFECTION,1
MA,MATERNAL EXPOSURE DURING PREGNANCY,1
MA,MOUTH ULCERATION,1
MA,MUCOSAL INFLAMMATION,1
MA,MYELOPATHY,1
MA,ONYCHOMYCOSIS,1
MA,OSTEOPOROSIS,1
MA,PARALYSIS FLACCID,1
MA,PARAPLEGIA,1
MA,PRODUCT USE ISSUE,1
MA,PYREXIA,1
MA,RENAL IMPAIRMENT,1
MA,STAPHYLOCOCCAL INFECTION,1
MA,SYNCOPE,1
MA,VITAMIN D DECREASED,1
MA,VOMITING,1
NL,SEPSIS,28
NL,PANCYTOPENIA,26
NL,PHOTOSENSITIVITY REACTION,26
NL,TOXICITY TO VARIOUS AGENTS,24
NL,CHEILITIS,22
NL,PNEUMONIA,22
NL,CEREBRAL VENOUS THROMBOSIS,20
NL,MUCOSAL INFLAMMATION,20
NL,PYREXIA,19
NL,DEATH,15
NL,DRUG INEFFECTIVE,15
NL,FATIGUE,15
NL,STOMATITIS,15
NL,LYMPHOPROLIFERATIVE DISORDER,14
NL,MALAISE,14
NL,NEUTROPENIA,14
NL,FEBRILE NEUTROPENIA,13
NL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,13
NL,METABOLIC ACIDOSIS,12
NL,INFECTION,11
NL,RENAL TUBULAR NECROSIS,11
NL,DYSPNOEA,10
NL,HEPATIC STEATOSIS,10
NL,NAUSEA,10
NL,DEHYDRATION,9
NL,ERYTHEMA,9
NL,FALL,9
NL,VOMITING,9
NL,MOUTH ULCERATION,8
NL,ACUTE KIDNEY INJURY,7
NL,BONE MARROW FAILURE,7
NL,CHEST PAIN,7
NL,DECREASED APPETITE,7
NL,HEPATIC FUNCTION ABNORMAL,7
NL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,7
NL,ANAEMIA,6
NL,BREAST CANCER,6
NL,CHOLESTASIS,6
NL,DIARRHOEA,6
NL,NEPHROPATHY TOXIC,6
NL,PNEUMONIA ASPIRATION,6
NL,PRURITUS,6
NL,RASH,6
NL,RENAL FAILURE,6
NL,RESPIRATORY TRACT INFECTION,6
NL,RHEUMATOID ARTHRITIS,6
NL,THROMBOCYTOPENIA,6
NL,WEIGHT DECREASED,6
NL,ABDOMINAL PAIN,5
NL,BLOOD ALBUMIN DECREASED,5
NL,CHILLS,5
NL,DIZZINESS,5
NL,DYSPHAGIA,5
NL,FUNGAL INFECTION,5
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
NL,HEADACHE,5
NL,HISTOPLASMOSIS DISSEMINATED,5
NL,JC VIRUS INFECTION,5
NL,MENINGITIS CHEMICAL,5
NL,PERIODONTITIS,5
NL,PERSONALITY CHANGE,5
NL,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
NL,PRODUCT USE IN UNAPPROVED INDICATION,5
NL,RENAL FAILURE ACUTE,5
NL,RESPIRATORY FAILURE,5
NL,URINARY TRACT INFECTION,5
NL,WHITE BLOOD CELL COUNT DECREASED,5
NL,ABORTION SPONTANEOUS,4
NL,ALANINE AMINOTRANSFERASE INCREASED,4
NL,CARDIAC FAILURE,4
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
NL,COGNITIVE DISORDER,4
NL,DEMENTIA,4
NL,GASTROINTESTINAL DISORDER,4
NL,HAEMOGLOBIN DECREASED,4
NL,HAEMORRHAGIC STROKE,4
NL,HUMERUS FRACTURE,4
NL,HYPOTENSION,4
NL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
NL,LUNG DISORDER,4
NL,MUCOCUTANEOUS LEISHMANIASIS,4
NL,NASOPHARYNGITIS,4
NL,NODULAR REGENERATIVE HYPERPLASIA,4
NL,PAIN IN EXTREMITY,4
NL,PANCREATITIS ACUTE,4
NL,PULMONARY EMBOLISM,4
NL,RENAL IMPAIRMENT,4
NL,SEIZURE,4
NL,WHIPPLE^S DISEASE,4
NL,ARTHRALGIA,3
NL,ARTHRITIS,3
NL,ASPARTATE AMINOTRANSFERASE INCREASED,3
NL,BACK PAIN,3
NL,BLOOD LACTATE DEHYDROGENASE INCREASED,3
NL,BREAST CANCER METASTATIC,3
NL,CANDIDA INFECTION,3
NL,CARDIAC DISORDER,3
NL,CELLULITIS,3
NL,CEREBROVASCULAR ACCIDENT,3
NL,CLOSTRIDIUM DIFFICILE INFECTION,3
NL,CONDITION AGGRAVATED,3
NL,COUGH,3
NL,DEEP VEIN THROMBOSIS,3
NL,DEPRESSED MOOD,3
NL,DEVICE RELATED INFECTION,3
NL,DISEASE PROGRESSION,3
NL,DRUG EFFECT DECREASED,3
NL,EMBOLISM,3
NL,EPILEPSY,3
NL,GAIT DISTURBANCE,3
NL,GLOMERULAR FILTRATION RATE DECREASED,3
NL,HEMIPARESIS,3
NL,HEPATIC ENZYME INCREASED,3
NL,HEPATIC FAILURE,3
NL,HIP FRACTURE,3
NL,INTERSTITIAL LUNG DISEASE,3
NL,LUNG ABSCESS,3
NL,LUNG INFECTION,3
NL,LYMPHADENOPATHY,3
NL,LYMPHOMA,3
NL,MATERNAL EXPOSURE DURING PREGNANCY,3
NL,METASTASES TO BONE,3
NL,MUSCULAR WEAKNESS,3
NL,MYALGIA,3
NL,NEUROLOGICAL SYMPTOM,3
NL,NEUROTOXICITY,3
NL,NIGHT SWEATS,3
NL,NON-HODGKIN^S LYMPHOMA,3
NL,OPPORTUNISTIC INFECTION,3
NL,OSTEONECROSIS,3
NL,PNEUMONIA KLEBSIELLA,3
NL,POLYARTHRITIS,3
NL,RASH MACULAR,3
NL,RED BLOOD CELL COUNT DECREASED,3
NL,SKIN CANCER,3
NL,SKIN DISORDER,3
NL,SKIN LESION,3
NL,SKIN ULCER,3
NL,SPLENOMEGALY,3
NL,TOOTH ABSCESS,3
NL,VENOOCCLUSIVE DISEASE,3
NL,VIRAL INFECTION,3
NL,WEIGHT INCREASED,3
NL,ABNORMAL BEHAVIOUR,2
NL,ACUTE MYOCARDIAL INFARCTION,2
NL,ACUTE RESPIRATORY DISTRESS SYNDROME,2
NL,ALOPECIA,2
NL,ALVEOLITIS ALLERGIC,2
NL,AMYOTROPHIC LATERAL SCLEROSIS,2
NL,ANGIOEDEMA,2
NL,APATHY,2
NL,APPENDICITIS,2
NL,ARTHRITIS BACTERIAL,2
NL,ASTHENIA,2
NL,ATRIAL FIBRILLATION,2
NL,B-CELL LYMPHOMA,2
NL,BASAL CELL CARCINOMA,2
NL,BRAIN HERNIATION,2
NL,BURSITIS,2
NL,C-REACTIVE PROTEIN INCREASED,2
NL,CARDIAC ARREST,2
NL,CEREBRAL INFARCTION,2
NL,COMA,2
NL,CONTUSION,2
NL,CROHN^S DISEASE,2
NL,DECUBITUS ULCER,2
NL,DELIRIUM,2
NL,DIABETES MELLITUS,2
NL,DISORIENTATION,2
NL,DRUG EFFECT INCOMPLETE,2
NL,DRUG ERUPTION,2
NL,ENCEPHALOPATHY,2
NL,GASTRIC HAEMORRHAGE,2
NL,GASTROINTESTINAL CARCINOMA,2
NL,GASTROINTESTINAL HAEMORRHAGE,2
NL,GASTROINTESTINAL TOXICITY,2
NL,HAEMATOCHEZIA,2
NL,HEPATIC ENCEPHALOPATHY,2
NL,HEPATIC FIBROSIS,2
NL,HERPES ZOSTER,2
NL,HYPERCALCAEMIA,2
NL,HYPERHIDROSIS,2
NL,HYPONATRAEMIA,2
NL,ILEAL STENOSIS,2
NL,IMMUNE SYSTEM DISORDER,2
NL,IMPAIRED HEALING,2
NL,INFLAMMATION,2
NL,INFLUENZA LIKE ILLNESS,2
NL,INTERVERTEBRAL DISCITIS,2
NL,JAUNDICE,2
NL,LEUKOPENIA,2
NL,LIBIDO DECREASED,2
NL,LUNG CONSOLIDATION,2
NL,LUNG NEOPLASM MALIGNANT,2
NL,MALIGNANT MELANOMA,2
NL,MALIGNANT NEOPLASM PROGRESSION,2
NL,MENINGITIS,2
NL,MIGRAINE WITH AURA,2
NL,MONOPARESIS,2
NL,MULTI-ORGAN FAILURE,2
NL,MYOCARDIAL INFARCTION,2
NL,NEOPLASM MALIGNANT,2
NL,NEUROPATHY PERIPHERAL,2
NL,NORMAL NEWBORN,2
NL,ORAL MUCOSAL BLISTERING,2
NL,PANCREATITIS,2
NL,PARAESTHESIA,2
NL,PETECHIAE,2
NL,PLEURAL EFFUSION,2
NL,POLYNEUROPATHY,2
NL,PORTAL VEIN THROMBOSIS,2
NL,PREGNANCY,2
NL,PREGNANCY ON ORAL CONTRACEPTIVE,2
NL,PRODUCT USE ISSUE,2
NL,PROSTATE CANCER,2
NL,SPINAL COMPRESSION FRACTURE,2
NL,STAPHYLOCOCCAL SEPSIS,2
NL,STREPTOCOCCAL INFECTION,2
NL,SUDDEN DEATH,2
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,2
NL,TACHYCARDIA,2
NL,TACHYPNOEA,2
NL,TENDON RUPTURE,2
NL,THROMBOSIS,2
NL,TOXIC SKIN ERUPTION,2
NL,TYPE 2 DIABETES MELLITUS,2
NL,ULCER,2
NL,UROSEPSIS,2
NL,URTICARIA,2
NL,WOUND,2
NL,ABASIA,1
NL,ABDOMINAL MASS,1
NL,ABDOMINAL PAIN UPPER,1
NL,ABSCESS,1
NL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
NL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
NL,ACUTE LEUKAEMIA,1
NL,ACUTE PRERENAL FAILURE,1
NL,AGITATION,1
NL,AMENORRHOEA,1
NL,ANAEMIA MACROCYTIC,1
NL,ANAL ULCER,1
NL,ANAPHYLACTIC REACTION,1
NL,ANGINA PECTORIS,1
NL,ARRHYTHMIA,1
NL,ARTHROPATHY,1
NL,ASCITES,1
NL,ASPERGILLOSIS,1
NL,ASPIRATION JOINT,1
NL,ASTHENOPIA,1
NL,ATELECTASIS,1
NL,ATRIAL NATRIURETIC PEPTIDE INCREASED,1
NL,ATYPICAL HAEMOLYTIC URAEMIC SYNDROME,1
NL,BACTERAEMIA,1
NL,BACTERIAL INFECTION,1
NL,BENIGN PROSTATIC HYPERPLASIA,1
NL,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
NL,BLADDER TRANSITIONAL CELL CARCINOMA,1
NL,BLINDNESS,1
NL,BLISTER INFECTED,1
NL,BLOOD BILIRUBIN INCREASED,1
NL,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
NL,BLOOD GLUCOSE ABNORMAL,1
NL,BLOOD GLUCOSE INCREASED,1
NL,BLOOD PRESSURE ABNORMAL,1
NL,BLOOD PRESSURE DIASTOLIC INCREASED,1
NL,BLOOD PRESSURE IMMEASURABLE,1
NL,BLOOD TEST ABNORMAL,1
NL,BODY FAT DISORDER,1
NL,BONE ABSCESS,1
NL,BONE DISORDER,1
NL,BONE MARROW DISORDER,1
NL,BONE PAIN,1
NL,BRADYKINESIA,1
NL,BRAIN NEOPLASM,1
NL,BREAST CANCER FEMALE,1
NL,BRONCHIAL OBSTRUCTION,1
NL,BRONCHIOLITIS,1
NL,BRONCHITIS,1
NL,BRONCHOSPASM,1
NL,BURSITIS INFECTIVE,1
NL,CARDIOMYOPATHY,1
NL,CATHETERISATION CARDIAC,1
NL,CENTRAL NERVOUS SYSTEM LESION,1
NL,CEREBRAL HAEMORRHAGE,1
NL,CERVIX CARCINOMA,1
NL,CHEST DISCOMFORT,1
NL,CHOLECYSTITIS,1
NL,CHRONIC GRAFT VERSUS HOST DISEASE,1
NL,CHRONIC HEPATITIS,1
NL,CHRONIC KIDNEY DISEASE,1
NL,CIRCULATORY COLLAPSE,1
NL,CLEAR CELL RENAL CELL CARCINOMA,1
NL,COAGULOPATHY,1
NL,COLECTOMY,1
NL,COLON CANCER,1
NL,COLON CANCER METASTATIC,1
NL,COMPLETED SUICIDE,1
NL,COMPUTERISED TOMOGRAM ABNORMAL,1
NL,CONFUSIONAL STATE,1
NL,CONJUNCTIVAL HAEMORRHAGE,1
NL,CONJUNCTIVAL HYPERAEMIA,1
NL,CONSTIPATION,1
NL,CRANIAL NERVE PARALYSIS,1
NL,CRYING,1
NL,CUTANEOUS VASCULITIS,1
NL,CYSTITIS NONINFECTIVE,1
NL,DEAFNESS UNILATERAL,1
NL,DEMODICIDOSIS,1
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NL,DEPRESSION,1
NL,DERMATITIS PSORIASIFORM,1
NL,DEVICE RELATED SEPSIS,1
NL,DIFFUSE LARGE B-CELL LYMPHOMA,1
NL,DISCOMFORT,1
NL,DISTURBANCE IN ATTENTION,1
NL,DIVERTICULUM,1
NL,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG INTOLERANCE,1
NL,DRUG LEVEL,1
NL,DRUG LEVEL ABOVE THERAPEUTIC,1
NL,DRUG SPECIFIC ANTIBODY PRESENT,1
NL,DRY MOUTH,1
NL,DUODENAL PERFORATION,1
NL,DUODENITIS,1
NL,DYSARTHRIA,1
NL,DYSGEUSIA,1
NL,DYSKINESIA,1
NL,DYSPHONIA,1
NL,DYSPLASIA,1
NL,DYSSTASIA,1
NL,DYSURIA,1
NL,ECTOPIC KIDNEY,1
NL,ELECTROCARDIOGRAM QT PROLONGED,1
NL,ELECTROENCEPHALOGRAM ABNORMAL,1
NL,EMBOLISM VENOUS,1
NL,ENTEROCOCCAL BACTERAEMIA,1
NL,EOSINOPHILIA,1
NL,EPIDIDYMITIS,1
NL,EPISTAXIS,1
NL,EPSTEIN-BARR VIRUS INFECTION,1
NL,ERYSIPELAS,1
NL,ERYTHROPOIESIS ABNORMAL,1
NL,ESCHERICHIA URINARY TRACT INFECTION,1
NL,EVACUATION OF RETAINED PRODUCTS OF CONCEPTION,1
NL,EXTERNAL AUDITORY CANAL ATRESIA,1
NL,FACE OEDEMA,1
NL,FEMOROACETABULAR IMPINGEMENT,1
NL,FEMUR FRACTURE,1
NL,FINE MOTOR SKILL DYSFUNCTION,1
NL,FISTULA,1
NL,FRACTURE,1
NL,FREEZING PHENOMENON,1
NL,FREQUENT BOWEL MOVEMENTS,1
NL,FRONTOTEMPORAL DEMENTIA,1
NL,FUNGAL SKIN INFECTION,1
NL,GASTRIC PERFORATION,1
NL,GASTRIC POLYPS,1
NL,GASTRIC VARICES HAEMORRHAGE,1
NL,GASTROINTESTINAL ISCHAEMIA,1
NL,GASTROOESOPHAGEAL CANCER,1
NL,GENERAL PHYSICAL CONDITION ABNORMAL,1
NL,GENERALISED OEDEMA,1
NL,GLAUCOMA,1
NL,GLIOBLASTOMA,1
NL,GRAFT VERSUS HOST DISEASE IN SKIN,1
NL,GRANULOCYTOPENIA,1
NL,GROIN PAIN,1
NL,HAEMATOLOGICAL MALIGNANCY,1
NL,HAEMATOMA,1
NL,HAEMATURIA,1
NL,HAEMOPHILUS INFECTION,1
NL,HAEMORRHAGE,1
NL,HAEMORRHAGIC DIATHESIS,1
NL,HAIR GROWTH ABNORMAL,1
NL,HAND FRACTURE,1
NL,HEAD DISCOMFORT,1
NL,HEART RATE DECREASED,1
NL,HEART RATE INCREASED,1
NL,HEART RATE IRREGULAR,1
NL,HEAVY EXPOSURE TO ULTRAVIOLET LIGHT,1
NL,HENOCH-SCHONLEIN PURPURA,1
NL,HEPATIC ENZYME ABNORMAL,1
NL,HEPATIC INFECTION FUNGAL,1
NL,HEPATITIS,1
NL,HEPATOMEGALY,1
NL,HEPATOTOXICITY,1
NL,HERPES VIRUS INFECTION,1
NL,HICCUPS,1
NL,HISTIOCYTOSIS HAEMATOPHAGIC,1
NL,HISTOPLASMOSIS,1
NL,HOSPITALISATION,1
NL,HYPERBILIRUBINAEMIA,1
NL,HYPERCAPNIA,1
NL,HYPERCHOLESTEROLAEMIA,1
NL,HYPERSENSITIVITY,1
NL,HYPERSENSITIVITY VASCULITIS,1
NL,HYPERTENSION,1
NL,HYPERVENTILATION,1
NL,HYPOACUSIS,1
NL,HYPOAESTHESIA,1
NL,HYPOAESTHESIA ORAL,1
NL,HYPOCALCAEMIA,1
NL,HYPOKALAEMIA,1
NL,HYPOMAGNESAEMIA,1
NL,HYPOPHOSPHATAEMIA,1
NL,HYPOVENTILATION,1
NL,ILEUS,1
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NL,INCREASED APPETITE,1
NL,INFLUENZA,1
NL,INFUSION RELATED REACTION,1
NL,INFUSION SITE HAEMATOMA,1
NL,INGROWING NAIL,1
NL,INSOMNIA,1
NL,INTENTIONAL PRODUCT MISUSE,1
NL,INTESTINAL OBSTRUCTION,1
NL,INTRACRANIAL HYPOTENSION,1
NL,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
NL,INTRAOCULAR PRESSURE INCREASED,1
NL,INVASIVE DUCTAL BREAST CARCINOMA,1
NL,INVESTIGATION,1
NL,JUVENILE IDIOPATHIC ARTHRITIS,1
NL,KLEBSIELLA INFECTION,1
NL,LABORATORY TEST ABNORMAL,1
NL,LACTIC ACIDOSIS,1
NL,LARGE INTESTINAL ULCER,1
NL,LARYNGEAL CANCER,1
NL,LARYNGEAL OEDEMA,1
NL,LEISHMANIASIS,1
NL,LICHENOID KERATOSIS,1
NL,LIPIDS INCREASED,1
NL,LIPOSARCOMA,1
NL,LIVER FUNCTION TEST INCREASED,1
NL,LOWER GASTROINTESTINAL HAEMORRHAGE,1
NL,LOWER LIMB FRACTURE,1
NL,LOWER RESPIRATORY TRACT INFECTION,1
NL,LUNG TRANSPLANT,1
NL,LUPUS-LIKE SYNDROME,1
NL,LYMPHANGIECTASIA,1
NL,LYMPHANGIOSIS CARCINOMATOSA,1
NL,LYMPHOCYTE PERCENTAGE ABNORMAL,1
NL,MALIGNANT RESPIRATORY TRACT NEOPLASM,1
NL,MASS,1
NL,MEDIASTINAL SHIFT,1
NL,MELAENA,1
NL,MEMORY IMPAIRMENT,1
NL,MENINGITIS BACTERIAL,1
NL,MENINGITIS PNEUMOCOCCAL,1
NL,MENTAL DISORDER,1
NL,MESENTERIC PANNICULITIS,1
NL,METABOLIC DISORDER,1
NL,METASTASES TO LUNG,1
NL,METASTASES TO LYMPH NODES,1
NL,METASTASES TO MENINGES,1
NL,MICTURITION FREQUENCY DECREASED,1
NL,MOBILITY DECREASED,1
NL,MUSCLE ABSCESS,1
NL,MUSCLE RIGIDITY,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MUSCULOSKELETAL PAIN,1
NL,MYELODYSPLASTIC SYNDROME,1
NL,MYOSCLEROSIS,1
NL,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
NL,NECK PAIN,1
NL,NEOPLASM PROGRESSION,1
NL,NEURALGIA,1
NL,NEUROLOGICAL DECOMPENSATION,1
NL,NO ADVERSE EVENT,1
NL,NODULAR VASCULITIS,1
NL,NODULE,1
NL,NON-SMALL CELL LUNG CANCER,1
NL,NON-SMALL CELL LUNG CANCER STAGE IV,1
NL,OEDEMA PERIPHERAL,1
NL,OESOPHAGEAL CANCER METASTATIC,1
NL,OESOPHAGEAL CARCINOMA,1
NL,OESOPHAGEAL VARICES HAEMORRHAGE,1
NL,ON AND OFF PHENOMENON,1
NL,OOPHORECTOMY,1
NL,OPTIC ISCHAEMIC NEUROPATHY,1
NL,OPTIC NERVE DISORDER,1
NL,OSTEITIS,1
NL,OSTEOMALACIA,1
NL,OSTEONECROSIS OF JAW,1
NL,OSTEOPOROSIS,1
NL,OSTEOSCLEROSIS,1
NL,OTITIS MEDIA,1
NL,OTOTOXICITY,1
NL,OVARIAN CYST,1
NL,PAIN,1
NL,PAIN THRESHOLD DECREASED,1
NL,PAINFUL RESPIRATION,1
NL,PAPILLARY THYROID CANCER,1
NL,PARKINSONIAN GAIT,1
NL,PARKINSON^S DISEASE,1
NL,PERICARDIAL EFFUSION,1
NL,PERIORBITAL OEDEMA,1
NL,PERIPHERAL COLDNESS,1
NL,PERIPHERAL MOTOR NEUROPATHY,1
NL,PERITONEAL MESOTHELIOMA MALIGNANT,1
NL,PHOTOPSIA,1
NL,PLASMA CELL MYELOMA,1
NL,PLEURISY,1
NL,PNEUMOCYSTIS JIROVECI PNEUMONIA,1
NL,PNEUMONIA INFLUENZAL,1
NL,PNEUMONIA LEGIONELLA,1
NL,PNEUMONITIS,1
NL,POLLAKIURIA,1
NL,POLYARTERITIS NODOSA,1
NL,POLYDACTYLY,1
NL,POLYMYOSITIS,1
NL,POLYP,1
NL,POST PROCEDURAL HAEMATOMA,1
NL,POSTOPERATIVE ABSCESS,1
NL,POSTOPERATIVE HERNIA,1
NL,PRERENAL FAILURE,1
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
NL,PSORIATIC ARTHROPATHY,1
NL,PSYCHOTIC DISORDER,1
NL,PULMONARY FIBROSIS,1
NL,PULMONARY HAEMORRHAGE,1
NL,PULMONARY HYPERTENSION,1
NL,PULMONARY NECROSIS,1
NL,PULMONARY OEDEMA,1
NL,PURPURA,1
NL,PUSTULAR PSORIASIS,1
NL,RADICULAR SYNDROME,1
NL,RADICULITIS,1
NL,RASH MACULO-PAPULAR,1
NL,RASH PUSTULAR,1
NL,RECTAL CANCER,1
NL,RECTAL CANCER METASTATIC,1
NL,RECTAL HAEMORRHAGE,1
NL,RENAL CANCER,1
NL,RENAL COLIC,1
NL,RENAL CYST,1
NL,RESTLESSNESS,1
NL,RETINAL DETACHMENT,1
NL,RETINAL TEAR,1
NL,RHABDOMYOLYSIS,1
NL,RIB FRACTURE,1
NL,RIGHT VENTRICULAR HYPERTROPHY,1
NL,SCAR,1
NL,SCLERODERMA,1
NL,SEPTIC SHOCK,1
NL,SEROTONIN SYNDROME,1
NL,SINUS TACHYCARDIA,1
NL,SKIN DISCOLOURATION,1
NL,SKIN EXFOLIATION,1
NL,SKIN INFECTION,1
NL,SKIN IRRITATION,1
NL,SKIN MASS,1
NL,SKIN WARM,1
NL,SLEEP APNOEA SYNDROME,1
NL,SOMNOLENCE,1
NL,SPEECH DISORDER,1
NL,SPUTUM PURULENT,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,STAPHYLOCOCCAL INFECTION,1
NL,STENOTROPHOMONAS INFECTION,1
NL,STENT PLACEMENT,1
NL,STOMA SITE DISCHARGE,1
NL,STOMA SITE ERYTHEMA,1
NL,STRESS,1
NL,SUBDURAL HAEMATOMA,1
NL,SUICIDE ATTEMPT,1
NL,SURGERY,1
NL,SWELLING,1
NL,SWELLING FACE,1
NL,SYNOVIAL CYST,1
NL,SYNOVITIS,1
NL,SYSTEMIC CANDIDA,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THROMBOTIC MICROANGIOPATHY,1
NL,TINEA PEDIS,1
NL,TONSILLAR INFLAMMATION,1
NL,TOOTH INFECTION,1
NL,TOOTHACHE,1
NL,TOXIC ENCEPHALOPATHY,1
NL,TRANSIENT ISCHAEMIC ATTACK,1
NL,TRANSURETHRAL BLADDER RESECTION,1
NL,TRIGGER FINGER,1
NL,TROPONIN INCREASED,1
NL,TUBERCULOSIS,1
NL,TUMOUR FLARE,1
NL,TYPE IV HYPERSENSITIVITY REACTION,1
NL,ULCERATIVE KERATITIS,1
NL,UNRESPONSIVE TO STIMULI,1
NL,UPPER RESPIRATORY TRACT INFECTION,1
NL,UTERINE PROLAPSE REPAIR,1
NL,VASCULAR ACCESS COMPLICATION,1
NL,VASCULITIS,1
NL,VENOOCCLUSIVE LIVER DISEASE,1
NL,VENTRICULAR EXTRASYSTOLES,1
NL,VERTIGO POSITIONAL,1
NL,VIITH NERVE PARALYSIS,1
NL,VISUAL ACUITY REDUCED,1
NL,VISUAL IMPAIRMENT,1
NL,VITREOUS FLOATERS,1
NL,WOUND COMPLICATION,1
NL,WOUND INFECTION,1
NZ,DRUG INEFFECTIVE,19
NZ,MALAISE,11
NZ,FATIGUE,10
NZ,PAIN IN EXTREMITY,10
NZ,ARTHRALGIA,8
NZ,DYSPNOEA,8
NZ,ARTHRITIS,7
NZ,COUGH,7
NZ,CROHN^S DISEASE,7
NZ,GAIT DISTURBANCE,7
NZ,PAIN,7
NZ,RHEUMATOID ARTHRITIS,7
NZ,ANXIETY,6
NZ,NAUSEA,6
NZ,RESPIRATORY FAILURE,6
NZ,ARTHROPATHY,5
NZ,CONDITION AGGRAVATED,5
NZ,HEADACHE,5
NZ,HYPOMAGNESAEMIA,5
NZ,INFECTION,5
NZ,PYREXIA,5
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,4
NZ,BACK PAIN,4
NZ,COLITIS,4
NZ,DEPRESSION,4
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,4
NZ,INTERSTITIAL LUNG DISEASE,4
NZ,MOUTH ULCERATION,4
NZ,PNEUMONITIS,4
NZ,SEPSIS,4
NZ,STRESS,4
NZ,WEIGHT DECREASED,4
NZ,WEIGHT INCREASED,4
NZ,ABDOMINAL PAIN,3
NZ,ANKYLOSING SPONDYLITIS,3
NZ,ASTHENIA,3
NZ,CHEST PAIN,3
NZ,DEATH,3
NZ,DRUG EFFECT DECREASED,3
NZ,FAECAL CALPROTECTIN INCREASED,3
NZ,FEELING ABNORMAL,3
NZ,GASTROOESOPHAGEAL REFLUX DISEASE,3
NZ,HYPOCALCAEMIA,3
NZ,INJECTION SITE BRUISING,3
NZ,INTERVERTEBRAL DISC PROTRUSION,3
NZ,LIVER FUNCTION TEST ABNORMAL,3
NZ,LUMBAR VERTEBRAL FRACTURE,3
NZ,MALIGNANT MELANOMA IN SITU,3
NZ,MOBILITY DECREASED,3
NZ,MUSCLE SPASMS,3
NZ,MUSCULOSKELETAL STIFFNESS,3
NZ,NERVE COMPRESSION,3
NZ,NEUTROPHIL COUNT DECREASED,3
NZ,OSTEOARTHRITIS,3
NZ,PARAESTHESIA,3
NZ,PNEUMONIA,3
NZ,SPINAL COMPRESSION FRACTURE,3
NZ,SPINAL DISORDER,3
NZ,UNEVALUABLE EVENT,3
NZ,VOMITING,3
NZ,ABDOMINAL PAIN UPPER,2
NZ,ACCELERATED HYPERTENSION,2
NZ,ADVERSE DRUG REACTION,2
NZ,ANAEMIA,2
NZ,ANAL FISTULA,2
NZ,ANAL ULCER,2
NZ,ANKLE FRACTURE,2
NZ,BLOOD PRESSURE DECREASED,2
NZ,BRONCHITIS,2
NZ,C-REACTIVE PROTEIN ABNORMAL,2
NZ,CARDIAC DISORDER,2
NZ,CARPAL TUNNEL SYNDROME,2
NZ,DEMYELINATION,2
NZ,DIARRHOEA,2
NZ,DISEASE PROGRESSION,2
NZ,DISEASE RECURRENCE,2
NZ,DIZZINESS,2
NZ,DRUG DOSE OMISSION,2
NZ,DRUG LEVEL DECREASED,2
NZ,DRY EYE,2
NZ,FIBROMYALGIA,2
NZ,GASTROINTESTINAL INFLAMMATION,2
NZ,HAEMOPTYSIS,2
NZ,HYPOTENSION,2
NZ,IMMUNODEFICIENCY,2
NZ,IMPAIRED WORK ABILITY,2
NZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
NZ,INFLAMMATION,2
NZ,INJECTION SITE PAIN,2
NZ,INSOMNIA,2
NZ,JOINT EFFUSION,2
NZ,JOINT INJURY,2
NZ,JOINT RANGE OF MOTION DECREASED,2
NZ,LETHARGY,2
NZ,MEMORY IMPAIRMENT,2
NZ,METASTASES TO LIVER,2
NZ,MONOCYTOSIS,2
NZ,MORAXELLA INFECTION,2
NZ,MUSCULOSKELETAL PAIN,2
NZ,MYALGIA,2
NZ,MYOCARDIAL INFARCTION,2
NZ,NEUROPATHY PERIPHERAL,2
NZ,NEUTROPHILIA,2
NZ,NIGHT SWEATS,2
NZ,PANCYTOPENIA,2
NZ,PHARYNGITIS,2
NZ,POLYARTHRITIS,2
NZ,PRODUCT QUALITY ISSUE,2
NZ,PROSTATISM,2
NZ,PSORIASIS,2
NZ,RHEUMATIC DISORDER,2
NZ,SCIATICA,2
NZ,SEIZURE,2
NZ,SKIN NECROSIS,2
NZ,STAPHYLOCOCCAL ABSCESS,2
NZ,SUPRAVENTRICULAR TACHYCARDIA,2
NZ,SWELLING,2
NZ,SYNCOPE,2
NZ,TREATMENT FAILURE,2
NZ,URINARY TRACT INFECTION,2
NZ,VASCULITIS,2
NZ,VIRAL INFECTION,2
NZ,VISUAL ACUITY REDUCED,2
NZ,WHITE BLOOD CELL COUNT INCREASED,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABDOMINAL TENDERNESS,1
NZ,ACQUIRED CLAW TOE,1
NZ,ACUTE KIDNEY INJURY,1
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NZ,ALLERGY TO VACCINE,1
NZ,ALOPECIA AREATA,1
NZ,ANAL ABSCESS,1
NZ,ANAPHYLACTIC REACTION,1
NZ,ANKLE OPERATION,1
NZ,ANORECTAL DISORDER,1
NZ,APHTHOUS STOMATITIS,1
NZ,APPENDICECTOMY,1
NZ,ARTHRITIS BACTERIAL,1
NZ,ARTHRITIS INFECTIVE,1
NZ,ARTHRODESIS,1
NZ,ASTHMA,1
NZ,BACTERIAL INFECTION,1
NZ,BARRETT^S OESOPHAGUS,1
NZ,BEDRIDDEN,1
NZ,BEHCET^S SYNDROME,1
NZ,BLOOD CHOLESTEROL INCREASED,1
NZ,BLOOD CREATININE INCREASED,1
NZ,BLOOD TEST ABNORMAL,1
NZ,BLOOD TRIGLYCERIDES INCREASED,1
NZ,BONE MARROW FAILURE,1
NZ,BONE PAIN,1
NZ,C-REACTIVE PROTEIN INCREASED,1
NZ,CANDIDA SEPSIS,1
NZ,CARBUNCLE,1
NZ,CARDIAC ARREST,1
NZ,CARDIAC FAILURE,1
NZ,CARDIAC FAILURE CONGESTIVE,1
NZ,CARDIAC MURMUR,1
NZ,CARDIOMEGALY,1
NZ,CAUDA EQUINA SYNDROME,1
NZ,CELLULITIS,1
NZ,CEREBROVASCULAR ACCIDENT,1
NZ,CHEST DISCOMFORT,1
NZ,CHILLS,1
NZ,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
NZ,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
NZ,COLECTOMY,1
NZ,COLITIS ULCERATIVE,1
NZ,COLORECTAL CANCER,1
NZ,COLOSTOMY,1
NZ,CONFUSIONAL STATE,1
NZ,CONGESTIVE CARDIOMYOPATHY,1
NZ,CONJUNCTIVAL DEPOSIT,1
NZ,CONSTIPATION,1
NZ,DEAFNESS UNILATERAL,1
NZ,DECREASED APPETITE,1
NZ,DEPRESSED MOOD,1
NZ,DERMATITIS,1
NZ,DERMATITIS PSORIASIFORM,1
NZ,DRUG EFFECT DELAYED,1
NZ,DRUG INTOLERANCE,1
NZ,DRY MOUTH,1
NZ,DUODENAL ULCER,1
NZ,DYSPHAGIA,1
NZ,DYSPNOEA EXERTIONAL,1
NZ,ECZEMA,1
NZ,EJECTION FRACTION DECREASED,1
NZ,EMOTIONAL DISORDER,1
NZ,ENERGY INCREASED,1
NZ,ERECTILE DYSFUNCTION,1
NZ,EXPOSURE VIA FATHER,1
NZ,EYE ALLERGY,1
NZ,EYE DISORDER,1
NZ,EYE SWELLING,1
NZ,EYELID OEDEMA,1
NZ,FACIAL PARALYSIS,1
NZ,FAECES DISCOLOURED,1
NZ,FEAR,1
NZ,FEAR OF INJECTION,1
NZ,FEBRILE NEUTROPENIA,1
NZ,FINE MOTOR SKILL DYSFUNCTION,1
NZ,FOOT DEFORMITY,1
NZ,FOOT OPERATION,1
NZ,FRACTURE,1
NZ,FREQUENT BOWEL MOVEMENTS,1
NZ,FRUSTRATION TOLERANCE DECREASED,1
NZ,GASTRIC DISORDER,1
NZ,GASTRIC INFECTION,1
NZ,GASTRIC ULCER,1
NZ,GASTRITIS,1
NZ,GASTROINTESTINAL DILATION PROCEDURE,1
NZ,GASTROINTESTINAL STENOSIS,1
NZ,GRANULOCYTES ABNORMAL,1
NZ,GRANULOMA,1
NZ,GRIP STRENGTH DECREASED,1
NZ,GROIN PAIN,1
NZ,HAEMATEMESIS,1
NZ,HENOCH-SCHONLEIN PURPURA,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HEPATIC FIBROSIS,1
NZ,HEPATIC STEATOSIS,1
NZ,HERNIA,1
NZ,HERNIA REPAIR,1
NZ,HYPERSENSITIVITY VASCULITIS,1
NZ,HYPERSOMNIA,1
NZ,HYPERTENSION,1
NZ,HYPOGLYCAEMIA,1
NZ,IGA NEPHROPATHY,1
NZ,IMPAIRED HEALING,1
NZ,INCISIONAL HERNIA,1
NZ,INFLAMMATORY MARKER INCREASED,1
NZ,INFLUENZA,1
NZ,INFUSION RELATED REACTION,1
NZ,INJECTION SITE DISCOMFORT,1
NZ,INJECTION SITE ERYTHEMA,1
NZ,INJECTION SITE HAEMORRHAGE,1
NZ,INJECTION SITE REACTION,1
NZ,INTESTINAL OPERATION,1
NZ,INTESTINAL RESECTION,1
NZ,JOINT CONTRACTURE,1
NZ,LARGE INTESTINAL STENOSIS,1
NZ,LEFT VENTRICULAR DYSFUNCTION,1
NZ,LIGAMENT RUPTURE,1
NZ,LIP BLISTER,1
NZ,LIP EXFOLIATION,1
NZ,LIP SWELLING,1
NZ,LIVER DISORDER,1
NZ,LOCALISED INFECTION,1
NZ,LUNG CONSOLIDATION,1
NZ,LUNG INFILTRATION,1
NZ,LUNG NEOPLASM MALIGNANT,1
NZ,LUPUS-LIKE SYNDROME,1
NZ,MACULAR OEDEMA,1
NZ,MALIGNANT MELANOMA,1
NZ,MEDICAL DEVICE REMOVAL,1
NZ,MENTAL DISORDER,1
NZ,METABOLIC SYNDROME,1
NZ,METASTASES TO LYMPH NODES,1
NZ,MOOD SWINGS,1
NZ,MOUTH HAEMORRHAGE,1
NZ,MUSCLE ATROPHY,1
NZ,MUSCLE MASS,1
NZ,MUSCULAR WEAKNESS,1
NZ,MUSCULOSKELETAL DISCOMFORT,1
NZ,MYCOBACTERIAL INFECTION,1
NZ,MYELODYSPLASTIC SYNDROME,1
NZ,MYOCARDIAL FIBROSIS,1
NZ,NASAL ULCER,1
NZ,NECK MASS,1
NZ,NECROSIS,1
NZ,NECROTISING SCLERITIS,1
NZ,NEOPLASM MALIGNANT,1
NZ,NEURALGIA,1
NZ,NEUTROPENIA,1
NZ,NEUTROPHIL COUNT INCREASED,1
NZ,NEUTROPHIL HYPERSEGMENTED MORPHOLOGY PRESENT,1
NZ,NON-CARDIAC CHEST PAIN,1
NZ,NONINFECTIVE GINGIVITIS,1
NZ,OESOPHAGEAL ULCER,1
NZ,OESOPHAGITIS CHEMICAL,1
NZ,OESOPHAGITIS ULCERATIVE,1
NZ,OPHTHALMIC HERPES ZOSTER,1
NZ,OPTIC NEURITIS,1
NZ,ORAL HERPES,1
NZ,ORAL PAPILLOMA,1
NZ,OROPHARYNGEAL PAIN,1
NZ,OSTEONECROSIS,1
NZ,OSTEONECROSIS OF JAW,1
NZ,OSTEOPOROSIS,1
NZ,PARVOVIRUS INFECTION,1
NZ,PATHOLOGICAL FRACTURE,1
NZ,PERIPHERAL ISCHAEMIA,1
NZ,PHARYNGEAL OEDEMA,1
NZ,PHARYNGITIS STREPTOCOCCAL,1
NZ,PHOTOPSIA,1
NZ,PLATELET COUNT DECREASED,1
NZ,PLEURAL EFFUSION,1
NZ,PLEURAL THICKENING,1
NZ,PLEURITIC PAIN,1
NZ,PNEUMOCYSTIS JIROVECII INFECTION,1
NZ,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NZ,PROCEDURAL PAIN,1
NZ,PRODUCT USE ISSUE,1
NZ,PSORIATIC ARTHROPATHY,1
NZ,PSYCHOTIC DISORDER,1
NZ,PULMONARY EMBOLISM,1
NZ,PULMONARY MASS,1
NZ,PYODERMA GANGRENOSUM,1
NZ,RASH ERYTHEMATOUS,1
NZ,RASH MACULAR,1
NZ,RASH PRURITIC,1
NZ,RESPIRATORY DISORDER,1
NZ,RESPIRATORY DISTRESS,1
NZ,RESTLESS LEGS SYNDROME,1
NZ,RETCHING,1
NZ,RHEUMATOID LUNG,1
NZ,RHINITIS,1
NZ,SARCOIDOSIS,1
NZ,SCLERITIS,1
NZ,SINUSITIS,1
NZ,SKIN DISORDER,1
NZ,SKIN EXFOLIATION,1
NZ,SKIN ULCER,1
NZ,SOMNOLENCE,1
NZ,STAPHYLOCOCCAL INFECTION,1
NZ,STEVENS-JOHNSON SYNDROME,1
NZ,STOMA SITE ULCER,1
NZ,STOMATITIS,1
NZ,SUBDURAL HAEMATOMA,1
NZ,SUICIDAL IDEATION,1
NZ,SWELLING FACE,1
NZ,SWOLLEN TONGUE,1
NZ,SYNOVITIS,1
NZ,TENDONITIS,1
NZ,THALAMIC INFARCTION,1
NZ,THERAPEUTIC RESPONSE DECREASED,1
NZ,THERAPEUTIC RESPONSE UNEXPECTED,1
NZ,TIBIA FRACTURE,1
NZ,TRANSIENT ISCHAEMIC ATTACK,1
NZ,TREMOR,1
NZ,TUBERCULOSIS,1
NZ,ULCER,1
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,1
NZ,URINE ABNORMALITY,1
NZ,URINE ODOUR ABNORMAL,1
NZ,UROSEPSIS,1
NZ,URTICARIA,1
NZ,UVEITIS,1
NZ,VISION BLURRED,1
NZ,WEIGHT BEARING DIFFICULTY,1
NZ,WHITE BLOOD CELL COUNT ABNORMAL,1
NZ,WISDOM TEETH REMOVAL,1
NG,ANAPHYLACTIC SHOCK,3
NG,BACTERIAL INFECTION,2
NG,PNEUMONITIS,2
NG,PULMONARY FIBROSIS,2
NG,SUBCUTANEOUS EMPHYSEMA,2
NG,CONVULSION,1
NG,ERYTHEMA MULTIFORME,1
NG,HYPERSENSITIVITY,1
NG,STAPHYLOCOCCAL INFECTION,1
NG,STILL^S DISEASE ADULT ONSET,1
NG,STOMATITIS,1
NO,FEBRILE NEUTROPENIA,131
NO,HAEMATOTOXICITY,127
NO,OSTEONECROSIS,44
NO,DISEASE PROGRESSION,37
NO,VENOOCCLUSIVE DISEASE,37
NO,DYSPNOEA,25
NO,PANCYTOPENIA,25
NO,RASH,23
NO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,19
NO,POLYNEUROPATHY,19
NO,RENAL FAILURE,17
NO,DEATH,16
NO,GENERAL PHYSICAL HEALTH DETERIORATION,16
NO,NAUSEA,16
NO,DRUG EFFECT DECREASED,15
NO,INTRACRANIAL VENOUS SINUS THROMBOSIS,15
NO,PNEUMONIA,15
NO,PYREXIA,15
NO,SEPSIS,15
NO,THROMBOCYTOPENIA,15
NO,TOXICITY TO VARIOUS AGENTS,15
NO,DIARRHOEA,14
NO,INFECTION,14
NO,COLITIS,13
NO,DEAFNESS,13
NO,DRUG INEFFECTIVE,13
NO,NEUTROPENIA,13
NO,RHEUMATOID ARTHRITIS,13
NO,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,11
NO,HEPATIC STEATOSIS,11
NO,MOTOR DYSFUNCTION,11
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,11
NO,PSORIASIS,11
NO,ALANINE AMINOTRANSFERASE INCREASED,10
NO,ASTHMA,10
NO,HEPATIC ENZYME INCREASED,10
NO,IMMUNOSUPPRESSION,10
NO,INTERSTITIAL LUNG DISEASE,10
NO,MOUTH ULCERATION,10
NO,PULMONARY TOXICITY,10
NO,RESPIRATORY FAILURE,10
NO,MEDICATION ERROR,9
NO,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,9
NO,ADENOCARCINOMA OF COLON,8
NO,ANAL SPHINCTER ATONY,8
NO,ILEUS,8
NO,MULTI-ORGAN FAILURE,8
NO,MYELOMALACIA,8
NO,MYELOPATHY,8
NO,NEOPLASM RECURRENCE,8
NO,NERVOUS SYSTEM DISORDER,8
NO,NEUROGENIC BLADDER,8
NO,PARALYSIS,8
NO,RASH PUSTULAR,8
NO,WRONG DRUG ADMINISTERED,8
NO,ACCIDENTAL OVERDOSE,7
NO,CONDITION AGGRAVATED,7
NO,DIZZINESS,7
NO,DRUG EFFECT INCOMPLETE,7
NO,HEADACHE,7
NO,HYPERTENSION,7
NO,HYPOAESTHESIA,7
NO,HYPOKALAEMIA,7
NO,HYPONATRAEMIA,7
NO,MEMORY IMPAIRMENT,7
NO,STOMATITIS,7
NO,ABDOMINAL PAIN UPPER,6
NO,AGRANULOCYTOSIS,6
NO,ARTHRALGIA,6
NO,ASPARTATE AMINOTRANSFERASE INCREASED,6
NO,BURSITIS,6
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,6
NO,CIRCULATORY COLLAPSE,6
NO,COLD SWEAT,6
NO,DRUG RESISTANCE,6
NO,FEMORAL NECK FRACTURE,6
NO,FLATULENCE,6
NO,HIP DEFORMITY,6
NO,INCORRECT DOSE ADMINISTERED,6
NO,INFLAMMATORY BOWEL DISEASE,6
NO,MALIGNANT NEOPLASM PROGRESSION,6
NO,MIGRAINE,6
NO,MYELITIS TRANSVERSE,6
NO,PNEUMONITIS,6
NO,REBOUND EFFECT,6
NO,RHEUMATIC DISORDER,6
NO,SWELLING,6
NO,UNRESPONSIVE TO STIMULI,6
NO,VOLVULUS,6
NO,VOMITING,6
NO,WHITE BLOOD CELL COUNT DECREASED,6
NO,ABDOMINAL PAIN,5
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,5
NO,ACUTE RESPIRATORY FAILURE,5
NO,ALOPECIA,5
NO,ATRIAL FIBRILLATION,5
NO,BLOOD BILIRUBIN INCREASED,5
NO,BODY TEMPERATURE FLUCTUATION,5
NO,CHEST PAIN,5
NO,COUGH,5
NO,GAIT DISTURBANCE,5
NO,GENITAL ULCERATION,5
NO,HEPATIC FIBROSIS,5
NO,HYPOGLYCAEMIA,5
NO,INFLUENZA LIKE ILLNESS,5
NO,LARGE INTESTINE POLYP,5
NO,MALAISE,5
NO,MEDIASTINAL ABSCESS,5
NO,MUCOUS MEMBRANE DISORDER,5
NO,NIGHT SWEATS,5
NO,OSTEOARTHRITIS,5
NO,PERIPHERAL COLDNESS,5
NO,PHOTOPHOBIA,5
NO,RADIATION PNEUMONITIS,5
NO,SKIN CANCER,5
NO,SPINAL CORD INJURY,5
NO,THERAPEUTIC RESPONSE UNEXPECTED,5
NO,TOOTH DISORDER,5
NO,WOUND,5
NO,ACCIDENTAL EXPOSURE TO PRODUCT,4
NO,ACUTE PROMYELOCYTIC LEUKAEMIA,4
NO,AMMONIA INCREASED,4
NO,AMYLASE INCREASED,4
NO,APLASTIC ANAEMIA,4
NO,B-CELL LYMPHOMA,4
NO,BLOOD LACTIC ACID INCREASED,4
NO,COGNITIVE DISORDER,4
NO,COLLAGEN DISORDER,4
NO,EXOSTOSIS,4
NO,FATIGUE,4
NO,HAEMORRHAGE,4
NO,INTENTIONAL PRODUCT MISUSE,4
NO,INTERNATIONAL NORMALISED RATIO INCREASED,4
NO,LUNG DISORDER,4
NO,MUCOSAL INFLAMMATION,4
NO,MUCOSAL ULCERATION,4
NO,OESOPHAGEAL CANDIDIASIS,4
NO,OSTEOSARCOMA METASTATIC,4
NO,PERICARDITIS,4
NO,PERONEAL NERVE PALSY,4
NO,PLEURISY,4
NO,PNEUMOMEDIASTINUM,4
NO,PROSTATE CANCER,4
NO,SKIN ATROPHY,4
NO,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,4
NO,SUBCUTANEOUS EMPHYSEMA,4
NO,THERAPEUTIC RESPONSE DECREASED,4
NO,TINNITUS,4
NO,ABSCESS ORAL,3
NO,ACUTE KIDNEY INJURY,3
NO,ACUTE MYELOID LEUKAEMIA,3
NO,ACUTE RESPIRATORY DISTRESS SYNDROME,3
NO,ANAEMIA,3
NO,ANAL FISTULA,3
NO,ANGIOEDEMA,3
NO,ANTIBODY TEST POSITIVE,3
NO,APRAXIA,3
NO,CEREBRAL VENOUS THROMBOSIS,3
NO,CHOLECYSTITIS,3
NO,COR PULMONALE,3
NO,DEVICE RELATED INFECTION,3
NO,DRY MOUTH,3
NO,GINGIVITIS,3
NO,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,3
NO,HEPATIC CANCER,3
NO,HYPERCALCAEMIA,3
NO,HYPOXIA,3
NO,INFUSION RELATED REACTION,3
NO,IRON OVERLOAD,3
NO,JOINT SWELLING,3
NO,LISTLESS,3
NO,LYMPHOMA,3
NO,METASTASES TO LUNG,3
NO,METASTASIS,3
NO,MYALGIA,3
NO,OBLITERATIVE BRONCHIOLITIS,3
NO,OESOPHAGEAL VARICES HAEMORRHAGE,3
NO,ORAL CANDIDIASIS,3
NO,OSTEOMYELITIS,3
NO,OSTEONECROSIS OF JAW,3
NO,OVERDOSE,3
NO,PNEUMONIA LEGIONELLA,3
NO,PRODUCT USE ISSUE,3
NO,PRURITUS,3
NO,RENAL IMPAIRMENT,3
NO,RESPIRATORY DISTRESS,3
NO,SYNCOPE,3
NO,TARDIVE DYSKINESIA,3
NO,TUBERCULOSIS,3
NO,URINARY TRACT INFECTION,3
NO,UROSEPSIS,3
NO,VISUAL ACUITY REDUCED,3
NO,ABORTION SPONTANEOUS,2
NO,ADRENOCORTICAL CARCINOMA,2
NO,ANXIETY,2
NO,ARTHRITIS,2
NO,BONE MARROW FAILURE,2
NO,CARDIAC FAILURE,2
NO,CHOLANGITIS,2
NO,CHRONIC GRAFT VERSUS HOST DISEASE,2
NO,COMPLETED SUICIDE,2
NO,CONGESTIVE CARDIOMYOPATHY,2
NO,CRITICAL ILLNESS POLYNEUROPATHY,2
NO,CROHN^S DISEASE,2
NO,DEAFNESS BILATERAL,2
NO,DECREASED APPETITE,2
NO,DEPRESSION,2
NO,DIARRHOEA HAEMORRHAGIC,2
NO,DIPLEGIA,2
NO,DISCOMFORT,2
NO,DISEASE RECURRENCE,2
NO,DYSPLASTIC NAEVUS,2
NO,EMPHYSEMA,2
NO,ENVIRONMENTAL EXPOSURE,2
NO,ERYSIPELAS,2
NO,EXPOSURE DURING PREGNANCY,2
NO,FAECAL INCONTINENCE,2
NO,FEBRILE CONVULSION,2
NO,FEEDING DISORDER,2
NO,HAEMOGLOBIN DECREASED,2
NO,HEPATIC FAILURE,2
NO,HERPES ZOSTER,2
NO,HYPERLIPIDAEMIA,2
NO,HYPERNATRAEMIA,2
NO,HYPOGAMMAGLOBULINAEMIA,2
NO,IMMUNE SYSTEM DISORDER,2
NO,IMMUNODEFICIENCY,2
NO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
NO,INSOMNIA,2
NO,LATENT TUBERCULOSIS,2
NO,LEUKOPENIA,2
NO,LIP BLISTER,2
NO,MATERNAL EXPOSURE BEFORE PREGNANCY,2
NO,MUCOSAL HAEMORRHAGE,2
NO,MYOCARDIAL INFARCTION,2
NO,NECROTISING FASCIITIS STREPTOCOCCAL,2
NO,NEUTROPENIC SEPSIS,2
NO,OSTEITIS,2
NO,OVARIAN CANCER STAGE IV,2
NO,OVERWEIGHT,2
NO,OXYGEN SATURATION DECREASED,2
NO,PAIN IN EXTREMITY,2
NO,PARAESTHESIA,2
NO,PEMPHIGOID,2
NO,PLATELET COUNT DECREASED,2
NO,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA,2
NO,PSORIATIC ARTHROPATHY,2
NO,PULMONARY EMBOLISM,2
NO,SECOND PRIMARY MALIGNANCY,2
NO,SIALOADENITIS,2
NO,SINUSITIS,2
NO,SOCIAL PROBLEM,2
NO,SYNOVITIS,2
NO,T-CELL LYMPHOMA,2
NO,TONGUE BLISTERING,2
NO,URINARY INCONTINENCE,2
NO,VARICELLA ZOSTER VIRUS INFECTION,2
NO,VOCAL CORD PARESIS,2
NO,ABSCESS LIMB,1
NO,ACCIDENTAL POISONING,1
NO,ACUTE MOTOR AXONAL NEUROPATHY,1
NO,ACUTE MYOCARDIAL INFARCTION,1
NO,ADJUSTMENT DISORDER,1
NO,ADVERSE EVENT,1
NO,ANAL HAEMORRHAGE,1
NO,ANAL HYPOAESTHESIA,1
NO,ANAPHYLACTIC REACTION,1
NO,ANAPHYLACTIC SHOCK,1
NO,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,1
NO,AORTIC ANEURYSM,1
NO,APHAGIA,1
NO,ARRHYTHMIA,1
NO,ASCITES,1
NO,ASTHENIA,1
NO,AUDITORY DISORDER,1
NO,BACK PAIN,1
NO,BACTERIAL INFECTION,1
NO,BALANCE DISORDER,1
NO,BILIARY CIRRHOSIS PRIMARY,1
NO,BILIARY COLIC,1
NO,BLADDER CANCER,1
NO,BLOOD ALKALINE PHOSPHATASE DECREASED,1
NO,BLOOD CREATININE INCREASED,1
NO,BLOOD DISORDER,1
NO,BLOOD GLUCOSE FLUCTUATION,1
NO,BLOOD PRESSURE INCREASED,1
NO,BLOOD TEST ABNORMAL,1
NO,BLOOD UREA INCREASED,1
NO,BONE CANCER,1
NO,BONE LESION,1
NO,BONE MARROW DISORDER,1
NO,BONE PAIN,1
NO,BRAIN HERNIATION,1
NO,BRAIN INJURY,1
NO,BREAST CANCER,1
NO,BRONCHOSPASM,1
NO,C-REACTIVE PROTEIN INCREASED,1
NO,CARDIAC MURMUR,1
NO,CEREBRAL INFARCTION,1
NO,CHEST DISCOMFORT,1
NO,CHEYNE-STOKES RESPIRATION,1
NO,CHILLS,1
NO,CHOLELITHIASIS,1
NO,CHROMATOPSIA,1
NO,CHRONIC HEPATIC FAILURE,1
NO,CHRONIC SINUSITIS,1
NO,COGWHEEL RIGIDITY,1
NO,COLECTOMY,1
NO,COORDINATION ABNORMAL,1
NO,CUTANEOUS VASCULITIS,1
NO,CYTOMEGALOVIRUS INFECTION,1
NO,CYTOPENIA,1
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NO,DIABETES MELLITUS,1
NO,DIABETIC KETOACIDOSIS,1
NO,DIFFUSE LARGE B-CELL LYMPHOMA,1
NO,DISEASE COMPLICATION,1
NO,DISSOCIATION,1
NO,DRUG CLEARANCE DECREASED,1
NO,DRUG DISPENSING ERROR,1
NO,DRUG LEVEL INCREASED,1
NO,DYSCHROMATOPSIA,1
NO,DYSPHAGIA,1
NO,DYSPNOEA EXERTIONAL,1
NO,ENCEPHALOPATHY,1
NO,ENTEROCOLITIS,1
NO,EPISTAXIS,1
NO,ERYTHEMA NODOSUM,1
NO,ESCHERICHIA SEPSIS,1
NO,EWING^S SARCOMA,1
NO,EYE INFECTION TOXOPLASMAL,1
NO,FEELING ABNORMAL,1
NO,FEMUR FRACTURE,1
NO,FIBROADENOMA OF BREAST,1
NO,FISTULA,1
NO,FLANK PAIN,1
NO,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III STAGE III,1
NO,FRACTURE,1
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
NO,GASTROINTESTINAL HAEMORRHAGE,1
NO,GASTROINTESTINAL TOXICITY,1
NO,GRANULOMATOSIS WITH POLYANGIITIS,1
NO,GROIN PAIN,1
NO,HAEMANGIOPERICYTOMA OF MENINGES,1
NO,HAEMATURIA,1
NO,HAEMOGLOBIN INCREASED,1
NO,HEAD DISCOMFORT,1
NO,HEAD INJURY,1
NO,HEPATIC CIRRHOSIS,1
NO,HEPATIC CONGESTION,1
NO,HEPATOMEGALY,1
NO,HERPES SIMPLEX,1
NO,HIATUS HERNIA,1
NO,HIP ARTHROPLASTY,1
NO,HISTIOCYTOSIS HAEMATOPHAGIC,1
NO,HYPERHIDROSIS,1
NO,HYPERVENTILATION,1
NO,HYPOACUSIS,1
NO,HYPOMAGNESAEMIA,1
NO,HYPOPHOSPHATAEMIA,1
NO,HYPOVENTILATION,1
NO,IGA NEPHROPATHY,1
NO,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
NO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NO,INFLAMMATORY MARKER INCREASED,1
NO,INFLUENZA,1
NO,INITIAL INSOMNIA,1
NO,INJECTION SITE PAIN,1
NO,INTRAOCULAR PRESSURE INCREASED,1
NO,JUVENILE IDIOPATHIC ARTHRITIS,1
NO,LACRIMAL DISORDER,1
NO,LEUKOCYTOSIS,1
NO,LIPOEDEMA,1
NO,LIVER FUNCTION TEST ABNORMAL,1
NO,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
NO,LUMBAR VERTEBRAL FRACTURE,1
NO,LUNG NEOPLASM,1
NO,LUNG NEOPLASM MALIGNANT,1
NO,LYMPHADENOPATHY,1
NO,LYMPHOCYTIC LEUKAEMIA,1
NO,MACULAR DEGENERATION,1
NO,MACULAR SCAR,1
NO,MASKED FACIES,1
NO,MEDULLOBLASTOMA RECURRENT,1
NO,MENTAL IMPAIRMENT,1
NO,METASTASES TO LIVER,1
NO,MOBILITY DECREASED,1
NO,MUSCLE CONTRACTIONS INVOLUNTARY,1
NO,MUSCLE RIGIDITY,1
NO,MUSCLE SPASMS,1
NO,MUSCULOSKELETAL STIFFNESS,1
NO,MYASTHENIA GRAVIS,1
NO,MYASTHENIC SYNDROME,1
NO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
NO,MYCOTIC ANEURYSM,1
NO,MYOCARDITIS,1
NO,MYOCLONUS,1
NO,NECK PAIN,1
NO,NEOPLASM PROGRESSION,1
NO,NEUROLOGICAL SYMPTOM,1
NO,NEUROPATHY PERIPHERAL,1
NO,NO ADVERSE EVENT,1
NO,NON-HODGKIN^S LYMPHOMA,1
NO,NON-SMALL CELL LUNG CANCER METASTATIC,1
NO,OBSTRUCTIVE AIRWAYS DISORDER,1
NO,OEDEMA MUCOSAL,1
NO,OEDEMA PERIPHERAL,1
NO,OPHTHALMIC VEIN THROMBOSIS,1
NO,ORAL MUCOSAL BLISTERING,1
NO,ORAL PAIN,1
NO,OROPHARYNGEAL PAIN,1
NO,OSTEOLYSIS,1
NO,OSTEOPENIA,1
NO,OSTEOPOROSIS,1
NO,OTOTOXICITY,1
NO,OVARIAN CANCER,1
NO,PAIN IN JAW,1
NO,PALPITATIONS,1
NO,PARAPLEGIA,1
NO,PARESIS,1
NO,PARKINSON^S DISEASE,1
NO,PARVOVIRUS B19 INFECTION,1
NO,PARVOVIRUS B19 TEST POSITIVE,1
NO,PARVOVIRUS INFECTION,1
NO,PHARYNGITIS,1
NO,PLEURAL EFFUSION,1
NO,PNEUMOCYSTIS JIROVECII INFECTION,1
NO,POOR QUALITY SLEEP,1
NO,PRODUCT QUALITY ISSUE,1
NO,PRODUCT SELECTION ERROR,1
NO,PRODUCT USE IN UNAPPROVED INDICATION,1
NO,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
NO,PROGRESSIVE SUPRANUCLEAR PALSY,1
NO,PULMONARY OEDEMA,1
NO,PULPITIS DENTAL,1
NO,PUSTULAR PSORIASIS,1
NO,QUALITY OF LIFE DECREASED,1
NO,RADIAL NERVE PALSY,1
NO,RALES,1
NO,RECTAL CANCER,1
NO,RECTAL PROLAPSE,1
NO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NO,RENAL TRANSPLANT,1
NO,RESPIRATORY TRACT INFECTION,1
NO,RESTLESS LEGS SYNDROME,1
NO,RETINAL INFARCTION,1
NO,ROTATOR CUFF SYNDROME,1
NO,SARCOMA,1
NO,SENSORY DISTURBANCE,1
NO,SEPTIC SHOCK,1
NO,SERUM FERRITIN INCREASED,1
NO,SICK SINUS SYNDROME,1
NO,SKIN DISORDER,1
NO,SKIN GRAFT REJECTION,1
NO,SKIN HAEMORRHAGE,1
NO,SOMNOLENCE,1
NO,SPEECH DISORDER,1
NO,SPINAL COLUMN STENOSIS,1
NO,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
NO,STEVENS-JOHNSON SYNDROME,1
NO,SUDDEN DEATH,1
NO,SUICIDE ATTEMPT,1
NO,SURGERY,1
NO,SYSTEMIC CANDIDA,1
NO,TACHYPNOEA,1
NO,THERAPY RESPONDER,1
NO,THROMBOCYTOSIS,1
NO,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NO,TRANSAMINASES INCREASED,1
NO,TRANSFUSION,1
NO,TRAUMATIC LUNG INJURY,1
NO,TREMOR,1
NO,TUBULOINTERSTITIAL NEPHRITIS,1
NO,URINE OUTPUT INCREASED,1
NO,VASCULITIC RASH,1
NO,VENOOCCLUSIVE LIVER DISEASE,1
NO,VENTRICULAR TACHYCARDIA,1
NO,VISUAL FIELD DEFECT,1
NO,VISUAL IMPAIRMENT,1
NO,WEIGHT DECREASED,1
NO,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
OM,ARTHRITIS BACTERIAL,1
OM,ARTHRITIS INFECTIVE,1
OM,HYPERSENSITIVITY,1
OM,MYOSITIS,1
OM,PSEUDOSEPSIS,1
OM,PYREXIA,1
OM,SYNOVITIS,1
PK,NEUTROPENIC SEPSIS,3
PK,PRODUCT USE IN UNAPPROVED INDICATION,2
PK,PYREXIA,2
PK,ACINETOBACTER BACTERAEMIA,1
PK,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
PK,ADVERSE EVENT,1
PK,BONE MARROW FAILURE,1
PK,DEATH,1
PK,GASTROINTESTINAL DISORDER,1
PK,HAEMATEMESIS,1
PK,HAEMATURIA,1
PK,HAEMORRHAGE,1
PK,HEPATIC ENCEPHALOPATHY,1
PK,HEPATITIS,1
PK,INFECTION,1
PK,LEUKAEMIA RECURRENT,1
PK,NEUTROPENIA,1
PK,PRODUCT USE ISSUE,1
PK,PULMONARY HAEMORRHAGE,1
PK,RESPIRATORY FAILURE,1
PK,SHOCK,1
PK,TUMOUR LYSIS SYNDROME,1
PK,URINARY INCONTINENCE,1
PK,VOMITING,1
PA,ERYTHEMA,2
PA,ABNORMAL SENSATION IN EYE,1
PA,CHOLECYSTITIS ACUTE,1
PA,CORNEAL INFECTION,1
PA,COUGH,1
PA,DIVERTICULAR PERFORATION,1
PA,DIVERTICULITIS,1
PA,DRY EYE,1
PA,ECCHYMOSIS,1
PA,EXPOSURE DURING PREGNANCY,1
PA,EYE INFECTION,1
PA,EYE PAIN,1
PA,HEADACHE,1
PA,HIP ARTHROPLASTY,1
PA,INFUSION RELATED REACTION,1
PA,OCULAR HYPERAEMIA,1
PA,PAIN,1
PA,PROCEDURAL PAIN,1
PA,RHEUMATOID ARTHRITIS,1
PA,SKIN ABRASION,1
PA,SKIN EXFOLIATION,1
PA,ULCERATIVE KERATITIS,1
PA,VOMITING,1
PY,BONE MARROW FAILURE,1
PY,SEPSIS,1
PY,SEPTIC SHOCK,1
PE,MALAISE,5
PE,PYREXIA,5
PE,ARTHRALGIA,4
PE,JOINT SWELLING,4
PE,PNEUMONIA,4
PE,VOMITING,4
PE,CAT SCRATCH DISEASE,3
PE,ERYTHEMA,3
PE,MUSCULAR WEAKNESS,3
PE,SKIN LESION,3
PE,TRICHODYSPLASIA SPINULOSA,3
PE,ABORTION SPONTANEOUS,2
PE,ANAEMIA,2
PE,ANKLE FRACTURE,2
PE,COUGH,2
PE,DRUG-INDUCED LIVER INJURY,2
PE,DYSPNOEA,2
PE,FALL,2
PE,FATIGUE,2
PE,GAIT DISTURBANCE,2
PE,HEADACHE,2
PE,HEPATIC ENZYME INCREASED,2
PE,INFUSION RELATED REACTION,2
PE,INTESTINAL OBSTRUCTION,2
PE,LUNG INFECTION,2
PE,MYOPATHY,2
PE,NO THERAPEUTIC RESPONSE,2
PE,PAIN IN EXTREMITY,2
PE,PRODUCT USE ISSUE,2
PE,RASH,2
PE,THROMBOCYTOPENIA,2
PE,WEIGHT DECREASED,2
PE,ABDOMINAL PAIN,1
PE,ALOPECIA,1
PE,ANAL FISTULA,1
PE,ASPERGILLOMA,1
PE,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
PE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PE,BLOOD CREATININE INCREASED,1
PE,BLOOD PRESSURE DECREASED,1
PE,BRUCELLOSIS,1
PE,BURSITIS,1
PE,CARDIAC INFECTION,1
PE,CELLULITIS,1
PE,CHEST PAIN,1
PE,CHILLS,1
PE,CHOLELITHIASIS,1
PE,CHONDRITIS,1
PE,CHRONIC GASTRITIS,1
PE,CHRONIC MYELOID LEUKAEMIA,1
PE,CONDITION AGGRAVATED,1
PE,CONJUNCTIVITIS,1
PE,DIZZINESS,1
PE,DRUG INEFFECTIVE,1
PE,DYSLIPIDAEMIA,1
PE,EPISTAXIS,1
PE,EXPOSURE DURING PREGNANCY,1
PE,EYE SWELLING,1
PE,FACE OEDEMA,1
PE,FIBROMA,1
PE,FIBROMYALGIA,1
PE,FOETAL DEATH,1
PE,GALLBLADDER POLYP,1
PE,GUILLAIN-BARRE SYNDROME,1
PE,HAEMATOTOXICITY,1
PE,HAEMOGLOBIN DECREASED,1
PE,HAEMORRHAGE INTRACRANIAL,1
PE,HEPATIC CYST,1
PE,HIGH RISK PREGNANCY,1
PE,HIP SURGERY,1
PE,HISTIOCYTOSIS HAEMATOPHAGIC,1
PE,HYPERSENSITIVITY,1
PE,HYPERTENSION,1
PE,HYPOTENSION,1
PE,INCORRECT DOSE ADMINISTERED,1
PE,INFECTION,1
PE,INGUINAL HERNIA,1
PE,INJECTION SITE PRURITUS,1
PE,INTERMITTENT CLAUDICATION,1
PE,INTERVERTEBRAL DISC CALCIFICATION,1
PE,KLEBSIELLA INFECTION,1
PE,LARYNGEAL OEDEMA,1
PE,LARYNGEAL PAIN,1
PE,LEUKOCYTOSIS,1
PE,LIP OEDEMA,1
PE,LIVER DISORDER,1
PE,LUNG INFILTRATION,1
PE,LUNG NEOPLASM MALIGNANT,1
PE,LYMPHOPROLIFERATIVE DISORDER,1
PE,MENISCUS INJURY,1
PE,MOVEMENT DISORDER,1
PE,MULTI-ORGAN FAILURE,1
PE,MUSCULOSKELETAL DISORDER,1
PE,NASOPHARYNGITIS,1
PE,NAUSEA,1
PE,NECK PAIN,1
PE,NEUTROPHILIA,1
PE,OEDEMA PERIPHERAL,1
PE,ORAL CANDIDIASIS,1
PE,OSTEOMYELITIS SALMONELLA,1
PE,PAIN,1
PE,PANCREATIC CARCINOMA,1
PE,PANCREATIC CYST,1
PE,PATHOGEN RESISTANCE,1
PE,PULMONARY OEDEMA,1
PE,PULMONARY TUBERCULOSIS,1
PE,PYELONEPHRITIS ACUTE,1
PE,RASH ERYTHEMATOUS,1
PE,RENAL CYST,1
PE,RESPIRATORY DISTRESS,1
PE,RESPIRATORY FAILURE,1
PE,RESPIRATORY TRACT INFECTION,1
PE,RHEUMATOID ARTHRITIS,1
PE,SEPSIS,1
PE,SHOCK,1
PE,SLEEP DISORDER,1
PE,TRANSAMINASES INCREASED,1
PE,TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME,1
PE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PE,UVEITIS,1
PH,DIABETES MELLITUS,2
PH,PAIN,2
PH,PULMONARY TUBERCULOSIS,2
PH,ACUTE CORONARY SYNDROME,1
PH,ACUTE MYOCARDIAL INFARCTION,1
PH,ANAEMIA,1
PH,ARTHRITIS,1
PH,BREAST CANCER RECURRENT,1
PH,CELLULITIS,1
PH,CHILLS,1
PH,CHRONIC GASTRITIS,1
PH,COLITIS,1
PH,DEVICE MALFUNCTION,1
PH,DYSPEPSIA,1
PH,DYSPNOEA,1
PH,FEBRILE NEUTROPENIA,1
PH,GASTRIC ULCER,1
PH,HAEMORRHAGIC DISORDER,1
PH,HELICOBACTER GASTRITIS,1
PH,HEPATITIS,1
PH,HYPERSENSITIVITY,1
PH,INFECTION,1
PH,INFLAMMATION,1
PH,IRON DEFICIENCY ANAEMIA,1
PH,NASAL CONGESTION,1
PH,NERVOUS SYSTEM DISORDER,1
PH,OESOPHAGITIS,1
PH,OSTEONECROSIS,1
PH,PAIN IN EXTREMITY,1
PH,PLEURAL EFFUSION,1
PH,PNEUMONIA,1
PH,PRODUCT USE IN UNAPPROVED INDICATION,1
PH,PRURITUS,1
PH,PSORIASIS,1
PH,PYREXIA,1
PH,RASH,1
PH,SEPSIS,1
PH,STOMATITIS,1
PH,SUDDEN CARDIAC DEATH,1
PH,SWELLING FACE,1
PH,THERAPEUTIC RESPONSE DECREASED,1
PH,TUBERCULOSIS,1
PH,VARICELLA,1
PL,DRUG INEFFECTIVE,38
PL,NAUSEA,33
PL,PYREXIA,27
PL,ASTHENIA,24
PL,VOMITING,24
PL,ANAEMIA,19
PL,TOXICITY TO VARIOUS AGENTS,19
PL,LEUKOPENIA,18
PL,PNEUMONIA,17
PL,RASH,16
PL,ABDOMINAL PAIN,15
PL,ALANINE AMINOTRANSFERASE INCREASED,15
PL,DYSPNOEA,15
PL,ERYTHEMA,13
PL,ABDOMINAL PAIN UPPER,11
PL,ASPARTATE AMINOTRANSFERASE INCREASED,11
PL,DISEASE PROGRESSION,11
PL,HEADACHE,11
PL,RESPIRATORY FAILURE,11
PL,DIZZINESS,10
PL,NEUTROPENIA,10
PL,VERTIGO,10
PL,CONDITION AGGRAVATED,9
PL,DERMATITIS EXFOLIATIVE,9
PL,POLYNEUROPATHY,9
PL,APHASIA,8
PL,ATAXIA,8
PL,CONSTIPATION,8
PL,DRUG LEVEL INCREASED,8
PL,KAPOSI^S SARCOMA,8
PL,LATENT TUBERCULOSIS,8
PL,MULTI-ORGAN FAILURE,8
PL,SEPSIS,8
PL,STOMATITIS,8
PL,THROMBOCYTOPENIA,8
PL,C-REACTIVE PROTEIN INCREASED,7
PL,CIRCULATORY COLLAPSE,7
PL,DYSPEPSIA,7
PL,EYELID OEDEMA,7
PL,GENERAL PHYSICAL HEALTH DETERIORATION,7
PL,INTERSTITIAL LUNG DISEASE,7
PL,OROPHARYNGEAL PAIN,7
PL,RESPIRATORY TRACT INFECTION,7
PL,SEIZURE,7
PL,SKIN LESION,7
PL,TRANSAMINASES INCREASED,7
PL,URINARY TRACT INFECTION,7
PL,ALOPECIA,6
PL,ARTHRALGIA,6
PL,BLOOD PRESSURE INCREASED,6
PL,DECREASED APPETITE,6
PL,DIARRHOEA,6
PL,DYSPHAGIA,6
PL,GASTROINTESTINAL HAEMORRHAGE,6
PL,HAEMATURIA,6
PL,ISCHAEMIC STROKE,6
PL,LYMPHADENOPATHY,6
PL,NEPHRITIS,6
PL,ORAL MUCOSA EROSION,6
PL,STAPHYLOCOCCAL INFECTION,6
PL,THERAPEUTIC RESPONSE DECREASED,6
PL,BRONCHITIS,5
PL,COUGH,5
PL,DEATH,5
PL,DRUG INTOLERANCE,5
PL,FACE OEDEMA,5
PL,HEPATIC ENZYME INCREASED,5
PL,HEPATIC FUNCTION ABNORMAL,5
PL,RENAL IMPAIRMENT,5
PL,RHEUMATOID ARTHRITIS,5
PL,SEPTIC SHOCK,5
PL,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,4
PL,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,4
PL,AGRANULOCYTOSIS,4
PL,APPENDICITIS,4
PL,ARRHYTHMIA,4
PL,ARTHRITIS,4
PL,BACTERIAL SEPSIS,4
PL,CHEST PAIN,4
PL,CYTOMEGALOVIRUS INFECTION,4
PL,ECTHYMA,4
PL,ERYTHEMA NODOSUM,4
PL,FUSARIUM INFECTION,4
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
PL,GASTROINTESTINAL NECROSIS,4
PL,HYPERTENSION,4
PL,MUCOSAL INFLAMMATION,4
PL,MUCOSAL ULCERATION,4
PL,OEDEMA,4
PL,ORTHOSTATIC HYPOTENSION,4
PL,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,4
PL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
PL,PULMONARY EMBOLISM,4
PL,STEVENS-JOHNSON SYNDROME,4
PL,WEIGHT DECREASED,4
PL,ACUTE HEPATIC FAILURE,3
PL,ALTERED STATE OF CONSCIOUSNESS,3
PL,ANGINA PECTORIS,3
PL,BLOOD TRIGLYCERIDES INCREASED,3
PL,BONE MARROW FAILURE,3
PL,BREAST CANCER METASTATIC,3
PL,CEREBRAL FUNGAL INFECTION,3
PL,COMA,3
PL,CONNECTIVE TISSUE DISORDER,3
PL,CYSTITIS HAEMORRHAGIC,3
PL,DISEASE RECURRENCE,3
PL,EMOTIONAL DISORDER,3
PL,FEBRILE NEUTROPENIA,3
PL,FOETAL EXPOSURE DURING PREGNANCY,3
PL,FUNGAEMIA,3
PL,GASTROINTESTINAL INFLAMMATION,3
PL,GRAFT VERSUS HOST DISEASE,3
PL,HAEMATOCRIT DECREASED,3
PL,HAEMOGLOBIN DECREASED,3
PL,HAEMORRHAGIC NECROTIC PANCREATITIS,3
PL,HEPATIC STEATOSIS,3
PL,HEPATOTOXICITY,3
PL,INFECTION,3
PL,INFLAMMATION,3
PL,INFLAMMATORY MARKER INCREASED,3
PL,KIDNEY TRANSPLANT REJECTION,3
PL,LOSS OF CONSCIOUSNESS,3
PL,LUNG DISORDER,3
PL,MALAISE,3
PL,MALIGNANT NEOPLASM PROGRESSION,3
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
PL,NECROSIS,3
PL,OEDEMA PERIPHERAL,3
PL,PALPITATIONS,3
PL,PANCREATITIS ACUTE,3
PL,PATHOLOGICAL FRACTURE,3
PL,PHOTOPHOBIA,3
PL,PREMATURE BABY,3
PL,PROTEINURIA,3
PL,PRURITUS,3
PL,RASH GENERALISED,3
PL,RENAL FAILURE,3
PL,RENAL FAILURE ACUTE,3
PL,RENAL TRANSPLANT FAILURE,3
PL,RHINORRHOEA,3
PL,STAPHYLOCOCCAL SEPSIS,3
PL,SYNCOPE,3
PL,TACHYCARDIA,3
PL,TONGUE OEDEMA,3
PL,TRANSPLANT FAILURE,3
PL,URTICARIA,3
PL,VIRAL INFECTION,3
PL,ABDOMINAL DISTENSION,2
PL,ABSCESS LIMB,2
PL,ACUTE ABDOMEN,2
PL,ACUTE GRAFT VERSUS HOST DISEASE,2
PL,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
PL,ACUTE LYMPHOCYTIC LEUKAEMIA,2
PL,ACUTE RESPIRATORY FAILURE,2
PL,ADENOVIRUS INFECTION,2
PL,ARTHRITIS BACTERIAL,2
PL,ATRIAL FIBRILLATION,2
PL,AVERSION,2
PL,BETA-2 GLYCOPROTEIN ANTIBODY POSITIVE,2
PL,BK VIRUS INFECTION,2
PL,BLADDER CANCER,2
PL,BLINDNESS,2
PL,BLOOD CHOLESTEROL INCREASED,2
PL,BREAST CANCER,2
PL,BREAST CANCER RECURRENT,2
PL,CARDIAC ARREST,2
PL,CATARACT,2
PL,CHEILITIS,2
PL,CHOLELITHIASIS,2
PL,CHRONIC GRAFT VERSUS HOST DISEASE,2
PL,CLOSTRIDIUM DIFFICILE COLITIS,2
PL,DECREASED IMMUNE RESPONSIVENESS,2
PL,DEEP VEIN THROMBOSIS,2
PL,DEMYELINATION,2
PL,DEPRESSION,2
PL,DERMATITIS,2
PL,DIVERTICULITIS,2
PL,DRUG ABUSE,2
PL,DRUG EFFECT INCOMPLETE,2
PL,EPISCLERITIS,2
PL,ESCHERICHIA INFECTION,2
PL,EYE PAIN,2
PL,FATIGUE,2
PL,FEAR OF EATING,2
PL,FLATULENCE,2
PL,GASTRITIS,2
PL,GASTROINTESTINAL DISORDER,2
PL,GRAFT VERSUS HOST DISEASE IN SKIN,2
PL,GRANULOMATOSIS WITH POLYANGIITIS,2
PL,HAEMATOCHEZIA,2
PL,HAEMORRHAGE,2
PL,HEART TRANSPLANT REJECTION,2
PL,HEPATOMEGALY,2
PL,HERPES ZOSTER,2
PL,HISTIOCYTOSIS HAEMATOPHAGIC,2
PL,HYPERHIDROSIS,2
PL,HYPERSENSITIVITY,2
PL,HYPOALBUMINAEMIA,2
PL,ILEUS PARALYTIC,2
PL,INTRAVENTRICULAR HAEMORRHAGE,2
PL,INTUSSUSCEPTION,2
PL,KERATITIS,2
PL,LEUKOCYTOSIS,2
PL,LIVER FUNCTION TEST INCREASED,2
PL,LOCAL SWELLING,2
PL,LUNG ADENOCARCINOMA,2
PL,LYMPHOCYTE COUNT DECREASED,2
PL,MENINGITIS,2
PL,METASTASES TO LUNG,2
PL,METASTASES TO LYMPH NODES,2
PL,MOBILITY DECREASED,2
PL,MOUTH ULCERATION,2
PL,MUCOSAL NECROSIS,2
PL,MULTI-ORGAN DISORDER,2
PL,MUSCULAR WEAKNESS,2
PL,MYOCARDIAL INFARCTION,2
PL,NASAL POLYPS,2
PL,NON-HODGKIN^S LYMPHOMA,2
PL,ORAL DISORDER,2
PL,ORAL PAIN,2
PL,ORCHITIS NONINFECTIVE,2
PL,OSTEOPOROSIS,2
PL,OVARIAN CANCER,2
PL,PALLOR,2
PL,PANCREATITIS NECROTISING,2
PL,PANCYTOPENIA,2
PL,PLATELET COUNT DECREASED,2
PL,PLEURAL EFFUSION,2
PL,POSTOPERATIVE WOUND INFECTION,2
PL,PRODUCT USE IN UNAPPROVED INDICATION,2
PL,PRODUCT USE ISSUE,2
PL,PSEUDOMONAS INFECTION,2
PL,PSORIASIS,2
PL,PULMONARY FIBROSIS,2
PL,PURPURA,2
PL,RED BLOOD CELL COUNT DECREASED,2
PL,SCEDOSPORIUM INFECTION,2
PL,SILENT MYOCARDIAL INFARCTION,2
PL,SKIN MASS,2
PL,SPINAL COMPRESSION FRACTURE,2
PL,STAPHYLOCOCCUS TEST POSITIVE,2
PL,THROMBOCYTOSIS,2
PL,TONGUE ULCERATION,2
PL,TRANSIENT ISCHAEMIC ATTACK,2
PL,UPPER RESPIRATORY TRACT INFECTION,2
PL,VENOOCCLUSIVE DISEASE,2
PL,VENTRICULAR EXTRASYSTOLES,2
PL,VISUAL IMPAIRMENT,2
PL,WEIGHT INCREASED,2
PL,WHITE BLOOD CELL COUNT DECREASED,2
PL,ABDOMINAL DISCOMFORT,1
PL,ABDOMINAL HERNIA,1
PL,ABDOMINAL LYMPHADENOPATHY,1
PL,ABORTION MISSED,1
PL,ACANTHOSIS,1
PL,ACCIDENTAL OVERDOSE,1
PL,ACINETOBACTER TEST POSITIVE,1
PL,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
PL,ACUTE MYELOID LEUKAEMIA,1
PL,ACUTE MYOCARDIAL INFARCTION,1
PL,ADRENAL MASS,1
PL,ALVEOLAR PROTEINOSIS,1
PL,AMYLOIDOSIS,1
PL,ANAEMIA OF CHRONIC DISEASE,1
PL,ANAL INFLAMMATION,1
PL,ANGIOPATHY,1
PL,ANKLE FRACTURE,1
PL,ANOGENITAL WARTS,1
PL,ANTINUCLEAR ANTIBODY POSITIVE,1
PL,ANXIETY,1
PL,AORTIC STENT INSERTION,1
PL,APATHY,1
PL,APLASIA,1
PL,APLASIA PURE RED CELL,1
PL,APLASTIC ANAEMIA,1
PL,APPENDICEAL ABSCESS,1
PL,APPENDIX CANCER,1
PL,ARRHYTHMIA SUPRAVENTRICULAR,1
PL,ASCITES,1
PL,ASPIRATION,1
PL,ATYPICAL PNEUMONIA,1
PL,B-CELL LYMPHOMA REFRACTORY,1
PL,BACTERIAL DIARRHOEA,1
PL,BACTERIAL INFECTION,1
PL,BACTERIAL TEST POSITIVE,1
PL,BALANCE DISORDER,1
PL,BLADDER TRANSITIONAL CELL CARCINOMA,1
PL,BLOOD BILIRUBIN DECREASED,1
PL,BLOOD CREATININE,1
PL,BLOOD CREATININE INCREASED,1
PL,BLOOD DISORDER,1
PL,BLOOD GLUCOSE INCREASED,1
PL,BLOOD PH INCREASED,1
PL,BLOOD PRESSURE DECREASED,1
PL,BLOOD UREA,1
PL,BLOOD URIC ACID,1
PL,BONE EROSION,1
PL,BONE NEOPLASM,1
PL,BRADYCARDIA,1
PL,BRAIN NATRIURETIC PEPTIDE INCREASED,1
PL,BRAIN NEOPLASM,1
PL,BREAST CANCER STAGE II,1
PL,CACHEXIA,1
PL,CARDIAC DISORDER,1
PL,CARDIAC FAILURE,1
PL,CARDIO-RESPIRATORY ARREST,1
PL,CARDIOLIPIN ANTIBODY,1
PL,CARDIOVASCULAR INSUFFICIENCY,1
PL,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
PL,CEREBRAL CYST,1
PL,CEREBRAL ISCHAEMIA,1
PL,CERVICAL VERTEBRAL FRACTURE,1
PL,CERVIX CARCINOMA,1
PL,CHEST DISCOMFORT,1
PL,CHEST X-RAY ABNORMAL,1
PL,CHLOROMA,1
PL,CHOKING,1
PL,CHRONIC HEPATITIS,1
PL,CHRONIC KIDNEY DISEASE,1
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT,1
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2,1
PL,CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4,1
PL,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PL,CLEAR CELL RENAL CELL CARCINOMA,1
PL,COGNITIVE DISORDER,1
PL,COLON CANCER,1
PL,COLORECTAL ADENOCARCINOMA,1
PL,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
PL,CONVULSION,1
PL,CORONARY ARTERY INSUFFICIENCY,1
PL,CREPITATIONS,1
PL,CROHN^S DISEASE,1
PL,CUSHINGOID,1
PL,CUTANEOUS LUPUS ERYTHEMATOSUS,1
PL,CYSTITIS,1
PL,CYTOMEGALOVIRUS COLITIS,1
PL,CYTOMEGALOVIRUS VIRAEMIA,1
PL,CYTOPENIA,1
PL,DELAYED PUBERTY,1
PL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PL,DIABETES MELLITUS,1
PL,DIFFUSE LARGE B-CELL LYMPHOMA,1
PL,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
PL,DISORIENTATION,1
PL,DISTURBANCE IN ATTENTION,1
PL,DIVERTICULAR PERFORATION,1
PL,DIVERTICULUM,1
PL,DRUG DEPENDENCE,1
PL,DRUG EFFECT DECREASED,1
PL,DRUG EFFECT DELAYED,1
PL,DRUG HYPERSENSITIVITY,1
PL,DRUG RESISTANCE,1
PL,DRUG-INDUCED LIVER INJURY,1
PL,DYSARTHRIA,1
PL,ECZEMA,1
PL,ENCEPHALITIS,1
PL,ENCEPHALITIS VIRAL,1
PL,ENDOMETRIAL CANCER,1
PL,ENGRAFT FAILURE,1
PL,EPISTAXIS,1
PL,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
PL,ERUCTATION,1
PL,ERYTHEMA MULTIFORME,1
PL,ERYTHRODERMIC PSORIASIS,1
PL,EXERCISE TOLERANCE DECREASED,1
PL,EXOPHTHALMOS,1
PL,EXPOSURE DURING PREGNANCY,1
PL,EYE DISORDER,1
PL,EYE NAEVUS,1
PL,EYELID PTOSIS,1
PL,FALL,1
PL,FALSE POSITIVE TUBERCULOSIS TEST,1
PL,FIBROMATOSIS,1
PL,FOETAL DEATH,1
PL,FOETAL GROWTH RESTRICTION,1
PL,FRACTURE,1
PL,GAIT DISTURBANCE,1
PL,GALLBLADDER ADENOCARCINOMA,1
PL,GALLBLADDER CANCER METASTATIC,1
PL,GANGRENE,1
PL,GASTRIC POLYPS,1
PL,GASTRIC ULCER,1
PL,GASTRIC ULCER HAEMORRHAGE,1
PL,GASTROENTERITIS,1
PL,GASTROINTESTINAL MUCOSAL DISORDER,1
PL,GASTROINTESTINAL PAIN,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,GENERALISED ERYTHEMA,1
PL,GENITAL HAEMORRHAGE,1
PL,GENITAL HERPES ZOSTER,1
PL,GENITAL LESION,1
PL,GESTATIONAL HYPERTENSION,1
PL,GIANT CELL TUMOUR OF TENDON SHEATH,1
PL,GINGIVAL HYPERTROPHY,1
PL,GLAUCOMA,1
PL,GLIOMA,1
PL,GOITRE,1
PL,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
PL,GRAFT VERSUS HOST DISEASE IN LIVER,1
PL,GRANULOCYTE COUNT INCREASED,1
PL,GRANULOCYTOPENIA,1
PL,HAEMANGIOMA OF LIVER,1
PL,HAEMATOMA,1
PL,HAEMATOTOXICITY,1
PL,HAEMOLYTIC ANAEMIA,1
PL,HAEMOPTYSIS,1
PL,HAEMORRHAGE URINARY TRACT,1
PL,HALLUCINATION,1
PL,HEAD INJURY,1
PL,HEART RATE INCREASED,1
PL,HEART RATE IRREGULAR,1
PL,HEPATIC CYST,1
PL,HEPATITIS C ANTIBODY POSITIVE,1
PL,HEPATOSPLENOMEGALY,1
PL,HERPES SIMPLEX,1
PL,HERPES VIRUS INFECTION,1
PL,HIATUS HERNIA,1
PL,HIP ARTHROPLASTY,1
PL,HODGKIN^S DISEASE,1
PL,HOSPITALISATION,1
PL,HUERTHLE CELL CARCINOMA,1
PL,HYPERCHOLESTEROLAEMIA,1
PL,HYPERKALAEMIA,1
PL,HYPERLIPIDAEMIA,1
PL,HYPOCAPNIA,1
PL,HYPOCHOLESTEROLAEMIA,1
PL,HYPOFIBRINOGENAEMIA,1
PL,HYPOGAMMAGLOBULINAEMIA,1
PL,HYPOXIA,1
PL,IMMUNODEFICIENCY,1
PL,IMMUNOSUPPRESSION,1
PL,IMPAIRED HEALING,1
PL,INCORRECT DOSE ADMINISTERED,1
PL,INFLUENZA LIKE ILLNESS,1
PL,INJECTION SITE EXTRAVASATION,1
PL,INJECTION SITE OEDEMA,1
PL,INJURY,1
PL,INTERVERTEBRAL DISC DEGENERATION,1
PL,INTERVERTEBRAL DISC DISORDER,1
PL,INTESTINAL STENOSIS,1
PL,INVASIVE BREAST CARCINOMA,1
PL,INVASIVE DUCTAL BREAST CARCINOMA,1
PL,IRITIS,1
PL,IRRITABILITY,1
PL,JOINT EFFUSION,1
PL,JOINT SWELLING,1
PL,JUVENILE IDIOPATHIC ARTHRITIS,1
PL,LARGE CELL LUNG CANCER,1
PL,LARGE INTESTINE POLYP,1
PL,LARYNGITIS,1
PL,LEUKAEMIA RECURRENT,1
PL,LICHEN MYXOEDEMATOSUS,1
PL,LIPIDS INCREASED,1
PL,LIPOMA,1
PL,LIVER FUNCTION TEST ABNORMAL,1
PL,LIVER INJURY,1
PL,LIVER TRANSPLANT,1
PL,LOW BIRTH WEIGHT BABY,1
PL,LOW DENSITY LIPOPROTEIN INCREASED,1
PL,LOWER LIMB FRACTURE,1
PL,LUNG NEOPLASM,1
PL,LUPUS-LIKE SYNDROME,1
PL,LYMPHADENOPATHY MEDIASTINAL,1
PL,LYMPHOMA,1
PL,LYMPHOPENIA,1
PL,MALIGNANT PLEURAL EFFUSION,1
PL,MASTICATION DISORDER,1
PL,MATERNAL EXPOSURE DURING PREGNANCY,1
PL,MENINGIOMA,1
PL,METABOLIC SYNDROME,1
PL,METASTASES TO ABDOMINAL CAVITY,1
PL,METASTASES TO BONE,1
PL,METASTASES TO PERITONEUM,1
PL,METASTASES TO PLEURA,1
PL,METASTASES TO THORAX,1
PL,MONOCLONAL B-CELL LYMPHOCYTOSIS,1
PL,MONOCYTE COUNT INCREASED,1
PL,MONONUCLEOSIS SYNDROME,1
PL,MOOD ALTERED,1
PL,MUCOSAL EROSION,1
PL,MUCOSAL TOXICITY,1
PL,MUCOUS MEMBRANE DISORDER,1
PL,MUSCLE DISORDER,1
PL,MUSCLE HAEMORRHAGE,1
PL,MUSCLE INJURY,1
PL,MUSCLE RIGIDITY,1
PL,MYCOSIS FUNGOIDES,1
PL,MYOCARDIAL ISCHAEMIA,1
PL,NEOPLASM,1
PL,NEPHROLITHIASIS,1
PL,NEUROLOGICAL SYMPTOM,1
PL,NIGHT SWEATS,1
PL,NODULE,1
PL,NON-SMALL CELL LUNG CANCER,1
PL,ORAL DISCOMFORT,1
PL,ORAL HERPES,1
PL,ORAL NEOPLASM,1
PL,ORBITAL OEDEMA,1
PL,OSTEOMYELITIS CHRONIC,1
PL,OSTEONECROSIS,1
PL,OSTEONECROSIS OF JAW,1
PL,OSTEOSARCOMA,1
PL,OVERDOSE,1
PL,PAIN,1
PL,PALATAL DISORDER,1
PL,PANCREATIC CARCINOMA,1
PL,PANCREATITIS HAEMORRHAGIC,1
PL,PAPILLARY THYROID CANCER,1
PL,PARALYSIS,1
PL,PELVIC ABSCESS,1
PL,PELVIC INFLAMMATORY DISEASE,1
PL,PERICARDIAL EFFUSION,1
PL,PERICARDITIS,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PERIPHERAL SWELLING,1
PL,PHARYNGEAL OEDEMA,1
PL,PHOTOSENSITIVITY REACTION,1
PL,PLATELET COUNT INCREASED,1
PL,POLYOMAVIRUS TEST POSITIVE,1
PL,PREMATURE DELIVERY,1
PL,PREMATURE SEPARATION OF PLACENTA,1
PL,PROCTALGIA,1
PL,PROCTITIS,1
PL,PRODUCTIVE COUGH,1
PL,PROSTATE CANCER,1
PL,PSEUDOMEMBRANOUS COLITIS,1
PL,PSEUDOMONAS TEST POSITIVE,1
PL,PSORIATIC ARTHROPATHY,1
PL,PULMONARY HAEMORRHAGE,1
PL,PULMONARY MASS,1
PL,PULMONARY MYCOSIS,1
PL,PURULENCE,1
PL,RASH ERYTHEMATOUS,1
PL,RECTAL HAEMORRHAGE,1
PL,RECTOSIGMOID CANCER,1
PL,RED BLOOD CELL SEDIMENTATION RATE DECREASED,1
PL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PL,REFRACTORY CANCER,1
PL,RENAL CELL CARCINOMA STAGE I,1
PL,RENAL CYST,1
PL,RESPIRATORY ARREST,1
PL,RETICULOCYTE COUNT DECREASED,1
PL,RETINAL DEPIGMENTATION,1
PL,RETROPERITONEAL ABSCESS,1
PL,RHEUMATOID VASCULITIS,1
PL,RICHTER^S SYNDROME,1
PL,SECONDARY IMMUNODEFICIENCY,1
PL,SEROSITIS,1
PL,SERRATIA SEPSIS,1
PL,SERUM FERRITIN INCREASED,1
PL,SINUS DISORDER,1
PL,SINUS TACHYCARDIA,1
PL,SKIN CANCER,1
PL,SKIN EXFOLIATION,1
PL,SKIN FISSURES,1
PL,SKIN HYPERPIGMENTATION,1
PL,SKIN INFECTION,1
PL,SKIN REACTION,1
PL,SKIN ULCER,1
PL,SMALL CELL LUNG CANCER METASTATIC,1
PL,SOFT TISSUE SWELLING,1
PL,SOMNOLENCE,1
PL,SPINAL PAIN,1
PL,SPLEEN DISORDER,1
PL,SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED,1
PL,SPLENOMEGALY,1
PL,SPUTUM PURULENT,1
PL,SQUAMOUS CELL CARCINOMA OF LUNG,1
PL,SQUAMOUS CELL CARCINOMA OF SKIN,1
PL,STENT-GRAFT ENDOLEAK,1
PL,STEWART-TREVES SYNDROME,1
PL,STOMATITIS HAEMORRHAGIC,1
PL,SUDDEN CARDIAC DEATH,1
PL,SUDDEN DEATH,1
PL,SWELLING,1
PL,SWELLING FACE,1
PL,SYNOVIAL CYST,1
PL,SYSTEMIC INFECTION,1
PL,SYSTEMIC MYCOSIS,1
PL,TACHYPNOEA,1
PL,TENDON INJURY,1
PL,THERAPEUTIC RESPONSE UNEXPECTED,1
PL,THERAPY RESPONDER,1
PL,THROAT TIGHTNESS,1
PL,THYROID CANCER,1
PL,TOOTH DISORDER,1
PL,TREATMENT FAILURE,1
PL,TREMOR,1
PL,TRICHOPHYTOSIS,1
PL,ULCER,1
PL,URINE ABNORMALITY,1
PL,UTERINE CANCER,1
PL,UTERINE LEIOMYOMA,1
PL,UTERINE POLYP,1
PL,VAGINAL HAEMORRHAGE,1
PL,VARICELLA ZOSTER VIRUS INFECTION,1
PL,VENTRICULAR ARRHYTHMIA,1
PL,VIITH NERVE PARALYSIS,1
PL,VIRAEMIA,1
PL,VIRAL HAEMORRHAGIC CYSTITIS,1
PL,VISUAL ACUITY REDUCED,1
PL,VOCAL CORD POLYP,1
PL,VOLVULUS OF SMALL BOWEL,1
PL,VULVAL CANCER,1
PL,WHITE BLOOD CELL COUNT INCREASED,1
PL,WOUND,1
PL,YERSINIA INFECTION,1
PT,MUCOSAL INFLAMMATION,16
PT,SEPSIS,16
PT,DRUG INEFFECTIVE,11
PT,NEOPLASM RECURRENCE,10
PT,PNEUMONIA,10
PT,FATIGUE,9
PT,FEBRILE NEUTROPENIA,9
PT,TOXIC EPIDERMAL NECROLYSIS,9
PT,HEPATOTOXICITY,8
PT,PYREXIA,8
PT,SEPTIC SHOCK,8
PT,DISSEMINATED INTRAVASCULAR COAGULATION,7
PT,CONDITION AGGRAVATED,6
PT,RHEUMATOID ARTHRITIS,6
PT,TOXICITY TO VARIOUS AGENTS,6
PT,TRANSAMINASES INCREASED,6
PT,WEIGHT DECREASED,6
PT,ARTHROPATHY,5
PT,COUGH,5
PT,HERPES ZOSTER,5
PT,PRODUCT USE IN UNAPPROVED INDICATION,5
PT,ADENOCARCINOMA OF COLON,4
PT,ARTHRALGIA,4
PT,DIARRHOEA,4
PT,DISSEMINATED TUBERCULOSIS,4
PT,DYSPNOEA,4
PT,INFLUENZA,4
PT,LEUKOPENIA,4
PT,MALAISE,4
PT,MYELOPATHY,4
PT,NEPHROLITHIASIS,4
PT,NEUTROPENIA,4
PT,PAIN,4
PT,PARAESTHESIA,4
PT,PSORIASIS,4
PT,PSORIATIC ARTHROPATHY,4
PT,RESPIRATORY FAILURE,4
PT,SKIN LESION,4
PT,THROMBOCYTOPENIA,4
PT,TUMOUR LYSIS SYNDROME,4
PT,VISCERAL LEISHMANIASIS,4
PT,ANAEMIA,3
PT,APLASIA,3
PT,ASTHENIA,3
PT,BREAST NEOPLASM,3
PT,C-REACTIVE PROTEIN INCREASED,3
PT,CENTRAL NERVOUS SYSTEM INFECTION,3
PT,CONSTIPATION,3
PT,CYSTITIS,3
PT,CYTOMEGALOVIRUS INFECTION,3
PT,HIATUS HERNIA,3
PT,HISTIOCYTOSIS HAEMATOPHAGIC,3
PT,IMMUNOSUPPRESSION,3
PT,INFECTED VARICOSE VEIN,3
PT,METASTASES TO LIVER,3
PT,MULTIPLE SCLEROSIS,3
PT,MUSCULAR WEAKNESS,3
PT,NAUSEA,3
PT,NOCARDIOSIS,3
PT,PANCYTOPENIA,3
PT,PNEUMONITIS,3
PT,PRODUCT USE ISSUE,3
PT,PRODUCTIVE COUGH,3
PT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
PT,PRURITUS,3
PT,PULMONARY FIBROSIS,3
PT,PULMONARY TUBERCULOSIS,3
PT,RASH,3
PT,RESPIRATORY TRACT INFECTION,3
PT,TUBERCULOSIS,3
PT,VARICOSE ULCERATION,3
PT,VOMITING,3
PT,ABDOMINAL PAIN,2
PT,ABDOMINAL PAIN UPPER,2
PT,ACNE,2
PT,ACUTE CORONARY SYNDROME,2
PT,ALANINE AMINOTRANSFERASE INCREASED,2
PT,ANGIOCENTRIC LYMPHOMA,2
PT,ARTHRITIS BACTERIAL,2
PT,ASPARTATE AMINOTRANSFERASE INCREASED,2
PT,AUTOIMMUNE HEPATITIS,2
PT,B-CELL LYMPHOMA,2
PT,BLADDER NEOPLASM,2
PT,BLOOD CHOLESTEROL INCREASED,2
PT,BRAIN DEATH,2
PT,CELLULITIS,2
PT,CEREBROVASCULAR ACCIDENT,2
PT,CHEST PAIN,2
PT,CHILLS,2
PT,CHOLESTASIS,2
PT,CHONDROSARCOMA,2
PT,CROHN^S DISEASE,2
PT,DEATH,2
PT,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,2
PT,DIPLOPIA,2
PT,DISEASE RECURRENCE,2
PT,DIVERTICULITIS,2
PT,DYSARTHRIA,2
PT,ENTEROCOLITIS,2
PT,ERYTHEMA NODOSUM,2
PT,FRACTURE,2
PT,GASTROINTESTINAL HAEMORRHAGE,2
PT,GASTROOESOPHAGEAL REFLUX DISEASE,2
PT,GLAUCOMA,2
PT,GLOMERULONEPHRITIS,2
PT,HAEMATURIA,2
PT,HAEMOGLOBIN DECREASED,2
PT,HEADACHE,2
PT,HEPATIC ENZYME INCREASED,2
PT,HEPATITIS TOXIC,2
PT,HODGKIN^S DISEASE STAGE III,2
PT,HYPERTENSION,2
PT,HYPOTENSION,2
PT,HYPOVOLAEMIC SHOCK,2
PT,IGA NEPHROPATHY,2
PT,INTESTINAL PSEUDO-OBSTRUCTION,2
PT,JOINT SWELLING,2
PT,LIMB INJURY,2
PT,LISTERIA SEPSIS,2
PT,LUPUS-LIKE SYNDROME,2
PT,LYMPHOPENIA,2
PT,METASTASES TO PERITONEUM,2
PT,MYALGIA,2
PT,MYELODYSPLASTIC SYNDROME,2
PT,NASAL OBSTRUCTION,2
PT,NASOPHARYNGITIS,2
PT,NEOPLASM,2
PT,NEPHROTIC SYNDROME,2
PT,NIGHT SWEATS,2
PT,NO THERAPEUTIC RESPONSE,2
PT,NON-HODGKIN^S LYMPHOMA,2
PT,OCULAR HYPERAEMIA,2
PT,OEDEMA,2
PT,OESOPHAGEAL HAEMORRHAGE,2
PT,ORAL HERPES,2
PT,OROPHARYNGEAL PAIN,2
PT,PARAPARESIS,2
PT,POLYARTHRITIS,2
PT,POLYSEROSITIS,2
PT,PROTEINURIA,2
PT,PULMONARY EMBOLISM,2
PT,PURULENT DISCHARGE,2
PT,PUSTULAR PSORIASIS,2
PT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
PT,RENAL AMYLOIDOSIS,2
PT,RESPIRATORY TRACT INFECTION BACTERIAL,2
PT,RHEUMATOID NODULE,2
PT,SARCOIDOSIS,2
PT,SKIN INFECTION,2
PT,SKIN ULCER,2
PT,SWELLING,2
PT,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PT,TENDONITIS,2
PT,THERAPEUTIC RESPONSE DECREASED,2
PT,TRANSFUSION,2
PT,TRANSIENT ISCHAEMIC ATTACK,2
PT,TRAUMATIC LUNG INJURY,2
PT,TREATMENT FAILURE,2
PT,TUMOUR HAEMORRHAGE,2
PT,ULCER,2
PT,VULVOVAGINAL PRURITUS,2
PT,ABDOMINAL HERNIA,1
PT,ABDOMINAL SEPSIS,1
PT,ABNORMAL FAECES,1
PT,ABORTION INDUCED,1
PT,ABSCESS LIMB,1
PT,ACUTE GRAFT VERSUS HOST DISEASE,1
PT,ACUTE KIDNEY INJURY,1
PT,ACUTE SINUSITIS,1
PT,ADENOMA BENIGN,1
PT,ADJUVANT THERAPY,1
PT,ALLERGIC COUGH,1
PT,ALOPECIA,1
PT,ANAL FISTULA,1
PT,ANAPHYLACTIC REACTION,1
PT,ANTINUCLEAR ANTIBODY POSITIVE,1
PT,ANXIETY,1
PT,AORTIC ANEURYSM,1
PT,APHASIA,1
PT,APHTHOUS STOMATITIS,1
PT,APHTHOUS ULCER,1
PT,ARTHRITIS,1
PT,ARTHROPOD STING,1
PT,ATRIAL FLUTTER,1
PT,AUTOINFLAMMATORY DISEASE,1
PT,B-CELL SMALL LYMPHOCYTIC LYMPHOMA STAGE I,1
PT,BACK PAIN,1
PT,BASAL CELL CARCINOMA,1
PT,BILIARY CIRRHOSIS PRIMARY,1
PT,BLADDER ADENOCARCINOMA STAGE I,1
PT,BLADDER CANCER,1
PT,BLOOD ALBUMIN DECREASED,1
PT,BLOOD BILIRUBIN INCREASED,1
PT,BLOOD CREATININE INCREASED,1
PT,BLOOD DISORDER,1
PT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
PT,BLOOD POTASSIUM DECREASED,1
PT,BLOOD PRESSURE INCREASED,1
PT,BLOOD PRESSURE SYSTOLIC INCREASED,1
PT,BLOOD UREA INCREASED,1
PT,BODY TEMPERATURE INCREASED,1
PT,BONE EROSION,1
PT,BONE MARROW FAILURE,1
PT,BRAIN NEOPLASM,1
PT,BREAST ABSCESS,1
PT,BREAST CANCER,1
PT,BRONCHOSPASM,1
PT,BURSITIS INFECTIVE,1
PT,BUTTERFLY RASH,1
PT,CATARACT,1
PT,CERVICAL DYSPLASIA,1
PT,CERVIX CARCINOMA,1
PT,CHEMICAL POISONING,1
PT,CHEST DISCOMFORT,1
PT,CHOLELITHIASIS,1
PT,CHOLURIA,1
PT,CHONDROPATHY,1
PT,CHONDROSARCOMA METASTATIC,1
PT,CHRONIC MYELOID LEUKAEMIA,1
PT,COCCYDYNIA,1
PT,COLITIS,1
PT,COLITIS ULCERATIVE,1
PT,COLORECTAL CANCER,1
PT,CONGENITAL ANOMALY,1
PT,CRYSTAL URINE PRESENT,1
PT,CULTURE POSITIVE,1
PT,CUTANEOUS VASCULITIS,1
PT,CYTOMEGALOVIRUS COLITIS,1
PT,DECREASED APPETITE,1
PT,DEMYELINATION,1
PT,DEPRESSION,1
PT,DERMATITIS EXFOLIATIVE,1
PT,DIABETES MELLITUS INADEQUATE CONTROL,1
PT,DIARRHOEA HAEMORRHAGIC,1
PT,DIFFUSE LARGE B-CELL LYMPHOMA,1
PT,DISCOMFORT,1
PT,DISEASE PROGRESSION,1
PT,DRUG EFFECT DECREASED,1
PT,DRUG EFFECT INCOMPLETE,1
PT,DRUG HYPERSENSITIVITY,1
PT,DUODENAL PERFORATION,1
PT,DYSPLASIA,1
PT,DYSURIA,1
PT,EMBOLISM VENOUS,1
PT,ENDOCARDITIS,1
PT,ENDOCRINE NEOPLASM,1
PT,EOSINOPHIL COUNT INCREASED,1
PT,EOSINOPHILIA,1
PT,EPISTAXIS,1
PT,EPSTEIN-BARR VIRUS TEST POSITIVE,1
PT,ERYSIPELAS,1
PT,ERYTHEMA,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EXTRA DOSE ADMINISTERED,1
PT,EXTRAPULMONARY TUBERCULOSIS,1
PT,EYE INFLAMMATION,1
PT,FAECAL CALPROTECTIN INCREASED,1
PT,FALL,1
PT,FOETAL DEATH,1
PT,FOETAL EXPOSURE DURING PREGNANCY,1
PT,FOOT DEFORMITY,1
PT,FREQUENT BOWEL MOVEMENTS,1
PT,FRUSTRATION TOLERANCE DECREASED,1
PT,GAIT DISTURBANCE,1
PT,GANGLIONEUROMA,1
PT,GASTRITIS,1
PT,GASTROINTESTINAL DISORDER,1
PT,GASTROINTESTINAL INFECTION,1
PT,GENERAL PHYSICAL HEALTH DETERIORATION,1
PT,GENERALISED ERYTHEMA,1
PT,GENITOURINARY TRACT INFECTION,1
PT,GESTATIONAL HYPERTENSION,1
PT,GLIOBLASTOMA,1
PT,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
PT,GLOMERULONEPHRITIS MEMBRANOUS,1
PT,GRANULOMA,1
PT,H1N1 INFLUENZA,1
PT,HAEMATOCHEZIA,1
PT,HAEMATOTOXICITY,1
PT,HAEMOLYTIC ANAEMIA,1
PT,HAEMOPTYSIS,1
PT,HAEMORRHAGE,1
PT,HAEMORRHAGIC STROKE,1
PT,HEMIPARESIS,1
PT,HEPATIC FUNCTION ABNORMAL,1
PT,HEPATIC INFECTION BACTERIAL,1
PT,HEPATIC PAIN,1
PT,HEPATIC STEATOSIS,1
PT,HEPATITIS,1
PT,HEPATITIS ACUTE,1
PT,HEPATOBILIARY CANCER,1
PT,HEPATOCELLULAR INJURY,1
PT,HEPATOMEGALY,1
PT,HERPES SIMPLEX,1
PT,HIDRADENITIS,1
PT,HIV INFECTION,1
PT,HYPERCHOLESTEROLAEMIA,1
PT,HYPERHIDROSIS,1
PT,HYPERTENSIVE CRISIS,1
PT,HYPERTONIA,1
PT,HYPOAESTHESIA,1
PT,HYPOCAPNIA,1
PT,HYPOGLYCAEMIA,1
PT,HYPOGONADISM,1
PT,HYPOKALAEMIA,1
PT,HYPOPERFUSION,1
PT,HYPOXIA,1
PT,IDIOSYNCRATIC DRUG REACTION,1
PT,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PT,INFECTED CYST,1
PT,INFECTION,1
PT,INFLAMMATION,1
PT,INFLAMMATORY MARKER INCREASED,1
PT,INFLUENZA LIKE ILLNESS,1
PT,INGUINAL HERNIA,1
PT,INJURY,1
PT,INSOMNIA,1
PT,INTESTINAL HAEMORRHAGE,1
PT,INTESTINAL ULCER,1
PT,INTRACRANIAL PRESSURE INCREASED,1
PT,INTRAOCULAR PRESSURE INCREASED,1
PT,INVESTIGATION ABNORMAL,1
PT,ISCHAEMIC STROKE,1
PT,JAUNDICE,1
PT,JOINT RANGE OF MOTION DECREASED,1
PT,JUVENILE IDIOPATHIC ARTHRITIS,1
PT,KLEBSIELLA INFECTION,1
PT,KNEE ARTHROPLASTY,1
PT,LACRIMATION INCREASED,1
PT,LATENT TUBERCULOSIS,1
PT,LEUKAEMIA RECURRENT,1
PT,LICHEN PLANUS,1
PT,LIP SWELLING,1
PT,LOBULAR BREAST CARCINOMA IN SITU,1
PT,LUNG DISORDER,1
PT,LUNG INFECTION,1
PT,LUNG NEOPLASM,1
PT,LYMPH NODE TUBERCULOSIS,1
PT,MALIGNANT MELANOMA,1
PT,MALIGNANT PERITONEAL NEOPLASM,1
PT,MECHANICAL VENTILATION,1
PT,MENINGIOMA,1
PT,MENINGITIS TUBERCULOUS,1
PT,MENORRHAGIA,1
PT,MENTAL STATUS CHANGES,1
PT,METASTASES TO LUNG,1
PT,MIGRAINE,1
PT,MOBILITY DECREASED,1
PT,MONARTHRITIS,1
PT,MOUTH ULCERATION,1
PT,MUCOSAL DISCOLOURATION,1
PT,MULTIPLE FRACTURES,1
PT,MULTIPLE SCLEROSIS RELAPSE,1
PT,MUSCLE RUPTURE,1
PT,MUSCLE SPASTICITY,1
PT,MUSCULOSKELETAL STIFFNESS,1
PT,MYCOSIS FUNGOIDES,1
PT,MYELITIS TRANSVERSE,1
PT,MYOCARDIAL INFARCTION,1
PT,MYOCARDIAL ISCHAEMIA,1
PT,NASAL INFLAMMATION,1
PT,NASAL SEPTUM DISORDER,1
PT,NASAL ULCER,1
PT,NEOPLASM PROSTATE,1
PT,NEUROENDOCRINE TUMOUR,1
PT,NODULE,1
PT,NON-HODGKIN^S LYMPHOMA STAGE IV,1
PT,NON-SMALL CELL LUNG CANCER,1
PT,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
PT,NOSOCOMIAL INFECTION,1
PT,ODYNOPHAGIA,1
PT,OEDEMA PERIPHERAL,1
PT,OESOPHAGEAL PAIN,1
PT,OROPHARYNGEAL NEOPLASM,1
PT,OSTEOARTHRITIS,1
PT,OSTEOMYELITIS,1
PT,OSTEONECROSIS,1
PT,OVARIAN CANCER,1
PT,OXYGEN SATURATION DECREASED,1
PT,PAIN IN EXTREMITY,1
PT,PAPILLOEDEMA,1
PT,PATHOLOGICAL FRACTURE,1
PT,PERICARDITIS TUBERCULOUS,1
PT,PERIORBITAL OEDEMA,1
PT,PHARYNGEAL INFLAMMATION,1
PT,PHOTOSENSITIVITY REACTION,1
PT,PLATELET COUNT DECREASED,1
PT,PLATELET COUNT INCREASED,1
PT,PNEUMONIA KLEBSIELLA,1
PT,PNEUMOTHORAX,1
PT,POLYMERASE CHAIN REACTION POSITIVE,1
PT,POLYP,1
PT,POLYURIA,1
PT,POTENTIATING DRUG INTERACTION,1
PT,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
PT,PROCTALGIA,1
PT,PRODUCT QUALITY ISSUE,1
PT,PROTEIN TOTAL DECREASED,1
PT,PROTEIN URINE PRESENT,1
PT,PRURITUS GENERALISED,1
PT,PULMONARY NECROSIS,1
PT,PULMONARY TOXICITY,1
PT,PYELONEPHRITIS,1
PT,PYOGENIC GRANULOMA,1
PT,RALES,1
PT,RASH PUSTULAR,1
PT,RAYNAUD^S PHENOMENON,1
PT,REACTIVE PERFORATING COLLAGENOSIS,1
PT,RECTAL HAEMORRHAGE,1
PT,RED BLOOD CELL COUNT DECREASED,1
PT,RENAL IMPAIRMENT,1
PT,RENAL MASS,1
PT,RENAL NEOPLASM,1
PT,RENAL PAIN,1
PT,RENAL TUBERCULOSIS,1
PT,RENAL TUBULAR NECROSIS,1
PT,RESPIRATORY DISORDER,1
PT,RIB FRACTURE,1
PT,SACROILIITIS,1
PT,SCAN ABNORMAL,1
PT,SCEDOSPORIUM INFECTION,1
PT,SEPTIC ARTHRITIS STAPHYLOCOCCAL,1
PT,SINUS TACHYCARDIA,1
PT,SJOGREN^S SYNDROME,1
PT,SKIN CANCER,1
PT,SKIN DISCOLOURATION,1
PT,SKIN DISORDER,1
PT,SKIN EXFOLIATION,1
PT,SKIN HYPERTROPHY,1
PT,SKIN MASS,1
PT,SKIN NECROSIS,1
PT,SOFT TISSUE INFECTION,1
PT,SOMNOLENCE,1
PT,SPINAL PAIN,1
PT,SPLENIC ARTERY THROMBOSIS,1
PT,SPUTUM DISCOLOURED,1
PT,STEATORRHOEA,1
PT,STENOTROPHOMONAS TEST POSITIVE,1
PT,STRESS,1
PT,STRONGYLOIDIASIS,1
PT,SYNOVIAL RUPTURE,1
PT,SYNOVITIS,1
PT,SYSTEMIC SCLERODERMA,1
PT,SYSTEMIC SCLEROSIS PULMONARY,1
PT,THERAPEUTIC PRODUCT INEFFECTIVE,1
PT,THERAPY NON-RESPONDER,1
PT,THERMOHYPOAESTHESIA,1
PT,THROMBOSIS,1
PT,THYMOMA,1
PT,TIBIA FRACTURE,1
PT,TINEA FACIEI,1
PT,TINEA INFECTION,1
PT,TONGUE DISORDER,1
PT,TONGUE GEOGRAPHIC,1
PT,TOOTH ABSCESS,1
PT,TOOTH LOSS,1
PT,TOOTHACHE,1
PT,TOXIC SKIN ERUPTION,1
PT,TREATMENT NONCOMPLIANCE,1
PT,TREMOR,1
PT,TRISMUS,1
PT,TUBERCULOSIS OF GENITOURINARY SYSTEM,1
PT,TUBULOINTERSTITIAL NEPHRITIS,1
PT,UNDERWEIGHT,1
PT,UPPER RESPIRATORY TRACT INFECTION,1
PT,URINARY RETENTION,1
PT,URINARY TRACT INFECTION,1
PT,URINARY TRACT INFECTION BACTERIAL,1
PT,UVEITIS,1
PT,VARICELLA ZOSTER VIRUS INFECTION,1
PT,VERTEBRAL FORAMINAL STENOSIS,1
PT,VISUAL IMPAIRMENT,1
PT,WEIGHT INCREASED,1
PT,WHITE BLOOD CELL COUNT DECREASED,1
PT,WHITE BLOOD CELL COUNT INCREASED,1
PT,WRIST FRACTURE,1
PR,INJECTION SITE PAIN,258
PR,NASOPHARYNGITIS,229
PR,PAIN,139
PR,ARTHRALGIA,115
PR,HEADACHE,112
PR,DRUG INEFFECTIVE,103
PR,PAIN IN EXTREMITY,82
PR,FATIGUE,73
PR,NAUSEA,60
PR,MALAISE,58
PR,PYREXIA,58
PR,BURNING SENSATION,56
PR,URINARY TRACT INFECTION,53
PR,ASTHMA,50
PR,DIZZINESS,49
PR,INJECTION SITE ERYTHEMA,49
PR,BRONCHITIS,48
PR,INFLAMMATION,46
PR,VOMITING,44
PR,ASTHENIA,43
PR,DIARRHOEA,43
PR,OROPHARYNGEAL PAIN,42
PR,HYPERSENSITIVITY,40
PR,PRURITUS,39
PR,COUGH,36
PR,PHARYNGITIS,35
PR,INJECTION SITE PRURITUS,34
PR,RASH,33
PR,FALL,30
PR,NASAL CONGESTION,30
PR,PSORIASIS,30
PR,HYPERTENSION,29
PR,BLOOD GLUCOSE INCREASED,28
PR,SINUSITIS,28
PR,ARTHRITIS,27
PR,BACK PAIN,27
PR,ABDOMINAL PAIN UPPER,24
PR,CELLULITIS,24
PR,CHEST PAIN,24
PR,DYSPHONIA,23
PR,GAIT DISTURBANCE,23
PR,PERIPHERAL SWELLING,23
PR,DYSPNOEA,22
PR,ERYTHEMA,22
PR,ABDOMINAL PAIN,21
PR,CHIKUNGUNYA VIRUS INFECTION,21
PR,URTICARIA,21
PR,HAEMOGLOBIN DECREASED,20
PR,CATARACT,19
PR,RHEUMATOID ARTHRITIS,19
PR,BONE PAIN,18
PR,INJECTION SITE HAEMATOMA,18
PR,MUSCULOSKELETAL PAIN,18
PR,PNEUMONIA,18
PR,DIABETES MELLITUS,17
PR,PRODUCTIVE COUGH,17
PR,DECREASED APPETITE,16
PR,DISCOMFORT,16
PR,INFECTION,16
PR,INJECTION SITE RASH,16
PR,NECK PAIN,16
PR,WEIGHT DECREASED,16
PR,ANXIETY,15
PR,GASTRITIS,15
PR,INFLUENZA,15
PR,JOINT SWELLING,15
PR,ABDOMINAL DISCOMFORT,14
PR,ALOPECIA,14
PR,ARTHROPATHY,13
PR,HAEMATOMA,13
PR,INJECTION SITE REACTION,13
PR,RASH MACULAR,13
PR,DEPRESSION,12
PR,FEELING ABNORMAL,12
PR,GASTROINTESTINAL INFLAMMATION,12
PR,INJECTION SITE INFLAMMATION,12
PR,INSOMNIA,12
PR,MOBILITY DECREASED,12
PR,MYALGIA,12
PR,BLOOD CHOLESTEROL INCREASED,11
PR,CHILLS,11
PR,CHOLELITHIASIS,11
PR,INCORRECT DOSE ADMINISTERED,11
PR,INJECTION SITE WARMTH,11
PR,PALPITATIONS,11
PR,ABSCESS,10
PR,DRUG DOSE OMISSION,10
PR,INJECTION SITE SWELLING,10
PR,INJECTION SITE URTICARIA,10
PR,OROPHARYNGEAL DISCOMFORT,10
PR,RESPIRATORY TRACT CONGESTION,10
PR,CONSTIPATION,9
PR,DERMATITIS ALLERGIC,9
PR,DIVERTICULITIS,9
PR,DRUG EFFECT INCOMPLETE,9
PR,EAR PAIN,9
PR,FUNGAL INFECTION,9
PR,HEPATIC ENZYME INCREASED,9
PR,HYPERCHOLESTEROLAEMIA,9
PR,HYPOAESTHESIA,9
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
PR,INJECTION SITE INDURATION,9
PR,MIGRAINE,9
PR,MUSCLE SPASMS,9
PR,NEPHROLITHIASIS,9
PR,OSTEOARTHRITIS,9
PR,SWELLING,9
PR,TACHYCARDIA,9
PR,UNEVALUABLE EVENT,9
PR,VAGINAL HAEMORRHAGE,9
PR,VIRAL INFECTION,9
PR,VITAMIN D DEFICIENCY,9
PR,DRUG EFFECT DECREASED,8
PR,DRUG PRESCRIBING ERROR,8
PR,DRY MOUTH,8
PR,EAR INFECTION,8
PR,FEELING HOT,8
PR,FIBROMYALGIA,8
PR,INTERVERTEBRAL DISC PROTRUSION,8
PR,LOCAL SWELLING,8
PR,PRURITUS GENERALISED,8
PR,RECTAL HAEMORRHAGE,8
PR,BACTERIAL INFECTION,7
PR,BLOOD PRESSURE INCREASED,7
PR,CONTUSION,7
PR,DEHYDRATION,7
PR,HYPERHIDROSIS,7
PR,INJECTION SITE HYPERSENSITIVITY,7
PR,MASS,7
PR,MUSCULOSKELETAL STIFFNESS,7
PR,PARAESTHESIA,7
PR,PHLEBITIS,7
PR,RHINORRHOEA,7
PR,TREMOR,7
PR,VISUAL IMPAIRMENT,7
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,7
PR,BALANCE DISORDER,6
PR,CARPAL TUNNEL SYNDROME,6
PR,DEPRESSED MOOD,6
PR,DIVERTICULUM,6
PR,DYSGEUSIA,6
PR,EXOSTOSIS,6
PR,EYE INFLAMMATION,6
PR,EYE SWELLING,6
PR,HAEMATOCHEZIA,6
PR,HAEMORRHOIDS,6
PR,HERPES ZOSTER,6
PR,IMMUNODEFICIENCY,6
PR,INJECTION SITE DISCOMFORT,6
PR,JOINT INJURY,6
PR,LIMB INJURY,6
PR,OSTEOPENIA,6
PR,OVARIAN CYST,6
PR,SOMNOLENCE,6
PR,SPINAL DISORDER,6
PR,SWELLING FACE,6
PR,VISION BLURRED,6
PR,WOUND,6
PR,ABDOMINAL DISTENSION,5
PR,AMNESIA,5
PR,BLINDNESS,5
PR,BREAST MASS,5
PR,CARDIAC DISORDER,5
PR,CARDIAC MURMUR,5
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
PR,CONGESTIVE CARDIOMYOPATHY,5
PR,DYSPHAGIA,5
PR,GASTROOESOPHAGEAL REFLUX DISEASE,5
PR,HEPATIC STEATOSIS,5
PR,KNEE ARTHROPLASTY,5
PR,LIMB DISCOMFORT,5
PR,OSTEOPOROSIS,5
PR,PROCEDURAL PAIN,5
PR,SKIN DISCOLOURATION,5
PR,SUBCUTANEOUS ABSCESS,5
PR,SURGERY,5
PR,TOOTH EXTRACTION,5
PR,UTERINE LEIOMYOMA,5
PR,VAGINAL INFECTION,5
PR,WHITE BLOOD CELL COUNT DECREASED,5
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
PR,ABASIA,4
PR,ANAEMIA,4
PR,BLISTER,4
PR,BLOOD GLUCOSE DECREASED,4
PR,BLOOD URINE PRESENT,4
PR,BREAST CANCER FEMALE,4
PR,CHEST DISCOMFORT,4
PR,CONDITION AGGRAVATED,4
PR,DENGUE FEVER,4
PR,DIABETES MELLITUS INADEQUATE CONTROL,4
PR,DRUG ADMINISTRATION ERROR,4
PR,DRUG HYPERSENSITIVITY,4
PR,DYSPEPSIA,4
PR,DYSURIA,4
PR,EPISTAXIS,4
PR,EYE DISORDER,4
PR,HIATUS HERNIA,4
PR,HYPERTRIGLYCERIDAEMIA,4
PR,HYPOTENSION,4
PR,INJECTION SITE BRUISING,4
PR,INJECTION SITE DISCOLOURATION,4
PR,INJECTION SITE HAEMORRHAGE,4
PR,LARYNGITIS,4
PR,MUSCULAR WEAKNESS,4
PR,MUSCULOSKELETAL DISCOMFORT,4
PR,MYOCARDIAL INFARCTION,4
PR,NEOPLASM MALIGNANT,4
PR,NERVE COMPRESSION,4
PR,NEUROPATHY PERIPHERAL,4
PR,PANCREATITIS,4
PR,PLATELET COUNT DECREASED,4
PR,PULMONARY MASS,4
PR,RASH GENERALISED,4
PR,RENAL FAILURE,4
PR,RESPIRATORY TRACT INFECTION,4
PR,SKIN ULCER,4
PR,SLEEP APNOEA SYNDROME,4
PR,SNEEZING,4
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
PR,TENDON RUPTURE,4
PR,THROAT IRRITATION,4
PR,THYROID CANCER,4
PR,THYROID DISORDER,4
PR,THYROID NEOPLASM,4
PR,TOOTHACHE,4
PR,UTERINE DISORDER,4
PR,WEIGHT INCREASED,4
PR,ABSCESS LIMB,3
PR,ADVERSE DRUG REACTION,3
PR,ALANINE AMINOTRANSFERASE INCREASED,3
PR,ANAL ABSCESS,3
PR,ANGINA PECTORIS,3
PR,BEDRIDDEN,3
PR,BLINDNESS UNILATERAL,3
PR,BLOOD TRIGLYCERIDES INCREASED,3
PR,BREAST CANCER,3
PR,CARDIOMEGALY,3
PR,CEREBRAL INFARCTION,3
PR,COLITIS,3
PR,CONJUNCTIVITIS,3
PR,DERMATITIS,3
PR,DEVICE MALFUNCTION,3
PR,DIPLOPIA,3
PR,DISORIENTATION,3
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,3
PR,DRUG INTOLERANCE,3
PR,DRY EYE,3
PR,EYE INFECTION,3
PR,EYE IRRITATION,3
PR,EYE PAIN,3
PR,EYE PRURITUS,3
PR,FEELING OF DESPAIR,3
PR,FOOT FRACTURE,3
PR,FRACTURE,3
PR,FUNGAL SKIN INFECTION,3
PR,GALLBLADDER OPERATION,3
PR,GASTRIC ULCER,3
PR,GASTROINTESTINAL PAIN,3
PR,GOITRE,3
PR,GRIP STRENGTH DECREASED,3
PR,HAEMATURIA,3
PR,HAEMORRHAGE,3
PR,HEAD INJURY,3
PR,HYPOTHYROIDISM,3
PR,IMPAIRED HEALING,3
PR,INCREASED APPETITE,3
PR,INGROWING NAIL,3
PR,INJECTION SITE CELLULITIS,3
PR,INTERVERTEBRAL DISC DISORDER,3
PR,INTESTINAL OBSTRUCTION,3
PR,IRRITABLE BOWEL SYNDROME,3
PR,JOINT RANGE OF MOTION DECREASED,3
PR,LICHEN PLANUS,3
PR,LOSS OF CONSCIOUSNESS,3
PR,LUNG DISORDER,3
PR,LYMPHOMA,3
PR,MEMORY IMPAIRMENT,3
PR,MENISCUS INJURY,3
PR,MENORRHAGIA,3
PR,MENSTRUAL DISORDER,3
PR,MOOD ALTERED,3
PR,MUSCULOSKELETAL DISORDER,3
PR,OCULAR HYPERAEMIA,3
PR,OEDEMA,3
PR,PANIC ATTACK,3
PR,POLYP,3
PR,POST PROCEDURAL COMPLICATION,3
PR,POSTOPERATIVE WOUND INFECTION,3
PR,PSORIATIC ARTHROPATHY,3
PR,RASH PAPULAR,3
PR,ROAD TRAFFIC ACCIDENT,3
PR,SCIATICA,3
PR,SECRETION DISCHARGE,3
PR,SEPSIS,3
PR,SKIN CANCER,3
PR,SPINAL PAIN,3
PR,STOMATITIS,3
PR,SYNOVIAL CYST,3
PR,THERAPEUTIC RESPONSE UNEXPECTED,3
PR,THERMAL BURN,3
PR,THYROID MASS,3
PR,TINNITUS,3
PR,TOOTH INFECTION,3
PR,URINARY INCONTINENCE,3
PR,URINARY TRACT INFECTION BACTERIAL,3
PR,UTERINE HAEMORRHAGE,3
PR,UTERINE POLYP,3
PR,VERTIGO,3
PR,WHITE BLOOD CELL COUNT INCREASED,3
PR,ABDOMINAL ADHESIONS,2
PR,AMENORRHOEA,2
PR,ANKLE FRACTURE,2
PR,ANKYLOSING SPONDYLITIS,2
PR,AORTIC ARTERIOSCLEROSIS,2
PR,ARTERIAL OCCLUSIVE DISEASE,2
PR,ASPARTATE AMINOTRANSFERASE INCREASED,2
PR,ASPHYXIA,2
PR,BACK INJURY,2
PR,BACTERIAL TEST POSITIVE,2
PR,BLOOD OESTROGEN DECREASED,2
PR,BLOOD POTASSIUM DECREASED,2
PR,BLOOD PRESSURE DECREASED,2
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
PR,BRONCHOSPASM,2
PR,BURSITIS,2
PR,CANDIDA INFECTION,2
PR,CARDIOVASCULAR DISORDER,2
PR,CELLULITIS STAPHYLOCOCCAL,2
PR,CEREBROVASCULAR ACCIDENT,2
PR,CROHN^S DISEASE,2
PR,CUTANEOUS LUPUS ERYTHEMATOSUS,2
PR,CYANOSIS,2
PR,DEATH,2
PR,DEVICE ISSUE,2
PR,DRY SKIN,2
PR,DYSMENORRHOEA,2
PR,EAR DISCOMFORT,2
PR,EYE ALLERGY,2
PR,EYELID PTOSIS,2
PR,FEMUR FRACTURE,2
PR,FIBROMA,2
PR,FLUID RETENTION,2
PR,GALLBLADDER DISORDER,2
PR,GASTRIC DISORDER,2
PR,GASTROINTESTINAL HAEMORRHAGE,2
PR,GINGIVAL DISORDER,2
PR,GINGIVITIS,2
PR,GLUCOSE TOLERANCE IMPAIRED,2
PR,GROIN ABSCESS,2
PR,HEART RATE DECREASED,2
PR,HEPATIC CIRRHOSIS,2
PR,HERNIA,2
PR,HIP ARTHROPLASTY,2
PR,HOSPITALISATION,2
PR,HYPOTHERMIA,2
PR,HYSTERECTOMY,2
PR,IMPETIGO,2
PR,INCOHERENT,2
PR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
PR,INFECTED BITES,2
PR,INFLAMMATORY MARKER INCREASED,2
PR,INJECTION SITE OEDEMA,2
PR,INJECTION SITE PAPULE,2
PR,INTESTINAL POLYP,2
PR,INTRADUCTAL PAPILLOMA OF BREAST,2
PR,JOINT ABSCESS,2
PR,JOINT DISLOCATION,2
PR,JOINT STIFFNESS,2
PR,LACRIMATION INCREASED,2
PR,LEUKOPENIA,2
PR,LIGAMENT RUPTURE,2
PR,LIP SWELLING,2
PR,LIPOMA,2
PR,LOCALISED INFECTION,2
PR,LOOSE TOOTH,2
PR,LOWER LIMB FRACTURE,2
PR,LUNG NEOPLASM,2
PR,LYMPHADENITIS,2
PR,MELANOCYTIC NAEVUS,2
PR,MENSTRUATION IRREGULAR,2
PR,MITRAL VALVE INCOMPETENCE,2
PR,MITRAL VALVE PROLAPSE,2
PR,MULTIPLE SCLEROSIS,2
PR,NEOPLASM,2
PR,NERVOUS SYSTEM DISORDER,2
PR,NERVOUSNESS,2
PR,NODULE,2
PR,ORAL HERPES,2
PR,ORAL INFECTION,2
PR,OROPHARYNGEAL PLAQUE,2
PR,OSTEOMYELITIS,2
PR,OVARIAN NEOPLASM,2
PR,OVERDOSE,2
PR,OXYGEN SATURATION DECREASED,2
PR,PELVIC PAIN,2
PR,PERICARDIAL EFFUSION,2
PR,PLANTAR FASCIITIS,2
PR,PLASMA CELL MYELOMA,2
PR,POLYURIA,2
PR,POST PROCEDURAL CELLULITIS,2
PR,POST PROCEDURAL INFECTION,2
PR,PRURITUS ALLERGIC,2
PR,PTERYGIUM,2
PR,PULMONARY GRANULOMA,2
PR,RED BLOOD CELL SEDIMENTATION RATE DECREASED,2
PR,RENAL CYST,2
PR,RENAL IMPAIRMENT,2
PR,RESPIRATORY DISORDER,2
PR,RESPIRATORY FAILURE,2
PR,RETINOPATHY,2
PR,RHINITIS,2
PR,ROTATOR CUFF SYNDROME,2
PR,SCAB,2
PR,SEIZURE,2
PR,SKIN MASS,2
PR,SPEECH DISORDER,2
PR,SPINAL OPERATION,2
PR,SPINAL OSTEOARTHRITIS,2
PR,STRESS,2
PR,TENDON INJURY,2
PR,THROMBOPHLEBITIS,2
PR,TOOTH FRACTURE,2
PR,TREATMENT FAILURE,2
PR,UMBILICAL HERNIA,2
PR,UTERINE CANCER,2
PR,UTERINE CYST,2
PR,UVEITIS,2
PR,VAGINAL CANCER,2
PR,VARICOSE VEIN,2
PR,VIRAL DIARRHOEA,2
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
PR,VULVOVAGINAL MYCOTIC INFECTION,2
PR,VULVOVAGINAL PRURITUS,2
PR,ABDOMINAL ABSCESS,1
PR,ABDOMINAL HERNIA,1
PR,ABDOMINOPLASTY,1
PR,ABORTION INDUCED,1
PR,ABSCESS BACTERIAL,1
PR,ABSCESS ORAL,1
PR,ACCIDENT,1
PR,ACCIDENT AT WORK,1
PR,ACCIDENTAL OVERDOSE,1
PR,ACNE,1
PR,ACQUIRED CARDIAC SEPTAL DEFECT,1
PR,ACUTE MYELOID LEUKAEMIA,1
PR,ADNEXA UTERI PAIN,1
PR,ADULT T-CELL LYMPHOMA/LEUKAEMIA,1
PR,ADVERSE EVENT,1
PR,ADVERSE REACTION,1
PR,AGGRESSION,1
PR,ALLERGIC SINUSITIS,1
PR,ANAL INFLAMMATION,1
PR,ANURIA,1
PR,APHASIA,1
PR,APHONIA,1
PR,APHTHOUS ULCER,1
PR,APPENDICEAL MUCOCOELE,1
PR,APPENDICITIS,1
PR,APTYALISM,1
PR,ARTERITIS,1
PR,ARTHROPOD BITE,1
PR,ARTHROPOD STING,1
PR,ARTICULAR CALCIFICATION,1
PR,ASPIRATION,1
PR,ATYPICAL PNEUMONIA,1
PR,AUDITORY DISORDER,1
PR,AUTOIMMUNE DISORDER,1
PR,AXILLARY MASS,1
PR,AXILLARY PAIN,1
PR,BACTERIAL TEST,1
PR,BENIGN HEPATIC NEOPLASM,1
PR,BENIGN OVARIAN TUMOUR,1
PR,BLADDER PAIN,1
PR,BLEPHAROSPASM,1
PR,BLOOD ALBUMIN DECREASED,1
PR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PR,BLOOD CHOLESTEROL ABNORMAL,1
PR,BLOOD CREATININE DECREASED,1
PR,BLOOD CREATININE INCREASED,1
PR,BLOOD DISORDER,1
PR,BLOOD ELECTROLYTES DECREASED,1
PR,BLOOD GLUCOSE ABNORMAL,1
PR,BLOOD GLUCOSE FLUCTUATION,1
PR,BLOOD KETONE BODY PRESENT,1
PR,BLOOD POTASSIUM INCREASED,1
PR,BLOOD TRIGLYCERIDES ABNORMAL,1
PR,BONE EROSION,1
PR,BONE SWELLING,1
PR,BRADYCARDIA,1
PR,BRAIN NEOPLASM,1
PR,BRAIN NEOPLASM MALIGNANT,1
PR,BREAST ABSCESS,1
PR,BREAST DISORDER,1
PR,BREAST DISORDER FEMALE,1
PR,BREAST NEOPLASM,1
PR,BRONCHITIS CHRONIC,1
PR,C-REACTIVE PROTEIN INCREASED,1
PR,CALCINOSIS,1
PR,CALCULUS URETHRAL,1
PR,CALCULUS URINARY,1
PR,CARDIAC ANEURYSM,1
PR,CARDIAC FAILURE,1
PR,CARDIAC FAILURE CONGESTIVE,1
PR,CARDIAC PACEMAKER REPLACEMENT,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CAROTID ARTERY OCCLUSION,1
PR,CARTILAGE INJURY,1
PR,CELLULITIS ORBITAL,1
PR,CENTRAL NERVOUS SYSTEM LESION,1
PR,CEREBRAL DISORDER,1
PR,CEREBRAL THROMBOSIS,1
PR,CERUMEN IMPACTION,1
PR,CERVICAL POLYP,1
PR,CHEILITIS,1
PR,CHEST X-RAY ABNORMAL,1
PR,CHOKING,1
PR,CHOLECYSTITIS,1
PR,CHOLECYSTITIS ACUTE,1
PR,CHOLECYSTITIS INFECTIVE,1
PR,CHRONIC GASTRITIS,1
PR,CHRONIC SINUSITIS,1
PR,COLITIS ULCERATIVE,1
PR,COLORECTAL CANCER,1
PR,CONVULSION,1
PR,COORDINATION ABNORMAL,1
PR,CORNEAL DISORDER,1
PR,CORONARY VEIN STENOSIS,1
PR,COSTOCHONDRITIS,1
PR,CYST,1
PR,CYSTITIS,1
PR,CYSTITIS HAEMORRHAGIC,1
PR,DEAFNESS BILATERAL,1
PR,DECREASED IMMUNE RESPONSIVENESS,1
PR,DEMENTIA ALZHEIMER^S TYPE,1
PR,DERMAL CYST,1
PR,DERMOID CYST,1
PR,DEVICE MATERIAL ISSUE,1
PR,DIABETIC NEUROPATHY,1
PR,DIABETIC RETINOPATHY,1
PR,DIAPHRAGMALGIA,1
PR,DIARRHOEA HAEMORRHAGIC,1
PR,DISLOCATION OF VERTEBRA,1
PR,DIVERTICULAR PERFORATION,1
PR,DRUG DISPENSING ERROR,1
PR,DRUG RESISTANCE,1
PR,DRUG THERAPY,1
PR,DRY THROAT,1
PR,DUPUYTREN^S CONTRACTURE,1
PR,DYSARTHRIA,1
PR,DYSSTASIA,1
PR,EAR CANAL STENOSIS,1
PR,EAR DISORDER,1
PR,ECHOCARDIOGRAM ABNORMAL,1
PR,EJECTION FRACTION DECREASED,1
PR,ELBOW DEFORMITY,1
PR,EMBOLISM,1
PR,EMOTIONAL DISORDER,1
PR,ENCEPHALITIS,1
PR,ENDOMETRIAL CANCER,1
PR,ENDOMETRIAL THICKENING,1
PR,ENDOMETRIOSIS,1
PR,EPILEPSY,1
PR,EXPOSURE DURING PREGNANCY,1
PR,EYE ABSCESS,1
PR,EYE DISCHARGE,1
PR,EYE HAEMORRHAGE,1
PR,EYE OPERATION,1
PR,EYE ULCER,1
PR,EYELID OEDEMA,1
PR,FACIAL PAIN,1
PR,FACIAL PARESIS,1
PR,FAECAL INCONTINENCE,1
PR,FAECES SOFT,1
PR,FEAR,1
PR,FEAR OF INJECTION,1
PR,FEEDING DISORDER,1
PR,FINGER DEFORMITY,1
PR,FISTULA,1
PR,FLANK PAIN,1
PR,FLAVIVIRUS INFECTION,1
PR,FOLATE DEFICIENCY,1
PR,FOOD AVERSION,1
PR,FOOT DEFORMITY,1
PR,FOOT OPERATION,1
PR,FRACTURE DELAYED UNION,1
PR,FURUNCLE,1
PR,GALLBLADDER NON-FUNCTIONING,1
PR,GALLBLADDER OEDEMA,1
PR,GANGRENE,1
PR,GASTRITIS EROSIVE,1
PR,GASTROINTESTINAL BACTERIAL INFECTION,1
PR,GASTROINTESTINAL COMPLICATION ASSOCIATED WITH DEVICE,1
PR,GASTROINTESTINAL DISORDER,1
PR,GASTROINTESTINAL FUNGAL INFECTION,1
PR,GASTROINTESTINAL INFECTION,1
PR,GASTROINTESTINAL TRACT IRRITATION,1
PR,GASTROINTESTINAL WALL THINNING,1
PR,GENERALISED OEDEMA,1
PR,GENITAL ABSCESS,1
PR,GENITAL INFECTION FUNGAL,1
PR,GINGIVAL ABSCESS,1
PR,GINGIVAL PAIN,1
PR,GRANULOMA,1
PR,GRANULOMATOSIS WITH POLYANGIITIS,1
PR,HAEMATOCRIT,1
PR,HAEMOGLOBIN,1
PR,HAEMOPTYSIS,1
PR,HAEMORRHAGIC OVARIAN CYST,1
PR,HAEMORRHAGIC STROKE,1
PR,HAIR TEXTURE ABNORMAL,1
PR,HALLUCINATION,1
PR,HAND DEFORMITY,1
PR,HAND FRACTURE,1
PR,HEAD DISCOMFORT,1
PR,HEARING IMPAIRED,1
PR,HEART RATE INCREASED,1
PR,HELICOBACTER INFECTION,1
PR,HEPATIC CANCER,1
PR,HEPATIC FAILURE,1
PR,HEPATIC PAIN,1
PR,HEPATIC RUPTURE,1
PR,HEPATITIS C,1
PR,HEPATOMEGALY,1
PR,HEPATOSPLENOMEGALY,1
PR,HORMONE LEVEL ABNORMAL,1
PR,HYPERAESTHESIA,1
PR,HYPERAMMONAEMIA,1
PR,HYPERCHLORHYDRIA,1
PR,HYPERKERATOSIS,1
PR,HYPERTHYROIDISM,1
PR,HYPOKALAEMIA,1
PR,HYPOPHAGIA,1
PR,HYPOSMIA,1
PR,IMMUNE SYSTEM DISORDER,1
PR,INCISIONAL HERNIA,1
PR,INCORRECT PRODUCT STORAGE,1
PR,INFECTED SKIN ULCER,1
PR,INJECTION SITE ABSCESS,1
PR,INJECTION SITE HYPOAESTHESIA,1
PR,INJECTION SITE INJURY,1
PR,INJECTION SITE IRRITATION,1
PR,INJECTION SITE MASS,1
PR,INJECTION SITE PARAESTHESIA,1
PR,INJECTION SITE PUSTULE,1
PR,INJECTION SITE SCAB,1
PR,INJECTION SITE ULCER,1
PR,INJECTION SITE VESICLES,1
PR,INTERNAL HAEMORRHAGE,1
PR,INTERVERTEBRAL DISC DISPLACEMENT,1
PR,INTERVERTEBRAL DISC OPERATION,1
PR,INTESTINAL HAEMORRHAGE,1
PR,INTESTINAL INFARCTION,1
PR,INTESTINAL MASS,1
PR,INTESTINAL PERFORATION,1
PR,INTESTINAL ULCER,1
PR,INTRA-ABDOMINAL HAEMATOMA,1
PR,ISCHAEMIC STROKE,1
PR,JAW FRACTURE,1
PR,JOINT EFFUSION,1
PR,KERATITIS,1
PR,KIDNEY INFECTION,1
PR,LABORATORY TEST ABNORMAL,1
PR,LACERATION,1
PR,LACRIMATION DECREASED,1
PR,LAPAROSCOPY,1
PR,LARGE INTESTINE PERFORATION,1
PR,LARYNGITIS ALLERGIC,1
PR,LE CELLS PRESENT,1
PR,LEFT VENTRICULAR DILATATION,1
PR,LIGAMENT INJURY,1
PR,LIGAMENT SPRAIN,1
PR,LIMB DEFORMITY,1
PR,LIVE BIRTH,1
PR,LIVER DISORDER,1
PR,LOWER RESPIRATORY TRACT INFECTION,1
PR,LUMBAR SPINAL STENOSIS,1
PR,LUNG INFECTION,1
PR,LUNG NEOPLASM MALIGNANT,1
PR,LYMPHOCYTE COUNT INCREASED,1
PR,MACULAR HOLE,1
PR,MAJOR DEPRESSION,1
PR,MEDIASTINAL MASS,1
PR,MEDICAL DEVICE SITE PAIN,1
PR,MEDICATION ERROR,1
PR,MENOPAUSE,1
PR,MENSTRUATION NORMAL,1
PR,MENTAL DISORDER,1
PR,MESENTERIC NEOPLASM,1
PR,METABOLIC ENCEPHALOPATHY,1
PR,MIDDLE EAR EFFUSION,1
PR,MITE ALLERGY,1
PR,MONOPLEGIA,1
PR,MOUTH HAEMORRHAGE,1
PR,MOUTH SWELLING,1
PR,MUCOSAL DISCOLOURATION,1
PR,MUCOUS MEMBRANE DISORDER,1
PR,MUSCLE STRAIN,1
PR,MYASTHENIA GRAVIS,1
PR,MYOCARDIAL NECROSIS MARKER INCREASED,1
PR,MYOSITIS,1
PR,NAIL DISCOLOURATION,1
PR,NAIL DISORDER,1
PR,NASAL HERPES,1
PR,NASAL PRURITUS,1
PR,NECK MASS,1
PR,NEPHRITIS,1
PR,NEURALGIA,1
PR,NEUROMYELITIS OPTICA,1
PR,NONINFECTIVE OOPHORITIS,1
PR,OBSTRUCTIVE AIRWAYS DISORDER,1
PR,OCCULT BLOOD POSITIVE,1
PR,OEDEMA PERIPHERAL,1
PR,ONYCHOCLASIS,1
PR,ONYCHOMADESIS,1
PR,ONYCHOMYCOSIS,1
PR,OPHTHALMOPLEGIA,1
PR,OPTIC NERVE DISORDER,1
PR,ORAL DISORDER,1
PR,ORAL FUNGAL INFECTION,1
PR,OROPHARYNGITIS FUNGAL,1
PR,OSTEITIS,1
PR,OSTEONECROSIS,1
PR,OTORRHOEA,1
PR,OVARIAN CANCER,1
PR,OVARIAN DISORDER,1
PR,PALLOR,1
PR,PANCREATIC DISORDER,1
PR,PARANASAL SINUS DISCOMFORT,1
PR,PAROSMIA,1
PR,PATELLA FRACTURE,1
PR,PATHOGEN RESISTANCE,1
PR,PERIPHERAL VASCULAR DISORDER,1
PR,PERIPHERAL VENOUS DISEASE,1
PR,PERIPROSTHETIC FRACTURE,1
PR,PERONEAL NERVE PALSY,1
PR,PHARYNGEAL INFLAMMATION,1
PR,PIGMENTATION DISORDER,1
PR,PLATELET COUNT INCREASED,1
PR,PLEURAL EFFUSION,1
PR,PNEUMONITIS,1
PR,PNEUMOTHORAX,1
PR,POLYDIPSIA,1
PR,POST PROCEDURAL HAEMORRHAGE,1
PR,POST PROCEDURAL HYPOTHYROIDISM,1
PR,POST PROCEDURAL STROKE,1
PR,PRE-EXISTING CONDITION IMPROVED,1
PR,PREMATURE DELIVERY,1
PR,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
PR,PRODUCT QUALITY ISSUE,1
PR,PRODUCT USE ISSUE,1
PR,PROSTATIC DISORDER,1
PR,PROSTATOMEGALY,1
PR,PROTEIN URINE PRESENT,1
PR,PULMONARY CONGESTION,1
PR,PULMONARY FUNCTION TEST DECREASED,1
PR,PULMONARY HILUM MASS,1
PR,PULMONARY OEDEMA,1
PR,PULMONARY PAIN,1
PR,PULMONARY TUBERCULOSIS,1
PR,PURULENCE,1
PR,PUSTULAR PSORIASIS,1
PR,QUALITY OF LIFE DECREASED,1
PR,RADICULOPATHY,1
PR,RADIUS FRACTURE,1
PR,RALES,1
PR,RASH PUSTULAR,1
PR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PR,RED CELL DISTRIBUTION WIDTH,1
PR,RENAL DISORDER,1
PR,RENAL PAIN,1
PR,RESPIRATORY DISTRESS,1
PR,RESPIRATORY RATE DECREASED,1
PR,RETINAL DETACHMENT,1
PR,RETINAL INFARCTION,1
PR,RETROPERITONEAL NEOPLASM,1
PR,RHONCHI,1
PR,RIB FRACTURE,1
PR,SACROILIITIS,1
PR,SARCOIDOSIS,1
PR,SENSORY LOSS,1
PR,SERONEGATIVE ARTHRITIS,1
PR,SHOCK,1
PR,SHOULDER OPERATION,1
PR,SINUS DISORDER,1
PR,SJOGREN^S SYNDROME,1
PR,SKELETAL INJURY,1
PR,SKIN BURNING SENSATION,1
PR,SKIN EXFOLIATION,1
PR,SKIN FISSURES,1
PR,SKIN HYPERPIGMENTATION,1
PR,SKIN HYPERPLASIA,1
PR,SKIN INFECTION,1
PR,SKIN IRRITATION,1
PR,SKIN PLAQUE,1
PR,SKIN WARM,1
PR,SLEEP DISORDER,1
PR,SPINAL COLUMN INJURY,1
PR,SPUTUM DISCOLOURED,1
PR,STAPHYLOCOCCAL ABSCESS,1
PR,STOMA SITE HAEMORRHAGE,1
PR,SUICIDAL IDEATION,1
PR,SWOLLEN TONGUE,1
PR,SYNCOPE,1
PR,TENDONITIS,1
PR,TERMINAL DRIBBLING,1
PR,THERAPEUTIC RESPONSE SHORTENED,1
PR,THROMBOCYTOPENIA,1
PR,THROMBOSIS,1
PR,TIBIA FRACTURE,1
PR,TINEA INFECTION,1
PR,TINEA PEDIS,1
PR,TONGUE DISORDER,1
PR,TOOTH IMPACTED,1
PR,TOXIC SHOCK SYNDROME,1
PR,TRACHEAL INFLAMMATION,1
PR,TRACHEAL STENOSIS,1
PR,TRAUMATIC HAEMATOMA,1
PR,TREATMENT NONCOMPLIANCE,1
PR,TRISMUS,1
PR,TUBERCULOSIS,1
PR,TYMPANIC MEMBRANE PERFORATION,1
PR,UPPER LIMB FRACTURE,1
PR,URINARY RETENTION,1
PR,URINARY TRACT DISORDER,1
PR,URINE ABNORMALITY,1
PR,URINE ODOUR ABNORMAL,1
PR,UTERINE ADHESIONS,1
PR,UTERINE ENLARGEMENT,1
PR,UTERINE HAEMATOMA,1
PR,UTERINE INFLAMMATION,1
PR,UTERINE PAIN,1
PR,VAGINAL CYST,1
PR,VAGINAL DISCHARGE,1
PR,VAGINAL DISORDER,1
PR,VENOUS OCCLUSION,1
PR,VERTEBRAL COLUMN MASS,1
PR,VESTIBULAR NEURONITIS,1
PR,VISUAL ACUITY REDUCED,1
PR,VITAMIN D DECREASED,1
PR,VOCAL CORD DISORDER,1
PR,VULVOVAGINAL PAIN,1
PR,WHITE BLOOD CELL COUNT ABNORMAL,1
PR,WRIST FRACTURE,1
QA,FEBRILE NEUTROPENIA,2
QA,SEPSIS,2
QA,GENERALISED TONIC-CLONIC SEIZURE,1
QA,TUMOUR LYSIS SYNDROME,1
RO,DRUG INEFFECTIVE,15
RO,ACUTE MYOCARDIAL INFARCTION,7
RO,ARTHRALGIA,6
RO,CONDITION AGGRAVATED,6
RO,PSORIASIS,6
RO,TUBERCULOSIS,6
RO,INJECTION SITE ERYTHEMA,5
RO,OSTEOPOROSIS,5
RO,PAIN IN EXTREMITY,5
RO,RHEUMATOID ARTHRITIS,5
RO,TREATMENT NONCOMPLIANCE,5
RO,VASCULAR STENT THROMBOSIS,5
RO,ANGINA PECTORIS,4
RO,CORONARY ARTERY DISEASE,4
RO,DIZZINESS,4
RO,DRUG INTOLERANCE,4
RO,HUMERUS FRACTURE,4
RO,INTENTIONAL DOSE OMISSION,4
RO,PNEUMONIA,4
RO,PRURITUS,4
RO,PULMONARY FIBROSIS,4
RO,RENAL FAILURE,4
RO,SEPSIS,4
RO,ABDOMINAL DISTENSION,3
RO,ANAEMIA,3
RO,ASTHENIA,3
RO,BONE MARROW FAILURE,3
RO,CEREBROVASCULAR ACCIDENT,3
RO,DEPRESSION,3
RO,DERMATITIS,3
RO,HERPES ZOSTER,3
RO,HYPERHIDROSIS,3
RO,INFECTION,3
RO,INTENTIONAL PRODUCT MISUSE,3
RO,LATENT TUBERCULOSIS,3
RO,LICHEN PLANUS,3
RO,MUSCLE FATIGUE,3
RO,NAUSEA,3
RO,PULMONARY EMBOLISM,3
RO,PULMONARY TUBERCULOSIS,3
RO,RASH,3
RO,SKIN EXFOLIATION,3
RO,SKIN TOXICITY,3
RO,THROMBOCYTOPENIA,3
RO,TRANSAMINASES INCREASED,3
RO,VISUAL IMPAIRMENT,3
RO,ABDOMINAL PAIN,2
RO,ABORTION INDUCED,2
RO,ACUTE MYELOID LEUKAEMIA,2
RO,ACUTE RESPIRATORY FAILURE,2
RO,AGITATION,2
RO,ALANINE AMINOTRANSFERASE INCREASED,2
RO,ANAPHYLACTIC SHOCK,2
RO,ANGIOEDEMA,2
RO,BACK PAIN,2
RO,CATARACT,2
RO,CELLULITIS,2
RO,COMA,2
RO,DERMATITIS ALLERGIC,2
RO,DYSPEPSIA,2
RO,DYSPNOEA,2
RO,EMOTIONAL DISTRESS,2
RO,ERYTHEMA,2
RO,HEPATIC ENZYME INCREASED,2
RO,HEPATOCELLULAR INJURY,2
RO,HEPATOMEGALY,2
RO,HYPERTROPHIC CARDIOMYOPATHY,2
RO,INCORRECT DRUG ADMINISTRATION RATE,2
RO,INFUSION RELATED REACTION,2
RO,INJECTION SITE INDURATION,2
RO,INSOMNIA,2
RO,INTRACRANIAL PRESSURE INCREASED,2
RO,IRON DEFICIENCY ANAEMIA,2
RO,LEUKOPENIA,2
RO,LUPUS-LIKE SYNDROME,2
RO,METAL POISONING,2
RO,METASTASES TO LIVER,2
RO,MOBILITY DECREASED,2
RO,MUCOSAL INFLAMMATION,2
RO,MUSCLE INJURY,2
RO,MYALGIA,2
RO,NASOPHARYNGITIS,2
RO,NEUTROPENIA,2
RO,OSTEOARTHRITIS,2
RO,PAIN,2
RO,RASH PAPULAR,2
RO,RASH PUSTULAR,2
RO,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
RO,RESPIRATORY TRACT INFECTION,2
RO,SKIN ULCER,2
RO,STAPHYLOCOCCAL INFECTION,2
RO,TYPE 2 DIABETES MELLITUS,2
RO,UPPER GASTROINTESTINAL HAEMORRHAGE,2
RO,URINARY TRACT INFECTION,2
RO,VOCAL CORD PARALYSIS,2
RO,WOUND,2
RO,ABDOMINAL PAIN UPPER,1
RO,ACCIDENT AT HOME,1
RO,ACINETOBACTER INFECTION,1
RO,ADENOCARCINOMA GASTRIC,1
RO,AGRANULOCYTOSIS,1
RO,ALVEOLITIS,1
RO,ANXIETY,1
RO,AORTIC ARTERIOSCLEROSIS,1
RO,APLASIA,1
RO,ARTHROPATHY,1
RO,ARTHROPOD BITE,1
RO,ASCITES,1
RO,ASPARTATE AMINOTRANSFERASE INCREASED,1
RO,ATAXIA,1
RO,ATRIAL FIBRILLATION,1
RO,AUTOIMMUNE HEPATITIS,1
RO,BLISTER,1
RO,BLOOD IMMUNOGLOBULIN G INCREASED,1
RO,BONE MARROW TOXICITY,1
RO,BONE NEOPLASM,1
RO,BORRELIA TEST POSITIVE,1
RO,BREAST CANCER,1
RO,BREAST CANCER METASTATIC,1
RO,BREAST CANCER RECURRENT,1
RO,BREAST NEOPLASM,1
RO,CANDIDA INFECTION,1
RO,CARDIAC FAILURE,1
RO,CARDIAC MURMUR,1
RO,CARDIO-RESPIRATORY ARREST,1
RO,CARDIOVASCULAR DISORDER,1
RO,CELL-MEDIATED CYTOTOXICITY,1
RO,CERVIX CARCINOMA,1
RO,CHILLS,1
RO,CHOLECYSTITIS,1
RO,CHOLESTASIS,1
RO,CHORIORETINOPATHY,1
RO,COAGULATION TEST ABNORMAL,1
RO,COMPARTMENT SYNDROME,1
RO,COMPLETED SUICIDE,1
RO,COMPLEX PARTIAL SEIZURES,1
RO,COUGH,1
RO,CYTOMEGALOVIRUS INFECTION,1
RO,DEATH,1
RO,DEEP VEIN THROMBOSIS,1
RO,DELUSION,1
RO,DERMATITIS EXFOLIATIVE,1
RO,DISEASE PROGRESSION,1
RO,DRUG DOSE OMISSION,1
RO,DRUG RESISTANCE,1
RO,DYSLIPIDAEMIA,1
RO,DYSPHAGIA,1
RO,ECCHYMOSIS,1
RO,EMPHYSEMA,1
RO,ENTEROBACTER PNEUMONIA,1
RO,EPILEPSY,1
RO,ERYTHEMA MULTIFORME,1
RO,ERYTHEMA NODOSUM,1
RO,EUPHORIC MOOD,1
RO,FALL,1
RO,FEBRILE NEUTROPENIA,1
RO,FINGER DEFORMITY,1
RO,FLUSHING,1
RO,FOOT DEFORMITY,1
RO,FREQUENT BOWEL MOVEMENTS,1
RO,GALLBLADDER OPERATION,1
RO,GASTRIC CANCER,1
RO,GASTRIC ULCER,1
RO,GASTRITIS,1
RO,GASTROINTESTINAL CARCINOMA,1
RO,GASTROINTESTINAL DISORDER,1
RO,GASTROINTESTINAL HAEMORRHAGE,1
RO,GASTROOESOPHAGEAL REFLUX DISEASE,1
RO,GENERAL PHYSICAL HEALTH DETERIORATION,1
RO,GENERALISED ERYTHEMA,1
RO,GLUCOSE TOLERANCE IMPAIRED,1
RO,GRAFT VERSUS HOST DISEASE IN SKIN,1
RO,GRAND MAL CONVULSION,1
RO,HAEMATURIA,1
RO,HAEMOGLOBIN DECREASED,1
RO,HAEMOLYTIC ANAEMIA,1
RO,HAEMORRHAGE,1
RO,HEADACHE,1
RO,HEPATIC CYST,1
RO,HEPATITIS,1
RO,HIATUS HERNIA,1
RO,HYPERGAMMAGLOBULINAEMIA,1
RO,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
RO,HYPERSENSITIVITY,1
RO,HYPERTENSION,1
RO,HYPERURICAEMIA,1
RO,HYPOALBUMINAEMIA,1
RO,HYPOGLYCAEMIA,1
RO,HYPOGLYCAEMIC COMA,1
RO,HYPOTENSION,1
RO,IMMUNODEFICIENCY,1
RO,IMMUNOGLOBULINS INCREASED,1
RO,IMMUNOSUPPRESSION,1
RO,INCORRECT DOSE ADMINISTERED,1
RO,INFLAMMATION,1
RO,INJECTION SITE PAIN,1
RO,INTENTIONAL PRODUCT USE ISSUE,1
RO,INTERVERTEBRAL DISCITIS,1
RO,INTESTINAL OBSTRUCTION,1
RO,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
RO,INVASIVE BREAST CARCINOMA,1
RO,JOINT CREPITATION,1
RO,JOINT SWELLING,1
RO,KERATOACANTHOMA,1
RO,KNEE ARTHROPLASTY,1
RO,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,1
RO,LIPASE INCREASED,1
RO,LOWER RESPIRATORY TRACT INFECTION,1
RO,LUNG ADENOCARCINOMA,1
RO,LUNG NEOPLASM,1
RO,LUNG SQUAMOUS CELL CARCINOMA METASTATIC,1
RO,LYMPHADENOPATHY,1
RO,LYMPHOPENIA,1
RO,LYMPHOPROLIFERATIVE DISORDER,1
RO,MALAISE,1
RO,MARROW HYPERPLASIA,1
RO,MENINGIOMA,1
RO,MENISCUS INJURY,1
RO,METASTASES TO BONE,1
RO,METASTASES TO SOFT TISSUE,1
RO,METASTASES TO SPINE,1
RO,MONOCLONAL GAMMOPATHY,1
RO,MUCOSAL HAEMORRHAGE,1
RO,MULTI-ORGAN FAILURE,1
RO,MUMPS,1
RO,MUSCLE SPASTICITY,1
RO,MUSCULAR WEAKNESS,1
RO,MUSCULOSKELETAL STIFFNESS,1
RO,MYASTHENIC SYNDROME,1
RO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
RO,MYOCARDIAL INFARCTION,1
RO,NASOPHARYNGEAL CANCER,1
RO,NEOPLASM OF APPENDIX,1
RO,NEPHROLITHIASIS,1
RO,NEPHROTIC SYNDROME,1
RO,NEUROTOXICITY,1
RO,OBESITY,1
RO,OEDEMA PERIPHERAL,1
RO,OPEN FRACTURE,1
RO,OSTEONECROSIS,1
RO,OSTEOPENIA,1
RO,OSTEOPOROTIC FRACTURE,1
RO,OVARIAN CYST,1
RO,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
RO,PALPITATIONS,1
RO,PANCREATITIS,1
RO,PANCYTOPENIA,1
RO,PARAPARESIS,1
RO,PERIPHERAL SWELLING,1
RO,PERITONEAL TUBERCULOSIS,1
RO,PERITONITIS,1
RO,PHARYNGOTONSILLITIS,1
RO,POLYNEUROPATHY,1
RO,PREGNANCY,1
RO,PROCEDURAL HAEMORRHAGE,1
RO,PROCEDURAL PAIN,1
RO,PRODUCT USE IN UNAPPROVED INDICATION,1
RO,PRODUCT USE ISSUE,1
RO,PROTEINURIA,1
RO,PSEUDOMONAS INFECTION,1
RO,PSORIATIC ARTHROPATHY,1
RO,PULMONARY HYPERTENSION,1
RO,PULMONARY MASS,1
RO,PYREXIA,1
RO,RASH ERYTHEMATOUS,1
RO,RECTAL HAEMORRHAGE,1
RO,RENAL COLIC,1
RO,RENAL NEOPLASM,1
RO,RESPIRATORY ARREST,1
RO,RIB FRACTURE,1
RO,SALPINGO-OOPHORITIS,1
RO,SECRETION DISCHARGE,1
RO,SELF-MEDICATION,1
RO,SENSITIVITY TO WEATHER CHANGE,1
RO,SEPTIC ARTHRITIS STREPTOCOCCAL,1
RO,SJOGREN^S SYNDROME,1
RO,SKIN DISCOLOURATION,1
RO,SKIN DISORDER,1
RO,SKIN EROSION,1
RO,SKIN LESION,1
RO,SKIN PLAQUE,1
RO,STAPHYLOCOCCAL SEPSIS,1
RO,STAPHYLOCOCCAL SKIN INFECTION,1
RO,STOMATITIS,1
RO,STOMATITIS HAEMORRHAGIC,1
RO,STUPOR,1
RO,SUBARACHNOID HAEMORRHAGE,1
RO,SUDDEN DEATH,1
RO,SUPERINFECTION,1
RO,SWELLING FACE,1
RO,SYNOVIAL CYST,1
RO,SYNOVITIS,1
RO,SYSTEMIC LUPUS ERYTHEMATOSUS,1
RO,THERAPEUTIC RESPONSE DECREASED,1
RO,THERAPY NON-RESPONDER,1
RO,THROMBOPHLEBITIS SUPERFICIAL,1
RO,TIBIA FRACTURE,1
RO,TUBERCULIN TEST POSITIVE,1
RO,TUBERCULOUS PLEURISY,1
RO,TYPE 1 DIABETES MELLITUS,1
RO,URTICARIA,1
RO,UVEITIS,1
RO,VARICES OESOPHAGEAL,1
RO,VASOGENIC CEREBRAL OEDEMA,1
RO,VERTEBRAL ARTERY OCCLUSION,1
RO,VERTIGO,1
RO,VOMITING,1
RU,SEPSIS,24
RU,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,23
RU,DRUG INEFFECTIVE,13
RU,STAPHYLOCOCCAL INFECTION,11
RU,MUCOSAL INFLAMMATION,10
RU,NAUSEA,10
RU,VOMITING,9
RU,ALANINE AMINOTRANSFERASE INCREASED,8
RU,ASPARTATE AMINOTRANSFERASE INCREASED,8
RU,NEUTROPENIA,8
RU,PNEUMONIA,8
RU,TRANSPLANT REJECTION,8
RU,CYTOPENIA,7
RU,LEUKOPENIA,7
RU,PANCYTOPENIA,7
RU,SEPTIC SHOCK,7
RU,BRONCHOPULMONARY ASPERGILLOSIS,6
RU,CONDITION AGGRAVATED,6
RU,PULMONARY TUBERCULOSIS,6
RU,ANAEMIA,5
RU,BACTERIAL INFECTION,5
RU,CUSHING^S SYNDROME,5
RU,DRUG RESISTANCE,5
RU,ERYTHEMA,5
RU,INFUSION RELATED REACTION,5
RU,ARTHRALGIA,4
RU,ASTHENIA,4
RU,BLOOD PRESSURE DECREASED,4
RU,BODY TEMPERATURE INCREASED,4
RU,DUODENAL ULCER,4
RU,GASTROENTERITIS,4
RU,HEADACHE,4
RU,HEPATIC ENZYME INCREASED,4
RU,PRODUCT USE IN UNAPPROVED INDICATION,4
RU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
RU,THROMBOCYTOPENIA,4
RU,VARICELLA,4
RU,ACUTE KIDNEY INJURY,3
RU,BLOOD PRESSURE INCREASED,3
RU,CARDIOPULMONARY FAILURE,3
RU,CHEST PAIN,3
RU,COLON CANCER,3
RU,DERMATITIS ALLERGIC,3
RU,ESCHERICHIA INFECTION,3
RU,HERPES VIRUS INFECTION,3
RU,HERPES ZOSTER,3
RU,HISTIOCYTOSIS HAEMATOPHAGIC,3
RU,INJECTION SITE ERYTHEMA,3
RU,JUVENILE IDIOPATHIC ARTHRITIS,3
RU,LEUKOCYTOSIS,3
RU,MELAENA,3
RU,MOUTH HAEMORRHAGE,3
RU,OSTEONECROSIS,3
RU,PANCREATITIS CHRONIC,3
RU,PRODUCT USE ISSUE,3
RU,PYREXIA,3
RU,RECTAL HAEMORRHAGE,3
RU,RESPIRATORY TRACT INFECTION VIRAL,3
RU,RHEUMATOID ARTHRITIS,3
RU,TRANSAMINASES INCREASED,3
RU,URTICARIA,3
RU,UVEITIS,3
RU,ABDOMINAL PAIN,2
RU,ACUTE GRAFT VERSUS HOST DISEASE,2
RU,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
RU,ACUTE RESPIRATORY FAILURE,2
RU,AGRANULOCYTOSIS,2
RU,ANAPHYLACTIC REACTION,2
RU,ANGIOEDEMA,2
RU,ARTHRITIS,2
RU,BODY HEIGHT BELOW NORMAL,2
RU,BONE PAIN,2
RU,BRONCHOSPASM,2
RU,CELLULITIS,2
RU,CYTOMEGALOVIRUS INFECTION,2
RU,DIARRHOEA,2
RU,DISSEMINATED TUBERCULOSIS,2
RU,DYSPNOEA,2
RU,EPSTEIN-BARR VIRUS INFECTION,2
RU,FEBRILE NEUTROPENIA,2
RU,FUNGAL INFECTION,2
RU,GENITAL HAEMORRHAGE,2
RU,GRAFT VERSUS HOST DISEASE IN SKIN,2
RU,HAEMATOTOXICITY,2
RU,HYPERBILIRUBINAEMIA,2
RU,HYPERTENSION,2
RU,HYPOTENSION,2
RU,INFECTION,2
RU,INJECTION SITE PAIN,2
RU,INTERSTITIAL LUNG DISEASE,2
RU,JAUNDICE,2
RU,LUNG INFECTION,2
RU,LYMPHADENITIS,2
RU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
RU,MULTIPLE-DRUG RESISTANCE,2
RU,NASOPHARYNGITIS,2
RU,NEPHRITIS,2
RU,PYODERMA STREPTOCOCCAL,2
RU,RENAL FAILURE,2
RU,RENAL FAILURE ACUTE,2
RU,RESPIRATORY FAILURE,2
RU,RESPIRATORY TRACT INFECTION,2
RU,STOMATITIS,2
RU,TACHYCARDIA,2
RU,TUBERCULOSIS,2
RU,TUMOUR LYSIS SYNDROME,2
RU,UPPER RESPIRATORY TRACT INFECTION,2
RU,URINARY RETENTION,2
RU,VIRAL INFECTION,2
RU,ABORTION SPONTANEOUS,1
RU,ABSCESS,1
RU,ABSCESS LIMB,1
RU,ACUTE LEUKAEMIA,1
RU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
RU,ACUTE MYOCARDIAL INFARCTION,1
RU,ADENOIDITIS,1
RU,ADRENAL INSUFFICIENCY,1
RU,ADVERSE EVENT,1
RU,ANAPHYLACTOID REACTION,1
RU,ANGINA UNSTABLE,1
RU,ANGIOPATHY,1
RU,ANKYLOSING SPONDYLITIS,1
RU,ANXIETY,1
RU,AORTIC VALVE INCOMPETENCE,1
RU,APLASTIC ANAEMIA,1
RU,ARTHRITIS BACTERIAL,1
RU,ASPHYXIA,1
RU,ATRIAL FIBRILLATION,1
RU,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
RU,AZOTAEMIA,1
RU,BILIARY DYSKINESIA,1
RU,BILIARY TRACT INFECTION,1
RU,BLADDER CANCER,1
RU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
RU,BLOOD CREATININE DECREASED,1
RU,BLOOD CREATININE INCREASED,1
RU,BLOOD GLUCOSE INCREASED,1
RU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
RU,BONE MARROW TOXICITY,1
RU,BONE MARROW TRANSPLANT REJECTION,1
RU,BONE OPERATION,1
RU,BREAST NEOPLASM,1
RU,BRONCHIOLITIS,1
RU,BRONCHOPNEUMONIA,1
RU,BUNDLE BRANCH BLOCK LEFT,1
RU,BUNDLE BRANCH BLOCK RIGHT,1
RU,BURSITIS INFECTIVE,1
RU,C-REACTIVE PROTEIN,1
RU,C-REACTIVE PROTEIN INCREASED,1
RU,CALCULUS URINARY,1
RU,CANDIDA INFECTION,1
RU,CARDIAC FAILURE ACUTE,1
RU,CARDIAC FAILURE CHRONIC,1
RU,CARDIAC FAILURE CONGESTIVE,1
RU,CARDIAC VALVE DISEASE,1
RU,CARDIOVASCULAR DISORDER,1
RU,CEREBRAL HAEMORRHAGE,1
RU,CEREBRAL THROMBOSIS,1
RU,CERVICAL CYST,1
RU,CERVIX CARCINOMA RECURRENT,1
RU,CERVIX CARCINOMA STAGE 0,1
RU,CHILLS,1
RU,CHRONIC GRAFT VERSUS HOST DISEASE,1
RU,CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME,1
RU,CHRONIC KIDNEY DISEASE,1
RU,COLD SWEAT,1
RU,COLITIS EROSIVE,1
RU,COLITIS ULCERATIVE,1
RU,CONFUSIONAL STATE,1
RU,CORONARY ARTERY DISEASE,1
RU,CROHN^S DISEASE,1
RU,CUSHINGOID,1
RU,CUTANEOUS SYMPTOM,1
RU,CYANOSIS,1
RU,CYSTITIS HAEMORRHAGIC,1
RU,CYTOMEGALOVIRUS COLITIS,1
RU,CYTOMEGALOVIRUS TEST POSITIVE,1
RU,CYTOMEGALOVIRUS VIRAEMIA,1
RU,DEAFNESS NEUROSENSORY,1
RU,DEVICE RELATED INFECTION,1
RU,DILATATION VENTRICULAR,1
RU,DISEASE PROGRESSION,1
RU,DISEASE RISK FACTOR,1
RU,DISORIENTATION,1
RU,DISSEMINATED INTRAVASCULAR COAGULATION,1
RU,DIZZINESS,1
RU,DRUG DOSE OMISSION,1
RU,DRUG EFFECT DECREASED,1
RU,DRUG HYPERSENSITIVITY,1
RU,DRUG LEVEL INCREASED,1
RU,DUODENOGASTRIC REFLUX,1
RU,DYSBACTERIOSIS,1
RU,DYSLIPIDAEMIA,1
RU,DYSPEPSIA,1
RU,EAR INFECTION,1
RU,ECTOPIC PREGNANCY,1
RU,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
RU,EMPYEMA,1
RU,ENCEPHALITIS,1
RU,ENCEPHALITIS CYTOMEGALOVIRUS,1
RU,EPSTEIN-BARR VIRAEMIA,1
RU,ERYSIPELAS,1
RU,ERYTHEMA NODOSUM,1
RU,ESCHERICHIA BACTERAEMIA,1
RU,ESCHERICHIA SEPSIS,1
RU,EXTREMITY NECROSIS,1
RU,FATIGUE,1
RU,FRACTURE,1
RU,GAIT DISTURBANCE,1
RU,GASTRIC CANCER,1
RU,GASTRIC POLYPS,1
RU,GASTRITIS,1
RU,GASTROINTESTINAL HAEMORRHAGE,1
RU,GASTROINTESTINAL NECROSIS,1
RU,GASTROOESOPHAGEAL REFLUX DISEASE,1
RU,GENERAL PHYSICAL HEALTH DETERIORATION,1
RU,GRAFT VERSUS HOST DISEASE IN EYE,1
RU,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
RU,GROWTH RETARDATION,1
RU,GUILLAIN-BARRE SYNDROME,1
RU,HAEMOGLOBIN DECREASED,1
RU,HAEMOLYSIS,1
RU,HAEMORRHAGIC VASCULITIS,1
RU,HEART VALVE INCOMPETENCE,1
RU,HEMIPARESIS,1
RU,HEPATIC FAILURE,1
RU,HEPATITIS,1
RU,HEPATITIS TOXIC,1
RU,HEPATOSPLENOMEGALY,1
RU,HERPES ZOSTER DISSEMINATED,1
RU,HICCUPS,1
RU,HOSPITALISATION,1
RU,HYPERAEMIA,1
RU,HYPERCHOLESTEROLAEMIA,1
RU,HYPERTENSIVE CRISIS,1
RU,HYPERTHERMIA,1
RU,IDIOPATHIC PULMONARY FIBROSIS,1
RU,IMMUNOGLOBULINS DECREASED,1
RU,INFLAMMATORY BOWEL DISEASE,1
RU,INJECTION SITE DISCOLOURATION,1
RU,INTENTIONAL PRODUCT MISUSE,1
RU,INTERVERTEBRAL DISC PROTRUSION,1
RU,INTESTINAL ADENOCARCINOMA,1
RU,INTESTINAL HAEMORRHAGE,1
RU,IRIDOCYCLITIS,1
RU,ISCHAEMIC CEREBRAL INFARCTION,1
RU,JOINT ARTHROPLASTY,1
RU,KIDNEY INFECTION,1
RU,LACUNAR STROKE,1
RU,LEFT ATRIAL DILATATION,1
RU,LEFT VENTRICULAR DYSFUNCTION,1
RU,LEUKAEMIC INFILTRATION RENAL,1
RU,LIVER FUNCTION TEST INCREASED,1
RU,LOSS OF CONSCIOUSNESS,1
RU,LUNG ADENOCARCINOMA,1
RU,LUNG NEOPLASM,1
RU,LYMPH NODE TUBERCULOSIS,1
RU,LYMPHADENOPATHY,1
RU,LYMPHOCYTE COUNT DECREASED,1
RU,LYMPHOCYTOSIS,1
RU,MATERNAL EXPOSURE BEFORE PREGNANCY,1
RU,MATERNAL EXPOSURE DURING PREGNANCY,1
RU,MAXILLARY SINUS PSEUDOCYST,1
RU,MENINGIOMA,1
RU,MENINGITIS,1
RU,MENINGITIS ASEPTIC,1
RU,MENTAL DISORDER,1
RU,MICROANGIOPATHY,1
RU,MONONEURITIS,1
RU,MUSCLE DISORDER,1
RU,MYOCARDIAL INFARCTION,1
RU,NEPHROPATHY TOXIC,1
RU,NEPHROPTOSIS,1
RU,NEUROPATHY PERIPHERAL,1
RU,NEUROTOXICITY,1
RU,NEUTROPENIC SEPSIS,1
RU,NEUTROPHIL COUNT INCREASED,1
RU,NO THERAPEUTIC RESPONSE,1
RU,OCULAR ICTERUS,1
RU,OEDEMA PERIPHERAL,1
RU,OSTEOARTHRITIS,1
RU,OSTEOCHONDROSIS,1
RU,OSTEOMYELITIS CHRONIC,1
RU,OSTEOTOMY,1
RU,OTITIS MEDIA,1
RU,OTITIS MEDIA ACUTE,1
RU,PANCREATIC DISORDER,1
RU,PANCREATITIS RELAPSING,1
RU,PARANASAL CYST,1
RU,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
RU,PATHOLOGICAL FRACTURE,1
RU,PERITONEAL PERFORATION,1
RU,PHLEBITIS,1
RU,PNEUMONIA CYTOMEGALOVIRAL,1
RU,PNEUMOTHORAX,1
RU,POSTOPERATIVE WOUND INFECTION,1
RU,PROCTITIS ULCERATIVE,1
RU,PRURITUS,1
RU,PSEUDOMONAS INFECTION,1
RU,PULMONARY EMBOLISM,1
RU,PULMONARY THROMBOSIS,1
RU,PURULENT DISCHARGE,1
RU,QUADRIPARESIS,1
RU,RADIUS FRACTURE,1
RU,RAYNAUD^S PHENOMENON,1
RU,RENAL CANCER,1
RU,RENAL CELL CARCINOMA,1
RU,RENAL IMPAIRMENT,1
RU,RENAL TUBERCULOSIS,1
RU,RETINAL ARTERY OCCLUSION,1
RU,SCIATICA,1
RU,SEIZURE,1
RU,SINUS ARRHYTHMIA,1
RU,SINUSITIS,1
RU,SKIN SWELLING,1
RU,SPEECH DISORDER,1
RU,STEATOHEPATITIS,1
RU,STRABISMUS,1
RU,SYNOVIAL RUPTURE,1
RU,SYSTEMIC LUPUS ERYTHEMATOSUS,1
RU,SYSTEMIC MYCOSIS,1
RU,T-CELL LYMPHOMA,1
RU,T-LYMPHOCYTE COUNT ABNORMAL,1
RU,THERAPEUTIC RESPONSE DECREASED,1
RU,THROMBOCYTOSIS,1
RU,THROMBOPHLEBITIS,1
RU,THROMBOSIS,1
RU,TONSILLITIS,1
RU,TOXIC ENCEPHALOPATHY,1
RU,TRANSIENT ISCHAEMIC ATTACK,1
RU,TREATMENT FAILURE,1
RU,TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM,1
RU,ULCER,1
RU,ULTRASOUND KIDNEY ABNORMAL,1
RU,URINARY TRACT INFECTION,1
RU,VASCULITIS,1
RU,VASCULITIS GASTROINTESTINAL,1
RU,VENOOCCLUSIVE DISEASE,1
RU,WEIGHT INCREASED,1
BL,BONE EROSION,1
BL,C-REACTIVE PROTEIN ABNORMAL,1
BL,CONDITION AGGRAVATED,1
BL,DRUG INEFFECTIVE,1
BL,JOINT STIFFNESS,1
BL,JOINT SWELLING,1
BL,MUSCULOSKELETAL STIFFNESS,1
BL,NASOPHARYNGITIS,1
BL,PAIN IN EXTREMITY,1
BL,PERIPHERAL SWELLING,1
BL,RHEUMATOID ARTHRITIS,1
BL,STRESS,1
PM,LICHEN SCLEROSUS,1
PM,VAGINAL INFECTION,1
SA,FEBRILE NEUTROPENIA,48
SA,THROMBOCYTOPENIA,12
SA,INFECTION,11
SA,AFFECT LABILITY,9
SA,CHOLESTASIS,9
SA,DEPRESSION,9
SA,ENDOCARDITIS BACTERIAL,9
SA,TOXICITY TO VARIOUS AGENTS,9
SA,NEUTROPENIA,8
SA,BONE MARROW TOXICITY,7
SA,HEPATOTOXICITY,7
SA,SKIN TOXICITY,7
SA,CYTOMEGALOVIRUS INFECTION,6
SA,MUCOSAL TOXICITY,6
SA,ORGANISING PNEUMONIA,6
SA,ARTHRITIS,5
SA,DRUG CLEARANCE DECREASED,5
SA,PULMONARY EMBOLISM,5
SA,COLITIS,4
SA,DEEP VEIN THROMBOSIS,4
SA,NEUTROPENIC COLITIS,4
SA,PANCYTOPENIA,4
SA,RHEUMATIC DISORDER,4
SA,SEPTIC SHOCK,4
SA,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,3
SA,ACUTE MYELOID LEUKAEMIA,3
SA,DIZZINESS,3
SA,DYSPNOEA,3
SA,INFECTION REACTIVATION,3
SA,MYCOBACTERIUM ABSCESSUS INFECTION,3
SA,PLEURAL EFFUSION,3
SA,PYREXIA,3
SA,RHINORRHOEA,3
SA,SEPSIS,3
SA,ACCIDENTAL OVERDOSE,2
SA,ACUTE KIDNEY INJURY,2
SA,ASTHMA,2
SA,BONE MARROW DISORDER,2
SA,BONE MARROW FAILURE,2
SA,BRAIN NEOPLASM,2
SA,DRUG ADMINISTRATION ERROR,2
SA,DRUG DOSE OMISSION,2
SA,GINGIVAL BLEEDING,2
SA,HEADACHE,2
SA,HYPOXIA,2
SA,INJECTION SITE ERYTHEMA,2
SA,INJECTION SITE PAIN,2
SA,MIDDLE EAST RESPIRATORY SYNDROME,2
SA,MUCOSAL INFLAMMATION,2
SA,PNEUMONITIS,2
SA,RESPIRATORY FAILURE,2
SA,SHOCK,2
SA,ABASIA,1
SA,ABDOMINAL DISCOMFORT,1
SA,ABNORMAL BEHAVIOUR,1
SA,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
SA,ACUTE MYOCARDIAL INFARCTION,1
SA,ARTHRALGIA,1
SA,ASTHENIA,1
SA,BACTERIAL INFECTION,1
SA,BENIGN INTRACRANIAL HYPERTENSION,1
SA,BLISTER,1
SA,BLOOD TRIGLYCERIDES INCREASED,1
SA,CARDIOMEGALY,1
SA,CHRONIC GRAFT VERSUS HOST DISEASE,1
SA,CLOSTRIDIUM DIFFICILE INFECTION,1
SA,COLONIC PSEUDO-OBSTRUCTION,1
SA,COMPLICATIONS OF BONE MARROW TRANSPLANT,1
SA,CONVULSION,1
SA,CORONA VIRUS INFECTION,1
SA,CYTOPENIA,1
SA,DECREASED APPETITE,1
SA,DISEASE PROGRESSION,1
SA,DRUG HYPERSENSITIVITY,1
SA,ENCEPHALITIS,1
SA,ENTEROCOCCAL INFECTION,1
SA,FATIGUE,1
SA,FUNGAL INFECTION,1
SA,GRANULOMA,1
SA,HAEMODYNAMIC INSTABILITY,1
SA,HAEMOPTYSIS,1
SA,HAEMORRHAGE,1
SA,HAEMORRHAGE INTRACRANIAL,1
SA,HEPATIC FUNCTION ABNORMAL,1
SA,HIGH DENSITY LIPOPROTEIN DECREASED,1
SA,HYPOTENSION,1
SA,LEUKAEMIC INFILTRATION EXTRAMEDULLARY,1
SA,LUNG INFECTION,1
SA,LUPUS-LIKE SYNDROME,1
SA,MONONEURITIS,1
SA,MUCOUS MEMBRANE DISORDER,1
SA,MUSCULAR WEAKNESS,1
SA,MYOSITIS,1
SA,NEOPLASM PROGRESSION,1
SA,NEPHROPATHY TOXIC,1
SA,NEUROPATHY PERIPHERAL,1
SA,OPTIC NEUROPATHY,1
SA,ORGAN FAILURE,1
SA,PAIN,1
SA,PLEURITIC PAIN,1
SA,PNEUMONIA,1
SA,POLYARTHRITIS,1
SA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
SA,PRODUCT USE IN UNAPPROVED INDICATION,1
SA,PRODUCT USE ISSUE,1
SA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
SA,PRURITUS,1
SA,PSEUDOMONAS TEST POSITIVE,1
SA,PSORIASIS,1
SA,PULMONARY ALVEOLAR HAEMORRHAGE,1
SA,RENAL FAILURE,1
SA,RENAL FAILURE ACUTE,1
SA,RENAL MASS,1
SA,RETINAL HAEMORRHAGE,1
SA,RETINOIC ACID SYNDROME,1
SA,RHEUMATOID FACTOR INCREASED,1
SA,SARCOIDOSIS,1
SA,SEIZURE,1
SA,TENDERNESS,1
SA,THERAPEUTIC RESPONSE DECREASED,1
SA,TOXOPLASMOSIS,1
SA,TRANSPLANT REJECTION,1
SA,TREMOR,1
SA,TUBERCULOSIS,1
SA,TUMOUR LYSIS SYNDROME,1
SA,UPPER RESPIRATORY TRACT INFECTION,1
SA,URINE OUTPUT DECREASED,1
SA,VIRAL INFECTION,1
SA,VISUAL IMPAIRMENT,1
SA,VOMITING,1
SA,WEIGHT BEARING DIFFICULTY,1
SA,WEIGHT DECREASED,1
SA,WEIGHT INCREASED,1
SN,PNEUMOTHORAX SPONTANEOUS,1
SN,TREATMENT NONCOMPLIANCE,1
RS,CHRONIC GRAFT VERSUS HOST DISEASE,56
RS,OVERLAP SYNDROME,56
RS,DRUG INEFFECTIVE,6
RS,INFECTION,6
RS,JOINT SWELLING,6
RS,TRANSAMINASES INCREASED,6
RS,ANAEMIA,5
RS,ARTHRALGIA,5
RS,HEPATIC FAILURE,5
RS,INJECTION SITE ERYTHEMA,5
RS,RHEUMATOID ARTHRITIS,5
RS,ABSCESS LIMB,4
RS,ATAXIA,4
RS,EYELID OEDEMA,4
RS,HEMIPARESIS,4
RS,LEUKOPENIA,4
RS,PANCYTOPENIA,4
RS,PNEUMONIA,4
RS,TOXICITY TO VARIOUS AGENTS,4
RS,TUMOUR NECROSIS,4
RS,ARACHNOIDITIS,3
RS,ASTHENIA,3
RS,BONE EROSION,3
RS,BRAIN OEDEMA,3
RS,BRONCHOPNEUMONIA,3
RS,CEREBRAL CALCIFICATION,3
RS,FATIGUE,3
RS,GENERALISED TONIC-CLONIC SEIZURE,3
RS,IRIDOCYCLITIS,3
RS,PULMONARY FIBROSIS,3
RS,PYREXIA,3
RS,URINARY TRACT INFECTION,3
RS,ACUTE MYOCARDIAL INFARCTION,2
RS,ALOPECIA,2
RS,ARTHRITIS,2
RS,ARTHROPATHY,2
RS,ASPHYXIA,2
RS,C-REACTIVE PROTEIN INCREASED,2
RS,DIZZINESS,2
RS,DRUG INTOLERANCE,2
RS,DYSPNOEA,2
RS,FALL,2
RS,HEREDITARY ANGIOEDEMA,2
RS,HERPES ZOSTER,2
RS,INJECTION SITE PRURITUS,2
RS,INJECTION SITE SWELLING,2
RS,IRON DEFICIENCY ANAEMIA,2
RS,LIMB INJURY,2
RS,LIP SWELLING,2
RS,MULTIPLE FRACTURES,2
RS,NEUTROPENIA,2
RS,PALLOR,2
RS,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
RS,RESPIRATORY TRACT INFECTION,2
RS,ROAD TRAFFIC ACCIDENT,2
RS,SEPSIS,2
RS,ABDOMINAL DISCOMFORT,1
RS,ABDOMINAL PAIN,1
RS,ABDOMINAL PAIN LOWER,1
RS,ACCIDENT,1
RS,ALANINE AMINOTRANSFERASE INCREASED,1
RS,APHTHOUS STOMATITIS,1
RS,APHTHOUS ULCER,1
RS,ARTHRITIS BACTERIAL,1
RS,ASPARTATE AMINOTRANSFERASE INCREASED,1
RS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
RS,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
RS,BLOOD CREATININE INCREASED,1
RS,BLOOD FIBRINOGEN DECREASED,1
RS,BLOOD TEST ABNORMAL,1
RS,BLOOD UREA INCREASED,1
RS,BORDERLINE OVARIAN TUMOUR,1
RS,BOWEN^S DISEASE,1
RS,BREAST CANCER,1
RS,BRONCHOSPASM,1
RS,CARDIAC ARREST,1
RS,CELLULITIS,1
RS,CHEST DISCOMFORT,1
RS,CHOLELITHIASIS,1
RS,CHORIOCARCINOMA,1
RS,CHORIORETINAL DISORDER,1
RS,CHRONIC GASTRITIS,1
RS,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RS,CONTUSION,1
RS,CROHN^S DISEASE,1
RS,CYST,1
RS,DECREASED APPETITE,1
RS,DERMATITIS,1
RS,DERMATITIS ALLERGIC,1
RS,DIARRHOEA,1
RS,DISEASE RECURRENCE,1
RS,DISSEMINATED TUBERCULOSIS,1
RS,DRUG HYPERSENSITIVITY,1
RS,DUODENITIS,1
RS,ENCEPHALOMYELITIS,1
RS,ENCEPHALOPATHY,1
RS,ERYTHEMA INDURATUM,1
RS,ERYTHEMA NODOSUM,1
RS,FACE OEDEMA,1
RS,FEELING HOT,1
RS,FEMUR FRACTURE,1
RS,FUNDOSCOPY ABNORMAL,1
RS,GALLBLADDER POLYP,1
RS,GASTRIC DISORDER,1
RS,GASTRITIS,1
RS,GASTROINTESTINAL DISORDER,1
RS,GASTROINTESTINAL MUCOSA HYPERAEMIA,1
RS,GYNAECOMASTIA,1
RS,HAEMATURIA,1
RS,HAEMORRHAGE,1
RS,HEPATIC ENZYME INCREASED,1
RS,HEPATIC STEATOSIS,1
RS,HEPATITIS,1
RS,HIP FRACTURE,1
RS,HYPOALBUMINAEMIA,1
RS,HYPOPROTEINAEMIA,1
RS,HYPOTENSION,1
RS,HYPOXIA,1
RS,INTENTION TREMOR,1
RS,LEUKOENCEPHALOPATHY,1
RS,LOCALISED OEDEMA,1
RS,LUNG DISORDER,1
RS,LYMPHOMA,1
RS,MACULOPATHY,1
RS,MALAISE,1
RS,MALIGNANT MELANOMA,1
RS,MASTITIS,1
RS,MUCOSAL DISCOLOURATION,1
RS,MUSCULOSKELETAL PAIN,1
RS,NAIL BED INFECTION,1
RS,NAUSEA,1
RS,NEPHROLITHIASIS,1
RS,NEURALGIA,1
RS,OPHTHALMIC HERPES ZOSTER,1
RS,OSTEITIS,1
RS,PALPITATIONS,1
RS,PLATELET COUNT DECREASED,1
RS,PNEUMOPERITONEUM,1
RS,PREGNANCY,1
RS,PRURITUS GENERALISED,1
RS,PSEUDOMEMBRANOUS COLITIS,1
RS,PSORIATIC ARTHROPATHY,1
RS,PULMONARY MASS,1
RS,PYELONEPHRITIS ACUTE,1
RS,RENAL FAILURE,1
RS,RESPIRATORY DISORDER,1
RS,RETINAL DETACHMENT,1
RS,RETINAL VEIN OCCLUSION,1
RS,RHEUMATOID NODULE,1
RS,RIB FRACTURE,1
RS,SEPTIC SHOCK,1
RS,SPEECH DISORDER DEVELOPMENTAL,1
RS,SPINAL COMPRESSION FRACTURE,1
RS,SQUAMOUS CELL CARCINOMA OF SKIN,1
RS,STAPHYLOCOCCAL INFECTION,1
RS,SYNOVITIS,1
RS,TACHYCARDIA,1
RS,THROAT TIGHTNESS,1
RS,THROMBOCYTOPENIA,1
RS,THROMBOPHLEBITIS,1
RS,TONGUE OEDEMA,1
RS,TOOTHACHE,1
RS,TRANSAMINASES ABNORMAL,1
RS,TRAUMATIC HAEMOTHORAX,1
RS,ULCERATIVE KERATITIS,1
RS,URTICARIA,1
RS,VAGINAL HAEMORRHAGE,1
RS,VARICELLA,1
RS,VARICELLA ZOSTER PNEUMONIA,1
RS,VOMITING,1
RS,WEIGHT DECREASED,1
SL,ABDOMINAL DISCOMFORT,1
SL,ACCIDENT,1
SL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SL,ANXIETY,1
SL,ARTHRALGIA,1
SL,ARTHRITIS,1
SL,ASTHENIA,1
SL,BONE PAIN,1
SL,BRAIN NEOPLASM,1
SL,BURNOUT SYNDROME,1
SL,CEREBRAL DISORDER,1
SL,CHILLS,1
SL,DEPRESSION,1
SL,DISABILITY,1
SL,DRUG HYPERSENSITIVITY,1
SL,DYSPNOEA,1
SL,EMOTIONAL DISTRESS,1
SL,FALL,1
SL,FATIGUE,1
SL,FEELING ABNORMAL,1
SL,FLATULENCE,1
SL,HEAD INJURY,1
SL,HYPERHIDROSIS,1
SL,INFECTION,1
SL,INSOMNIA,1
SL,INTENTIONAL PRODUCT MISUSE,1
SL,IRRITABILITY,1
SL,JOINT SWELLING,1
SL,LOSS OF CONSCIOUSNESS,1
SL,LOSS OF EMPLOYMENT,1
SL,MALAISE,1
SL,MENTAL FATIGUE,1
SL,MOBILITY DECREASED,1
SL,MUSCLE DISORDER,1
SL,MUSCULAR WEAKNESS,1
SL,MUSCULOSKELETAL PAIN,1
SL,NAUSEA,1
SL,NERVE INJURY,1
SL,PAIN,1
SL,PAIN IN EXTREMITY,1
SL,PARAESTHESIA,1
SL,PERICARDITIS,1
SL,PERIPHERAL SWELLING,1
SL,PRODUCTIVE COUGH,1
SL,PRURITUS,1
SL,PYREXIA,1
SL,SEXUAL ABUSE,1
SL,SKIN ATROPHY,1
SL,SKIN DISCOLOURATION,1
SL,SKIN DISORDER,1
SL,STRESS,1
SL,SWELLING,1
SL,UNDERDOSE,1
SL,URINARY INCONTINENCE,1
SL,URTICARIA,1
SL,VOMITING,1
SL,WALKING AID USER,1
SL,WHITE BLOOD CELL COUNT DECREASED,1
SL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SG,DISSEMINATED TUBERCULOSIS,6
SG,DEATH,5
SG,HEPATITIS E,5
SG,HAEMORRHAGE INTRACRANIAL,4
SG,MANIA,4
SG,PSORIASIS,4
SG,ARTHRITIS BACTERIAL,3
SG,BONE TUBERCULOSIS,3
SG,GASTRODUODENITIS,3
SG,LYMPH NODE TUBERCULOSIS,3
SG,MENINGITIS TUBERCULOUS,3
SG,MYELOPATHY,3
SG,ANAEMIA,2
SG,BREAST CANCER,2
SG,COLITIS,2
SG,DRUG EFFECT INCOMPLETE,2
SG,DRUG INEFFECTIVE,2
SG,FEBRILE NEUTROPENIA,2
SG,HISTIOCYTOSIS HAEMATOPHAGIC,2
SG,HYPOTHYROIDISM,2
SG,MYCOBACTERIAL INFECTION,2
SG,PNEUMONIA,2
SG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
SG,SEPSIS,2
SG,STATUS EPILEPTICUS,2
SG,SYSTEMIC MYCOSIS,2
SG,THROMBOCYTOPENIA,2
SG,TRANSAMINASES INCREASED,2
SG,ABDOMINAL DISTENSION,1
SG,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
SG,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SG,APLASIA PURE RED CELL,1
SG,AREFLEXIA,1
SG,ARTHRALGIA,1
SG,ASTHMA,1
SG,AUTOIMMUNE DISORDER,1
SG,CARDIOMYOPATHY,1
SG,CELL-MEDIATED CYTOTOXICITY,1
SG,CHRONIC GRAFT VERSUS HOST DISEASE,1
SG,CONDITION AGGRAVATED,1
SG,CYTOMEGALOVIRUS HEPATITIS,1
SG,DEAFNESS NEUROSENSORY,1
SG,DECREASED VIBRATORY SENSE,1
SG,DEMYELINATION,1
SG,DERMATITIS ACNEIFORM,1
SG,DIABETES MELLITUS,1
SG,DISEASE PROGRESSION,1
SG,DRUG INTOLERANCE,1
SG,GASTROINTESTINAL HAEMORRHAGE,1
SG,GRAFT VERSUS HOST DISEASE IN SKIN,1
SG,HAEMODYNAMIC INSTABILITY,1
SG,HIRSUTISM,1
SG,HISTOPLASMOSIS DISSEMINATED,1
SG,HUMAN RHINOVIRUS TEST POSITIVE,1
SG,HYPERTRIGLYCERIDAEMIA,1
SG,HYPOAESTHESIA,1
SG,HYPOGLYCAEMIA,1
SG,HYPOKINESIA,1
SG,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
SG,INFECTION,1
SG,JOINT CREPITATION,1
SG,JOINT EFFUSION,1
SG,JOINT RANGE OF MOTION DECREASED,1
SG,JOINT SWELLING,1
SG,LATENT TUBERCULOSIS,1
SG,LEUKOENCEPHALOPATHY,1
SG,LOSS OF CONSCIOUSNESS,1
SG,LUNG INFECTION,1
SG,MEASLES,1
SG,MENTAL DISORDER,1
SG,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SG,MUSCULAR WEAKNESS,1
SG,MUSCULOSKELETAL STIFFNESS,1
SG,MYALGIA,1
SG,MYCOBACTERIUM ABSCESSUS INFECTION,1
SG,NECK PAIN,1
SG,NEOPLASM MALIGNANT,1
SG,NEUTROPENIA,1
SG,NEUTROPENIC SEPSIS,1
SG,ORGANISING PNEUMONIA,1
SG,OSTEOPOROSIS,1
SG,PANCYTOPENIA,1
SG,PARAPARESIS,1
SG,PNEUMOTHORAX,1
SG,PRODUCT USE IN UNAPPROVED INDICATION,1
SG,PRODUCT USE ISSUE,1
SG,RASH,1
SG,RASH PUSTULAR,1
SG,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
SG,RENAL TUBULAR DISORDER,1
SG,RESPIRATORY FAILURE,1
SG,RHABDOMYOLYSIS,1
SG,ROMBERG TEST POSITIVE,1
SG,SKIN INFECTION,1
SG,SOFT TISSUE INFECTION,1
SG,SOMATOSENSORY EVOKED POTENTIALS ABNORMAL,1
SG,SPINAL OSTEOARTHRITIS,1
SG,STRESS FRACTURE,1
SG,STRIDOR,1
SG,SYNOVITIS,1
SG,TENOSYNOVITIS,1
SG,TOXICITY TO VARIOUS AGENTS,1
SG,TUMOUR LYSIS SYNDROME,1
SG,UPPER LIMB FRACTURE,1
SG,URINARY TRACT INFECTION,1
SG,WEIGHT INCREASED,1
SK,HEPATIC ENZYME INCREASED,3
SK,HYPERTENSION,3
SK,ALOPECIA,2
SK,CHOLECYSTITIS INFECTIVE,2
SK,DEATH,2
SK,DRUG INEFFECTIVE,2
SK,FEBRILE NEUTROPENIA,2
SK,GALLBLADDER PERFORATION,2
SK,GASTROINTESTINAL DISORDER,2
SK,NEPHROPATHY TOXIC,2
SK,RENAL FAILURE,2
SK,ABSCESS,1
SK,ADENOCARCINOMA PANCREAS,1
SK,ALTERED STATE OF CONSCIOUSNESS,1
SK,APPENDICITIS PERFORATED,1
SK,ARTHRITIS INFECTIVE,1
SK,ASTHMA,1
SK,BALANCE DISORDER,1
SK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
SK,BLOOD BILIRUBIN INCREASED,1
SK,BLOOD CREATININE INCREASED,1
SK,BREAST CANCER,1
SK,BREAST CANCER STAGE I,1
SK,BRONCHOPNEUMONIA,1
SK,BRONCHOPULMONARY ASPERGILLOSIS,1
SK,CALCINOSIS,1
SK,CHRONIC KIDNEY DISEASE,1
SK,CONDITION AGGRAVATED,1
SK,CROHN^S DISEASE,1
SK,DERMATOMYOSITIS,1
SK,DIARRHOEA,1
SK,DISEASE PROGRESSION,1
SK,DIVERTICULITIS,1
SK,DIZZINESS,1
SK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
SK,DYSPHAGIA,1
SK,DYSPNOEA,1
SK,EPISTAXIS,1
SK,FACIAL PARALYSIS,1
SK,GAIT DISTURBANCE,1
SK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SK,GASTRIC DISORDER,1
SK,GASTROINTESTINAL HAEMORRHAGE,1
SK,GINGIVAL HYPERTROPHY,1
SK,HAEMOTHORAX,1
SK,HEPATIC FAILURE,1
SK,HEPATORENAL FAILURE,1
SK,HODGKIN^S DISEASE,1
SK,HYDROTHORAX,1
SK,HYPERCHOLESTEROLAEMIA,1
SK,HYPERTRICHOSIS,1
SK,ILEUS,1
SK,ILEUS PARALYTIC,1
SK,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
SK,INTERFERON GAMMA RELEASE ASSAY POSITIVE,1
SK,INTERVERTEBRAL DISCITIS,1
SK,JEJUNAL PERFORATION,1
SK,LEUKOCYTOSIS,1
SK,LIPOATROPHY,1
SK,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III,1
SK,LUNG NEOPLASM MALIGNANT,1
SK,LYME DISEASE,1
SK,METASTASES TO LIVER,1
SK,METASTASES TO LUNG,1
SK,METASTATIC NEOPLASM,1
SK,MULTI-ORGAN FAILURE,1
SK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SK,NAUSEA,1
SK,NEUROTOXICITY,1
SK,ORAL HERPES,1
SK,OSTEONECROSIS,1
SK,PANCREATITIS,1
SK,PANCREATITIS ACUTE,1
SK,PANCYTOPENIA,1
SK,PNEUMOMEDIASTINUM,1
SK,PNEUMONIA,1
SK,PNEUMONIA BACTERIAL,1
SK,POLYNEUROPATHY,1
SK,PULMONARY EMBOLISM,1
SK,PYREXIA,1
SK,RECTAL ADENOCARCINOMA,1
SK,RESPIRATORY FAILURE,1
SK,SEIZURE,1
SK,SEPSIS,1
SK,SHOCK HAEMORRHAGIC,1
SK,SKIN STRIAE,1
SK,SKIN TOXICITY,1
SK,SLEEP DISORDER,1
SK,SOMNOLENCE,1
SK,SPEECH DISORDER,1
SK,STOMATITIS,1
SK,TACHYCARDIA,1
SK,TOXIC SKIN ERUPTION,1
SK,TYPE 2 DIABETES MELLITUS,1
SK,VOMITING,1
SK,WEIGHT DECREASED,1
SI,PANCYTOPENIA,11
SI,NAUSEA,5
SI,VOMITING,5
SI,CARDIAC FAILURE,4
SI,NEUTROPENIA,4
SI,OSTEOPOROSIS,4
SI,STOMATITIS,4
SI,ACUTE RESPIRATORY FAILURE,3
SI,ANTIPHOSPHOLIPID SYNDROME,3
SI,CATARACT,3
SI,CYSTITIS,3
SI,DIABETES MELLITUS,3
SI,HAEMATOMA,3
SI,INSOMNIA,3
SI,PAIN,3
SI,PERIANAL ERYTHEMA,3
SI,PETECHIAE,3
SI,PULMONARY EMBOLISM,3
SI,RENAL FAILURE,3
SI,STAPHYLOCOCCAL INFECTION,3
SI,TOXICITY TO VARIOUS AGENTS,3
SI,TREATMENT FAILURE,3
SI,ANAEMIA,2
SI,ANAL ULCER,2
SI,APHTHOUS STOMATITIS,2
SI,BACTERIAL INFECTION,2
SI,BASAL CELL CARCINOMA,2
SI,CEREBROVASCULAR ACCIDENT,2
SI,DRUG RESISTANCE,2
SI,DUODENAL ULCER,2
SI,ERYTHROPOIESIS ABNORMAL,2
SI,FATIGUE,2
SI,GASTROINTESTINAL HAEMORRHAGE,2
SI,GINGIVAL BLEEDING,2
SI,HEADACHE,2
SI,HEMIPARESIS,2
SI,HEPATIC ENZYME INCREASED,2
SI,INFECTION,2
SI,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,2
SI,LOWER RESPIRATORY TRACT INFECTION VIRAL,2
SI,MACROCYTOSIS,2
SI,MALIGNANT MELANOMA,2
SI,MELAENA,2
SI,MOBILITY DECREASED,2
SI,MOUTH HAEMORRHAGE,2
SI,PANCREATIC CYST,2
SI,PRODUCT USE ISSUE,2
SI,PYREXIA,2
SI,SECONDARY AMYLOIDOSIS,2
SI,SEPSIS,2
SI,SHOCK HAEMORRHAGIC,2
SI,THROMBOCYTOPENIA,2
SI,ABDOMINAL PAIN UPPER,1
SI,ABDOMINAL WALL HAEMATOMA,1
SI,ACUTE INTERSTITIAL PNEUMONITIS,1
SI,ADENOCARCINOMA,1
SI,ADRENAL INSUFFICIENCY,1
SI,ALOPECIA,1
SI,ANAEMIA MEGALOBLASTIC,1
SI,ANORECTAL DISCOMFORT,1
SI,APHTHOUS ULCER,1
SI,ARRHYTHMIA,1
SI,ARTHRALGIA,1
SI,ARTHRITIS,1
SI,ARTHROPATHY,1
SI,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
SI,BILE DUCT OBSTRUCTION,1
SI,BLOOD PRESSURE DECREASED,1
SI,BONE MARROW DISORDER,1
SI,BONE MARROW FAILURE,1
SI,BONE PAIN,1
SI,BURNING SENSATION MUCOSAL,1
SI,CARDIOMEGALY,1
SI,CAROTID ARTERY THROMBOSIS,1
SI,CEREBRAL HAEMORRHAGE,1
SI,CEREBRAL INFARCTION,1
SI,CHOLECYSTITIS,1
SI,CHRONIC HEPATITIS,1
SI,CONDITION AGGRAVATED,1
SI,CONGESTIVE CARDIOMYOPATHY,1
SI,CYTOMEGALOVIRUS INFECTION,1
SI,DEPRESSION SUICIDAL,1
SI,DEVICE RELATED SEPSIS,1
SI,DRUG INEFFECTIVE,1
SI,DYSPHAGIA,1
SI,DYSPNOEA,1
SI,EPIDERMOLYSIS,1
SI,EPISTAXIS,1
SI,FEBRILE NEUTROPENIA,1
SI,GASTROINTESTINAL INFECTION,1
SI,GINGIVAL PAIN,1
SI,GLOSSODYNIA,1
SI,GRAFT VERSUS HOST DISEASE IN SKIN,1
SI,HAEMOGLOBIN DECREASED,1
SI,HEPATITIS TOXIC,1
SI,HEPATORENAL SYNDROME,1
SI,HYPERTENSION,1
SI,HYPOACUSIS,1
SI,INFUSION RELATED REACTION,1
SI,INTESTINAL HAEMORRHAGE,1
SI,LEFT VENTRICULAR DYSFUNCTION,1
SI,LEGIONELLA INFECTION,1
SI,LEUKOPENIA,1
SI,LIVER DISORDER,1
SI,LOCALISED INFECTION,1
SI,LYMPHOMA,1
SI,MEDICATION ERROR,1
SI,MEGAKARYOCYTES DECREASED,1
SI,METASTASES TO BONE,1
SI,METASTASES TO LIVER,1
SI,MITRAL VALVE INCOMPETENCE,1
SI,MOUTH ULCERATION,1
SI,MUCOSAL INFLAMMATION,1
SI,MULTIPLE SCLEROSIS,1
SI,MULTIPLE SCLEROSIS RELAPSE,1
SI,NAIL INFECTION,1
SI,NEOPLASM,1
SI,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
SI,ORAL INFECTION,1
SI,ORAL MUCOSAL ERYTHEMA,1
SI,ORAL VIRAL INFECTION,1
SI,PEPTOSTREPTOCOCCUS INFECTION,1
SI,PERIPHERAL ARTERY THROMBOSIS,1
SI,PLATELET COUNT INCREASED,1
SI,PLEURAL EFFUSION,1
SI,PROCTALGIA,1
SI,PSEUDOMONAS INFECTION,1
SI,PSORIASIS,1
SI,RECTAL ADENOCARCINOMA,1
SI,RED BLOOD CELL COUNT INCREASED,1
SI,RESPIRATORY TRACT INFECTION,1
SI,RHEUMATIC DISORDER,1
SI,RHEUMATOID ARTHRITIS,1
SI,RIB FRACTURE,1
SI,STREPTOCOCCAL SEPSIS,1
SI,TOOTH LOSS,1
SI,TOXIC LEUKOENCEPHALOPATHY,1
SI,TRANSIENT ISCHAEMIC ATTACK,1
SI,TRICUSPID VALVE INCOMPETENCE,1
SI,TUBERCULOSIS,1
SI,TUBULOINTERSTITIAL NEPHRITIS,1
SI,UPPER RESPIRATORY TRACT INFECTION,1
SI,URINARY TRACT INFECTION,1
SI,UTERINE LEIOMYOMA,1
SI,VASCULITIS,1
SI,VENTRICULAR EXTRASYSTOLES,1
SI,VENTRICULAR HYPERTROPHY,1
SI,VENTRICULAR HYPOKINESIA,1
SI,VENTRICULAR TACHYCARDIA,1
SI,WEIGHT DECREASED,1
ZA,DRUG INEFFECTIVE,25
ZA,RHEUMATOID ARTHRITIS,21
ZA,DEPRESSION,13
ZA,PNEUMONIA,13
ZA,HEADACHE,12
ZA,MALAISE,12
ZA,SEPSIS,12
ZA,ARTHRALGIA,11
ZA,HYPERTENSION,11
ZA,PAIN,10
ZA,LOWER RESPIRATORY TRACT INFECTION,9
ZA,CONDITION AGGRAVATED,8
ZA,DEATH,8
ZA,PYREXIA,8
ZA,TUBERCULOSIS,8
ZA,DYSPNOEA,7
ZA,JOINT SWELLING,7
ZA,RASH,7
ZA,SPINAL OSTEOARTHRITIS,7
ZA,CACHEXIA,6
ZA,CHEST PAIN,6
ZA,COUGH,6
ZA,DEEP VEIN THROMBOSIS,6
ZA,HYPERSENSITIVITY,6
ZA,INFECTION,6
ZA,PULMONARY TUBERCULOSIS,6
ZA,THERAPEUTIC RESPONSE DECREASED,6
ZA,ABDOMINAL PAIN,5
ZA,DEFORMITY,5
ZA,DYSLIPIDAEMIA,5
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,5
ZA,IMPAIRED WORK ABILITY,5
ZA,MACULOPATHY,5
ZA,MIGRAINE,5
ZA,NEPHROLITHIASIS,5
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
ZA,PULMONARY EMBOLISM,5
ZA,RENAL IMPAIRMENT,5
ZA,ARTHRITIS,4
ZA,CEREBROVASCULAR ACCIDENT,4
ZA,DIARRHOEA,4
ZA,DIZZINESS,4
ZA,DRUG EFFECT DECREASED,4
ZA,FATIGUE,4
ZA,HAEMOGLOBIN DECREASED,4
ZA,JOINT TUBERCULOSIS,4
ZA,LIVER INJURY,4
ZA,MOUTH ULCERATION,4
ZA,MYOCARDIAL INFARCTION,4
ZA,PAIN IN EXTREMITY,4
ZA,PEPTIC ULCER,4
ZA,PNEUMONIA VIRAL,4
ZA,SEPTIC SHOCK,4
ZA,ACUTE KIDNEY INJURY,3
ZA,ADDISON^S DISEASE,3
ZA,ANAEMIA,3
ZA,ARTHROPATHY,3
ZA,ASTHENIA,3
ZA,BONE LOSS,3
ZA,BRONCHITIS,3
ZA,C-REACTIVE PROTEIN INCREASED,3
ZA,CATARACT,3
ZA,DRUG INTOLERANCE,3
ZA,DRUG-INDUCED LIVER INJURY,3
ZA,HEPATIC FIBROSIS,3
ZA,HEPATOTOXICITY,3
ZA,INFLAMMATION,3
ZA,INTERSTITIAL LUNG DISEASE,3
ZA,JOINT DESTRUCTION,3
ZA,LYMPHADENOPATHY,3
ZA,MOBILITY DECREASED,3
ZA,MUSCULOSKELETAL STIFFNESS,3
ZA,NAUSEA,3
ZA,NEUTROPENIA,3
ZA,ORGANISING PNEUMONIA,3
ZA,OSTEOARTHRITIS,3
ZA,PANCYTOPENIA,3
ZA,PERIPHERAL SWELLING,3
ZA,PLEURAL EFFUSION,3
ZA,PNEUMONITIS,3
ZA,PRODUCT USE IN UNAPPROVED INDICATION,3
ZA,PRODUCT USE ISSUE,3
ZA,RESPIRATORY DISTRESS,3
ZA,RESPIRATORY TRACT INFECTION,3
ZA,SKIN ULCER,3
ZA,SPEECH DISORDER,3
ZA,SPINAL FUSION SURGERY,3
ZA,URINARY TRACT INFECTION,3
ZA,VOMITING,3
ZA,WEIGHT DECREASED,3
ZA,WEIGHT INCREASED,3
ZA,ABDOMINAL ADHESIONS,2
ZA,ABSCESS,2
ZA,ADVERSE DRUG REACTION,2
ZA,ADVERSE EVENT,2
ZA,APHONIA,2
ZA,ATRIAL FIBRILLATION,2
ZA,BASAL CELL CARCINOMA,2
ZA,BENIGN PROSTATIC HYPERPLASIA,2
ZA,BLOOD CREATININE INCREASED,2
ZA,BRAIN NEOPLASM,2
ZA,CARDIAC ARREST,2
ZA,CARDIAC DISORDER,2
ZA,CARDITIS,2
ZA,CARPAL TUNNEL SYNDROME,2
ZA,CLOSTRIDIUM DIFFICILE INFECTION,2
ZA,COLECTOMY,2
ZA,COLITIS,2
ZA,CONFUSIONAL STATE,2
ZA,CONSTIPATION,2
ZA,CROHN^S DISEASE,2
ZA,DECREASED APPETITE,2
ZA,DIARRHOEA HAEMORRHAGIC,2
ZA,DRUG EFFECT INCOMPLETE,2
ZA,DRUG RESISTANCE,2
ZA,DRY MOUTH,2
ZA,ESCHERICHIA URINARY TRACT INFECTION,2
ZA,EYE DISORDER,2
ZA,EYE SWELLING,2
ZA,FEELING ABNORMAL,2
ZA,FLUSHING,2
ZA,GAIT DISTURBANCE,2
ZA,GASTRIC ULCER,2
ZA,GASTROINTESTINAL DISORDER,2
ZA,GASTROINTESTINAL HAEMORRHAGE,2
ZA,GLUCOSE TOLERANCE IMPAIRED,2
ZA,HAEMOPTYSIS,2
ZA,HAEMORRHAGE,2
ZA,HEPATITIS,2
ZA,HERNIA,2
ZA,HERPES ZOSTER,2
ZA,HOSPITALISATION,2
ZA,HOT FLUSH,2
ZA,IMMUNE SYSTEM DISORDER,2
ZA,INFLAMMATORY MARKER INCREASED,2
ZA,INFLUENZA,2
ZA,INJECTION SITE PRURITUS,2
ZA,INTESTINAL PERFORATION,2
ZA,IRON DEFICIENCY ANAEMIA,2
ZA,JOINT ANKYLOSIS,2
ZA,JOINT DISLOCATION,2
ZA,LOCAL SWELLING,2
ZA,LUNG DISORDER,2
ZA,LYMPHOMA,2
ZA,MULTI-ORGAN FAILURE,2
ZA,MULTIPLE-DRUG RESISTANCE,2
ZA,NEUTROPHIL COUNT INCREASED,2
ZA,NIGHT SWEATS,2
ZA,OESOPHAGEAL CANDIDIASIS,2
ZA,OSTEOPOROSIS,2
ZA,PALPITATIONS,2
ZA,PLEURITIC PAIN,2
ZA,PNEUMOTHORAX,2
ZA,POSTOPERATIVE WOUND COMPLICATION,2
ZA,PRODUCT QUALITY ISSUE,2
ZA,PRURITUS,2
ZA,RASH ERYTHEMATOUS,2
ZA,RENAL FAILURE,2
ZA,RENAL TUBULAR NECROSIS,2
ZA,RESPIRATORY FAILURE,2
ZA,RHEUMATIC FEVER,2
ZA,SALMONELLOSIS,2
ZA,SCROTAL ABSCESS,2
ZA,SINUSITIS,2
ZA,SLEEP DISORDER,2
ZA,TENDON RUPTURE,2
ZA,TOXICITY TO VARIOUS AGENTS,2
ZA,TRANSAMINASES INCREASED,2
ZA,TREATMENT FAILURE,2
ZA,UNEVALUABLE EVENT,2
ZA,UPPER RESPIRATORY TRACT INFECTION,2
ZA,WEIGHT BEARING DIFFICULTY,2
ZA,WHITE BLOOD CELL COUNT DECREASED,2
ZA,ABASIA,1
ZA,ABDOMINAL DISTENSION,1
ZA,ABDOMINAL HERNIA,1
ZA,ABDOMINAL LYMPHADENOPATHY,1
ZA,ABDOMINAL PAIN UPPER,1
ZA,ABNORMAL PRODUCT OF CONCEPTION,1
ZA,ABSCESS LIMB,1
ZA,ABSCESS ORAL,1
ZA,ACCIDENTAL OVERDOSE,1
ZA,ACTINIC KERATOSIS,1
ZA,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ZA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
ZA,ADENOMYOSIS,1
ZA,ALANINE AMINOTRANSFERASE ABNORMAL,1
ZA,ANAL FISTULA,1
ZA,ANAL HAEMORRHAGE,1
ZA,ANGIOEDEMA,1
ZA,ANKYLOSING SPONDYLITIS,1
ZA,ANXIETY,1
ZA,AORTIC CALCIFICATION,1
ZA,AORTIC ELONGATION,1
ZA,APHTHOUS ULCER,1
ZA,ARTHRITIS BACTERIAL,1
ZA,ARTHROSCOPY,1
ZA,ARTICULAR CALCIFICATION,1
ZA,ATYPICAL PNEUMONIA,1
ZA,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
ZA,BACK PAIN,1
ZA,BENIGN HEPATIC NEOPLASM,1
ZA,BIPOLAR DISORDER,1
ZA,BLADDER CANCER,1
ZA,BLADDER TRANSITIONAL CELL CARCINOMA,1
ZA,BLEEDING VARICOSE VEIN,1
ZA,BLINDNESS,1
ZA,BLOOD CALCIUM DECREASED,1
ZA,BLOOD CHLORIDE DECREASED,1
ZA,BLOOD CORTICOTROPHIN DECREASED,1
ZA,BLOOD CORTISOL DECREASED,1
ZA,BLOOD PRESSURE DECREASED,1
ZA,BLOOD UREA INCREASED,1
ZA,BONE DISORDER,1
ZA,BONE MARROW FAILURE,1
ZA,BRAIN NEOPLASM MALIGNANT,1
ZA,BREAST CANCER,1
ZA,BRONCHIOLITIS,1
ZA,BRONCHOPNEUMONIA,1
ZA,BUDD-CHIARI SYNDROME,1
ZA,C-REACTIVE PROTEIN ABNORMAL,1
ZA,C-REACTIVE PROTEIN DECREASED,1
ZA,CAESAREAN SECTION,1
ZA,CARDIAC FAILURE,1
ZA,CARDIOMEGALY,1
ZA,CARDIOMYOPATHY,1
ZA,CATARACT OPERATION,1
ZA,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
ZA,CERVICAL CYST,1
ZA,CERVICAL RADICULOPATHY,1
ZA,CHEST DISCOMFORT,1
ZA,CHOLECYSTITIS,1
ZA,CHOLELITHIASIS,1
ZA,CHRONIC GRAFT VERSUS HOST DISEASE,1
ZA,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
ZA,COLITIS ISCHAEMIC,1
ZA,COLITIS ULCERATIVE,1
ZA,COLON CANCER,1
ZA,COLON INJURY,1
ZA,COLONOSCOPY ABNORMAL,1
ZA,COLORECTAL CANCER METASTATIC,1
ZA,COLPOCELE,1
ZA,COMA,1
ZA,CONNECTIVE TISSUE DISORDER,1
ZA,CUSHINGOID,1
ZA,CUTANEOUS VASCULITIS,1
ZA,CYSTITIS,1
ZA,CYSTOCELE,1
ZA,CYTOMEGALOVIRUS INFECTION,1
ZA,DEAFNESS,1
ZA,DECREASED IMMUNE RESPONSIVENESS,1
ZA,DEHYDRATION,1
ZA,DELIRIUM,1
ZA,DEMENTIA,1
ZA,DEMYELINATION,1
ZA,DEPRESSED MOOD,1
ZA,DERMATITIS ALLERGIC,1
ZA,DEVELOPMENTAL GLAUCOMA,1
ZA,DIABETES MELLITUS,1
ZA,DIABETES MELLITUS INADEQUATE CONTROL,1
ZA,DIFFUSE LARGE B-CELL LYMPHOMA,1
ZA,DISEASE PROGRESSION,1
ZA,DISSEMINATED INTRAVASCULAR COAGULATION,1
ZA,DRUG HYPERSENSITIVITY,1
ZA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ZA,DRUG TOLERANCE DECREASED,1
ZA,DUODENITIS,1
ZA,DYSGEUSIA,1
ZA,DYSPEPSIA,1
ZA,ECZEMA,1
ZA,ELECTROLYTE IMBALANCE,1
ZA,ENDOMETRIAL ABLATION,1
ZA,ENDOMETRIAL DISORDER,1
ZA,ERYTHEMA,1
ZA,EXERCISE TOLERANCE DECREASED,1
ZA,EXOSTOSIS,1
ZA,EXPOSURE DURING PREGNANCY,1
ZA,FAECALOMA,1
ZA,FEEDING DISORDER,1
ZA,FEELING COLD,1
ZA,FEELING HOT,1
ZA,FEMORAL NECK FRACTURE,1
ZA,FEMUR FRACTURE,1
ZA,FIBROADENOMA OF BREAST,1
ZA,FIBULA FRACTURE,1
ZA,FOWLER^S SYNDROME,1
ZA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ZA,GASTRITIS,1
ZA,GASTRITIS HAEMORRHAGIC,1
ZA,GASTROENTERITIS VIRAL,1
ZA,GASTROINTESTINAL ANASTOMOTIC COMPLICATION,1
ZA,GASTROINTESTINAL BACTERIAL INFECTION,1
ZA,GASTROINTESTINAL MELANOSIS,1
ZA,GINGIVAL BLEEDING,1
ZA,GLAUCOMA,1
ZA,GOUT,1
ZA,GRANULOMA,1
ZA,GUILLAIN-BARRE SYNDROME,1
ZA,HAEMATEMESIS,1
ZA,HAEMOCHROMATOSIS,1
ZA,HAEMORRHOIDS,1
ZA,HEART VALVE INCOMPETENCE,1
ZA,HEPATIC ENZYME INCREASED,1
ZA,HEPATIC FAILURE,1
ZA,HEPATIC STEATOSIS,1
ZA,HEPATITIS A,1
ZA,HISTIOCYTOSIS HAEMATOPHAGIC,1
ZA,HIV TEST POSITIVE,1
ZA,HYPERCHOLESTEROLAEMIA,1
ZA,HYPERGLYCAEMIA,1
ZA,HYPERSPLENISM,1
ZA,HYPERTENSIVE EMERGENCY,1
ZA,HYPERTENSIVE NEPHROPATHY,1
ZA,HYPOACUSIS,1
ZA,HYPOAESTHESIA ORAL,1
ZA,HYPOCALCAEMIA,1
ZA,HYPOGAMMAGLOBULINAEMIA,1
ZA,HYPOPHAGIA,1
ZA,HYPOTENSION,1
ZA,HYPOTHYROIDISM,1
ZA,IMMUNODEFICIENCY,1
ZA,IMMUNOSUPPRESSION,1
ZA,INCARCERATED INGUINAL HERNIA,1
ZA,INCISION SITE ABSCESS,1
ZA,INFECTED SKIN ULCER,1
ZA,INFECTIOUS MONONUCLEOSIS,1
ZA,INFECTIVE EXACERBATION OF BRONCHIECTASIS,1
ZA,INFERTILITY,1
ZA,INGUINAL HERNIA_ OBSTRUCTIVE,1
ZA,INJECTION SITE DISCOLOURATION,1
ZA,INJECTION SITE ERYTHEMA,1
ZA,INJECTION SITE MASS,1
ZA,INJECTION SITE PAIN,1
ZA,INJECTION SITE SWELLING,1
ZA,INSOMNIA,1
ZA,INSULIN RESISTANCE,1
ZA,INTERVERTEBRAL DISC DEGENERATION,1
ZA,INTERVERTEBRAL DISC SPACE NARROWING,1
ZA,INTESTINAL DILATATION,1
ZA,INTESTINAL OBSTRUCTION,1
ZA,INTESTINAL SEPSIS,1
ZA,INVASIVE LOBULAR BREAST CARCINOMA,1
ZA,IRRITABLE BOWEL SYNDROME,1
ZA,JAUNDICE,1
ZA,JOINT LOCK,1
ZA,JOINT RANGE OF MOTION DECREASED,1
ZA,JOINT STIFFNESS,1
ZA,JUVENILE IDIOPATHIC ARTHRITIS,1
ZA,KIDNEY INFECTION,1
ZA,KNEE ARTHROPLASTY,1
ZA,KNEE OPERATION,1
ZA,LARGE INTESTINE PERFORATION,1
ZA,LEUKOPENIA,1
ZA,LIP SWELLING,1
ZA,LIVIDITY,1
ZA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
ZA,LOWER RESPIRATORY TRACT INFLAMMATION,1
ZA,LUNG INFECTION,1
ZA,LUPUS-LIKE SYNDROME,1
ZA,LYMPHOCYTE COUNT DECREASED,1
ZA,MACROCYTOSIS,1
ZA,MACULAR DEGENERATION,1
ZA,MARFAN^S SYNDROME,1
ZA,MASTECTOMY,1
ZA,MATERNAL EXPOSURE DURING PREGNANCY,1
ZA,MELAENA,1
ZA,MEMORY IMPAIRMENT,1
ZA,MENINGOCOCCAL SEPSIS,1
ZA,MENSTRUATION IRREGULAR,1
ZA,METASTASES TO LUNG,1
ZA,MITRAL VALVE PROLAPSE,1
ZA,MUCOSAL INFLAMMATION,1
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ZA,MUSCLE SPASMS,1
ZA,MUSCLE STRAIN,1
ZA,MUSCULOSKELETAL PAIN,1
ZA,MYELODYSPLASTIC SYNDROME,1
ZA,NAIL INFECTION,1
ZA,NASAL DISCOMFORT,1
ZA,NASAL OBSTRUCTION,1
ZA,NECK PAIN,1
ZA,NERVOUSNESS,1
ZA,NEUROPATHY PERIPHERAL,1
ZA,NEUTROPENIC INFECTION,1
ZA,NEUTROPENIC SEPSIS,1
ZA,NORMAL NEWBORN,1
ZA,OCULAR TOXICITY,1
ZA,OEDEMA,1
ZA,OPTIC NEURITIS,1
ZA,ORAL CANDIDIASIS,1
ZA,ORAL HERPES,1
ZA,ORAL MUCOSAL EXFOLIATION,1
ZA,OSTEONECROSIS,1
ZA,OSTEOPENIA,1
ZA,OSTEOPOROTIC FRACTURE,1
ZA,OSTEOSCLEROSIS,1
ZA,PAIN IN JAW,1
ZA,PARAESTHESIA,1
ZA,PARALYSIS,1
ZA,PARAPLEGIA,1
ZA,PATERNAL EXPOSURE TIMING UNSPECIFIED,1
ZA,PELVIC PROLAPSE,1
ZA,PEPTIC ULCER PERFORATION,1
ZA,PERIARTHRITIS,1
ZA,PERICARDIAL EFFUSION,1
ZA,PERICARDITIS,1
ZA,PERIPHERAL EMBOLISM,1
ZA,PERIPHERAL ISCHAEMIA,1
ZA,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
ZA,PHARYNGITIS,1
ZA,PHLEBITIS,1
ZA,PHOTODERMATOSIS,1
ZA,PHYSICAL DISABILITY,1
ZA,PNEUMOCONIOSIS,1
ZA,PNEUMONIA ASPIRATION,1
ZA,PNEUMONIA CYTOMEGALOVIRAL,1
ZA,POST PROCEDURAL DISCHARGE,1
ZA,POST PROCEDURAL HAEMORRHAGE,1
ZA,POSTOPERATIVE WOUND INFECTION,1
ZA,PREGNANCY ON CONTRACEPTIVE,1
ZA,PRODUCTIVE COUGH,1
ZA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ZA,PROSTATE CANCER,1
ZA,PRURITUS GENERALISED,1
ZA,PSORIASIS,1
ZA,PSORIATIC ARTHROPATHY,1
ZA,PULMONARY TOXICITY,1
ZA,PURULENT DISCHARGE,1
ZA,PURULENT PERICARDITIS,1
ZA,RAPIDLY PROGRESSIVE OSTEOARTHRITIS,1
ZA,RASH GENERALISED,1
ZA,RASH PRURITIC,1
ZA,RECTAL CANCER,1
ZA,RECTAL PROLAPSE,1
ZA,RECTOCELE,1
ZA,RED BLOOD CELL COUNT DECREASED,1
ZA,RED CELL DISTRIBUTION WIDTH INCREASED,1
ZA,RENAL CANCER METASTATIC,1
ZA,RESTLESS LEGS SYNDROME,1
ZA,RETINAL DETACHMENT,1
ZA,RHEUMATOID FACTOR INCREASED,1
ZA,RHINITIS ALLERGIC,1
ZA,RHINORRHOEA,1
ZA,ROAD TRAFFIC ACCIDENT,1
ZA,ROSAI-DORFMAN SYNDROME,1
ZA,ROTATOR CUFF SYNDROME,1
ZA,RUSSELL^S VIPER VENOM TIME ABNORMAL,1
ZA,SECRETION DISCHARGE,1
ZA,SELECTIVE IGG SUBCLASS DEFICIENCY,1
ZA,SHOCK,1
ZA,SHOULDER DEFORMITY,1
ZA,SHOULDER OPERATION,1
ZA,SJOGREN^S SYNDROME,1
ZA,SKIN ATROPHY,1
ZA,SKIN DISORDER,1
ZA,SKIN REACTION,1
ZA,SNEEZING,1
ZA,SPINAL CORD HAEMORRHAGE,1
ZA,SPLENOMEGALY,1
ZA,SPONDYLITIS,1
ZA,SQUAMOUS CELL CARCINOMA,1
ZA,STAPHYLOCOCCAL SKIN INFECTION,1
ZA,STAPHYLOCOCCUS TEST POSITIVE,1
ZA,STEVENS-JOHNSON SYNDROME,1
ZA,STOMA COMPLICATION,1
ZA,STOMATITIS,1
ZA,SWELLING FACE,1
ZA,SWOLLEN TONGUE,1
ZA,SYNOVIAL CYST,1
ZA,SYNOVITIS,1
ZA,SYSTEMIC LUPUS ERYTHEMATOSUS,1
ZA,TACHYCARDIA PAROXYSMAL,1
ZA,TAKAYASU^S ARTERITIS,1
ZA,TEMPOROMANDIBULAR JOINT SYNDROME,1
ZA,THERAPY NON-RESPONDER,1
ZA,THROAT IRRITATION,1
ZA,THYROID NEOPLASM,1
ZA,THYROIDECTOMY,1
ZA,TICK-BORNE FEVER,1
ZA,TOOTH ABSCESS,1
ZA,TOOTH FRACTURE,1
ZA,TUBERCULIN TEST POSITIVE,1
ZA,TUBERCULOSIS OF INTRATHORACIC LYMPH NODES,1
ZA,TUBULOINTERSTITIAL NEPHRITIS,1
ZA,UNDERDOSE,1
ZA,UNDERWEIGHT,1
ZA,UPPER RESPIRATORY TRACT INFLAMMATION,1
ZA,UPPER-AIRWAY COUGH SYNDROME,1
ZA,UROSEPSIS,1
ZA,UTERINE LEIOMYOMA,1
ZA,UTERINE NEOPLASM,1
ZA,UVEITIS,1
ZA,VARICOSE VEINS SUBLINGUAL,1
ZA,VASCULITIS,1
ZA,VERTEBRAL FORAMINAL STENOSIS,1
ZA,VERTEBRAL LESION,1
ZA,VISUAL IMPAIRMENT,1
ZA,VULVOVAGINAL CANDIDIASIS,1
ZA,WHEEZING,1
ZA,WHITE BLOOD CELL COUNT INCREASED,1
ZA,WOUND DEHISCENCE,1
ZA,WOUND SEPSIS,1
ZA,WRIST DEFORMITY,1
ES,TOXICITY TO VARIOUS AGENTS,73
ES,PANCYTOPENIA,57
ES,DRUG INEFFECTIVE,53
ES,CONDITION AGGRAVATED,52
ES,PYREXIA,43
ES,PNEUMONIA,37
ES,BONE MARROW FAILURE,35
ES,NEUTROPENIA,33
ES,NEUROTOXICITY,32
ES,ERYTHEMA,29
ES,SEPTIC SHOCK,29
ES,SOMNOLENCE,28
ES,THROMBOCYTOPENIA,27
ES,HEADACHE,26
ES,ANAEMIA,25
ES,TRANSAMINASES INCREASED,25
ES,MUCOSAL INFLAMMATION,24
ES,PAIN,24
ES,PLEURAL EFFUSION,21
ES,DISORIENTATION,20
ES,EUPHORIC MOOD,20
ES,LEUKOENCEPHALOPATHY,20
ES,ERYTHRODERMIC PSORIASIS,19
ES,RESPIRATORY FAILURE,19
ES,SKIN ULCER,19
ES,C-REACTIVE PROTEIN INCREASED,18
ES,PSORIASIS,18
ES,STUPOR,18
ES,VOMITING,18
ES,ASTHENIA,16
ES,CANDIDA INFECTION,16
ES,DEEP VEIN THROMBOSIS,16
ES,MOUTH ULCERATION,16
ES,INFECTION,15
ES,INJECTION SITE PAIN,15
ES,RHEUMATOID ARTHRITIS,15
ES,SEPSIS,15
ES,ARTHRITIS,14
ES,CYTOMEGALOVIRUS INFECTION,14
ES,DIARRHOEA,14
ES,HYPERTENSION,14
ES,NAUSEA,14
ES,POLYMYALGIA RHEUMATICA,14
ES,PSORIATIC ARTHROPATHY,14
ES,RED BLOOD CELL SEDIMENTATION RATE INCREASED,14
ES,ARTHRITIS INFECTIVE,13
ES,INFUSION RELATED REACTION,13
ES,INJECTION SITE ERYTHEMA,13
ES,MULTI-ORGAN FAILURE,13
ES,PAIN IN EXTREMITY,13
ES,URINARY TRACT INFECTION,13
ES,ARTHRALGIA,12
ES,DIZZINESS,12
ES,FEBRILE NEUTROPENIA,12
ES,HEPATOTOXICITY,12
ES,LEUKOPENIA,12
ES,DEMYELINATION,11
ES,FATIGUE,11
ES,INTRACRANIAL PRESSURE INCREASED,11
ES,MALAISE,11
ES,NASOPHARYNGITIS,11
ES,OVERDOSE,11
ES,PRODUCT USE IN UNAPPROVED INDICATION,11
ES,RASH,11
ES,CEREBELLAR SYNDROME,10
ES,DYSPHAGIA,10
ES,FALL,10
ES,GRAFT VERSUS HOST DISEASE,10
ES,HEPATITIS,10
ES,PNEUMONITIS,10
ES,RENAL FAILURE,10
ES,RESPIRATORY TRACT INFECTION,10
ES,VISCERAL LEISHMANIASIS,10
ES,WEIGHT DECREASED,10
ES,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,9
ES,BRONCHOPULMONARY ASPERGILLOSIS,9
ES,COUGH,9
ES,DEVICE RELATED INFECTION,9
ES,DYSPNOEA,9
ES,HAEMORRHAGE,9
ES,INJECTION SITE PRURITUS,9
ES,INTERSTITIAL LUNG DISEASE,9
ES,LYMPHADENOPATHY,9
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,9
ES,PRODUCT USE ISSUE,9
ES,RENAL IMPAIRMENT,9
ES,SCROTAL ULCER,9
ES,SINUSITIS,9
ES,STOMATITIS,9
ES,TUBERCULOSIS,9
ES,ACANTHAMOEBA INFECTION,8
ES,ATELECTASIS,8
ES,BLOOD CREATININE INCREASED,8
ES,BURSITIS,8
ES,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,8
ES,DEATH,8
ES,DRUG EFFECT INCOMPLETE,8
ES,FEELING ABNORMAL,8
ES,HEPATIC ENZYME INCREASED,8
ES,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,8
ES,PUSTULAR PSORIASIS,8
ES,SKIN EROSION,8
ES,TOXIC EPIDERMAL NECROLYSIS,8
ES,ACUTE KIDNEY INJURY,7
ES,ACUTE MYELOID LEUKAEMIA,7
ES,ACUTE MYOCARDIAL INFARCTION,7
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,7
ES,ASPERGILLUS INFECTION,7
ES,ATAXIA,7
ES,CHRONIC GRAFT VERSUS HOST DISEASE,7
ES,DECREASED IMMUNE RESPONSIVENESS,7
ES,DRUG INTOLERANCE,7
ES,EPSTEIN-BARR VIRUS INFECTION,7
ES,GAIT DISTURBANCE,7
ES,HISTIOCYTOSIS HAEMATOPHAGIC,7
ES,HYPERSENSITIVITY,7
ES,INFLAMMATION,7
ES,INJECTION SITE URTICARIA,7
ES,MEDICATION ERROR,7
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,7
ES,MYELODYSPLASTIC SYNDROME,7
ES,NASAL POLYPS,7
ES,PARAESTHESIA,7
ES,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
ES,STAPHYLOCOCCAL INFECTION,7
ES,ABDOMINAL PAIN UPPER,6
ES,ACUTE GRAFT VERSUS HOST DISEASE,6
ES,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,6
ES,ASPARTATE AMINOTRANSFERASE INCREASED,6
ES,ASTHMA,6
ES,ATRIAL FIBRILLATION,6
ES,CHEST PAIN,6
ES,DISEASE RECURRENCE,6
ES,HAEMATOTOXICITY,6
ES,HEMIPARESIS,6
ES,HYPERREFLEXIA,6
ES,ILEUS PARALYTIC,6
ES,IMMUNODEFICIENCY,6
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
ES,INJECTION SITE INFLAMMATION,6
ES,LUNG INFILTRATION,6
ES,NEOPLASM RECURRENCE,6
ES,PNEUMOTHORAX,6
ES,PULMONARY EMBOLISM,6
ES,RADICULOPATHY,6
ES,RHEUMATOID LUNG,6
ES,UVEITIS,6
ES,ABDOMINAL PAIN,5
ES,ALANINE AMINOTRANSFERASE INCREASED,5
ES,ALOPECIA,5
ES,ARTHRITIS BACTERIAL,5
ES,ATYPICAL FEMUR FRACTURE,5
ES,BACK PAIN,5
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,5
ES,BRONCHITIS,5
ES,CARDIAC FAILURE,5
ES,CEREBROVASCULAR ACCIDENT,5
ES,CYSTITIS HAEMORRHAGIC,5
ES,DEAFNESS NEUROSENSORY,5
ES,DECREASED APPETITE,5
ES,ENCEPHALOPATHY,5
ES,EOSINOPHILIA,5
ES,FACE OEDEMA,5
ES,FOLLICULITIS,5
ES,GASTROINTESTINAL DISORDER,5
ES,GRAFT VERSUS HOST DISEASE IN EYE,5
ES,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,5
ES,HERPES ZOSTER,5
ES,HYPERKERATOSIS,5
ES,HYPOAESTHESIA,5
ES,HYPOTENSION,5
ES,ILL-DEFINED DISORDER,5
ES,INJECTION SITE HAEMATOMA,5
ES,MENINGITIS,5
ES,MYALGIA,5
ES,MYOCARDIAL INFARCTION,5
ES,OEDEMA,5
ES,OEDEMA PERIPHERAL,5
ES,PERIPHERAL SENSORY NEUROPATHY,5
ES,PERIPHERAL SWELLING,5
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
ES,PROSTATE CANCER,5
ES,PRURITUS,5
ES,PULMONARY TOXICITY,5
ES,PULMONARY TUBERCULOSIS,5
ES,RHINITIS ALLERGIC,5
ES,SLEEP APNOEA SYNDROME,5
ES,THROMBOTIC MICROANGIOPATHY,5
ES,URTICARIA,5
ES,ABDOMINAL DISCOMFORT,4
ES,ACCIDENTAL OVERDOSE,4
ES,ACUTE RESPIRATORY FAILURE,4
ES,ADVERSE DRUG REACTION,4
ES,AGRANULOCYTOSIS,4
ES,AUDITORY PERSEVERATION,4
ES,BACTERAEMIA,4
ES,BACTERIAL INFECTION,4
ES,BICYTOPENIA,4
ES,BLADDER CANCER,4
ES,BLISTER,4
ES,BLOOD CHOLESTEROL INCREASED,4
ES,CACHEXIA,4
ES,CARDIOTOXICITY,4
ES,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,4
ES,CONFUSIONAL STATE,4
ES,DEPRESSION,4
ES,DIPLOPIA,4
ES,DISEASE PROGRESSION,4
ES,DISSEMINATED TUBERCULOSIS,4
ES,DRUG ADMINISTRATION ERROR,4
ES,ENCEPHALITIS,4
ES,ENTEROCOCCAL INFECTION,4
ES,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,4
ES,ESCHERICHIA URINARY TRACT INFECTION,4
ES,HERPES VIRUS INFECTION,4
ES,HYPOKALAEMIA,4
ES,IMMUNOSUPPRESSION,4
ES,INCORRECT DOSAGE ADMINISTERED,4
ES,INJECTION SITE REACTION,4
ES,JOINT SWELLING,4
ES,LYMPHOPENIA,4
ES,MALIGNANT MELANOMA,4
ES,MOBILITY DECREASED,4
ES,NEPHROPATHY TOXIC,4
ES,NYSTAGMUS,4
ES,PARESIS CRANIAL NERVE,4
ES,PLEURISY,4
ES,PREMATURE MENOPAUSE,4
ES,PULMONARY OEDEMA,4
ES,SKIN LESION,4
ES,SQUAMOUS CELL CARCINOMA,4
ES,SYSTEMIC MYCOSIS,4
ES,THERAPEUTIC RESPONSE DECREASED,4
ES,ABASIA,3
ES,ABSCESS,3
ES,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,3
ES,ADVERSE EVENT,3
ES,ANGIOEDEMA,3
ES,ANXIETY,3
ES,APHASIA,3
ES,APHTHOUS ULCER,3
ES,APLASIA,3
ES,ARRHYTHMIA,3
ES,AUTOIMMUNE HEPATITIS,3
ES,BLOOD GLUCOSE ABNORMAL,3
ES,BLOOD PRESSURE DECREASED,3
ES,BLOOD PRESSURE INCREASED,3
ES,BLOOD URIC ACID INCREASED,3
ES,BODY TEMPERATURE INCREASED,3
ES,BRONCHOSPASM,3
ES,CATARACT,3
ES,CELLULITIS,3
ES,CEREBRAL THROMBOSIS,3
ES,CHOLECYSTITIS ACUTE,3
ES,CLEAR CELL RENAL CELL CARCINOMA,3
ES,CLOSTRIDIUM DIFFICILE INFECTION,3
ES,COLECTOMY,3
ES,COLITIS ULCERATIVE,3
ES,COLON CANCER,3
ES,CONGENITAL CARDIOVASCULAR ANOMALY,3
ES,CONTUSION,3
ES,CROHN^S DISEASE,3
ES,CUTANEOUS LUPUS ERYTHEMATOSUS,3
ES,DERMATITIS EXFOLIATIVE,3
ES,DERMATITIS PSORIASIFORM,3
ES,DIABETES MELLITUS,3
ES,DISCOMFORT,3
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
ES,DYSARTHRIA,3
ES,DYSMETRIA,3
ES,EPISTAXIS,3
ES,ESCHERICHIA BACTERAEMIA,3
ES,FEELING HOT,3
ES,FINGER DEFORMITY,3
ES,FLUSHING,3
ES,FOETAL EXPOSURE DURING PREGNANCY,3
ES,FUNGAL INFECTION,3
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
ES,GASTROINTESTINAL HAEMORRHAGE,3
ES,GRAFT VERSUS HOST DISEASE IN LUNG,3
ES,HAEMATOMA,3
ES,HAEMOGLOBIN DECREASED,3
ES,HEPATIC FUNCTION ABNORMAL,3
ES,HEPATITIS B REACTIVATION,3
ES,HYPOPROTEINAEMIA,3
ES,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,3
ES,IMPAIRED HEALING,3
ES,INFLUENZA,3
ES,INJECTION SITE MASS,3
ES,INJECTION SITE WARMTH,3
ES,INTESTINAL PERFORATION,3
ES,IRRITABILITY,3
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
ES,LEUKAEMIA RECURRENT,3
ES,LIVER INJURY,3
ES,LOCAL SWELLING,3
ES,MATERNAL EXPOSURE BEFORE PREGNANCY,3
ES,METABOLIC ACIDOSIS,3
ES,MOUTH HAEMORRHAGE,3
ES,MUCOSAL TOXICITY,3
ES,MUSCULOSKELETAL STIFFNESS,3
ES,NAIL DYSTROPHY,3
ES,NECROSIS,3
ES,NEOPLASM PROGRESSION,3
ES,NON-HODGKIN^S LYMPHOMA,3
ES,ODYNOPHAGIA,3
ES,ORAL CANDIDIASIS,3
ES,OROPHARYNGEAL PAIN,3
ES,OSTEONECROSIS OF JAW,3
ES,PARADOXICAL DRUG REACTION,3
ES,PETECHIAE,3
ES,PHARYNGITIS,3
ES,PLATELET COUNT DECREASED,3
ES,PNEUMONIA LEGIONELLA,3
ES,PROTEUS INFECTION,3
ES,PSEUDOMONAS INFECTION,3
ES,PULMONARY FIBROSIS,3
ES,RASH PRURITIC,3
ES,RED BLOOD CELL SCHISTOCYTES PRESENT,3
ES,RESPIRATORY DISORDER,3
ES,SECOND PRIMARY MALIGNANCY,3
ES,SECRETION DISCHARGE,3
ES,SKIN DISORDER,3
ES,SKIN HYPERPIGMENTATION,3
ES,SKIN REACTION,3
ES,SPEECH DISORDER,3
ES,SPINAL COMPRESSION FRACTURE,3
ES,STAPHYLOCOCCAL BACTERAEMIA,3
ES,STREPTOCOCCAL INFECTION,3
ES,TACHYCARDIA,3
ES,THROMBOSIS,3
ES,TOOTH DISORDER,3
ES,TOXIC SKIN ERUPTION,3
ES,UPPER RESPIRATORY TRACT INFECTION,3
ES,VIRAL HAEMORRHAGIC CYSTITIS,3
ES,VISUAL IMPAIRMENT,3
ES,ABDOMINAL SEPSIS,2
ES,ABNORMAL BEHAVIOUR,2
ES,ACIDOSIS HYPERCHLORAEMIC,2
ES,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,2
ES,ALANINE AMINOTRANSFERASE ABNORMAL,2
ES,ALVEOLITIS ALLERGIC,2
ES,ANAL FISTULA,2
ES,ANAL INFLAMMATION,2
ES,ANGIOCENTRIC LYMPHOMA,2
ES,ANKYLOSING SPONDYLITIS,2
ES,ASPARTATE AMINOTRANSFERASE ABNORMAL,2
ES,ATYPICAL MYCOBACTERIAL INFECTION,2
ES,AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME,2
ES,BASAL CELL CARCINOMA,2
ES,BLOOD TRIGLYCERIDES INCREASED,2
ES,BONE MARROW TOXICITY,2
ES,BRAIN INJURY,2
ES,CARDIAC ARREST,2
ES,CATHETER SITE INFECTION,2
ES,CELL-MEDIATED IMMUNE DEFICIENCY,2
ES,CHOLELITHIASIS,2
ES,CHORIORETINOPATHY,2
ES,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,2
ES,CHRONIC KIDNEY DISEASE,2
ES,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
ES,CLAUDICATION OF JAW MUSCLES,2
ES,CLOSTRIDIUM DIFFICILE COLITIS,2
ES,COAGULOPATHY,2
ES,COGNITIVE DISORDER,2
ES,COLITIS,2
ES,CONVULSION,2
ES,COSTOCHONDRITIS,2
ES,CUTANEOUS LEISHMANIASIS,2
ES,CUTANEOUS LYMPHOMA,2
ES,CUTANEOUS VASCULITIS,2
ES,CYTOMEGALOVIRUS CHORIORETINITIS,2
ES,CYTOMEGALOVIRUS GASTROENTERITIS,2
ES,DIVERTICULITIS,2
ES,DRUG DISPENSING ERROR,2
ES,DRUG EFFECT DECREASED,2
ES,DRUG HYPERSENSITIVITY,2
ES,DRUG LEVEL INCREASED,2
ES,DRUG-INDUCED LIVER INJURY,2
ES,DYSKINESIA,2
ES,DYSTONIA,2
ES,DYSURIA,2
ES,EAR INFECTION,2
ES,ECZEMA,2
ES,EMBOLISM,2
ES,ENTEROCOLITIS,2
ES,EPSTEIN-BARR VIRAEMIA,2
ES,ESCHERICHIA SEPSIS,2
ES,EYE PAIN,2
ES,EYELID OEDEMA,2
ES,FEAR OF INJECTION,2
ES,FEBRILE BONE MARROW APLASIA,2
ES,FOOT DEFORMITY,2
ES,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,2
ES,GASTROINTESTINAL TOXICITY,2
ES,GENERAL PHYSICAL HEALTH DETERIORATION,2
ES,GENITAL ULCERATION,2
ES,GROIN PAIN,2
ES,HAEMATEMESIS,2
ES,HAEMOGLOBIN ABNORMAL,2
ES,HEPATIC FAILURE,2
ES,HODGKIN^S DISEASE,2
ES,HYDROCEPHALUS,2
ES,HYPERGLYCAEMIA,2
ES,HYPERHIDROSIS,2
ES,HYPOAESTHESIA ORAL,2
ES,HYPONATRAEMIA,2
ES,HYPOXIA,2
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
ES,INCORRECT DRUG ADMINISTRATION DURATION,2
ES,INJECTION SITE HAEMORRHAGE,2
ES,INJECTION SITE RASH,2
ES,INTENTIONAL PRODUCT USE ISSUE,2
ES,INVASIVE DUCTAL BREAST CARCINOMA,2
ES,ISCHAEMIC STROKE,2
ES,JC VIRUS TEST POSITIVE,2
ES,JUVENILE IDIOPATHIC ARTHRITIS,2
ES,LATENT TUBERCULOSIS,2
ES,LEFT VENTRICULAR DYSFUNCTION,2
ES,LETHARGY,2
ES,LOBAR PNEUMONIA,2
ES,LOCALISED INFECTION,2
ES,LOWER RESPIRATORY TRACT INFECTION,2
ES,LUNG NEOPLASM MALIGNANT,2
ES,LUPUS-LIKE SYNDROME,2
ES,MALIGNANT NEOPLASM OF CONJUNCTIVA,2
ES,MALIGNANT NEOPLASM PROGRESSION,2
ES,MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL,2
ES,MELAENA,2
ES,MENINGOENCEPHALITIS HERPETIC,2
ES,MOTOR DYSFUNCTION,2
ES,MUSCULAR WEAKNESS,2
ES,MUSCULOSKELETAL DISORDER,2
ES,MUSCULOSKELETAL PAIN,2
ES,MYCOBACTERIUM FORTUITUM INFECTION,2
ES,MYELOPATHY,2
ES,MYOCLONUS,2
ES,NEUROLOGICAL DECOMPENSATION,2
ES,ONYCHOCLASIS,2
ES,OPTIC ISCHAEMIC NEUROPATHY,2
ES,ORAL PAIN,2
ES,OSTEOPENIA,2
ES,OSTEOPOROSIS,2
ES,PALLOR,2
ES,PERIPHERAL ISCHAEMIA,2
ES,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
ES,PERSONALITY DISORDER,2
ES,PHLEBITIS,2
ES,PNEUMONIA PNEUMOCOCCAL,2
ES,POLYMYOSITIS,2
ES,POLYOMAVIRUS TEST POSITIVE,2
ES,POST PROCEDURAL COMPLICATION,2
ES,PRODUCTIVE COUGH,2
ES,PRURITUS GENERALISED,2
ES,PSEUDOMONAL SEPSIS,2
ES,PSYCHOMOTOR HYPERACTIVITY,2
ES,PSYCHOTIC DISORDER,2
ES,PULMONARY SEPSIS,2
ES,RASH ERYTHEMATOUS,2
ES,RECTAL ADENOCARCINOMA,2
ES,RENAL CELL CARCINOMA,2
ES,RENAL DISORDER,2
ES,RENAL FAILURE CHRONIC,2
ES,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
ES,RHEUMATOID FACTOR DECREASED,2
ES,RHEUMATOID FACTOR INCREASED,2
ES,ROAD TRAFFIC ACCIDENT,2
ES,SCIATICA,2
ES,SEPTIC ARTHRITIS STAPHYLOCOCCAL,2
ES,SKIN BURNING SENSATION,2
ES,SKIN EXFOLIATION,2
ES,SKIN HAEMORRHAGE,2
ES,SPINAL DISORDER,2
ES,SPINAL FRACTURE,2
ES,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,2
ES,SUBILEUS,2
ES,SURGERY,2
ES,SWELLING,2
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,2
ES,THROMBOPHLEBITIS,2
ES,TRANSIENT ISCHAEMIC ATTACK,2
ES,TRANSPLANT DYSFUNCTION,2
ES,TREMOR,2
ES,TRICHODYSPLASIA SPINULOSA,2
ES,TUMOUR LYSIS SYNDROME,2
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,2
ES,URINARY RETENTION,2
ES,URINARY TRACT INFECTION BACTERIAL,2
ES,VENOOCCLUSIVE LIVER DISEASE,2
ES,VENTRICULAR TACHYCARDIA,2
ES,VULVOVAGINAL CANDIDIASIS,2
ES,WRONG DRUG ADMINISTERED,2
ES,ABDOMINAL ABSCESS,1
ES,ABDOMINAL DISTENSION,1
ES,ABORTION INDUCED,1
ES,ACARODERMATITIS,1
ES,ACCIDENT,1
ES,ACINETOBACTER INFECTION,1
ES,ACINETOBACTER TEST POSITIVE,1
ES,ACUTE CORONARY SYNDROME,1
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,1
ES,ACUTE MOTOR AXONAL NEUROPATHY,1
ES,ACUTE MYELOID LEUKAEMIA RECURRENT,1
ES,ACUTE SINUSITIS,1
ES,AGGRESSION,1
ES,ALOPECIA AREATA,1
ES,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,AMYLOIDOSIS,1
ES,AMYOTROPHIC LATERAL SCLEROSIS,1
ES,ANAL HAEMORRHAGE,1
ES,ANALGESIC THERAPY,1
ES,ANAPHYLACTIC REACTION,1
ES,ANGINA PECTORIS,1
ES,ANTINUCLEAR ANTIBODY INCREASED,1
ES,APATHY,1
ES,APHONIA,1
ES,APHTHOUS STOMATITIS,1
ES,APLASIA PURE RED CELL,1
ES,APPENDICITIS,1
ES,APPLICATION SITE PAPULES,1
ES,ARACHNOIDITIS,1
ES,ARTERIOSCLEROSIS,1
ES,ARTHROPATHY,1
ES,ASCITES,1
ES,AUTOIMMUNE DISORDER,1
ES,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
ES,AUTONOMIC NEUROPATHY,1
ES,AXONAL NEUROPATHY,1
ES,B-CELL LYMPHOMA,1
ES,BACTERIAL SEPSIS,1
ES,BENIGN NEOPLASM OF THYROID GLAND,1
ES,BILIARY NEOPLASM,1
ES,BLADDER NEOPLASM,1
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE III,1
ES,BLAST CELL COUNT INCREASED,1
ES,BLEEDING VARICOSE VEIN,1
ES,BLINDNESS,1
ES,BLINDNESS TRANSIENT,1
ES,BLINDNESS UNILATERAL,1
ES,BLOOD CHOLESTEROL ABNORMAL,1
ES,BLOOD FOLATE DECREASED,1
ES,BLOOD GLUCOSE INCREASED,1
ES,BLOOD PRESSURE FLUCTUATION,1
ES,BODY MASS INDEX INCREASED,1
ES,BONE INFARCTION,1
ES,BONE PAIN,1
ES,BRAIN STEM SYNDROME,1
ES,BREAST CANCER,1
ES,BREAST CYST,1
ES,BREAST NEOPLASM,1
ES,BULLOUS IMPETIGO,1
ES,BURKITT^S LYMPHOMA RECURRENT,1
ES,CALCIUM DEFICIENCY,1
ES,CANDIDA PNEUMONIA,1
ES,CARDIAC DISORDER,1
ES,CARDIAC FAILURE CONGESTIVE,1
ES,CARDIOMEGALY,1
ES,CATHETER SITE ERYTHEMA,1
ES,CATHETER SITE PAIN,1
ES,CATHETER SITE SWELLING,1
ES,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
ES,CEREBRAL ISCHAEMIA,1
ES,CEREBRAL VENOUS THROMBOSIS,1
ES,CERVICAL DYSPLASIA,1
ES,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,1
ES,CHEST DISCOMFORT,1
ES,CHEST X-RAY ABNORMAL,1
ES,CHILLS,1
ES,CHOKING SENSATION,1
ES,CHOLECYSTITIS CHRONIC,1
ES,CHOLESTEATOMA,1
ES,CHONDROPATHY,1
ES,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
ES,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT,1
ES,CHRONIC RESPIRATORY DISEASE,1
ES,CLUMSINESS,1
ES,CNS VENTRICULITIS,1
ES,COLON CANCER METASTATIC,1
ES,COLON NEOPLASM,1
ES,COLORECTAL ADENOCARCINOMA,1
ES,COMPLEMENT FACTOR DECREASED,1
ES,COMPLETED SUICIDE,1
ES,CONCOMITANT DISEASE AGGRAVATED,1
ES,CONJUNCTIVAL NEOPLASM,1
ES,CONJUNCTIVITIS VIRAL,1
ES,CONSTIPATION,1
ES,COORDINATION ABNORMAL,1
ES,CORONARY ARTERY DISEASE,1
ES,CRANIOCEREBRAL INJURY,1
ES,CREPITATIONS,1
ES,CRITICAL ILLNESS POLYNEUROPATHY,1
ES,CUSHINGOID,1
ES,CYANOSIS,1
ES,CYST,1
ES,CYSTIC FIBROSIS,1
ES,CYTOMEGALOVIRUS COLITIS,1
ES,CYTOMEGALOVIRUS ENTERITIS,1
ES,CYTOMEGALOVIRUS TEST POSITIVE,1
ES,CYTOPENIA,1
ES,DEAFNESS,1
ES,DEMYELINATING POLYNEUROPATHY,1
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,1
ES,DEPRESSED MOOD,1
ES,DERMATITIS ACNEIFORM,1
ES,DERMATITIS ALLERGIC,1
ES,DERMATITIS BULLOUS,1
ES,DEVICE DISLOCATION,1
ES,DEVICE LOOSENING,1
ES,DEVICE RELATED SEPSIS,1
ES,DIAPHRAGMATIC DISORDER,1
ES,DIARRHOEA INFECTIOUS,1
ES,DIFFUSE ALOPECIA,1
ES,DIFFUSE LARGE B-CELL LYMPHOMA,1
ES,DIFFUSE LARGE B-CELL LYMPHOMA STAGE II,1
ES,DISSEMINATED CRYPTOCOCCOSIS,1
ES,DISTURBANCE IN ATTENTION,1
ES,DRUG LEVEL ABOVE THERAPEUTIC,1
ES,DRUG PRESCRIBING ERROR,1
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
ES,DRUG RESISTANCE,1
ES,DRUG SPECIFIC ANTIBODY,1
ES,DRY MOUTH,1
ES,DYSGEUSIA,1
ES,DYSGRAPHIA,1
ES,DYSPEPSIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSTHYMIC DISORDER,1
ES,EAR PRURITUS,1
ES,EATING DISORDER,1
ES,EMPHYSEMA,1
ES,EMPYEMA,1
ES,ENCEPHALITIS VIRAL,1
ES,ENDOCARDITIS,1
ES,ENDOMETRIAL ADENOCARCINOMA,1
ES,ENDOMETRIAL CANCER,1
ES,ENTEROBACTER INFECTION,1
ES,ENTEROCOCCUS TEST POSITIVE,1
ES,ENTEROCUTANEOUS FISTULA,1
ES,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
ES,EPSTEIN-BARR VIRUS TEST POSITIVE,1
ES,ERYTHEMA MULTIFORME,1
ES,ESCHERICHIA INFECTION,1
ES,EWING^S SARCOMA,1
ES,EXPOSURE DURING PREGNANCY,1
ES,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
ES,EXTRAPULMONARY TUBERCULOSIS,1
ES,EXTRAPYRAMIDAL DISORDER,1
ES,EYE INFLAMMATION,1
ES,EYE PRURITUS,1
ES,EYE SWELLING,1
ES,EYELID PTOSIS,1
ES,FACIAL PAIN,1
ES,FAT TISSUE INCREASED,1
ES,FEAR,1
ES,FEEDING DISORDER,1
ES,FEMUR FRACTURE,1
ES,FIBROMA,1
ES,FIBROMYALGIA,1
ES,FIBULA FRACTURE,1
ES,FOETAL DEATH,1
ES,FORMICATION,1
ES,FRACTURE,1
ES,FRACTURE DELAYED UNION,1
ES,FUNGAL SEPSIS,1
ES,FUNGAL SKIN INFECTION,1
ES,FUSARIUM INFECTION,1
ES,GASTRIC DISORDER,1
ES,GASTRIC INFECTION,1
ES,GASTRIC ULCER,1
ES,GASTROENTERITIS,1
ES,GASTROENTERITIS SALMONELLA,1
ES,GASTROINTESTINAL DYSPLASIA,1
ES,GINGIVAL ABSCESS,1
ES,GINGIVAL PAIN,1
ES,GLIOBLASTOMA,1
ES,GLOMERULONEPHRITIS MEMBRANOUS,1
ES,GONOCOCCAL PELVIC INFLAMMATORY DISEASE,1
ES,GRAFT VERSUS HOST DISEASE IN INTESTINE,1
ES,GRAFT VERSUS HOST DISEASE IN SKIN,1
ES,GRANULOMATOUS PNEUMONITIS,1
ES,GROWTH RETARDATION,1
ES,GUILLAIN-BARRE SYNDROME,1
ES,GYNAECOMASTIA,1
ES,HAEMATOCHEZIA,1
ES,HAEMATOCOLPOS,1
ES,HAEMATURIA,1
ES,HAEMOLYTIC ANAEMIA,1
ES,HAEMOLYTIC URAEMIC SYNDROME,1
ES,HAEMOPTYSIS,1
ES,HAIR COLOUR CHANGES,1
ES,HAIR FOLLICLE TUMOUR BENIGN,1
ES,HAND DEFORMITY,1
ES,HEAD DISCOMFORT,1
ES,HEART RATE INCREASED,1
ES,HELICOBACTER INFECTION,1
ES,HEPATIC STEATOSIS,1
ES,HEPATITIS TOXIC,1
ES,HEPATOSPLENOMEGALY,1
ES,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
ES,HIATUS HERNIA,1
ES,HIDRADENITIS,1
ES,HILAR LYMPHADENOPATHY,1
ES,HIP FRACTURE,1
ES,HISTOPLASMOSIS,1
ES,HOT FLUSH,1
ES,HUMERUS FRACTURE,1
ES,HYPERAESTHESIA,1
ES,HYPERTENSIVE HEART DISEASE,1
ES,HYPERTRANSAMINASAEMIA,1
ES,HYPERTRICHOSIS,1
ES,HYPERTRIGLYCERIDAEMIA,1
ES,HYPOCHROMIC ANAEMIA,1
ES,HYPOTHYROIDISM,1
ES,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
ES,IMMUNE THROMBOCYTOPENIC PURPURA,1
ES,INCORRECT DOSE ADMINISTERED,1
ES,INCORRECT PRODUCT STORAGE,1
ES,INCORRECT STORAGE OF DRUG,1
ES,INCREASED APPETITE,1
ES,INCREASED TENDENCY TO BRUISE,1
ES,INFECTED CYST,1
ES,INFECTED SEROMA,1
ES,INFECTIOUS MONONUCLEOSIS,1
ES,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
ES,INFLAMMATORY BOWEL DISEASE,1
ES,INFLAMMATORY MARKER INCREASED,1
ES,INFUSION SITE REACTION,1
ES,INHIBITORY DRUG INTERACTION,1
ES,INJECTION SITE BRUISING,1
ES,INJECTION SITE DISCOMFORT,1
ES,INJECTION SITE INDURATION,1
ES,INJECTION SITE IRRITATION,1
ES,INJECTION SITE NECROSIS,1
ES,INJECTION SITE PLAQUE,1
ES,INJURY,1
ES,INTENTIONAL SELF-INJURY,1
ES,INTERMITTENT CLAUDICATION,1
ES,INTERNAL HAEMORRHAGE,1
ES,INTERVERTEBRAL DISC DISORDER,1
ES,INTESTINAL ISCHAEMIA,1
ES,INTESTINAL OBSTRUCTION,1
ES,INTESTINAL POLYP,1
ES,INTESTINAL STENOSIS,1
ES,INTESTINAL ULCER,1
ES,JC VIRUS INFECTION,1
ES,JOINT DISLOCATION,1
ES,JOINT EFFUSION,1
ES,JOINT STIFFNESS,1
ES,KAPOSI^S SARCOMA,1
ES,KIDNEY INFECTION,1
ES,KLEBSIELLA INFECTION,1
ES,KLEBSIELLA SEPSIS,1
ES,KLEBSIELLA TEST POSITIVE,1
ES,KNEE ARTHROPLASTY,1
ES,KYPHOSIS,1
ES,LABORATORY TEST ABNORMAL,1
ES,LACUNAR STROKE,1
ES,LARGE CELL LUNG CANCER,1
ES,LARGE INTESTINE PERFORATION,1
ES,LEUKOCYTOSIS,1
ES,LEUKOPLAKIA,1
ES,LIBIDO DECREASED,1
ES,LIMB CRUSHING INJURY,1
ES,LIMB DEFORMITY,1
ES,LIMB INJURY,1
ES,LIP ULCERATION,1
ES,LIPIDS INCREASED,1
ES,LISTERIA SEPSIS,1
ES,LISTERIOSIS,1
ES,LIVER DISORDER,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG ADENOCARCINOMA METASTATIC,1
ES,LUNG CONSOLIDATION,1
ES,LUNG INFECTION,1
ES,LUPUS NEPHRITIS,1
ES,LYMPH NODE TUBERCULOSIS,1
ES,LYMPHADENOPATHY MEDIASTINAL,1
ES,LYMPHOCYTE PERCENTAGE DECREASED,1
ES,LYMPHOPROLIFERATIVE DISORDER,1
ES,MACULAR DEGENERATION,1
ES,MACULAR OEDEMA,1
ES,MAJOR DEPRESSION,1
ES,MALIGNANT FIBROUS HISTIOCYTOMA,1
ES,MANTLE CELL LYMPHOMA RECURRENT,1
ES,MECHANICAL URTICARIA,1
ES,MEDICATION RESIDUE PRESENT,1
ES,MENINGITIS CHEMICAL,1
ES,MENINGITIS CRYPTOCOCCAL,1
ES,MENINGITIS LISTERIA,1
ES,MESENTERIC PANNICULITIS,1
ES,METABOLIC DISORDER,1
ES,METRORRHAGIA,1
ES,MIGRAINE,1
ES,MILLER FISHER SYNDROME,1
ES,MITRAL VALVE INCOMPETENCE,1
ES,MONONEURITIS,1
ES,MONONEUROPATHY MULTIPLEX,1
ES,MONOPLEGIA,1
ES,MOOD SWINGS,1
ES,MORPHOEA,1
ES,MOUTH CYST EXCISION,1
ES,MOUTH SWELLING,1
ES,MUCOSAL EROSION,1
ES,MUCOSAL HAEMORRHAGE,1
ES,MULTI-ORGAN DISORDER,1
ES,MULTIPLE-DRUG RESISTANCE,1
ES,MUSCLE TIGHTNESS,1
ES,MUTISM,1
ES,MYCOSIS FUNGOIDES,1
ES,MYELOFIBROSIS,1
ES,NAIL DISCOLOURATION,1
ES,NAIL DISORDER,1
ES,NECK PAIN,1
ES,NEOPLASM MALIGNANT,1
ES,NEPHROPATHY,1
ES,NERVE COMPRESSION,1
ES,NERVOUSNESS,1
ES,NEUROLOGICAL SYMPTOM,1
ES,NEUROPATHY PERIPHERAL,1
ES,NEUTROPENIC COLITIS,1
ES,NEUTROPHILIA,1
ES,NIGHT SWEATS,1
ES,NIGHTMARE,1
ES,NIKOLSKY^S SIGN,1
ES,NO ADVERSE EVENT,1
ES,NO THERAPEUTIC RESPONSE,1
ES,NODULE,1
ES,NON-SMALL CELL LUNG CANCER,1
ES,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
ES,OEDEMA GENITAL,1
ES,OESOPHAGEAL CANDIDIASIS,1
ES,OESOPHAGEAL MUCOSAL TEAR,1
ES,OLIGURIA,1
ES,ONYCHOLYSIS,1
ES,ONYCHOMADESIS,1
ES,OPTIC NEURITIS,1
ES,ORAL DISCOMFORT,1
ES,ORAL DISORDER,1
ES,ORAL HERPES,1
ES,ORAL LICHEN PLANUS,1
ES,ORAL MUCOSA EROSION,1
ES,ORAL PRURITUS,1
ES,ORGANISING PNEUMONIA,1
ES,OROPHARYNGEAL CANDIDIASIS,1
ES,OSTEOARTHRITIS,1
ES,OSTEOMYELITIS,1
ES,OSTEONECROSIS,1
ES,OVARIAN CANCER METASTATIC,1
ES,OVARIAN CANCER STAGE IV,1
ES,OVARIAN CYST,1
ES,OVARIAN ENDOMETRIOID CARCINOMA,1
ES,OXYGEN SATURATION DECREASED,1
ES,PACHYMENINGITIS,1
ES,PAIN OF SKIN,1
ES,PALATAL OEDEMA,1
ES,PALMAR ERYTHEMA,1
ES,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
ES,PALPITATIONS,1
ES,PANCREATIC CARCINOMA,1
ES,PANCREATIC CARCINOMA METASTATIC,1
ES,PANCREATITIS ACUTE,1
ES,PAPILLARY RENAL CELL CARCINOMA,1
ES,PAPILLARY THYROID CANCER,1
ES,PAPULE,1
ES,PARAINFLUENZAE VIRUS INFECTION,1
ES,PARAKERATOSIS,1
ES,PARALYSIS,1
ES,PARAPROTEINAEMIA,1
ES,PARESIS,1
ES,PATHOGEN RESISTANCE,1
ES,PELVIC FRACTURE,1
ES,PELVIC INFLAMMATORY DISEASE,1
ES,PELVIC PAIN,1
ES,PEMPHIGOID,1
ES,PERITONITIS,1
ES,PHARYNGEAL ERYTHEMA,1
ES,PHOTOPHOBIA,1
ES,PHOTOSENSITIVITY REACTION,1
ES,PLASMABLASTIC LYMPHOMA,1
ES,PLEUROPERICARDITIS,1
ES,PNEUMOCOCCAL INFECTION,1
ES,PNEUMONIA HAEMOPHILUS,1
ES,PNEUMONIA KLEBSIELLA,1
ES,PNEUMONIA NECROTISING,1
ES,PNEUMONIA STREPTOCOCCAL,1
ES,POLYARTERITIS NODOSA,1
ES,POLYARTHRITIS,1
ES,POLYCHONDRITIS,1
ES,POLYCYTHAEMIA,1
ES,POST PROCEDURAL DISCOMFORT,1
ES,POST PROCEDURAL HAEMATOMA,1
ES,POST PROCEDURAL HAEMORRHAGE,1
ES,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA,1
ES,PRESCRIBED OVERDOSE,1
ES,PRESYNCOPE,1
ES,PROCEDURAL PAIN,1
ES,PROTEINURIA,1
ES,PSITTACOSIS,1
ES,PSYCHOMOTOR RETARDATION,1
ES,PUBIS FRACTURE,1
ES,PULMONARY ALVEOLAR HAEMORRHAGE,1
ES,PULMONARY ARTERY THROMBOSIS,1
ES,PULMONARY FUNCTION TEST ABNORMAL,1
ES,PULMONARY HAEMORRHAGE,1
ES,PULMONARY HYPERTENSION,1
ES,PULMONARY MASS,1
ES,PURPURA,1
ES,PURULENT DISCHARGE,1
ES,PYELONEPHRITIS,1
ES,PYONEPHROSIS,1
ES,RADICULITIS,1
ES,RALES,1
ES,RASH GENERALISED,1
ES,RASH MACULO-PAPULAR,1
ES,RASH MORBILLIFORM,1
ES,RASH PUSTULAR,1
ES,RECTAL CANCER,1
ES,RECTAL HAEMORRHAGE,1
ES,RENAL CANCER,1
ES,RENAL CANCER RECURRENT,1
ES,RENAL COLIC,1
ES,RENAL FAILURE ACUTE,1
ES,RENAL NEOPLASM,1
ES,RENAL PAIN,1
ES,RESPIRATORY DISTRESS,1
ES,RESPIRATORY RATE INCREASED,1
ES,RESTLESSNESS,1
ES,RETINAL HAEMORRHAGE,1
ES,RETINAL OEDEMA,1
ES,RETINAL VASCULAR DISORDER,1
ES,SALMONELLA SEPSIS,1
ES,SALMONELLOSIS,1
ES,SALPINGITIS,1
ES,SARCOIDOSIS,1
ES,SCAB,1
ES,SCOLIOSIS,1
ES,SEASONAL ALLERGY,1
ES,SENSORY DISTURBANCE,1
ES,SHOCK,1
ES,SHRINKING LUNG SYNDROME,1
ES,SINUS HEADACHE,1
ES,SINUS TACHYCARDIA,1
ES,SKIN BACTERIAL INFECTION,1
ES,SKIN CANCER,1
ES,SKIN DISCOLOURATION,1
ES,SKIN MASS,1
ES,SKIN TOXICITY,1
ES,SMALL CELL LUNG CANCER EXTENSIVE STAGE,1
ES,SMALL INTESTINE ADENOCARCINOMA,1
ES,SOFT TISSUE NECROSIS,1
ES,SOLAR LENTIGO,1
ES,SPONDYLITIS,1
ES,SPOTTED FEVER RICKETTSIA TEST POSITIVE,1
ES,SQUAMOUS CELL CARCINOMA OF LUNG,1
ES,SQUAMOUS CELL CARCINOMA OF SKIN,1
ES,STEM CELL TRANSPLANT,1
ES,STEVENS-JOHNSON SYNDROME,1
ES,STRESS FRACTURE,1
ES,SUBCLAVIAN VEIN THROMBOSIS,1
ES,SUBDURAL HYGROMA,1
ES,SUPERINFECTION BACTERIAL,1
ES,SUSAC^S SYNDROME,1
ES,SWELLING FACE,1
ES,SYNCOPE,1
ES,SYNOVIAL RUPTURE,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,TENDON INJURY,1
ES,TENDON RUPTURE,1
ES,TENOSYNOVITIS,1
ES,THERAPEUTIC RESPONSE DELAYED,1
ES,THERAPEUTIC RESPONSE UNEXPECTED,1
ES,THERAPY NON-RESPONDER,1
ES,THROAT IRRITATION,1
ES,THYROID DISORDER,1
ES,TIBIA FRACTURE,1
ES,TONGUE DISORDER,1
ES,TONGUE NEOPLASM,1
ES,TONGUE PRURITUS,1
ES,TONSILLAR HYPERTROPHY,1
ES,TONSILLITIS,1
ES,TONSILLITIS STREPTOCOCCAL,1
ES,TOOTH INFECTION,1
ES,TOOTHACHE,1
ES,TORULOPSIS INFECTION,1
ES,TRACHEITIS,1
ES,TREATMENT FAILURE,1
ES,TREATMENT NONCOMPLIANCE,1
ES,TUBERCULOID LEPROSY,1
ES,TYPE IV HYPERSENSITIVITY REACTION,1
ES,ULCER,1
ES,UNEVALUABLE EVENT,1
ES,UNRESPONSIVE TO STIMULI,1
ES,UPPER LIMB FRACTURE,1
ES,URINARY INCONTINENCE,1
ES,URINARY TRACT DISORDER,1
ES,URINARY TRACT INFECTION ENTEROCOCCAL,1
ES,URINARY TRACT OBSTRUCTION,1
LK,HEPATITIS,1
SE,PYREXIA,25
SE,DYSPNOEA,23
SE,FATIGUE,23
SE,PNEUMONIA,20
SE,ALVEOLITIS,13
SE,INTERSTITIAL LUNG DISEASE,13
SE,LEUKAEMIA RECURRENT,12
SE,PAIN,12
SE,HEADACHE,11
SE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,11
SE,PULMONARY FIBROSIS,11
SE,SEPSIS,11
SE,HYPERSENSITIVITY,10
SE,ANAEMIA,9
SE,BREAST CANCER,9
SE,DEATH,9
SE,DRUG INEFFECTIVE,9
SE,METASTASES TO LIVER,9
SE,NAUSEA,9
SE,PANCYTOPENIA,9
SE,ARTHRALGIA,8
SE,COUGH,8
SE,BLADDER CANCER,7
SE,CARDIAC FAILURE,7
SE,MALAISE,7
SE,PARAESTHESIA,7
SE,ABDOMINAL PAIN,6
SE,ADENOCARCINOMA,6
SE,AGRANULOCYTOSIS,6
SE,BACTERIAL INFECTION,6
SE,BLOOD CREATININE INCREASED,6
SE,CHILLS,6
SE,HYPOAESTHESIA,6
SE,MALIGNANT MELANOMA,6
SE,MUCOSAL INFLAMMATION,6
SE,MYOCARDIAL INFARCTION,6
SE,PSORIASIS,6
SE,PULMONARY EMBOLISM,6
SE,RASH,6
SE,RHEUMATOID ARTHRITIS,6
SE,THROMBOCYTOPENIA,6
SE,TUBERCULOSIS,6
SE,ABDOMINAL DISTENSION,5
SE,ACUTE KIDNEY INJURY,5
SE,ANXIETY,5
SE,ATRIAL FIBRILLATION,5
SE,BACK PAIN,5
SE,BALANCE DISORDER,5
SE,BLADDER NEOPLASM,5
SE,C-REACTIVE PROTEIN INCREASED,5
SE,CHEST PAIN,5
SE,COGNITIVE DISORDER,5
SE,DEPRESSION,5
SE,DIZZINESS,5
SE,FALL,5
SE,FEBRILE NEUTROPENIA,5
SE,HEPATOTOXICITY,5
SE,HERPES ZOSTER,5
SE,HYPERTENSION,5
SE,LUNG NEOPLASM MALIGNANT,5
SE,LYMPHOMA,5
SE,MEMORY IMPAIRMENT,5
SE,PETECHIAE,5
SE,PRODUCT USE ISSUE,5
SE,RENAL FAILURE,5
SE,SQUAMOUS CELL CARCINOMA,5
SE,TACHYCARDIA,5
SE,ANAL CANCER,4
SE,BONE MARROW FAILURE,4
SE,BRONCHITIS,4
SE,BURNING SENSATION,4
SE,CARDIAC ARREST,4
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,4
SE,CONFUSIONAL STATE,4
SE,DYSPHONIA,4
SE,HALLUCINATION,4
SE,HEPATIC STEATOSIS,4
SE,HYPONATRAEMIA,4
SE,JC VIRUS INFECTION,4
SE,LUNG ABSCESS,4
SE,LUNG DISORDER,4
SE,MALIGNANT NEOPLASM OF AMPULLA OF VATER,4
SE,MIGRAINE,4
SE,MUSCLE SPASMS,4
SE,MYELODYSPLASTIC SYNDROME,4
SE,OROPHARYNGEAL PAIN,4
SE,OSTEONECROSIS,4
SE,PALPITATIONS,4
SE,PELVIC PAIN,4
SE,PLEURISY,4
SE,PNEUMOCYSTIS JIROVECII INFECTION,4
SE,PNEUMOCYSTIS JIROVECII PNEUMONIA,4
SE,POLYNEUROPATHY,4
SE,PRURITUS,4
SE,RASH ERYTHEMATOUS,4
SE,RESPIRATORY FAILURE,4
SE,RESPIRATORY TRACT INFECTION,4
SE,SARCOMA,4
SE,SKIN HYPERPIGMENTATION,4
SE,THYROID CANCER,4
SE,TRANSAMINASES INCREASED,4
SE,VOMITING,4
SE,WEIGHT DECREASED,4
SE,WHEEZING,4
SE,ABSCESS,3
SE,ACUTE RESPIRATORY DISTRESS SYNDROME,3
SE,ARTHRITIS BACTERIAL,3
SE,ARTHROPATHY,3
SE,B-CELL LYMPHOMA,3
SE,BLOOD IMMUNOGLOBULIN G DECREASED,3
SE,BLOOD PRESSURE DECREASED,3
SE,BLOOD PRESSURE INCREASED,3
SE,BREAST CANCER FEMALE,3
SE,CHEST DISCOMFORT,3
SE,CHOLECYSTITIS,3
SE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,3
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
SE,COLITIS,3
SE,COMA,3
SE,CONDITION AGGRAVATED,3
SE,CYSTITIS HAEMORRHAGIC,3
SE,DECREASED APPETITE,3
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,3
SE,DIPLOPIA,3
SE,DIVERTICULAR PERFORATION,3
SE,DUODENAL ULCER HAEMORRHAGE,3
SE,DYSPHAGIA,3
SE,ERYTHEMA,3
SE,EYE SWELLING,3
SE,GASTROINTESTINAL CARCINOMA,3
SE,HAEMORRHAGE,3
SE,HEMIPARESIS,3
SE,HEPATIC ENZYME INCREASED,3
SE,HODGKIN^S DISEASE,3
SE,HYPERHIDROSIS,3
SE,HYPOTENSION,3
SE,INFUSION RELATED REACTION,3
SE,LARGE INTESTINAL ULCER HAEMORRHAGE,3
SE,LEUKOPENIA,3
SE,LIP SWELLING,3
SE,LOWER URINARY TRACT SYMPTOMS,3
SE,METASTASES TO LUNG,3
SE,MOUTH ULCERATION,3
SE,MUSCULAR WEAKNESS,3
SE,NEUTROPENIA,3
SE,PERIPHERAL SWELLING,3
SE,PERITONITIS,3
SE,PERSONALITY CHANGE,3
SE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
SE,PROSTATE CANCER,3
SE,PULMONARY OEDEMA,3
SE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
SE,SEIZURE,3
SE,SLEEP DISORDER,3
SE,SOFT TISSUE INFECTION,3
SE,STAPHYLOCOCCAL INFECTION,3
SE,STOMATITIS,3
SE,SYNCOPE,3
SE,TOXICITY TO VARIOUS AGENTS,3
SE,VIRAL INFECTION,3
SE,VISUAL IMPAIRMENT,3
SE,ABDOMINAL PAIN UPPER,2
SE,ADENOCARCINOMA OF COLON,2
SE,ALANINE AMINOTRANSFERASE INCREASED,2
SE,ALOPECIA,2
SE,ANGER,2
SE,APHASIA,2
SE,ASTHENIA,2
SE,ATYPICAL FEMUR FRACTURE,2
SE,AUTOIMMUNE HEPATITIS,2
SE,BALANOPOSTHITIS,2
SE,BILE DUCT CANCER,2
SE,BIOPSY LYMPH GLAND ABNORMAL,2
SE,BLINDNESS,2
SE,BLOOD ALBUMIN DECREASED,2
SE,BREAST CANCER METASTATIC,2
SE,BURSITIS,2
SE,CEREBRAL HAEMORRHAGE,2
SE,CEREBRAL INFARCTION,2
SE,CEREBROVASCULAR ACCIDENT,2
SE,CERVIX CARCINOMA,2
SE,COLITIS ULCERATIVE,2
SE,COMPUTERISED TOMOGRAM ABNORMAL,2
SE,CONJUNCTIVITIS,2
SE,DEEP VEIN THROMBOSIS,2
SE,DEPRESSED MOOD,2
SE,DERMATITIS,2
SE,DERMATITIS BULLOUS,2
SE,DERMATITIS PSORIASIFORM,2
SE,DEVICE RELATED INFECTION,2
SE,DIARRHOEA,2
SE,DISEASE PROGRESSION,2
SE,DISTURBANCE IN ATTENTION,2
SE,DIVERTICULITIS,2
SE,DRUG EFFECT DECREASED,2
SE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
SE,DYSARTHRIA,2
SE,DYSPNOEA EXERTIONAL,2
SE,EMPHYSEMA,2
SE,ENCEPHALITIS,2
SE,ERYSIPELAS,2
SE,EYE INFECTION,2
SE,FUNGAL INFECTION,2
SE,GAIT DISTURBANCE,2
SE,GASTRIC DISORDER,2
SE,GASTROINTESTINAL HAEMORRHAGE,2
SE,GASTROINTESTINAL MUCOCOELE,2
SE,GENERAL PHYSICAL HEALTH DETERIORATION,2
SE,GUILLAIN-BARRE SYNDROME,2
SE,HAMARTOMA,2
SE,HEPATOCELLULAR CARCINOMA,2
SE,HYPERSOMNIA,2
SE,INFECTION,2
SE,INFECTION SUSCEPTIBILITY INCREASED,2
SE,INJECTION SITE RASH,2
SE,INSOMNIA,2
SE,INTENTIONAL SELF-INJURY,2
SE,JOINT SWELLING,2
SE,LEFT VENTRICULAR FAILURE,2
SE,LIP ULCERATION,2
SE,LIVER DISORDER,2
SE,LUNG CANCER METASTATIC,2
SE,LUNG INFILTRATION,2
SE,LYMPH NODE TUBERCULOSIS,2
SE,MALIGNANT PERITONEAL NEOPLASM,2
SE,MALIGNANT RESPIRATORY TRACT NEOPLASM,2
SE,MANIA,2
SE,MENINGOENCEPHALITIS HERPETIC,2
SE,METASTASES TO BONE,2
SE,METASTASES TO PERITONEUM,2
SE,METASTATIC LYMPHOMA,2
SE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
SE,MYOSITIS,2
SE,NASOPHARYNGITIS,2
SE,NEOPLASM MALIGNANT,2
SE,NEPHROTIC SYNDROME,2
SE,NIGHT SWEATS,2
SE,NODULAR MELANOMA,2
SE,NON-HODGKIN^S LYMPHOMA,2
SE,OEDEMA PERIPHERAL,2
SE,OPHTHALMIC HERPES ZOSTER,2
SE,ORAL HERPES,2
SE,OSTEITIS,2
SE,OSTEONECROSIS OF JAW,2
SE,OTITIS MEDIA,2
SE,PANCREATIC CARCINOMA METASTATIC,2
SE,PLATELET COUNT DECREASED,2
SE,POSITRON EMISSION TOMOGRAM ABNORMAL,2
SE,PRODUCT USE IN UNAPPROVED INDICATION,2
SE,PRURITUS GENERALISED,2
SE,PSEUDOMONAL SEPSIS,2
SE,PSORIATIC ARTHROPATHY,2
SE,PULSELESS ELECTRICAL ACTIVITY,2
SE,RECTAL HAEMORRHAGE,2
SE,RENAL ABSCESS,2
SE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
SE,RHABDOMYOLYSIS,2
SE,SALIVARY GLAND ENLARGEMENT,2
SE,SKIN CANCER,2
SE,SKIN DISCOLOURATION,2
SE,SKIN REACTION,2
SE,STIFF PERSON SYNDROME,2
SE,SURGERY,2
SE,SWELLING,2
SE,SWELLING FACE,2
SE,SYSTEMIC CANDIDA,2
SE,SYSTEMIC LUPUS ERYTHEMATOSUS,2
SE,T-CELL TYPE ACUTE LEUKAEMIA,2
SE,TENDON RUPTURE,2
SE,TRANSIENT ISCHAEMIC ATTACK,2
SE,TREMOR,2
SE,UPPER RESPIRATORY TRACT INFECTION,2
SE,URINARY TRACT INFECTION,2
SE,VERTIGO,2
SE,VISUAL ACUITY REDUCED,2
SE,VULVAL HAEMORRHAGE,2
SE,WEIGHT INCREASED,2
SE,WOUND,2
SE,ABDOMINAL DISCOMFORT,1
SE,ABDOMINAL LYMPHADENOPATHY,1
SE,ABNORMAL BEHAVIOUR,1
SE,ABSCESS LIMB,1
SE,ACIDOSIS,1
SE,ACUTE GRAFT VERSUS HOST DISEASE,1
SE,ACUTE LEUKAEMIA,1
SE,ACUTE LYMPHOCYTIC LEUKAEMIA,1
SE,ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME,1
SE,ADVERSE EVENT,1
SE,AGEUSIA,1
SE,AGITATION,1
SE,ALLERGIC OEDEMA,1
SE,ALVEOLITIS ALLERGIC,1
SE,AMYOTROPHIC LATERAL SCLEROSIS,1
SE,ANAL SPHINCTER ATONY,1
SE,ANAPHYLACTIC REACTION,1
SE,ANKLE FRACTURE,1
SE,ANOSMIA,1
SE,ANTI-GAD ANTIBODY POSITIVE,1
SE,ANTINUCLEAR ANTIBODY INCREASED,1
SE,ANTINUCLEAR ANTIBODY POSITIVE,1
SE,ANURIA,1
SE,APATHY,1
SE,APPENDICITIS,1
SE,ARTERIAL RUPTURE,1
SE,ARTHRITIS,1
SE,ARTHROPOD BITE,1
SE,ASCITES,1
SE,ASPARTATE AMINOTRANSFERASE INCREASED,1
SE,ASTHMA,1
SE,ASTROCYTOMA,1
SE,ATAXIA,1
SE,ATELECTASIS,1
SE,ATRIAL FLUTTER,1
SE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
SE,BACILLUS BACTERAEMIA,1
SE,BACILLUS INFECTION,1
SE,BACTERAEMIA,1
SE,BASAL CELL CARCINOMA,1
SE,BENIGN HEPATIC NEOPLASM,1
SE,BENIGN NEOPLASM OF ADRENAL GLAND,1
SE,BENIGN NEOPLASM OF THYROID GLAND,1
SE,BENIGN SALIVARY GLAND NEOPLASM,1
SE,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
SE,BILE DUCT STENOSIS,1
SE,BLISTER,1
SE,BLOOD PRESSURE FLUCTUATION,1
SE,BONE MARROW TOXICITY,1
SE,BORRELIA INFECTION,1
SE,BRADYCARDIA,1
SE,BRAIN ABSCESS,1
SE,BRAIN NEOPLASM,1
SE,BRAIN STEM HAEMORRHAGE,1
SE,BRONCHIECTASIS,1
SE,BRONCHIOLITIS,1
SE,BURSITIS INFECTIVE,1
SE,CAMPYLOBACTER GASTROENTERITIS,1
SE,CARDIAC DISORDER,1
SE,CARDIAC FAILURE CONGESTIVE,1
SE,CARDIAC HYPERTROPHY,1
SE,CARDIAC VALVE DISEASE,1
SE,CARDIAC VALVE VEGETATION,1
SE,CARDIOMEGALY,1
SE,CARDIOVASCULAR INSUFFICIENCY,1
SE,CATAPLEXY,1
SE,CATARRH,1
SE,CEREBRAL DISORDER,1
SE,CERVICAL DYSPLASIA,1
SE,CHOLANGIOCARCINOMA,1
SE,CHOLECYSTITIS ACUTE,1
SE,CHOLESTASIS,1
SE,CHRONIC GRAFT VERSUS HOST DISEASE,1
SE,CHRONIC HEPATITIS,1
SE,CIRCULATORY COLLAPSE,1
SE,COLON CANCER,1
SE,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
SE,CONGENITAL ANOMALY,1
SE,CONVULSION,1
SE,CONVULSIONS LOCAL,1
SE,CROHN^S DISEASE,1
SE,CSF IMMUNOGLOBULIN INCREASED,1
SE,CYST,1
SE,CYSTATIN C INCREASED,1
SE,CYSTITIS,1
SE,CYTOMEGALOVIRUS INFECTION,1
SE,DECREASED VIBRATORY SENSE,1
SE,DELUSIONAL DISORDER_ UNSPECIFIED TYPE,1
SE,DENTAL FISTULA,1
SE,DEPRESSION SUICIDAL,1
SE,DEPRESSIVE SYMPTOM,1
SE,DERMATITIS CONTACT,1
SE,DIARRHOEA HAEMORRHAGIC,1
SE,DISCOMFORT,1
SE,DRUG EFFECT INCOMPLETE,1
SE,DRUG HYPERSENSITIVITY,1
SE,DRUG INTOLERANCE,1
SE,DRUG RESISTANCE,1
SE,DRY MOUTH,1
SE,DYSGEUSIA,1
SE,DYSKINESIA,1
SE,DYSPLASTIC NAEVUS,1
SE,DYSSTASIA,1
SE,EAR CANAL ABRASION,1
SE,EAR PAIN,1
SE,EAR SWELLING,1
SE,EMBOLISM,1
SE,EMPYEMA,1
SE,ENCEPHALITIS AUTOIMMUNE,1
SE,ENCEPHALOPATHY,1
SE,ENDOMETRITIS,1
SE,ENTEROVIRUS INFECTION,1
SE,EPILEPSY,1
SE,EPISTAXIS,1
SE,EPSTEIN-BARR VIRUS INFECTION,1
SE,ERECTILE DYSFUNCTION,1
SE,EXPOSURE DURING PREGNANCY,1
SE,EXTENSOR PLANTAR RESPONSE,1
SE,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE),1
SE,EXTRASYSTOLES,1
SE,FACIAL NEURALGIA,1
SE,FEELING ABNORMAL,1
SE,FEMUR FRACTURE,1
SE,FLUID RETENTION,1
SE,FOETAL EXPOSURE DURING PREGNANCY,1
SE,FOLLICULITIS,1
SE,FORMICATION,1
SE,FRONTOTEMPORAL DEMENTIA,1
SE,GAIT INABILITY,1
SE,GALLBLADDER PERFORATION,1
SE,GASTRIC CANCER,1
SE,GASTROENTERITIS ESCHERICHIA COLI,1
SE,GASTROENTERITIS VIRAL,1
SE,GASTROINTESTINAL CANCER METASTATIC,1
SE,GASTROINTESTINAL DISORDER,1
SE,GASTROINTESTINAL INFECTION,1
SE,GENERALISED ERYTHEMA,1
SE,GENERALISED OEDEMA,1
SE,GENITAL NEOPLASM MALIGNANT FEMALE,1
SE,GINGIVITIS,1
SE,GLAUCOMA,1
SE,GOUT,1
SE,GRAFT VERSUS HOST DISEASE,1
SE,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
SE,GRANULOMATOSIS WITH POLYANGIITIS,1
SE,GROWTH RETARDATION,1
SE,HAEMATEMESIS,1
SE,HAEMATOCHEZIA,1
SE,HAEMATOLOGICAL MALIGNANCY,1
SE,HAEMATURIA,1
SE,HAEMOGLOBIN DECREASED,1
SE,HAEMORRHAGIC DIATHESIS,1
SE,HAPTOGLOBIN DECREASED,1
SE,HEART RATE INCREASED,1
SE,HEART VALVE INCOMPETENCE,1
SE,HEPATIC CANCER,1
SE,HEPATIC FAILURE,1
SE,HEPATIC FUNCTION ABNORMAL,1
SE,HEPATITIS,1
SE,HEPATITIS B,1
SE,HEPATITIS CHRONIC ACTIVE,1
SE,HERPES SIMPLEX,1
SE,HERPES ZOSTER OTICUS,1
SE,HIDRADENITIS,1
SE,HYDROTHORAX,1
SE,HYPERREFLEXIA,1
SE,HYPERTONIA,1
SE,HYPOACUSIS,1
SE,HYPOAESTHESIA ORAL,1
SE,HYPOTHYROIDISM,1
SE,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
SE,IGA NEPHROPATHY,1
SE,IMMUNODEFICIENCY,1
SE,IMPLANT SITE INFLAMMATION,1
SE,IMPULSE-CONTROL DISORDER,1
SE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SE,INFECTION REACTIVATION,1
SE,INFECTIOUS MONONUCLEOSIS,1
SE,INFLAMMATION,1
SE,INFLUENZA LIKE ILLNESS,1
SE,INITIAL INSOMNIA,1
SE,INJECTION SITE ERYTHEMA,1
SE,INJECTION SITE PAIN,1
SE,INJECTION SITE PRURITUS,1
SE,INJECTION SITE REACTION,1
SE,INTENTIONAL PRODUCT USE ISSUE,1
SE,INTESTINAL ADENOCARCINOMA,1
SE,INTESTINAL PERFORATION,1
SE,IRIDOCYCLITIS,1
SE,IRITIS,1
SE,ISCHAEMIC ULCER,1
SE,KERATITIS INTERSTITIAL,1
SE,KNEE ARTHROPLASTY,1
SE,LACRIMAL GLAND ENLARGEMENT,1
SE,LACRIMATION DISORDER,1
SE,LARYNGEAL CANCER,1
SE,LARYNGITIS,1
SE,LEFT VENTRICULAR ENLARGEMENT,1
SE,LEGIONELLA INFECTION,1
SE,LEIOMYOMA,1
SE,LENTIGO MALIGNA,1
SE,LEUKAEMIA,1
SE,LEUKOCYTOSIS,1
SE,LIP PRURITUS,1
SE,LISTERIA SEPSIS,1
SE,LIVEDO RETICULARIS,1
SE,LOSS OF CONSCIOUSNESS,1
SE,LOWER RESPIRATORY TRACT INFECTION,1
SE,LUNG ADENOCARCINOMA,1
SE,LUNG CONSOLIDATION,1
SE,LYMPHADENOPATHY,1
SE,MALIGNANT MELANOMA IN SITU,1
SE,MALIGNANT MELANOMA STAGE IV,1
SE,MALIGNANT NEOPLASM PROGRESSION,1
SE,MASS,1
SE,MEDICAL DEVICE COMPLICATION,1
SE,MEDICATION ERROR,1
SE,MELAENA,1
SE,MENINGITIS,1
SE,MESENTERIC VEIN THROMBOSIS,1
SE,METABOLIC DISORDER,1
SE,METASTASES TO LYMPH NODES,1
SE,METASTASIS,1
SE,MITRAL VALVE DISEASE,1
SE,MOTOR DYSFUNCTION,1
SE,MOUTH SWELLING,1
SE,MUCOUS MEMBRANE DISORDER,1
SE,MULTIPLE SCLEROSIS,1
SE,MULTIPLE SCLEROSIS RELAPSE,1
SE,MUSCLE RIGIDITY,1
SE,MUSCULOSKELETAL DISORDER,1
SE,MUSCULOSKELETAL PAIN,1
SE,MUSCULOSKELETAL STIFFNESS,1
SE,MYALGIA,1
SE,MYCOBACTERIUM ABSCESSUS INFECTION,1
SE,MYCOSIS FUNGOIDES,1
SE,MYELITIS,1
SE,MYOCARDIAL ISCHAEMIA,1
SE,MYOPATHY,1
SE,NASAL CONGESTION,1
SE,NEOPLASM SKIN,1
SE,NEURALGIA,1
SE,NEUROLOGICAL DECOMPENSATION,1
SE,NEUROLOGICAL EXAMINATION ABNORMAL,1
SE,NEUROLOGICAL SYMPTOM,1
SE,NEUTROPHILIA,1
SE,NIGHTMARE,1
SE,NYSTAGMUS,1
SE,OBSESSIVE THOUGHTS,1
SE,OCULAR VASCULITIS,1
SE,OEDEMA,1
SE,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
SE,OPTIC NEUROPATHY,1
SE,OVARIAN CANCER,1
SE,PAIN IN EXTREMITY,1
SE,PAIN IN JAW,1
SE,PALLOR,1
SE,PANCREATIC CARCINOMA,1
SE,PANCREATITIS,1
SE,PANNICULITIS,1
SE,PAPILLARY THYROID CANCER,1
SE,PAPILLARY TUMOUR OF RENAL PELVIS,1
SE,PARAESTHESIA ORAL,1
SE,PARKINSON^S DISEASE,1
SE,PATHOLOGICAL FRACTURE,1
SE,PEMPHIGOID,1
SE,PENILE SQUAMOUS CELL CARCINOMA,1
SE,PERICARDIAL HAEMORRHAGE,1
SE,PERICARDITIS,1
SE,PERICARDITIS INFECTIVE,1
SE,PERIODONTITIS,1
SE,PERIPHERAL COLDNESS,1
SE,PHARYNGEAL INFLAMMATION,1
SE,PHARYNGEAL OEDEMA,1
SE,PLEURAL FIBROSIS,1
SE,PLEURAL HAEMORRHAGE,1
SE,PLEURAL MESOTHELIOMA,1
SE,PLEUROPERICARDITIS,1
SE,PNEUMONIA LEGIONELLA,1
SE,PNEUMONITIS,1
SE,POLYARTHRITIS,1
SE,POLYMYOSITIS,1
SE,POLYOMAVIRUS TEST POSITIVE,1
SE,POST HERPETIC NEURALGIA,1
SE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
SE,POST VIRAL FATIGUE SYNDROME,1
SE,PRECANCEROUS SKIN LESION,1
SE,PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA RECURRENT,1
SE,PREMATURE DELIVERY,1
SE,PROTEINURIA,1
SE,PRURITUS ALLERGIC,1
SE,PSEUDOMEMBRANOUS COLITIS,1
SE,PSOAS ABSCESS,1
SE,PULMONARY CONGESTION,1
SE,PULMONARY PAIN,1
SE,PULMONARY SARCOIDOSIS,1
SE,PULMONARY TUBERCULOSIS,1
SE,PULPITIS DENTAL,1
SE,PURULENT DISCHARGE,1
SE,PYOMYOSITIS,1
SE,QUADRIPARESIS,1
SE,RASH PAPULAR,1
SE,RECTAL ADENOCARCINOMA,1
SE,RECTAL CANCER,1
SE,RECTAL PERFORATION,1
SE,RENAL COLIC,1
SE,RENAL IMPAIRMENT,1
SE,RESPIRATORY DEPRESSION,1
SE,RESTLESS LEGS SYNDROME,1
SE,RETINAL ARTERY OCCLUSION,1
SE,RETINAL VASCULAR THROMBOSIS,1
SE,RHEUMATOID NODULE,1
SE,RIB FRACTURE,1
SE,ROSACEA,1
SE,SALMONELLOSIS,1
SE,SCLERITIS,1
SE,SENSITISATION,1
SE,SHOULDER OPERATION,1
SE,SKIN EXFOLIATION,1
SE,SKIN FISSURES,1
SE,SKIN NEOPLASM EXCISION,1
SE,SKIN ULCER,1
SE,SKIN WOUND,1
SE,SLEEP APNOEA SYNDROME,1
SE,SLOW SPEECH,1
SE,SMALL CELL LUNG CANCER,1
SE,SMALL INTESTINAL STENOSIS,1
SE,SPEECH DISORDER,1
SE,SPINAL COMPRESSION FRACTURE,1
SE,SPINAL OPERATION,1
SE,SPLENIC INFARCTION,1
SE,SPLENOMEGALY,1
SE,SPONDYLOLISTHESIS,1
SE,SQUAMOUS CELL CARCINOMA OF SKIN,1
SE,STAPHYLOCOCCAL SEPSIS,1
SE,STEM CELL TRANSPLANT,1
SE,SUBCUTANEOUS ABSCESS,1
SE,SUDDEN DEATH,1
SE,SUICIDAL IDEATION,1
SE,T-CELL LYMPHOMA,1
SE,TENDON DISORDER,1
SE,THERAPEUTIC RESPONSE UNEXPECTED,1
SE,THROAT IRRITATION,1
SE,THYMIC CANCER METASTATIC,1
SE,THYROID FUNCTION TEST ABNORMAL,1
SE,TOOTH INFECTION,1
SE,TOOTH LOSS,1
SE,TRANSITIONAL CELL CARCINOMA,1
SE,TRANSPLANT FAILURE,1
SE,TRANSPLANTATION COMPLICATION,1
SE,TUBERCULOUS PLEURISY,1
SE,TUBULOINTERSTITIAL NEPHRITIS,1
SE,TUMOUR LYSIS SYNDROME,1
SE,UROSEPSIS,1
SE,URTICARIA,1
SE,UTERINE CANCER,1
SE,UVEITIS,1
SE,VARICOSE VEIN,1
SE,VASCULITIS CEREBRAL,1
SE,VENTRICULAR FIBRILLATION,1
SE,VISION BLURRED,1
SE,VITAL CAPACITY DECREASED,1
SE,VOCAL CORD PARALYSIS,1
SE,WALDENSTROM^S MACROGLOBULINAEMIA,1
SE,WHITE BLOOD CELL COUNT DECREASED,1
SE,WHITE BLOOD CELL COUNT INCREASED,1
SE,WHITE MATTER LESION,1
CH,PANCYTOPENIA,46
CH,RENAL FAILURE,31
CH,ACUTE KIDNEY INJURY,25
CH,TOXICITY TO VARIOUS AGENTS,21
CH,DRUG INEFFECTIVE,20
CH,PNEUMOCYSTIS JIROVECII PNEUMONIA,20
CH,LYMPHOPENIA,17
CH,PNEUMONIA,17
CH,SEPSIS,17
CH,VARICELLA ZOSTER VIRUS INFECTION,17
CH,VOMITING,17
CH,DIARRHOEA,16
CH,STOMATITIS,16
CH,ABDOMINAL PAIN,15
CH,OVERDOSE,15
CH,NAUSEA,14
CH,PYREXIA,14
CH,AGRANULOCYTOSIS,13
CH,DISEASE PROGRESSION,13
CH,FEBRILE NEUTROPENIA,13
CH,LEUKOPENIA,13
CH,THROMBOCYTOPENIA,13
CH,ACCIDENTAL OVERDOSE,12
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,12
CH,ANAEMIA,12
CH,HAEMATOTOXICITY,12
CH,NEUTROPENIA,12
CH,PAIN,11
CH,HEADACHE,10
CH,MUCOSAL INFLAMMATION,10
CH,BONE MARROW TOXICITY,9
CH,DYSPNOEA,9
CH,GENERAL PHYSICAL HEALTH DETERIORATION,9
CH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,9
CH,JAUNDICE,9
CH,SEPTIC SHOCK,9
CH,BONE MARROW FAILURE,8
CH,BRONCHOPULMONARY ASPERGILLOSIS,8
CH,CARDIOGENIC SHOCK,8
CH,DRUG PRESCRIBING ERROR,8
CH,ENCEPHALITIS,8
CH,HAEMOLYSIS,8
CH,HEPATIC ENZYME INCREASED,8
CH,INFECTION,8
CH,ORAL HERPES,8
CH,STRESS CARDIOMYOPATHY,8
CH,BLOOD BILIRUBIN INCREASED,7
CH,CONFUSIONAL STATE,7
CH,DRUG EFFECT INCOMPLETE,7
CH,GASTROINTESTINAL HAEMORRHAGE,7
CH,MULTI-ORGAN FAILURE,7
CH,POLYNEUROPATHY,7
CH,ASTHENIA,6
CH,C-REACTIVE PROTEIN INCREASED,6
CH,CARDIAC FAILURE,6
CH,CEREBELLAR SYNDROME,6
CH,CHEST PAIN,6
CH,DIVERTICULITIS,6
CH,DRUG LEVEL INCREASED,6
CH,FATIGUE,6
CH,HYPOAESTHESIA,6
CH,HYPOTENSION,6
CH,INFLUENZA LIKE ILLNESS,6
CH,MOUTH ULCERATION,6
CH,OEDEMA PERIPHERAL,6
CH,PRODUCT USE ISSUE,6
CH,RESPIRATORY FAILURE,6
CH,CARDIOMYOPATHY,5
CH,CELLULITIS,5
CH,CHILLS,5
CH,DECREASED APPETITE,5
CH,DIFFUSE LARGE B-CELL LYMPHOMA,5
CH,DRUG-INDUCED LIVER INJURY,5
CH,EPILEPSY,5
CH,EPSTEIN-BARR VIRUS INFECTION,5
CH,ERYSIPELAS,5
CH,HYDROCEPHALUS,5
CH,HYPERSENSITIVITY,5
CH,LIVER INJURY,5
CH,LUNG DISORDER,5
CH,LYMPHADENOPATHY,5
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
CH,NATURAL KILLER CELL COUNT INCREASED,5
CH,NEUTROPENIC COLITIS,5
CH,TRANSAMINASES INCREASED,5
CH,VULVAL CANCER STAGE 0,5
CH,WEIGHT DECREASED,5
CH,ACUTE GRAFT VERSUS HOST DISEASE,4
CH,ALTERED STATE OF CONSCIOUSNESS,4
CH,CNS VENTRICULITIS,4
CH,COLORECTAL CANCER,4
CH,CYTOMEGALOVIRUS COLITIS,4
CH,DEATH,4
CH,DEHYDRATION,4
CH,DEVICE RELATED INFECTION,4
CH,DIVERTICULAR PERFORATION,4
CH,DYSPHAGIA,4
CH,ENCEPHALOPATHY,4
CH,ERYTHEMA,4
CH,GAIT DISTURBANCE,4
CH,GENITAL EROSION,4
CH,GRAFT VERSUS HOST DISEASE,4
CH,HAEMATOMA,4
CH,HAEMOLYTIC URAEMIC SYNDROME,4
CH,HODGKIN^S DISEASE,4
CH,HYPERTENSION,4
CH,IMMUNOSUPPRESSION,4
CH,LEUKAEMIA,4
CH,LIVER DISORDER,4
CH,LOSS OF CONSCIOUSNESS,4
CH,MEDICATION ERROR,4
CH,PAIN IN EXTREMITY,4
CH,PANCREATIC CARCINOMA,4
CH,PANCREATITIS ACUTE,4
CH,PARAESTHESIA,4
CH,PNEUMONIA ASPIRATION,4
CH,PNEUMONITIS,4
CH,PRODUCT USE IN UNAPPROVED INDICATION,4
CH,RASH,4
CH,RASH GENERALISED,4
CH,SINUSITIS,4
CH,SKIN ULCER,4
CH,VARICELLA,4
CH,ABDOMINAL PAIN UPPER,3
CH,ALANINE AMINOTRANSFERASE INCREASED,3
CH,ALOPECIA,3
CH,ARTHRITIS,3
CH,BALANOPOSTHITIS,3
CH,CEREBRAL HAEMORRHAGE,3
CH,CHOLESTASIS,3
CH,CLOSTRIDIUM DIFFICILE COLITIS,3
CH,COLITIS ISCHAEMIC,3
CH,COMA,3
CH,DERMATITIS,3
CH,DIARRHOEA HAEMORRHAGIC,3
CH,DISEASE RECURRENCE,3
CH,DISSEMINATED INTRAVASCULAR COAGULATION,3
CH,DISTURBANCE IN ATTENTION,3
CH,DRUG ADMINISTRATION ERROR,3
CH,DRUG INTOLERANCE,3
CH,EPISTAXIS,3
CH,EWING^S SARCOMA,3
CH,FALL,3
CH,GASTRITIS,3
CH,GASTROENTERITIS ESCHERICHIA COLI,3
CH,GASTROINTESTINAL CARCINOMA,3
CH,GASTROINTESTINAL DISORDER,3
CH,HAEMORRHAGE,3
CH,HEPATITIS,3
CH,HEPATITIS E,3
CH,HUMAN HERPESVIRUS 6 INFECTION,3
CH,HYPERAMMONAEMIA,3
CH,HYPOGLYCAEMIA,3
CH,IMPAIRED HEALING,3
CH,INCORRECT DOSE ADMINISTERED,3
CH,INFLUENZA,3
CH,INTERSTITIAL LUNG DISEASE,3
CH,LICHENOID KERATOSIS,3
CH,LUPUS-LIKE SYNDROME,3
CH,LYMPHOCYTOSIS,3
CH,LYMPHOMA,3
CH,METABOLIC ENCEPHALOPATHY,3
CH,MULTIPLE SCLEROSIS,3
CH,MYELITIS,3
CH,NECROTISING RETINITIS,3
CH,ODYNOPHAGIA,3
CH,OESOPHAGITIS,3
CH,ORAL CANDIDIASIS,3
CH,PERIPHERAL SENSORY NEUROPATHY,3
CH,PRURITUS,3
CH,PSORIASIS,3
CH,PULMONARY EMBOLISM,3
CH,PULMONARY MASS,3
CH,RHEUMATOID ARTHRITIS,3
CH,SOMNOLENCE,3
CH,STAPHYLOCOCCAL BACTERAEMIA,3
CH,STATUS EPILEPTICUS,3
CH,SYSTEMIC LUPUS ERYTHEMATOSUS,3
CH,TOXIC ENCEPHALOPATHY,3
CH,ABDOMINAL DISCOMFORT,2
CH,ANORECTAL CELLULITIS,2
CH,ASPARTATE AMINOTRANSFERASE INCREASED,2
CH,ASPERGILLUS INFECTION,2
CH,B-CELL LYMPHOMA,2
CH,BACTERAEMIA,2
CH,BICYTOPENIA,2
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CH,BRADYCARDIA,2
CH,BRAIN OEDEMA,2
CH,CHEST DISCOMFORT,2
CH,CHRONIC GRAFT VERSUS HOST DISEASE,2
CH,CLOSTRIDIUM DIFFICILE INFECTION,2
CH,CONDITION AGGRAVATED,2
CH,COUGH,2
CH,CYTOMEGALOVIRUS INFECTION,2
CH,CYTOMEGALOVIRUS VIRAEMIA,2
CH,DEEP VEIN THROMBOSIS,2
CH,DELIRIUM,2
CH,DEMYELINATION,2
CH,DEPRESSION,2
CH,DIFFUSE AXONAL INJURY,2
CH,DRUG CLEARANCE DECREASED,2
CH,DYSAESTHESIA,2
CH,DYSARTHRIA,2
CH,DYSGEUSIA,2
CH,EXPOSURE DURING PREGNANCY,2
CH,EYE DISORDER,2
CH,FAECES DISCOLOURED,2
CH,FAECES SOFT,2
CH,GASTROENTERITIS,2
CH,GASTROINTESTINAL INFECTION,2
CH,GASTROINTESTINAL ULCER HAEMORRHAGE,2
CH,HAEMOGLOBIN DECREASED,2
CH,HAEMOPHILUS INFECTION,2
CH,HAEMORRHAGIC ANAEMIA,2
CH,HEPATIC FAILURE,2
CH,HEPATIC FIBROSIS,2
CH,HEPATOCELLULAR INJURY,2
CH,HERPES ZOSTER CUTANEOUS DISSEMINATED,2
CH,HUMAN METAPNEUMOVIRUS TEST POSITIVE,2
CH,HYPOGLOSSAL NERVE PARESIS,2
CH,HYPOPHAGIA,2
CH,HYPOXIA,2
CH,IGA NEPHROPATHY,2
CH,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
CH,INFECTION IN AN IMMUNOCOMPROMISED HOST,2
CH,INFLAMMATION,2
CH,INFUSION RELATED REACTION,2
CH,INTENTIONAL PRODUCT MISUSE,2
CH,INTRACRANIAL PRESSURE INCREASED,2
CH,KLEBSIELLA INFECTION,2
CH,LACRIMATION INCREASED,2
CH,LEFT VENTRICULAR DYSFUNCTION,2
CH,LEWIS-SUMNER SYNDROME,2
CH,LIVER ABSCESS,2
CH,LUNG NEOPLASM MALIGNANT,2
CH,MALAISE,2
CH,MENINGOCOCCAL BACTERAEMIA,2
CH,MENTAL DISORDER,2
CH,METASTASES TO BONE,2
CH,MIGRAINE,2
CH,MOBILITY DECREASED,2
CH,MONOPARESIS,2
CH,MUCOCUTANEOUS ULCERATION,2
CH,MUSCULAR WEAKNESS,2
CH,MUSCULOSKELETAL PAIN,2
CH,MYELITIS TRANSVERSE,2
CH,MYOCARDIAL FIBROSIS,2
CH,MYOCARDITIS,2
CH,NECROTISING FASCIITIS,2
CH,NEPHROTIC SYNDROME,2
CH,NEUROTOXICITY,2
CH,NEUTROPENIC SEPSIS,2
CH,NON-ALCOHOLIC STEATOHEPATITIS,2
CH,OSTEONECROSIS,2
CH,OSTEONECROSIS OF JAW,2
CH,PAPILLOEDEMA,2
CH,PARALYSIS,2
CH,PARESIS ANAL SPHINCTER,2
CH,PERIPHERAL SWELLING,2
CH,PERITONITIS,2
CH,PETECHIAE,2
CH,PNEUMOCONIOSIS,2
CH,POISONING,2
CH,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
CH,POSTOPERATIVE WOUND INFECTION,2
CH,PREMATURE BABY,2
CH,PRODUCTIVE COUGH,2
CH,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
CH,PSEUDOMONAS INFECTION,2
CH,PSORIATIC ARTHROPATHY,2
CH,PULMONARY ALVEOLAR HAEMORRHAGE,2
CH,PURPURA FULMINANS,2
CH,QUADRIPARESIS,2
CH,RADICULOPATHY,2
CH,RECTAL CANCER,2
CH,RENAL FAILURE ACUTE,2
CH,RENAL IMPAIRMENT,2
CH,RENAL TUBULAR DISORDER,2
CH,RESPIRATORY TRACT INFECTION,2
CH,RETINOPATHY,2
CH,SARCOIDOSIS,2
CH,SKIN LESION,2
CH,SKIN NECROSIS,2
CH,SOFT TISSUE INFECTION,2
CH,SQUAMOUS CELL CARCINOMA OF THE CERVIX,2
CH,SUPERINFECTION BACTERIAL,2
CH,SYNCOPE,2
CH,SYSTEMIC CANDIDA,2
CH,TONGUE DISORDER,2
CH,TONSILLITIS,2
CH,TRANSIENT ISCHAEMIC ATTACK,2
CH,TREMOR,2
CH,ULCER,2
CH,URINARY INCONTINENCE,2
CH,URTICARIA,2
CH,VIRAL MYOCARDITIS,2
CH,VISION BLURRED,2
CH,ABASIA,1
CH,ABDOMINAL INFECTION,1
CH,ABDOMINAL TENDERNESS,1
CH,ABDOMINAL WOUND DEHISCENCE,1
CH,ABNORMAL SENSATION IN EYE,1
CH,ABORTION SPONTANEOUS,1
CH,ABSCESS OF SALIVARY GLAND,1
CH,ACCIDENTAL POISONING,1
CH,ACCOMMODATION DISORDER,1
CH,ACUTE CORONARY SYNDROME,1
CH,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
CH,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
CH,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
CH,ACUTE MYELOID LEUKAEMIA,1
CH,ACUTE MYOCARDIAL INFARCTION,1
CH,ACUTE PRERENAL FAILURE,1
CH,ACUTE PULMONARY OEDEMA,1
CH,ACUTE RESPIRATORY FAILURE,1
CH,ADENOCARCINOMA GASTRIC,1
CH,ADENOCARCINOMA OF THE CERVIX,1
CH,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
CH,ADVERSE EVENT,1
CH,ALLODYNIA,1
CH,ALVEOLITIS,1
CH,AMYLOIDOSIS,1
CH,ANAPHYLACTIC REACTION,1
CH,ANKYLOSING SPONDYLITIS,1
CH,ANURIA,1
CH,ANXIETY,1
CH,APATHY,1
CH,APHASIA,1
CH,APOPTOSIS,1
CH,APOPTOTIC COLONOPATHY,1
CH,ARTERIOSCLEROSIS,1
CH,ARTERIOSCLEROSIS CORONARY ARTERY,1
CH,ARTHRALGIA,1
CH,ARTHRITIS INFECTIVE,1
CH,ASCITES,1
CH,ATAXIA,1
CH,ATRIAL FIBRILLATION,1
CH,AUTOIMMUNE HEPATITIS,1
CH,B-LYMPHOCYTE COUNT DECREASED,1
CH,BACK PAIN,1
CH,BACTERIAL DISEASE CARRIER,1
CH,BACTERIAL INFECTION,1
CH,BACTERIAL TEST POSITIVE,1
CH,BASAL CELL CARCINOMA,1
CH,BLADDER CANCER,1
CH,BLADDER TRANSITIONAL CELL CARCINOMA,1
CH,BLAST CELLS PRESENT,1
CH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
CH,BLOOD CREATININE DECREASED,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD PRESSURE INCREASED,1
CH,BREAST CANCER METASTATIC,1
CH,BRONCHITIS CHRONIC,1
CH,BRONCHOPNEUMONIA,1
CH,BRONCHOSPASM,1
CH,BUNDLE BRANCH BLOCK LEFT,1
CH,CARCINOEMBRYONIC ANTIGEN INCREASED,1
CH,CARDIAC ARREST,1
CH,CARDIAC FAILURE CONGESTIVE,1
CH,CARDIAC HYPERTROPHY,1
CH,CATARACT,1
CH,CELL DEATH,1
CH,CELLULITIS GANGRENOUS,1
CH,CENTRAL NERVOUS SYSTEM INFECTION,1
CH,CEREBRAL ASPERGILLOSIS,1
CH,CEREBRAL THROMBOSIS,1
CH,CHEILITIS,1
CH,CHOLECYSTITIS,1
CH,CHOLECYSTITIS ACUTE,1
CH,CHOLELITHIASIS,1
CH,CHOLESTATIC LIVER INJURY,1
CH,CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS,1
CH,CHRONIC KIDNEY DISEASE,1
CH,CLOSTRIDIAL INFECTION,1
CH,CLUSTER HEADACHE,1
CH,COAGULOPATHY,1
CH,COLECTOMY,1
CH,COLITIS ULCERATIVE,1
CH,COLON NEOPLASM,1
CH,CONGESTIVE CARDIOMYOPATHY,1
CH,CONSTIPATION,1
CH,CONTRAINDICATED PRODUCT ADMINISTERED,1
CH,CONUS MEDULLARIS SYNDROME,1
CH,CORONARY ARTERY DISEASE,1
CH,CORONARY ARTERY STENOSIS,1
CH,DEAFNESS,1
CH,DECUBITUS ULCER,1
CH,DEMYELINATING POLYNEUROPATHY,1
CH,DERMATITIS ATOPIC,1
CH,DIZZINESS,1
CH,DRUG DOSE TITRATION NOT PERFORMED,1
CH,DRUG ERUPTION,1
CH,DRY EYE,1
CH,DRY MOUTH,1
CH,DRY SKIN,1
CH,DUODENITIS,1
CH,DUODENITIS HAEMORRHAGIC,1
CH,DYSKINESIA,1
CH,DYSPNOEA EXERTIONAL,1
CH,END STAGE RENAL DISEASE,1
CH,ENDOCARDITIS,1
CH,ENDOCARDITIS BACTERIAL,1
CH,ENDOMETRIAL HYPERTROPHY,1
CH,ENGRAFT FAILURE,1
CH,ENTEROBACTER INFECTION,1
CH,EOSINOPHILIA,1
CH,EOSINOPHILIC PUSTULAR FOLLICULITIS,1
CH,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
CH,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
CH,ESCHERICHIA PYELONEPHRITIS,1
CH,ESCHERICHIA SEPSIS,1
CH,ESCHERICHIA TEST POSITIVE,1
CH,EYELID OEDEMA,1
CH,EYELID PTOSIS,1
CH,FAECAL INCONTINENCE,1
CH,FEELING DRUNK,1
CH,FIBROSIS,1
CH,FOETAL EXPOSURE DURING PREGNANCY,1
CH,FOLATE DEFICIENCY,1
CH,FORMICATION,1
CH,GALLBLADDER DISORDER,1
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CH,GASTRIC HAEMORRHAGE,1
CH,GASTRIC ULCER,1
CH,GASTROINTESTINAL ANASTOMOTIC LEAK,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GENITAL HERPES,1
CH,GENITAL HERPES SIMPLEX,1
CH,GENITOURINARY TRACT INFECTION,1
CH,GINGIVITIS,1
CH,GLIOMA,1
CH,GLYCOSURIA,1
CH,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
CH,GRAFT VERSUS HOST DISEASE IN LUNG,1
CH,GRAND MAL CONVULSION,1
CH,HAEMATURIA,1
CH,HAEMORRHAGIC STROKE,1
CH,HAPTOGLOBIN DECREASED,1
CH,HEMIPLEGIA,1
CH,HEPATIC CIRRHOSIS,1
CH,HEPATOSPLENIC CANDIDIASIS,1
CH,HEPATOTOXICITY,1
CH,HERPES SIMPLEX,1
CH,HERPES SIMPLEX PHARYNGITIS,1
CH,HERPES VIRUS INFECTION,1
CH,HERPES ZOSTER MENINGOENCEPHALITIS,1
CH,HERPES ZOSTER MENINGOMYELITIS,1
CH,HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE III,1
CH,HORDEOLUM,1
CH,HORNER^S SYNDROME,1
CH,HUMORAL IMMUNE DEFECT,1
CH,HYPERCALCAEMIA,1
CH,HYPERCAPNIC COMA,1
CH,HYPERHIDROSIS,1
CH,HYPERPHOSPHATAEMIA,1
CH,HYPERTHERMIA,1
CH,HYPERTHYROIDISM,1
CH,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
CH,HYPONATRAEMIA,1
CH,HYPOREFLEXIA,1
CH,HYPOTONIA,1
CH,HYPOVOLAEMIC SHOCK,1
CH,IMMUNE SYSTEM DISORDER,1
CH,IMMUNOBLASTIC LYMPHOMA,1
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
CH,INTENTIONAL OVERDOSE,1
CH,INTESTINAL ULCER,1
CH,INTESTINAL VILLI ATROPHY,1
CH,INTRA-ABDOMINAL HAEMORRHAGE,1
CH,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
CH,JOINT EFFUSION,1
CH,KLEBSIELLA BACTERAEMIA,1
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CH,LACTIC ACIDOSIS,1
CH,LARYNGEAL OEDEMA,1
CH,LATENT TUBERCULOSIS,1
CH,LEFT VENTRICULAR FAILURE,1
CH,LEUKAEMIA RECURRENT,1
CH,LEUKOENCEPHALOPATHY,1
CH,LIBIDO DISORDER,1
CH,LIP DRY,1
CH,LIP OEDEMA,1
CH,LIPASE INCREASED,1
CH,LIPOMA,1
CH,LOWER RESPIRATORY TRACT INFECTION,1
CH,LUNG ADENOCARCINOMA,1
CH,LUNG ADENOCARCINOMA STAGE IV,1
CH,LUNG INFECTION,1
CH,LUNG INFILTRATION,1
CH,LYMPHADENITIS,1
CH,LYMPHANGITIS,1
CH,LYMPHATIC DISORDER,1
CH,LYMPHOPROLIFERATIVE DISORDER,1
CH,MACULE,1
CH,MALIGNANT MELANOMA,1
CH,MALIGNANT NEOPLASM OF ISLETS OF LANGERHANS,1
CH,MALIGNANT NEOPLASM PROGRESSION,1
CH,MANTLE CELL LYMPHOMA,1
CH,MATERNAL EXPOSURE BEFORE PREGNANCY,1
CH,MEDICATION MONITORING ERROR,1
CH,MEMORY IMPAIRMENT,1
CH,MENINGEAL DISORDER,1
CH,MENINGITIS,1
CH,MENINGITIS CRYPTOCOCCAL,1
CH,MENINGITIS LEPTOSPIRAL,1
CH,MENINGITIS TUBERCULOUS,1
CH,MENINGOCOCCAL SEPSIS,1
CH,MENOMETRORRHAGIA,1
CH,METABOLIC ACIDOSIS,1
CH,METABOLIC ALKALOSIS,1
CH,METASTASES TO LUNG,1
CH,METASTASES TO LYMPH NODES,1
CH,METRORRHAGIA,1
CH,MICROANGIOPATHY,1
CH,MITRAL VALVE INCOMPETENCE,1
CH,MIXED LIVER INJURY,1
CH,MOANING,1
CH,MONARTHRITIS,1
CH,MUSCLE INJURY,1
CH,MYALGIA,1
CH,MYCOBACTERIUM KANSASII INFECTION,1
CH,MYOCARDIAL INFARCTION,1
CH,MYOCARDIAL ISCHAEMIA,1
CH,MYOSITIS,1
CH,NASOPHARYNGITIS,1
CH,NEURALGIA,1
CH,NIGHT SWEATS,1
CH,NO THERAPEUTIC RESPONSE,1
CH,NOCARDIOSIS,1
CH,NON-HODGKIN^S LYMPHOMA RECURRENT,1
CH,NON-SMALL CELL LUNG CANCER STAGE IIIB,1
CH,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
CH,OEDEMATOUS PANCREATITIS,1
CH,OLIGURIA,1
CH,OPHTHALMIC HERPES ZOSTER,1
CH,OPTIC ISCHAEMIC NEUROPATHY,1
CH,ORAL DISCOMFORT,1
CH,ORAL FUNGAL INFECTION,1
CH,OROPHARYNGEAL CANDIDIASIS,1
CH,OROPHARYNGEAL PAIN,1
CH,OSTEOMYELITIS,1
CH,OSTEOPENIA,1
CH,OTITIS MEDIA,1
CH,OVARIAN CANCER,1
CH,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CH,PANCREATIC FISTULA,1
CH,PANCREATIC NEOPLASM,1
CH,PANCREATIC STEATOSIS,1
CH,PANCREATITIS,1
CH,PAPILLOMA VIRAL INFECTION,1
CH,PARAESTHESIA ORAL,1
CH,PARESIS,1
CH,PARTIAL SEIZURES,1
CH,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
CH,PERICARDIAL EFFUSION,1
CH,PERICARDITIS,1
CH,PERIPHERAL COLDNESS,1
CH,PERIPHERAL MOTOR NEUROPATHY,1
CH,PERSONALITY CHANGE,1
CH,PHARYNGEAL OEDEMA,1
CH,PHOTOPHOBIA,1
CH,PHOTOSENSITIVITY REACTION,1
CH,PLEURAL EFFUSION,1
CH,PNEUMONIA FUNGAL,1
CH,PNEUMONIA LEGIONELLA,1
CH,PNEUMONIA VIRAL,1
CH,PNEUMOTHORAX,1
CH,POLLAKIURIA,1
CH,POLYARTHRITIS,1
CH,PRE-ECLAMPSIA,1
CH,PREMATURE LABOUR,1
CH,PREMATURE RUPTURE OF MEMBRANES,1
CH,PROCEDURAL PAIN,1
CH,PRODUCT PREPARATION ERROR,1
CH,PSYCHOMOTOR RETARDATION,1
CH,PULMONARY ARTERIAL HYPERTENSION,1
CH,PULMONARY FIBROSIS,1
CH,PULMONARY HILUM MASS,1
CH,PULMONARY OEDEMA,1
CH,PULMONARY TOXICITY,1
CH,PULMONARY TUBERCULOSIS,1
CH,PUPILS UNEQUAL,1
CH,RADICULITIS,1
CH,RALES,1
CH,RASH MACULO-PAPULAR,1
CH,RENAL CANCER,1
CH,RENAL INJURY,1
CH,RESPIRATORY DISTRESS,1
CH,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
CH,RESPIRATORY TRACT INFLAMMATION,1
CH,RETICULOCYTE COUNT INCREASED,1
CH,RETROPERITONEAL LYMPHADENOPATHY,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,SCHIZOPHRENIA,1
CH,SENSORY DISTURBANCE,1
CH,SEROSITIS,1
CH,SERUM SICKNESS,1
CH,SIALOADENITIS,1
CH,SILICOSIS,1
CH,SINUS TACHYCARDIA,1
CH,SJOGREN^S SYNDROME,1
CH,SKIN DISORDER,1
CH,SKIN EROSION,1
CH,SKIN EXFOLIATION,1
CH,SKIN HAEMORRHAGE,1
CH,SKIN INFECTION,1
CH,SKIN MASS,1
CH,SKIN TEST POSITIVE,1
CH,SMALL INTESTINE CARCINOMA,1
CH,SOPOR,1
CH,SPINAL FUSION SURGERY,1
CH,SQUAMOUS CELL CARCINOMA OF LUNG,1
CH,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,STEM CELL TRANSPLANT,1
CH,STERNITIS,1
CH,STILL^S DISEASE,1
CH,STOMATOCYTES PRESENT,1
CH,STREPTOCOCCAL INFECTION,1
CH,SUBCUTANEOUS ABSCESS,1
CH,SUICIDE ATTEMPT,1
CH,SWELLING,1
CH,SYNOVIAL RUPTURE,1
CH,SYNOVITIS,1
CH,SYPHILIS,1
CH,T-CELL LYMPHOMA,1
CH,T-CELL TYPE ACUTE LEUKAEMIA,1
CH,T-LYMPHOCYTE COUNT DECREASED,1
CH,TACHYCARDIA,1
CH,TAKAYASU^S ARTERITIS,1
CH,TEMPORAL ARTERITIS,1
CH,TENDON RUPTURE,1
CH,THERAPEUTIC RESPONSE DECREASED,1
CH,THERAPY CESSATION,1
CH,TOXIC NEUROPATHY,1
CH,TOXOPLASMOSIS,1
CH,TRANSCATHETER AORTIC VALVE IMPLANTATION,1
CH,TRICUSPID VALVE INCOMPETENCE,1
CH,TYPE I HYPERSENSITIVITY,1
CH,TYPE IV HYPERSENSITIVITY REACTION,1
CH,ULNA FRACTURE,1
CH,UNINTENDED PREGNANCY,1
CH,UPPER RESPIRATORY TRACT INFECTION,1
CH,UPPER RESPIRATORY TRACT INFECTION BACTERIAL,1
CH,URINARY TRACT INFECTION,1
CH,UVEITIS,1
CH,VAGINAL HAEMORRHAGE,1
CH,VAGINAL INFECTION,1
CH,VASCULITIS,1
CH,VENOOCCLUSIVE DISEASE,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR FIBRILLATION,1
CH,VENTRICULAR TACHYCARDIA,1
CH,VERTIGO,1
CH,VIITH NERVE PARALYSIS,1
CH,VITAMIN B12 DEFICIENCY,1
CH,VITAMIN D DEFICIENCY,1
CH,VULVAL CANCER,1
CH,VULVOVAGINAL CANDIDIASIS,1
CH,WEIGHT INCREASED,1
CH,WHIPPLE^S DISEASE,1
CH,WHITE BLOOD CELL COUNT DECREASED,1
CH,WOUND DEHISCENCE,1
SY,MYALGIA,2
SY,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SY,ARTHRALGIA,1
SY,ASTHENIA,1
SY,BACK PAIN,1
SY,BONE MARROW FAILURE,1
SY,CENTRAL NERVOUS SYSTEM LESION,1
SY,DECREASED APPETITE,1
SY,DEMYELINATION,1
SY,DIARRHOEA,1
SY,DRUG HYPERSENSITIVITY,1
SY,DRUG INEFFECTIVE,1
SY,DYSPEPSIA,1
SY,ELECTROCARDIOGRAM CHANGE,1
SY,FATIGUE,1
SY,GASTROINTESTINAL HAEMORRHAGE,1
SY,HAEMATOTOXICITY,1
SY,HAEMATURIA,1
SY,HEMIPARESIS,1
SY,INFUSION RELATED REACTION,1
SY,INTERVERTEBRAL DISC DEGENERATION,1
SY,INTERVERTEBRAL DISC PROTRUSION,1
SY,LUNG INFECTION,1
SY,METABOLIC ACIDOSIS,1
SY,MYELOFIBROSIS,1
SY,PANCYTOPENIA,1
SY,PERONEAL NERVE PALSY,1
SY,PYREXIA,1
SY,RESPIRATORY ACIDOSIS,1
SY,SEPTIC SHOCK,1
SY,SPINAL COLUMN STENOSIS,1
SY,SPLENOMEGALY,1
SY,SPONDYLOLISTHESIS,1
SY,URINARY TRACT INFECTION,1
SY,VIRAL INFECTION,1
SY,VISUAL IMPAIRMENT,1
TW,EPIDERMAL NECROSIS,37
TW,TOXICITY TO VARIOUS AGENTS,35
TW,PNEUMONIA,29
TW,TUBERCULOSIS,29
TW,PYREXIA,28
TW,PULMONARY TUBERCULOSIS,27
TW,HYPOALBUMINAEMIA,23
TW,THROMBOCYTOPENIA,20
TW,LEUKOPENIA,18
TW,CELLULITIS,17
TW,DRUG CLEARANCE DECREASED,17
TW,SEPSIS,17
TW,PANCYTOPENIA,15
TW,SEPTIC SHOCK,15
TW,RESPIRATORY FAILURE,14
TW,FALL,13
TW,PLEURAL EFFUSION,13
TW,COUGH,12
TW,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,12
TW,DEATH,11
TW,DIARRHOEA,11
TW,DRUG LEVEL INCREASED,11
TW,GASTROOESOPHAGEAL REFLUX DISEASE,11
TW,PSORIASIS,11
TW,ACUTE KIDNEY INJURY,9
TW,DECREASED APPETITE,9
TW,HAEMOGLOBIN DECREASED,9
TW,HEPATITIS B,9
TW,SHOCK,9
TW,URINARY TRACT INFECTION,9
TW,WHITE BLOOD CELL COUNT DECREASED,9
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,8
TW,ARTHRALGIA,8
TW,ASTHENIA,8
TW,CHOLELITHIASIS,8
TW,DYSPNOEA,8
TW,JAUNDICE,8
TW,LUNG INFILTRATION,8
TW,OSTEOARTHRITIS,8
TW,VOMITING,8
TW,ACUTE MYOCARDIAL INFARCTION,7
TW,ERYTHEMA,7
TW,GASTROINTESTINAL HAEMORRHAGE,7
TW,HERPES ZOSTER,7
TW,INFECTION,7
TW,MOUTH ULCERATION,7
TW,NASOPHARYNGITIS,7
TW,RENAL CYST,7
TW,ANAEMIA,6
TW,C-REACTIVE PROTEIN INCREASED,6
TW,CARDIAC TAMPONADE,6
TW,CYTOMEGALOVIRUS INFECTION,6
TW,DIZZINESS,6
TW,EXTRAPULMONARY TUBERCULOSIS,6
TW,FEBRILE NEUTROPENIA,6
TW,PERICARDIAL EFFUSION,6
TW,PULMONARY OEDEMA,6
TW,PYELONEPHRITIS ACUTE,6
TW,RENAL FAILURE,6
TW,ROAD TRAFFIC ACCIDENT,6
TW,SKIN ULCER,6
TW,ABDOMINAL PAIN,5
TW,ACUTE GRAFT VERSUS HOST DISEASE,5
TW,ASCITES,5
TW,ASPARTATE AMINOTRANSFERASE INCREASED,5
TW,CHILLS,5
TW,CONDITION AGGRAVATED,5
TW,FOOT DEFORMITY,5
TW,GAIT DISTURBANCE,5
TW,GASTRIC ULCER,5
TW,GRAFT VERSUS HOST DISEASE,5
TW,HEPATIC CIRRHOSIS,5
TW,HEPATIC STEATOSIS,5
TW,INTERSTITIAL LUNG DISEASE,5
TW,LYMPHOMA,5
TW,NAUSEA,5
TW,NEPHROLITHIASIS,5
TW,OEDEMA PERIPHERAL,5
TW,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
TW,RESPIRATORY DISTRESS,5
TW,SPLENOMEGALY,5
TW,ABDOMINAL DISTENSION,4
TW,ABDOMINAL PAIN UPPER,4
TW,ACUTE HEPATIC FAILURE,4
TW,ALANINE AMINOTRANSFERASE INCREASED,4
TW,CARDIOMEGALY,4
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
TW,CONTUSION,4
TW,DRUG INEFFECTIVE,4
TW,FEMUR FRACTURE,4
TW,HAEMATOMA,4
TW,HAEMORRHOIDS,4
TW,HEADACHE,4
TW,HEPATIC FUNCTION ABNORMAL,4
TW,HYDRONEPHROSIS,4
TW,HYPONATRAEMIA,4
TW,INFECTIVE ANEURYSM,4
TW,LATENT TUBERCULOSIS,4
TW,LIVER DISORDER,4
TW,LUNG INFECTION,4
TW,MENINGITIS HAEMOPHILUS,4
TW,MUCOSAL INFLAMMATION,4
TW,MYOCARDIAL INFARCTION,4
TW,OROPHARYNGEAL PAIN,4
TW,PERIPHERAL SWELLING,4
TW,PLATELET COUNT DECREASED,4
TW,RENAL IMPAIRMENT,4
TW,TREATMENT FAILURE,4
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,4
TW,URINE OUTPUT DECREASED,4
TW,VENTRICULAR ARRHYTHMIA,4
TW,ABDOMINAL WALL ABSCESS,3
TW,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,3
TW,ACUTE RESPIRATORY FAILURE,3
TW,AORTIC ANEURYSM,3
TW,ARTHRITIS,3
TW,ATYPICAL MYCOBACTERIAL INFECTION,3
TW,BILIARY TRACT INFECTION,3
TW,BLOOD ALBUMIN DECREASED,3
TW,BONE MARROW FAILURE,3
TW,BREAST CANCER,3
TW,CARDIOTOXICITY,3
TW,CERVICAL DYSPLASIA,3
TW,CHEST PAIN,3
TW,CHEST X-RAY ABNORMAL,3
TW,CHRONIC GASTRITIS,3
TW,CHRONIC HEPATITIS,3
TW,ESCHERICHIA URINARY TRACT INFECTION,3
TW,GASTRODUODENAL ULCER,3
TW,HAEMATOCHEZIA,3
TW,HEPATIC ENCEPHALOPATHY,3
TW,HEPATIC FAILURE,3
TW,HEPATIC NEOPLASM,3
TW,HYPOPHAGIA,3
TW,HYPOTENSION,3
TW,HYPOXIA,3
TW,IRITIS,3
TW,KLEBSIELLA INFECTION,3
TW,LARGE INTESTINE POLYP,3
TW,LUNG ABSCESS,3
TW,LUNG ADENOCARCINOMA,3
TW,LUNG NEOPLASM MALIGNANT,3
TW,LYMPHOPROLIFERATIVE DISORDER,3
TW,MUCORMYCOSIS,3
TW,MULTI-ORGAN FAILURE,3
TW,MYCOBACTERIAL INFECTION,3
TW,NECROTISING FASCIITIS,3
TW,OEDEMA,3
TW,OSTEONECROSIS,3
TW,PAIN,3
TW,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
TW,PRODUCT USE ISSUE,3
TW,PRURITUS,3
TW,RASH,3
TW,RHEUMATOID ARTHRITIS,3
TW,SINUSITIS,3
TW,SJOGREN^S SYNDROME,3
TW,SKIN LESION,3
TW,SPINAL COMPRESSION FRACTURE,3
TW,SPINAL OSTEOARTHRITIS,3
TW,STAPHYLOCOCCAL INFECTION,3
TW,SWELLING FACE,3
TW,TACHYCARDIA,3
TW,TRANSPLANT REJECTION,3
TW,ULCER,3
TW,UTERINE LEIOMYOMA,3
TW,WHITE BLOOD CELL COUNT INCREASED,3
TW,WOUND,3
TW,ABASIA,2
TW,ABDOMINAL INFECTION,2
TW,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,2
TW,ACUTE MYELOID LEUKAEMIA,2
TW,ADRENAL INSUFFICIENCY,2
TW,ALOPECIA,2
TW,ALTERED STATE OF CONSCIOUSNESS,2
TW,ALVEOLITIS ALLERGIC,2
TW,ANGIODYSPLASIA,2
TW,ARTHRITIS BACTERIAL,2
TW,BACTERAEMIA,2
TW,BILE DUCT OBSTRUCTION,2
TW,BILE DUCT STONE,2
TW,BLOOD CALCIUM DECREASED,2
TW,BLOOD CREATININE INCREASED,2
TW,BONE ABSCESS,2
TW,BREAST CANCER FEMALE,2
TW,BREAST CANCER IN SITU,2
TW,CEREBRAL INFARCTION,2
TW,CHEST DISCOMFORT,2
TW,CHRONIC GRAFT VERSUS HOST DISEASE,2
TW,COAGULOPATHY,2
TW,COLD SWEAT,2
TW,CYST,2
TW,CYSTITIS HAEMORRHAGIC,2
TW,DEHYDRATION,2
TW,DIABETES MELLITUS,2
TW,DISEASE RECURRENCE,2
TW,DUODENAL ULCER PERFORATION,2
TW,DYSPHAGIA,2
TW,ENDOMETRIOSIS,2
TW,ENTEROCOCCAL INFECTION,2
TW,ESCHERICHIA INFECTION,2
TW,EXOSTOSIS,2
TW,GASTRITIS,2
TW,GASTRITIS EROSIVE,2
TW,GENERALISED OEDEMA,2
TW,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,2
TW,GRANULOMA,2
TW,HAEMATOCRIT DECREASED,2
TW,HEAD INJURY,2
TW,HEART INJURY,2
TW,HEPATITIS B REACTIVATION,2
TW,HYPERBILIRUBINAEMIA,2
TW,INFLAMMATION,2
TW,INTERNAL HAEMORRHAGE,2
TW,IRIDOCYCLITIS,2
TW,JOINT ANKYLOSIS,2
TW,KAPOSI^S VARICELLIFORM ERUPTION,2
TW,LEUKOCYTOSIS,2
TW,LIMB INJURY,2
TW,LISTERIOSIS,2
TW,LIVER FUNCTION TEST ABNORMAL,2
TW,LIVER INJURY,2
TW,LOSS OF CONSCIOUSNESS,2
TW,LUNG CANCER METASTATIC,2
TW,LYMPHADENOPATHY,2
TW,MALAISE,2
TW,MALIGNANT NEOPLASM PROGRESSION,2
TW,MASS,2
TW,MENINGITIS,2
TW,METABOLIC ACIDOSIS,2
TW,MUCOSAL ULCERATION,2
TW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
TW,NEOPLASM,2
TW,NODULE,2
TW,OCCULT BLOOD POSITIVE,2
TW,ORAL MUCOSA EROSION,2
TW,ORGANISING PNEUMONIA,2
TW,OSTEOMYELITIS,2
TW,OSTEONECROSIS OF JAW,2
TW,OSTEOPOROSIS,2
TW,OVERDOSE,2
TW,PAIN IN EXTREMITY,2
TW,PANCREATIC CARCINOMA METASTATIC,2
TW,PANCREATITIS ACUTE,2
TW,PARAESTHESIA,2
TW,PERITONITIS,2
TW,PNEUMONIA CRYPTOCOCCAL,2
TW,POLYP,2
TW,PORTAL VEIN THROMBOSIS,2
TW,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
TW,PRODUCTIVE COUGH,2
TW,PSEUDOMONAS INFECTION,2
TW,PULMONARY MASS,2
TW,RASH ERYTHEMATOUS,2
TW,RED BLOOD CELL COUNT DECREASED,2
TW,RHINORRHOEA,2
TW,RIB FRACTURE,2
TW,SCOLIOSIS,2
TW,SKIN GRAFT,2
TW,SKIN NECROSIS,2
TW,SPUTUM DISCOLOURED,2
TW,SPUTUM RETENTION,2
TW,STAPHYLOCOCCAL SEPSIS,2
TW,SYMPTOM MASKED,2
TW,SYSTEMIC LUPUS ERYTHEMATOSUS,2
TW,TRANSIENT GLOBAL AMNESIA,2
TW,TUBERCULIN TEST POSITIVE,2
TW,TUBERCULOUS PLEURISY,2
TW,WEIGHT DECREASED,2
TW,WEIGHT INCREASED,2
TW,ABDOMINAL DISCOMFORT,1
TW,ABSCESS,1
TW,ABSCESS LIMB,1
TW,ACARODERMATITIS,1
TW,ACCIDENT,1
TW,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
TW,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
TW,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
TW,ACUTE PULMONARY OEDEMA,1
TW,ADENOCARCINOMA,1
TW,ADENOCARCINOMA OF COLON,1
TW,ALPHA 1 FOETOPROTEIN INCREASED,1
TW,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
TW,ALVEOLAR OSTEITIS,1
TW,ANAL FISSURE,1
TW,ANAPHYLACTIC SHOCK,1
TW,ANOPLASTY,1
TW,AORTIC ARTERIOSCLEROSIS,1
TW,AORTIC DISORDER,1
TW,AORTIC VALVE INCOMPETENCE,1
TW,APPENDICITIS,1
TW,ARTERIAL HAEMORRHAGE,1
TW,ARTERIOSCLEROSIS,1
TW,ATELECTASIS,1
TW,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
TW,ATYPICAL PNEUMONIA,1
TW,AUTOIMMUNE DISORDER,1
TW,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
TW,B-CELL LYMPHOMA,1
TW,BACK PAIN,1
TW,BACTERIAL INFECTION,1
TW,BASOPHIL COUNT INCREASED,1
TW,BEDRIDDEN,1
TW,BK VIRUS INFECTION,1
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TW,BLOOD BILIRUBIN INCREASED,1
TW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TW,BLOOD CULTURE POSITIVE,1
TW,BLOOD LACTIC ACID INCREASED,1
TW,BLOOD PRESSURE ABNORMAL,1
TW,BLOOD PRESSURE DECREASED,1
TW,BLOOD PRESSURE INCREASED,1
TW,BLOOD UREA DECREASED,1
TW,BLOOD UREA INCREASED,1
TW,BONE MARROW INFILTRATION,1
TW,BONE MARROW TRANSPLANT REJECTION,1
TW,BONE PAIN,1
TW,BRADYCARDIA,1
TW,BRAIN NEOPLASM,1
TW,BRAIN OEDEMA,1
TW,BRONCHIAL METAPLASIA,1
TW,BRONCHIECTASIS,1
TW,BRONCHOPULMONARY ASPERGILLOSIS,1
TW,CALCULUS URETERIC,1
TW,CANDIDA INFECTION,1
TW,CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT,1
TW,CARCINOMA IN SITU,1
TW,CARDIAC FAILURE,1
TW,CARDIAC FAILURE CONGESTIVE,1
TW,CAROTID ARTERIOSCLEROSIS,1
TW,CATARACT,1
TW,CEREBELLAR INFARCTION,1
TW,CEREBRAL ARTERY OCCLUSION,1
TW,CEREBRAL ATROPHY,1
TW,CEREBRAL CALCIFICATION,1
TW,CEREBRAL HAEMORRHAGE,1
TW,CEREBRAL VENTRICLE DILATATION,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,CEREBROVASCULAR ARTERIOVENOUS MALFORMATION,1
TW,CERVICAL MYELOPATHY,1
TW,CERVIX CARCINOMA,1
TW,CHOLANGIOCARCINOMA,1
TW,CHOLECYSTITIS ACUTE,1
TW,CHOLECYSTITIS CHRONIC,1
TW,CHORIORETINITIS,1
TW,CHROMATURIA,1
TW,CHRONIC HEPATITIS B,1
TW,CHRONIC HEPATITIS C,1
TW,CHRONIC KIDNEY DISEASE,1
TW,CLAVICLE FRACTURE,1
TW,COLITIS,1
TW,COLORECTAL CANCER,1
TW,CONDUCTION DISORDER,1
TW,CONSTIPATION,1
TW,CORONARY ARTERY DISEASE,1
TW,CROHN^S DISEASE,1
TW,CRYPTOCOCCOSIS,1
TW,CUTANEOUS TUBERCULOSIS,1
TW,CYTOMEGALOVIRUS VIRAEMIA,1
TW,DELIRIUM,1
TW,DEMYELINATION,1
TW,DENTAL CARIES,1
TW,DIFFUSE LARGE B-CELL LYMPHOMA,1
TW,DISCOMFORT,1
TW,DISEASE PROGRESSION,1
TW,DISSEMINATED INTRAVASCULAR COAGULATION,1
TW,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
TW,DRUG RESISTANCE,1
TW,DRY EYE,1
TW,DRY SKIN,1
TW,DUODENAL ULCER,1
TW,DYSURIA,1
TW,EAR INFECTION,1
TW,EJECTION FRACTION DECREASED,1
TW,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
TW,EMPHYSEMA,1
TW,EMPYEMA,1
TW,ERYTHEMA NODOSUM,1
TW,ESCHERICHIA SEPSIS,1
TW,EXPOSED BONE IN JAW,1
TW,FACIAL PAIN,1
TW,FACIAL PARALYSIS,1
TW,FAECES DISCOLOURED,1
TW,FASCIITIS,1
TW,FASCIOTOMY,1
TW,FEELING COLD,1
TW,FEMORAL ARTERY EMBOLISM,1
TW,FIBROSIS,1
TW,FINGER DEFORMITY,1
TW,FLANK PAIN,1
TW,FLATULENCE,1
TW,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
TW,FRACTURE TREATMENT,1
TW,GALLBLADDER DISORDER,1
TW,GALLBLADDER OEDEMA,1
TW,GASTRIC CANCER,1
TW,GASTRIC HAEMORRHAGE,1
TW,GENERALISED ERYTHEMA,1
TW,GINGIVAL BLEEDING,1
TW,GINGIVAL HYPERTROPHY,1
TW,GINGIVITIS,1
TW,GLAUCOMA,1
TW,GRAFT VERSUS HOST DISEASE IN LIVER,1
TW,HAEMANGIOMA,1
TW,HAEMATEMESIS,1
TW,HAEMATURIA,1
TW,HAEMOLYTIC ANAEMIA,1
TW,HAEMORRHAGE,1
TW,HAEMORRHAGE INTRACRANIAL,1
TW,HAEMORRHAGIC ASCITES,1
TW,HAEMORRHAGIC CYST,1
TW,HAEMORRHOID OPERATION,1
TW,HAEMOSTASIS,1
TW,HAPTOGLOBIN DECREASED,1
TW,HEART RATE INCREASED,1
TW,HEPATIC CALCIFICATION,1
TW,HEPATIC CANCER METASTATIC,1
TW,HEPATIC CANCER STAGE III,1
TW,HEPATIC CYST,1
TW,HEPATIC ENZYME INCREASED,1
TW,HEPATIC HAEMORRHAGE,1
TW,HEPATIC MASS,1
TW,HEPATIC NECROSIS,1
TW,HEPATITIS,1
TW,HEPATITIS B DNA INCREASED,1
TW,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
TW,HEPATITIS B SURFACE ANTIGEN POSITIVE,1
TW,HEPATITIS C RNA INCREASED,1
TW,HEPATITIS CHOLESTATIC,1
TW,HEPATITIS FULMINANT,1
TW,HEPATOCELLULAR CARCINOMA,1
TW,HEPATOMEGALY,1
TW,HEPATORENAL SYNDROME,1
TW,HEPATOTOXICITY,1
TW,HERPES VIRUS INFECTION,1
TW,HODGKIN^S DISEASE,1
TW,HOSPITALISATION,1
TW,HUMERUS FRACTURE,1
TW,HYPERPLASIA,1
TW,HYPERTENSIVE HEART DISEASE,1
TW,HYPERTRIGLYCERIDAEMIA,1
TW,HYPOAESTHESIA,1
TW,HYPOKALAEMIA,1
TW,HYPOVOLAEMIC SHOCK,1
TW,IMMUNODEFICIENCY,1
TW,IMPAIRED HEALING,1
TW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TW,INFERIOR VENA CAVA SYNDROME,1
TW,INFLAMMATORY PSEUDOTUMOUR,1
TW,INTERFERON GAMMA RELEASE ASSAY POSITIVE,1
TW,INTERVERTEBRAL DISC COMPRESSION,1
TW,INTERVERTEBRAL DISC DEGENERATION,1
TW,INTESTINAL PERFORATION,1
TW,INTESTINAL TUBERCULOSIS,1
TW,INTRA-ABDOMINAL HAEMORRHAGE,1
TW,INTRACRANIAL ANEURYSM,1
TW,JOINT DISLOCATION,1
TW,JOINT STIFFNESS,1
TW,JOINT SWELLING,1
TW,KLEBSIELLA SEPSIS,1
TW,KNEE ARTHROPLASTY,1
TW,KYPHOSIS,1
TW,LACERATION,1
TW,LEPTOSPIROSIS,1
TW,LEUKAEMIA,1
TW,LEUKAEMIA CUTIS,1
TW,LIMB CRUSHING INJURY,1
TW,LIP AND/OR ORAL CAVITY CANCER,1
TW,LOCAL SWELLING,1
TW,LOWER LIMB FRACTURE,1
TW,LUMBAR SPINAL STENOSIS,1
TW,LUNG ADENOCARCINOMA STAGE 0,1
TW,LUNG ADENOCARCINOMA STAGE II,1
TW,LYMPHADENITIS,1
TW,LYMPHOCYTE COUNT INCREASED,1
TW,LYMPHOID TISSUE HYPERPLASIA,1
TW,MENINGIOMA,1
TW,MENINGITIS CRYPTOCOCCAL,1
TW,MENINGITIS VIRAL,1
TW,METASTASES TO CENTRAL NERVOUS SYSTEM,1
TW,METASTASES TO LIVER,1
TW,MITRAL VALVE INCOMPETENCE,1
TW,MOBILITY DECREASED,1
TW,MOUTH HAEMORRHAGE,1
TW,MUSCULAR WEAKNESS,1
TW,MYALGIA,1
TW,MYCETOMA MYCOTIC,1
TW,MYELOPATHY,1
TW,MYOCARDIAL ISCHAEMIA,1
TW,MYOPATHY,1
TW,NASAL DISCHARGE DISCOLOURATION,1
TW,NEOPLASM PROGRESSION,1
TW,NEPHROPATHY,1
TW,NEUTROPENIA,1
TW,NEUTROPHIL COUNT DECREASED,1
TW,NO THERAPEUTIC RESPONSE,1
TW,NUCHAL RIGIDITY,1
TW,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
TW,ORAL DISCOMFORT,1
TW,OSTEOPENIA,1
TW,OVARIAN CANCER,1
TW,OVARIAN CYST,1
TW,PALPITATIONS,1
TW,PANCREATIC NEOPLASM,1
TW,PANCREATITIS,1
TW,PANNICULITIS LOBULAR,1
TW,PAPILLARY THYROID CANCER,1
TW,PATHOLOGICAL FRACTURE,1
TW,PELVIC NEOPLASM,1
TW,PEPTIC ULCER,1
TW,PERFORATION BILE DUCT,1
TW,PERICARDIAL HAEMORRHAGE,1
TW,PERIODONTITIS,1
TW,PERITONEAL HAEMORRHAGE,1
TW,PERITONEAL TUBERCULOSIS,1
TW,PERITONITIS BACTERIAL,1
TW,PHARYNGEAL OEDEMA,1
TW,PITUITARY TUMOUR BENIGN,1
TW,PLATELET COUNT ABNORMAL,1
TW,PLEURAL CALCIFICATION,1
TW,PLEURISY,1
TW,PNEUMONIA HAEMOPHILUS,1
TW,PNEUMONIA KLEBSIELLA,1
TW,PNEUMONIA LEGIONELLA,1
TW,PNEUMONIA NECROTISING,1
TW,PNEUMONIA PSEUDOMONAL,1
TW,PNEUMONIA PSEUDOMONAS AERUGINOSA,1
TW,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,1
TW,PNEUMONIA STAPHYLOCOCCAL,1
TW,POST PROCEDURAL DISCHARGE,1
TW,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
TW,PROTHROMBIN LEVEL INCREASED,1
TW,PROTHROMBIN TIME PROLONGED,1
TW,PRURITUS GENERALISED,1
TW,PSEUDOMONAL SEPSIS,1
TW,PULMONARY CONGESTION,1
TW,PULMONARY EMBOLISM,1
TW,PULMONARY FIBROSIS,1
TW,PULMONARY TOXICITY,1
TW,PULMONARY VALVE INCOMPETENCE,1
TW,RASH GENERALISED,1
TW,RECTAL POLYP,1
TW,RENAL CELL CARCINOMA,1
TW,RENAL FAILURE ACUTE,1
TW,RENAL FAILURE CHRONIC,1
TW,RIB DEFORMITY,1
TW,SACROILIITIS,1
TW,SALIVARY GLAND CANCER,1
TW,SALMONELLA TEST POSITIVE,1
TW,SCHIZOPHRENIA,1
TW,SCHWANNOMA,1
TW,SENSORIMOTOR DISORDER,1
TW,SEPTAL PANNICULITIS,1
TW,SINUS TACHYCARDIA,1
TW,SKIN EROSION,1
TW,SKIN EXFOLIATION,1
TW,SKIN FIBROSIS,1
TW,SKIN OEDEMA,1
TW,SKIN PLAQUE,1
TW,SOMNOLENCE,1
TW,SPINAL CORD COMPRESSION,1
TW,SPINAL PAIN,1
TW,SPLENIC RUPTURE,1
TW,SPONDYLOLISTHESIS,1
TW,SQUAMOUS CELL CARCINOMA,1
TW,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
TW,STAG HORN CALCULUS,1
TW,STERNAL FRACTURE,1
TW,STOMATITIS,1
TW,STREPTOCOCCAL INFECTION,1
TW,SUBARACHNOID HAEMORRHAGE,1
TW,SUBDURAL HAEMATOMA,1
TW,SUDDEN DEATH,1
TW,SUPRAVENTRICULAR EXTRASYSTOLES,1
TW,SURGERY,1
TW,SYNOVIAL DISORDER,1
TW,SYNOVITIS,1
TW,TENDERNESS,1
TW,TENDON RUPTURE,1
TW,THERAPEUTIC RESPONSE DECREASED,1
TW,THYROID CANCER,1
TW,THYROID NEOPLASM,1
TW,TINNITUS,1
TW,TOOTH DISORDER,1
TW,TOXIC ENCEPHALOPATHY,1
TW,TRANSAMINASES INCREASED,1
TW,TRANSITIONAL CELL CARCINOMA,1
TW,TREATMENT NONCOMPLIANCE,1
TW,TRICUSPID VALVE INCOMPETENCE,1
TW,TROPONIN I INCREASED,1
TW,TUMOUR HAEMORRHAGE,1
TW,UPPER RESPIRATORY TRACT INFECTION,1
TW,UPPER RESPIRATORY TRACT INFLAMMATION,1
TW,URETERAL NEOPLASM,1
TW,URETERIC OBSTRUCTION,1
TW,URETEROLITHIASIS,1
TW,URINARY TRACT INFECTION ENTEROCOCCAL,1
TW,URINE OSMOLARITY DECREASED,1
TW,URINE OSMOLARITY INCREASED,1
TW,UROSEPSIS,1
TW,UVEITIS,1
TW,VARICELLA,1
TW,VARICOSE VEIN,1
TW,VASCULAR INSUFFICIENCY,1
TW,VENTRICULAR TACHYCARDIA,1
TW,VERTEBROBASILAR INSUFFICIENCY,1
TW,VERTEBROPLASTY,1
TW,VIRAL TEST POSITIVE,1
TW,VISION BLURRED,1
TW,WEIGHT FLUCTUATION,1
TW,WHEEZING,1
TW,WHITE BLOOD CELL COUNT ABNORMAL,1
TW,WOUND COMPLICATION,1
TW,WOUND INFECTION PSEUDOMONAS,1
TH,DRUG-INDUCED LIVER INJURY,8
TH,HEPATITIS,7
TH,OVARIAN DISORDER,5
TH,SEPSIS,4
TH,DISSEMINATED INTRAVASCULAR COAGULATION,3
TH,HYPOVOLAEMIC SHOCK,3
TH,INFECTION,3
TH,NAUSEA,3
TH,PYREXIA,3
TH,RENAL TUBULAR NECROSIS,3
TH,SEPTIC SHOCK,3
TH,THROMBOCYTOPENIA,3
TH,TOXIC EPIDERMAL NECROLYSIS,3
TH,VAGINAL HAEMORRHAGE,3
TH,ACUTE RESPIRATORY DISTRESS SYNDROME,2
TH,BLOOD GONADOTROPHIN DECREASED,2
TH,BRONCHIECTASIS,2
TH,DIVERTICULITIS,2
TH,DRUG HYPERSENSITIVITY,2
TH,DYSPNOEA,2
TH,GASTRITIS,2
TH,HYPERSENSITIVITY,2
TH,LACTIC ACIDOSIS,2
TH,MATERNAL EXPOSURE DURING PREGNANCY,2
TH,PNEUMONIA,2
TH,RENAL FAILURE,2
TH,TESTICULAR DISORDER,2
TH,URINARY TRACT INFECTION,2
TH,ACUTE ABDOMEN,1
TH,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
TH,ALANINE AMINOTRANSFERASE INCREASED,1
TH,ANAEMIA,1
TH,ANIMAL BITE,1
TH,ARTHRITIS BACTERIAL,1
TH,ASPARTATE AMINOTRANSFERASE INCREASED,1
TH,BRONCHITIS,1
TH,CARDIAC FAILURE,1
TH,CELLULITIS,1
TH,CERVIX HAEMORRHAGE UTERINE,1
TH,CONDITION AGGRAVATED,1
TH,CONVULSION,1
TH,COUGH,1
TH,DECREASED APPETITE,1
TH,DEEP VEIN THROMBOSIS,1
TH,DEMENTIA,1
TH,EAR SWELLING,1
TH,ENURESIS,1
TH,EXTERNAL EAR DISORDER,1
TH,EYE INFECTION FUNGAL,1
TH,FATIGUE,1
TH,FEBRILE NEUTROPENIA,1
TH,GALLBLADDER INJURY,1
TH,GASTROENTERITIS,1
TH,GAZE PALSY,1
TH,HEPATIC STEATOSIS,1
TH,HEPATITIS B,1
TH,HYPERTENSION,1
TH,HYPOKALAEMIA,1
TH,IMMUNODEFICIENCY,1
TH,INCORRECT DOSE ADMINISTERED,1
TH,JAUNDICE,1
TH,LUNG INFECTION,1
TH,MALIGNANT NEOPLASM PROGRESSION,1
TH,MUCOSAL INFLAMMATION,1
TH,OVERDOSE,1
TH,PANCREATIC CARCINOMA,1
TH,PELVIC VENOUS THROMBOSIS,1
TH,PERFORATION,1
TH,PLEURAL EFFUSION,1
TH,PNEUMONIA BACTERIAL,1
TH,POLYARTHRITIS,1
TH,PRODUCT USE IN UNAPPROVED INDICATION,1
TH,PRODUCT USE ISSUE,1
TH,PSORIASIS,1
TH,PULMONARY HYPERTENSION,1
TH,PULMONARY TUBERCULOSIS,1
TH,PUNCTURE SITE DISCHARGE,1
TH,RASH MACULO-PAPULAR,1
TH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
TH,RESPIRATORY FAILURE,1
TH,SEROMA,1
TH,SIALOADENITIS,1
TH,SINUSITIS,1
TH,SINUSITIS FUNGAL,1
TH,SKIN INFECTION,1
TH,STEVENS-JOHNSON SYNDROME,1
TH,SUBCUTANEOUS ABSCESS,1
TH,SUPERINFECTION,1
TH,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TH,TRACHEOBRONCHITIS,1
TH,TUMOUR LYSIS SYNDROME,1
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TH,VOMITING,1
TH,WEIGHT DECREASED,1
TN,MUCOSAL INFLAMMATION,17
TN,BONE MARROW FAILURE,14
TN,SEPTIC SHOCK,14
TN,TOXICITY TO VARIOUS AGENTS,14
TN,RENAL FAILURE,10
TN,HEPATOCELLULAR INJURY,9
TN,SKIN LESION,7
TN,GRAFT VERSUS HOST DISEASE,6
TN,LUNG DISORDER,6
TN,PANCYTOPENIA,6
TN,CEREBELLAR SYNDROME,5
TN,CHOLESTASIS,5
TN,ERYTHEMA,5
TN,NEUROTOXICITY,5
TN,ODYNOPHAGIA,5
TN,RENAL FAILURE ACUTE,5
TN,VOMITING,5
TN,DISSEMINATED INTRAVASCULAR COAGULATION,4
TN,DYSPHAGIA,4
TN,GLOMERULONEPHRITIS MINIMAL LESION,4
TN,HEPATOTOXICITY,4
TN,PYREXIA,4
TN,RASH,4
TN,TUBULOINTERSTITIAL NEPHRITIS,4
TN,AGITATION,3
TN,AUTOIMMUNE HEPATITIS,3
TN,DIARRHOEA,3
TN,DIARRHOEA HAEMORRHAGIC,3
TN,HAEMATEMESIS,3
TN,INFLUENZA,3
TN,LEISHMANIASIS,3
TN,MELAENA,3
TN,NAUSEA,3
TN,OEDEMA,3
TN,PANNICULITIS,3
TN,RESPIRATORY FAILURE,3
TN,ALANINE AMINOTRANSFERASE INCREASED,2
TN,ASPARTATE AMINOTRANSFERASE INCREASED,2
TN,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
TN,DRUG INEFFECTIVE,2
TN,ENDOCARDITIS,2
TN,FEBRILE NEUTROPENIA,2
TN,FUSARIUM INFECTION,2
TN,GASTRIC DISORDER,2
TN,GASTROINTESTINAL TOXICITY,2
TN,GINGIVAL DISORDER,2
TN,HAEMORRHAGE,2
TN,HYPOTENSION,2
TN,JAUNDICE,2
TN,MATERNAL EXPOSURE DURING PREGNANCY,2
TN,MENTAL DISORDER,2
TN,MOUTH ULCERATION,2
TN,MYCOSIS FUNGOIDES,2
TN,NEPHROTIC SYNDROME,2
TN,PSORIASIS,2
TN,PULMONARY CONGESTION,2
TN,SKIN HYPERPIGMENTATION,2
TN,STOMATITIS,2
TN,ABASIA,1
TN,ABDOMINAL PAIN,1
TN,ABDOMINAL PAIN UPPER,1
TN,ACUTE PULMONARY OEDEMA,1
TN,AMAUROSIS,1
TN,ANAPHYLACTIC SHOCK,1
TN,ANKYLOSING SPONDYLITIS,1
TN,ARTHRALGIA,1
TN,ASTHENIA,1
TN,BLISTER,1
TN,BLOOD CREATININE INCREASED,1
TN,BONE MARROW TOXICITY,1
TN,BRONCHIAL DISORDER,1
TN,BRONCHITIS,1
TN,CELL DEATH,1
TN,CEREBRAL ISCHAEMIA,1
TN,CHEST PAIN,1
TN,CONFUSIONAL STATE,1
TN,DEHYDRATION,1
TN,DELUSION,1
TN,DIABETES MELLITUS,1
TN,DISSEMINATED TUBERCULOSIS,1
TN,DRUG INTOLERANCE,1
TN,DYSPHONIA,1
TN,DYSPNOEA,1
TN,EXPOSURE DURING PREGNANCY,1
TN,FUNGAL INFECTION,1
TN,GASTROINTESTINAL DISORDER,1
TN,GASTROINTESTINAL HAEMORRHAGE,1
TN,GENERAL PHYSICAL CONDITION ABNORMAL,1
TN,GENERAL PHYSICAL HEALTH DETERIORATION,1
TN,GINGIVAL INJURY,1
TN,GRANULOMATOUS LIVER DISEASE,1
TN,HAEMATOTOXICITY,1
TN,HALLUCINATION,1
TN,HEADACHE,1
TN,HEPATITIS,1
TN,HYPERNATRAEMIA,1
TN,INCORRECT DRUG ADMINISTRATION DURATION,1
TN,INCORRECT DRUG ADMINISTRATION RATE,1
TN,LEFT VENTRICULAR FAILURE,1
TN,MACULE,1
TN,NEPHROPATHY TOXIC,1
TN,NEUTROPENIA,1
TN,OEDEMA PERIPHERAL,1
TN,OLIGURIA,1
TN,PIGMENTATION DISORDER,1
TN,PRODUCT USE ISSUE,1
TN,PROTEINURIA,1
TN,PRURITUS,1
TN,PSORIATIC ARTHROPATHY,1
TN,PUSTULAR PSORIASIS,1
TN,RASH ERYTHEMATOUS,1
TN,RASH PAPULAR,1
TN,RASH PAPULOSQUAMOUS,1
TN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
TN,REMISSION NOT ACHIEVED,1
TN,SALIVARY HYPERSECRETION,1
TN,SCAB,1
TN,SKIN PLAQUE,1
TN,SKIN TOXICITY,1
TN,SKIN ULCER,1
TN,SMALL CELL CARCINOMA,1
TN,SWELLING FACE,1
TN,SYSTEMIC MYCOSIS,1
TN,T-CELL LYMPHOMA,1
TN,TACHYCARDIA,1
TN,TOXIC EPIDERMAL NECROLYSIS,1
TN,TRANSAMINASES INCREASED,1
TN,VENTRICULAR EXTRASYSTOLES,1
TN,WEIGHT DECREASED,1
TR,TOXICITY TO VARIOUS AGENTS,49
TR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,40
TR,PANCYTOPENIA,30
TR,FEBRILE NEUTROPENIA,28
TR,PYREXIA,25
TR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,24
TR,DRUG INEFFECTIVE,23
TR,SEIZURE,23
TR,MUCOSAL INFLAMMATION,22
TR,NAUSEA,20
TR,NEUTROPENIA,19
TR,DIARRHOEA,18
TR,PAIN,18
TR,STOMATITIS,18
TR,HEPATIC ENZYME INCREASED,17
TR,INFLUENZA,17
TR,SEPSIS,17
TR,VOMITING,15
TR,MOUTH ULCERATION,14
TR,THROMBOCYTOPENIA,14
TR,ELECTROLYTE IMBALANCE,13
TR,INCORRECT DOSE ADMINISTERED,13
TR,ASPERGILLUS INFECTION,12
TR,ASTHENIA,12
TR,BONE MARROW FAILURE,12
TR,LOSS OF CONSCIOUSNESS,12
TR,RESPIRATORY DISTRESS,12
TR,CONDITION AGGRAVATED,11
TR,CYTOMEGALOVIRUS INFECTION,11
TR,EYELID PTOSIS,11
TR,HAEMATURIA,11
TR,HYPOTENSION,11
TR,LEUKOPENIA,11
TR,PNEUMONIA,11
TR,RASH,11
TR,SKIN ULCER,11
TR,URINARY TRACT INFECTION,11
TR,ANAEMIA,10
TR,MATERNAL EXPOSURE DURING PREGNANCY,10
TR,METABOLIC ACIDOSIS,10
TR,NECROTISING COLITIS,10
TR,ATELECTASIS,9
TR,C-REACTIVE PROTEIN INCREASED,9
TR,CEREBRAL ASPERGILLOSIS,9
TR,EMPHYSEMA,9
TR,HERPES SIMPLEX,9
TR,ILEUS,9
TR,JOINT SWELLING,9
TR,PRODUCT USE IN UNAPPROVED INDICATION,9
TR,RENAL FAILURE,9
TR,SKIN LESION,9
TR,STENOTROPHOMONAS INFECTION,9
TR,ALOPECIA,8
TR,COLITIS,8
TR,DELIRIUM,8
TR,DYSPNOEA,8
TR,FALL,8
TR,GRAFT VERSUS HOST DISEASE IN SKIN,8
TR,MALNUTRITION,8
TR,PRURITUS,8
TR,SEPTIC SHOCK,8
TR,ABDOMINAL PAIN,7
TR,ACUTE GRAFT VERSUS HOST DISEASE,7
TR,CEREBROVASCULAR DISORDER,7
TR,COUGH,7
TR,DIPLOPIA,7
TR,DRUG RESISTANCE,7
TR,DYSPHAGIA,7
TR,ENCEPHALOPATHY,7
TR,FATIGUE,7
TR,FOLATE DEFICIENCY,7
TR,MENINGITIS TUBERCULOUS,7
TR,NERVOUS SYSTEM DISORDER,7
TR,TUBERCULOSIS,7
TR,WERNICKE^S ENCEPHALOPATHY,7
TR,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,6
TR,CEREBRAL THROMBOSIS,6
TR,DERMATITIS BULLOUS,6
TR,DIARRHOEA HAEMORRHAGIC,6
TR,HEADACHE,6
TR,HEPATITIS B,6
TR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,6
TR,ULCER,6
TR,VAGINAL HAEMORRHAGE,6
TR,ACCIDENTAL OVERDOSE,5
TR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,5
TR,ARTHRALGIA,5
TR,BLINDNESS,5
TR,BONE DISORDER,5
TR,BRAIN ABSCESS,5
TR,CANDIDA INFECTION,5
TR,DEATH,5
TR,DEHYDRATION,5
TR,DIABETES MELLITUS,5
TR,EXPOSURE DURING PREGNANCY,5
TR,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,5
TR,HEPATITIS CHOLESTATIC,5
TR,HEPATOTOXICITY,5
TR,HISTIOCYTOSIS HAEMATOPHAGIC,5
TR,HYPERCALCAEMIA,5
TR,HYPERTENSION,5
TR,MUSCLE SPASMS,5
TR,OESOPHAGEAL STENOSIS,5
TR,POLYCYTHAEMIA,5
TR,PRODUCT USE ISSUE,5
TR,RASH MACULAR,5
TR,ULCER HAEMORRHAGE,5
TR,ACUTE HEPATIC FAILURE,4
TR,ANGIOEDEMA,4
TR,ARTHROPATHY,4
TR,BLADDER CANCER,4
TR,BLOOD GLUCOSE INCREASED,4
TR,BONE TUBERCULOSIS,4
TR,CARDIAC ARREST,4
TR,CHOLESTASIS,4
TR,CHRONIC GRAFT VERSUS HOST DISEASE,4
TR,CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER,4
TR,CYTOMEGALOVIRUS CHORIORETINITIS,4
TR,CYTOMEGALOVIRUS VIRAEMIA,4
TR,CYTOTOXIC OEDEMA,4
TR,DISEASE PROGRESSION,4
TR,DISEASE RECURRENCE,4
TR,EPSTEIN-BARR VIRUS INFECTION,4
TR,EYE MOVEMENT DISORDER,4
TR,FOOD INTERACTION,4
TR,GAIT DISTURBANCE,4
TR,GASTROINTESTINAL DISORDER,4
TR,GENITAL ULCERATION,4
TR,GRAFT VERSUS HOST DISEASE,4
TR,H1N1 INFLUENZA,4
TR,HALLUCINATION,4
TR,HEPATIC FAILURE,4
TR,HEPATIC FIBROSIS,4
TR,HEPATOSPLENIC CANDIDIASIS,4
TR,INFECTION,4
TR,INJECTION SITE PAIN,4
TR,INJECTION SITE PRURITUS,4
TR,INJECTION SITE SWELLING,4
TR,JAUNDICE,4
TR,KIDNEY RUPTURE,4
TR,LEUKOENCEPHALOPATHY,4
TR,NEUROPATHY PERIPHERAL,4
TR,NEUROTOXICITY,4
TR,ORAL CANDIDIASIS,4
TR,ORAL DISORDER,4
TR,ORAL MUCOSA EROSION,4
TR,OVERDOSE,4
TR,PELVIC PAIN,4
TR,PERIPHERAL SWELLING,4
TR,PLEURAL EFFUSION,4
TR,PSORIASIS,4
TR,REBOUND EFFECT,4
TR,RENAL IMPAIRMENT,4
TR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
TR,TREATMENT NONCOMPLIANCE,4
TR,TREMOR,4
TR,VARICELLA ZOSTER VIRUS INFECTION,4
TR,VIITH NERVE PARALYSIS,4
TR,WEIGHT DECREASED,4
TR,ABDOMINAL DISTENSION,3
TR,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,3
TR,ACUTE MYOCARDIAL INFARCTION,3
TR,ALTERED STATE OF CONSCIOUSNESS,3
TR,ANAPHYLACTIC REACTION,3
TR,APHASIA,3
TR,APHTHOUS ULCER,3
TR,APLASTIC ANAEMIA,3
TR,ASCITES,3
TR,ASTHMA,3
TR,B-CELL LYMPHOMA,3
TR,BACK PAIN,3
TR,BK VIRUS INFECTION,3
TR,BLOOD CHOLESTEROL INCREASED,3
TR,BONE PAIN,3
TR,BRONCHITIS,3
TR,CARDIAC DISORDER,3
TR,CHEST DISCOMFORT,3
TR,CORONARY ARTERY THROMBOSIS,3
TR,CROHN^S DISEASE,3
TR,CYTOPENIA,3
TR,DRUG EFFECT INCOMPLETE,3
TR,ENTEROCOLITIS,3
TR,ERYTHEMA,3
TR,EYE INFECTION TOXOPLASMAL,3
TR,GENERAL PHYSICAL HEALTH DETERIORATION,3
TR,GENERALISED TONIC-CLONIC SEIZURE,3
TR,HAEMATOCHEZIA,3
TR,HAEMOGLOBIN DECREASED,3
TR,HAEMORRHAGE,3
TR,HYPERAEMIA,3
TR,HYPERSENSITIVITY,3
TR,HYPOAESTHESIA,3
TR,HYPOALBUMINAEMIA,3
TR,HYPOREFLEXIA,3
TR,IMMUNE THROMBOCYTOPENIC PURPURA,3
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
TR,INJECTION SITE BRUISING,3
TR,INSOMNIA,3
TR,INTRA-ABDOMINAL HAEMORRHAGE,3
TR,LETHARGY,3
TR,LOCAL SWELLING,3
TR,LOW DENSITY LIPOPROTEIN INCREASED,3
TR,LUNG INFECTION,3
TR,MALIGNANT NEOPLASM PROGRESSION,3
TR,MEDIAL TIBIAL STRESS SYNDROME,3
TR,MEMORY IMPAIRMENT,3
TR,MOTOR DYSFUNCTION,3
TR,MULTIPLE SCLEROSIS,3
TR,MUSCULOSKELETAL PAIN,3
TR,MYOPATHY,3
TR,OEDEMA,3
TR,OSTEONECROSIS OF JAW,3
TR,PAIN IN EXTREMITY,3
TR,PHOTOSENSITIVITY REACTION,3
TR,PNEUMONIA CYTOMEGALOVIRAL,3
TR,POLYNEUROPATHY,3
TR,PULMONARY MASS,3
TR,PULMONARY OEDEMA,3
TR,RASH ERYTHEMATOUS,3
TR,RASH PUSTULAR,3
TR,RENAL FAILURE ACUTE,3
TR,RETINAL DETACHMENT,3
TR,RHEUMATOID ARTHRITIS,3
TR,SPEECH DISORDER,3
TR,SYNOVITIS,3
TR,T-CELL TYPE ACUTE LEUKAEMIA,3
TR,TOOTH INFECTION,3
TR,TOXIC ENCEPHALOPATHY,3
TR,TUBERCULOSIS GASTROINTESTINAL,3
TR,TUMOUR LYSIS SYNDROME,3
TR,VASCULITIC RASH,3
TR,WALKING DISABILITY,3
TR,WHITE BLOOD CELL COUNT DECREASED,3
TR,ABASIA,2
TR,ABSCESS,2
TR,ACUTE HEPATITIS B,2
TR,ACUTE KIDNEY INJURY,2
TR,ACUTE LYMPHOCYTIC LEUKAEMIA,2
TR,ALANINE AMINOTRANSFERASE INCREASED,2
TR,ANAPHYLACTIC SHOCK,2
TR,AORTITIS,2
TR,ARTHRITIS FUNGAL,2
TR,AUTOIMMUNE THYROIDITIS,2
TR,BASAL CELL CARCINOMA,2
TR,BLOOD BILIRUBIN INCREASED,2
TR,BLOOD COUNT ABNORMAL,2
TR,BLOOD PRESSURE INCREASED,2
TR,BLOOD TEST ABNORMAL,2
TR,CATARACT,2
TR,CEREBRAL VENOUS THROMBOSIS,2
TR,CHEST PAIN,2
TR,CHRONIC GRANULOMATOUS DISEASE,2
TR,CYST,2
TR,CYSTITIS HAEMORRHAGIC,2
TR,DIZZINESS,2
TR,DRUG PRESCRIBING ERROR,2
TR,DYSPHONIA,2
TR,EOSINOPHIL COUNT INCREASED,2
TR,ERECTILE DYSFUNCTION,2
TR,FEMALE GENITAL TRACT FISTULA,2
TR,FOETAL EXPOSURE DURING PREGNANCY,2
TR,FUNGAL OESOPHAGITIS,2
TR,FUNGAL SKIN INFECTION,2
TR,GENITAL LABIAL ADHESIONS,2
TR,HAEMATOTOXICITY,2
TR,HAEMODYNAMIC INSTABILITY,2
TR,HAEMORRHAGE INTRACRANIAL,2
TR,HEPATITIS,2
TR,HEPATITIS B REACTIVATION,2
TR,HEPATITIS TOXIC,2
TR,HERPES ZOSTER,2
TR,HERPES ZOSTER DISSEMINATED,2
TR,HYPERGLYCAEMIA,2
TR,HYPERHIDROSIS,2
TR,HYPERTHYROIDISM,2
TR,HYPOCALCAEMIA,2
TR,HYPOGAMMAGLOBULINAEMIA,2
TR,HYPOKALAEMIA,2
TR,HYPOPHAGIA,2
TR,HYPOVOLAEMIA,2
TR,INFLAMMATION,2
TR,INFUSION RELATED REACTION,2
TR,INJECTION SITE ERYTHEMA,2
TR,INJECTION SITE HAEMORRHAGE,2
TR,INJECTION SITE REACTION,2
TR,INTRACRANIAL PRESSURE INCREASED,2
TR,INTRACRANIAL VENOUS SINUS THROMBOSIS,2
TR,KLUVER-BUCY SYNDROME,2
TR,LIGAMENT RUPTURE,2
TR,LISTERIA ENCEPHALITIS,2
TR,LYMPHADENOPATHY,2
TR,MALAISE,2
TR,MEDICATION ERROR,2
TR,MENISCUS INJURY,2
TR,MUSCLE INJURY,2
TR,MUSCULAR WEAKNESS,2
TR,MUSCULOSKELETAL STIFFNESS,2
TR,NECK PAIN,2
TR,NUTRITIONAL CONDITION ABNORMAL,2
TR,OEDEMA PERIPHERAL,2
TR,OESTROGEN DEFICIENCY,2
TR,OLIGOHYDRAMNIOS,2
TR,OROPHARYNGEAL PAIN,2
TR,OSTEOMYELITIS,2
TR,OSTEONECROSIS,2
TR,OSTEOPOROSIS,2
TR,OVARIAN FAILURE,2
TR,PATHOGEN RESISTANCE,2
TR,PLEURAL HAEMORRHAGE,2
TR,POLYP,2
TR,PREMATURE BABY,2
TR,PREMATURE DELIVERY,2
TR,PRIMARY HYPOGONADISM,2
TR,PRODUCT QUALITY ISSUE,2
TR,PSEUDOMONAL SEPSIS,2
TR,PULMONARY EMBOLISM,2
TR,RASH MACULO-PAPULAR,2
TR,RENAL TUBULAR DISORDER,2
TR,RHEUMATOID LUNG,2
TR,RHEUMATOID NODULE,2
TR,RICHTER^S SYNDROME,2
TR,SERUM FERRITIN INCREASED,2
TR,SHOCK HAEMORRHAGIC,2
TR,SKIN EXFOLIATION,2
TR,SKIN NECROSIS,2
TR,SOFT TISSUE INFECTION,2
TR,SPINAL COMPRESSION FRACTURE,2
TR,SPLENOMEGALY,2
TR,STRABISMUS,2
TR,SUBCUTANEOUS ABSCESS,2
TR,THERAPEUTIC RESPONSE DECREASED,2
TR,THORACIC HAEMORRHAGE,2
TR,THROMBOCYTOSIS,2
TR,TOOTH ABSCESS,2
TR,TOXIC EPIDERMAL NECROLYSIS,2
TR,TRANSAMINASES INCREASED,2
TR,TREATMENT FAILURE,2
TR,ULCERATIVE KERATITIS,2
TR,UPPER LIMB FRACTURE,2
TR,UPPER RESPIRATORY TRACT INFECTION,2
TR,UTERINE DISORDER,2
TR,UVEITIS,2
TR,VASCULITIS,2
TR,VENOOCCLUSIVE DISEASE,2
TR,VIRAEMIA,2
TR,WOUND,2
TR,ABDOMINAL DISCOMFORT,1
TR,ABDOMINAL PAIN UPPER,1
TR,ABDOMINAL TENDERNESS,1
TR,ABORTION SPONTANEOUS,1
TR,ABSCESS JAW,1
TR,ACINETOBACTER INFECTION,1
TR,ACUTE ABDOMEN,1
TR,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
TR,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
TR,ADENOIDAL DISORDER,1
TR,ADENOIDAL HYPERTROPHY,1
TR,ADENOVIRUS INFECTION,1
TR,ADVERSE EVENT,1
TR,AFFECTIVE DISORDER,1
TR,AGRANULOCYTOSIS,1
TR,AKINESIA,1
TR,AMENORRHOEA,1
TR,ANAL FISSURE,1
TR,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
TR,APATHY,1
TR,APHONIA,1
TR,APHTHOUS STOMATITIS,1
TR,ARTERIOSCLEROSIS CORONARY ARTERY,1
TR,ARTHRITIS,1
TR,ARTHRITIS BACTERIAL,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ASPERGILLOMA,1
TR,ATROPHY,1
TR,AUDITORY DISORDER,1
TR,BACTERIAL INFECTION,1
TR,BACTERIAL PYELONEPHRITIS,1
TR,BACTERIAL SEPSIS,1
TR,BENIGN INTRACRANIAL HYPERTENSION,1
TR,BILE DUCT OBSTRUCTION,1
TR,BIOPSY INTESTINE ABNORMAL,1
TR,BLADDER NEOPLASM,1
TR,BLISTER,1
TR,BLOOD CHOLESTEROL ABNORMAL,1
TR,BLOOD CREATINE ABNORMAL,1
TR,BLOOD CREATININE INCREASED,1
TR,BLOOD GLUCOSE ABNORMAL,1
TR,BLOOD OSMOLARITY DECREASED,1
TR,BLOOD PRESSURE DECREASED,1
TR,BONE CANCER,1
TR,BONE MARROW EOSINOPHILIC LEUKOCYTE COUNT INCREASED,1
TR,BONE MARROW TRANSPLANT,1
TR,BONE MARROW TRANSPLANT REJECTION,1
TR,BREATH SOUNDS ABNORMAL,1
TR,BURKITT^S LYMPHOMA,1
TR,CACHEXIA,1
TR,CARDIAC DISCOMFORT,1
TR,CARDIAC FAILURE,1
TR,CARDIOTOXICITY,1
TR,CARDIOVASCULAR INSUFFICIENCY,1
TR,CELLULITIS,1
TR,CEREBRAL ATROPHY,1
TR,CHEILITIS,1
TR,CHLOROMA,1
TR,CHOLECYSTITIS,1
TR,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,1
TR,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
TR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
TR,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
TR,COMA HEPATIC,1
TR,CONFUSIONAL STATE,1
TR,CONGESTIVE CARDIOMYOPATHY,1
TR,CONJUNCTIVITIS,1
TR,CONTUSION,1
TR,CYANOSIS,1
TR,CYSTITIS,1
TR,CYTOMEGALOVIRUS ENTEROCOLITIS,1
TR,DACRYOSTENOSIS ACQUIRED,1
TR,DEAFNESS,1
TR,DEAFNESS NEUROSENSORY,1
TR,DECREASED APPETITE,1
TR,DELUSION OF REFERENCE,1
TR,DENTAL CARIES,1
TR,DEPRESSION,1
TR,DERMATITIS,1
TR,DIFFUSE ALOPECIA,1
TR,DIFFUSE LARGE B-CELL LYMPHOMA,1
TR,DISCOMFORT,1
TR,DISSEMINATED INTRAVASCULAR COAGULATION,1
TR,DISSEMINATED TUBERCULOSIS,1
TR,DIVERTICULUM,1
TR,DRUG ADMINISTRATION ERROR,1
TR,DRUG DOSE OMISSION,1
TR,DRUG HYPERSENSITIVITY,1
TR,DRUG LEVEL ABOVE THERAPEUTIC,1
TR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TR,DRY EYE,1
TR,DRY THROAT,1
TR,DYSLIPIDAEMIA,1
TR,DYSPEPSIA,1
TR,DYSURIA,1
TR,EAR PAIN,1
TR,ECCHYMOSIS,1
TR,EMBOLISM,1
TR,EMOTIONAL DISORDER,1
TR,END STAGE RENAL DISEASE,1
TR,ENDOCARDITIS,1
TR,ENDOMETRIOSIS,1
TR,EOSINOPHILIA,1
TR,EUPHORIC MOOD,1
TR,EXTENSOR PLANTAR RESPONSE,1
TR,EXTRAOCULAR MUSCLE PARESIS,1
TR,EYE DISCHARGE,1
TR,EYE PAIN,1
TR,FACTOR XI DEFICIENCY,1
TR,FAECES DISCOLOURED,1
TR,FEAR,1
TR,FEBRILE INFECTION,1
TR,FEELING ABNORMAL,1
TR,FEMORAL NECK FRACTURE,1
TR,FIBULA FRACTURE,1
TR,FLUID RETENTION,1
TR,FOETAL DEATH,1
TR,FOOT FRACTURE,1
TR,FUNGAL INFECTION,1
TR,GALLBLADDER OBSTRUCTION,1
TR,GASTRIC HAEMORRHAGE,1
TR,GASTRITIS,1
TR,GASTROINTESTINAL EROSION,1
TR,GASTROINTESTINAL INFLAMMATION,1
TR,GASTROINTESTINAL INJURY,1
TR,GASTROINTESTINAL MUCOSA HYPERAEMIA,1
TR,GASTROINTESTINAL OEDEMA,1
TR,GASTROINTESTINAL TOXICITY,1
TR,GENERALISED ERYTHEMA,1
TR,GLOMERULONEPHRITIS,1
TR,GRAFT VERSUS HOST DISEASE IN EYE,1
TR,GRAFT VERSUS HOST DISEASE IN INTESTINE,1
TR,GRAFT VERSUS HOST DISEASE IN LUNG,1
TR,GRANULOMA,1
TR,GROWTH RETARDATION,1
TR,GYNAECOMASTIA,1
TR,HAEMANGIOMA OF BONE,1
TR,HAEMATEMESIS,1
TR,HAEMOLYTIC ANAEMIA,1
TR,HAEMOPTYSIS,1
TR,HAEMORRHOIDS,1
TR,HAEMOSIDEROSIS,1
TR,HAIR COLOUR CHANGES,1
TR,HALLUCINATION_ AUDITORY,1
TR,HALLUCINATIONS_ MIXED,1
TR,HEAD DISCOMFORT,1
TR,HEMIPLEGIA,1
TR,HEPATIC LESION,1
TR,HEPATITIS B DNA INCREASED,1
TR,HERBAL INTERACTION,1
TR,HERPES DERMATITIS,1
TR,HIATUS HERNIA,1
TR,HICCUPS,1
TR,HOSPITALISATION,1
TR,HUMAN CHORIONIC GONADOTROPIN INCREASED,1
TR,HYDROCEPHALUS,1
TR,HYPERKERATOSIS,1
TR,HYPERPARATHYROIDISM SECONDARY,1
TR,HYPERTENSIVE CRISIS,1
TR,HYPERTRIGLYCERIDAEMIA,1
TR,HYPONATRAEMIA,1
TR,HYPOTHYROIDISM,1
TR,IDEAS OF REFERENCE,1
TR,IMMUNODEFICIENCY,1
TR,IMPAIRED HEALING,1
TR,INCISION SITE OEDEMA,1
TR,INGUINAL HERNIA,1
TR,INJECTION SITE VESICLES,1
TR,INTERSTITIAL LUNG DISEASE,1
TR,INTESTINAL ULCER,1
TR,IRIDOCYCLITIS,1
TR,IRON DEFICIENCY,1
TR,IRRITABILITY,1
TR,JOINT DISLOCATION,1
TR,JUDGEMENT IMPAIRED,1
TR,JUGULAR VEIN THROMBOSIS,1
TR,KERATITIS FUNGAL,1
TR,KOUNIS SYNDROME,1
TR,LACRIMATION INCREASED,1
TR,LEIOMYOMA,1
TR,LEUKOCYTOSIS,1
TR,LIP HAEMORRHAGE,1
TR,LIVER DISORDER,1
TR,LIVER FUNCTION TEST ABNORMAL,1
TR,LIVER FUNCTION TEST INCREASED,1
TR,LOWER LIMB FRACTURE,1
TR,LUMBAR VERTEBRAL FRACTURE,1
TR,LUMBOSACRAL RADICULOPATHY,1
TR,LUNG ADENOCARCINOMA,1
TR,LUNG DISORDER,1
TR,LUNG INFILTRATION,1
TR,LYMPHOMA,1
TR,MASS,1
TR,MASTICATION DISORDER,1
TR,MEAN CELL VOLUME INCREASED,1
TR,MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
TR,MESOTHELIOMA MALIGNANT,1
TR,METASTASIS,1
TR,MOUTH HAEMORRHAGE,1
TR,MUCOSAL DRYNESS,1
TR,MULTI-ORGAN FAILURE,1
TR,MULTIPLE-DRUG RESISTANCE,1
TR,MUSCLE ATROPHY,1
TR,MYASTHENIA GRAVIS,1
TR,MYOCARDIAL INFARCTION,1
TR,MYOCARDITIS,1
TR,NAIL BED DISORDER,1
TR,NAIL DISCOLOURATION,1
TR,NAIL DISORDER,1
TR,NASAL SEPTUM PERFORATION,1
TR,NASOPHARYNGITIS,1
TR,NEPHROLITHIASIS,1
TR,NEPHROTIC SYNDROME,1
TR,NEURALGIA,1
TR,NEUTROPENIC COLITIS,1
TR,NEUTROPHIL COUNT DECREASED,1
TR,NODULE,1
TR,NON-HODGKIN^S LYMPHOMA,1
TR,OESOPHAGEAL CANDIDIASIS,1
TR,OESOPHAGITIS,1
TR,OLIGURIA,1
TR,ONYCHOLYSIS,1
TR,OPEN ANGLE GLAUCOMA,1
TR,ORAL LICHEN PLANUS,1
TR,ORGANISING PNEUMONIA,1
TR,OROPHARYNGEAL PLAQUE,1
TR,OTITIS EXTERNA,1
TR,OTITIS MEDIA,1
TR,OVARIAN CYST,1
TR,OVERLAP SYNDROME,1
TR,PALPITATIONS,1
TR,PANCREATIC PSEUDOCYST,1
TR,PANCREATIC STEATOSIS,1
TR,PANCREATITIS,1
TR,PANCREATITIS NECROTISING,1
TR,PANCREATITIS RELAPSING,1
TR,PAPILLOEDEMA,1
TR,PAPILLOMA VIRAL INFECTION,1
TR,PARAPARESIS,1
TR,PERCUSSION TEST ABNORMAL,1
TR,PERIPHERAL ARTERY THROMBOSIS,1
TR,PERIPHERAL PARALYSIS,1
TR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
TR,PERITONEAL NECROSIS,1
TR,PERITONEAL NEOPLASM,1
TR,PERONEAL NERVE PALSY,1
TR,PHARYNGEAL OEDEMA,1
TR,PHARYNGITIS,1
TR,PILONIDAL CYST,1
TR,PLASMA CELL MYELOMA,1
TR,PLATELET COUNT DECREASED,1
TR,PLEURISY,1
TR,PLEURITIC PAIN,1
TR,PNEUMONIA PNEUMOCOCCAL,1
TR,PNEUMONIA STAPHYLOCOCCAL,1
TR,POISONING,1
TR,POLLAKIURIA,1
TR,POLYOMAVIRUS TEST POSITIVE,1
TR,POSTOPERATIVE WOUND INFECTION,1
TR,PREMATURE LABOUR,1
TR,PROCEDURAL PNEUMOTHORAX,1
TR,PROSTHESIS IMPLANTATION,1
TR,PROTEIN URINE PRESENT,1
TR,PROTEINURIA,1
TR,PSEUDOMONAS INFECTION,1
TR,PSEUDOMONAS TEST POSITIVE,1
TR,PSOAS ABSCESS,1
TR,PSORIATIC ARTHROPATHY,1
TR,PSYCHOTIC DISORDER,1
TR,PULMONARY HYPERTENSION,1
TR,PULMONARY TOXICITY,1
TR,PULPITIS DENTAL,1
TR,PURPURA,1
TR,PURULENCE,1
TR,PUSTULAR PSORIASIS,1
TR,RASH PRURITIC,1
TR,REFLUX GASTRITIS,1
TR,RENAL FAILURE CHRONIC,1
TR,RENAL MASS,1
TR,RENAL VEIN THROMBOSIS,1
TR,RESPIRATORY FAILURE,1
TR,RESTLESSNESS,1
TR,RETINAL VEIN THROMBOSIS,1
TR,RETROPERITONEAL HAEMORRHAGE,1
TR,RHABDOMYOLYSIS,1
TR,RHEUMATOID VASCULITIS,1
TR,SACROILIITIS,1
TR,SCAN ABNORMAL,1
TR,SCAR,1
TR,SCLERODACTYLIA,1
TR,SERUM FERRITIN ABNORMAL,1
TR,SERUM SICKNESS,1
TR,SINUSITIS,1
TR,SINUSITIS FUNGAL,1
TR,SKIN BURNING SENSATION,1
TR,SKIN CANCER,1
TR,SKIN EROSION,1
TR,SKIN FISSURES,1
TR,SKIN HYPERPIGMENTATION,1
TR,SKIN INFECTION,1
TR,SKIN MASS,1
TR,SKIN REACTION,1
TR,SKIN TOXICITY,1
TR,SOMNOLENCE,1
TR,SPINAL COLUMN STENOSIS,1
TR,STAPHYLOCOCCUS TEST POSITIVE,1
TR,STATUS EPILEPTICUS,1
TR,STENOTROPHOMONAS TEST POSITIVE,1
TR,STEVENS-JOHNSON SYNDROME,1
TR,STILL^S DISEASE ADULT ONSET,1
TR,STRESS,1
TR,SUBCLAVIAN VEIN THROMBOSIS,1
TR,SUICIDAL IDEATION,1
TR,SWELLING FACE,1
TR,SYSTEMIC INFECTION,1
TR,TACHYCARDIA,1
TR,TACHYPNOEA,1
TR,TAKAYASU^S ARTERITIS,1
TR,THROMBOPHLEBITIS,1
TR,THROMBOTIC MICROANGIOPATHY,1
TR,TIBIA FRACTURE,1
TR,TINNITUS,1
TR,TONGUE INJURY,1
TR,TONSILLAR HYPERTROPHY,1
TR,TOOTHACHE,1
TR,TOXIC SKIN ERUPTION,1
TR,TRANSIENT ISCHAEMIC ATTACK,1
TR,TRISMUS,1
TR,TUBAL RUPTURE,1
TR,TUBERCULIN TEST POSITIVE,1
TR,UMBILICAL HERNIA,1
TR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TR,UPPER-AIRWAY COUGH SYNDROME,1
TR,URINE OSMOLARITY INCREASED,1
TR,URINE SODIUM INCREASED,1
TR,URTICARIA,1
TR,VANISHING BILE DUCT SYNDROME,1
TR,VENA CAVA THROMBOSIS,1
TR,VERTIGO,1
TR,VISUAL IMPAIRMENT,1
TR,VITAMIN B12 DECREASED,1
TR,VITAMIN B12 DEFICIENCY,1
TR,WHITE BLOOD CELL COUNT INCREASED,1
TR,WOUND INFECTION,1
TR,WRIST FRACTURE,1
TR,XEROPHTHALMIA,1
UG,FUNGAL INFECTION,1
UG,HAEMORRHAGE INTRACRANIAL,1
UG,KLEBSIELLA SEPSIS,1
UG,PLASMODIUM FALCIPARUM INFECTION,1
UG,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
UG,SHOCK,1
UG,TRANSPLANT FAILURE,1
UA,ANAEMIA,2
UA,APLASTIC ANAEMIA,2
UA,CEREBRAL HAEMORRHAGE,2
UA,COMA,2
UA,DRUG-INDUCED LIVER INJURY,2
UA,LEUKOPENIA,2
UA,MENINGITIS,2
UA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
UA,PETECHIAE,2
UA,PNEUMONIA,2
UA,PULMONARY TUBERCULOSIS,2
UA,SEPSIS,2
UA,THROMBOCYTOPENIA,2
UA,ACUTE LYMPHOCYTIC LEUKAEMIA,1
UA,APHASIA,1
UA,BODY TEMPERATURE INCREASED,1
UA,BONE MARROW FAILURE,1
UA,BONE TUBERCULOSIS,1
UA,CARDIAC ARREST,1
UA,CARDIOVASCULAR INSUFFICIENCY,1
UA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
UA,CHRONIC SINUSITIS,1
UA,ENCEPHALITIS,1
UA,ENCEPHALITIS VIRAL,1
UA,FEBRILE NEUTROPENIA,1
UA,FUNGAL INFECTION,1
UA,GASTROINTESTINAL DISORDER,1
UA,HAEMORRHAGE,1
UA,HEADACHE,1
UA,HEPATOTOXICITY,1
UA,HYPERTENSIVE CRISIS,1
UA,HYPOCOAGULABLE STATE,1
UA,ILEUS PARALYTIC,1
UA,LIVER FUNCTION TEST ABNORMAL,1
UA,MONOPARESIS,1
UA,NEUROGENIC BLADDER,1
UA,PERIODONTITIS,1
UA,PURPURA,1
UA,RENAL COLIC,1
UA,RENAL IMPAIRMENT,1
UA,RESPIRATORY ARREST,1
UA,RESPIRATORY FAILURE,1
UA,SALIVARY GLAND MUCOCOELE,1
UA,SPEECH DISORDER,1
UA,SQUAMOUS CELL CARCINOMA OF THE VAGINA,1
UA,STOMATITIS,1
UA,TUBERCULOSIS,1
UA,URTICARIA,1
UA,VENOUS THROMBOSIS LIMB,1
AE,PANNICULITIS,5
AE,DRUG INEFFECTIVE,3
AE,PSORIASIS,3
AE,RASH,3
AE,COUGH,2
AE,LEUKOPENIA,2
AE,PNEUMONIA,2
AE,THROMBOCYTOPENIA,2
AE,ABASIA,1
AE,ADVERSE DRUG REACTION,1
AE,ANAEMIA,1
AE,APHAGIA,1
AE,APHONIA,1
AE,ARTHRALGIA,1
AE,ARTHRITIS,1
AE,ARTHROPATHY,1
AE,BACK PAIN,1
AE,BACTERIAL INFECTION,1
AE,BLOOD CREATINE INCREASED,1
AE,CONFUSIONAL STATE,1
AE,DEATH,1
AE,DEHYDRATION,1
AE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AE,DRUG ERUPTION,1
AE,HAEMOPTYSIS,1
AE,HEADACHE,1
AE,HYPOKALAEMIA,1
AE,HYPOMAGNESAEMIA,1
AE,HYPONATRAEMIA,1
AE,HYPOTENSION,1
AE,INCISION SITE PAIN,1
AE,INCORRECT PRODUCT STORAGE,1
AE,INJECTION SITE PAIN,1
AE,INTESTINAL MASS,1
AE,LEUKOCYTOSIS,1
AE,LOWER RESPIRATORY TRACT INFECTION,1
AE,LYMPHOCYTOSIS,1
AE,MALAISE,1
AE,MUCOSAL ULCERATION,1
AE,MULTI-ORGAN FAILURE,1
AE,NAUSEA,1
AE,NEUROLOGICAL DECOMPENSATION,1
AE,OEDEMA MOUTH,1
AE,OEDEMA PERIPHERAL,1
AE,OVARIAN CYST,1
AE,OVARIAN ENLARGEMENT,1
AE,PANCYTOPENIA,1
AE,PERIPHERAL ISCHAEMIA,1
AE,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
AE,POST PROCEDURAL SWELLING,1
AE,PRODUCT QUALITY ISSUE,1
AE,PUSTULAR PSORIASIS,1
AE,PYREXIA,1
AE,RAYNAUD^S PHENOMENON,1
AE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AE,RENAL FAILURE ACUTE,1
AE,RENAL IMPAIRMENT,1
AE,RENAL TUBULAR DISORDER,1
AE,RHEUMATOID NODULE,1
AE,SEPSIS,1
AE,SEPTAL PANNICULITIS,1
AE,SKIN BURNING SENSATION,1
AE,SKIN ULCER,1
AE,SPLENOMEGALY,1
AE,SPONDYLOARTHROPATHY,1
AE,TYPE I HYPERSENSITIVITY,1
AE,URINE OUTPUT DECREASED,1
AE,URTICARIA,1
AE,VASCULITIS,1
AE,VOMITING,1
GB,LOWER RESPIRATORY TRACT INFECTION,421
GB,MALAISE,363
GB,PNEUMONIA,250
GB,DRUG INEFFECTIVE,223
GB,HEADACHE,212
GB,DYSPNOEA,211
GB,PAIN,203
GB,PANCYTOPENIA,200
GB,NAUSEA,195
GB,SEPSIS,167
GB,DIARRHOEA,166
GB,VOMITING,164
GB,ARTHRALGIA,163
GB,RHEUMATOID ARTHRITIS,160
GB,URINARY TRACT INFECTION,157
GB,PYREXIA,149
GB,CONDITION AGGRAVATED,148
GB,DIZZINESS,146
GB,FALL,145
GB,FATIGUE,145
GB,INFECTION,133
GB,RASH,131
GB,ABDOMINAL PAIN,129
GB,COUGH,125
GB,DEATH,119
GB,CELLULITIS,111
GB,LIVER FUNCTION TEST ABNORMAL,111
GB,PSORIASIS,102
GB,PAIN IN EXTREMITY,101
GB,PERIPHERAL SWELLING,94
GB,NEUTROPENIA,90
GB,PULMONARY FIBROSIS,86
GB,CONFUSIONAL STATE,85
GB,LETHARGY,81
GB,ENCEPHALOPATHY,80
GB,CHEST PAIN,79
GB,ARTHRITIS,75
GB,NEUTROPENIC SEPSIS,74
GB,RENAL IMPAIRMENT,74
GB,JOINT SWELLING,73
GB,MATERNAL EXPOSURE BEFORE PREGNANCY,72
GB,ACUTE KIDNEY INJURY,69
GB,MOUTH ULCERATION,69
GB,MUSCULAR WEAKNESS,69
GB,HYPOTENSION,68
GB,ATRIAL FIBRILLATION,65
GB,BASAL CELL CARCINOMA,65
GB,PNEUMONITIS,65
GB,ALOPECIA,64
GB,NASOPHARYNGITIS,64
GB,ANAEMIA,62
GB,ALANINE AMINOTRANSFERASE INCREASED,61
GB,BACK PAIN,60
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,60
GB,ERYTHEMA,60
GB,SOMNOLENCE,60
GB,OROPHARYNGEAL PAIN,59
GB,PLATELET COUNT DECREASED,59
GB,PRURITUS,59
GB,TOXICITY TO VARIOUS AGENTS,59
GB,WEIGHT DECREASED,59
GB,ARTHROPATHY,58
GB,CHILLS,57
GB,ASTHENIA,56
GB,CEREBROVASCULAR ACCIDENT,55
GB,CONSTIPATION,55
GB,DEPRESSION,55
GB,HYPERTENSION,55
GB,LOSS OF CONSCIOUSNESS,54
GB,WHITE BLOOD CELL COUNT DECREASED,52
GB,MYALGIA,51
GB,CARDIAC FAILURE,50
GB,MOBILITY DECREASED,50
GB,MYOCARDIAL INFARCTION,50
GB,DRUG DOSE OMISSION,49
GB,PULMONARY EMBOLISM,49
GB,RESPIRATORY FAILURE,49
GB,LUNG NEOPLASM MALIGNANT,48
GB,MUCOSAL INFLAMMATION,47
GB,PARAESTHESIA,47
GB,CONTUSION,46
GB,GENERAL PHYSICAL HEALTH DETERIORATION,46
GB,EPISTAXIS,45
GB,DISEASE RECURRENCE,44
GB,GASTRITIS,44
GB,HYPERSENSITIVITY,44
GB,INJECTION SITE REACTION,43
GB,DECREASED APPETITE,42
GB,MYOCARDIAL ISCHAEMIA,42
GB,PLEURAL EFFUSION,42
GB,SYNCOPE,42
GB,MUSCULOSKELETAL STIFFNESS,41
GB,PULMONARY OEDEMA,41
GB,RASH PRURITIC,41
GB,VIRAL INFECTION,41
GB,BLISTER,40
GB,BLOOD PRESSURE INCREASED,40
GB,FEELING ABNORMAL,40
GB,HEMIPARESIS,40
GB,HYPERHIDROSIS,40
GB,INTERSTITIAL LUNG DISEASE,40
GB,NEUTROPHIL COUNT DECREASED,40
GB,ABDOMINAL DISCOMFORT,39
GB,GAIT DISTURBANCE,39
GB,INFLUENZA,39
GB,PRODUCTIVE COUGH,39
GB,TREMOR,39
GB,ABDOMINAL DISTENSION,38
GB,ANAPHYLACTIC REACTION,38
GB,ANXIETY,38
GB,SKIN CANCER,38
GB,DEPRESSED MOOD,37
GB,HAEMOGLOBIN DECREASED,37
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,37
GB,INJECTION SITE ERYTHEMA,37
GB,PSORIATIC ARTHROPATHY,37
GB,SUICIDAL IDEATION,37
GB,SWELLING FACE,37
GB,CROHN^S DISEASE,36
GB,IMMUNOSUPPRESSION,36
GB,MULTI-ORGAN FAILURE,36
GB,MUSCLE SPASMS,36
GB,BREAST CANCER,35
GB,GASTROINTESTINAL HAEMORRHAGE,35
GB,ANGINA PECTORIS,34
GB,BONE MARROW FAILURE,34
GB,C-REACTIVE PROTEIN INCREASED,34
GB,OEDEMA PERIPHERAL,34
GB,SKIN ULCER,34
GB,SQUAMOUS CELL CARCINOMA,34
GB,DEEP VEIN THROMBOSIS,33
GB,INFLUENZA LIKE ILLNESS,33
GB,URTICARIA,33
GB,BRONCHIECTASIS,32
GB,CHOLELITHIASIS,32
GB,DIVERTICULITIS,32
GB,LEUKOENCEPHALOPATHY,32
GB,LYMPHADENOPATHY,32
GB,MALIGNANT MELANOMA,32
GB,PANCREATITIS,32
GB,RASH GENERALISED,32
GB,THROMBOCYTOPENIA,32
GB,WHITE BLOOD CELL COUNT INCREASED,32
GB,ABDOMINAL PAIN UPPER,31
GB,ASTHMA,31
GB,HYPOAESTHESIA,31
GB,RECTAL HAEMORRHAGE,31
GB,RENAL FAILURE ACUTE,31
GB,APHASIA,30
GB,BALANCE DISORDER,30
GB,DISEASE PROGRESSION,30
GB,DYSARTHRIA,30
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,30
GB,LEUKOPENIA,30
GB,LIVER DISORDER,30
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,30
GB,MUSCULOSKELETAL PAIN,30
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,30
GB,VISUAL IMPAIRMENT,30
GB,DIABETIC KETOACIDOSIS,29
GB,DRUG EFFECT INCOMPLETE,29
GB,HEPATIC STEATOSIS,29
GB,NECK PAIN,29
GB,TACHYCARDIA,29
GB,CARDIAC ARREST,28
GB,FEBRILE NEUTROPENIA,28
GB,TOOTH ABSCESS,28
GB,VISION BLURRED,28
GB,BONE PAIN,27
GB,CARDIAC FAILURE CONGESTIVE,27
GB,HERPES ZOSTER,27
GB,PALPITATIONS,27
GB,PRODUCT USE ISSUE,27
GB,RENAL FAILURE,27
GB,BLOOD TEST ABNORMAL,26
GB,HEPATIC CIRRHOSIS,26
GB,KNEE ARTHROPLASTY,26
GB,LOCALISED INFECTION,26
GB,LUNG CANCER METASTATIC,26
GB,PRESYNCOPE,26
GB,SWELLING,26
GB,DEHYDRATION,25
GB,DRUG HYPERSENSITIVITY,25
GB,DRY MOUTH,25
GB,GASTROINTESTINAL DISORDER,25
GB,IMMUNODEFICIENCY,25
GB,INJECTION SITE PAIN,25
GB,MEMORY IMPAIRMENT,25
GB,NODULE,25
GB,OSTEOPOROSIS,25
GB,PYELONEPHRITIS,25
GB,STEVENS-JOHNSON SYNDROME,25
GB,BRADYCARDIA,24
GB,DIABETES MELLITUS,24
GB,DIFFUSE LARGE B-CELL LYMPHOMA,24
GB,LUNG INFECTION,24
GB,MALIGNANT NEOPLASM PROGRESSION,24
GB,MIGRAINE,24
GB,NEOPLASM MALIGNANT,24
GB,PLEURISY,24
GB,SEPTIC SHOCK,24
GB,SKIN EXFOLIATION,24
GB,SKIN LESION,24
GB,ABNORMAL LOSS OF WEIGHT,23
GB,ADVERSE DRUG REACTION,23
GB,HEART RATE INCREASED,23
GB,INJECTION SITE BRUISING,23
GB,LUPUS-LIKE SYNDROME,23
GB,METASTASES TO LIVER,23
GB,OESOPHAGITIS,23
GB,PROSTATE CANCER,23
GB,SLEEP DISORDER,23
GB,TRANSIENT ISCHAEMIC ATTACK,23
GB,AGITATION,22
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,22
GB,DYSPHONIA,22
GB,FEMUR FRACTURE,22
GB,INVASIVE DUCTAL BREAST CARCINOMA,22
GB,LOCAL SWELLING,22
GB,NEPHROLITHIASIS,22
GB,NEUROLOGICAL SYMPTOM,22
GB,NEUROPATHY PERIPHERAL,22
GB,TOXIC EPIDERMAL NECROLYSIS,22
GB,ACUTE MYELOID LEUKAEMIA,21
GB,HAEMATEMESIS,21
GB,HAEMATOCHEZIA,21
GB,HAEMORRHAGE,21
GB,INFUSION RELATED REACTION,21
GB,INSOMNIA,21
GB,MENORRHAGIA,21
GB,SURGERY,21
GB,UROSEPSIS,21
GB,UVEITIS,21
GB,ACUTE MYOCARDIAL INFARCTION,20
GB,FLUID RETENTION,20
GB,IMMOBILE,20
GB,INJECTION SITE PRURITUS,20
GB,NIGHT SWEATS,20
GB,PANCREATITIS ACUTE,20
GB,SKIN INFECTION,20
GB,STAPHYLOCOCCAL INFECTION,20
GB,THERAPEUTIC RESPONSE DECREASED,20
GB,BRONCHOPNEUMONIA,19
GB,DRY EYE,19
GB,EMPHYSEMA,19
GB,HAEMATURIA,19
GB,ORAL CANDIDIASIS,19
GB,THROMBOSIS,19
GB,TONSILLITIS,19
GB,WHEEZING,19
GB,AMNESIA,18
GB,BLOOD DISORDER,18
GB,CHEST DISCOMFORT,18
GB,CHOLECYSTITIS,18
GB,COLITIS,18
GB,DRUG RESISTANCE,18
GB,DYSKINESIA,18
GB,HYPONATRAEMIA,18
GB,MYELODYSPLASTIC SYNDROME,18
GB,NEUROTOXICITY,18
GB,NO THERAPEUTIC RESPONSE,18
GB,ABSCESS,17
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,17
GB,BLOOD CREATININE INCREASED,17
GB,CATARACT,17
GB,CUSHINGOID,17
GB,DEMYELINATION,17
GB,FEMORAL NECK FRACTURE,17
GB,LIVER INJURY,17
GB,LUNG DISORDER,17
GB,PRODUCT SUBSTITUTION ISSUE,17
GB,PRODUCT USE IN UNAPPROVED INDICATION,17
GB,PULMONARY CONGESTION,17
GB,RASH ERYTHEMATOUS,17
GB,RASH MACULAR,17
GB,RHINORRHOEA,17
GB,SKIN DISORDER,17
GB,WEIGHT INCREASED,17
GB,WOUND,17
GB,ADVERSE EVENT,16
GB,AFFECT LABILITY,16
GB,BILIARY SEPSIS,16
GB,BLADDER CANCER,16
GB,BLADDER NEOPLASM,16
GB,DRY SKIN,16
GB,ECZEMA,16
GB,GASTRIC ULCER,16
GB,HYPOGAMMAGLOBULINAEMIA,16
GB,LUNG CONSOLIDATION,16
GB,METASTASES TO BONE,16
GB,MOVEMENT DISORDER,16
GB,RENAL CANCER,16
GB,SEIZURE,16
GB,SENSORY DISTURBANCE,16
GB,SKIN DISCOLOURATION,16
GB,ARTHRITIS BACTERIAL,15
GB,BLOOD ALBUMIN DECREASED,15
GB,BRAIN OEDEMA,15
GB,CONTRAINDICATED PRODUCT ADMINISTERED,15
GB,CONVULSION,15
GB,DEVICE MALFUNCTION,15
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,15
GB,FEELING HOT,15
GB,HEPATIC FUNCTION ABNORMAL,15
GB,HEPATOTOXICITY,15
GB,HYPERKALAEMIA,15
GB,INFLAMMATION,15
GB,LIMB DISCOMFORT,15
GB,LIVER FUNCTION TEST INCREASED,15
GB,NON-HODGKIN^S LYMPHOMA,15
GB,OSTEOARTHRITIS,15
GB,OXYGEN SATURATION DECREASED,15
GB,SINUSITIS,15
GB,SWOLLEN TONGUE,15
GB,UPPER RESPIRATORY TRACT INFECTION,15
GB,URINE OUTPUT DECREASED,15
GB,ALVEOLITIS ALLERGIC,14
GB,AMYLOIDOSIS,14
GB,ANGIOEDEMA,14
GB,ARTERIOSCLEROSIS CORONARY ARTERY,14
GB,ATAXIA,14
GB,BLOOD BILIRUBIN INCREASED,14
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,14
GB,BREAST CANCER FEMALE,14
GB,CARDIO-RESPIRATORY ARREST,14
GB,DELIRIUM,14
GB,DYSPEPSIA,14
GB,EYE SWELLING,14
GB,HEPATIC FAILURE,14
GB,HIP FRACTURE,14
GB,LEFT VENTRICULAR DYSFUNCTION,14
GB,LUNG ADENOCARCINOMA,14
GB,NASAL DRYNESS,14
GB,PUSTULAR PSORIASIS,14
GB,RASH PUSTULAR,14
GB,SKIN REACTION,14
GB,STEATORRHOEA,14
GB,TREATMENT FAILURE,14
GB,TUBERCULOSIS,14
GB,WEIGHT BEARING DIFFICULTY,14
GB,ABORTION SPONTANEOUS,13
GB,AGRANULOCYTOSIS,13
GB,CEREBRAL HAEMORRHAGE,13
GB,COLITIS ULCERATIVE,13
GB,DEMENTIA,13
GB,DISTURBANCE IN ATTENTION,13
GB,DRUG INTOLERANCE,13
GB,DRUG-INDUCED LIVER INJURY,13
GB,DYSPNOEA EXERTIONAL,13
GB,HAEMORRHOIDS,13
GB,HALLUCINATION,13
GB,JAUNDICE,13
GB,JOINT DISLOCATION,13
GB,KIDNEY INFECTION,13
GB,LACTIC ACIDOSIS,13
GB,LIMB INJURY,13
GB,LIP SWELLING,13
GB,MASS,13
GB,METASTATIC NEOPLASM,13
GB,NERVOUS SYSTEM DISORDER,13
GB,OVERDOSE,13
GB,PANIC ATTACK,13
GB,PNEUMOTHORAX,13
GB,SKIN FISSURES,13
GB,SPINAL PAIN,13
GB,SPUTUM DISCOLOURED,13
GB,STOMATITIS,13
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,13
GB,URINARY RETENTION,13
GB,ABNORMAL DREAMS,12
GB,ACUTE CORONARY SYNDROME,12
GB,ACUTE LYMPHOCYTIC LEUKAEMIA,12
GB,ASCITES,12
GB,ATYPICAL FEMUR FRACTURE,12
GB,BLOOD COUNT ABNORMAL,12
GB,BLOOD PRESSURE DECREASED,12
GB,BRONCHITIS,12
GB,BRONCHOSPASM,12
GB,BURSITIS,12
GB,CARDIOVASCULAR DISORDER,12
GB,COLON CANCER,12
GB,CONTRAINDICATED DRUG ADMINISTERED,12
GB,DEVICE RELATED INFECTION,12
GB,DYSPHAGIA,12
GB,DYSSTASIA,12
GB,DYSURIA,12
GB,EPILEPSY,12
GB,FLATULENCE,12
GB,FOLATE DEFICIENCY,12
GB,GASTROOESOPHAGEAL REFLUX DISEASE,12
GB,GINGIVAL DISORDER,12
GB,HYPOPHAGIA,12
GB,HYPOXIA,12
GB,JUVENILE IDIOPATHIC ARTHRITIS,12
GB,MELAENA,12
GB,MOOD SWINGS,12
GB,MUSCULOSKELETAL CHEST PAIN,12
GB,PERITONITIS,12
GB,POTENTIATING DRUG INTERACTION,12
GB,PSYCHOTIC DISORDER,12
GB,SCAR,12
GB,STRESS,12
GB,TOE OPERATION,12
GB,ULCER,12
GB,ULCERATIVE KERATITIS,12
GB,VARICELLA,12
GB,VENTRICULAR DYSFUNCTION,12
GB,VIITH NERVE PARALYSIS,12
GB,VISUAL ACUITY REDUCED,12
GB,ABDOMINAL PAIN LOWER,11
GB,ANKLE FRACTURE,11
GB,APLASTIC ANAEMIA,11
GB,BRAIN INJURY,11
GB,BRAIN NEOPLASM,11
GB,CANDIDA INFECTION,11
GB,CEREBRAL HYPOPERFUSION,11
GB,CLOSTRIDIUM DIFFICILE INFECTION,11
GB,CORONARY ARTERY DISEASE,11
GB,DIPLOPIA,11
GB,DRUG CLEARANCE DECREASED,11
GB,DRUG PRESCRIBING ERROR,11
GB,EAR INFECTION,11
GB,EPSTEIN-BARR VIRUS INFECTION,11
GB,EXPOSURE DURING PREGNANCY,11
GB,EXTRASYSTOLES,11
GB,GROIN PAIN,11
GB,HEPATIC ENZYME INCREASED,11
GB,HOT FLUSH,11
GB,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,11
GB,HYPOKALAEMIA,11
GB,JOINT STIFFNESS,11
GB,LYMPHOCYTE COUNT DECREASED,11
GB,MIGRAINE WITH AURA,11
GB,MUCOSAL ULCERATION,11
GB,ORAL INFECTION,11
GB,PAIN OF SKIN,11
GB,PAROSMIA,11
GB,PELVIC PAIN,11
GB,PERICARDITIS,11
GB,PROCEDURAL PAIN,11
GB,PROCTALGIA,11
GB,PULMONARY HAEMORRHAGE,11
GB,PULMONARY MASS,11
GB,RENAL PAIN,11
GB,SKIN OEDEMA,11
GB,SOCIAL AVOIDANT BEHAVIOUR,11
GB,SPEECH DISORDER,11
GB,VASCULAR INJURY,11
GB,ACANTHOSIS,10
GB,ALVEOLITIS,10
GB,ASPERGILLUS INFECTION,10
GB,BLOOD CREATINE INCREASED,10
GB,BODY TEMPERATURE INCREASED,10
GB,BONE DISORDER,10
GB,CARCINOMA IN SITU OF SKIN,10
GB,CEREBRAL ATROPHY,10
GB,CEREBRAL INFARCTION,10
GB,CIRCULATORY COLLAPSE,10
GB,DEPRESSIVE SYMPTOM,10
GB,DERMATITIS,10
GB,DISINHIBITION,10
GB,DISORIENTATION,10
GB,DIVERTICULUM,10
GB,DRUG EFFECT DECREASED,10
GB,DRUG EFFECT DELAYED,10
GB,DRUG LEVEL INCREASED,10
GB,EAR PAIN,10
GB,EMPYEMA,10
GB,EOSINOPHIL COUNT INCREASED,10
GB,EXTRAVASATION BLOOD,10
GB,EYE DISORDER,10
GB,FEELING COLD,10
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
GB,GASTROENTERITIS,10
GB,GRIP STRENGTH DECREASED,10
GB,HAEMOPTYSIS,10
GB,INJECTION SITE SWELLING,10
GB,INTERVERTEBRAL DISCITIS,10
GB,INTESTINAL PERFORATION,10
GB,IRRITABILITY,10
GB,LYMPHOMA,10
GB,MEAN CELL VOLUME INCREASED,10
GB,MENSTRUAL DISORDER,10
GB,MENTAL DISORDER,10
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,10
GB,METASTASES TO LUNG,10
GB,MUCOUS MEMBRANE DISORDER,10
GB,MULTIPLE SCLEROSIS,10
GB,MUSCULOSKELETAL DISCOMFORT,10
GB,NEUTROPHIL COUNT INCREASED,10
GB,NEUTROPHILIC DERMATOSIS,10
GB,OEDEMA,10
GB,OPTIC NEUROPATHY,10
GB,ORAL PAIN,10
GB,PALLOR,10
GB,PANCREATIC CARCINOMA,10
GB,PETECHIAE,10
GB,PHARYNGITIS,10
GB,PRURITUS GENERALISED,10
GB,RASH MACULO-PAPULAR,10
GB,RESPIRATORY TRACT INFECTION,10
GB,SQUAMOUS CELL CARCINOMA OF LUNG,10
GB,TIBIA FRACTURE,10
GB,TOOTH DISORDER,10
GB,UNEVALUABLE EVENT,10
GB,ADENOCARCINOMA OF COLON,9
GB,ATRIAL FLUTTER,9
GB,BREAST CANCER METASTATIC,9
GB,CARDIOGENIC SHOCK,9
GB,COAGULOPATHY,9
GB,CYANOSIS,9
GB,CYTOPENIA,9
GB,DECREASED IMMUNE RESPONSIVENESS,9
GB,DENTAL CARIES,9
GB,DISCOMFORT,9
GB,DYSGEUSIA,9
GB,EATING DISORDER,9
GB,HIP ARTHROPLASTY,9
GB,INFECTED SKIN ULCER,9
GB,INGROWING NAIL,9
GB,INTESTINAL ISCHAEMIA,9
GB,INTESTINAL OBSTRUCTION,9
GB,JAW FRACTURE,9
GB,LICHEN SCLEROSUS,9
GB,LIVEDO RETICULARIS,9
GB,NAIL DISORDER,9
GB,PERICARDIAL EFFUSION,9
GB,PERIPHERAL VASCULAR DISORDER,9
GB,PHARYNGEAL OEDEMA,9
GB,PNEUMONIA ASPIRATION,9
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,9
GB,PULMONARY TUBERCULOSIS,9
GB,RED BLOOD CELL COUNT DECREASED,9
GB,RENAL DISORDER,9
GB,RENAL FAILURE CHRONIC,9
GB,RHEUMATOID LUNG,9
GB,SECOND PRIMARY MALIGNANCY,9
GB,SIMPLE PARTIAL SEIZURES,9
GB,SKIN BURNING SENSATION,9
GB,TEMPORAL ARTERITIS,9
GB,TINNITUS,9
GB,VERTIGO,9
GB,WOUND INFECTION,9
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,8
GB,ADENOVIRUS INFECTION,8
GB,B-CELL LYMPHOMA,8
GB,BILIARY COLIC,8
GB,BLOOD URINE PRESENT,8
GB,BURNING SENSATION,8
GB,CARDIAC DISORDER,8
GB,CARPAL TUNNEL SYNDROME,8
GB,CERVICAL DYSPLASIA,8
GB,COGNITIVE DISORDER,8
GB,EXFOLIATIVE RASH,8
GB,FACE INJURY,8
GB,GASTROINTESTINAL MOTILITY DISORDER,8
GB,HAEMATOCRIT DECREASED,8
GB,HALLUCINATION_ VISUAL,8
GB,HIATUS HERNIA,8
GB,HYPERGLYCAEMIA,8
GB,HYPERSOMNIA,8
GB,HYPOGLYCAEMIA,8
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,8
GB,INFLAMMATORY MARKER INCREASED,8
GB,INTERVERTEBRAL DISC PROTRUSION,8
GB,ISCHAEMIC STROKE,8
GB,JOINT EFFUSION,8
GB,LEFT VENTRICULAR FAILURE,8
GB,MYELITIS TRANSVERSE,8
GB,NASAL CONGESTION,8
GB,NERVOUSNESS,8
GB,NIGHTMARE,8
GB,OTITIS MEDIA,8
GB,OVARIAN CANCER,8
GB,PAPILLOEDEMA,8
GB,POLLAKIURIA,8
GB,POSTMENOPAUSAL HAEMORRHAGE,8
GB,POSTOPERATIVE WOUND INFECTION,8
GB,PYODERMA GANGRENOSUM,8
GB,RECTAL CANCER,8
GB,RESPIRATORY DISORDER,8
GB,SCAB,8
GB,SKIN HAEMORRHAGE,8
GB,SKIN IRRITATION,8
GB,SKIN NECROSIS,8
GB,SPONDYLITIS,8
GB,TONSIL CANCER,8
GB,UMBILICAL HERNIA,8
GB,UNRESPONSIVE TO STIMULI,8
GB,VITAMIN B12 DECREASED,8
GB,WHITE BLOOD CELL COUNT ABNORMAL,8
GB,ACUTE PSYCHOSIS,7
GB,AMENORRHOEA,7
GB,ANAL ABSCESS,7
GB,BLOOD FOLATE DECREASED,7
GB,BLOOD UREA INCREASED,7
GB,BREAST PAIN,7
GB,BREAST TENDERNESS,7
GB,BRONCHIAL CARCINOMA,7
GB,BRONCHITIS CHRONIC,7
GB,CARDIOTOXICITY,7
GB,CEREBRAL DISORDER,7
GB,CHEMOTHERAPEUTIC DRUG LEVEL INCREASED,7
GB,CHOKING,7
GB,CLOSTRIDIUM DIFFICILE COLITIS,7
GB,DEVICE RELATED SEPSIS,7
GB,DIFFUSE ALVEOLAR DAMAGE,7
GB,DRUG SPECIFIC ANTIBODY PRESENT,7
GB,DUODENITIS,7
GB,ELECTROLYTE IMBALANCE,7
GB,EMBOLISM,7
GB,EYE CONTUSION,7
GB,EYELID PTOSIS,7
GB,FLANK PAIN,7
GB,FLUID OVERLOAD,7
GB,FLUSHING,7
GB,FOOT DEFORMITY,7
GB,FRACTURE,7
GB,GASTRIC CANCER,7
GB,GASTROINTESTINAL CARCINOMA,7
GB,HAEMORRHAGE INTRACRANIAL,7
GB,HEAD TITUBATION,7
GB,HOSPITALISATION,7
GB,HUMERUS FRACTURE,7
GB,HYDRONEPHROSIS,7
GB,HYPERCALCAEMIA,7
GB,HYPOVOLAEMIC SHOCK,7
GB,INCORRECT DOSE ADMINISTERED,7
GB,INJECTION SITE HAEMORRHAGE,7
GB,INTERVERTEBRAL DISC DISORDER,7
GB,INTRADUCTAL PROLIFERATIVE BREAST LESION,7
GB,LICHENOID KERATOSIS,7
GB,LYMPHOPENIA,7
GB,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,7
GB,MELANOCYTIC NAEVUS,7
GB,MUSCLE STRAIN,7
GB,MYOCARDITIS,7
GB,NASOPHARYNGEAL CANCER,7
GB,NEOPLASM,7
GB,NEURALGIA,7
GB,NON-SMALL CELL LUNG CANCER,7
GB,OESOPHAGEAL CARCINOMA,7
GB,ORAL HERPES,7
GB,OSTEOPENIA,7
GB,OVARIAN CYST,7
GB,PARAESTHESIA ORAL,7
GB,PATHOLOGICAL FRACTURE,7
GB,PELVIC FRACTURE,7
GB,PERIPHERAL COLDNESS,7
GB,PERTUSSIS,7
GB,PLASMA CELL MYELOMA,7
GB,PNEUMONIA KLEBSIELLA,7
GB,PORTAL HYPERTENSION,7
GB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,7
GB,PROTEIN TOTAL DECREASED,7
GB,PUBIS FRACTURE,7
GB,QUADRIPLEGIA,7
GB,RALES,7
GB,RASH VESICULAR,7
GB,RESPIRATORY DISTRESS,7
GB,RHEUMATIC DISORDER,7
GB,RHINITIS,7
GB,SERUM PROCOLLAGEN TYPE III N-TERMINAL PROPEPTIDE INCREASED,7
GB,SKIN ATROPHY,7
GB,SNEEZING,7
GB,SQUAMOUS CELL CARCINOMA OF SKIN,7
GB,STAPHYLOCOCCAL SEPSIS,7
GB,SUBDURAL HYGROMA,7
GB,SUPRAVENTRICULAR TACHYCARDIA,7
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,7
GB,THIRST DECREASED,7
GB,TYPE 1 DIABETES MELLITUS,7
GB,URETEROCELE,7
GB,VASCULAR DEMENTIA,7
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,7
GB,WITHDRAWAL SYNDROME,7
GB,ABNORMAL BEHAVIOUR,6
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,6
GB,ACUTE INTERSTITIAL PNEUMONITIS,6
GB,AGGRESSION,6
GB,ANAEMIA MEGALOBLASTIC,6
GB,APATHY,6
GB,ARRHYTHMIA,6
GB,ARTHRITIS INFECTIVE,6
GB,AXIAL SPONDYLOARTHRITIS,6
GB,BLOOD LACTATE DEHYDROGENASE INCREASED,6
GB,BLOOD PHOSPHORUS DECREASED,6
GB,CAMPYLOBACTER GASTROENTERITIS,6
GB,CARDIOMEGALY,6
GB,CHRONIC GRAFT VERSUS HOST DISEASE,6
GB,COORDINATION ABNORMAL,6
GB,CRYING,6
GB,CYTOMEGALOVIRUS INFECTION,6
GB,DACTYLITIS,6
GB,DELUSION,6
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,6
GB,DISSEMINATED INTRAVASCULAR COAGULATION,6
GB,DRY THROAT,6
GB,EPIGLOTTITIS,6
GB,ERECTILE DYSFUNCTION,6
GB,ERYTHRODERMIC PSORIASIS,6
GB,ESCHERICHIA INFECTION,6
GB,EXCORIATION,6
GB,EXERCISE TOLERANCE DECREASED,6
GB,EYE INFECTION,6
GB,EYE PAIN,6
GB,FACIAL PARALYSIS,6
GB,FINE MOTOR SKILL DYSFUNCTION,6
GB,FRUSTRATION TOLERANCE DECREASED,6
GB,FURUNCLE,6
GB,GALLBLADDER PAIN,6
GB,GALLBLADDER PERFORATION,6
GB,GASTRIC ULCER HAEMORRHAGE,6
GB,GENERALISED TONIC-CLONIC SEIZURE,6
GB,GRAND MAL CONVULSION,6
GB,GROWTH RETARDATION,6
GB,HEPATIC CANCER,6
GB,HYPERKERATOSIS,6
GB,HYPOMAGNESAEMIA,6
GB,ILL-DEFINED DISORDER,6
GB,IMPAIRED HEALING,6
GB,INFECTIVE EXACERBATION OF BRONCHIECTASIS,6
GB,INJECTION SITE RASH,6
GB,INJECTION SITE VESICLES,6
GB,INTENTIONAL OVERDOSE,6
GB,INTESTINAL MASS,6
GB,INTRACRANIAL PRESSURE INCREASED,6
GB,IRON DEFICIENCY,6
GB,JOINT INJURY,6
GB,LARYNGEAL ULCERATION,6
GB,LESION EXCISION,6
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,6
GB,MALIGNANT PLEURAL EFFUSION,6
GB,MEDICATION ERROR,6
GB,METASTASIS,6
GB,MORAXELLA INFECTION,6
GB,MULTI-ORGAN DISORDER,6
GB,MYOPATHY,6
GB,MYOSITIS,6
GB,NERVE INJURY,6
GB,NEUROLOGICAL DECOMPENSATION,6
GB,OPHTHALMIC HERPES SIMPLEX,6
GB,OSTEOMYELITIS,6
GB,OSTEONECROSIS,6
GB,PALINDROMIC RHEUMATISM,6
GB,PAPILLOMA VIRAL INFECTION,6
GB,PAPULE,6
GB,PARALYSIS,6
GB,PARANOIA,6
GB,PARONYCHIA,6
GB,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,6
GB,PERIPROSTHETIC FRACTURE,6
GB,PHOTOPHOBIA,6
GB,PLEURITIC PAIN,6
GB,POST INFLAMMATORY PIGMENTATION CHANGE,6
GB,POST PROCEDURAL INFECTION,6
GB,PROCTITIS,6
GB,PULMONARY HYPERTENSION,6
GB,RESPIRATORY TRACT HAEMORRHAGE,6
GB,SARCOIDOSIS,6
GB,SECONDARY ADRENOCORTICAL INSUFFICIENCY,6
GB,SJOGREN^S SYNDROME,6
GB,SKIN TIGHTNESS,6
GB,SMALL INTESTINAL OBSTRUCTION,6
GB,SPLENOMEGALY,6
GB,SUBDURAL HAEMATOMA,6
GB,SYNOVITIS,6
GB,TENDON GRAFT,6
GB,TONGUE ULCERATION,6
GB,TOOTH INFECTION,6
GB,TOOTH LOSS,6
GB,TUBULOINTERSTITIAL NEPHRITIS,6
GB,URINARY TRACT DISORDER,6
GB,VASCULITIS,6
GB,VITAMIN D DEFICIENCY,6
GB,VITH NERVE PARALYSIS,6
GB,VOLVULUS,6
GB,ABDOMINAL SEPSIS,5
GB,ABDOMINAL TENDERNESS,5
GB,ACUTE LUNG INJURY,5
GB,ADDISON^S DISEASE,5
GB,AGEUSIA,5
GB,ALCOHOL POISONING,5
GB,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,5
GB,ANAL CANCER,5
GB,AORTIC ANEURYSM,5
GB,APPENDICITIS,5
GB,ASPARTATE AMINOTRANSFERASE INCREASED,5
GB,BACTERAEMIA,5
GB,BACTERIAL SEPSIS,5
GB,BLAST CELLS PRESENT,5
GB,BLOOD PRESSURE FLUCTUATION,5
GB,BODY HEIGHT DECREASED,5
GB,BREAST SWELLING,5
GB,CEREBELLAR INFARCTION,5
GB,CEREBELLAR SYNDROME,5
GB,CEREBROVASCULAR DISORDER,5
GB,CHEMICAL BURN OF RESPIRATORY TRACT,5
GB,CHOLECYSTITIS ACUTE,5
GB,COMA SCALE ABNORMAL,5
GB,DEAFNESS,5
GB,DEAFNESS UNILATERAL,5
GB,DERMATITIS ALLERGIC,5
GB,DERMATITIS EXFOLIATIVE,5
GB,DIARRHOEA HAEMORRHAGIC,5
GB,DIVERTICULAR PERFORATION,5
GB,DROP ATTACKS,5
GB,DRUG DISPENSING ERROR,5
GB,DRUG MONITORING PROCEDURE NOT PERFORMED,5
GB,ECZEMA ASTEATOTIC,5
GB,EMBOLISM ARTERIAL,5
GB,EOSINOPHILIA,5
GB,EPIGLOTTIS ULCER,5
GB,ESCHERICHIA URINARY TRACT INFECTION,5
GB,ESSENTIAL HYPERTENSION,5
GB,EYE INFECTION TOXOPLASMAL,5
GB,EYE PRURITUS,5
GB,FOETAL DEATH,5
GB,FOOT OPERATION,5
GB,FOREIGN BODY,5
GB,FOREIGN BODY SENSATION IN EYES,5
GB,FUNGAL INFECTION,5
GB,GASTRIC DISORDER,5
GB,GASTRIC HAEMORRHAGE,5
GB,GASTROINTESTINAL PERFORATION,5
GB,GINGIVAL RECESSION,5
GB,GOUT,5
GB,GRAFT VERSUS HOST DISEASE IN SKIN,5
GB,GYNAECOMASTIA,5
GB,HAEMATOMA,5
GB,HAEMATOTOXICITY,5
GB,HAIR COLOUR CHANGES,5
GB,HERPES OPHTHALMIC,5
GB,HICCUPS,5
GB,HISTIOCYTOSIS HAEMATOPHAGIC,5
GB,HIV TEST POSITIVE,5
GB,HODGKIN^S DISEASE,5
GB,HYPOTONIA,5
GB,INJECTION SITE ULCER,5
GB,INTESTINAL FISTULA,5
GB,IRIDOCYCLITIS,5
GB,IRON DEFICIENCY ANAEMIA,5
GB,JAUNDICE CHOLESTATIC,5
GB,JOINT DESTRUCTION,5
GB,LARYNGEAL OEDEMA,5
GB,LEUKAEMIA,5
GB,MENINGITIS,5
GB,MENOPAUSE,5
GB,MENTAL IMPAIRMENT,5
GB,METASTATIC SQUAMOUS CELL CARCINOMA,5
GB,MOUTH HAEMORRHAGE,5
GB,MUCOCUTANEOUS ULCERATION,5
GB,MUSCLE TWITCHING,5
GB,NEPHRITIS,5
GB,NEUROENDOCRINE CARCINOMA OF THE SKIN,5
GB,OESOPHAGEAL SPASM,5
GB,OVULATION PAIN,5
GB,PANCREAS INFECTION,5
GB,PELVIC CYST,5
GB,PEMPHIGOID,5
GB,PENILE CANCER,5
GB,PERIPHERAL ISCHAEMIA,5
GB,PLASMA CELL MYELOMA RECURRENT,5
GB,PLATELET COUNT ABNORMAL,5
GB,PNEUMOCONIOSIS,5
GB,PSEUDOMONAS INFECTION,5
GB,PULMONARY AIR LEAKAGE,5
GB,PULMONARY SEPSIS,5
GB,PULSELESS ELECTRICAL ACTIVITY,5
GB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
GB,RED CELL DISTRIBUTION WIDTH INCREASED,5
GB,RENAL CYST,5
GB,RESORPTION BONE INCREASED,5
GB,RETINOPATHY,5
GB,SCAR PAIN,5
GB,SCIATICA,5
GB,SENSORY LOSS,5
GB,SKIN NEOPLASM EXCISION,5
GB,SMALL FIBRE NEUROPATHY,5
GB,SPINAL DEFORMITY,5
GB,STOMA SITE EXTRAVASATION,5
GB,STRESS FRACTURE,5
GB,SUDDEN HEARING LOSS,5
GB,SUICIDE ATTEMPT,5
GB,TENDON RUPTURE,5
GB,TENSION HEADACHE,5
GB,TRAUMATIC LUNG INJURY,5
GB,VENOOCCLUSIVE DISEASE,5
GB,VIRAL LOAD,5
GB,VULVOVAGINAL DRYNESS,5
GB,VULVOVAGINAL RASH,5
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,5
GB,ABSCESS LIMB,4
GB,ACCIDENTAL OVERDOSE,4
GB,ACTINIC KERATOSIS,4
GB,ACUTE GRAFT VERSUS HOST DISEASE,4
GB,ADENOCARCINOMA,4
GB,AIR EMBOLISM,4
GB,ANAPHYLACTIC SHOCK,4
GB,ANGINA UNSTABLE,4
GB,ANOSMIA,4
GB,AORTIC STENOSIS,4
GB,APHONIA,4
GB,ATELECTASIS,4
GB,ATRIOVENTRICULAR BLOCK COMPLETE,4
GB,AUTOIMMUNE HEPATITIS,4
GB,BIPOLAR DISORDER,4
GB,BLINDNESS TRANSIENT,4
GB,BLOOD CALCIUM INCREASED,4
GB,BLOOD CHOLESTEROL INCREASED,4
GB,BLOOD MAGNESIUM INCREASED,4
GB,BLOOD PHOSPHORUS INCREASED,4
GB,BLOOD POTASSIUM INCREASED,4
GB,BLOOD SODIUM DECREASED,4
GB,BONE DENSITY DECREASED,4
GB,BOWEN^S DISEASE,4
GB,BRONCHOPULMONARY ASPERGILLOSIS,4
GB,BURKITT^S LYMPHOMA,4
GB,BURNING MOUTH SYNDROME,4
GB,CARDIAC FUNCTION TEST ABNORMAL,4
GB,CENTRAL NERVOUS SYSTEM LESION,4
GB,CERVIX CARCINOMA STAGE 0,4
GB,CHILLBLAINS,4
GB,CHLOROMA,4
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,4
GB,CLUMSINESS,4
GB,COLON NEOPLASM,4
GB,CORONARY ARTERY STENOSIS,4
GB,CUTANEOUS LUPUS ERYTHEMATOSUS,4
GB,CUTANEOUS VASCULITIS,4
GB,CYST,4
GB,DIVERTICULUM INTESTINAL,4
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,4
GB,DYSPLASIA,4
GB,EMOTIONAL DISORDER,4
GB,ENDOMETRIOSIS,4
GB,EXTRADURAL HAEMATOMA,4
GB,FEELING OF BODY TEMPERATURE CHANGE,4
GB,FLUID INTAKE REDUCED,4
GB,FOOD POISONING,4
GB,FOOT FRACTURE,4
GB,FRACTURE NONUNION,4
GB,GASTROINTESTINAL INFECTION,4
GB,GINGIVAL PAIN,4
GB,GLAUCOMA,4
GB,GLIOBLASTOMA,4
GB,GLIOBLASTOMA MULTIFORME,4
GB,GLOSSODYNIA,4
GB,HEARING IMPAIRED,4
GB,HEART DISEASE CONGENITAL,4
GB,HERPES SIMPLEX,4
GB,HYDROCEPHALUS,4
GB,HYPERTHYROIDISM,4
GB,HYPOACUSIS,4
GB,HYSTERECTOMY,4
GB,IDIOPATHIC PNEUMONIA SYNDROME,4
GB,IDIOPATHIC PULMONARY FIBROSIS,4
GB,INCOHERENT,4
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
GB,INGUINAL HERNIA,4
GB,JOINT ARTHROPLASTY,4
GB,LABORATORY TEST ABNORMAL,4
GB,LOCAL REACTION,4
GB,MATERNAL EXPOSURE DURING PREGNANCY,4
GB,METASTASES TO SPINE,4
GB,METRORRHAGIA,4
GB,MOOD ALTERED,4
GB,MUSCLE ABSCESS,4
GB,MUSCLE ATROPHY,4
GB,MUSCULOSKELETAL DISORDER,4
GB,NERVE COMPRESSION,4
GB,NEUTRALISING ANTIBODIES POSITIVE,4
GB,NON-CARDIAC CHEST PAIN,4
GB,OBSESSIVE-COMPULSIVE DISORDER,4
GB,OBSTRUCTIVE AIRWAYS DISORDER,4
GB,OCULAR HYPERAEMIA,4
GB,OESOPHAGEAL ADENOCARCINOMA,4
GB,OESOPHAGEAL CANCER METASTATIC,4
GB,OESOPHAGEAL ULCER HAEMORRHAGE,4
GB,OESOPHAGEAL VARICES HAEMORRHAGE,4
GB,ONYCHOMADESIS,4
GB,OPTIC NEURITIS,4
GB,OSTEOMALACIA,4
GB,OSTEONECROSIS OF JAW,4
GB,PANCREATIC FAILURE,4
GB,PARESIS,4
GB,PHOTOPSIA,4
GB,PHOTOSENSITIVITY REACTION,4
GB,PLATELET COUNT INCREASED,4
GB,PNEUMATOSIS INTESTINALIS,4
GB,PNEUMOCYSTIS JIROVECII INFECTION,4
GB,PNEUMONIA LEGIONELLA,4
GB,PNEUMOPERITONEUM,4
GB,POISONING DELIBERATE,4
GB,POLYMYALGIA RHEUMATICA,4
GB,POST PROCEDURAL HAEMORRHAGE,4
GB,PREMATURE BABY,4
GB,PRODUCT FORMULATION ISSUE,4
US,DRUG INEFFECTIVE,11030
US,ARTHRALGIA,5632
US,INJECTION SITE PAIN,5449
US,PAIN,4171
US,FATIGUE,4018
US,NAUSEA,3850
US,RHEUMATOID ARTHRITIS,3339
US,PAIN IN EXTREMITY,3321
US,HEADACHE,3202
US,INJECTION SITE ERYTHEMA,2222
US,DRUG HYPERSENSITIVITY,2109
US,MALAISE,2103
US,JOINT SWELLING,2070
US,DIARRHOEA,2052
US,INJECTION SITE BRUISING,1882
US,NASOPHARYNGITIS,1858
US,SINUSITIS,1815
US,COUGH,1794
US,RASH,1699
US,VOMITING,1655
US,PSORIASIS,1654
US,DRUG DOSE OMISSION,1650
US,BACK PAIN,1594
US,DRUG EFFECT INCOMPLETE,1593
US,ALOPECIA,1586
US,MUSCULOSKELETAL STIFFNESS,1568
US,PYREXIA,1568
US,DYSPNOEA,1549
US,PNEUMONIA,1478
US,INJECTION SITE PRURITUS,1419
US,DIZZINESS,1394
US,PERIPHERAL SWELLING,1381
US,FALL,1321
US,CONDITION AGGRAVATED,1292
US,ASTHENIA,1257
US,INJECTION SITE SWELLING,1240
US,DRUG EFFECT DECREASED,1208
US,INJECTION SITE REACTION,1199
US,GAIT DISTURBANCE,1158
US,TREATMENT FAILURE,1127
US,MUSCULOSKELETAL PAIN,1053
US,INFECTION,1050
US,FEELING ABNORMAL,1041
US,ABDOMINAL DISCOMFORT,1017
US,ARTHRITIS,1013
US,BRONCHITIS,1007
US,PRURITUS,1007
US,INJECTION SITE HAEMORRHAGE,1003
US,WEIGHT DECREASED,980
US,URINARY TRACT INFECTION,955
US,INCORRECT DOSE ADMINISTERED,915
US,OROPHARYNGEAL PAIN,910
US,HEPATIC ENZYME INCREASED,905
US,WEIGHT INCREASED,858
US,MOBILITY DECREASED,833
US,HYPOAESTHESIA,825
US,ABDOMINAL PAIN,810
US,DRUG INTOLERANCE,798
US,INSOMNIA,788
US,ERYTHEMA,784
US,LOCAL SWELLING,771
US,OSTEOARTHRITIS,766
US,CONTUSION,755
US,ABDOMINAL PAIN UPPER,753
US,INFLUENZA,753
US,DEPRESSION,751
US,HYPERSENSITIVITY,732
US,MUSCLE SPASMS,726
US,UPPER RESPIRATORY TRACT INFECTION,711
US,HYPERTENSION,703
US,DEVICE MALFUNCTION,693
US,ANXIETY,683
US,CHEST PAIN,680
US,PARAESTHESIA,677
US,PSORIATIC ARTHROPATHY,670
US,JOINT STIFFNESS,662
US,HERPES ZOSTER,642
US,SWELLING,630
US,ANAEMIA,626
US,MYALGIA,611
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,600
US,STOMATITIS,586
US,LIVER FUNCTION TEST INCREASED,585
US,URTICARIA,582
US,ARTHROPATHY,577
US,DECREASED APPETITE,561
US,SEPSIS,559
US,DEVICE ISSUE,557
US,MUSCULAR WEAKNESS,552
US,NECK PAIN,539
US,RHINORRHOEA,534
US,CROHN^S DISEASE,530
US,THERAPEUTIC RESPONSE DECREASED,530
US,INJECTION SITE WARMTH,516
US,CHILLS,506
US,OEDEMA PERIPHERAL,495
US,NASAL CONGESTION,494
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,484
US,INJECTION SITE RASH,482
US,FEBRILE NEUTROPENIA,480
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,475
US,INFLAMMATION,468
US,GASTROINTESTINAL DISORDER,467
US,DEATH,465
US,INFLUENZA LIKE ILLNESS,458
US,MEMORY IMPAIRMENT,450
US,CONSTIPATION,447
US,INJECTION SITE URTICARIA,439
US,MIGRAINE,420
US,CELLULITIS,419
US,SOMNOLENCE,410
US,HYPERHIDROSIS,395
US,PRODUCT USE ISSUE,394
US,NODULE,387
US,ADVERSE DRUG REACTION,382
US,STRESS,377
US,BLOOD PRESSURE INCREASED,375
US,HYPOTENSION,370
US,GASTROOESOPHAGEAL REFLUX DISEASE,369
US,DEHYDRATION,366
US,VISION BLURRED,366
US,STAPHYLOCOCCAL INFECTION,364
US,DYSPEPSIA,359
US,JOINT RANGE OF MOTION DECREASED,356
US,VISUAL IMPAIRMENT,355
US,LIVER FUNCTION TEST ABNORMAL,345
US,NEUROPATHY PERIPHERAL,342
US,FIBROMYALGIA,341
US,TREMOR,339
US,IMPAIRED HEALING,336
US,CATARACT,334
US,WHITE BLOOD CELL COUNT DECREASED,333
US,ASTHMA,331
US,CHEST DISCOMFORT,330
US,BLOOD GLUCOSE INCREASED,318
US,RASH PRURITIC,316
US,ABDOMINAL DISTENSION,312
US,BLISTER,310
US,FEELING HOT,309
US,NEUTROPENIA,307
US,FUNGAL INFECTION,305
US,UNEVALUABLE EVENT,305
US,RESPIRATORY TRACT CONGESTION,299
US,CONFUSIONAL STATE,295
US,KNEE ARTHROPLASTY,289
US,THROMBOCYTOPENIA,287
US,DRY MOUTH,285
US,INFUSION RELATED REACTION,282
US,EAR INFECTION,281
US,INJECTION SITE MASS,281
US,VIRAL INFECTION,281
US,TOXICITY TO VARIOUS AGENTS,280
US,PRODUCTIVE COUGH,279
US,DRY SKIN,278
US,PANCYTOPENIA,278
US,LUNG DISORDER,275
US,CEREBROVASCULAR ACCIDENT,273
US,MYOCARDIAL INFARCTION,273
US,BURNING SENSATION,271
US,PALPITATIONS,270
US,ADVERSE EVENT,269
US,LOCALISED INFECTION,268
US,DIVERTICULITIS,265
US,DYSPHAGIA,261
US,DYSPHONIA,260
US,LOSS OF CONSCIOUSNESS,259
US,CYSTITIS,257
US,FOOT DEFORMITY,256
US,DIABETES MELLITUS,255
US,INTERVERTEBRAL DISC PROTRUSION,252
US,RENAL FAILURE,251
US,DRY EYE,248
US,ATRIAL FIBRILLATION,246
US,BALANCE DISORDER,245
US,MOUTH ULCERATION,244
US,EPISTAXIS,243
US,SKIN DISCOLOURATION,241
US,SKIN EXFOLIATION,241
US,NEPHROLITHIASIS,237
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,236
US,OSTEOPOROSIS,233
US,INCORRECT PRODUCT STORAGE,231
US,SEIZURE,230
US,SINUS CONGESTION,230
US,LYMPHADENOPATHY,229
US,RASH ERYTHEMATOUS,226
US,ACTIVITIES OF DAILY LIVING IMPAIRED,224
US,INJECTION SITE DISCOLOURATION,224
US,MUCOSAL INFLAMMATION,224
US,BONE PAIN,221
US,SYNOVITIS,221
US,THROMBOSIS,221
US,INTENTIONAL PRODUCT MISUSE,220
US,ALANINE AMINOTRANSFERASE INCREASED,219
US,HEART RATE INCREASED,218
US,BLOOD CHOLESTEROL INCREASED,217
US,SWELLING FACE,216
US,THROAT IRRITATION,216
US,PULMONARY EMBOLISM,215
US,INJECTION SITE INDURATION,212
US,ABASIA,211
US,ACUTE KIDNEY INJURY,211
US,SLEEP DISORDER,209
US,PLEURAL EFFUSION,206
US,RESPIRATORY FAILURE,205
US,SURGERY,205
US,THERAPEUTIC RESPONSE UNEXPECTED,205
US,PLATELET COUNT DECREASED,204
US,UNDERDOSE,201
US,COLITIS,200
US,HOT FLUSH,200
US,ACCIDENTAL EXPOSURE TO PRODUCT,199
US,GASTROINTESTINAL HAEMORRHAGE,199
US,LACERATION,196
US,LIVER DISORDER,195
US,SKIN ULCER,195
US,HAEMOGLOBIN DECREASED,194
US,RESPIRATORY TRACT INFECTION,193
US,BREAST CANCER,191
US,HAEMORRHAGE,191
US,ROTATOR CUFF SYNDROME,191
US,FLUSHING,186
US,INCREASED TENDENCY TO BRUISE,186
US,LIMB DISCOMFORT,186
US,RASH PAPULAR,186
US,GASTROENTERITIS VIRAL,185
US,JOINT EFFUSION,181
US,PHARYNGITIS STREPTOCOCCAL,181
US,SINUS DISORDER,181
US,THERAPY NON-RESPONDER,180
US,AMNESIA,179
US,CARDIAC DISORDER,179
US,NIGHT SWEATS,179
US,ORAL HERPES,179
US,SYSTEMIC LUPUS ERYTHEMATOSUS,179
US,PANCREATITIS,178
US,SYNCOPE,178
US,TACHYCARDIA,176
US,HAND DEFORMITY,175
US,DYSGEUSIA,174
US,NERVOUSNESS,173
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,173
US,PULMONARY MASS,172
US,DISCOMFORT,171
US,OEDEMA,171
US,LETHARGY,170
US,LEUKOPENIA,170
US,MUSCULOSKELETAL DISCOMFORT,170
US,TOOTH INFECTION,170
US,ORAL PAIN,169
US,ASPARTATE AMINOTRANSFERASE INCREASED,168
US,GASTRIC DISORDER,168
US,RASH MACULAR,167
US,TENDERNESS,167
US,CARDIAC FAILURE CONGESTIVE,166
US,JOINT INJURY,166
US,MUSCULOSKELETAL DISORDER,166
US,POLLAKIURIA,166
US,WHEEZING,165
US,DISEASE PROGRESSION,164
US,SNEEZING,164
US,PRURITUS GENERALISED,162
US,ROAD TRAFFIC ACCIDENT,162
US,FINGER DEFORMITY,161
US,PRODUCT QUALITY ISSUE,161
US,TRANSAMINASES INCREASED,161
US,SKIN LESION,160
US,EAR PAIN,159
US,EXOSTOSIS,159
US,LUNG INFECTION,159
US,VERTIGO,158
US,WOUND,158
US,ACNE,156
US,LIMB INJURY,156
US,DEEP VEIN THROMBOSIS,155
US,KIDNEY INFECTION,155
US,CARPAL TUNNEL SYNDROME,154
US,RASH GENERALISED,154
US,INTERVERTEBRAL DISC DEGENERATION,153
US,DYSSTASIA,151
US,RENAL IMPAIRMENT,151
US,FLATULENCE,150
US,WHITE BLOOD CELL COUNT INCREASED,150
US,BLOOD CREATININE INCREASED,149
US,CLOSTRIDIUM DIFFICILE INFECTION,149
US,FLUID RETENTION,148
US,DYSURIA,147
US,EYE PAIN,147
US,ANAPHYLACTIC REACTION,146
US,HAEMATOCHEZIA,146
US,IMMUNE SYSTEM DISORDER,146
US,SKIN DISORDER,146
US,FEAR OF INJECTION,145
US,FOOT FRACTURE,145
US,BASAL CELL CARCINOMA,144
US,HEPATIC STEATOSIS,144
US,PAIN IN JAW,144
US,PROCEDURAL PAIN,144
US,SJOGREN^S SYNDROME,144
US,BURSITIS,143
US,GRIP STRENGTH DECREASED,140
US,HIP ARTHROPLASTY,139
US,INTERSTITIAL LUNG DISEASE,138
US,TOOTHACHE,138
US,CHOLELITHIASIS,137
US,OSTEOMYELITIS,137
US,MENISCUS INJURY,136
US,BONE DISORDER,134
US,INJECTION SITE PAPULE,133
US,LABORATORY TEST ABNORMAL,133
US,NO THERAPEUTIC RESPONSE,132
US,SCAR,132
US,BLOOD POTASSIUM DECREASED,130
US,COLITIS ULCERATIVE,129
US,HYPOKALAEMIA,129
US,INJECTION SITE EXTRAVASATION,129
US,PRODUCT USE IN UNAPPROVED INDICATION,128
US,SCIATICA,128
US,RECTAL HAEMORRHAGE,126
US,C-REACTIVE PROTEIN INCREASED,125
US,SEPTIC SHOCK,125
US,SPINAL COLUMN STENOSIS,125
US,TOOTH DISORDER,124
US,CORONARY ARTERY OCCLUSION,123
US,DISTURBANCE IN ATTENTION,123
US,EYE DISORDER,123
US,SPINAL OSTEOARTHRITIS,123
US,TOOTH ABSCESS,123
US,SLEEP APNOEA SYNDROME,122
US,LARYNGITIS,121
US,PULMONARY FIBROSIS,121
US,UPPER LIMB FRACTURE,121
US,BACTERIAL INFECTION,120
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,120
US,IRRITABILITY,120
US,OSTEOPENIA,120
US,ARTHROPOD BITE,119
US,INTESTINAL OBSTRUCTION,119
US,DEPRESSED MOOD,118
US,RHEUMATOID NODULE,118
US,JOINT DISLOCATION,117
US,OCULAR HYPERAEMIA,117
US,EYE SWELLING,116
US,HYPOXIA,116
US,NERVE COMPRESSION,116
US,DRUG ADMINISTRATION ERROR,115
US,FEMUR FRACTURE,114
US,POST PROCEDURAL COMPLICATION,114
US,CANDIDA INFECTION,113
US,FEELING COLD,113
US,SINUS HEADACHE,113
US,HOSPITALISATION,112
US,LOWER RESPIRATORY TRACT INFECTION,112
US,BLOOD PRESSURE DECREASED,111
US,DYSARTHRIA,111
US,IMMUNODEFICIENCY,111
US,INJECTION SITE DISCOMFORT,111
US,NEURALGIA,111
US,CYST,110
US,JOINT CREPITATION,110
US,NEUROTOXICITY,110
US,TINNITUS,109
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,108
US,MASS,108
US,PHARYNGEAL OEDEMA,106
US,FURUNCLE,105
US,SKIN INFECTION,105
US,BONE MARROW FAILURE,104
US,HIP FRACTURE,104
US,TENDON RUPTURE,104
US,MUSCULOSKELETAL CHEST PAIN,103
US,UVEITIS,103
US,BLOOD BILIRUBIN INCREASED,102
US,PULMONARY OEDEMA,102
US,SPEECH DISORDER,102
US,TENDONITIS,102
US,VISUAL ACUITY REDUCED,102
US,HYPOPHAGIA,101
US,SEASONAL ALLERGY,101
US,UPPER-AIRWAY COUGH SYNDROME,101
US,ADVERSE REACTION,100
US,BACK DISORDER,100
US,HYPERSOMNIA,100
US,IMMUNOSUPPRESSION,100
US,VITAMIN D DECREASED,100
US,HIATUS HERNIA,99
US,INJURY,99
US,RIB FRACTURE,99
US,LACRIMATION INCREASED,98
US,RESPIRATORY DISORDER,98
US,DYSPNOEA EXERTIONAL,97
US,MENTAL STATUS CHANGES,97
US,NO ADVERSE EVENT,97
US,PNEUMONITIS,97
US,VITAMIN D DEFICIENCY,97
US,CLOSTRIDIUM DIFFICILE COLITIS,96
US,GASTRITIS,96
US,CRYING,95
US,HEPATIC CIRRHOSIS,95
US,RED BLOOD CELL COUNT DECREASED,94
US,SYNOVIAL CYST,94
US,TRANSIENT ISCHAEMIC ATTACK,94
US,CARDIAC ARREST,93
US,CONVULSION,93
US,PARANASAL SINUS HYPERSECRETION,93
US,RENAL DISORDER,93
US,ABSCESS,92
US,HERNIA,92
US,SCAB,92
US,VAGINAL HAEMORRHAGE,92
US,INJURY ASSOCIATED WITH DEVICE,91
US,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,91
US,TOOTH FRACTURE,91
US,DENTAL CARIES,90
US,SKIN CANCER,90
US,SPUTUM DISCOLOURED,90
US,MALIGNANT MELANOMA,89
US,NEOPLASM PROGRESSION,89
US,SPINAL PAIN,89
US,BACTERAEMIA,88
US,HYPOTHYROIDISM,88
US,PHOTOSENSITIVITY REACTION,88
US,FREQUENT BOWEL MOVEMENTS,87
US,GENERAL PHYSICAL HEALTH DETERIORATION,87
US,INJECTION SITE VESICLES,87
US,MOVEMENT DISORDER,87
US,PHARYNGITIS,87
US,LUPUS-LIKE SYNDROME,86
US,OXYGEN SATURATION DECREASED,86
US,POOR QUALITY SLEEP,86
US,ANKLE FRACTURE,85
US,INJECTION SITE NODULE,85
US,PAIN OF SKIN,85
US,SKIN HAEMORRHAGE,85
US,ACUTE RESPIRATORY DISTRESS SYNDROME,84
US,BLOOD URINE PRESENT,84
US,DEVICE RELATED INFECTION,84
US,HAEMORRHOIDS,84
US,HEPATOTOXICITY,84
US,SMALL INTESTINAL OBSTRUCTION,84
US,APHASIA,83
US,BLOOD TEST ABNORMAL,83
US,EYE IRRITATION,83
US,HALLUCINATION,83
US,ILL-DEFINED DISORDER,83
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,83
US,LYMPHOMA,83
US,SQUAMOUS CELL CARCINOMA,83
US,HYPOACUSIS,82
US,IRRITABLE BOWEL SYNDROME,82
US,PHOTOPHOBIA,82
US,CHONDROPATHY,81
US,OVERDOSE,81
US,SPINAL FRACTURE,81
US,GALLBLADDER DISORDER,80
US,HAEMATURIA,80
US,HYPONATRAEMIA,80
US,NEEDLE ISSUE,80
US,ORAL MUCOSAL BLISTERING,80
US,SKIN BURNING SENSATION,80
US,CHRONIC KIDNEY DISEASE,79
US,EYE INFECTION,79
US,SKIN PLAQUE,79
US,URINARY INCONTINENCE,79
US,CARDIAC FAILURE,78
US,GASTRIC ULCER,78
US,GOUT,78
US,JOINT LOCK,78
US,TUBERCULOSIS,78
US,BLOOD GLUCOSE DECREASED,77
US,FOETAL EXPOSURE DURING PREGNANCY,77
US,LUNG NEOPLASM MALIGNANT,77
US,POST PROCEDURAL INFECTION,77
US,DISORIENTATION,76
US,DRUG EFFECT DELAYED,76
US,GLAUCOMA,76
US,HEPATIC FAILURE,76
US,LIGAMENT SPRAIN,76
US,NERVOUS SYSTEM DISORDER,76
US,PERICARDIAL EFFUSION,76
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,76
US,TOOTH EXTRACTION,75
US,SECRETION DISCHARGE,74
US,BLINDNESS,73
US,DEAFNESS,73
US,EYE PRURITUS,73
US,NEOPLASM MALIGNANT,73
US,DISEASE RECURRENCE,72
US,HEAD INJURY,72
US,HYPERGLYCAEMIA,72
US,PALLOR,72
US,RENAL FAILURE ACUTE,72
US,WOUND INFECTION,72
US,ENCEPHALOPATHY,71
US,HAEMOPTYSIS,71
US,INCREASED UPPER AIRWAY SECRETION,71
US,LIP SWELLING,71
US,DISABILITY,70
US,DRUG SPECIFIC ANTIBODY PRESENT,69
US,ECZEMA,69
US,FOOT OPERATION,69
US,PROSTATE CANCER,69
US,SUICIDAL IDEATION,69
US,ULCER,69
US,ANKYLOSING SPONDYLITIS,68
US,APHONIA,68
US,FACIAL PAIN,68
US,HEPATIC ENZYME ABNORMAL,68
US,SCRATCH,68
US,SKIN FISSURES,68
US,CONTRAINDICATED PRODUCT ADMINISTERED,67
US,GRAFT VERSUS HOST DISEASE,67
US,SWOLLEN TONGUE,67
US,ASCITES,66
US,DECREASED IMMUNE RESPONSIVENESS,66
US,EMOTIONAL DISORDER,66
US,NEUTROPHIL COUNT DECREASED,66
US,ORAL CANDIDIASIS,66
US,ARTHRITIS INFECTIVE,65
US,EXPOSURE DURING PREGNANCY,65
US,KNEE OPERATION,65
US,LOWER LIMB FRACTURE,65
US,THERAPY CESSATION,65
US,BLOOD IRON DECREASED,64
US,COGNITIVE DISORDER,64
US,EAR DISCOMFORT,64
US,HEMIPARESIS,64
US,RESTLESS LEGS SYNDROME,64
US,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,63
US,BLOOD COUNT ABNORMAL,63
US,RETCHING,63
US,SKIN MASS,63
US,SPINAL OPERATION,63
US,ACUTE RESPIRATORY FAILURE,62
US,BLOOD PRESSURE ABNORMAL,62
US,BODY HEIGHT DECREASED,62
US,CONJUNCTIVITIS,62
US,EMOTIONAL DISTRESS,62
US,FEAR,62
US,HYSTERECTOMY,62
US,OSTEONECROSIS,62
US,TUBERCULIN TEST POSITIVE,62
US,ABDOMINAL PAIN LOWER,61
US,AGITATION,61
US,NERVE INJURY,61
US,PLEURISY,61
US,WRIST FRACTURE,61
US,ARRHYTHMIA,60
US,CHOLECYSTECTOMY,60
US,CHROMATURIA,60
US,DYSKINESIA,60
US,LEUKOENCEPHALOPATHY,60
US,MOOD ALTERED,60
US,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,60
US,PNEUMOCYSTIS JIROVECII PNEUMONIA,60
US,PNEUMOTHORAX,60
US,COMA,59
US,HEAD DISCOMFORT,59
US,MALIGNANT NEOPLASM PROGRESSION,59
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,59
US,MUSCLE STRAIN,59
US,RASH PUSTULAR,59
US,THROAT TIGHTNESS,59
US,TYPE 2 DIABETES MELLITUS,59
US,CARTILAGE ATROPHY,58
US,GLOSSODYNIA,58
US,INJECTION SITE IRRITATION,58
US,MULTIPLE SCLEROSIS,58
US,MUSCLE TWITCHING,58
US,ACUTE MYELOID LEUKAEMIA,57
US,ATELECTASIS,57
US,INTENTIONAL PRODUCT USE ISSUE,57
US,PANIC ATTACK,57
US,SPINAL DISORDER,57
US,URINARY RETENTION,57
US,BEDRIDDEN,56
US,BLOOD SODIUM DECREASED,56
US,COAGULOPATHY,56
US,GAIT INABILITY,56
US,HYPERLIPIDAEMIA,56
US,INFLAMMATORY MARKER INCREASED,56
US,LUNG INFILTRATION,56
US,MEDICATION ERROR,56
US,MENTAL DISORDER,56
US,PRE-EXISTING CONDITION IMPROVED,56
US,WALKING AID USER,56
US,BODY TEMPERATURE INCREASED,55
US,DRUG DISPENSING ERROR,55
US,FAECES DISCOLOURED,55
US,GASTROINTESTINAL INFECTION,55
US,HEPATIC FUNCTION ABNORMAL,55
US,JOINT WARMTH,55
US,MENTAL IMPAIRMENT,55
US,MUSCLE ATROPHY,55
US,DEVICE FAILURE,54
US,POOR QUALITY DRUG ADMINISTERED,54
US,POSTOPERATIVE WOUND INFECTION,54
US,PUSTULAR PSORIASIS,54
US,RHEUMATOID FACTOR INCREASED,54
US,CARDIOMYOPATHY,53
US,COLD SWEAT,53
US,EATING DISORDER,53
US,GROIN PAIN,53
US,LIGAMENT RUPTURE,53
US,ORAL DISORDER,53
US,THINKING ABNORMAL,53
US,TRIGGER FINGER,53
US,VENOOCCLUSIVE LIVER DISEASE,53
US,BLOOD GLUCOSE ABNORMAL,52
US,BLOOD TRIGLYCERIDES INCREASED,52
US,CORONARY ARTERY DISEASE,52
US,DERMATITIS CONTACT,52
US,DRUG RESISTANCE,52
US,INJECTION SITE INFLAMMATION,52
US,MACULAR DEGENERATION,52
US,MICTURITION URGENCY,52
US,PELVIC FRACTURE,52
US,PERIPHERAL COLDNESS,52
US,SPINAL FUSION SURGERY,52
US,VULVOVAGINAL MYCOTIC INFECTION,52
US,GINGIVAL PAIN,51
US,JOINT DESTRUCTION,51
US,NAIL DISORDER,51
US,TOOTH LOSS,51
US,DERMATITIS,50
US,DIPLOPIA,50
US,DRUG-INDUCED LIVER INJURY,50
US,IMPAIRED WORK ABILITY,50
US,INCREASED APPETITE,50
US,MOOD SWINGS,50
US,ONYCHOMYCOSIS,50
US,PAPULE,50
US,SKIN ATROPHY,50
US,SKIN WARM,50
US,HISTOPLASMOSIS,49
US,HYPERAESTHESIA,49
US,MENORRHAGIA,49
US,MUSCLE TIGHTNESS,49
US,RAYNAUD^S PHENOMENON,49
US,RENAL CYST,49
US,SQUAMOUS CELL CARCINOMA OF SKIN,49
US,STREPTOCOCCAL INFECTION,49
US,COLON CANCER,48
US,DIVERTICULUM,48
US,FACIAL PARALYSIS,48
US,HAEMATOCRIT DECREASED,48
US,HISTIOCYTOSIS HAEMATOPHAGIC,48
US,HISTOPLASMOSIS DISSEMINATED,48
US,LIVER INJURY,48
US,PULMONARY HYPERTENSION,48
US,SKIN IRRITATION,48
US,TENDON DISORDER,48
US,THIRST,48
US,THYROID DISORDER,48
US,DELIRIUM,47
US,JUVENILE IDIOPATHIC ARTHRITIS,47
US,RESPIRATORY DISTRESS,47
US,SPINAL COMPRESSION FRACTURE,47
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,46
US,DRUG PRESCRIBING ERROR,46
US,EMBOLISM,46
US,EYE INFLAMMATION,46
US,LIMB OPERATION,46
US,PRESYNCOPE,46
US,SINUS TACHYCARDIA,46
US,THERAPEUTIC RESPONSE SHORTENED,46
US,AGEUSIA,45
US,EXPIRED PRODUCT ADMINISTERED,45
US,FUNGAL SKIN INFECTION,45
US,HAEMATOMA,45
US,HEART RATE IRREGULAR,45
US,LARGE INTESTINE POLYP,45
US,LEUKOCYTOSIS,45
US,PARANASAL SINUS DISCOMFORT,45
US,PRODUCT STORAGE ERROR,45
US,SCOLIOSIS,45
US,ARTHRITIS BACTERIAL,44
US,EPSTEIN-BARR VIRUS INFECTION,44
US,HYPERKERATOSIS,44
US,HYPOGLYCAEMIA,44
US,HYPOKINESIA,44
US,INTESTINAL PERFORATION,44
US,OBESITY,44
US,OSTEONECROSIS OF JAW,44
US,ATAXIA,43
US,CONCUSSION,43
US,ILEUS,43
US,INTRAOCULAR PRESSURE INCREASED,43
US,MYELODYSPLASTIC SYNDROME,43
US,NASAL DISCOMFORT,43
US,ONYCHOCLASIS,43
US,PELVIC PAIN,43
US,TREATMENT NONCOMPLIANCE,43
US,CARDIOMEGALY,42
US,GASTROINTESTINAL PAIN,42
US,GINGIVAL BLEEDING,42
US,LYMPHOEDEMA,42
US,PLANTAR FASCIITIS,42
US,SARCOIDOSIS,42
US,TUMOUR LYSIS SYNDROME,42
US,WOUND INFECTION STAPHYLOCOCCAL,42
US,BRADYCARDIA,41
US,HAIR TEXTURE ABNORMAL,41
US,HYPOALBUMINAEMIA,41
US,INTESTINAL STENOSIS,41
US,IRITIS,41
US,IRON DEFICIENCY ANAEMIA,41
US,NASAL DISCHARGE DISCOLOURATION,41
US,PANCREATITIS ACUTE,41
US,SKIN REACTION,41
US,VASCULITIS,41
US,BLADDER DISORDER,40
US,CYTOMEGALOVIRUS INFECTION,40
US,DEFORMITY,40
US,DERMATITIS ALLERGIC,40
US,DEVICE DISLOCATION,40
US,DRUG ERUPTION,40
US,GASTROINTESTINAL INFLAMMATION,40
US,HAND FRACTURE,40
US,HERPES VIRUS INFECTION,40
US,INCORRECT DRUG ADMINISTRATION DURATION,40
US,INTERVERTEBRAL DISC DISORDER,40
US,JAUNDICE,40
US,JOINT ARTHROPLASTY,40
US,SHOULDER ARTHROPLASTY,40
US,UROSEPSIS,40
US,WHITE BLOOD CELL COUNT ABNORMAL,40
US,WOUND SECRETION,40
US,ABDOMINAL HERNIA,39
US,ACUTE LYMPHOCYTIC LEUKAEMIA,39
US,ASPERGILLUS INFECTION,39
US,BACK INJURY,39
US,BLOOD UREA INCREASED,39
US,GENERALISED OEDEMA,39
US,LATENT TUBERCULOSIS,39
US,MALNUTRITION,39
US,MIDDLE INSOMNIA,39
US,MYELOPATHY,39
US,NASAL ULCER,39
US,UPPER RESPIRATORY TRACT CONGESTION,39
US,VITREOUS FLOATERS,39
US,ABORTION SPONTANEOUS,38
US,AUTOIMMUNE DISORDER,38
US,BLOOD DISORDER,38
US,BREAST MASS,38
US,DIFFUSE LARGE B-CELL LYMPHOMA,38
US,FEELING JITTERY,38
US,FISTULA,38
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,38
US,HEPATOMEGALY,38
US,HYPOCALCAEMIA,38
US,MENINGITIS,38
US,PULMONARY CONGESTION,38
US,PULMONARY THROMBOSIS,38
US,PURULENT DISCHARGE,38
US,SENSORY DISTURBANCE,38
US,SUICIDE ATTEMPT,38
US,URINE ODOUR ABNORMAL,38
US,ABDOMINAL ABSCESS,37
US,ANIMAL BITE,37
US,BLOOD ALKALINE PHOSPHATASE INCREASED,37
US,BLOOD PRESSURE FLUCTUATION,37
US,CARDIAC FLUTTER,37
US,DRY THROAT,37
US,FLANK PAIN,37
US,FULL BLOOD COUNT DECREASED,37
US,INCONTINENCE,37
US,ORAL DISCOMFORT,37
US,PROCEDURAL COMPLICATION,37
US,TENDON PAIN,37
US,TONSILLITIS,37
US,VISUAL FIELD DEFECT,37
US,B-CELL LYMPHOMA,36
US,BONE DENSITY DECREASED,36
US,CARTILAGE INJURY,36
US,CATARACT OPERATION,36
US,CYTOPENIA,36
US,ESSENTIAL HYPERTENSION,36
US,FEEDING DISORDER,36
US,FLUID OVERLOAD,36
US,HEART RATE DECREASED,36
US,OVARIAN CYST,36
US,PULMONARY TOXICITY,36
US,RESTLESSNESS,36
US,RHEUMATOID LUNG,36
US,SUBDURAL HAEMATOMA,36
US,ANGIOEDEMA,35
US,AORTIC ANEURYSM,35
US,CARDIAC MURMUR,35
US,CRANIOSYNOSTOSIS,35
US,GINGIVITIS,35
US,GOITRE,35
US,HYPERTRIGLYCERIDAEMIA,35
US,LUMBAR SPINAL STENOSIS,35
US,RHINITIS,35
US,SLUGGISHNESS,35
US,ABNORMAL LOSS OF WEIGHT,34
US,BLINDNESS UNILATERAL,34
US,BONE EROSION,34
US,BREAST CANCER FEMALE,34
US,COELIAC DISEASE,34
US,CUSHINGOID,34
US,DRUG CLEARANCE DECREASED,34
US,HEARING IMPAIRED,34
US,KNEE DEFORMITY,34
US,LIPASE INCREASED,34
US,PLATELET COUNT INCREASED,34
US,UNRESPONSIVE TO STIMULI,34
US,ACUTE GRAFT VERSUS HOST DISEASE,33
US,ANTINUCLEAR ANTIBODY POSITIVE,33
US,BLOOD CALCIUM DECREASED,33
US,CHOLECYSTITIS,33
US,COCCIDIOIDOMYCOSIS,33
US,ECCHYMOSIS,33
US,HAEMATEMESIS,33
US,HAEMORRHAGIC DIATHESIS,33
US,MATERNAL EXPOSURE DURING PREGNANCY,33
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,33
US,TIBIA FRACTURE,33
US,UTERINE LEIOMYOMA,33
US,WEIGHT BEARING DIFFICULTY,33
US,ABNORMAL BEHAVIOUR,32
US,ACCIDENTAL OVERDOSE,32
US,ACUTE MYOCARDIAL INFARCTION,32
US,ANGER,32
US,BUNION,32
US,CAROTID ARTERY OCCLUSION,32
US,CYTOMEGALOVIRUS VIRAEMIA,32
US,DEVICE BREAKAGE,32
US,FEELING OF BODY TEMPERATURE CHANGE,32
US,GASTROENTERITIS,32
US,HAEMORRHAGE INTRACRANIAL,32
US,HYPOAESTHESIA ORAL,32
US,IMPAIRED GASTRIC EMPTYING,32
US,LARGE INTESTINE PERFORATION,32
US,MULTI-ORGAN FAILURE,32
US,ORAL INFECTION,32
US,PNEUMONIA BACTERIAL,32
US,RETINAL DETACHMENT,32
US,SENSORY LOSS,32
US,THYROID NEOPLASM,32
US,UMBILICAL HERNIA,32
US,ACUTE HEPATIC FAILURE,31
US,ANIMAL SCRATCH,31
US,APNOEA,31
US,BONE LOSS,31
US,CHEILITIS,31
US,CREPITATIONS,31
US,DEMENTIA,31
US,DEPRESSED LEVEL OF CONSCIOUSNESS,31
US,DIARRHOEA HAEMORRHAGIC,31
US,DIVERTICULAR PERFORATION,31
US,ERUCTATION,31
US,HEPATITIS,31
US,HYPERCALCAEMIA,31
US,INTERNAL HAEMORRHAGE,31
US,INTRAMEDULLARY ROD INSERTION,31
US,METASTASES TO BONE,31
US,NON-HODGKIN^S LYMPHOMA,31
US,POLYARTHRITIS,31
US,POST PROCEDURAL HAEMORRHAGE,31
US,SHOCK,31
US,SINUS OPERATION,31
US,SKIN ABRASION,31
US,VARICOSE VEIN,31
US,ACCIDENT,30
US,APPENDICITIS,30
US,BLOOD BLISTER,30
US,BLOOD CALCIUM INCREASED,30
US,CARDIO-RESPIRATORY ARREST,30
US,CHOKING,30
US,DEMYELINATION,30
US,ESCHERICHIA INFECTION,30
US,EXTRA DOSE ADMINISTERED,30
US,EYELID OEDEMA,30
US,FOLLICULITIS,30
US,GALLBLADDER OPERATION,30
US,GENERALISED TONIC-CLONIC SEIZURE,30
US,GLUCOSE TOLERANCE IMPAIRED,30
US,HERPES SIMPLEX,30
US,IMPAIRED DRIVING ABILITY,30
US,MALABSORPTION,30
US,METABOLIC ACIDOSIS,30
US,NEOPLASM,30
US,OESOPHAGITIS,30
US,PARAESTHESIA ORAL,30
US,PARKINSON^S DISEASE,30
US,PERICARDITIS,30
US,SHOULDER OPERATION,30
US,STAPHYLOCOCCAL BACTERAEMIA,30
US,SYRINGE ISSUE,30
US,THERMAL BURN,30
US,VENOOCCLUSIVE DISEASE,30
US,WEIGHT FLUCTUATION,30
US,ARTERIAL OCCLUSIVE DISEASE,29
US,ATRIAL SEPTAL DEFECT,29
US,ATYPICAL PNEUMONIA,29
US,BLADDER CANCER,29
US,BREAST PAIN,29
US,DECREASED ACTIVITY,29
US,EAR CONGESTION,29
US,EMPHYSEMA,29
US,EYE HAEMORRHAGE,29
US,HYPERCHOLESTEROLAEMIA,29
US,INFLAMMATORY BOWEL DISEASE,29
US,INGUINAL HERNIA,29
US,INITIAL INSOMNIA,29
US,LYME DISEASE,29
US,MOTOR DYSFUNCTION,29
US,MULTIPLE SCLEROSIS RELAPSE,29
US,PAINFUL RESPIRATION,29
US,PRECANCEROUS SKIN LESION,29
US,PROCTALGIA,29
US,SECOND PRIMARY MALIGNANCY,29
US,SENSITIVITY OF TEETH,29
US,STRESS FRACTURE,29
US,TENOSYNOVITIS,29
US,ADRENAL INSUFFICIENCY,28
US,ANAL FISTULA,28
US,APHAGIA,28
US,BLOOD MAGNESIUM DECREASED,28
US,CEREBRAL HAEMORRHAGE,28
US,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,28
US,GLOMERULAR FILTRATION RATE DECREASED,28
US,HYPERBILIRUBINAEMIA,28
US,HYPOMAGNESAEMIA,28
US,INCISION SITE INFECTION,28
US,INGROWING NAIL,28
US,LARGE INTESTINAL STENOSIS,28
US,MELANOCYTIC NAEVUS,28
US,MITRAL VALVE INCOMPETENCE,28
US,NIGHTMARE,28
US,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,28
US,RASH MACULO-PAPULAR,28
US,RED CELL DISTRIBUTION WIDTH INCREASED,28
US,VIITH NERVE PARALYSIS,28
US,WOUND COMPLICATION,28
US,ABNORMAL DREAMS,27
US,APPETITE DISORDER,27
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,27
US,BRAIN NEOPLASM,27
US,HEPATITIS C,27
US,INCORRECT STORAGE OF DRUG,27
US,INFECTIOUS MONONUCLEOSIS,27
US,MIDDLE EAR EFFUSION,27
US,NASAL DRYNESS,27
US,NEPHROPATHY TOXIC,27
US,OPTIC NEURITIS,27
US,OVERWEIGHT,27
US,PARALYSIS,27
US,PERIPHERAL SENSORY NEUROPATHY,27
US,PETECHIAE,27
US,PSEUDOMONAS INFECTION,27
US,PYELONEPHRITIS,27
US,SKIN PAPILLOMA,27
US,TEMPERATURE INTOLERANCE,27
US,ANGINA PECTORIS,26
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,26
US,DECREASED INTEREST,26
US,DIZZINESS POSTURAL,26
US,FRACTURE,26
US,GASTRIC INFECTION,26
US,GRAFT VERSUS HOST DISEASE IN SKIN,26
US,HELICOBACTER INFECTION,26
US,HUMERUS FRACTURE,26
US,HYPERKALAEMIA,26
US,LIP BLISTER,26
US,MENSTRUAL DISORDER,26
US,MUSCLE RUPTURE,26
US,ONYCHOMADESIS,26
US,PNEUMONIA ASPIRATION,26
US,PREMATURE BABY,26
US,ABDOMINAL ADHESIONS,25
US,ANOSMIA,25
US,ARTERIOSCLEROSIS CORONARY ARTERY,25
US,BLOOD ALBUMIN DECREASED,25
US,CENTRAL NERVOUS SYSTEM LESION,25
US,CHRONIC SINUSITIS,25
US,COLECTOMY,25
US,COMPRESSION FRACTURE,25
US,EJECTION FRACTION DECREASED,25
US,HEPATIC FIBROSIS,25
US,JOINT CONTRACTURE,25
US,METASTASES TO LIVER,25
US,NODAL OSTEOARTHRITIS,25
US,PERITONITIS,25
US,PERONEAL NERVE PALSY,25
US,PLASMA CELL MYELOMA,25
US,RENAL FUNCTION TEST ABNORMAL,25
US,SKIN INDURATION,25
US,SPLENOMEGALY,25
US,SUNBURN,25
US,SUPRAVENTRICULAR TACHYCARDIA,25
US,TENDON INJURY,25
US,THYROID FUNCTION TEST ABNORMAL,25
US,TONGUE DISCOLOURATION,25
US,VITAMIN B12 DECREASED,25
US,WHITE BLOOD CELL DISORDER,25
UM,OSTEOSCLEROSIS,1
UM,SPINAL COMPRESSION FRACTURE,1
UY,PYREXIA,5
UY,ANAEMIA,3
UY,ANOSMIA,2
UY,CHRONIC SINUSITIS,2
UY,HEADACHE,2
UY,HERPES ZOSTER,2
UY,LUNG INFECTION,2
UY,MUSCLE SPASMS,2
UY,RHINORRHOEA,2
UY,SPINAL PAIN,2
UY,ALOPECIA,1
UY,ALVEOLITIS ALLERGIC,1
UY,AORTIC ANEURYSM,1
UY,ARTHRALGIA,1
UY,BACK PAIN,1
UY,BLINDNESS,1
UY,CARTILAGE INJURY,1
UY,CERVICAL DYSPLASIA,1
UY,COMPLICATION ASSOCIATED WITH DEVICE,1
UY,CORONARY ARTERY DILATATION,1
UY,COUGH,1
UY,CYST,1
UY,DEATH,1
UY,DIARRHOEA,1
UY,DISSEMINATED TUBERCULOSIS,1
UY,DRUG INEFFECTIVE,1
UY,DYSPNOEA,1
UY,FATIGUE,1
UY,FEMOROACETABULAR IMPINGEMENT,1
UY,FLUID RETENTION,1
UY,GASTRITIS EROSIVE,1
UY,GASTROINTESTINAL HAEMORRHAGE,1
UY,HAEMODYNAMIC INSTABILITY,1
UY,HAEMORRHAGIC ANAEMIA,1
UY,HEPATIC ENZYME INCREASED,1
UY,HIP ARTHROPLASTY,1
UY,HYPERSENSITIVITY,1
UY,HYPOGLYCAEMIA,1
UY,INFLAMMATION,1
UY,INFLUENZA,1
UY,INFLUENZA LIKE ILLNESS,1
UY,INTESTINAL OBSTRUCTION,1
UY,INTESTINAL STENOSIS,1
UY,JUVENILE IDIOPATHIC ARTHRITIS,1
UY,KNEE DEFORMITY,1
UY,LARGE INTESTINE POLYP,1
UY,LIGAMENT DISORDER,1
UY,MEDICATION ERROR,1
UY,MELANOCYTIC NAEVUS,1
UY,MUSCULOSKELETAL DISCOMFORT,1
UY,NEPHROTIC SYNDROME,1
UY,OEDEMA,1
UY,OVARIAN CYST,1
UY,OXYGEN SATURATION DECREASED,1
UY,PERITONITIS,1
UY,PLEURAL EFFUSION,1
UY,PNEUMONIA,1
UY,PREMATURE BABY,1
UY,PRODUCTIVE COUGH,1
UY,PSORIASIS,1
UY,PULMONARY HILAR ENLARGEMENT,1
UY,PULMONARY MASS,1
UY,RECTAL CANCER STAGE II,1
UY,RECTAL TENESMUS,1
UY,RECTAL ULCER,1
UY,RENAL FAILURE,1
UY,RENAL IMPAIRMENT,1
UY,RESPIRATORY FAILURE,1
UY,RESPIRATORY TRACT INFECTION VIRAL,1
UY,RHINITIS,1
UY,SCAR,1
UY,SEPTIC SHOCK,1
UY,SKIN MASS,1
UY,SUTURE RUPTURE,1
UY,THERAPEUTIC RESPONSE UNEXPECTED,1
UY,THROMBOCYTOPENIA,1
UY,TONSILLITIS,1
UY,TUBERCULOSIS,1
UY,URINARY TRACT INFECTION,1
UY,UTERINE INFECTION,1
UY,VOMITING,1
VE,TUBERCULIN TEST POSITIVE,35
VE,ARTHRALGIA,12
VE,INFLUENZA,7
VE,COUGH,5
VE,PNEUMONIA,5
VE,RENAL FAILURE,5
VE,URINARY TRACT INFECTION,5
VE,CHIKUNGUNYA VIRUS INFECTION,4
VE,DIARRHOEA,4
VE,HAEMOGLOBIN DECREASED,4
VE,INFARCTION,4
VE,PYREXIA,4
VE,RESPIRATORY ARREST,4
VE,VOMITING,4
VE,DEPRESSION,3
VE,EPISTAXIS,3
VE,GAIT DISTURBANCE,3
VE,HYPERSENSITIVITY,3
VE,MALAISE,3
VE,PAIN,3
VE,RESPIRATORY TRACT INFECTION,3
VE,RHEUMATOID ARTHRITIS,3
VE,WEIGHT DECREASED,3
VE,ABASIA,2
VE,ABDOMINAL PAIN,2
VE,ADVERSE DRUG REACTION,2
VE,ALOPECIA,2
VE,ARTHRITIS,2
VE,BACTERAEMIA,2
VE,BENIGN OVARIAN TUMOUR,2
VE,BREAST CYST,2
VE,BRONCHITIS,2
VE,CARPAL TUNNEL SYNDROME,2
VE,CEREBRAL DISORDER,2
VE,CEREBROVASCULAR ACCIDENT,2
VE,CONVULSION,2
VE,DRUG INEFFECTIVE,2
VE,DYSPHAGIA,2
VE,DYSPNOEA,2
VE,FALL,2
VE,FEBRILE NEUTROPENIA,2
VE,GASTRITIS,2
VE,GRANULOMA,2
VE,HEPATOTOXICITY,2
VE,HYPERTENSION,2
VE,HYSTERECTOMY,2
VE,IMPAIRED HEALING,2
VE,JOINT SWELLING,2
VE,MYCOSIS FUNGOIDES,2
VE,MYOCARDIAL INFARCTION,2
VE,OVARIAN CYST,2
VE,PANCYTOPENIA,2
VE,POISONING,2
VE,PSORIASIS,2
VE,PULMONARY OEDEMA,2
VE,RENAL CYST,2
VE,RESPIRATORY DISTRESS,2
VE,ROAD TRAFFIC ACCIDENT,2
VE,TACHYCARDIA,2
VE,THROMBOSIS,2
VE,TOOTH EXTRACTION,2
VE,UTERINE LEIOMYOMA,2
VE,ABDOMINAL ADHESIONS,1
VE,ABDOMINAL DISCOMFORT,1
VE,ABORTION SPONTANEOUS,1
VE,ACCIDENT,1
VE,ACUTE PULMONARY HISTOPLASMOSIS,1
VE,ADRENAL INSUFFICIENCY,1
VE,AMMONIA ABNORMAL,1
VE,ANGINA PECTORIS,1
VE,ANTINUCLEAR ANTIBODY POSITIVE,1
VE,APPENDICITIS,1
VE,ARTHROPATHY,1
VE,ASPHYXIA,1
VE,ASTHMA,1
VE,BENIGN NEOPLASM OF TESTIS,1
VE,BENIGN NEOPLASM OF THYROID GLAND,1
VE,BLADDER PROLAPSE,1
VE,BLISTER,1
VE,BLOOD GLUCOSE INCREASED,1
VE,BLOOD PRESSURE DECREASED,1
VE,BONE DISORDER,1
VE,BREAST ABSCESS,1
VE,BREAST CANCER FEMALE,1
VE,BULIMIA NERVOSA,1
VE,CARDIAC DISORDER,1
VE,CARDIAC FAILURE,1
VE,CARDIOVASCULAR DISORDER,1
VE,CELLULITIS,1
VE,CERVIX CARCINOMA,1
VE,CHOKING,1
VE,CHOLECYSTITIS,1
VE,CHRONIC TONSILLITIS,1
VE,CONFUSIONAL STATE,1
VE,CONTRAST MEDIA ALLERGY,1
VE,CORNEAL TRANSPLANT,1
VE,CRITICAL ILLNESS,1
VE,DEATH,1
VE,DECREASED APPETITE,1
VE,DEHYDRATION,1
VE,DERMATITIS ALLERGIC,1
VE,DEVICE BREAKAGE,1
VE,DEVICE DISLOCATION,1
VE,DIABETES MELLITUS INADEQUATE CONTROL,1
VE,DIABETIC FOOT,1
VE,DIZZINESS,1
VE,DRY EYE,1
VE,DYSPEPSIA,1
VE,EAR DISORDER,1
VE,ENDOMETRIAL CANCER,1
VE,ENTEROCOLITIS BACTERIAL,1
VE,EPILEPSY,1
VE,EYE INFECTION,1
VE,EYE OPERATION,1
VE,EYE PRURITUS,1
VE,EYE SWELLING,1
VE,FATIGUE,1
VE,FEELING COLD,1
VE,FEMUR FRACTURE,1
VE,FLUID RETENTION,1
VE,GALLBLADDER OPERATION,1
VE,GASTRITIS HAEMORRHAGIC,1
VE,GENERAL PHYSICAL HEALTH DETERIORATION,1
VE,GLAUCOMA,1
VE,GOITRE,1
VE,HAEMATURIA,1
VE,HAEMORRHAGE,1
VE,HAND FRACTURE,1
VE,HEADACHE,1
VE,HEARING IMPAIRED,1
VE,HENOCH-SCHONLEIN PURPURA,1
VE,HEPATIC STEATOSIS,1
VE,HEPATITIS,1
VE,HEPATITIS C,1
VE,HERNIA,1
VE,HERNIAL EVENTRATION,1
VE,HIP ARTHROPLASTY,1
VE,HIP FRACTURE,1
VE,HYPERHIDROSIS,1
VE,IMMUNOSUPPRESSION,1
VE,INCREASED UPPER AIRWAY SECRETION,1
VE,INFECTIOUS MONONUCLEOSIS,1
VE,INFLAMMATION,1
VE,INTERVERTEBRAL DISC COMPRESSION,1
VE,KIDNEY ENLARGEMENT,1
VE,LABORATORY TEST ABNORMAL,1
VE,LACRIMATION DECREASED,1
VE,LEIOMYOMA,1
VE,LIPOMA,1
VE,LIVER DISORDER,1
VE,LOWER LIMB FRACTURE,1
VE,LUNG DISORDER,1
VE,LUNG NEOPLASM,1
VE,LUNG NEOPLASM MALIGNANT,1
VE,LYMPHADENOPATHY,1
VE,MENSTRUAL DISORDER,1
VE,MOUTH ULCERATION,1
VE,MUCOSAL INFLAMMATION,1
VE,MULTI-ORGAN FAILURE,1
VE,MUSCULOSKELETAL DISCOMFORT,1
VE,MYOFASCIAL PAIN SYNDROME,1
VE,NASAL DISCOMFORT,1
VE,NASAL OBSTRUCTION,1
VE,NASAL TURBINATE ABNORMALITY,1
VE,NASOPHARYNGITIS,1
VE,NEOPLASM,1
VE,NERVE COMPRESSION,1
VE,NO THERAPEUTIC RESPONSE,1
VE,OCULAR HYPERAEMIA,1
VE,ODYNOPHAGIA,1
VE,ORAL MUCOSAL BLISTERING,1
VE,OSTEOARTHRITIS,1
VE,OSTEOPOROSIS,1
VE,OVARIAN CYST RUPTURED,1
VE,OVARIAN FIBROMA,1
VE,PAIN IN EXTREMITY,1
VE,PANCREATIC DISORDER,1
VE,PANCREATITIS,1
VE,PERIPHERAL SWELLING,1
VE,PHLEBITIS,1
VE,PLATELET COUNT DECREASED,1
VE,PLATELET COUNT INCREASED,1
VE,POLYCYSTIC OVARIES,1
VE,POLYDIPSIA,1
VE,POLYNEUROPATHY,1
VE,POSTOPERATIVE WOUND INFECTION,1
VE,PRODUCTIVE COUGH,1
VE,PRURITUS,1
VE,PSYCHOTIC DISORDER,1
VE,PULMONARY EMBOLISM,1
VE,PULMONARY FIBROSIS,1
VE,PULMONARY HAEMORRHAGE,1
VE,PULMONARY MASS,1
VE,PULMONARY MYCOSIS,1
VE,PULMONARY PAIN,1
VE,RENAL DISORDER,1
VE,RENAL FAILURE ACUTE,1
VE,RESPIRATORY FAILURE,1
VE,RESPIRATORY TRACT INFECTION BACTERIAL,1
VE,RHINORRHOEA,1
VE,SCAR,1
VE,SEIZURE,1
VE,SEPSIS,1
VE,SKIN TOXICITY,1
VE,SOFT TISSUE INFECTION,1
VE,SPINAL COLUMN INJURY,1
VE,SWELLING FACE,1
VE,SYNOVIAL CYST,1
VE,SYNOVIAL RUPTURE,1
VE,SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX ABNORMAL,1
VE,TENDON RUPTURE,1
VE,THROAT IRRITATION,1
VE,THROMBOPHLEBITIS,1
VE,TONSILLAR HAEMORRHAGE,1
VE,TONSILLITIS,1
VE,TOXICITY TO VARIOUS AGENTS,1
VE,TRANSAMINASES INCREASED,1
VE,TUBERCULIN TEST,1
VE,ULCER,1
VE,UMBILICAL HERNIA,1
VE,UNEVALUABLE EVENT,1
VE,UNINTENDED PREGNANCY,1
VE,UPPER LIMB FRACTURE,1
VE,URETHRAL DISORDER,1
VE,UTERINE DISORDER,1
VE,UTERINE HAEMORRHAGE,1
VE,VARICOSE ULCERATION,1
VE,VARICOSE VEIN,1
VE,VERTIGO,1
VE,VIRAL INFECTION,1
VE,VISION BLURRED,1
VE,YELLOW SKIN,1
VN,WHITE BLOOD CELL COUNT DECREASED,3
VN,ALANINE AMINOTRANSFERASE INCREASED,2
VN,ARTHRALGIA,2
VN,HAEMOGLOBIN DECREASED,2
VN,INFUSION RELATED REACTION,2
VN,NEUTROPENIA,2
VN,PLATELET COUNT DECREASED,2
VN,TUBERCULOSIS,2
VN,AFFERENT LOOP SYNDROME,1
VN,ANAEMIA,1
VN,ANAPHYLACTIC REACTION,1
VN,ASPARTATE AMINOTRANSFERASE INCREASED,1
VN,BLOOD PRESSURE IMMEASURABLE,1
VN,CATARACT,1
VN,CEREBRAL HAEMORRHAGE,1
VN,CHEST DISCOMFORT,1
VN,CHILLS,1
VN,CSF PRESSURE INCREASED,1
VN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
VN,DIARRHOEA,1
VN,DYSPNOEA,1
VN,ERYTHEMA,1
VN,EYE PAIN,1
VN,FATIGUE,1
VN,FRACTURE,1
VN,GALLBLADDER POLYP,1
VN,HEADACHE,1
VN,HEART RATE INCREASED,1
VN,HERPES ZOSTER,1
VN,HIP ARTHROPLASTY,1
VN,HISTIOCYTOSIS HAEMATOPHAGIC,1
VN,HYPOAESTHESIA,1
VN,INTENTIONAL PRODUCT MISUSE,1
VN,JOINT SWELLING,1
VN,LEUKAEMIA,1
VN,MIGRAINE,1
VN,MUSCLE STRAIN,1
VN,MYALGIA,1
VN,OCULAR HYPERAEMIA,1
VN,ORAL HERPES,1
VN,OSTEOARTHRITIS,1
VN,OTITIS MEDIA,1
VN,PAIN,1
VN,PARALYSIS,1
VN,PLATELET AGGREGATION,1
VN,PLEURAL EFFUSION,1
VN,PNEUMONITIS,1
VN,POLYNEUROPATHY,1
VN,PRODUCT USE ISSUE,1
VN,PYREXIA,1
VN,RASH,1
VN,RENAL FAILURE,1
VN,RESPIRATORY TRACT INFLAMMATION,1
VN,SEPSIS,1
VN,THERAPEUTIC RESPONSE DECREASED,1
VN,TOOTH ABSCESS,1
VN,TRANSAMINASES INCREASED,1
VN,TREMOR,1
VI,HEADACHE,1
VI,INTENTIONAL PRODUCT MISUSE,1
VI,PERIPHERAL SWELLING,1
